<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31909768</PMID>
      <DateRevised>
        <Year>2018</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-302X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>JACC. Basic to translational science</Title>
          <ISOAbbreviation>JACC Basic Transl Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The <i>Bslc2</i> <sup>-/-</sup> Mouse: Adding a Missing Phenotype to the Repertoire of HFpEF Animal Models.</ArticleTitle>
        <Pagination>
          <MedlinePgn>938-939</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacbts.2019.11.004</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Salloum</LastName>
            <ForeName>Fadi N</ForeName>
            <Initials>FN</Initials>
            <AffiliationInfo>
              <Affiliation>Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Toldo</LastName>
            <ForeName>Stefano</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JACC Basic Transl Sci</MedlineTA>
        <NlmUniqueID>101677259</NlmUniqueID>
        <ISSNLinking>2452-302X</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>JACC Basic Transl Sci. 2019 Nov 20;4(8):924-937</RefSource>
          <PMID Version="1">31909301</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HFpEF</Keyword>
        <Keyword MajorTopicYN="N">lean diabetic</Keyword>
        <Keyword MajorTopicYN="N">seipin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909768</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jacbts.2019.11.004</ArticleId>
        <ArticleId IdType="pii">S2452-302X(19)30359-6</ArticleId>
        <ArticleId IdType="pmc">PMC6938890</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31909769</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-302X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>JACC. Basic to translational science</Title>
          <ISOAbbreviation>JACC Basic Transl Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Paradoxical Cardiorenal Responses Following Acute Vasodilator/Natriuretic Treatment in Presystolic Heart Failure: Should We Be Surprised?</ArticleTitle>
        <Pagination>
          <MedlinePgn>973-975</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacbts.2019.11.002</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Polonsky</LastName>
            <ForeName>Tamar S</ForeName>
            <Initials>TS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bakris</LastName>
            <ForeName>George L</ForeName>
            <Initials>GL</Initials>
            <AffiliationInfo>
              <Affiliation>American Heart Association Comprehensive Hypertension Center, Section of Endocrinology, Diabetes and Metabolism, University of Chicago Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JACC Basic Transl Sci</MedlineTA>
        <NlmUniqueID>101677259</NlmUniqueID>
        <ISSNLinking>2452-302X</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>JACC Basic Transl Sci. 2019 Dec 23;4(8):962-972</RefSource>
          <PMID Version="1">31909303</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">glomerular filtration rate</Keyword>
        <Keyword MajorTopicYN="N">natriuresis</Keyword>
        <Keyword MajorTopicYN="N">nesiritide</Keyword>
        <Keyword MajorTopicYN="N">systolic heart failure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909769</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jacbts.2019.11.002</ArticleId>
        <ArticleId IdType="pii">S2452-302X(19)30357-2</ArticleId>
        <ArticleId IdType="pmc">PMC6938987</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31909770</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-302X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>JACC. Basic to translational science</Title>
          <ISOAbbreviation>JACC Basic Transl Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The New Promise of Mitochondrial Transplantation for Myocardial Recovery.</ArticleTitle>
        <Pagination>
          <MedlinePgn>889-890</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacbts.2019.11.009</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>W H Wilson</ForeName>
            <Initials>WHW</Initials>
            <AffiliationInfo>
              <Affiliation>Kaufman Center for Heart Failure and Recovery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JACC Basic Transl Sci</MedlineTA>
        <NlmUniqueID>101677259</NlmUniqueID>
        <ISSNLinking>2452-302X</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>JACC Basic Transl Sci. 2019 Dec 23;4(8):871-888</RefSource>
          <PMID Version="1">31909298</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">coronary blood flow</Keyword>
        <Keyword MajorTopicYN="N">heart failure</Keyword>
        <Keyword MajorTopicYN="N">ischemic-reperfusion</Keyword>
        <Keyword MajorTopicYN="N">mitochondrial transplant</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909770</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jacbts.2019.11.009</ArticleId>
        <ArticleId IdType="pii">S2452-302X(19)30409-7</ArticleId>
        <ArticleId IdType="pmc">PMC6938866</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31909771</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-302X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>JACC. Basic to translational science</Title>
          <ISOAbbreviation>JACC Basic Transl Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Targeting Muscles in the Brain to Enhance Cerebral Perfusion.</ArticleTitle>
        <Pagination>
          <MedlinePgn>959-961</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacbts.2019.11.003</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Jin-Moo</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and the Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Diwan</LastName>
            <ForeName>Abhinav</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Internal Medicine, Washington University School of Medicine and John Cochran Veterans Affairs Medical Center, St. Louis, Missouri.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zipfel</LastName>
            <ForeName>Gregory J</ForeName>
            <Initials>GJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery and the Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JACC Basic Transl Sci</MedlineTA>
        <NlmUniqueID>101677259</NlmUniqueID>
        <ISSNLinking>2452-302X</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>JACC Basic Transl Sci. 2019 Nov 27;4(8):940-958</RefSource>
          <PMID Version="1">31909302</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cerebral autoregulation</Keyword>
        <Keyword MajorTopicYN="N">chronic heart failure</Keyword>
        <Keyword MajorTopicYN="N">cystic fibrosis transmembrane regulator</Keyword>
        <Keyword MajorTopicYN="N">subarachnoid hemorrhage</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909771</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jacbts.2019.11.003</ArticleId>
        <ArticleId IdType="pii">S2452-302X(19)30358-4</ArticleId>
        <ArticleId IdType="pmc">PMC6938911</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31909772</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-302X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>JACC. Basic to translational science</Title>
          <ISOAbbreviation>JACC Basic Transl Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Therapeutic Treatment Approaches Post-Myocardial Infarction: A Bias Toward Formyl Peptide Receptor Agonists.</ArticleTitle>
        <Pagination>
          <MedlinePgn>921-923</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacbts.2019.11.008</ELocationID>
        <Abstract>
          <AbstractText Label="First Author" NlmCategory="UNASSIGNED"/>
          <AbstractText Label="Corresponding Author" NlmCategory="UNASSIGNED"/>
          <CopyrightInformation>© 2019 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zaman</LastName>
            <ForeName>Rysa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Epelman</LastName>
            <ForeName>Slava</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ted Rogers Centre for Heart Research, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JACC Basic Transl Sci</MedlineTA>
        <NlmUniqueID>101677259</NlmUniqueID>
        <ISSNLinking>2452-302X</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>JACC Basic Transl Sci. 2019 Nov 13;4(8):905-920</RefSource>
          <PMID Version="1">31909300</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">formyl peptide receptor</Keyword>
        <Keyword MajorTopicYN="N">macrophages</Keyword>
        <Keyword MajorTopicYN="N">monocytes</Keyword>
        <Keyword MajorTopicYN="N">myocardial infarction</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909772</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jacbts.2019.11.008</ArticleId>
        <ArticleId IdType="pii">S2452-302X(19)30408-5</ArticleId>
        <ArticleId IdType="pmc">PMC6938984</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909773</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2042-650X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2018</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Food &amp; function</Title>
          <ISOAbbreviation>Food Funct</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Baicalein reduces hepatic fat accumulation by activating AMPK in oleic acid-induced HepG2 cells and high-fat diet-induced non-insulin-resistant mice.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9fo02237f</ELocationID>
        <Abstract>
          <AbstractText>Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease worldwide; thus, a dietary supplement that can restrict hepatic fat accumulation is needed. Baicalein, a major component of Scutellaria baicalensis, is used as a dietary supplement in Eastern and Western cultures and can reduce hepatic fat accumulation. However, the detailed mechanism by which baicalein exerts this effect has yet to be elucidated in vivo and in vitro. In this study, we characterized the hepatic fat-lowering activity of baicalein and found that baicalein reduced hepatic fat accumulation by activating AMPK and suppressing SREBP1 cleavage, thus consequently inhibiting the transcriptional activity of SREBP1 and the synthesis of hepatic fat in oleic acid-induced HepG2 cells and high-fat diet-induced non-insulin-resistant mice. Moreover, baicalein improved NAFLD by decreasing TC, increasing HDLC, decreasing LDLC, affecting antioxidant activity, and exerting other effects. Therefore, the mechanism of baicalein with regard to NAFLD prevention and treatment might involve effects on multiple targets and pathways. Our study supports the use of baicalein as a dietary supplement due to its ability to reduce hepatic fat accumulation and to ameliorate NAFLD-related biochemical abnormalities.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Wenlong</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2560-652X</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Research, School of Life Sciences, Shandong University of Technology, Zibo, Shandong, People's Republic of China. 512649113@qq.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Panpan</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomedical Research, School of Life Sciences, Shandong University of Technology, Zibo, Shandong, People's Republic of China. 512649113@qq.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Tianqi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>College of Life Science, Yangtze University, Jingzhou, Hubei, People's Republic of China. jingdali_shenqi@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xudong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Weilong</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomass Resources, Taizhou University, Taizhou, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jingda</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>College of Life Science, Yangtze University, Jingzhou, Hubei, People's Republic of China. jingdali_shenqi@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Food Funct</MedlineTA>
        <NlmUniqueID>101549033</NlmUniqueID>
        <ISSNLinking>2042-6496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909773</ArticleId>
        <ArticleId IdType="doi">10.1039/c9fo02237f</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909774</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2042-650X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Food &amp; function</Title>
          <ISOAbbreviation>Food Funct</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Vanillin enhances the passive transport rate and absorption of drugs with moderate oral bioavailability in vitro and in vivo by affecting the membrane structure.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9fo02846c</ELocationID>
        <Abstract>
          <AbstractText>Vanillin is a popular flavoring agent in the food, tobacco, and perfume industries. In this paper, we investigated the effect of vanillin on the transport rates of drugs with different levels of permeability (acyclovir, hydrochlorothiazide, propranolol and carbamazepine) through a Caco-2 cell bidirectional transport experiment. We also explored the underlying mechanism using an in silico technique and fluorescence anisotropy measurements. The influence of vanillin on the pharmacokinetics of drugs whose transport rates were affected by vanillin in vitro was then studied in vivo. Results showed that vanillin (100 μM) increased the cumulative amount of passively transported drugs (2.1-fold of hydrochlorothiazide, 1.49-fold of propranolol, 1.35-fold of acyclovir, and 1.34-fold of carbamazepine) in vitro. Molecular dynamics simulations revealed that vanillin disordered the structure of the lipid bilayer and reduced the energy barrier of drugs across the center of the membrane. The anisotropy of TMA-DPH also decreased in Caco-2 cells after treatment with vanillin (25 and 100 μM) and indicated an increase in membrane fluidity, which was dose-dependent. An oral bioavailability study indicated that vanillin (100 mg kg-1) significantly enhanced the Cmax and AUC0-6 of hydrochlorothiazide by 1.42-fold and 1.28-fold, respectively, and slightly elevated the Cmax of propranolol. In conclusion, vanillin can significantly increase the absorption of drugs with moderate oral bioavailability in vitro and in vivo by loosening the membrane. Thus, the concurrent consumption of drugs with food containing vanillin may result in increased drug plasma concentration and pose potential health risks.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Wen'ge</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2266-3230</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Material Medical Integration and Transformation for Brain Disorders, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. viviansector@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Yingzhuo</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, Sichuan Cancer Hospital, Chengdu, 610011, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wen</LastName>
            <ForeName>Wen</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Material Medical Integration and Transformation for Brain Disorders, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. viviansector@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. mingming2199@aliyun.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jiasi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. mingming2199@aliyun.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiang</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. mingming2199@aliyun.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yinfan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. mingming2199@aliyun.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Shijun</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Material Medical Integration and Transformation for Brain Disorders, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. viviansector@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Simin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. mingming2199@aliyun.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Ping</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2863-7348</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Material Medical Integration and Transformation for Brain Disorders, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China. viviansector@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Food Funct</MedlineTA>
        <NlmUniqueID>101549033</NlmUniqueID>
        <ISSNLinking>2042-6496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909774</ArticleId>
        <ArticleId IdType="doi">10.1039/c9fo02846c</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909775</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9234</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dalton transactions (Cambridge, England : 2003)</Title>
          <ISOAbbreviation>Dalton Trans</ISOAbbreviation>
        </Journal>
        <ArticleTitle>"Old dog, new tricks": the lone pair effect inducing divergent optical responses in lead cyanurates containing π-bonds.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9dt04313f</ELocationID>
        <Abstract>
          <AbstractText>The stereochemically active lone pair (SCALP) effect of Pb2+ plays a vital role in enhancing the nonlinear optical response and engineering the band gap of lead-based materials with intriguing properties. Herein, we combined SCALP Pb2+ cations and π-conjugated (HC3N3O3)2- anions into one structure to investigate the tunable optical properties. Two lead cyanurates, namely, Pb3(HC3N3O3)2(OH)2 (I) and its partly cadmium-substituted analog Pb2Cd(HC3N3O3)2(OH)2 (II) were grown by the mild hydrothermal method. They exhibited greatly narrowed bandgaps and enhanced optical anisotropy resulting from the SCALP effect. In addition, divergent optical responses induced from the involved Pb (6s26p2) and Cd (4d105s2) were elaborated by a combination of experimental and theoretical analyses.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Xianghe</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-1185-2201</Identifier>
            <AffiliationInfo>
              <Affiliation>Beijing Center for Crystal Research and Development, Key Laboratory of Functional Crystals and Laser Technology, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China. xiamingjun@mail.ipc.ac.cn and Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Kaijin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Chemical Materials, China Academy of Engineering Physics, Mianyang 621900, China. wlyin@caep.cn and Physics and Space Science College, China West Normal University, Nanchong 637002, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-4932-1329</Identifier>
            <AffiliationInfo>
              <Affiliation>Beijing Center for Crystal Research and Development, Key Laboratory of Functional Crystals and Laser Technology, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China. xiamingjun@mail.ipc.ac.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Chemical Materials, China Academy of Engineering Physics, Mianyang 621900, China. wlyin@caep.cn and Physics and Space Science College, China West Normal University, Nanchong 637002, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Zheshuai</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Beijing Center for Crystal Research and Development, Key Laboratory of Functional Crystals and Laser Technology, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China. xiamingjun@mail.ipc.ac.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yin</LastName>
            <ForeName>Wenlong</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2660-0891</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Chemical Materials, China Academy of Engineering Physics, Mianyang 621900, China. wlyin@caep.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Mingjun</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8092-6150</Identifier>
            <AffiliationInfo>
              <Affiliation>Beijing Center for Crystal Research and Development, Key Laboratory of Functional Crystals and Laser Technology, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China. xiamingjun@mail.ipc.ac.cn and Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dalton Trans</MedlineTA>
        <NlmUniqueID>101176026</NlmUniqueID>
        <ISSNLinking>1477-9226</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909775</ArticleId>
        <ArticleId IdType="doi">10.1039/c9dt04313f</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909776</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1364-548X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemical communications (Cambridge, England)</Title>
          <ISOAbbreviation>Chem. Commun. (Camb.)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Optimization of a heterogeneous Pd-Cu/zeolite Y Wacker catalyst for ethylene oxidation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9cc08835k</ELocationID>
        <Abstract>
          <AbstractText>Exchanging low amounts of palladium with excess copper in a heterogeneous zeolite Y catalyst leads to high Wacker activity and mitigates activity loss by reducing the extent of palladium sintering. Employing periodic regenerative treatments in oxygen to remove carbon deposits and reoxidize palladium results in the partial (but reversible) recovery of the high initial activity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Imbao</LastName>
            <ForeName>Jerick</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-6468-0832</Identifier>
            <AffiliationInfo>
              <Affiliation>Paul Scherrer Institute, 5232 Villigen PSI, Switzerland. maarten.nachtegaal@psi.ch and Institute for Chemistry and Bioengineering, ETH Zurich, Vladimir-Prelog-Weg 1, 8093 Zurich, Switzerland. jeroen.vanbokhoven@chem.ethz.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Bokhoven</LastName>
            <ForeName>Jeroen A</ForeName>
            <Initials>JA</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-4166-2284</Identifier>
            <AffiliationInfo>
              <Affiliation>Paul Scherrer Institute, 5232 Villigen PSI, Switzerland. maarten.nachtegaal@psi.ch and Institute for Chemistry and Bioengineering, ETH Zurich, Vladimir-Prelog-Weg 1, 8093 Zurich, Switzerland. jeroen.vanbokhoven@chem.ethz.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nachtegaal</LastName>
            <ForeName>Maarten</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Paul Scherrer Institute, 5232 Villigen PSI, Switzerland. maarten.nachtegaal@psi.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Chem Commun (Camb)</MedlineTA>
        <NlmUniqueID>9610838</NlmUniqueID>
        <ISSNLinking>1359-7345</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909776</ArticleId>
        <ArticleId IdType="doi">10.1039/c9cc08835k</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909777</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2042-650X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Food &amp; function</Title>
          <ISOAbbreviation>Food Funct</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dietary fiber isolated from sweet potato residues promotes a healthy gut microbiome profile.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9fo01009b</ELocationID>
        <Abstract>
          <AbstractText>This study investigated the impact of dietary fiber from sweet potato residue (SPDF) on the diversity of the gut microbiota. An in vitro batch culture system simulating the human gut was used to understand the prebiotic role of SPDF. The results showed that SPDF mediated a significant increase in the concentrations of Bifidobacterium and Lactobacillus, whereas induced a significant decrease of Enterobacillus, Clostridium perfringens and Bacteroides. The prebiotic index and Bifidobacterium/Enterobacillus value were also significantly increased in SPDF groups compared to those of the control group, suggesting that SPDF had prebiotic effects. Furthermore, to investigate the effects of SPDF on the intestinal microecosystem, diets containing different concentrations of SPDF were used to feed Wistar rats for 4 weeks. 16S rRNA gene sequencing, short chain fatty acid quantification and physiochemical property analysis in the rat feces were then conducted. The results showed that SPDF significantly increased the Bacteroidetes to Firmicutes ratio at the phylum level and the amount of Akkermansia was also increased at the genus level, which was confirmed by qRT-PCR. The production of propionate and butyrate in the rat feces of both 3% and 15% SPDF groups was higher than that in the control group, which was further confirmed by the decrease of pH. Additionally, SPDF supplementation in this study resulted in a higher villus height to fossa depth ratio, which indicated improved digestion and absorption in the GI tract. Our findings support the utilization of SPDF from sweet potato residue in the development of potentially prebiotic food products for improving intestinal health.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Man</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-7878-7697</Identifier>
            <AffiliationInfo>
              <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 10048, China. tj-085@163.com wangjing@th.btbu.edu.cn and College of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province 221116, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xuezhi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>College of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province 221116, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Shengmin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Wilmar (Shanghai) Biotechnology Research &amp; Development Center Co., Ltd., Shanghai, 200137, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Thomas T Y</ForeName>
            <Initials>TTY</Initials>
            <AffiliationInfo>
              <Affiliation>Diet, Genomics and Immunology Lab, Beltsville Human Nutrition Research Center, ARS, USDA, Beltsville, MD 20705, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Sihan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>College of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province 221116, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Kunlong</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>College of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province 221116, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yongxin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province 221116, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tian</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2371-3153</Identifier>
            <AffiliationInfo>
              <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 10048, China. tj-085@163.com wangjing@th.btbu.edu.cn and College of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu Province 221116, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4896-0142</Identifier>
            <AffiliationInfo>
              <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 10048, China. tj-085@163.com wangjing@th.btbu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Food Funct</MedlineTA>
        <NlmUniqueID>101549033</NlmUniqueID>
        <ISSNLinking>2042-6496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909777</ArticleId>
        <ArticleId IdType="doi">10.1039/c9fo01009b</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909778</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9234</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Dalton transactions (Cambridge, England : 2003)</Title>
          <ISOAbbreviation>Dalton Trans</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Facile synthesis of a new Cu(ii) complex with an unsymmetrical ligand and its use as an O<sub>3</sub> donor metalloligand in the synthesis of Cu(ii)-Mn(ii) complexes: structures, magnetic properties, and catalytic oxidase activities.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9dt04315b</ELocationID>
        <Abstract>
          <AbstractText>A new, facile Cu(ii) template method has been employed for the unsymmetrical dicondensation of 1,2-ethylenediamine with salicylaldehyde and o-vanillin. The mononuclear complex, [CuL] (1), thus obtained, has been used as an O3 donor metalloligand for the synthesis of four new Cu(ii)-Mn(ii) complexes, [(CuL)MnCl2] (2), [(CuL)Mn(NO3)2(CH3OH)]n (3), {[(CuL)Mn(benz)(H2O)]2·(CuL)2(ClO4)2} (4) and [(CuL)Mn(benz)Cl]2 (5) (where benz = benzoate). Single-crystal structural analyses reveal that 2 is a dinuclear complex while complex 3 is polymeric with a repeating dinuclear [(CuL)Mn(NO3)2(CH3OH)] unit, linked via the nitrate ion. Both 4 and 5 are discrete tetranuclear complexes, where the dinuclear units [(CuL)Mn(benz)(H2O)] and [(CuL)Mn(benz)Cl] are connected by double benzoate and double chloride bridges, respectively. In complex 4, two monomeric [CuL] units are cocrystallized with the tetranuclear complex. An important difference in the structure of 4 from the other three complexes is that one solvent water molecule is coordinated to each Mn(ii) ion, which makes complex 4 catalytically very active towards mimicking catecholase and phenoxazinone synthase-like oxidation reactions. The turnover numbers (kcat) for the aerial oxidation of 3,5-di-tert-butylcatechol and o-aminophenol are 399 h-1 and 230 h-1, respectively. The evidence of the intermediate species in the mass spectra indicates possible heterometallic cooperation where the Mn(ii) center helps in substrate binding and Cu(ii) participates in the oxidation reactions with molecular oxygen. Cyclic voltammetry measurements suggest the reduction of Cu(ii) to Cu(i) during the catalytic process. Temperature-dependent dc molar magnetic susceptibility measurements reveal that complexes 2-5 are antiferromagnetically coupled with the exchange coupling constants (J) of J = -13.5 cm-1 and J = -13.5 cm-1 for 2 and 3, respectively, J1 = -12.6 cm-1 and J2 = -1.20 cm-1 for complex 4 and J1 = -13.24 cm-1 and J2 = 0.36 cm-1 for complex 5 as is expected from the Cu-O-Mn bridging angles.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dutta</LastName>
            <ForeName>Sabarni</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University College of Science, University of Calcutta, 92, A.P.C. Road, Kolkata 700 009, India. ghosh_59@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mayans</LastName>
            <ForeName>Júlia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Departament de Química Inorgànica I Orgànica, Secció Inorgànica and Institut de Nanosciència I Nanotecnologia (IN2UB), Martíi Franqués 1-11, 08028, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghosh</LastName>
            <ForeName>Ashutosh</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-2026-7565</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University College of Science, University of Calcutta, 92, A.P.C. Road, Kolkata 700 009, India. ghosh_59@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dalton Trans</MedlineTA>
        <NlmUniqueID>101176026</NlmUniqueID>
        <ISSNLinking>1477-9226</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909778</ArticleId>
        <ArticleId IdType="doi">10.1039/c9dt04315b</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909780</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1527-330X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Aesthetic surgery journal</Title>
          <ISOAbbreviation>Aesthet Surg J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Commentary on: Deep Cheek Fat Volumes and Midfacial Aging.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">sjz283</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/asj/sjz283</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pessa</LastName>
            <ForeName>Joel E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, University of Florida, Gainesville, FL.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Aesthet Surg J</MedlineTA>
        <NlmUniqueID>9707469</NlmUniqueID>
        <ISSNLinking>1090-820X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909780</ArticleId>
        <ArticleId IdType="pii">5697973</ArticleId>
        <ArticleId IdType="doi">10.1093/asj/sjz283</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909779</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1364-5528</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Analyst</Title>
          <ISOAbbreviation>Analyst</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nanoelectrochemical biosensors for monitoring ROS in cancer cells.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9an02390a</ELocationID>
        <Abstract>
          <AbstractText>Compared with normal cells, cancer or tumor cells have a specific microenvironment and apparently possess a relatively large amount of ROS/RNS, and their overexpression is one of the important reasons for tumor development and deterioration. Therefore, monitoring the changes of intracellular ROS/RNS can improve the awareness of the clinical manifestations of the disease, which will be beneficial for the early diagnosis of cancer and improving treatment efficiency. Herein, in this study we have exploited and constructed a novel strategy based on the SiC@C nanowire electrode for intracellular electrochemical analysis to monitor ROS levels in cancer or tumor cells. Firstly, the SiC@C nanowire electrode was utilized to detect the intracellular ROS radical changes involved in the relevant biological processes of cancer cells where fluorescent zinc nanoclusters were biosynthesized in situ in target cancer cells by using the intracellular microenvironment and specificity of these cancer cells. By combining a confocal fluorescence microscopy study simultaneously, our observations illustrate that accompanied by the apparent change of the intracellular ROS, these in situ biosynthesized fluorescent nanoclusters gradually accumulate inside the cytosolic area with the increase of the reaction time. Moreover, it is evident that the size of the SiC@C nanoelectrodes can match the single cell dimensions, and its unique high spatial resolution provides the possibility of relevant intracellular molecular detection. These nanoelectrochemical biosensors can be adopted to quantitatively determine the change of the ROS content in target single cells in the relevant biological microenvironment or during the in situ biosynthesis process, and are also beneficial for understanding the related mechanism of some specific biological processes including the in situ synthesis at the single cell level.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yihan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Huan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Hang</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Weihua</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8951-075X</Identifier>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jialei</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Xuerui</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Maonan</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8044-758X</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xuemei</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-6882-7774</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics (Chien-Shiung Wu Lab), School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. xuewang@seu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Analyst</MedlineTA>
        <NlmUniqueID>0372652</NlmUniqueID>
        <ISSNLinking>0003-2654</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909779</ArticleId>
        <ArticleId IdType="doi">10.1039/c9an02390a</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909781</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1367-4811</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bioinformatics (Oxford, England)</Title>
          <ISOAbbreviation>Bioinformatics</ISOAbbreviation>
        </Journal>
        <ArticleTitle>iq: an R package to estimate relative protein abundances from ion quantification in DIA-MS-based proteomics.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">btz961</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btz961</ELocationID>
        <Abstract>
          <AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">We present an R package called iq to enable accurate protein quantification for label-free data-independent acquisition (DIA) mass spectrometry-based proteomics, a recently developed global approach with superior quantitative consistency. We implement the popular maximal peptide ratio extraction module of the MaxLFQ algorithm, so far only applicable to data dependent acquisition mode using the software suite MaxQuant. Moreover, our implementation shows, for each protein separately, the validity of quantification over all samples. Hence, iq exports a state-of-the-art protein quantification algorithm to the emerging DIA mode in an open-source implementation.</AbstractText>
          <AbstractText Label="AVAILABILITY" NlmCategory="BACKGROUND">The open-source R package is available on CRAN, https://github.com/tvpham/iq/releases and oncoproteomics.nl/iq.</AbstractText>
          <AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="BACKGROUND">Supplementary data are available at Bioinformatics online.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pham</LastName>
            <ForeName>Thang V</ForeName>
            <Initials>TV</Initials>
            <AffiliationInfo>
              <Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Henneman</LastName>
            <ForeName>Alex A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jimenez</LastName>
            <ForeName>Connie R</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Bioinformatics</MedlineTA>
        <NlmUniqueID>9808944</NlmUniqueID>
        <ISSNLinking>1367-4803</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909781</ArticleId>
        <ArticleId IdType="pii">5697917</ArticleId>
        <ArticleId IdType="doi">10.1093/bioinformatics/btz961</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31909782</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1528-0020</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>130</Volume>
            <Issue>Suppl_1</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Dec</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Blood</Title>
          <ISOAbbreviation>Blood</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Exteriorisation of Mannoses on Human Erythrocyte Membrane Skeleton Provides 'Eat Me' Signals for Oxidatively Damaged Cells to be Cleared By Macrophages: A Pathway Mediating Hemolysis in Sickle Cell Disease.</ArticleTitle>
        <Pagination>
          <MedlinePgn>919</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1182/blood.V130.Suppl_1.919.919</ELocationID>
        <Abstract>
          <AbstractText Label="DISCLOSURES" NlmCategory="UNASSIGNED">Vickers: University of Aberdeen: Patents &amp; Royalties: About to apply for patent. Barker: University of Aberdeen: Employment, Patents &amp; Royalties: About to apply for patent. Cao: University of Aberdeen: Patents &amp; Royalties: About to apply for patent.</AbstractText>
          <CopyrightInformation>© 2017 by The American Society of Hematology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vickers</LastName>
            <ForeName>Mark A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Blood Transfusion Centre, ABERDEEN, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barker</LastName>
            <ForeName>Robert N</ForeName>
            <Initials>RN</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Huan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wassall</LastName>
            <ForeName>Heather J</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Forrester</LastName>
            <ForeName>Megan A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hall</LastName>
            <ForeName>Lindsay S</ForeName>
            <Initials>LS</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moss</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Scottish National Blood Transfusion Service, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Henderson</LastName>
            <ForeName>Sadie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Scottish National Blood Transfusion Service, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Konieczny</LastName>
            <ForeName>Gabriela</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beverly</LastName>
            <ForeName>Minter</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shepherd</LastName>
            <ForeName>Jenna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haslam</LastName>
            <ForeName>Stuart M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Life Sciences, Imperial College London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rees</LastName>
            <ForeName>David C</ForeName>
            <Initials>DC</Initials>
            <AffiliationInfo>
              <Affiliation>King's College London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilson</LastName>
            <ForeName>Heather M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tampakis</LastName>
            <ForeName>Dimitrios</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>Maria-Louise</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Blood</MedlineTA>
        <NlmUniqueID>7603509</NlmUniqueID>
        <ISSNLinking>0006-4971</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909782</ArticleId>
        <ArticleId IdType="pii">83709</ArticleId>
        <ArticleId IdType="doi">10.1182/blood.V130.Suppl_1.919.919</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909783</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1442-2050</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</Title>
          <ISOAbbreviation>Dis. Esophagus</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">doz095</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/dote/doz095</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Endoscopic eradication therapy of dysplastic Barrett's esophagus (BE) and early esophageal neoplasia has emerged as an effective treatment option. Data for the role of spray cryotherapy (SCT) in this setting is relatively limited.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the safety and long-term outcomes of SCT-based multimodal therapy in the management of dysplastic BE and early esophageal neoplasia.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">Single-center, retrospective, cohort study.</AbstractText>
          <AbstractText Label="SETTING" NlmCategory="METHODS">Academic, tertiary care center between August 2008 and February 2019.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective chart review was conducted of the prospectively maintained endoscopic cryotherapy database at our center. Fifty-seven patients were identified who underwent SCT treatment for dysplastic BE and esophageal or Gastro-esophageal (GE) junction adenocarcinoma during the study period. Primary outcome was complete eradication of intestinal metaplasia (CE-IM); secondary outcome was complete eradication of dysplasia (CE-D).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 171 SCT procedures were performed in 57 patients. The majority of patients were male (89.5%) with long-segment BE (93%; mean segment length 6.2 cm). Complete follow-up data was available for 56 of these 57 patients. 43.9% (25/57) of patients underwent radiofrequency ablation (RFA) during the course of treatment (e.g. after initiating SCT). 33.3% of patients (19/57) were RFA failures prior to SCT. Additionally, 68.4% (39/57) of patients underwent endoscopic resection (EMR) prior to SCT as part of our multimodal approach to treatment of BE dysplasia/neoplasia. Four patients (7%) are currently undergoing active ablation and/or EMR treatment. CE-IM was achieved in 75% (39/52) of patients, and CE-D in 98.1% (51/52). Mean duration of overall follow-up was 4.8 years, with mean CE-IM durability of 2.6 years.</AbstractText>
          <AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Single-center only, retrospective study design.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SCT-based multimodal endoscopic therapy can achieve very high CE-IM (75%) and CE-D (&gt;98%) rates in a high-risk population with esophageal dysplasia and/or neoplasia.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kaul</LastName>
            <ForeName>Vivek</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, University of Rochester Medical Center and Strong Memorial Hospital, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bittner</LastName>
            <ForeName>Krystle</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, University of Rochester Medical Center and Strong Memorial Hospital, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ullah</LastName>
            <ForeName>Asad</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, University of Rochester Medical Center and Strong Memorial Hospital, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kothari</LastName>
            <ForeName>Shivangi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, University of Rochester Medical Center and Strong Memorial Hospital, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Dis Esophagus</MedlineTA>
        <NlmUniqueID>8809160</NlmUniqueID>
        <ISSNLinking>1120-8694</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Barrett’s esophagus</Keyword>
        <Keyword MajorTopicYN="N">cryotherapy</Keyword>
        <Keyword MajorTopicYN="N">dysplasia</Keyword>
        <Keyword MajorTopicYN="N">endoscopic ablation</Keyword>
        <Keyword MajorTopicYN="N">esophageal adenocarcinoma</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909783</ArticleId>
        <ArticleId IdType="pii">5697877</ArticleId>
        <ArticleId IdType="doi">10.1093/dote/doz095</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909784</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1528-0020</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Blood</Title>
          <ISOAbbreviation>Blood</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Peripherally Inserted Central Catheters Lead to a High Risk of Venous Thromboembolism in Children.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">blood.2019002260</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1182/blood.2019002260</ELocationID>
        <Abstract>
          <AbstractText>The incidence of venous thromboembolism (VTE) in children has seen a sharp increase in recent years with the majority of cases secondary to central venous catheters (CVCs). Among CVCs, the number of peripherally inserted central catheters (PICCs) placed in children has risen significantly. In this multi-center, prospective, observational cohort study, we enrolled patients aged 6 months to 18 years with newly placed PICCs or tunneled lines (TLs) and compared the incidence of VTE between them. We also evaluated the incidence and risk factors of CVC-related VTE, central line associated bloodstream infections (CLABSIs) and catheter malfunctions in PICCs and TLs. A total of 1967 CVCs placed in 1742 unique subjects were included in the analysis. The incidence of catheter-related VTE was 5.9{plus minus}0.63%. The majority of the cases, 80%, were in subjects with PICCs which had a significantly higher risk of catheter-related VTE than subjects with TLs (HR=8.5, 95%CI, 3.1-23, p&lt;0.001). PICCs were also significantly more likely to have a CLABSI (HR=1.6, 95%CI: 1.2-2.2, p=0.002) and CVC malfunction (HR=2.0, 95%CI: 1.6-2.4, p&lt;0.001) compared to TLs. Increased risk of CVC-related VTE was found in patients with a prior history of VTE (HR=23, 95%CI: 4-127, p&lt;0.001), multi-lumen CVC (HR=3.9, 95%CI: 1.8-8.9, p=0.003) and leukemia (HR=3.5, 95%CI: 1.3-9.0, p=0.031). Children with PICCs had a significantly higher incidence of catheter-related VTE, CLABSI and CVC malfunction over TLs. The results suggest that pause be taken prior to placing a CVC, especially PICCs, due to the serious complications they have been shown to cause.</AbstractText>
          <CopyrightInformation>Copyright © 2019 American Society of Hematology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jaffray</LastName>
            <ForeName>Julie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Chlidren's Hospital Los Angeles, Los Angeles, California, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Witmer</LastName>
            <ForeName>Char</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Brien</LastName>
            <ForeName>Sarah H</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Nationwide Children's Hospital, Columbus, Ohio, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Diaz</LastName>
            <ForeName>Rosa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Texas Children's Hospital, Houston, Texas, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ji</LastName>
            <ForeName>Lingyun</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>University of Southern California, Keck School of Medicine, Los Angeles, California, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krava</LastName>
            <ForeName>Emily</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital Los Angeles, Los Angeles, California, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Young</LastName>
            <ForeName>Guy</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital Los Angeles, Los Angeles, California, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Blood</MedlineTA>
        <NlmUniqueID>7603509</NlmUniqueID>
        <ISSNLinking>0006-4971</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909784</ArticleId>
        <ArticleId IdType="pii">430029</ArticleId>
        <ArticleId IdType="doi">10.1182/blood.2019002260</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909785</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-3207</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The American journal of clinical nutrition</Title>
          <ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evidence of gut enteropathy and factors associated with undernutrition among slum-dwelling adults in Bangladesh.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">nqz327</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ajcn/nqz327</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Adult undernutrition (BMI &lt;18.5 kg/m2) is responsible for immune deficits, increased risk of disease burden, and higher rates of mortality. The prevalence of adult undernutrition in Bangladesh is substantial, but there have been few studies on the etiology of this condition for the inhabitants of urban slums.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to identify the factors associated with undernutrition among slum-dwelling adults in Bangladesh.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A case-control study was conducted in the Bauniabadh area of Dhaka, Bangladesh. 270 adult participants (135 cases with a BMI &lt;18.5 and 135 controls with a BMI between 18.5 and 24.9) aged 18-45 y were enrolled between October 2018 and January 2019. Sociodemographic variables, dietary diversity, micronutrient deficiencies, psychological symptoms, infection, and biomarkers of gut health were assessed to identify the factors associated with undernutrition using multivariable logistic regression analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A higher number of siblings [adjusted odds ratio (aOR): 1.39; 95% CI: 1.11, 1.77], increased self-reporting questionnaire-20 score (an instrument to screen mental health disorders and detect psychological symptoms) (aOR: 1.12; 95% CI: 1.04, 1.23), elevated fecal concentration of α-1 antitrypsin (aOR: 4.82; 95% CI: 1.01, 25.29), and anemia (aOR: 3.63; 95% CI: 1.62, 8.58) were positively associated with undernutrition in adults. Age (aOR: 0.90; 95% CI: 0.84, 0.96), dietary diversity score (aOR: 0.75; 95% CI: 0.56, 0.99), C-reactive protein (aOR: 0.82; 95% CI: 0.73, 0.92), Helicobacter pylori infection (aOR: 0.11; 95% CI: 0.05, 0.23), and always washing hands before eating or preparing foods (aOR: 0.33; 95% CI: 0.12, 0.87) were associated with reduced odds of undernutrition among the study population.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results indicate that undernutrition in slum-dwelling adults in Bangladesh is associated with numerous physiological and sociodemographic factors, including evidence of gastrointestinal inflammation and altered intestinal permeability.</AbstractText>
          <CopyrightInformation>Copyright © The Author(s) 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fahim</LastName>
            <ForeName>Shah Mohammad</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Das</LastName>
            <ForeName>Subhasish</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gazi</LastName>
            <ForeName>Md Amran</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alam</LastName>
            <ForeName>Md Ashraful</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahfuz</LastName>
            <ForeName>Mustafa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Life Sciences, University of Tampere, Tanpere, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Tahmeed</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Global Health, University of Washington, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Clin Nutr</MedlineTA>
        <NlmUniqueID>0376027</NlmUniqueID>
        <ISSNLinking>0002-9165</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BMI</Keyword>
        <Keyword MajorTopicYN="N">Bangladesh</Keyword>
        <Keyword MajorTopicYN="N">SRQ-20</Keyword>
        <Keyword MajorTopicYN="N">adults</Keyword>
        <Keyword MajorTopicYN="N">anemia</Keyword>
        <Keyword MajorTopicYN="N">dietary diversity</Keyword>
        <Keyword MajorTopicYN="N">gut enteropathy</Keyword>
        <Keyword MajorTopicYN="N">micronutrient deficiencies</Keyword>
        <Keyword MajorTopicYN="N">undernutrition</Keyword>
        <Keyword MajorTopicYN="N">α-1 antitrypsin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909785</ArticleId>
        <ArticleId IdType="pii">5698012</ArticleId>
        <ArticleId IdType="doi">10.1093/ajcn/nqz327</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909786</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1442-2050</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</Title>
          <ISOAbbreviation>Dis. Esophagus</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Changes in high-resolution manometric diagnosis over time: implications for clinical decision-making.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">doz094</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/dote/doz094</ELocationID>
        <Abstract>
          <AbstractText>Although High resolution esophageal manometry (HRM) is the gold standard to assess esophageal motility, little is known about the stability of the manometric diagnosis over time and its implications for management. To assess the stability and usefulness of repeat HRM in patients presenting with esophageal symptoms over time we performed this retrospective study of patients with esophageal symptoms. Medical records, questionnaires, and HRM tracing were independently reviewed using the Chicago classification. The primary objective was to assess the stability of the manometric diagnosis over time; secondary objective was its change (positive or negative). At least one repeat study was performed in 86 patients (36% women, ages 20-86, with mild to moderate symptoms), while 26 had a third procedure. Mean intervals between studies were 15 ± 1.6 months (for baseline v. first study) and 13 ± 0.8 months (for second to third study). Of the 27 patients initially with a normal study, 11 changed (five had esophago-gastric junction outflow obstruction [EGJOO], two diffuse esophageal spasm [DES], one jackhammer esophagus [JE], and three ineffective esophageal motility [IEM] [41% change]). Of the 24 patients with initial EGJOO, only nine retained it (65.2% change). Of nine patients with initial DES, four changed (44.4% change). Similarly, different diagnosis was seen in 7 of 24 initial IEM patients (22.7% change). Only one patient had achalasia initially and this remained stable. Additional changes were noted on a third HRM. Fluidity in the HRM diagnosis over time questions its validity at any timepoint and raises doubts about the need for intervention.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Triadafilopoulos</LastName>
            <ForeName>George</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Stanford Esophageal Multidimensional Program in Innovation and Research Excellence (SEMPIRE), Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamal</LastName>
            <ForeName>Afrin</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Stanford Esophageal Multidimensional Program in Innovation and Research Excellence (SEMPIRE), Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zikos</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Stanford Esophageal Multidimensional Program in Innovation and Research Excellence (SEMPIRE), Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nguyen</LastName>
            <ForeName>Linda</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Stanford Esophageal Multidimensional Program in Innovation and Research Excellence (SEMPIRE), Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clarke</LastName>
            <ForeName>John O</ForeName>
            <Initials>JO</Initials>
            <AffiliationInfo>
              <Affiliation>Stanford Esophageal Multidimensional Program in Innovation and Research Excellence (SEMPIRE), Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Dis Esophagus</MedlineTA>
        <NlmUniqueID>8809160</NlmUniqueID>
        <ISSNLinking>1120-8694</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dysphagia</Keyword>
        <Keyword MajorTopicYN="N">esophageal motility disorders</Keyword>
        <Keyword MajorTopicYN="N">high-resolution impedance manometry</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909786</ArticleId>
        <ArticleId IdType="pii">5697879</ArticleId>
        <ArticleId IdType="doi">10.1093/dote/doz094</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909787</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-4935</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bioscience reports</Title>
          <ISOAbbreviation>Biosci. Rep.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Overexpression of TGR5 alleviates myocardial ischemia/reperfusion injury via AKT/GSK-3β mediated inflammation and mitochondrial pathway.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">BSR20193482</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1042/BSR20193482</ELocationID>
        <Abstract>
          <AbstractText>Ischemia/reperfusion (I/R) injury reduces cell proliferation, triggers inflammation, promotes cell apoptosis and necrosis, which is the leading reasons of morbidity and mortality in patients with cardiac disease. TGR5 is shown to express in hearts, but its functional role in I/R-induced myocardial injury is unclear. In this study, we aimed to explore the underlying molecular mechanism of TGR5 in hypoxia/reoxygenation (H/R)-induced cardiomyocyte injury in vitro. The results showed that TGR5 was significantly up-regulated in H9C2 (rat cardiomyocyte cells) and HCM (human cardiomyocytes) after H/R. Overexpression of TGR5 significantly improved cell proliferation, alleviated apoptosis rate, the activities of caspase-3, cleaved caspases-3 and Bax protein expression levels, and increased Bcl-2 level. Overexpression of TGR5 significantly up-regulated ROS generation, stabilized the mitochondrial membrane potential (MMP), and reduced the concentration of intracellular Ca2+ as well as cytosolic translocation of mitochondrial cytochrome c (cyto-c). Meanwhile, overexpressed TGR5 also enhanced the mRNA and protein levels of interleukin (IL)-10, and decreased the mRNA and protein levels of interleukin (IL)-6 and tumor necrosis factor α (TNF-α). The shTGR5+H/R group followed opposite trends. In addition, overexpressed TGR5 induced an increase in the levels of p-AKT and p-GSK-3β. The protective effects of TGR5 were partially reversed by AKT inhibitor MK-2206. Taken together, these results suggest that TGR5 attenuates I/R-induced mitochondrial dysfunction and cell apoptosis as well as inflammation, and these protections may through AKT/GSK-3βpathway.</AbstractText>
          <CopyrightInformation>Copyright 2020 The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Junzhi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>The Ninth Hospital of Xi'an, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Ruining</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>The Ninth Hospital of Xi'an, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wan</LastName>
            <ForeName>Hong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>The TCM Encephalopathy Hospital of Xi'an, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biosci Rep</MedlineTA>
        <NlmUniqueID>8102797</NlmUniqueID>
        <ISSNLinking>0144-8463</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AKT/GSK-3β</Keyword>
        <Keyword MajorTopicYN="N">TGR5</Keyword>
        <Keyword MajorTopicYN="N">apoptosis</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">schemia/reperfusion (I/R)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909787</ArticleId>
        <ArticleId IdType="pii">221795</ArticleId>
        <ArticleId IdType="doi">10.1042/BSR20193482</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909788</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1537-6591</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title>
          <ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Risk prediction in people living with HIV: are we hitting the target?</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">ciz1219</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciz1219</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Galaviz</LastName>
            <ForeName>Karla I</ForeName>
            <Initials>KI</Initials>
            <AffiliationInfo>
              <Affiliation>Hubert Department of Global Health, Emory University, Atlanta, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gonzalez-Casanova</LastName>
            <ForeName>Ines</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Hubert Department of Global Health, Emory University, Atlanta, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alonso</LastName>
            <ForeName>Alvaro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Emory University, Atlanta, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Infect Dis</MedlineTA>
        <NlmUniqueID>9203213</NlmUniqueID>
        <ISSNLinking>1058-4838</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">mental health</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
        <Keyword MajorTopicYN="N">screening</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909788</ArticleId>
        <ArticleId IdType="pii">5695786</ArticleId>
        <ArticleId IdType="doi">10.1093/cid/ciz1219</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909789</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1367-4811</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Bioinformatics (Oxford, England)</Title>
          <ISOAbbreviation>Bioinformatics</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A novel method SEProm for prokaryotic promoter prediction based on DNA structure and energetics.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">btz941</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btz941</ELocationID>
        <Abstract>
          <AbstractText Label="MOTIVATION" NlmCategory="BACKGROUND">Despite conservation in general architecture of promoters and protein-DNA interaction interface of RNA polymerases among various prokaryotes, identification of promoter regions in the whole genome sequences remains a daunting challenge. The available tools for promoter prediction do not seem to address the problem satisfactorily, apparently because the biochemical nature of promoter signals is yet to be understood fully. Using twenty eight structural and three energetic parameters, we found that prokaryotic promoter regions have a unique structural and energy state, quite distinct from that of coding regions, and the information for this signature state is in-built in their sequences. We developed a novel promoter prediction tool from these thirty one parameters using various statistical techniques.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Here, we introduce SEProm, a novel tool that is developed by studying and utilizing the in-built structural and energy information of DNA sequences, which is applicable to all prokaryotes including archaea. Compared to five most recent, diverged and current best available tools, SEProm performs much better, predicting promoters with an 'F-value' of 82.04 and 'Precision' of 81.08. The next best 'F-value' was obtained with PromPredict (72.14) followed by BProm (68.37). On the basis of 'Precision' value, the next best 'Precision' was observed for Pepper (75.39) followed by PromPredict (72.01). SEProm maintained the lead even when comparison was done on two test organisms (not involved in training for SEProm).</AbstractText>
          <AbstractText Label="AVAILABILITY" NlmCategory="BACKGROUND">The software is freely available with easy to follow instructions (www.scfbio-iitd.res.in/software/TSS_Predict.jsp).</AbstractText>
          <AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="BACKGROUND">Supplementary data are available at Bioinformatics online.</AbstractText>
          <CopyrightInformation>© The Author(s) (2020). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mishra</LastName>
            <ForeName>Akhilesh</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Supercomputing Facility for Bioinformatics &amp; Computational Biology, Indian Institute of Technology Delhi, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Kusuma School of Biological Sciences, Indian Institute of Technology, Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dhanda</LastName>
            <ForeName>Sahil</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Supercomputing Facility for Bioinformatics &amp; Computational Biology, Indian Institute of Technology Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siwach</LastName>
            <ForeName>Priyanka</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Supercomputing Facility for Bioinformatics &amp; Computational Biology, Indian Institute of Technology Delhi, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, Chaudhary Devi Lal University, Sirsa, Haryana, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aggarwal</LastName>
            <ForeName>Shruti</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Supercomputing Facility for Bioinformatics &amp; Computational Biology, Indian Institute of Technology Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jayaram</LastName>
            <ForeName>B</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Supercomputing Facility for Bioinformatics &amp; Computational Biology, Indian Institute of Technology Delhi, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Kusuma School of Biological Sciences, Indian Institute of Technology, Delhi, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Indian Institute of Technology, Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Bioinformatics</MedlineTA>
        <NlmUniqueID>9808944</NlmUniqueID>
        <ISSNLinking>1367-4803</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909789</ArticleId>
        <ArticleId IdType="pii">5697916</ArticleId>
        <ArticleId IdType="doi">10.1093/bioinformatics/btz941</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909790</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1541-6100</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of nutrition</Title>
          <ISOAbbreviation>J. Nutr.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dietary Potassium Intake Remains Low and Sodium Intake Remains High, and Most Sodium is Derived from Home Food Preparation for Chinese Adults, 1991-2015 Trends.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">nxz332</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jn/nxz332</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intervention strategies to reduce sodium intake and increase potassium intake may decrease blood pressure; however, most are focused on reducing sodium in processed food globally.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We attempt to fill important gaps in understanding the dynamics of these dietary determinants of hypertension in China.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We used data on 29,926 adults aged ≥20 y between 1991 and 2015 from an ongoing cohort, the China Health and Nutrition Survey. We collected detailed diet data with use of weighing methods with 3 consecutive 24-h recalls. With panel data random-effects models, we analyzed factors associated with sodium and potassium intakes and sodium to potassium (Na/K) ratios.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sodium intake decreased from 6.3 g/d in 1991 to 4.1 g/d in 2015, still twice the tolerable upper intake recommended by the WHO. Potassium intake was 1.7 g/d in 1991 and 1.5 g/d in 2015, below half that recommended by the WHO. The Na/K ratio decreased from 4.1 (ratios in g) in 1991 to 3.1 in 2015, 5 times the recommendation of the WHO. More than two-thirds (67%) of sodium intake was from salt added during food preparation, with 8.8% from processed foods in 2015, up from 5.0% in 1991. The most at-risk populations lived in China's central region and rural areas, were middle aged, had lower educations, or were farmers.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sodium intake is very high across all regions in China. As part of sodium reduction efforts, China should target people living in the central region and adults aged above 60 whose sodium intakes are much higher. Strategies to decrease sodium intake and increase potassium intake should be different from those applied in the Western world where the major source is processed food. Reduced sodium higher potassium salts should become a major policy initiative in China.</AbstractText>
          <CopyrightInformation>Copyright © The Author(s) 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Du</LastName>
            <ForeName>Shufa</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition and Carolina Population Center, CB #8120 Carolina Square, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Huijun</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Bing</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Popkin</LastName>
            <ForeName>Barry M</ForeName>
            <Initials>BM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition and Carolina Population Center, CB #8120 Carolina Square, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Nutr</MedlineTA>
        <NlmUniqueID>0404243</NlmUniqueID>
        <ISSNLinking>0022-3166</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">China</Keyword>
        <Keyword MajorTopicYN="N">dietary trends</Keyword>
        <Keyword MajorTopicYN="N">hypertension</Keyword>
        <Keyword MajorTopicYN="N">potassium</Keyword>
        <Keyword MajorTopicYN="N">sodium</Keyword>
        <Keyword MajorTopicYN="N">sodium food sources</Keyword>
        <Keyword MajorTopicYN="N">sodium to potassium ratio</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909790</ArticleId>
        <ArticleId IdType="pii">5698014</ArticleId>
        <ArticleId IdType="doi">10.1093/jn/nxz332</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909791</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1464-3677</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal for quality in health care : journal of the International Society for Quality in Health Care</Title>
          <ISOAbbreviation>Int J Qual Health Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Quality healthcare in extreme adversity: Developing a framework for action.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">mzz131</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/intqhc/mzz131</ELocationID>
        <Abstract>
          <AbstractText>Quality issue: Improving quality of care has become a global health priority to improve health outcomes and strengthen health systems, particularly in the context of achieving universal health coverage. Initial assessment: The delivery of quality essential health services in settings of extreme adversity, such as fragile, conflict-affected, vulnerable or disaster contexts, has been identified as a high priority globally to address the massive level of need. Choice of solution: This paper provides an action framework to systematically address the quality of health services for state and non-state actors working in such settings. The framework is designed to be practical, comprehensible and simple in adoption and implementation. It describes challenges, a set of medical needs and population priorities, a menu of quality-related interventions, and a hierarchy of health system levels defining the roles and responsibilities of key actors. Conclusion: Optimizing the use of limited resources in delivering the best quality possible in 'the hardest of the hard settings' is imperative.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Leatherman</LastName>
            <ForeName>Sheila</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina 27599-7400, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tawfik</LastName>
            <ForeName>Linda</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina 27599-7400, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaff</LastName>
            <ForeName>Dilshad</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina 27599-7400, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaworski</LastName>
            <ForeName>Grace</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina 27599-7400, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Neilson</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Integrated Health Services, World Health Organization, Geneva 1211, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Letaief</LastName>
            <ForeName>Mondher</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>World Health Organization, Regional Office for the Eastern Mediterranean, Cairo 11371, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Syed</LastName>
            <ForeName>Shamsuzzoha Babar</ForeName>
            <Initials>SB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Integrated Health Services, World Health Organization, Geneva 1211, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Qual Health Care</MedlineTA>
        <NlmUniqueID>9434628</NlmUniqueID>
        <ISSNLinking>1353-4505</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">conflict</Keyword>
        <Keyword MajorTopicYN="N">extreme adversity</Keyword>
        <Keyword MajorTopicYN="N">fragile settings</Keyword>
        <Keyword MajorTopicYN="N">framework</Keyword>
        <Keyword MajorTopicYN="N">humanitarian crises</Keyword>
        <Keyword MajorTopicYN="N">interventions</Keyword>
        <Keyword MajorTopicYN="N">quality of care</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909791</ArticleId>
        <ArticleId IdType="pii">5697933</ArticleId>
        <ArticleId IdType="doi">10.1093/intqhc/mzz131</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909792</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1525-3163</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of animal science</Title>
          <ISOAbbreviation>J. Anim. Sci.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Immune system stimulation increases the irreversible loss of cysteine to taurine, but not sulfate, in starter pigs.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">skaa001</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jas/skaa001</ELocationID>
        <Abstract>
          <AbstractText>An isotope tracer study was conducted to evaluate the effects of ISS on the irreversible loss of Cys to Tau and SO4, as well as GSH synthesis, during the fed state in pigs. We previously have reported that ISS increases plasma Cys flux and the GSH synthesis rate at the tissue and whole-body levels in growing pigs. Thus, the current aricle presents the data on the irreversible loss of Cys during ISS in pigs. Ten gilts (BW 7.0 ± 0.12 kg) were feed restricted a SAA limiting diet and injected twice with either saline (n = 4) or increasing amounts of E.coli lipopolysaccharide (n = 6). The day after the second injection, a 5-h primed continuous intravenous infusion of 35S-Cys was conducted. Immune system stimulation reduced plasma Cys and total SAA concentrations (16 and 21%, respectively; P &lt;0.05). However, ISS had no effect on the plasma concentrations of Tau and SO4, nor did it affect the appearance of 35S in plasma Tau, plasma SO4, urinary Tau, or urinary SO4 (P &gt; 0.19). On a whole-body basis and including urinary excretion, ISS increased the appearance of 35S in Tau by 67% (P &lt;0.05), but tended to decrease the appearance of 35S in SO4 by 22% (P &lt; 0.09). Overall, the current findings indicate that during ISS, decreased plasma SAA concentrations and increased plasma Cys flux are attributed in part to increased rates of Cys conversion to Tau, but not Cys catabolism to SO4. Thus, increased utilization of Cys for the synthesis of immune system metabolites, such as GSH and Tau, is likely the main contributor to increased Cys flux during ISS in pigs. In addition, the irreversible loss of Cys during ISS is small and has a minimal impact on the daily SAA requirements of starter pigs.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rakhshandeh</LastName>
            <ForeName>Anoosh</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal and Food Science, Texas Tech University, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Lange</LastName>
            <ForeName>Cornelis F M</ForeName>
            <Initials>CFM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Htoo</LastName>
            <ForeName>John K</ForeName>
            <Initials>JK</Initials>
            <AffiliationInfo>
              <Affiliation>Evonik Nutrition &amp; Care GmbH, Rodenbacher Chaussee, Hanau, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rakhshandeh</LastName>
            <ForeName>Amanda R</ForeName>
            <Initials>AR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, South Plains College, Levelland, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Anim Sci</MedlineTA>
        <NlmUniqueID>8003002</NlmUniqueID>
        <ISSNLinking>0021-8812</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cysteine catabolism</Keyword>
        <Keyword MajorTopicYN="N">immune system stimulation</Keyword>
        <Keyword MajorTopicYN="N">pig</Keyword>
        <Keyword MajorTopicYN="N">sulfate</Keyword>
        <Keyword MajorTopicYN="N">taurine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909792</ArticleId>
        <ArticleId IdType="pii">5698019</ArticleId>
        <ArticleId IdType="doi">10.1093/jas/skaa001</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909793</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4637</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pain medicine (Malden, Mass.)</Title>
          <ISOAbbreviation>Pain Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Flipping the Pain Care Model: A Sociopsychobiological Approach to High-Value Chronic Pain Care.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">pnz336</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/pm/pnz336</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Much of the pain care in the United States is costly and associated with limited benefits and significant harms, representing a crisis of value. We explore the current factors that lead to low-value pain care within the United States and provide an alternate model for pain care, as well as an implementation example for this model that is expected to produce high-value pain care.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">From the perspective of aiming for high-value care (defined as care that maximizes clinical benefit while minimizing harm and cost), we describe the current evidence practice gap (EPG) for pain care in the United States, which has developed as current clinical care diverges from existing evidence. A discussion of the biomedical, biopsychosocial, and sociopsychobiological (SPB) models of pain care is used to elucidate the origins of the current EPG and the unconscious factors that perpetuate pain care systems despite poor results.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">An interprofessional pain team within the Veterans Health Administration is described as an example of a pain care system that has been designed to deliver high-value pain care and close the EPG by implementing the SPB model.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Adopting and implementing a sociopsychobiological model may be an effective approach to address the current evidence practice gap and deliver high-value pain care in the United States. The Phoenix VA Health Care System's Chronic Pain Wellness Center may serve as a template for providing high-value, evidence-based pain care for patients with high-impact chronic pain who also have medical, mental health, and opioid use disorder comorbidities.</AbstractText>
          <CopyrightInformation>2019 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mardian</LastName>
            <ForeName>Aram S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Phoenix VA Health Care System Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Arizona College of Medicine-Phoenix Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hanson</LastName>
            <ForeName>Eric R</ForeName>
            <Initials>ER</Initials>
            <AffiliationInfo>
              <Affiliation>Phoenix VA Health Care System Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Arizona College of Medicine-Phoenix Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villarroel</LastName>
            <ForeName>Lisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Arizona Department of Health Services Phoenix, Arizona, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karnik</LastName>
            <ForeName>Anita D</ForeName>
            <Initials>AD</Initials>
            <AffiliationInfo>
              <Affiliation>Phoenix VA Health Care System Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Arizona College of Medicine-Phoenix Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sollenberger</LastName>
            <ForeName>John G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>Phoenix VA Health Care System Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Arizona College of Medicine-Phoenix Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okvat</LastName>
            <ForeName>Heather A</ForeName>
            <Initials>HA</Initials>
            <AffiliationInfo>
              <Affiliation>Phoenix VA Health Care System Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dhanjal-Reddy</LastName>
            <ForeName>Amrita</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Phoenix VA Health Care System Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Arizona College of Medicine-Phoenix Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rehman</LastName>
            <ForeName>Shakaib</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Phoenix VA Health Care System Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Arizona College of Medicine-Phoenix Phoenix, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pain Med</MedlineTA>
        <NlmUniqueID>100894201</NlmUniqueID>
        <ISSNLinking>1526-2375</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Biomedical</Keyword>
        <Keyword MajorTopicYN="N">Biopsychosocial</Keyword>
        <Keyword MajorTopicYN="N">Evidence Practice Gap</Keyword>
        <Keyword MajorTopicYN="N">Sociopsychobiological</Keyword>
        <Keyword MajorTopicYN="N">Value</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909793</ArticleId>
        <ArticleId IdType="pii">5698036</ArticleId>
        <ArticleId IdType="doi">10.1093/pm/pnz336</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909794</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2047-217X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>GigaScience</Title>
          <ISOAbbreviation>Gigascience</ISOAbbreviation>
        </Journal>
        <ArticleTitle>CAMITAX: Taxon labels for microbial genomes.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">giz154</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/gigascience/giz154</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The number of microbial genome sequences is increasing exponentially, especially thanks to recent advances in recovering complete or near-complete genomes from metagenomes and single cells. Assigning reliable taxon labels to genomes is key and often a prerequisite for downstream analyses.</AbstractText>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">We introduce CAMITAX, a scalable and reproducible workflow for the taxonomic labelling of microbial genomes recovered from isolates, single cells, and metagenomes. CAMITAX combines genome distance-, 16S ribosomal RNA gene-, and gene homology-based taxonomic assignments with phylogenetic placement. It uses Nextflow to orchestrate reference databases and software containers and thus combines ease of installation and use with computational reproducibility. We evaluated the method on several hundred metagenome-assembled genomes with high-quality taxonomic annotations from the TARA Oceans project, and we show that the ensemble classification method in CAMITAX improved on all individual methods across tested ranks.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While we initially developed CAMITAX to aid the Critical Assessment of Metagenome Interpretation (CAMI) initiative, it evolved into a comprehensive software package to reliably assign taxon labels to microbial genomes. CAMITAX is available under Apache License 2.0 at https://github.com/CAMI-challenge/CAMITAX.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bremges</LastName>
            <ForeName>Andreas</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Inhoffenstraße 7, 38124 Braunschweig, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fritz</LastName>
            <ForeName>Adrian</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McHardy</LastName>
            <ForeName>Alice C</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Gigascience</MedlineTA>
        <NlmUniqueID>101596872</NlmUniqueID>
        <ISSNLinking>2047-217X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CAMI</Keyword>
        <Keyword MajorTopicYN="N">Docker</Keyword>
        <Keyword MajorTopicYN="N">Genome Taxonomy</Keyword>
        <Keyword MajorTopicYN="N">Nextflow</Keyword>
        <Keyword MajorTopicYN="N">Phylogenetic Placement</Keyword>
        <Keyword MajorTopicYN="N">Reproducible Research</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909794</ArticleId>
        <ArticleId IdType="pii">5698015</ArticleId>
        <ArticleId IdType="doi">10.1093/gigascience/giz154</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909795</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2393</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>QJM : monthly journal of the Association of Physicians</Title>
          <ISOAbbreviation>QJM</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Misconception about purple urine bag syndrome.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">hcz333</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcz333</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chong</LastName>
            <ForeName>Vui Heng</ForeName>
            <Initials>VH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, PMMPHAMB Hospital, Tutong, Brunei Darussalam.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>QJM</MedlineTA>
        <NlmUniqueID>9438285</NlmUniqueID>
        <ISSNLinking>1460-2393</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Purple urine bag syndrome</Keyword>
        <Keyword MajorTopicYN="N">urinary tract infection</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909795</ArticleId>
        <ArticleId IdType="pii">5697924</ArticleId>
        <ArticleId IdType="doi">10.1093/qjmed/hcz333</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909796</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2393</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>QJM : monthly journal of the Association of Physicians</Title>
          <ISOAbbreviation>QJM</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Response to letter to editor from Dr Vui Chong: misconception about purple urine bag syndrome.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">hcz334</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcz334</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Seak</LastName>
            <ForeName>Chen-June</ForeName>
            <Initials>CJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lim</LastName>
            <ForeName>Michelle Wan Xuan</ForeName>
            <Initials>MWX</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Medicine, International Medical University, Kuala Lumpur, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seak</LastName>
            <ForeName>Joanna Chen-Yeen</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Sarawak General Hospital, Kuching, Sarawak, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goh</LastName>
            <ForeName>Zhong Ning Leonard</ForeName>
            <Initials>ZNL</Initials>
            <AffiliationInfo>
              <Affiliation>Sarawak General Hospital, Kuching, Sarawak, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seak</LastName>
            <ForeName>Chen-Ken</ForeName>
            <Initials>CK</Initials>
            <AffiliationInfo>
              <Affiliation>Sarawak General Hospital, Kuching, Sarawak, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>QJM</MedlineTA>
        <NlmUniqueID>9438285</NlmUniqueID>
        <ISSNLinking>1460-2393</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Purple Urine bag syndrome (PUBS)</Keyword>
        <Keyword MajorTopicYN="N">urinary tract infection</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909796</ArticleId>
        <ArticleId IdType="pii">5697927</ArticleId>
        <ArticleId IdType="doi">10.1093/qjmed/hcz334</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909797</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4637</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pain medicine (Malden, Mass.)</Title>
          <ISOAbbreviation>Pain Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chronic Pain and Sleep Disturbances: A Pragmatic Review of Their Relationships, Comorbidities, and Treatments.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">pnz343</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/pm/pnz343</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this review is to answer three questions: 1) How are chronic pain severity and pain duration affected in patients with chronic pain and sleep disturbances that occur simultaneously? 2) What are common comorbidities and pain-related symptoms seen in patients with chronic pain and sleep disturbances? and 3) What are potentially effective pharmacological and nonpharmacological treatment options for both conditions?</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Ovid Medline and PubMed were searched. Search terms included sleep wake disorder, chronic pain, fibromyalgia, treatment outcome, psychotherapy, complementary therapies, and therapeutics. Studies that assessed outcomes between individuals with chronic pain and those with concurrent chronic pain and sleep disturbances were included. Randomized controlled clinical trials of treatments for both conditions were included.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen studies indicated that patients with both chronic pain and sleep disturbances have greater pain severity, longer duration of pain, greater disability, and are less physically active than those without sleep disturbances. Patients with both conditions are more likely to have concurrent depression, catastrophizing, anxiety, and suicidal ideation. Thirty-three randomized controlled trials assessed treatment for both chronic pain and sleep disturbances. Pregabalin was the most frequently studied medication, showing improvement in pain and sleep symptoms. Cognitive behavioral therapy for insomnia showed long-term improvement in sleep for patients with chronic pain.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Individuals with chronic pain and sleep disturbances have greater symptom severity, longer duration of symptoms, more disability, and additional comorbidities. Pharmacological and nonpharmacological treatments may be useful in the treatment of concurrent chronic pain and sleep disturbances, but further study is needed.</AbstractText>
          <CopyrightInformation>2019 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Husak</LastName>
            <ForeName>Aubrey J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bair</LastName>
            <ForeName>Matthew J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>VA Health Services Research and Development Center for Health Information and Communication Department of Veterans Affairs, Veterans Health Administration, Indianapolis, Indiana.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Regenstrief Institute Inc., Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pain Med</MedlineTA>
        <NlmUniqueID>100894201</NlmUniqueID>
        <ISSNLinking>1526-2375</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chronic Pain</Keyword>
        <Keyword MajorTopicYN="N">Comorbidity</Keyword>
        <Keyword MajorTopicYN="N">Insomnia</Keyword>
        <Keyword MajorTopicYN="N">Pain Outcomes</Keyword>
        <Keyword MajorTopicYN="N">Sleep Disturbances</Keyword>
        <Keyword MajorTopicYN="N">Treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909797</ArticleId>
        <ArticleId IdType="pii">5698034</ArticleId>
        <ArticleId IdType="doi">10.1093/pm/pnz343</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909798</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2393</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>QJM : monthly journal of the Association of Physicians</Title>
          <ISOAbbreviation>QJM</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Warthin's Tumor Mimicking Metastasis from Lung Cancer.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">hcz324</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcz324</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Biao</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lv</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Practice, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Zhi</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pu</LastName>
            <ForeName>Jiang-Tao</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Tian-Yang</ForeName>
            <Initials>TY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>QJM</MedlineTA>
        <NlmUniqueID>9438285</NlmUniqueID>
        <ISSNLinking>1460-2393</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909798</ArticleId>
        <ArticleId IdType="pii">5697925</ArticleId>
        <ArticleId IdType="doi">10.1093/qjmed/hcz324</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909799</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1945-7197</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of clinical endocrinology and metabolism</Title>
          <ISOAbbreviation>J. Clin. Endocrinol. Metab.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">dgz315</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1210/clinem/dgz315</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Arterial hypertension (AHT) is one of the most frequent pathologies in the general population. Subtypes of essential hypertension characterized by low-renin levels allowed the identification of two different clinical entities: aldosterone-mediated mineralocorticoid receptor (MR) activation and cortisol-mediated MR activation.</AbstractText>
          <AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">This review is based upon a search of Pubmed and Google Scholar databases, up to August 2019, for all publications relating to endocrine hypertension, apparent mineralocorticoid excess (AME) and cortisol (F) to cortisone (E) metabolism.</AbstractText>
          <AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">The spectrum of cortisol-mediated MR activation includes the classic AME to milder (nonclassic) forms of AME, the latter with a much higher prevalence (7.1%) than classic AME but different phenotype and genotype. NC-AME is mainly related to partial 11βHSD2 deficiency associated with genetic variations and epigenetic modifications (first hit) and potential additive actions of endogenous or exogenous inhibitors (i.e., glycyrrhetinic acid-like factors (GALFS)) and other factors (i.e. age, high sodium intake) (second hit). Subjects with NC-AME are characterized by high F/E ratio and low E levels, normal and elevated blood pressure, low-renin and increased urinary potassium excretion. NC-AME condition should benefits from low-sodium and potassium diet recommendations and monotherapy with MR antagonists.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NC-AME has higher prevalence and a milder phenotypical spectrum than AME. NC-AME etiology is associated to a first hit (gene &amp; epigene level) and an additive second hit. NC-AME subjects are candidates to be treated with MR antagonists aimed to improve blood pressure, end-organ damage and modulate the renin levels.</AbstractText>
          <CopyrightInformation>© Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Carvajal</LastName>
            <ForeName>Cristian A</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Millennium Institute on Immunology and Immunotherapy (IMII-ICM), Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro Traslacional de Endocrinología UC (CETREN).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tapia-Castillo</LastName>
            <ForeName>Alejandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Millennium Institute on Immunology and Immunotherapy (IMII-ICM), Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro Traslacional de Endocrinología UC (CETREN).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vecchiola</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Millennium Institute on Immunology and Immunotherapy (IMII-ICM), Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro Traslacional de Endocrinología UC (CETREN).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baudrand</LastName>
            <ForeName>Rene</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro Traslacional de Endocrinología UC (CETREN).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fardella</LastName>
            <ForeName>Carlos E</ForeName>
            <Initials>CE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Millennium Institute on Immunology and Immunotherapy (IMII-ICM), Santiago, Chile.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro Traslacional de Endocrinología UC (CETREN).</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Endocrinol Metab</MedlineTA>
        <NlmUniqueID>0375362</NlmUniqueID>
        <ISSNLinking>0021-972X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AME</Keyword>
        <Keyword MajorTopicYN="N">Nonclassic AME</Keyword>
        <Keyword MajorTopicYN="N">arterial hypertension</Keyword>
        <Keyword MajorTopicYN="N">low renin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909799</ArticleId>
        <ArticleId IdType="pii">5691192</ArticleId>
        <ArticleId IdType="doi">10.1210/clinem/dgz315</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909800</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-2393</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>QJM : monthly journal of the Association of Physicians</Title>
          <ISOAbbreviation>QJM</ISOAbbreviation>
        </Journal>
        <ArticleTitle>What Mae West might have had to say to today's doctors.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">hcaa001</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcaa001</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jolobe</LastName>
            <ForeName>Oscar M P</ForeName>
            <Initials>OMP</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Division, Manchester Medical Society, Simon Building, Brunswick Street, Manchester, M 13 9PL.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>QJM</MedlineTA>
        <NlmUniqueID>9438285</NlmUniqueID>
        <ISSNLinking>1460-2393</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909800</ArticleId>
        <ArticleId IdType="pii">5697926</ArticleId>
        <ArticleId IdType="doi">10.1093/qjmed/hcaa001</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909801</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1945-2403</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of analytical toxicology</Title>
          <ISOAbbreviation>J Anal Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An Optimized Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry Assay for the Determination of Ethyl Palmitate in Hair.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">bkz085</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jat/bkz085</ELocationID>
        <Abstract>
          <AbstractText>The use of hair as a matrix for the evaluation of chronic ethanol drinking behavior presents the advantage of a longer window of detection and higher specificity when compared to classical biochemical markers. The most recent recommendations the Society of Hair Testing (SOHT) indicate that ethyl palmitate (EtP) hair levels can be used to estimate the ethanol drinking behavior, alternatively to the combined measurement of four main fatty acid ethyl esters. In this study, solid-phase microextraction (SPME) conditions for the extraction of EtP from hair were optimized using response surface analysis, after a Box-Behnken experiment. Analyses were performed by GC-MS. The optimized HS-SPME conditions, using a PDMS-DVB (65 μm) fiber, were pre-adsorption time of 6 min, extraction time of 60 min and incubation temperature of 94°C. The linear range was 0.05 to 3 ng mg-1, with accuracy within 95.15-109.91%. Between-assay and within-assay precision were 8.58-12.53 and 6.12-6.82%, respectively. The extraction yield was 61.3-71.9%. The assay was applied to hair specimens obtained from 46 volunteers, all presenting EtP levels within the linear range of the assay. Using a statistically designed experiment, a sensitive SPME-GC-MS assay for the measurement of EtP in hair was developed and validated, requiring only 20 mg of hair.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bastiani</LastName>
            <ForeName>M F</ForeName>
            <Initials>MF</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Analytical Toxicology, Feevale University, Novo Hamburgo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute of Forensic Science and Technology (INCT Forense), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lizot</LastName>
            <ForeName>L L F</ForeName>
            <Initials>LLF</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Analytical Toxicology, Feevale University, Novo Hamburgo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute of Forensic Science and Technology (INCT Forense), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Da Silva</LastName>
            <ForeName>A C C</ForeName>
            <Initials>ACC</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Analytical Toxicology, Feevale University, Novo Hamburgo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hahn</LastName>
            <ForeName>R Z</ForeName>
            <Initials>RZ</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Analytical Toxicology, Feevale University, Novo Hamburgo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dries</LastName>
            <ForeName>S S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perassolo</LastName>
            <ForeName>M S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antunes</LastName>
            <ForeName>M V</ForeName>
            <Initials>MV</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Analytical Toxicology, Feevale University, Novo Hamburgo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Linden</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Analytical Toxicology, Feevale University, Novo Hamburgo, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute of Forensic Science and Technology (INCT Forense), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Novo Hamburgo, RS, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Toxicol</MedlineTA>
        <NlmUniqueID>7705085</NlmUniqueID>
        <ISSNLinking>0146-4760</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909801</ArticleId>
        <ArticleId IdType="pii">5697552</ArticleId>
        <ArticleId IdType="doi">10.1093/jat/bkz085</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909802</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4637</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pain medicine (Malden, Mass.)</Title>
          <ISOAbbreviation>Pain Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antiseptic Agents.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">pnz342</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/pm/pnz342</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Clark</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Rehabilitation and Regenerative Medicine Columbia University Medical Center, New York, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Napa Pain Institute Napa, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miller</LastName>
            <ForeName>David C</ForeName>
            <Initials>DC</Initials>
            <AffiliationInfo>
              <Affiliation>Rehabilitation and Regenerative Medicine Columbia University Medical Center, New York, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Napa Pain Institute Napa, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pain Med</MedlineTA>
        <NlmUniqueID>100894201</NlmUniqueID>
        <ISSNLinking>1526-2375</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909802</ArticleId>
        <ArticleId IdType="pii">5698029</ArticleId>
        <ArticleId IdType="doi">10.1093/pm/pnz342</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909803</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4637</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pain medicine (Malden, Mass.)</Title>
          <ISOAbbreviation>Pain Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinician Knowledge, Attitudes, and Practice Regarding Cannabis: Results from a National Veterans Health Administration Survey.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">pnz322</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/pm/pnz322</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cannabis is increasingly available and used for medical and recreational purposes, but few studies have assessed provider knowledge, attitudes, and practice regarding cannabis.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We administered a 47-item electronic survey to assess nationwide Veterans Health Administration (VHA) clinician knowledge, beliefs, attitudes, and practice regarding patients' use of cannabis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We received 249 completed surveys from 39 states and the District of Columbia. Fifty-five percent of respondents were female, 74% were white, and the mean age was 50 years. There were knowledge gaps among a substantial minority of respondents in specific areas: terminology, psychoactive effects of cannabis components, VHA policy, and evidence regarding benefits and harms of cannabis. Most respondents were likely or very likely to plan to taper opioids if urine drug testing was positive for tetra-hydro cannabinol (THC; 73%). A significantly greater proportion of respondents from states in which cannabis is illegal for any purpose (odds ratio [OR] = 4.9, 95% confidence interval [CI] = 2.0-10.8) or is recreationally illegal (OR = 5.0, 95% CI = 2.4-10.8) reported being likely or very likely to taper opioids as compared with respondents from states in which cannabis is legal for medical and recreational purposes.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among the sample, we found knowledge gaps, areas of discomfort discussing key aspects of cannabis use with their patients, and variation in practice regarding opioids in patients also using THC. These results suggest a need for more widespread clinician education about cannabis, as well as an opportunity to develop more robust guidance and evidence regarding management of patients using prescription opioids and cannabis concomitantly.</AbstractText>
          <CopyrightInformation>2019 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kansagara</LastName>
            <ForeName>Devan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Center to Improve Veteran Involvement in their Care (CIVIC) VA Portland Health Care System, Portland, Oregon.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Medicine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morasco</LastName>
            <ForeName>Benjamin J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>Center to Improve Veteran Involvement in their Care (CIVIC) VA Portland Health Care System, Portland, Oregon.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Psychiatry Oregon Health and Science University, Portland, Oregon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iacocca</LastName>
            <ForeName>Megan O</ForeName>
            <Initials>MO</Initials>
            <AffiliationInfo>
              <Affiliation>Center to Improve Veteran Involvement in their Care (CIVIC) VA Portland Health Care System, Portland, Oregon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bair</LastName>
            <ForeName>Matthew J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>VA Center for Health Information and Communication Indiana University School of Medicine and Regenstrief Institute, Indianapolis, Indiana.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hooker</LastName>
            <ForeName>Elizabeth R</ForeName>
            <Initials>ER</Initials>
            <AffiliationInfo>
              <Affiliation>Center to Improve Veteran Involvement in their Care (CIVIC) VA Portland Health Care System, Portland, Oregon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Becker</LastName>
            <ForeName>William C</ForeName>
            <Initials>WC</Initials>
            <AffiliationInfo>
              <Affiliation>Pain Research Informatics, Multimorbidities, &amp; Education (PRIME) Center of Innovation, VA Connecticut Healthcare System, West Haven, Virginia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pain Med</MedlineTA>
        <NlmUniqueID>100894201</NlmUniqueID>
        <ISSNLinking>1526-2375</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cannabis</Keyword>
        <Keyword MajorTopicYN="N">Clinician Attitudes</Keyword>
        <Keyword MajorTopicYN="N">Veterans Administration</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909803</ArticleId>
        <ArticleId IdType="pii">5698028</ArticleId>
        <ArticleId IdType="doi">10.1093/pm/pnz322</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909804</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2048-7207</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the Pediatric Infectious Diseases Society</Title>
          <ISOAbbreviation>J Pediatric Infect Dis Soc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Abdominal Tuberculosis in Children: Challenges, Uncertainty, and Confusion.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">piz093</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jpids/piz093</ELocationID>
        <Abstract>
          <AbstractText>The diagnosis of abdominal tuberculosis (TB) is challenging, and the prevalence of abdominal TB in children is likely underestimated. It may present with nonspecific abdominal symptoms and signs, but children who present with pulmonary TB may have additional abdominal subclinical involvement. Diagnosis is specifically challenging because none of the available diagnostic tools provide adequate sensitivity and specificity. In this review, we summarize the best available evidence on abdominal TB in children, covering the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment. We propose a diagnostic approach that could be followed for symptomatic children. We believe that a combination of investigations could be useful to both aid diagnosis and define the extent of the disease, and we propose that abdominal ultrasound should be used more frequently in children with possible TB and any abdominal symptoms. This neglected disease has received little attention to date, and further research is warranted.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sartoris</LastName>
            <ForeName>Giulia</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Sciences, Giannina Gaslini Institute, University of Genoa, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seddon</LastName>
            <ForeName>James A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, Imperial College London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rabie</LastName>
            <ForeName>Helena</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nel</LastName>
            <ForeName>Etienne D</ForeName>
            <Initials>ED</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schaaf</LastName>
            <ForeName>H Simon</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Pediatric Infect Dis Soc</MedlineTA>
        <NlmUniqueID>101586049</NlmUniqueID>
        <ISSNLinking>2048-7193</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">abdominal</Keyword>
        <Keyword MajorTopicYN="N">children</Keyword>
        <Keyword MajorTopicYN="N">gastrointestinal</Keyword>
        <Keyword MajorTopicYN="N">tuberculosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909804</ArticleId>
        <ArticleId IdType="pii">5697911</ArticleId>
        <ArticleId IdType="doi">10.1093/jpids/piz093</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909805</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1349-9157</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of radiation research</Title>
          <ISOAbbreviation>J. Radiat. Res.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The effects of short-term calorie restriction on mutations in the spleen cells of infant-irradiated mice.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">rrz078</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jrr/rrz078</ELocationID>
        <Abstract>
          <AbstractText>The risk of cancer due to exposure to ionizing radiation is higher in infants than in adults. In a previous study, the effect of adult-onset calorie restriction (CR) on carcinogenesis in mice after early-life exposure to X-rays was examined (Shang, Y, Kakinuma, S, Yamauchi, K, et al. Cancer prevention by adult-onset calorie restriction after infant exposure to ionizing radiation in B6C3F1 male mice. Int J Cancer. 2014; 135: 1038-47). The results showed that the tumor frequency was reduced in the CR group. However, the mechanism of tumor suppression by CR is not yet clear. In this study, we examined the effects of CR on radiation-induced mutations using gpt delta mice, which are useful to analyze mutations in various tissues throughout the whole body. Infant male mice (1-week old) were exposed to 3.8 Gy X-rays and fed a control (95 kcal/week/mouse) or CR (65 kcal/week/mouse) diet from adult stage (7-weeks old). Mice were sacrificed at the age of 7 weeks, 8 weeks and 100 days, and organs (spleen, liver, lung, thymus) were harvested. Mutations at the gpt gene in the DNA from the spleen were analyzed by using a gpt assay protocol that detects primarily point mutations in the gpt gene. The results showed that mutation frequencies were decreased in CR groups compared with non-CR groups. Sequence analysis of the gpt gene in mutants revealed a reduction in the G:C to T:A transversion in CR groups. Since it is known that 8-oxoguanine could result in this base substitution and that CR has an effect of reducing oxidative stress, these results indicate that the suppression of oxidative stress by CR is the cause of the reduction of this transversion.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kakomi</LastName>
            <ForeName>Saori</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate School of Science and Engineering, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakayama</LastName>
            <ForeName>Takafumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate School of Science and Engineering, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shang</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsuruoka</LastName>
            <ForeName>Chizuru</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sunaoshi</LastName>
            <ForeName>Masaaki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morioka</LastName>
            <ForeName>Takamitsu</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shimada</LastName>
            <ForeName>Yoshiya</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kakinuma</LastName>
            <ForeName>Shizuko</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate School of Science and Engineering, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tachibana</LastName>
            <ForeName>Akira</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate School of Science and Engineering, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Radiat Res</MedlineTA>
        <NlmUniqueID>0376611</NlmUniqueID>
        <ISSNLinking>0449-3060</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
          gpt delta mouse</Keyword>
        <Keyword MajorTopicYN="N">X-rays</Keyword>
        <Keyword MajorTopicYN="N">calorie restriction</Keyword>
        <Keyword MajorTopicYN="N">infant exposure</Keyword>
        <Keyword MajorTopicYN="N">mutagenesis</Keyword>
        <Keyword MajorTopicYN="N">oxidative stress</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909805</ArticleId>
        <ArticleId IdType="pii">5697479</ArticleId>
        <ArticleId IdType="doi">10.1093/jrr/rrz078</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909806</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2393</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>113</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>QJM : monthly journal of the Association of Physicians</Title>
          <ISOAbbreviation>QJM</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recreational drug use of over-the-counter (OTC) medication: loperamide and the opiate epidemic.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcz315</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Donnelly</LastName>
            <ForeName>Seamas C</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Editor-in-Chief, QJM.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>QJM</MedlineTA>
        <NlmUniqueID>9438285</NlmUniqueID>
        <ISSNLinking>1460-2393</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909806</ArticleId>
        <ArticleId IdType="pii">5697903</ArticleId>
        <ArticleId IdType="doi">10.1093/qjmed/hcz315</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909807</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1930-613X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Military medicine</Title>
          <ISOAbbreviation>Mil Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Military Health System Access to Care: Performance and Perceptions.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">usz463</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/milmed/usz463</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Access to care (ATC) is an important component of providing quality healthcare. Clinics need to be able to accurately measure access; however, patients' reports of access may be different from performance-based data gathered using administrative measures. The purpose of this research is to examine the relationship between ATC administrative data and patient survey results.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This is a retrospective study performed in military medical treatment facilities. Survey data were obtained from the Joint Outpatient Experience Survey (JOES), and administrative data were collected from the Military Health System Data Repository. The data period was from May 2016 through March 2017 for 135 parent Military Treatment Facilities. This study was approved under the Defense Health Agency Internal Review Board (IRB number: CDO-15-2025). The analyses compare JOES ATC measures to administrative ATC measures. Overall correlation analyses and multivariate regression analyses were performed in order to generate observable correlations between access and healthcare measures (both administrative measures and patient survey items).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Results show moderate correlations between the facilities' ATC survey items and administrative measures. These correlations were affected by the composition of the facility patient mix. The patient-based ATC measures from the JOES survey are related to administrative ATC measures collected and monitored by the facilities. In each final regression model, the coefficients for the ATC administrative variables were significant and negative which indicates that as the wait time for an appointment increases, patients' ratings of the time between scheduling and appointment dates declines and patients' assessments of being able to see a provider declines as well.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Measuring ATC is a vital step in ensuring the health of patients and the provision of high quality care. Both patient surveys and administrative data are widely used for measuring ATC. This study found statistically significant moderate associations between survey and administrative ATC measures, which remained significant even after controlling for patient characteristics of the facilities. These study results suggest that administrative data can provide an accurate assessment of access; however, survey items can be useful for diagnosing potential issues with access, such as call center scheduling and provider availability. Future studies should explore the gaps in research surrounding best practices at facilities which have high patient experience with access, and look at other survey measures related to access, such as telephone resources and web-based communication programs.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abiero</LastName>
            <ForeName>Beatrice</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Ipsos US Public Affairs, San Antonio, Texas 2020 K St NW Suite #410, Washington DC 20006.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beamer</LastName>
            <ForeName>Sharon</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>US Navy, Bureau of Medicine and Surgery, 7700 Arlington Blvd, Suite 5113, Falls Church VA 22042.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roshwalb</LastName>
            <ForeName>Alan</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Ipsos US Public Affairs, San Antonio, Texas 2020 K St NW Suite #410, Washington DC 20006.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sackett</LastName>
            <ForeName>Amanda</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Ipsos US Public Affairs, San Antonio, Texas 2020 K St NW Suite #410, Washington DC 20006.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gliner</LastName>
            <ForeName>Melissa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Defense Health Agency, 7700 Arlington Boulevard Suite 5101, Falls Church VA 22042-5101.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marshall-Aiyelawo</LastName>
            <ForeName>Kimberley</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Defense Health Agency, 7700 Arlington Boulevard Suite 5101, Falls Church VA 22042-5101.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ellison</LastName>
            <ForeName>Janice</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Air Force Medical Readiness Agency, 2261 Hughes Ave, Suite 153, Joint Base San Antonio, Lackland, TX 78236-1025.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McDavid</LastName>
            <ForeName>Terry</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>US Army, Office of the Surgeon General, 5109 Leesburg Pike, Falls Church VA 22041.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bannick</LastName>
            <ForeName>Richard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Defense Health Agency, 7700 Arlington Boulevard Suite 5101, Falls Church VA 22042-5101.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muraida</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Air Force Medical Readiness Agency, 2261 Hughes Ave, Suite 153, Joint Base San Antonio, Lackland, TX 78236-1025.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Mil Med</MedlineTA>
        <NlmUniqueID>2984771R</NlmUniqueID>
        <ISSNLinking>0026-4075</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909807</ArticleId>
        <ArticleId IdType="pii">5697932</ArticleId>
        <ArticleId IdType="doi">10.1093/milmed/usz463</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909808</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1945-2403</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of analytical toxicology</Title>
          <ISOAbbreviation>J Anal Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">bkz084</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jat/bkz084</ELocationID>
        <Abstract>
          <AbstractText>Synthetic cannabinoids pose significant threats to public health and safety, as their implications in overdose and adverse events continue to arise in United States and around the world. Synthetic cannabinoids have seen several generations of chemically diverse structural elements, impacting potency and effects. These factors create new analytical challenges for forensic laboratories. This report describes an efficient liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) assay for the identification of synthetic cannabinoid parent compounds and metabolites, including real-time identification of emergent compounds, using a SCIEX TripleTOF® 5600+ with non-targeted SWATH® acquisition. Method validation evaluated precision/accuracy, limits of detection, interferences, processed sample stability and carryover, for which 19 parent compounds and 19 metabolites were tested. To demonstrate feasibility, de-identified blood sample extracts were acquired from a large forensic toxicology laboratory and analyzed using the validated LC-QTOF-MS assay. In mid-2018, 200 blood extracts were analyzed, demonstrating a 19% positivity rate with &gt; 94% agreement rate with original testing. In addition, three newly discovered synthetic cannabinoids were identified, including 5F-MDMB-PICA, 4-cyano CUMYL-BUTINACA and 5F-EDMB-PINACA. These synthetic cannabinoids were previously unreported in forensic toxicology casework in the United States. 5F-MDMB-PICA has become the most prevalent synthetic cannabinoid in United States, as of early 2019. These results demonstrate the effectiveness of this assay and workflow in the identification and characterization of synthetic cannabinoids, as well as the usefulness of sample-mining using non-targeted mass acquisition by LC-QTOF-MS for the discovery of NPS. High resolution mass spectrometry should be considered when developing new or novel assays for synthetic cannabinoids.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Krotulski</LastName>
            <ForeName>Alex J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Forensic Science Research and Education (CFSRE), Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohr</LastName>
            <ForeName>Amanda L A</ForeName>
            <Initials>ALA</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Forensic Science Research and Education (CFSRE), Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Logan</LastName>
            <ForeName>Barry K</ForeName>
            <Initials>BK</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Forensic Science Research and Education (CFSRE), Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NMS Labs, 200 Welsh Rd, Horsham, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Toxicol</MedlineTA>
        <NlmUniqueID>7705085</NlmUniqueID>
        <ISSNLinking>0146-4760</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909808</ArticleId>
        <ArticleId IdType="pii">5623010</ArticleId>
        <ArticleId IdType="doi">10.1093/jat/bkz084</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909809</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1541-6100</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of nutrition</Title>
          <ISOAbbreviation>J. Nutr.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Replacing Saturated Fats with Unsaturated Fats from Walnuts or Vegetable Oils Lowers Atherogenic Lipoprotein Classes Without Increasing Lipoprotein(a).</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">nxz313</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jn/nxz313</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Walnuts have established lipid-/lipoprotein-lowering properties; however, their effect on lipoprotein subclasses has not been investigated. Furthermore, the mechanisms by which walnuts improve lipid/lipoprotein concentrations are incompletely understood.</AbstractText>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We aimed to examine, as exploratory outcomes of this trial, the effect of replacing SFAs with unsaturated fats from walnuts or vegetable oils on lipoprotein subclasses, cholesterol efflux, and proprotein convertase subtilisin/kexin type 9 (PCSK9).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A randomized, crossover, controlled-feeding study was conducted in individuals at risk of cardiovascular disease (CVD) (n = 34; 62% men; mean ± SD age 44 ± 10 y; BMI: 30.1 ± 4.9 kg/m2). After a 2-wk run-in diet (12% SFAs, 7% PUFAs, 12% MUFAs), subjects consumed the following diets, in randomized order, for 6 wk: 1) walnut diet (WD) [57-99 g/d walnuts, 7% SFAs, 16% PUFAs [2.7% α-linolenic acid (ALA)], 9% MUFAs]; 2) walnut fatty acid-matched diet [7% SFAs, 16% PUFAs (2.6% ALA), 9% MUFAs]; and 3) oleic acid replaces ALA diet (ORAD) [7% SFAs, 14% PUFAs (0.4% ALA); 12% MUFAs] (all percentages listed are of total kilocalories ). Serum collected after the run-in (baseline) and each diet period was analyzed for lipoprotein classes and subclasses (vertical auto profile), cholesterol efflux, and PCSK9. Linear mixed models were used for data analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with the ORAD, total cholesterol (mean ± SEM -8.9± 2.3 mg/dL; -5.1%; P &lt; 0.001), non-HDL cholesterol (-7.4 ± 2.0 mg/dL; -5.4%; P = 0.001), and LDL cholesterol (-6.9 ± 1.9 mg/dL; -6.5%; P = 0.001) were lower after the WD; no other pairwise differences existed. There were no between-diet differences for HDL-cholesterol or LDL-cholesterol subclasses. Lipoprotein(a) [Lp(a)], cholesterol efflux, and PCSK9 were unchanged after the diets.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In individuals at risk of CVD, replacement of SFAs with unsaturated fats from walnuts or vegetable oils improved lipid/lipoprotein classes, including LDL-cholesterol, non-HDL cholesterol, and total cholesterol, without an increase in Lp(a). These improvements were not explained by changes in cholesterol efflux capacity or PCSK9. This trial was registered at clinicaltrials.gov as NCT01235832.</AbstractText>
          <CopyrightInformation>Copyright © The Author(s) 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tindall</LastName>
            <ForeName>Alyssa M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kris-Etherton</LastName>
            <ForeName>Penny M</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Petersen</LastName>
            <ForeName>Kristina S</ForeName>
            <Initials>KS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT01235832</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Nutr</MedlineTA>
        <NlmUniqueID>0404243</NlmUniqueID>
        <ISSNLinking>0022-3166</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PCSK9</Keyword>
        <Keyword MajorTopicYN="N">cholesterol efflux</Keyword>
        <Keyword MajorTopicYN="N">lipids</Keyword>
        <Keyword MajorTopicYN="N">lipoproteins</Keyword>
        <Keyword MajorTopicYN="N">walnut</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909809</ArticleId>
        <ArticleId IdType="pii">5698016</ArticleId>
        <ArticleId IdType="doi">10.1093/jn/nxz313</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909810</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1574-6968</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>FEMS microbiology letters</Title>
          <ISOAbbreviation>FEMS Microbiol. Lett.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>DNA sequencing reveals bacterial communities in midgut and other parts of the larvae of Spodoptera exigua Hubner (Lepidoptera: Noctuidae).</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">fnaa002</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/femsle/fnaa002</ELocationID>
        <Abstract>
          <AbstractText>Gut microbiota had been suggested as an important component of host defense. However, microbiota in other parts of the body have rarely been characterized. In our present work, we give a detailed view of the body of S. exigua larvae, the midgut with intestinal contents (MG), midgut excluding intestinal contents (PM), intestinal contents (IC), and remaining parts excluding the MG (RM), with the objective of revealing the complexity of microorganisms and comparing the biodiversity of the S. exigua larvae-associated microbiota. Our results provide the first evidence that 3rd and 5th larvae samples of S.exigua were dominated by members of the phyla Firmicutes and Proteobacteria. In addition, there were no obvious differences in relative abundances of microbiota among MG, PM and RM at the phylum level. MG3 and MG5 (nearly RM5) harbored the richest microbial community, with much higher abundance of Halomonas, Pseudomonas and Methylobacterium, respectively. Intestinal contents contained the lowest diversity and highest abundance of Enterococcus. Knowledge of the bacteria in a major herbivorous insect, such as S. exigua, can facilitate the acquisition of special biological resources for agricultural pest control.</AbstractText>
          <CopyrightInformation>© FEMS 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Xueke</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Cotton Research, Chinese Academy of Agricultural Sciences, Anyang, Henan 455000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Wendan</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Junyu</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Lijuan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Cotton Research, Chinese Academy of Agricultural Sciences, Anyang, Henan 455000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ji</LastName>
            <ForeName>Jichao</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Cotton Research, Chinese Academy of Agricultural Sciences, Anyang, Henan 455000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Xiangzhen</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Kaixin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shuai</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Cotton Research, Chinese Academy of Agricultural Sciences, Anyang, Henan 455000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Jinjie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Zhengzhou Reseach Base, State Key Laboratory of Cotton Biology, Zhengzhou University, 4550001, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Cotton Research, Chinese Academy of Agricultural Sciences, Anyang, Henan 455000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>FEMS Microbiol Lett</MedlineTA>
        <NlmUniqueID>7705721</NlmUniqueID>
        <ISSNLinking>0378-1097</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
          Enterococcus
        </Keyword>
        <Keyword MajorTopicYN="N">
          Spodoptera exigua
        </Keyword>
        <Keyword MajorTopicYN="N">3rd and 5th larvae</Keyword>
        <Keyword MajorTopicYN="N">Firmicutes</Keyword>
        <Keyword MajorTopicYN="N">Gut microbiota</Keyword>
        <Keyword MajorTopicYN="N">Proteobacteria</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909810</ArticleId>
        <ArticleId IdType="pii">5697957</ArticleId>
        <ArticleId IdType="doi">10.1093/femsle/fnaa002</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909811</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1541-6100</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of nutrition</Title>
          <ISOAbbreviation>J. Nutr.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Provision of Lipid-Based Nutrient Supplements to Mothers During Pregnancy and 6 Months Postpartum and to Their Infants from 6 to 18 Months Promotes Infant Gut Microbiota Diversity at 18 Months of Age but Not Microbiota Maturation in a Rural Malawian Setting: Secondary Outcomes of a Randomized Trial.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">nxz298</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jn/nxz298</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diet may alter the configuration of gut microbiota, but the impact of prenatal and postnatal nutritional interventions on infant gut microbiota has not been investigated.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We evaluated whether providing lipid-based nutrient supplements (LNSs) to mother-infant dyads promotes a more diverse and mature infant gut microbiota, compared to maternal supplementation with multiple micronutrients (MMN) or iron and folic acid (IFA).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled 869 pregnant women in a randomized trial in Malawi. There were 3 study groups, with women receiving 1 MMN capsule daily during pregnancy and 6 mo postpartum, or 1 LNS sachet (20 g) daily during pregnancy and 6 mo postpartum, or 1 IFA capsule daily (during pregnancy) then a placebo daily (postpartum). Infants in the LNS group received LNS from 6 to 18 mo; infants in the other groups did not receive supplements. The infants' fecal microbiota were characterized by PCR amplification and sequencing of the bacterial 16S rRNA gene (variable region 4). The primary outcomes were microbiota α diversity and maturation [as microbiota-for-age z score (MAZ)]. Specific associations of taxa with intervention were established with indicator species analysis (ISA).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Primary outcomes did not differ between IFA and MMN groups, so these groups were combined (IFA + MMN). Mean ± SD α diversity was higher in the LNS group at 18 mo for Shannon index [3.01 ± 0.57 (LNS) compared with 2.91 ± 0.60 (IFA + MMN), P = 0.032] and Pielou's evenness index [0.61 ± 0.08 (LNS) compared with 0.60 ± 0.09 (IFA + MMN), P = 0.043]; no significant differences were observed at 1, 6, 12, or 30 mo. MAZ and β diversity did not differ at any age. We found 10 and 3 operational taxonomic units (OTUs) positively associated with LNS and IFA + MMN, respectively; however, these associations became nonsignificant following false discovery rate correction at 10%.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prenatal and postnatal LNS intake promoted infant gut microbiota diversity at 18 mo, after 12 mo of child supplementation, but did not alter microbiota maturation. This trial was registered at clinicaltrials.gov as NCT01239693.</AbstractText>
          <CopyrightInformation>Copyright © The Author(s) 2020.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kamng'ona</LastName>
            <ForeName>Arox W</ForeName>
            <Initials>AW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, University of Malawi, College of Medicine, Blantyre, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Young</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Global Nutrition and Department of Nutrition, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arnold</LastName>
            <ForeName>Charles D</ForeName>
            <Initials>CD</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Global Nutrition and Department of Nutrition, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patson</LastName>
            <ForeName>Noel</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health and Family Medicine, University of Malawi, College of Medicine, Blantyre, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jorgensen</LastName>
            <ForeName>Josh M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Global Nutrition and Department of Nutrition, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kortekangas</LastName>
            <ForeName>Emma</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Child Health Research, University of Tampere Faculty of Medicine and Life Sciences, 33100 Tampere, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chaima</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health and Family Medicine, University of Malawi, College of Medicine, Blantyre, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malamba</LastName>
            <ForeName>Chikondi</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health and Family Medicine, University of Malawi, College of Medicine, Blantyre, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ashorn</LastName>
            <ForeName>Ulla</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Child Health Research, University of Tampere Faculty of Medicine and Life Sciences, 33100 Tampere, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheung</LastName>
            <ForeName>Yin B</ForeName>
            <Initials>YB</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Health Services &amp; Systems Research and Center for Quantitative Medicine, Duke-NUS Medical School, Singapore 169857.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ashorn</LastName>
            <ForeName>Per</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Child Health Research, University of Tampere Faculty of Medicine and Life Sciences, 33100 Tampere, Finland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Tampere University Hospital, 33520 Tampere, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maleta</LastName>
            <ForeName>Kenneth</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health and Family Medicine, University of Malawi, College of Medicine, Blantyre, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dewey</LastName>
            <ForeName>Kathryn G</ForeName>
            <Initials>KG</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Global Nutrition and Department of Nutrition, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT01239693</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Nutr</MedlineTA>
        <NlmUniqueID>0404243</NlmUniqueID>
        <ISSNLinking>0022-3166</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">gut microbiota</Keyword>
        <Keyword MajorTopicYN="N">infants diet</Keyword>
        <Keyword MajorTopicYN="N">lipid-based nutrient supplements</Keyword>
        <Keyword MajorTopicYN="N">microbiota diversity</Keyword>
        <Keyword MajorTopicYN="N">multiple micronutrients</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909811</ArticleId>
        <ArticleId IdType="pii">5698017</ArticleId>
        <ArticleId IdType="doi">10.1093/jn/nxz298</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909812</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-6653</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Genome biology and evolution</Title>
          <ISOAbbreviation>Genome Biol Evol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differential Expression in Testis and Liver Transcriptomes from Four Species of Peromyscus (Rodentia: Cricetidae).</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">evz280</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/gbe/evz280</ELocationID>
        <Abstract>
          <AbstractText>The genus Peromyscus represents a rapidly diverged clade of Cricetid rodents that contains multiple cryptic species and has a propensity for morphologic conservation across its members. The unresolved relationships in previously proposed phylogenies reflect a suspected rapid adaptive radiation. To identify functional groups of genes that may be important in reproductive isolation in a reoccurring fashion across the Peromyscus phylogeny, liver and testis transcriptomes from four species (P. attwateri, P. boylii, P. leucopus, and P. maniculatus) were generated and differential expression (DE) tests were conducted. Taxa were selected to represent members diverged from a common ancestor: P. attwateri + P. boylii (Clade A), and P. leucopus + P. maniculatus (Clade B). Comparison of clades (A vs B) suggested 252 transcripts had significant DE in the liver dataset whereas significant DE was identified for 657 transcripts in the testis dataset. Further, 45 genes had DE isoforms in the 657 testis transcripts and most of these functioned in major reproductive roles such as acrosome assembly, spermatogenesis, and cell cycle processes (meiosis). DE transcripts in the liver mapped to more broad GO terms (metabolic processes, catabolic processes, response to chemical, and regulatory processes), and DE transcripts in the testis mapped to GO terms associated with reproductive processes, such as meiosis, sperm motility, acrosome assembly, and sperm-egg fusion. These results suggest that a suite of genes that conduct similar functions in the testes may be responsible for the adaptive radiation events and potential reoccurring speciation of Peromyscus in terms of reproduction through varying expression levels.</AbstractText>
          <CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lindsey</LastName>
            <ForeName>Laramie L</ForeName>
            <Initials>LL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Texas Tech University, Lubbock, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Platt</LastName>
            <ForeName>Roy N</ForeName>
            <Initials>RN</Initials>
            <AffiliationInfo>
              <Affiliation>Genetics Department, Texas Biomedical Research Institute, San Antonio, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Phillips</LastName>
            <ForeName>Caleb D</ForeName>
            <Initials>CD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Texas Tech University, Lubbock, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Natural Science Research Laboratory, Museum of Texas Tech University, Lubbock, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ray</LastName>
            <ForeName>David A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Texas Tech University, Lubbock, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bradley</LastName>
            <ForeName>Robert D</ForeName>
            <Initials>RD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Texas Tech University, Lubbock, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Natural Science Research Laboratory, Museum of Texas Tech University, Lubbock, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Genome Biol Evol</MedlineTA>
        <NlmUniqueID>101509707</NlmUniqueID>
        <ISSNLinking>1759-6653</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
          Peromyscus
        </Keyword>
        <Keyword MajorTopicYN="N">comparative genomics</Keyword>
        <Keyword MajorTopicYN="N">differential expression</Keyword>
        <Keyword MajorTopicYN="N">lineage diversification</Keyword>
        <Keyword MajorTopicYN="N">transcriptome</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909812</ArticleId>
        <ArticleId IdType="pii">5697918</ArticleId>
        <ArticleId IdType="doi">10.1093/gbe/evz280</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909813</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2431</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>71</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of experimental botany</Title>
          <ISOAbbreviation>J. Exp. Bot.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mitigating the impact of climate change on plant productivity and ecosystem sustainability.</ArticleTitle>
        <Pagination>
          <MedlinePgn>451-456</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jxb/erz518</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pareek</LastName>
            <ForeName>Ashwani</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Stress Physiology and Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dhankher</LastName>
            <ForeName>Om Parkash</ForeName>
            <Initials>OP</Initials>
            <AffiliationInfo>
              <Affiliation>Stockbridge School of Agriculture, University of Massachusetts, Amherst, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Foyer</LastName>
            <ForeName>Christine H</ForeName>
            <Initials>CH</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biosciences, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Exp Bot</MedlineTA>
        <NlmUniqueID>9882906</NlmUniqueID>
        <ISSNLinking>0022-0957</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Climate change</Keyword>
        <Keyword MajorTopicYN="N">drought</Keyword>
        <Keyword MajorTopicYN="N">food security</Keyword>
        <Keyword MajorTopicYN="N">heat stress</Keyword>
        <Keyword MajorTopicYN="N">rice</Keyword>
        <Keyword MajorTopicYN="N">salinity</Keyword>
        <Keyword MajorTopicYN="N">wheat</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909813</ArticleId>
        <ArticleId IdType="pii">5697955</ArticleId>
        <ArticleId IdType="doi">10.1093/jxb/erz518</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909814</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2431</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>71</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of experimental botany</Title>
          <ISOAbbreviation>J. Exp. Bot.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>In search for drought-tolerant soybean: is the slow-wilting phenotype more than just a curiosity?</ArticleTitle>
        <Pagination>
          <MedlinePgn>457-460</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jxb/erz235</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kunert</LastName>
            <ForeName>Karl</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plant and Soil Sciences, Forestry and Agricultural Biotechnology Institute, University of Pretoria, Pretoria, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vorster</LastName>
            <ForeName>Barend J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plant and Soil Sciences, Forestry and Agricultural Biotechnology Institute, University of Pretoria, Pretoria, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Exp Bot</MedlineTA>
        <NlmUniqueID>9882906</NlmUniqueID>
        <ISSNLinking>0022-0957</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Aquaporins</Keyword>
        <Keyword MajorTopicYN="N">delayed wilting response</Keyword>
        <Keyword MajorTopicYN="N">drought tolerance</Keyword>
        <Keyword MajorTopicYN="N">drought-tolerant soybean</Keyword>
        <Keyword MajorTopicYN="N">slow wilting QTL</Keyword>
        <Keyword MajorTopicYN="N">slow-wilting phenotype</Keyword>
        <Keyword MajorTopicYN="N">slow-wilting soybean</Keyword>
        <Keyword MajorTopicYN="N">water-conservation mechanism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909814</ArticleId>
        <ArticleId IdType="pii">5697940</ArticleId>
        <ArticleId IdType="doi">10.1093/jxb/erz235</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909815</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-4637</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pain medicine (Malden, Mass.)</Title>
          <ISOAbbreviation>Pain Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rhomboid Intercostal Catheters for Postoperative Pain After Scapular Fracture Surgery.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">pnz334</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/pm/pnz334</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Elsharkawy</LastName>
            <ForeName>Hesham</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Anesthesia and Pain Management Outcomes Research, Anesthesiology Institute, Cleveland, Ohio.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CCLCM of Case Western Reserve University Cleveland Clinic, Cleveland, Ohio, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ince</LastName>
            <ForeName>Ilker</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology and Reanimation School of Medicine, Ataturk University, Erzurum, Turkey.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Anesthesiology Institute Outcomes Research Department Cleveland Clinic, Cleveland, Ohio.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Anesthesiology Clinical Research Office Ataturk University, Erzurum, TURKEY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malik</LastName>
            <ForeName>Mohammed Faysal</ForeName>
            <Initials>MF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Regional Anesthesia and Acute Pain Management Cleveland Clinic, Cleveland, Ohio, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roques</LastName>
            <ForeName>Vicente</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>nesthesia Intensive Care and Chronic Pain Treatment, University Hospital Virgen de la Arrixaca, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pain Med</MedlineTA>
        <NlmUniqueID>100894201</NlmUniqueID>
        <ISSNLinking>1526-2375</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909815</ArticleId>
        <ArticleId IdType="pii">5698030</ArticleId>
        <ArticleId IdType="doi">10.1093/pm/pnz334</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909816</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1795-990X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Scandinavian journal of work, environment &amp; health</Title>
          <ISOAbbreviation>Scand J Work Environ Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Work-related exposure to violence or threats and risk of mental disorders and symptoms: a systematic review and meta-analysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.5271/sjweh.3877</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">3877</ELocationID>
        <Abstract>
          <AbstractText>Objective This review aimed to examine systematically the epidemiological evidence linking work-related exposure to violence and threats thereof with risk of mental disorders and mental ill-health symptoms. Methods We searched PubMed, EMBASE, PsycINFO and Web of Science to identify original studies that provide quantitative risk estimates. The evidence was weighted according to completeness of reporting, potential common method bias, and bias due to differential selection and drop out, selective reporting, and misclassification of exposure and outcome. Results We identified 14 cross-sectional and 10 cohort studies with eligible risk estimates, of which 4 examined depressive disorder and reported an elevated risk among the exposed [pooled relative risk (RR) 1.42, 95% confidence interval (CI) 1.31-1.54, I <sup>2</sup>=0%]. The occurrence of depressive and anxiety symptoms, burnout and psychological distress was examined in 17 studies (pooled RR 2.33, 95% CI 3.17, I <sup>2</sup>=42%), and 3 studies examined risk of sleep disturbance (pooled RR 1.22, 95% CI 1.09-1.37, I2=0%). In most studies, common method bias and confounding could not be ruled out with confidence and strong heterogeneity in most outcome definitions invalidate the strict interpretation of most pooled risk estimates. Conclusion The reviewed studies consistently indicate associations between workplace violence and mental health problems. However, due to methodological limitations the causal associations (if any) may be stronger or weaker than the ones reported in this study. Prospective studies with independent and validated reporting of exposure and outcome and repeated follow-up with relevant intervals are highly warranted.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rudkjoebing</LastName>
            <ForeName>Laura A</ForeName>
            <Initials>LA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark. laura.aviaja.rudkjoebing.01@regionh.dk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bungum</LastName>
            <ForeName>Ane Berger</ForeName>
            <Initials>AB</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flachs</LastName>
            <ForeName>Esben Meulengracht</ForeName>
            <Initials>EM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eller</LastName>
            <ForeName>Nanna Hurwitz</ForeName>
            <Initials>NH</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borritz</LastName>
            <ForeName>Marianne</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aust</LastName>
            <ForeName>Birgit</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rugulies</LastName>
            <ForeName>Reiner</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rod</LastName>
            <ForeName>Naja Hulvej</ForeName>
            <Initials>NH</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Biering</LastName>
            <ForeName>Karin</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bonde</LastName>
            <ForeName>Jens Peter</ForeName>
            <Initials>JP</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Finland</Country>
        <MedlineTA>Scand J Work Environ Health</MedlineTA>
        <NlmUniqueID>7511540</NlmUniqueID>
        <ISSNLinking>0355-3140</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909816</ArticleId>
        <ArticleId IdType="pii">3877</ArticleId>
        <ArticleId IdType="doi">10.5271/sjweh.3877</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909817</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1868-4297</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cardiovascular intervention and therapeutics</Title>
          <ISOAbbreviation>Cardiovasc Interv Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Role of transesophageal echocardiography in percutaneous mitral valve repair using MitraClip.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12928-019-00638-1</ELocationID>
        <Abstract>
          <AbstractText>Mitral regurgitation (MR) is the most common valvular heart disease in developed countries because of the aging populations. Percutaneous intervention for MR has been established as an alternative treatment to surgical mitral valve (MV) repair in patients with high surgical risks. Percutaneous edge-to-edge MV repair using the MitraClip system (Abbott, Menlo Park, CA, USA) is currently indicated for primary and secondary MR in Japan. For transesophageal echocardiography (TEE)-guided intervention, knowledge of TEE is essential for the success of the procedure. Here, we review the role of intraprocedural TEE in MV repair using the MitraClip system.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Izumo</LastName>
            <ForeName>Masaki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki-City, 216-8511, Japan. heartizumo@yahoo.co.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Akashi</LastName>
            <ForeName>Yoshihiro J</ForeName>
            <Initials>YJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki-City, 216-8511, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Japan</Country>
        <MedlineTA>Cardiovasc Interv Ther</MedlineTA>
        <NlmUniqueID>101522043</NlmUniqueID>
        <ISSNLinking>1868-4297</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Mitral regurgitation</Keyword>
        <Keyword MajorTopicYN="N">Percutaneous mitral valve repair</Keyword>
        <Keyword MajorTopicYN="N">Transesophageal echocardiography</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909817</ArticleId>
        <ArticleId IdType="doi">10.1007/s12928-019-00638-1</ArticleId>
        <ArticleId IdType="pii">10.1007/s12928-019-00638-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909819</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4679</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical psychology</Title>
          <ISOAbbreviation>J Clin Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Serving those who serve: Psychotherapy with military clients.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jclp.22917</ELocationID>
        <Abstract>
          <AbstractText>As in the Vietnam era, the wars in Iraq and Afghanistan are not the focus of the nightly news. Nevertheless, there are countless numbers of individuals enlisting, serving, deploying, redeploying, and leaving military branches every day. These individuals are underserved in many ways, especially after they end their formal relationship with their service. The purpose of this introduction is to describe the ongoing concerns and psychological problems of our military personnel and the efforts, described by the authors of papers in this issue, to address these concerns and problems.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Raskin</LastName>
            <ForeName>Patricia M</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>Teachers College, Columbia University, New York, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Psychol</MedlineTA>
        <NlmUniqueID>0217132</NlmUniqueID>
        <ISSNLinking>0021-9762</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909819</ArticleId>
        <ArticleId IdType="doi">10.1002/jclp.22917</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Bronfenbrenner, U. (1979). The ecology of human development: Experiments by nature and design. Cambridge, MA: Harvard University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Hartman, A., Schuermann, H., &amp; Kenney, J. (2018). U.S. Army soldiers’ trust and confidence in mental health professionals. The Professional Counselor, 8, 213-225.</Citation>
        </Reference>
        <Reference>
          <Citation>Mobbs, M. C., &amp; Bonanno, G. A. (2018). Beyond war and PTSD: The crucial role of transition stress in the lives of military veterans. Clinical Psychology Review, 59, 137-144.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909818</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-5447</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Australasian physical &amp; engineering sciences in medicine</Title>
          <ISOAbbreviation>Australas Phys Eng Sci Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nanodosimetric understanding to the dependence of the relationship between dose-averaged lineal energy on nanoscale and LET on ion species.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s13246-020-00840-z</ELocationID>
        <Abstract>
          <AbstractText>With the extension of ion species in ion-beam radiotherapy, the sole dependence of relative biological effectiveness (RBE) on linear energy transfer (LET) is insufficient when comparing RBE for ion beams with the same LET value. The aim of the present study was to provide a systematic study of the nanodosimetry for ion beams with the same LET value. Based on the calculated LET profiles of ion beams with range about 130 mm, lineal energy spectra and dose-averaged lineal energy [Formula: see text] on 4 nm site for various clinical ion beams were obtained. Then, the lineal energy spectra and [Formula: see text] values were compared for ion beams with the same LET values. The results showed that the relationships between [Formula: see text] and LET for various ion beams present an dependence on ion species. For ion beams with the same LET value, the ion beams with smaller nucleon number yielded greater [Formula: see text] values. The probability of the small-nucleon-number ion beams to generate large energy deposition events on nanoscale was higher than that of the large-nucleon-number ion beams. The dependence of the relationship between RBE and LET on ion species might be attributed to the fluctuation of energy depositions on nanometer scale.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Tianyuan</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Xinguo</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Zhongying</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Pengbo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Yuanyuan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Guosheng</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Weiqiang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Qiang</ForeName>
            <Initials>Q</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-1502-8415</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 73000, China. liqiang@impcas.ac.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Science, Lanzhou, 730000, China. liqiang@impcas.ac.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Gansu Province, Lanzhou, 730000, China. liqiang@impcas.ac.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China. liqiang@impcas.ac.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2018YFC0115702</GrantID>
            <Agency>National Key Research and Development Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>61631001</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>11875299</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>U1532264</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>11705247</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>11505249</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>11475231</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2015340</GrantID>
            <Agency>Youth Innovation Promotion Association of Chinese Academy of Sciences</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017454</GrantID>
            <Agency>Youth Innovation Promotion Association of Chinese Academy of Sciences</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2016</GrantID>
            <Agency>Light of West China Program of the Chinese Academy of Sciences</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Australas Phys Eng Sci Med</MedlineTA>
        <NlmUniqueID>8208130</NlmUniqueID>
        <ISSNLinking>0158-9938</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dose-averaged lineal energy</Keyword>
        <Keyword MajorTopicYN="N">Ion species</Keyword>
        <Keyword MajorTopicYN="N">LET</Keyword>
        <Keyword MajorTopicYN="N">Nanodosimetry</Keyword>
        <Keyword MajorTopicYN="N">RBE</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909818</ArticleId>
        <ArticleId IdType="doi">10.1007/s13246-020-00840-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s13246-020-00840-z</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909820</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Muscle &amp; nerve</Title>
          <ISOAbbreviation>Muscle Nerve</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neurodevelopmental, Behavioral, and Emotional Symptoms Common in Duchenne Muscular Dystrophy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/mus.26803</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">We studied neurodevelopmental and behavioral/emotional symptoms in patients with Duchenne muscular dystrophy (DMD).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective case series of neurodevelopmental and behavioral/emotional symptoms obtained through review of systems of 700 DMD patients in relation to dystrophin gene mutations.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The most common symptoms encountered were emotional/behavioral dysregulation (38.7%), inattention/hyperactive features (31.4%), obsessive and compulsive features (25.0%), and language/speech delays (24.4%). Most patients (72.7%) had at least one symptom. Patients with mutations near the 3' end of the dystrophin gene were at higher risk for developing inattention/hyperactive features, language/speech delays, and global intellectual delays. Those with mutations between exon 31 and 79 had higher risk of clustering of symptoms when compared with those upstream of exon 30.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Neurodevelopmental, emotional, and behavioral symptoms are common comorbidities in DMD. There is higher prevalence of inattention/hyperactive features, language/speech delays and global intellectual delays in genotypes affecting the 3' end of the dystrophin gene. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Darmahkasih</LastName>
            <ForeName>Andrew J</ForeName>
            <Initials>AJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4902-2425</Identifier>
            <AffiliationInfo>
              <Affiliation>Pediatric Residency Program, University of California, Irvine/Children's Hospital of Orange County, Orange, CA, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rybalsky</LastName>
            <ForeName>Irina</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Division, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tian</LastName>
            <ForeName>Cuixia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neurology, Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shellenbarger</LastName>
            <ForeName>Karen C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Massachusetts Medical School, Worchester, MA, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Horn</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neurology, Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lambert</LastName>
            <ForeName>Joshua T</ForeName>
            <Initials>JT</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3195-8735</Identifier>
            <AffiliationInfo>
              <Affiliation>Neurology Division, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wong</LastName>
            <ForeName>Brenda L</ForeName>
            <Initials>BL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Massachusetts Medical School, Worchester, MA, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Muscle Nerve</MedlineTA>
        <NlmUniqueID>7803146</NlmUniqueID>
        <ISSNLinking>0148-639X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Duchenne muscular dystrophy</Keyword>
        <Keyword MajorTopicYN="N">behavioral disorders</Keyword>
        <Keyword MajorTopicYN="N">cognitive impairment</Keyword>
        <Keyword MajorTopicYN="N">emotional disorders</Keyword>
        <Keyword MajorTopicYN="N">neurodevelopmental disorders</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>01</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909820</ArticleId>
        <ArticleId IdType="doi">10.1002/mus.26803</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909821</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0142</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer</Title>
          <ISOAbbreviation>Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An invitation for optimal inclusivity: Investing in communities to advance equity in biomedical research and cancer care.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.32683</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Meade</LastName>
            <ForeName>Cathy D</ForeName>
            <Initials>CD</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6422-8248</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Population Science, Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gwede</LastName>
            <ForeName>Clement K</ForeName>
            <Initials>CK</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Population Science, Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer</MedlineTA>
        <NlmUniqueID>0374236</NlmUniqueID>
        <ISSNLinking>0008-543X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CBPR</Keyword>
        <Keyword MajorTopicYN="N">clinical trials and biospecimen research</Keyword>
        <Keyword MajorTopicYN="N">community engagement</Keyword>
        <Keyword MajorTopicYN="N">diversity in cancer research</Keyword>
        <Keyword MajorTopicYN="N">health disparities</Keyword>
        <Keyword MajorTopicYN="N">health equity</Keyword>
        <Keyword MajorTopicYN="N">inclusivity</Keyword>
        <Keyword MajorTopicYN="N">partnerships</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909821</ArticleId>
        <ArticleId IdType="doi">10.1002/cncr.32683</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Mamun A, Nsiah NY, Srinivasan M, et al. Diversity in the era of precision medicine-from bench to bedside implementation. Ethn Dis. 2019;29:517-524.</Citation>
        </Reference>
        <Reference>
          <Citation>Garrido P, Aldaz A, Vera R, et al. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH. Clin Transl Oncol. 2018;20:443-447.</Citation>
        </Reference>
        <Reference>
          <Citation>Kensler TW, Spira A, Garber JE, et al. Transforming cancer prevention through precision medicine and immune-oncology. Cancer Prev Res (Phila). 2016;9:2-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Lippman SM, Abate-Shen C, Maresso KL, et al. AACR White Paper: Shaping the Future of Cancer Prevention-A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018;11:735-778.</Citation>
        </Reference>
        <Reference>
          <Citation>Blackburn EH. Cancer interception. Cancer Prev Res (Phila). 2011;4:787-792.</Citation>
        </Reference>
        <Reference>
          <Citation>Unger JM, Cook E, Tai E, Bleyer A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book. 2016;36:185-198.</Citation>
        </Reference>
        <Reference>
          <Citation>Menon U, Ashing K, Chang MW, et al. Application of the ConNECT framework to precision health and health disparities. Nurs Res. 2019;68:99-109.</Citation>
        </Reference>
        <Reference>
          <Citation>Spratt DE, Chan T, Waldron L, et al. Racial/ethnic disparities in genomic sequencing. JAMA Oncol. 2016;2:1070-1074.</Citation>
        </Reference>
        <Reference>
          <Citation>Barrett NJ, Rodriguez EM, Iachan R, et al. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers. Cancer. 2019;125:000-000.</Citation>
        </Reference>
        <Reference>
          <Citation>Kagawa-Singer M, Dressler W, George S, Elwood W, Expert Panel Members. The cultural framework for health: an integrative approach for research and program design and evaluation. Bethesda, MD: Office of Behavioral and Social Science Research (OBSSR); 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Dang JH, Rodriguez EM, Luque JS, Erwin DO, Meade CD, Chen MS Jr. Engaging diverse populations about biospecimen donation for cancer research. J Community Genet. 2014;5:313-327.</Citation>
        </Reference>
        <Reference>
          <Citation>Luque JS, Quinn GP, Montel-Ishino FA, et al; Tampa Bay Community Cancer Network Partners. Formative research on perceptions of biobanking: what community members think. J Cancer Educ. 2012;27:91-99.</Citation>
        </Reference>
        <Reference>
          <Citation>Zahnd WE, Fogleman AJ, Jenkins WD. Rural-urban disparities in stage of diagnosis among cancers with preventive opportunities. Am J Prev Med. 2018;54:688-698.</Citation>
        </Reference>
        <Reference>
          <Citation>Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int. 2000;15:259-267.</Citation>
        </Reference>
        <Reference>
          <Citation>Minkler M. Community Organizing and Community Building for Health and Welfare. 3rd ed. Rutgers University Press; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Hebert JR, Braun KL, Meade CD, Bloom J, Kobetz E. Community-based participatory research adds value to the National Cancer Institute's research portfolio. Prog Community Health Partnersh. 2015;9(suppl):1-4.</Citation>
        </Reference>
        <Reference>
          <Citation>Paskett ED, Hiatt RA. Catchment areas and community outreach and engagement: the new mandate for NCI-designated cancer centers. Cancer Epidemiol Biomarkers Prev. 2018;27:517-519.</Citation>
        </Reference>
        <Reference>
          <Citation>Kraft SA, Cho MK, Gillespie K, et al. Beyond consent: building trusting relationships with diverse populations in precision medicine research. Am J Bioeth. 2018;18:3-20.</Citation>
        </Reference>
        <Reference>
          <Citation>Quinn GP, Gwede CK, Meade CD. Diversity beyond race and ethnicity: enhancing inclusion with an expanded definition of diversity. Am J Bioeth. 2018;18:47-48.</Citation>
        </Reference>
        <Reference>
          <Citation>Collins P, Bilge S. Intersectionality. Polity Press; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Alcaraz KI, Sly J, Ashing K, et al. The ConNECT Framework: a model for advancing behavioral medicine science and practice to foster health equity. J Behav Med. 2017;40:23-38.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909822</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1326-5377</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Medical journal of Australia</Title>
          <ISOAbbreviation>Med. J. Aust.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>How to perform a skin biopsy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.5694/mja2.50473</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wark</LastName>
            <ForeName>Kirsty Jl</ForeName>
            <Initials>KJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0258-7485</Identifier>
            <AffiliationInfo>
              <Affiliation>Liverpool Hospital, Sydney, NSW.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Saxon D</ForeName>
            <Initials>SD</Initials>
            <AffiliationInfo>
              <Affiliation>Royal North Shore Hospital, Sydney, NSW.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Sydney, Sydney, NSW.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sebaratnam</LastName>
            <ForeName>Deshan F</ForeName>
            <Initials>DF</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5896-8178</Identifier>
            <AffiliationInfo>
              <Affiliation>Liverpool Hospital, Sydney, NSW.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sydney Children's Hospitals Network, Sydney, NSW.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Med J Aust</MedlineTA>
        <NlmUniqueID>0400714</NlmUniqueID>
        <ISSNLinking>0025-729X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Biopsy</Keyword>
        <Keyword MajorTopicYN="N">Dermatitis</Keyword>
        <Keyword MajorTopicYN="N">Dermatologic surgical procedures</Keyword>
        <Keyword MajorTopicYN="N">Melanoma</Keyword>
        <Keyword MajorTopicYN="N">Nevus</Keyword>
        <Keyword MajorTopicYN="N">Skin neoplasms</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909822</ArticleId>
        <ArticleId IdType="doi">10.5694/mja2.50473</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004: a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006; 55: 490-500.</Citation>
        </Reference>
        <Reference>
          <Citation>Hussain W, Hafiji J, Stanley AG, Khan KM. Dermatology and junior doctors: an evaluation of education, perceptions and self-assessed competencies. Br J Dermatol 2008; 159: 505-506.</Citation>
        </Reference>
        <Reference>
          <Citation>Sebaratnam DF, Murrell DF. Dermatology training and practice in Australia. Int J Dermatol 2014; 53: 1259-1264.</Citation>
        </Reference>
        <Reference>
          <Citation>de Menezes SL, Kelly JW, Wolfe R, et al. The increasing use of shave biopsy for diagnosing invasive melanoma in Australia. Med J Aust 2019; 211: 213-218. https://www.mja.com.au/journal/2019/211/5/increasing-use-shave-biopsy-diagnosing-invasive-melanoma-australia</Citation>
        </Reference>
        <Reference>
          <Citation>Elston DM, Stratman EJ, Miller SJ. Skin biopsy: biopsy issues in specific diseases. J Am Acad Dermatol 2016; 74: 1-16.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909823</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0142</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer</Title>
          <ISOAbbreviation>Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.32695</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The sensitive detection of recurrent colorectal cancer (CRC) by the measurement of circulating tumor DNA (ctDNA) might improve the chance of a cure. This study compared a quantitative methylated ctDNA test with carcinoembryonic antigen (CEA) in the setting of surveillance for recurrence.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Blood samples collected either during surveillance or within 12 months of the confirmation of recurrence were assayed for ctDNA (methylated branched-chain amino acid transaminase 1 [BCAT1]/Ikaros family zinc-finger 1 protein [IKZF1]) and CEA. The optimal ctDNA threshold was determined by receiver operating characteristic analysis, and the test performance for the detection of recurrence was compared with CEA (5 ng/mL threshold).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The study cohort comprised 144 eligible patients and included 50 recurrence events. The sensitivity of the methylated ctDNA test for recurrence was 66.0% (95% confidence interval [CI], 57.1%-69.3%), which was significantly higher than the sensitivity of CEA (31.9%; 95% CI, 22.8%-36.6%; P &lt; .001). The sensitivity for resectable recurrence (n = 20) was also higher (ctDNA, 60.0%; CEA, 20.0%; P = .01). The specificity did not differ between the tests (ctDNA, 97.9%; 95% CI, 93.2%-99.6%; CEA, 96.4%; 95% CI, 91.4%-99.0%). When adjustments were made for other predictors of the presence of recurrence, a positive ctDNA test was an independent predictor (odds ratio, 155.7; 95% CI, 17.9-1360.6; P &lt; .001), whereas CEA was not (odds ratio, 2.5; 95% CI, 0.3-20.6; P = .407).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The quantitative ctDNA test showed superior sensitivity in comparison with CEA without a difference in the specificity for detecting recurrent CRC. Longitudinal studies are warranted to further assess the utility (specifically the survival benefit) of methylated BCAT1/IKZF1 ctDNA in the surveillance of patients with CRC.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Symonds</LastName>
            <ForeName>Erin L</ForeName>
            <Initials>EL</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2451-0358</Identifier>
            <AffiliationInfo>
              <Affiliation>Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pedersen</LastName>
            <ForeName>Susanne K</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genomics Pty, Ltd, North Ryde, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murray</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genomics Pty, Ltd, North Ryde, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Byrne</LastName>
            <ForeName>Susan E</ForeName>
            <Initials>SE</Initials>
            <AffiliationInfo>
              <Affiliation>Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roy</LastName>
            <ForeName>Amitesh</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karapetis</LastName>
            <ForeName>Christos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hollington</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rabbitt</LastName>
            <ForeName>Philippa</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jones</LastName>
            <ForeName>Frederick S</ForeName>
            <Initials>FS</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genomics, Inc, Bridgewater, New Jersey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>LaPointe</LastName>
            <ForeName>Lawrence</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genomics, Inc, Bridgewater, New Jersey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Segelov</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, School of Clinical Sciences, Monash Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Translational Oncology Research Laboratory, Monash University, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Young</LastName>
            <ForeName>Graeme P</ForeName>
            <Initials>GP</Initials>
            <AffiliationInfo>
              <Affiliation>Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Clinical Genomics</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>APP1006242</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>APP1017083</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer</MedlineTA>
        <NlmUniqueID>0374236</NlmUniqueID>
        <ISSNLinking>0008-543X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ikaros family zinc-finger 1 protein (IKZF1)</Keyword>
        <Keyword MajorTopicYN="N">blood test</Keyword>
        <Keyword MajorTopicYN="N">branched-chain amino acid transaminase 1 (BCAT1)</Keyword>
        <Keyword MajorTopicYN="N">circulating tumor DNA (ctDNA)</Keyword>
        <Keyword MajorTopicYN="N">colorectal cancer</Keyword>
        <Keyword MajorTopicYN="N">methylation</Keyword>
        <Keyword MajorTopicYN="N">recurrence</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909823</ArticleId>
        <ArticleId IdType="doi">10.1002/cncr.32695</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31:4465-4470.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsang ME, Jayaraman S, Karanicolas PJ, Wei AC. Colorectal liver metastases. In: Wright FC, Escallon J, Cukier M, Tsang ME, Hameed U, eds. Surgical Oncology Manual. Springer; 2016:101-113.</Citation>
        </Reference>
        <Reference>
          <Citation>Neo EL, Beeke C, Price T, et al. South Australian clinical registry for metastatic colorectal cancer. ANZ J Surg. 2011;81:352-357.</Citation>
        </Reference>
        <Reference>
          <Citation>Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224ra224.</Citation>
        </Reference>
        <Reference>
          <Citation>Saluja H, Karapetis CS, Pedersen SK, Young GP, Symonds EL. The use of circulating tumor DNA for prognosis of gastrointestinal cancers. Front Oncol. 2018;8:275.</Citation>
        </Reference>
        <Reference>
          <Citation>Reinert T, Henriksen TV, Christensen E, et al. Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer. JAMA Oncol. 2019;5:1124-1131.</Citation>
        </Reference>
        <Reference>
          <Citation>Tie J, Wang Y, Tomasetti C, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8:346ra392.</Citation>
        </Reference>
        <Reference>
          <Citation>Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883-892.</Citation>
        </Reference>
        <Reference>
          <Citation>Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011;8:686-700.</Citation>
        </Reference>
        <Reference>
          <Citation>Behrouz Sharif S, Hashemzadeh S, Mousavi Ardehaie R, et al. Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker. Oncol Lett. 2016;12:5335-5343.</Citation>
        </Reference>
        <Reference>
          <Citation>Toiyama Y, Okugawa Y, Goel A. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochem Biophys Res Commun. 2014;455:43-57.</Citation>
        </Reference>
        <Reference>
          <Citation>Symonds EL, Pedersen SK, Baker RT, et al. A blood test for methylated BCAT1 and IKZF1 vs. a fecal immunochemical test for detection of colorectal neoplasia. Clin Transl Gastroenterol. 2016;7:e137.</Citation>
        </Reference>
        <Reference>
          <Citation>Symonds EL, Pedersen SK, Murray DH, et al. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection. Clin Epigenetics. 2018;10:63.</Citation>
        </Reference>
        <Reference>
          <Citation>Young GP, Pedersen SK, Mansfield S, et al. A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer. Cancer Med. 2016;5:2763-2772.</Citation>
        </Reference>
        <Reference>
          <Citation>Metser U, You J, McSweeney S, Freeman M, Hendler A. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. AJR Am J Roentgenol. 2010;194:766-771.</Citation>
        </Reference>
        <Reference>
          <Citation>Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A; ESMO Guidelines Working Group. Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v70-v77.</Citation>
        </Reference>
        <Reference>
          <Citation>Poston GJ, Tait D, O’Connell S, Bennett A, Berendse S; Guideline Development Group. Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ. 2011;343:d6751.</Citation>
        </Reference>
        <Reference>
          <Citation>Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24:5313-5327.</Citation>
        </Reference>
        <Reference>
          <Citation>Duffy MJ, van Dalen A, Haglund C, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43:1348-1360.</Citation>
        </Reference>
        <Reference>
          <Citation>Chao M, Gibbs P. Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer. J Clin Oncol. 2009;27:e279-e280.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicholson BD, Shinkins B, Pathiraja I, et al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev. 2015;12:CD011134.</Citation>
        </Reference>
        <Reference>
          <Citation>Ruibal Morell A. CEA serum levels in non-neoplastic disease. Int J Biol Markers. 1992;7:160-166.</Citation>
        </Reference>
        <Reference>
          <Citation>Pedersen SK, Symonds EL, Baker RT, et al. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer. 2015;15:654.</Citation>
        </Reference>
        <Reference>
          <Citation>Tie J, Kinde I, Wang Y, et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol. 2015;26:1715-1722.</Citation>
        </Reference>
        <Reference>
          <Citation>Bhangu JS, Beer A, Mittlbock M, et al. Circulating free methylated tumor DNA markers for sensitive assessment of tumor burden and early response monitoring in patients receiving systemic chemotherapy for colorectal cancer liver metastasis. Ann Surg. 2018;268:894-902.</Citation>
        </Reference>
        <Reference>
          <Citation>Overman MJ, Morris V, Moinova H, et al. Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin. Oncotarget. 2016;7:67495-67506.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang MT, Asthana S, Gao SP, et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2016;34:155-163.</Citation>
        </Reference>
        <Reference>
          <Citation>Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214-218.</Citation>
        </Reference>
        <Reference>
          <Citation>Fu B, Yan P, Zhang S, et al. Cell-free circulating methylated SEPT9 for noninvasive diagnosis and monitoring of colorectal cancer. Dis Markers. 2018;2018:6437104.</Citation>
        </Reference>
        <Reference>
          <Citation>Sposato LA, Lam Y, Karapetis C, et al. Observation of “complete clinical response” in rectal cancer after neoadjuvant chemoradiation: the Flinders experience. Asia Pac J Clin Oncol. 2018;14:439-445.</Citation>
        </Reference>
        <Reference>
          <Citation>Day D, Frentzas S, Naidu CA, Segelov E, Green M. Current utility and future applications of ctDNA in colorectal cancer. In: Segelov E, ed. Advances in the Molecular Understanding of Colorectal Cancer. IntechOpen; 2018.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909824</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0142</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer</Title>
          <ISOAbbreviation>Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.32487</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Engaging diverse populations in biomedical research, including biospecimen donation, remains a national challenge. This study examined factors associated with an invitation to participate in biomedical research, intent to participate in biomedical research in the future, and participation in biomedical research and biospecimen donation among a diverse, multilingual, community-based sample across 3 distinct geographic areas.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Three National Cancer Institute-designated cancer centers engaged in community partnerships to develop and implement population health assessments, reaching a convenience sample of 4343 participants spanning their respective catchment areas. Data harmonization, multiple imputation, and multivariable logistic modeling were used.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">African Americans, Hispanic/Latinos, and other racial minority groups were more likely to be offered opportunities to participate in biomedical research compared to whites. Access to care, history of cancer, educational level, survey language, nativity, and rural residence also influenced opportunity, intent, and actual participation in biomedical research.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Traditionally underserved racial and ethnic groups reported heightened opportunity and interest in participating in biomedical research. Well-established community partnerships and long-standing community engagement around biomedical research led to a diverse sample being reached at each site and may in part explain the current study findings. However, this study illustrates an ongoing need to establish trust and diversify biomedical research participation through innovative and tailored approaches. National Cancer Institute-designated cancer centers have the potential to increase opportunities for diverse participation in biomedical research through community partnerships and engagement. Additional work remains to identify and address system-level and individual-level barriers to participation in both clinical trials and biospecimen donation for research.</AbstractText>
          <CopyrightInformation>© 2020 American Cancer Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Barrett</LastName>
            <ForeName>Nadine J</ForeName>
            <Initials>NJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0439-5209</Identifier>
            <AffiliationInfo>
              <Affiliation>Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Community and Family Medicine, Duke School of Medicine, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Duke Clinical and Translational Science Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodriguez</LastName>
            <ForeName>Elisa M</ForeName>
            <Initials>EM</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1433-5816</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iachan</LastName>
            <ForeName>Ronaldo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>ICF, Rockville, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hyslop</LastName>
            <ForeName>Terry</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ingraham</LastName>
            <ForeName>Kearston L</ForeName>
            <Initials>KL</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2842-0413</Identifier>
            <AffiliationInfo>
              <Affiliation>Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le</LastName>
            <ForeName>Gem M</ForeName>
            <Initials>GM</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Vulnerable Populations, Division of General Internal Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Kelly</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>ICF, Rockville, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haring</LastName>
            <ForeName>Rodney C</ForeName>
            <Initials>RC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5386-1205</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rivadeneira</LastName>
            <ForeName>Natalie A</ForeName>
            <Initials>NA</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Vulnerable Populations, Division of General Internal Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Erwin</LastName>
            <ForeName>Deborah O</ForeName>
            <Initials>DO</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fish</LastName>
            <ForeName>Laura J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Middleton</LastName>
            <ForeName>Deidre</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>ICF, Rockville, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hiatt</LastName>
            <ForeName>Robert A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, School of Medicine, University of California at San Francisco, San Francisco, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patierno</LastName>
            <ForeName>Steven R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarkar</LastName>
            <ForeName>Urmimala</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gage-Bouchard</LastName>
            <ForeName>Elizabeth A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30-CA014236</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer</MedlineTA>
        <NlmUniqueID>0374236</NlmUniqueID>
        <ISSNLinking>0008-543X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">biospecimen donation</Keyword>
        <Keyword MajorTopicYN="N">clinical trials</Keyword>
        <Keyword MajorTopicYN="N">community engagement</Keyword>
        <Keyword MajorTopicYN="N">disparities</Keyword>
        <Keyword MajorTopicYN="N">diversity in research participation</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909824</ArticleId>
        <ArticleId IdType="doi">10.1002/cncr.32487</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Al-Refaie WB, Vickers SM, Zhong W, Parsons H, Rothenberger D, Habermann EB. Cancer trials versus the real world in the United States. Ann Surg. 2011;254:438-442; discussion 442-443.</Citation>
        </Reference>
        <Reference>
          <Citation>Du W, Gadgeel SM, Simon MS. Predictors of enrollment in lung cancer clinical trials. Cancer. 2006;106:420-425.</Citation>
        </Reference>
        <Reference>
          <Citation>Freedman LS, Simon R, Foulkes MA, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-the perspective of NIH clinical trialists. Control Clin Trials. 1995;16:277-285; discussion 286-289, 293-309.</Citation>
        </Reference>
        <Reference>
          <Citation>Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720-2726.</Citation>
        </Reference>
        <Reference>
          <Citation>Newman LA, Roff NK, Weinberg AD. Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all. Ann Surg Oncol. 2008;15:1818-1819.</Citation>
        </Reference>
        <Reference>
          <Citation>Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328-3334.</Citation>
        </Reference>
        <Reference>
          <Citation>Langford AT, Resnicow K, Roberts JS, Zikmund-Fisher BJ. Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: sociodemographic and numeracy correlates. J Genet Couns. 2012;21:440-447.</Citation>
        </Reference>
        <Reference>
          <Citation>Baquet CR, Commiskey P, Daniel Mullins C, Mishra SI. Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev. 2006;30:24-33.</Citation>
        </Reference>
        <Reference>
          <Citation>Paskett ED, Cooper MR, Stark N, et al. Clinical trial enrollment of rural patients with cancer. Cancer Pract. 2002;10:28-35.</Citation>
        </Reference>
        <Reference>
          <Citation>Unger JM, Hershman DL, Albain KS, et al. Patient income level and cancer clinical trial participation. J Clin Oncol. 2013;31:536-542.</Citation>
        </Reference>
        <Reference>
          <Citation>Vanderpool RC, Kornfeld J, Mills L, Byrne MM. Rural-urban differences in discussions of cancer treatment clinical trials. Patient Educ Couns. 2011;85:e69-e74.</Citation>
        </Reference>
        <Reference>
          <Citation>Unger JM, Cook E, Tai E, Bleyer A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book. 2016;35:185-198.</Citation>
        </Reference>
        <Reference>
          <Citation>Langford AT, Resnicow K, Beasley DD. Outcomes from the Body &amp; Soul Clinical Trials Project: a university-church partnership to improve African American enrollment in a clinical trial registry. Patient Educ Couns. 2015;98:245-250.</Citation>
        </Reference>
        <Reference>
          <Citation>Dang JH, Rodriguez EM, Luque JS, Erwin DO, Meade CD, Chen MS Jr. Engaging diverse populations about biospecimen donation for cancer research. J Community Genet. 2014;5:313-327.</Citation>
        </Reference>
        <Reference>
          <Citation>Hagiwara N, Berry-Bobovski L, Francis C, Ramsey L, Chapman RA, Albrecht TL. Unexpected findings in the exploration of African American underrepresentation in biospecimen collection and biobanks. J Cancer Educ. 2014;29:580-587.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodriguez EM, Saad-Harfouche FG, Miller A, et al. Engaging diverse populations in biospecimen donation: results from the Hoy y Manana study. J Community Genet. 2016;7:271-277.</Citation>
        </Reference>
        <Reference>
          <Citation>Llanos AA, Young GS, Baltic R, et al. Predictors of willingness to participate in biospecimen donation and biobanking among Appalachian adults. J Health Care Poor Underserved. 2018;29:743-766.</Citation>
        </Reference>
        <Reference>
          <Citation>Haring RC, Henry WA, Hudson M, Rodriguez EM, Taualii M. Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). J Cancer Educ. 2018;33:44-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Durant RW, Wenzel JA, Scarinci IC, et al. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer. 2014;120(suppl 7):1097-1105.</Citation>
        </Reference>
        <Reference>
          <Citation>Tai CG, Hiatt RA. The population burden of cancer: research driven by the catchment area of a cancer center. Epidemiol Rev. 2017;39:108-122.</Citation>
        </Reference>
        <Reference>
          <Citation>US Census Bureau. US Census Bureau; 2018. Accessed August 9, 2019. https://www.census.gov/en.html</Citation>
        </Reference>
        <Reference>
          <Citation>Hiatt RA, Sibley A, Fejerman L, et al. The San Francisco Cancer Initiative: a community effort to reduce the population burden of cancer. Health Aff (Millwood). 2018;37:54-61.</Citation>
        </Reference>
        <Reference>
          <Citation>US Census Bureau. American Community Survey. US Census Bureau; 2018. Accessed August 9, 2019. https://www.census.gov/quickfacts/fact/table/sanfranciscocountycalifornia/PST045217</Citation>
        </Reference>
        <Reference>
          <Citation>Gage-Bouchard EA, Rawl S. Standardizing measurement of social and behavioral dimensions of cancer prevention and control to enhance outreach and engagement in NCI-designated cancer centers. Cancer Epidemiol Biomarkers Prev. 2019;28:431-434.</Citation>
        </Reference>
        <Reference>
          <Citation>Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York: John Wiley &amp; Sons, 2002.</Citation>
        </Reference>
        <Reference>
          <Citation>Rubin DB. Multiple Imputation for Nonresponse in Surveys. John Wiley &amp; Sons, 1987.</Citation>
        </Reference>
        <Reference>
          <Citation>McElfish PA, Long CR, Selig JP, et al. Health research participation, opportunity, and willingness among minority and rural communities of Arkansas. Clin Transl Sci. 2018;11:487-497.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodriguez EM, Torres ET, Erwin DO. Awareness and interest in biospecimen donation for cancer research: views from gatekeepers and prospective participants in the Latino community. J Community Genet. 2013;4:461-468.</Citation>
        </Reference>
        <Reference>
          <Citation>Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40:108-115.</Citation>
        </Reference>
        <Reference>
          <Citation>Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8:188-194.</Citation>
        </Reference>
        <Reference>
          <Citation>Langford AT, Resnicow K, Dimond EP, et al. Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program. Cancer. 2014;120:877-884.</Citation>
        </Reference>
        <Reference>
          <Citation>Dang JHT, Chen MS Jr. Time, trust, and transparency: lessons learned from collecting blood biospecimens for cancer research from the Asian American community. Cancer. 2018;124(suppl 7):1614-1621.</Citation>
        </Reference>
        <Reference>
          <Citation>Wallerstein NB, Duran B. Using community-based participatory research to address health disparities. Health Promot Pract. 2006;7:312-323.</Citation>
        </Reference>
        <Reference>
          <Citation>Gwede CK, Castro E, Brandon TH, et al. Developing strategies for reducing cancer disparities via cross-institutional collaboration: outreach efforts for the partnership between the Ponce School of Medicine and the Moffitt Cancer Center. Health Promot Pract. 2012;13:807-815.</Citation>
        </Reference>
        <Reference>
          <Citation>Barrett N, Vann Hawkins T, Wilder J, et al. Implementation of a health disparities and equity program at the Duke Cancer Institute- an NCI-designated Comprehensive Cancer Center. Oncology Issues. 2016;31:48-53.</Citation>
        </Reference>
        <Reference>
          <Citation>Barrett NJ, Ingraham KL, Vann Hawkins T, Moorman PG. Engaging African Americans in research: the recruiter's perspective. Ethn Dis. 2017;27:453-462.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909825</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-7793</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of physiology</Title>
          <ISOAbbreviation>J. Physiol. (Lond.)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reduced Na<sup>+</sup> K<sup>+</sup> -ATPase activity may reduce amino acid uptake in IUGR fetal sheep muscle despite unchanged ex vivo amino acid transporter activity.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1113/JP278933</ELocationID>
        <Abstract>
          <AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">Fetuses with intrauterine growth restriction (IUGR) have reduced muscle mass that persists postnatally, which may contribute to their increased risk for adult onset metabolic diseases, such as diabetes and obesity. Amino acid transporter mediated histidine uptake and system L amino acid transporter activity were similar in sarcolemmal membranes isolated from control and IUGR hindlimb skeletal muscle. Activity of Na<sup>+</sup> K<sup>+</sup> -ATPase, which is responsible for establishing the sodium gradient necessary for system A and N amino acid transporter function, was significantly reduced in IUGR skeletal muscle sarcolemma compared to control. ATP content was lower in IUGR skeletal muscle. Expression and phosphorylation of proteins in the mTOR pathway were similar in control and IUGR skeletal muscle homogenate. Our data suggest that lower Na<sup>+</sup> K<sup>+</sup> -ATPase activity, which reduces the driving force for active amino acid transport, and lower ATP availability contribute to reduced amino acid uptake and protein synthesis in IUGR fetal skeletal muscle.</AbstractText>
          <AbstractText Label="ABSTRACT" NlmCategory="UNASSIGNED">Fetuses with intrauterine growth restriction (IUGR) have lower muscle mass that persists postnatally. Using a sheep model of placental insufficiency and IUGR, we have previously demonstrated lower net total uptake of amino acids by the fetal hindlimb and lower skeletal muscle protein synthesis rates. To investigate the mechanisms underlying these changes, we tested the hypothesis that ex vivo amino acid transporter and Na<sup>+</sup> K<sup>+</sup> -ATPase activity is reduced, and ex vivo ATP levels are lower in hindlimb skeletal muscle of the IUGR fetus. We developed a novel protocol to measure transporter mediated histidine uptake, system L amino acid transporter activity, and Na<sup>+</sup> K<sup>+</sup> -ATPase activity using sarcolemmal membranes isolated from hindlimb muscle of control (CON, n = 11-12) and IUGR (n = 12) late gestation fetal sheep. We also determined ATP content and the activity of insulin and mTOR signalling, which are involved in regulating cellular amino acid uptake and protein synthesis, by measuring the expression and phosphorylation of AKT, 4E-BP1, eIF2α, AMPKα, p70 S6 kinase and rpS6 in muscle homogenates. Transporter mediated histidine uptake and system L activity were similar in control and IUGR sarcolemma, but ex vivo Na<sup>+</sup> K<sup>+</sup> -ATPase activity was lower by 64% (P = 0.019) in IUGR sarcolemma. ATP content was lower by 25% (P = 0.007) in IUGR muscle. Insulin, AMPK, and mTOR signalling activity was similar in control and IUGR muscle. We speculate that reduced muscle sarcolemmal Na<sup>+</sup> K<sup>+</sup> -ATPase activity and lower ATP content diminishes the sodium gradient in vivo, resulting in a reduced driving force for sodium dependent transporters and subsequently lower muscle amino acid uptake. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stremming</LastName>
            <ForeName>Jane</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8517-2463</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jansson</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Powell</LastName>
            <ForeName>Theresa L</ForeName>
            <Initials>TL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rozance</LastName>
            <ForeName>Paul J</ForeName>
            <Initials>PJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8835-9832</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>Laura D</ForeName>
            <Initials>LD</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0292-5029</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Physiol</MedlineTA>
        <NlmUniqueID>0266262</NlmUniqueID>
        <ISSNLinking>0022-3751</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">fetal development</Keyword>
        <Keyword MajorTopicYN="N">fetal programming</Keyword>
        <Keyword MajorTopicYN="N">skeletal muscle</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909825</ArticleId>
        <ArticleId IdType="doi">10.1113/JP278933</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909826</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-9861</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of comparative neurology</Title>
          <ISOAbbreviation>J. Comp. Neurol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The astrocyte network in the ventral nerve cord neuropil of the Drosophila third-instar larva.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cne.24852</ELocationID>
        <Abstract>
          <AbstractText>Understanding neuronal function at the local and circuit level requires understanding astrocyte function. We have provided a detailed analysis of astrocyte morphology and territory in the Drosophila 3<sup>rd</sup> -instar VNC where there already exists considerable understanding of the neuronal network. Astrocyte shape varies more than previously reported; many have bilaterally symmetrical partners, many have a high percentage of their arborization in adjacent segments, and many have branches that follow structural features. Taken together, our data are consistent with, but not fully explained by, a model of a developmental growth process dominated by competitive or repulsive interactions between astrocytes. Our data suggest that the model also should include cell-autonomous aspects, as well as use of structural features for growth. Variation in location of arborization territory for identified astrocytes was great enough that a standardized scheme of neuropil division among the six astrocytes that populate each hemi-segment is not possible at the 3<sup>rd</sup> instar. The arborizations of the astrocytes can extend across neuronal functional domains. The ventral astrocyte in particular, whose territory can extend well into the proprioceptive region of the neuropil, has no obvious branching pattern that correlates with domains of particular sensory modalities, suggesting that the astrocyte would respond to neuronal activity in any of the sensory modalities, perhaps integrating across them. This study sets the stage for future studies that will generate a robust, functionally-oriented connectome that includes both partners in neuronal circuits - the neurons and the glial cells, providing the foundation necessary for studies to elucidate neuron-glia interactions in this neuropil. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hernandez</LastName>
            <ForeName>Ernesto</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Illinois at Chicago School of Medicine, 1601 Parkview Ave, Rockford, IL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>MacNamee</LastName>
            <ForeName>Sarah E</ForeName>
            <Initials>SE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inscopix, 2452 Embarcadero Way, Palo Alto, CA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaplan</LastName>
            <ForeName>Leah R</ForeName>
            <Initials>LR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Consortium for Science, Policy &amp; Outcomes, Arizona State University, 1800 I St NW, Suite 300, Washington, DC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lance</LastName>
            <ForeName>Kim</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garcia-Verdugo</LastName>
            <ForeName>Hector D</ForeName>
            <Initials>HD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farhadi</LastName>
            <ForeName>Dara S</ForeName>
            <Initials>DS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Medicine - Phoenix, 475 N 5th St, University of Arizona, Phoenix, AZ.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deer</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University Information Technology Service, Research Technologies Group, Data Visualization Team, University of Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Si Woo</ForeName>
            <Initials>SW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oland</LastName>
            <ForeName>Lynne A</ForeName>
            <Initials>LA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9296-6923</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Arizona, Tucson, AZ.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Comp Neurol</MedlineTA>
        <NlmUniqueID>0406041</NlmUniqueID>
        <ISSNLinking>0021-9967</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">glial cells</Keyword>
        <Keyword MajorTopicYN="N">neuron-glia interaction</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909826</ArticleId>
        <ArticleId IdType="doi">10.1002/cne.24852</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909827</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4679</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical psychology</Title>
          <ISOAbbreviation>J Clin Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Psychotherapy for veterans navigating the military-to-civilian transition: A case study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jclp.22924</ELocationID>
        <Abstract>
          <AbstractText>Veterans face a range of challenges as they transition out of the military and into civilian life. For some, this period of transition is characterized by loss of identity, loss of daily structure, loss of community, and confusion about where they fit within society. If not attended to, problems associated with the military-to-civilian transition can lead to significant functional impairment. Yet, little is known about how psychotherapy can support this period of adjustment that every veteran will face. This article presents a case study of a veteran struggling to adjust to the civilian world following his service in the military. Critical areas of assessment, conceptualization, and intervention are explicated to help inform best practices for mental health providers working with veterans.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stevenson</LastName>
            <ForeName>Brian J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>VISN 1 New England Mental Illness Research, Education and Clinical Center, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Psychol</MedlineTA>
        <NlmUniqueID>0217132</NlmUniqueID>
        <ISSNLinking>0021-9762</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">identity</Keyword>
        <Keyword MajorTopicYN="N">masculinity</Keyword>
        <Keyword MajorTopicYN="N">men</Keyword>
        <Keyword MajorTopicYN="N">psychotherapy</Keyword>
        <Keyword MajorTopicYN="N">transition</Keyword>
        <Keyword MajorTopicYN="N">veterans</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909827</ArticleId>
        <ArticleId IdType="doi">10.1002/jclp.22924</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Addis, M. E., &amp; Mahalik, J. R. (2003). Men, masculinity, and the contexts of help-seeking. American Psychologist, 58(1), 5-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Atuel, H. R., &amp; Castro, C. A. (2018). Military cultural competence. Clinical Social Work Journal, 46, 74-82. https://doi.org/10.1007/s10615-018-0651-z</Citation>
        </Reference>
        <Reference>
          <Citation>Crawford, E. F., Elbogen, E. B., Wagner, H. R., Kudler, H., Calhoun, P. S., Brancu, M., &amp; Straits-Troster, K. A. (2015). Surveying treatment preferences in U.S. Iraq-Afghanistan veterans with PTSD symptoms: A step toward veteran-centered care. Journal of Traumatic Stress, 28(2), 118-126. https://doi.org/10.1002/jts.21993</Citation>
        </Reference>
        <Reference>
          <Citation>Duffy, R. D., Blustein, D. L., Diemer, M. A., &amp; Autin, K. L. (2016). The psychology of working theory. Journal of Counseling Psychology, 63(2), 127-148. https://doi.org/10.1037/cou0000140</Citation>
        </Reference>
        <Reference>
          <Citation>Englar-Carlson, M., &amp; Kiselica, M. S. (2013). Affirming the strengths in men: A positive masculinity approach to assisting male clients. Journal of Counseling &amp; Development, 91(4), 399-409.</Citation>
        </Reference>
        <Reference>
          <Citation>Erikson, E. H. (1959). Identity and the life cycle: Selected papers. Psychological Issues, 1, 1-171.</Citation>
        </Reference>
        <Reference>
          <Citation>Gottfredson, L. S. (2005). Using Gottfredson's theory of circumscription and compromise in career guidance and counseling. In S. D. Brown &amp; R. W. Lent (Eds.), Career development and counseling: Putting theory and research to work (pp. 71-100). New York, NY: Wiley.</Citation>
        </Reference>
        <Reference>
          <Citation>Hammer, J. H., &amp; Good, G. E. (2010). Positive psychology: An empirical examination of beneficial aspects of endorsement of masculine norms. Psychology of Men &amp; Masculinity, 11, 303-318. https://doi.org/10.1037a0019056</Citation>
        </Reference>
        <Reference>
          <Citation>Kiselica, M. S., &amp; Englar-Carlson, M. (2010). Identifying, affirming, and building upon male strengths: The positive psychology/positive masculinity model of psychotherapy with boys and men. Psychotherapy: Theory, Research, Practice, Training, 47(3), 276-287.</Citation>
        </Reference>
        <Reference>
          <Citation>Linehan, M. M. (2014). DBT skills training handout and worksheets (2nd ed.). New York, NY: The Guilford Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Litz, B. T., Stein, N., Delaney, E., Lebowitz, L., Nash, W. P., Silva, C., &amp; Maguen, S. (2009). Moral injury and moral repair in war veterans: A preliminary model and intervention strategy. Clinical Psychology Review, 29, 695-706. https://doi.org/10.1016/j.cpr.2009.07.003</Citation>
        </Reference>
        <Reference>
          <Citation>Mittal, D., Drummond, K. L., Blevins, D., Curran, G., Corrigan, P., &amp; Sullivan, G. (2013). Stigma associated with PTSD: Perceptions of treatment-seeking combat veterans. Psychiatric Rehabilitation Journal, 36(2), 86-92. https://doi.org/10.1037/h0094976</Citation>
        </Reference>
        <Reference>
          <Citation>Mobbs, M. C., &amp; Bonanno, G. A. (2018). Beyond war and PTSD: The crucial role of transition stress in the lives of military veterans. Clinical Psychology Review, 59, 137-144. https://doi.org/10.1016/j.cpr.2017.11.007</Citation>
        </Reference>
        <Reference>
          <Citation>Richardson, M. S. (2012). Counseling for work and relationships. The Counseling Psychologist, 40(2), 190-242. https://doi.org/10.1177/0011000011406452</Citation>
        </Reference>
        <Reference>
          <Citation>Stevenson, B. J., Gorman, J. A., Crossman, D. M., &amp; Mueller, L. (2019). Integrating vocational counseling and assessment within psychiatric rehabilitation: A call to the field from veterans in recovery. Chicago, IL: Poster presented at the American Psychological Association Convention.</Citation>
        </Reference>
        <Reference>
          <Citation>Stevenson, B. J., Thrower, S., Mueller, L., &amp; Kelly, M. M. (2019). Social-environmental predictors of vocational identity in veterans with co-occurring mental health and substance use disorders. Manuscript submitted for publication.</Citation>
        </Reference>
        <Reference>
          <Citation>Yanos, P. T., Roe, D., &amp; Lysaker, P. H. (2010). The impact of illness identity on recovery from severe mental illness. American Journal of Psychiatric Rehabilitation, 13(2), 73-93. https://doi.org/10.1080/15487761003756860</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909828</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2052</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Animal genetics</Title>
          <ISOAbbreviation>Anim. Genet.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genome-enable prediction for health traits using high-density SNP panel in US Holstein cattle.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/age.12892</ELocationID>
        <Abstract>
          <AbstractText>The objective of this study was to compare accuracies of different Bayesian regression models in predicting molecular breeding values for health traits in Holstein cattle. The dataset was composed of 2505 records reporting the occurrence of retained fetal membranes (RFM), metritis (MET), mastitis (MAST), displaced abomasum (DA), lameness (LS), clinical endometritis (CE), respiratory disease (RD), dystocia (DYST) and subclinical ketosis (SCK) in Holstein cows, collected between 2012 and 2014 in 16 dairies located across the US. Cows were genotyped with the Illumina BovineHD (HD, 777K). The quality controls for SNP genotypes were HWE P-value of at least 1 × 10<sup>-10</sup> ; MAF greater than 0.01 and call rate greater than 0.95. The FImpute program was used for imputation of missing SNP markers. The effect of each SNP was estimated using the Bayesian Ridge Regression (BRR), Bayes A, Bayes B and Bayes Cπ methods. The prediction quality was assessed by the area under the curve, the prediction mean square error and the correlation between genomic breeding value and the observed phenotype, using a leave-one-out cross-validation technique that avoids iterative cross-validation. The highest accuracies of predictions achieved were: RFM [Bayes B (0.34)], MET [BRR (0.36)], MAST [Bayes B (0.55), DA [Bayes Cπ (0.26)], LS [Bayes A (0.12)], CE [Bayes A (0.32)], RD [Bayes Cπ (0.23)], DYST [Bayes A (0.35)] and SCK [Bayes Cπ (0.38)] models. Except for DA, LS and RD, the predictive abilities were similar between the methods. A strong relationship between the predictive ability and the heritability of the trait was observed, where traits with higher heritability achieved higher accuracy and lower bias when compared with those with low heritability. Overall, it has been shown that a high-density SNP panel can be used successfully to predict genomic breeding values of health traits in Holstein cattle and that the model of choice will depend mostly on the genetic architecture of the trait.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Animal Genetics published by John Wiley &amp; Sons Ltd on behalf of Stichting International Foundation for Animal Genetics.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lopes</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, University of Wisconsin, Madison, WI, 53706, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosa</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, University of Wisconsin, Madison, WI, 53706, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pinedo</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7111-3377</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, Colorado State University, Fort Collins, CO, 80521, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>J E P</ForeName>
            <Initials>JEP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chebel</LastName>
            <ForeName>R C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galvao</LastName>
            <ForeName>K N</ForeName>
            <Initials>KN</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schuenemann</LastName>
            <ForeName>G M</ForeName>
            <Initials>GM</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, The Ohio State University, Columbus, OH, 43210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bicalho</LastName>
            <ForeName>R C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Cornell University, Ithaca, NY, 14850, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gilbert</LastName>
            <ForeName>R O</ForeName>
            <Initials>RO</Initials>
            <AffiliationInfo>
              <Affiliation>School of Veterinary Medicine, Ross University, Saint Kitts, Saint Kitts and Nevis, West Indies.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodrigez-Zas</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, University of Illinois, Urbana-Champaign, IL, 61790, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seabury</LastName>
            <ForeName>C M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Texas A&amp;M University, College Station, TX, 77843, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thatcher</LastName>
            <ForeName>W</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Sciences, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2013-68004</GrantID>
            <Agency>USDA NIFA AFRI Translational Genomics for Improved Fertility of Animals</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Anim Genet</MedlineTA>
        <NlmUniqueID>8605704</NlmUniqueID>
        <ISSNLinking>0268-9146</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bayesian regression models</Keyword>
        <Keyword MajorTopicYN="N">dairy</Keyword>
        <Keyword MajorTopicYN="N">genomic prediction</Keyword>
        <Keyword MajorTopicYN="N">reproduction</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909828</ArticleId>
        <ArticleId IdType="doi">10.1111/age.12892</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Bauman D.E. &amp; Currie W.B. (1980) Partitioning of nutrients during pregnancy and lactation: a review of mechanisms involving homeostasis and homeorhesis. Journal of Dairy Science 63, 1514-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Bolormaa S., Pryce J.E., Kemper K.E., Hayes B.J., Zhang Y., Tier B., Barendse W., Reverter A. &amp; Goddard M.E. (2013a) Detection of quantitative trait loci in Bos indicus and Bos taurus cattle using genome-wide association studies. Genetetics Selection Evolution 45, 43.</Citation>
        </Reference>
        <Reference>
          <Citation>Bolormaa S., Pryce J.E., Kemper K. et al. (2013b) Accuracy of prediction of genomic breeding values for residual feed intake and carcass and meat quality traits in Bos taurus, Bos indicus, and composite beef cattle. Journal of Animal Science 91, 3088-104.</Citation>
        </Reference>
        <Reference>
          <Citation>de los Campos G., Hickey J.M., Pong-Wong R., Daetwyler H.D. &amp; Calus M.P.L. (2013) Whole-genome regression and prediction methods applied to plant and animal breeding. Genetics 193, 327-45.</Citation>
        </Reference>
        <Reference>
          <Citation>de los Campos G. &amp; Pérez-Rodríguez P. (2014) Bayesian Generalized Linear Regression. R package version 1.0.4. Available at: http://CRAN.R-project.org/package=BGLR (accessed August 1, 2019).</Citation>
        </Reference>
        <Reference>
          <Citation>Daetwyler H.D., Pong-Wong R., Villanueva B. &amp; Woolliams J.A. (2010) The impact of genetic architecture on genome-wide evaluation methods. Genetics 185, 1021-31.</Citation>
        </Reference>
        <Reference>
          <Citation>Fernandes Júnior G.A., Rosa G.J.M., Valente B.D. et al. (2016) Genomic prediction of breeding values for carcass traits in Nellore cattle. Genetetics Selection Evolution 48, 7.</Citation>
        </Reference>
        <Reference>
          <Citation>Gagneur J.M., Elze C. &amp; Tresch A. (2011) Selective phenotyping, entropy reduction, and the mastermind game. BMC Bioinformatics 12, 406.</Citation>
        </Reference>
        <Reference>
          <Citation>Gelfand A.E. &amp; Sahu S.K. (1999) Identifiability, improper priors and Gibbs sampling for generalized linear models. Journal of the American Statistical Association 94, 247-53.</Citation>
        </Reference>
        <Reference>
          <Citation>Gelfand M.S. (1992) Statistical analysis and prediction of the exonic structure of human genes. Journal of Molecular Evolution 35, 239-52.</Citation>
        </Reference>
        <Reference>
          <Citation>Gelman A. &amp; Rubin D.B. (1992) Inference from iterative simulation using multiple sequences. Statistical Science 7, 457-72.</Citation>
        </Reference>
        <Reference>
          <Citation>Geweke J. (1992) Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments. In: Bayesian Statistics 4 (Ed. by J.M. Bernardo, J.O. Berger, A.P. Dawid &amp; A.F.M. Smith), pp 169-93. Oxford University Press, Oxford, UK.</Citation>
        </Reference>
        <Reference>
          <Citation>Gianola D. (2013) Priors in whole-genome regression: the Bayesian alphabet returns. Genetics 194, 573-96.</Citation>
        </Reference>
        <Reference>
          <Citation>Gianola D. &amp; Schön C.C. (2016) Cross-validation without doing cross-validation in genome-enabled prediction. G3: Genes|Genomes|Genetics 6, 3107-28.</Citation>
        </Reference>
        <Reference>
          <Citation>Goff J.P. (2004) Macromineral disorders of the transition cow. Veterinary Clinics of North America: Food Animal Practice 20, 471-94.</Citation>
        </Reference>
        <Reference>
          <Citation>Habier D., Fernando R.L., Kizilkaya K. &amp; Garrick D.J. (2011) Extension of the Bayesian alphabet for genomic selection. BMC Bioinformatics 12, 186.</Citation>
        </Reference>
        <Reference>
          <Citation>Hammon D.S., Evjen I.M., Dhiman T.R., Goff J.P. &amp; Walters J.L. (2006) Neutrophil function and energy status in Holstein cows with uterine health disorders. Veterinary Immunology and Immunopathology 113, 21-9.</Citation>
        </Reference>
        <Reference>
          <Citation>König S. &amp; May K. (2019) Invited review: Phenotyping strategies and quantitative-genetic background of resistance, tolerance and resilience associated traits in dairy cattle. Animal 13, 897-908.</Citation>
        </Reference>
        <Reference>
          <Citation>LeBlanc S.J., Lissemore K.D., Kelton D.F., Duffield T.F. &amp; Leslie K.E. (2006) Major advances in disease prevention in dairy cattle. Journal of Dairy Science 89, 1267-79.</Citation>
        </Reference>
        <Reference>
          <Citation>Madsen P. &amp; Jensen J. (2008) A User's Guide to DMU. A Package for Analysing Multivariate Mixed Models. Version 6. Release 4.7. Danish Institute of Agricultural Sciences, Tjele.</Citation>
        </Reference>
        <Reference>
          <Citation>Magnabosco C.U., Lopes F.B., Fragoso R.C., Eifert E.C., Valente B.D., Rosa G.J. &amp; Sainz R.D. (2016) Accuracy of genomic breeding values for meat tenderness in Polled Nellore cattle. Journal of Animal Science 94, 2752-60.</Citation>
        </Reference>
        <Reference>
          <Citation>Meuwissen T.H.E., Hayes B.J. &amp; Goddard M.E. (2001) Prediction of total genetic value using genome-wide dense marker maps. Genetics 157, 1819-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Miar Y., Plastow G.S., Bruce H.L., Moore S.S., Durunna O.N., Nkrumah J.D. &amp; Wang Z. (2014) Estimation of genetic and phenotypic parameters for ultrasound and carcass merit traits in crossbred beef cattle. Canadian Journal of Animal Science 94, 273-80.</Citation>
        </Reference>
        <Reference>
          <Citation>Neves H.H., Carvalheiro R., Brien A.M.O. et al. (2014) Accuracy of genomic predictions in Bos indicus (Nellore) cattle. Genetics Selection Evolution 46, 17.</Citation>
        </Reference>
        <Reference>
          <Citation>Pérez P., de los Campos G., Crossa J. &amp; Gianola D. (2010) Genomic-enabled prediction based on molecular markers and pedigree using the Bayesian linear regression package in R. Plant Genome Journal 3, 106.</Citation>
        </Reference>
        <Reference>
          <Citation>Ribeiro E.S., Lima F.S., Greco L.F. et al. (2013) Prevalence of periparturient diseases and effects on fertility of seasonally calving grazing dairy cows supplemented with concentrates. Journal of Dairy Science 96, 5682-97.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosa G.J.M., Padovani C.R. &amp; Gianola D. (2003) Robust linear mixed models with normal/independent distributions and Bayesian MCMC implementation. Biometrical Journal 45, 573-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Santos J.E.P., Bisinotto R.S., Ribeiro E.S., Lima F.S., Greco L.F., Staples C.R. &amp; Thatcher W.W. (2010) Applying nutrition and physiology to improve reproduction in dairy cattle. Reproduction and Fertility Supplement 67, 387-403.</Citation>
        </Reference>
        <Reference>
          <Citation>Sargolzaei M., Chesnais J. &amp; Schenkel F.S. (2014) FImpute Users’ Guide. 17. Available at: http://animalbiosciences.uoguelph.ca/~msargol/fimpute/ (accessed June 1, 2019).</Citation>
        </Reference>
        <Reference>
          <Citation>Vehtari A., Gelman A. &amp; Gabry J. (2017) Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Statistics and Computing 27, 1413-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Weller J.I., Ezra E. &amp; Ron M. (2017) Invited review: A perspective on the future of genomic selection in dairy cattle. Journal of Dairy Science 100, 8633-44.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909829</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1930-7837</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>12</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of dental education</Title>
          <ISOAbbreviation>J Dent Educ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>2020: A new inflection point.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jdd.12010</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Reddy</LastName>
            <ForeName>Michael S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Univesity of California, San Francisco School of Dentistry, San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Dent Educ</MedlineTA>
        <NlmUniqueID>8000150</NlmUniqueID>
        <ISSNLinking>0022-0337</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>D</CitationSubset>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909829</ArticleId>
        <ArticleId IdType="doi">10.1002/jdd.12010</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Cotter JC, Wilson KJ, Mallonee LF. Impact of HPV immunization training on dental hygiene students’ attitudes and confidence regarding HPV preventive education. J Dent Educ. 2019. published online ahead of print 14 Oct.</Citation>
        </Reference>
        <Reference>
          <Citation>Chaffee BW, Urata J, Silverstein S, Couch ET. Dental hygienists’ and dentists’ tobacco cessation continuing education preferences: application of a discrete choice method. J Dent Educ. 2019. published online ahead of print 14 Oct.</Citation>
        </Reference>
        <Reference>
          <Citation>Natto ZS. Dental students’ knowledge and attitudes about electronic cigarettes: a cross-sectional study at one Saudi university. J Dent Educ. 2019. Published online ahead of print 14 Oct.</Citation>
        </Reference>
        <Reference>
          <Citation>Partido BB, Henderson RP, Kennedy M. Improving the awareness of musculoskeletal disorder risks among dental educators. J Dent Educ. 2019. published online ahead of print 14 Oct.</Citation>
        </Reference>
        <Reference>
          <Citation>Kolcu MIB, Öztürkçü OSK, Kaki GD. Evaluation of a distance education course using the 4C-ID model for continuing endodontics education. J Dent Educ. 2019. published online ahead of print 12 Aug.</Citation>
        </Reference>
        <Reference>
          <Citation>Canares G, Dhar V. Pediatric dental residency program directors’ perspectives on and use of social media for resident selection and education. J Dent Educ. 2019. published online ahead of print 9 Sept.</Citation>
        </Reference>
        <Reference>
          <Citation>Gorucu-Coskuner H, Atik E, Taner T. Comparison of live-video and video demonstration methods in clinical orthodontics education. J Dent Educ. 2019. Published online ahead of print 23 Sept.</Citation>
        </Reference>
        <Reference>
          <Citation>Should Dental Schools Consider Term Limits for Deans? Two Viewpoints. Coplen AE, Branco de Costa J, Drukteines SE Should Dental Schools Consider Term Limits for Deans? Two Viewpoints. Viewpoint 1: dental school deans should have term limits. Everett, RJ, González-Cabezas, C, Younai, FS. Viewpoint 2: dental school deans should not have term limits. J Dent Educ. 2019. published online ahead of print 23 Sept.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909831</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2567</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Immunology</Title>
          <ISOAbbreviation>Immunology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>CD8α<sup>-</sup> conventional dendritic cells control Vβ T cell immunity in response to Staphylococcus aureus infection in mice.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/imm.13171</ELocationID>
        <Abstract>
          <AbstractText>Dendritic cells (DCs) are potent immune cells that control innate and adaptive immune responses. Previous studies have shown that the DCs are required for protection against Staphylococcus aureus (S. aureus) infection. However, the role of conventional DC (cDC) subsets during S. aureus infection in vivo has not been well investigated. In this study, we examined the function of spleen DC subsets in the activation of immunity against S. aureus infection. C57BL/6 mice were infected intravenously with S. aureus and DC and T cell activation were analyzed in vivo. We found that the spleen CD8α<sup>-</sup> cDCs phagocytosed S. aureus more efficiently than type-1 conventional DCs (cDC1s) did. Moreover, the CD8α<sup>-</sup> cDCs contributed to the production of pro-inflammatory cytokines in response to S. aureus infection, while the cDC1s did not. In addition, infection with S. aureus promoted an increase in the number of Vβ T cells. The CD4<sup>+</sup> and CD8<sup>+</sup> Vβ T cells upregulated the production of interferon-gamma (IFN-γ) and interleukin-17 (IL-17) in response to S. aureus infection. Importantly, the induction of IFN-γ and IL-17 production in CD4<sup>+</sup> and CD8<sup>+</sup> Vβ T cells was mediated by S. aureus-stimulated CD8α<sup>-</sup> cDCs, whereas cDC1s failed to promote IFN-γ and IL-17 production in the cells. Therefore, these data suggested that the spleen CD8α<sup>-</sup> cDCs are the main DC subsets for induction of S. aureus superantigen specific immunity.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Shanghai Public Health Clinical Center &amp; Institutes of Biomedical Sciences, Fudan University, Shanghai, 201508, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Shanghai Public Health Clinical Center &amp; Institutes of Biomedical Sciences, Fudan University, Shanghai, 201508, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xiaoyan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Shanghai Public Health Clinical Center &amp; Institutes of Biomedical Sciences, Fudan University, Shanghai, 201508, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Jianqing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Shanghai Public Health Clinical Center &amp; Institutes of Biomedical Sciences, Fudan University, Shanghai, 201508, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Jun-O</ForeName>
            <Initials>JO</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4216-8111</Identifier>
            <AffiliationInfo>
              <Affiliation>Shanghai Public Health Clinical Center &amp; Institutes of Biomedical Sciences, Fudan University, Shanghai, 201508, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Immunology</MedlineTA>
        <NlmUniqueID>0374672</NlmUniqueID>
        <ISSNLinking>0019-2805</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
Staphylococcus aureus
</Keyword>
        <Keyword MajorTopicYN="N">CD8α- dendritic cells</Keyword>
        <Keyword MajorTopicYN="N">IFN-γ</Keyword>
        <Keyword MajorTopicYN="N">IL-17</Keyword>
        <Keyword MajorTopicYN="N">Vβ T cells</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909831</ArticleId>
        <ArticleId IdType="doi">10.1111/imm.13171</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909830</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-987X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of computational chemistry</Title>
          <ISOAbbreviation>J Comput Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>fromage: A library for the study of molecular crystal excited states at the aggregate scale.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcc.26144</ELocationID>
        <Abstract>
          <AbstractText>The study of photoexcitations in molecular aggregates faces the twofold problem of the increased computational cost associated with excited states and the complexity of the interactions among the constituent monomers. A mechanistic investigation of these processes requires the analysis of the intermolecular interactions, the effect of the environment, and 3D arrangements or crystal packing on the excited states. A considerable number of techniques have been tailored to navigate these obstacles; however, they are usually restricted to in-house codes and thus require a disproportionate effort to adopt by researchers approaching the field. Herein, we present the FRamewOrk for Molecular AGgregate Excitations (fromage), which implements a collection of such techniques in a Python library complemented with ready-to-use scripts. The program structure is presented and the principal features available to the user are described: geometrical analysis, exciton characterization, and a variety of ONIOM schemes. Each is illustrated by examples of diverse organic molecules in condensed phase settings. The program is available at https://github.com/Crespo-Otero-group/fromage.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Journal of Computational Chemistry published by Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rivera</LastName>
            <ForeName>Miguel</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3699-2403</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dommett</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sidat</LastName>
            <ForeName>Amir</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rahim</LastName>
            <ForeName>Warda</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crespo-Otero</LastName>
            <ForeName>Rachel</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8725-5350</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>EP/L000202/1</GrantID>
            <Agency>Engineering and Physical Sciences Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>EP/P020194/1</GrantID>
            <Agency>Engineering and Physical Sciences Research Council</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>EP/R029385/1</GrantID>
            <Agency>Engineering and Physical Sciences Research Council</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Comput Chem</MedlineTA>
        <NlmUniqueID>9878362</NlmUniqueID>
        <ISSNLinking>0192-8651</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ONIOM</Keyword>
        <Keyword MajorTopicYN="N">Python library</Keyword>
        <Keyword MajorTopicYN="N">exciton</Keyword>
        <Keyword MajorTopicYN="N">molecular aggregate</Keyword>
        <Keyword MajorTopicYN="N">photochemistry</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909830</ArticleId>
        <ArticleId IdType="doi">10.1002/jcc.26144</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>J. Aragó, A. Troisi, Phys. Rev. Lett. 2015, 114, 026402.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Dovesi, A. Erba, R. Orlando, C. M. Zicovich-Wilson, B. Civalleri, L. Maschio, M. Rérat, S. Casassa, J. Baima, S. Salustro, B. Kirtman, Wiley Interdiscip. Rev. Comput. Mol. Sci. 2018, 8, e1360.</Citation>
        </Reference>
        <Reference>
          <Citation>C. R. Groom, I. J. Bruno, M. P. Lightfoot, S. C. Ward, Acta Crystallogr. Sect. B 2016, 72, 171.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Hjorth Larsen, J. Jørgen Mortensen, J. Blomqvist, I. E. Castelli, R. Christensen, M. Du lak, J. Friis, M. N. Groves, B. Hammer, C. Hargus, E. D. Hermes, P. C. Jennings, P. Bjerre Jensen, J. Kermode, J. R. Kitchin, E. Leonhard Kolsbjerg, J. Kubal, K. Kaasbjerg, S. Lysgaard, J. Bergmann Maronsson, T. Maxson, T. Olsen, L. Pastewka, A. Peterson, C. Rostgaard, J. Schiøtz, O. Schütt, M. Strange, K. S. Thygesen, T. Vegge, L. Vilhelmsen, M. Walter, Z. Zeng, K. W. Jacobsen, J. Phys. Condens. Matter 2017, 273002, 29.</Citation>
        </Reference>
        <Reference>
          <Citation>RDKit: Open-Source Cheminformatics, http://www.rdkit.org (accessed 1st of January 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Lu, M. R. Farrow, P. Fayon, A. J. Logsdail, A. A. Sokol, C. R. A. Catlow, P. Sherwood, T. W. Keal, J. Chem. Theory Comput. 2019, 15, 1317.</Citation>
        </Reference>
        <Reference>
          <Citation>A. V. Akimov, J. Comput. Chem. 2016, 37, 1626.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Aradi, B. Hourahine, T. Frauenheim, J. Phys. Chem. A 2007, 111, 5678.</Citation>
        </Reference>
        <Reference>
          <Citation>M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A. V. Marenich, J. Bloino, B. G. Janesko, R. Gomperts, B. Mennucci, H. P. Hratchian, J. V. Ortiz, A. F. Izmaylov, J. L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V. G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J. A. Montgomery Jr., J. E. Peralta, F. Ogliaro, M. J. Bearpark, J. J. Heyd, E. N. Brothers, K. N. Kudin, V. N. Staroverov, T. A. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. P. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, J. M. Millam, M. Klene, C. Adamo, R. Cammi, J. W. Ochterski, R. L. Martin, K. Morokuma, O. Farkas, J. B. Foresman, D. J. Fox, Gaussian 16 Revision B.01, Gaussian Inc., Wallingford, CT 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Aquilante, J. Autschbach, R. K. Carlson, L. F. Chibotaru, M. G. Delcey, L. De Vico, I. F. Galván, N. Ferré, L. M. Frutos, L. Gagliardi, M. Garavelli, A. Giussani, C. E. Hoyer, G. L. Manni, H. Lischka, D. Ma, P. Å. Malmqvist, T. Müller, A. Nenov, M. Olivucci, T. B. Pedersen, D. Peng, F. Plasser, B. Pritchard, M. Reiher, I. Rivalta, I. Schapiro, J. Segarra-Mart'ı, M. Stenrup, D. G. Truhlar, L. Ungur, A. Valentini, S. Vancoillie, V. Veryazov, V. P. Vysotskiy, O. Weingart, F. Zapata, R. Lindh, J. Comput. Chem. 2016, 37, 506.</Citation>
        </Reference>
        <Reference>
          <Citation>TURBOMOLE V6.2 2010, A Development of University of Karlsruhe and Forschungszentrum Karlsruhe GmbH, 1989-2007, TURBOMOLE GmbH, Since 2007. http://www.turbomole.com (accessed 1st of January 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>M. Rivera, M. Dommett, R. Crespo-Otero, J. Chem, Theory Comput. 2019, 15, 2504.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Stojanović, R. Crespo-Otero, ChemPhotoChem 2019, 3, 907. https://doi.org/10.1002/cptc.201900075</Citation>
        </Reference>
        <Reference>
          <Citation>M. Dommett, M. Rivera, M. T. H. Smith, R. Crespo-Otero, Chemrxiv 2019. https://doi.org/10.26434/chemrxiv.8283710.v1</Citation>
        </Reference>
        <Reference>
          <Citation>T. Oliphant, NumPy: A Guide to NumPy, Trelgol Publishing, Spanish Fork, UT 2006. http://www.numpy.org/.</Citation>
        </Reference>
        <Reference>
          <Citation>P. P. Eric Jones, Travis Oliphant, SciPy: Open Source Scientific Tools for Python, 2001. http://www.scipy.org/ (accessed 1st of January 2020).</Citation>
        </Reference>
        <Reference>
          <Citation>S. E. Derenzo, M. K. Klintenberg, M. J. Weber, J. Chem. Phys. 2000, 112, 2074.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Klintenberg, S. Derenzo, M. Weber, Comput. Phys. Commun. 2000, 131, 120.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Dommett, M. Rivera, R. Crespo-Otero, J. Phys. Chem. Lett. 2017, 8, 6148.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Crespo-Otero, Q. Li, L. Blancafort, Chem. Asian J. 2019, 14, 700.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Voronoi, J. Reine Angew. Math. 1907, 133, 97.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Procacci, R. Scateni, Int. J. Quantum Chem. 1992, 42, 1515.</Citation>
        </Reference>
        <Reference>
          <Citation>J. S. Hunjan, B. C. Eu, J. Chem. Phys. 2010, 132, 134510.</Citation>
        </Reference>
        <Reference>
          <Citation>J. L. Abascal, M. A. Gonzalez, J. L. Aragones, C. Valeriani, J. Chem. Phys. 2013, 138, 084508.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Menzl, M. A. Gonzalez, P. Geiger, F. Caupin, J. L. Abascal, C. Valeriani, C. Dellago, Proc. Natl. Acad. Sci. U.S.A. 2016, 113, 13582.</Citation>
        </Reference>
        <Reference>
          <Citation>X. Cheng, K. Wang, S. Huang, H. Zhang, H. Zhang, Y. Wang, Angew. Chem. Int. Ed. 2015, 54, 8369.</Citation>
        </Reference>
        <Reference>
          <Citation>N. I. Zahid, M. S. Mahmood, B. Subramanian, S. Mohd Said, O. K. Abou-Zied, J. Phys. Chem. Lett. 2017, 8, 5603.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Kasha, H. R. Rawls, M. Ashraf El-Bayoumi, Pure Appl. Chem. 1965, 11, 371.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Tang, H. Liu, F. Li, Y. Wang, H. Zhang, ChemComm 2016, 52, 6577.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Plasser, H. Lischka, J. Chem. Theory Comput. 2012, 8, 2777.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Plasser, Theodore: A Package for Theoretical Density, Orbital Relaxation, and Exciton Analysis, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Crespo-Otero, M. Barbatti, Theor. Chem. Acc. 2012, 131, 1237.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Sen, R. Crespo-Otero, O. Weingart, W. Thiel, M. Barbatti, J. Chem. Theory Comput. 2013, 9, 533.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Botoshansky, F. H. Herbstein, M. Kapon, Helv. Chim. Acta 2003, 86, 1113.</Citation>
        </Reference>
        <Reference>
          <Citation>F. C. Spano, D. Beljonne, Photophysical Properties of Molecular Aggregates "101", World Scientific, Hackensack 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Jurinovich, L. Cupellini, C. A. Guido, B. Mennucci, J. Comput. Chem. 2018, 39, 279.</Citation>
        </Reference>
        <Reference>
          <Citation>C.-P. Hsu, Acc. Chem. Res. 2009, 42, 509.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Gierschner, D. Oelkrug, H.-J. Egelhaaf, J. Phys. Chem. Lett. 2013, 4, 2686.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Shi, L. E. Aguilar Suarez, S. J. Yoon, S. Varghese, C. Serpa, S. Y. Park, L. Lüer, D. Roca-Sanjuán, B. Milián-Medina, J. Gierschner, J. Phys. Chem. C 2017, 121, 23166.</Citation>
        </Reference>
        <Reference>
          <Citation>P. F. Van Hutten, J. Wildeman, A. Meetsma, G. Hadziioannou, J. Am. Chem. Soc. 1999, 121, 5910.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Giannozzi, S. Baroni, N. Bonini, M. Calandra, R. Car, C. Cavazzoni, D. Ceresoli, G. L. Chiarotti, M. Cococcioni, I. Dabo, A. Dal Corso, S. de Gironcoli, S. Fabris, G. Fratesi, R. Gebauer, U. Gerstmann, C. Gougoussis, A. Kokalj, M. Lazzeri, L. Martin-Samos, N. Marzari, F. Mauri, R. Mazzarello, S. Paolini, A. Pasquarello, L. Paulatto, C. Sbraccia, S. Scandolo, G. Sclauzero, A. P. Seitsonen, A. Smogunov, P. Umari, R. M. Wentzcovitch, J. Phys. Condens. Matter 2009, 21, 395502.</Citation>
        </Reference>
        <Reference>
          <Citation>R. P. Fornari, P. Rowe, D. Padula, A. Troisi, J. Chem. Theory Comput. 2017, 13, 3754.</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Kochman, A. Bil, C. A. Morrison, Phys. Chem. Chem. Phys. 2013, 15, 10803.</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Kochman, C. A. Morrison, J. Chem. Theory Comput. 2013, 9, 1182.</Citation>
        </Reference>
        <Reference>
          <Citation>J. R.-G. Pedregal, I. Funes-Ardoiz, G. Sciortino, J.-E. Sánchez-Aparicio, G. Ujaque, A. Lledós, J.-D. Maréchal, F. Maseras, J. Comput. Chem. 2018, 40, 381-386.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Metz, J. Kästner, A. A. Sokol, T. W. Keal, P. Sherwood, Wiley Interdiscip. Rev. Comput. Mol. Sci. 2014, 4, 101.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Maseras, K. Morokuma, J. Comput. Chem. 1995, 16, 1170.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Humbel, S. Sieber, K. Morokuma, J. Chem. Phys. 1996, 105, 1959.</Citation>
        </Reference>
        <Reference>
          <Citation>L. W. Chung, W. M. C. Sameera, R. Ramozzi, A. J. Page, M. Hatanaka, G. P. Petrova, T. V. Harris, X. Li, Z. Ke, F. Liu, H.-B. Li, L. Ding, K. Morokuma, Chem. Rev. 2015, 115, 5678.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Presti, A. Pedone, I. Ciofini, F. Labat, M. C. Menziani, C. Adamo, Theor. Chem. Acc. 2016, 135, 86.</Citation>
        </Reference>
        <Reference>
          <Citation>H. P. Hratchian, P. V. Parandekar, K. Raghavachari, M. J. Frisch, T. Vreven, Journal of Chemical Physics 2008, 128, 034107.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Kittel, Introduction to solid state physics, 8th ed., John Wiley &amp; Sons, Inc., New York, NY 2005.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Kantorovich, Quantum theory of the solid state: An introduction, Springer Netherlands, Dordrecht 2004.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Weber, J. Schmedt auf der Günne, Phys. Chem. Chem. Phys. 2010, 12, 583.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Wilbraham, C. Adamo, F. Labat, I. Ciofini, J. Chem. Theory Comput. 2016, 12, 3316.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Wang, R. M. Wolf, J. W. Caldwell, P. A. Kollman, D. A. Case, J. Comput. Chem. 2004, 25, 1157.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Wang, W. Wang, P. A. Kollman, D. A. Case, J. Mol. Graph. 2006, 25, 247.</Citation>
        </Reference>
        <Reference>
          <Citation>B. G. Levine, J. D. Coe, T. J. Martınez, J. Phys. Chem. B 2008, 112, 405.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Gozem, F. Melaccio, A. Valentini, M. Filatov, M. Huix-Rotllant, N. Ferré, L. M. Frutos, C. Angeli, A. I. Krylov, A. A. Granovsky, R. Lindh, M. Olivucci, J. Chem. Theory Comput. 2014, 10, 3074.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Tuna, D. Lefrancois, L. Wolanśki, S. Gozem, I. Schapiro, T. Andruniów, A. Dreuw, M. Olivucci, J. Chem. Theory Comput. 2015, 11, 5758.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Crespo-Otero, A. Mardykov, E. Sanchez-Garcia, W. Sander, M. Barbatti, Phys. Chem. Chem. Phys. 2014, 16, 18877.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Barbatti, R. Crespo-Otero, Top. Curr. Chem. 2016, 368, 415.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Dommett, R. Crespo-Otero, Phys. Chem. Chem. Phys. 2017, 19, 2409.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Presti, F. Labat, A. Pedone, M. J. Frisch, H. P. Hratchian, I. Ciofini, M. C. Menziani, C. Adamo, J. Chem. Theory Comput. 2014, 10, 5577.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Presti, F. Labat, A. Pedone, M. J. Frisch, H. P. Hratchian, I. Ciofini, M. Cristina Menziani, C. Adamo, J. Comput. Chem. 2016, 37, 861.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Presti, L. Wilbraham, C. Targa, F. Labat, A. Pedone, M. C. Menziani, I. Ciofini, C. Adamo, J. Phys. Chem. B 2017, 121, 5747.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Y. Toukmaji, J. A. Board, Comput. Phys. Commun. 1996, 95, 73.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Sauer, Chem. Rev. 1989, 89, 199.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909832</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4679</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical psychology</Title>
          <ISOAbbreviation>J Clin Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Challenging the patient and therapist during evolving phases of a veteran's treatment within a strong public-private partnership.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jclp.22922</ELocationID>
        <Abstract>
          <AbstractText>Veterans Health Administration (VA) Medical Centers provide excellent care for many veterans. However, there are a number of veterans who are ineligible or choose not to access mental health treatment at the VA. To meet the needs of those veterans and of military family members, private centers have emerged to fill in gaps where care is unavailable or scarce. This paper describes how one such center, the Steven A. Cohen Military Family Center at NYU Langone Health, partnered with the local VA hospital to give one veteran ineligible for free mental health services the care he desperately needed. The case demonstrates the transformative work that can take place when public-private partnerships are forged and evidence-based treatments can be provided in a flexible way. It also illustrates the complexity of many veterans' presentations, which in this case required the therapist to continually challenge her conceptualization as she and the patient navigated different phases of his treatment.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Spray</LastName>
            <ForeName>Amanda M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, New York University School of Medicine, Steven A. Cohen Military Family Center, NYU Langone Health, New York City, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wen</LastName>
            <ForeName>Irina</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, New York University School of Medicine, Steven A. Cohen Military Family Center, NYU Langone Health, New York City, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Price</LastName>
            <ForeName>Laura E</ForeName>
            <Initials>LE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, New York University School of Medicine, Steven A. Cohen Military Family Center, NYU Langone Health, New York City, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marmar</LastName>
            <ForeName>Charles R</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, New York University School of Medicine, Steven A. Cohen Military Family Center, NYU Langone Health, New York City, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Psychol</MedlineTA>
        <NlmUniqueID>0217132</NlmUniqueID>
        <ISSNLinking>0021-9762</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cognitive behavioral therapy</Keyword>
        <Keyword MajorTopicYN="N">cognitive processing therapy</Keyword>
        <Keyword MajorTopicYN="N">military families</Keyword>
        <Keyword MajorTopicYN="N">partnerships</Keyword>
        <Keyword MajorTopicYN="N">veterans</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909832</ArticleId>
        <ArticleId IdType="doi">10.1002/jclp.22922</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>APA Presidential Task Force on Evidence-Based Practice (2006). Evidence-based practice in psychology. American Psychologist, 61(6), 271-285.</Citation>
        </Reference>
        <Reference>
          <Citation>Brown, R. L., &amp; Rounds, L. A. (1995). Conjoint screening questionnaires for alcohol and other drug abuse: Criterion validity in a primary care practice. Wisconsin Medical Journal, 94, 135-140.</Citation>
        </Reference>
        <Reference>
          <Citation>Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., &amp; Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Archives of Internal Medicine, 158(16), 1789-1795. https://doi.org/10.1001/archinte.158.16.1789</Citation>
        </Reference>
        <Reference>
          <Citation>Endicott, J., Nee, J., Harrison, W., &amp; Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacology Bulletin, 29, 321-326.</Citation>
        </Reference>
        <Reference>
          <Citation>Engel, A. G., Malta, L. S., Davies, C. A., &amp; Baker, M. M. (2011). Clinical effectiveness of using an integrated model to treat depressive symptoms in veterans affairs primary care clinics and its impact on health care utilization. The primary care companion for CNS disorders, 13(4), PCC.10m01096.</Citation>
        </Reference>
        <Reference>
          <Citation>Farmer, C. M., Jaycox, L. H., Marshall, G. N., Schell, T. L., Tanielian, T., Vaughn, C. A., &amp; Wrenn, G. (2011). A Needs Assessment of New York State Veterans: Final Report to the New York State Health Foundation. Santa Monica, CA: RAND Corporation. Retrieved from https://www.rand.org/pubs/technical_reports/TR920</Citation>
        </Reference>
        <Reference>
          <Citation>Foa, E., Hembree, E., &amp; Rothbaum, B. (2007). Prolonged exposure therapy for PTSD: Therapists guide. New York, NY: Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Karlin, B. E., Ruzek, J. I., Chard, K. M., Eftekhari, A., Monson, C., Hembree, E. A., … Foa, E. B. (2010). Dissemination of evidence-based psychological treatments for posttraumatic stress disorder in the Veterans Health Administration. Journal of Traumatic Stress, 23(6), 663-673.</Citation>
        </Reference>
        <Reference>
          <Citation>Kroenke, K., Spitzer, R. L., &amp; Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613.</Citation>
        </Reference>
        <Reference>
          <Citation>Price, R. A., Sloss, E. M., Cefalu, M., Farmer, C. M., &amp; Hussey, P. S. (2018). Comparing quality of care in Veterans Affairs and Non-Veterans Affairs settings. Journal of General Internal Medicine, 33(10), 1631-1638.</Citation>
        </Reference>
        <Reference>
          <Citation>Resick, P. A., Monson, C. M., &amp; Chard, K. M. (2016). Cognitive processing therapy for PTSD: A comprehensive manual. New York, NY: Guilford Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwab, K., Baker, G., Ivins, B., Sluss-Tiller, M., Lux, W., &amp; Warden, D. (2006). The Brief Traumatic Brain Injury Screen (BTBIS): Investigating the validity of a self-report instrument for detecting traumatic brain injury (TBI) in troops returning from deployment in Afghanistan and Iraq. Neurology, 66, A235.</Citation>
        </Reference>
        <Reference>
          <Citation>Spitzer, R. L., Kroenke, K., Williams, J. B. W., &amp; Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder. Archives of Internal Medicine, 166, 1092-1097.</Citation>
        </Reference>
        <Reference>
          <Citation>Weathers, F.W., Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., &amp; Schnurr, P.P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909833</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4679</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical psychology</Title>
          <ISOAbbreviation>J Clin Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The impact of emotion dysregulation on positive and negative symptoms in schizophrenia spectrum disorders: A systematic review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jclp.22915</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Accumulating research evidence supports the role of emotion dysregulation in the etiology of schizophrenia spectrum disorders. The present systematic review synthesized the extant literature and aimed to determine the effects of cognitive emotion regulation strategies and global emotion dysregulation on positive and negative symptoms in schizophrenia spectrum disorders.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">A comprehensive systematic review was conducted to identify quantitative studies published between 2000 and 2019. A total of 22 studies were included in this review.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, maladaptive cognitive emotion regulation strategies of rumination, worry, and suppression were generally related to more positive symptoms, while global emotion dysregulation was related to more positive and negative symptoms.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results provide preliminary and conceptual evidence on the role of emotion dysregulation in understanding schizophrenia spectrum disorders. Psychological treatment should further determine the therapeutic value of addressing emotion dysregulation to improve positive and negative symptoms in schizophrenia spectrum disorders.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jianlin</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-0981-0643</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychological Medicine, National University of Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Division, Institute of Mental Health, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chua</LastName>
            <ForeName>Jesselyn Jia-Xin</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, National University of Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chong</LastName>
            <ForeName>Siow Ann</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Research Division, Institute of Mental Health, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Subramaniam</LastName>
            <ForeName>Mythily</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Research Division, Institute of Mental Health, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahendran</LastName>
            <ForeName>Rathi</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychological Medicine, National University Hospital, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Academic Development Department, Duke-NUS Medical School, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Psychol</MedlineTA>
        <NlmUniqueID>0217132</NlmUniqueID>
        <ISSNLinking>0021-9762</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">emotion dysregulation</Keyword>
        <Keyword MajorTopicYN="N">etiology</Keyword>
        <Keyword MajorTopicYN="N">maintenance</Keyword>
        <Keyword MajorTopicYN="N">psychosis</Keyword>
        <Keyword MajorTopicYN="N">schizophrenia spectrum disorders</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909833</ArticleId>
        <ArticleId IdType="doi">10.1002/jclp.22915</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Aldao, A., &amp; Nolen-Hoeksema, S. (2012). When are adaptive strategies more predictive of psychopathology? Journal of Abnormal Psychology, 121(1), 276-281. https://doi.org/10.1037/a0023598</Citation>
        </Reference>
        <Reference>
          <Citation>Badcock, J. C., Paulik, G., &amp; Maybery, M. T. (2011). The role of emotion regulation in auditory hallucinations. Psychiatry Research, 185(3), 303-308. https://doi.org/10.1016/j.psychres.2010.07.011</Citation>
        </Reference>
        <Reference>
          <Citation>Bardeen, J. R., &amp; Fergus, T. A. (2014). An examination of the incremental contribution of emotion regulation difficulties to health anxiety beyond specific emotion regulation strategies. Journal of Anxiety Disorders, 28(4), 394-401. https://doi.org/10.1016/j.janxdis.2014.03.002</Citation>
        </Reference>
        <Reference>
          <Citation>Bonfils, K. A., Minor, K. S., Leonhardt, B. L., &amp; Lysaker, P. H. (2018). Metacognitive self-reflectivity moderates the relationship between distress tolerance and empathy in schizophrenia. Psychiatry Research, 265, 1-6. https://doi.org/10.1016/j.psychres.2018.04.042</Citation>
        </Reference>
        <Reference>
          <Citation>Borenstein, M., Hedges, L. V., Higgins, J. P. T., &amp; Rothstein, H. R. (2009). Introduction to meta-analysis. Chichester, West Sussex, UK: John Wiley &amp; Sons.</Citation>
        </Reference>
        <Reference>
          <Citation>Dryman, M. T., &amp; Heimberg, R. G. (2018). Emotion regulation in social anxiety and depression: A systematic review of expressive suppression and cognitive reappraisal. Clinical Psychology Review, 65, 17-42. https://doi.org/10.1016/j.cpr.2018.07.004</Citation>
        </Reference>
        <Reference>
          <Citation>Foster, C., Startup, H., Potts, L., &amp; Freeman, D. (2010). A randomized controlled trial of a worry intervention for individuals with persistent persecutory delusions. Journal of Behavior Therapy &amp; Experimental Psychiatry, 41, 45-51. https://doi.org/10.1016/j.jbtep.2009.09.001</Citation>
        </Reference>
        <Reference>
          <Citation>Freeman, D., Dunn, G., &amp; Startup, H. (2015). Effects of cognitive behavior therapy for worry on persecutory delusions in patients with psychosis (WIT): A parallel, single-blind, randomized controlled trial with a mediation analysis. Lancet Psychiatry, 2, 305-313. https://doi.org/10.1016/S2215-0366(15)00039-5</Citation>
        </Reference>
        <Reference>
          <Citation>Fresco, D. M., Frankel, A. N., Mennin, D. S., Turk, C. L., &amp; Heimberg, R. G. (2002). Distinct and overlapping features of rumination and worry: The relationship of cognitive production to negative affective states. Cognitive Therapy and Research, 26(2), 179-188. https://doi.org/10.1023/A:1014517718949</Citation>
        </Reference>
        <Reference>
          <Citation>Garety, P. A., &amp; Freeman, D. (2013). The past and future of delusions research: From the inexplicable to the treatable. The British Journal of Psychiatry, 203, 327-333. https://doi.org/10.1192/bjp.bp.113.126953</Citation>
        </Reference>
        <Reference>
          <Citation>Gratz, K. L., &amp; Roemer, L. (2004). Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment, 26, 41-54. https://doi.org/10.1007/s10862-008-9102-4</Citation>
        </Reference>
        <Reference>
          <Citation>Grezellschak, S., Jansen, A., &amp; Westermann, S. (2017). Emotion regulation in patients with psychosis: A link between insomnia and paranoid ideation? Journal of Behavior Therapy and Experimental Psychiatry, 56, 27-32. https://doi.org/10.1016/j.jbtep.2016.08.001</Citation>
        </Reference>
        <Reference>
          <Citation>Gross, J. J. (1999). Emotion regulation: Past, present, future. Cognition &amp; Emotion, 13(5), 551-573. https://doi.org/10.1080/026999399379186</Citation>
        </Reference>
        <Reference>
          <Citation>Hallion, L. S., Steinman, S. A., Tolin, D. F., &amp; Diefenbach, G. J. (2018). Psychometric properties of the difficulties in emotion regulation scale (DERS) and its short forms in adults with emotional disorders. Frontiers in Psychology, 9, 539. https://doi.org/10.3389/fpsyg.2018.00539</Citation>
        </Reference>
        <Reference>
          <Citation>Henry, J. D., Rendell, P. G., Green, M. J., McDonald, S., &amp; O'Donnell, M. (2008). Emotion regulation in schizophrenia: Affective, social, and clinical correlates of suppression and reappraisal. Journal of Abnormal Psychology, 117(2), 473-478. https://doi.org/10.1037/0021-843X.117.2.473</Citation>
        </Reference>
        <Reference>
          <Citation>Higgins, J. P. T., Thompson, S. G., Deeks, J. J., &amp; Altman, D. G. (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327(7414), 557-560. https://doi.org/10.1136/bmj.327.7414.557</Citation>
        </Reference>
        <Reference>
          <Citation>Khoury, B., Lecomte, T., Comtois, G., &amp; Nicole, L. (2015). Third-wave strategies for emotion regulation in early psychosis: A pilot study. Early Intervention in Psychiatry, 9, 76-83. https://doi.org/10.1111/eip.12095</Citation>
        </Reference>
        <Reference>
          <Citation>Kircanski, K., Thompson, R. J., Sorenson, J., Sherdell, L., &amp; Gotlib, I. H. (2015). Rumination and worry in daily life: Examining the naturalistic validity of theoretical constructs. Clinical Psychological Science, 3(6), 926-939. https://doi.org/10.1177/2167702614566603</Citation>
        </Reference>
        <Reference>
          <Citation>Kramer, I., Simons, C. J. P., Wigman, J. T. W., Collip, D., Jacobs, N., Derom, C., … Wichers, M. (2013). Time-lagged moment-to-moment interplay between negative affect and paranoia: New insight in the affective pathway to psychosis. Schizophrenia Bulletin, 40, 278-286. https://doi.org/10.1093/schbul/sbs194</Citation>
        </Reference>
        <Reference>
          <Citation>Lincoln, T. M., Hartmann, M., Kother, U., &amp; Moritiz, S. (2015). Dealing with feeling: Specific emotion regulation skills predict responses to stress in psychosis. Psychiatry Research, 228, 216-222. https://doi.org/10.1016/j.psychres.2015.04.003</Citation>
        </Reference>
        <Reference>
          <Citation>Lincoln, T. M., &amp; Peters, E. (2019). A systematic review and discussion of symptom specific cognitive behavioural approaches to delusions and hallucinations. Schizophrenia Research, 203, 66-79. https://doi.org/10.1016/j.schres.2017.12.014</Citation>
        </Reference>
        <Reference>
          <Citation>Moran, E. K., Culbreth, A. J., &amp; Barch, D. M. (2018). Emotion regulation predicts everyday emotion experience and social function in schizophrenia. Clinical Psychological Science, 6(2), 271-279. https://doi.org/10.1177/2167702617738827</Citation>
        </Reference>
        <Reference>
          <Citation>Morrison, A. P., &amp; Wells, A. (2007). Relationships between worry, psychotic experiences and emotional distress in patients with schizophrenia spectrum diagnoses and comparisons with anxious and non-patient groups. Behaviour Research and Therapy, 45(7), 1593-1600.</Citation>
        </Reference>
        <Reference>
          <Citation>NIH National Heart, Lung and Blood Institute (2018). Study quality assessment tools. Retrieved from https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools</Citation>
        </Reference>
        <Reference>
          <Citation>Nittel, C. M., Lincoln, T. M., Lamster, F., Leube, D., Rief, W., Kircher, T., &amp; Mehl, S. (2018). Expressive suppression is associated with state paranoia in psychosis: An experience sampling study on the association between adaptive and maladaptive emotion regulation strategies and paranoia. British Journal of Clinical Psychology, 57, 291-312. https://doi.org/10.1111/bjc.12174</Citation>
        </Reference>
        <Reference>
          <Citation>O'Driscoll, C., Laing, J., &amp; Mason, O. (2014). Cognitive emotion regulation strategies, alexithymia and dissociation in schizophrenia, a review and meta-analysis. Clinical Psychology Review, 34, 482-495. https://doi.org/10.1016/j.cpr.2014.07.002</Citation>
        </Reference>
        <Reference>
          <Citation>Owens, K. A., Haddock, G., &amp; Berry, K. (2013). The role of the therapeutic alliance in the regulation of emotion in psychosis: An attachment perspective. Clinical Psychology and Psychotherapy, 20, 523-530. https://doi.org/10.1002/cpp.1793</Citation>
        </Reference>
        <Reference>
          <Citation>Perry, Y., Henry, J. D., &amp; Grisham, J. R. (2011). The habitual use of emotion regulation strategies in schizophrenia. British Journal of Clinical Psychology, 50(2), 217-222. https://doi.org/10.1111/j.2044-8260.2010.02001.x</Citation>
        </Reference>
        <Reference>
          <Citation>Ricarte, J. J., Del Rey, F., Ros, L., Latorre, J. M., &amp; Berna, F. (2018). Abstract and experiential thinking differentially account for anomalous perception of reality in people with or without schizophrenia. Schizophrenia Research, 193, 43-50. https://doi.org/10.1016/j.schres.2017.04.007</Citation>
        </Reference>
        <Reference>
          <Citation>Schaefer, J., Giangrande, E., Winberger, D. R., &amp; Dickinson, D. (2013). The global cognitive impairment in schizophrenia: Consistent over decades and around the world. Schizophrenia Research, 150(1), 42-50. https://doi.org/10.1016/j.schres.2013.07.009</Citation>
        </Reference>
        <Reference>
          <Citation>Sloan, E., Hall, K., Moulding, R., Bryce, S., Mildred, H., &amp; Staiger, P. K. (2017). Emotion regulation as a transdiagnostic treatment construct across anxiety, depression, substance, eating and borderline personality disorders: A systematic review. Clinical Psychology Review, 57, 141-163. https://doi.org/10.1016/j.cpr.2017.09.002</Citation>
        </Reference>
        <Reference>
          <Citation>Startup, H., Freeman, D., &amp; Garety, P. A. (2007). Persecutory delusions and catastrophic worry in psychosis: Developing the understanding of delusion distress and persistence. Behaviour Research and Therapy, 45, 523-537. https://doi.org/10.1016/j.brat.2006.04.006</Citation>
        </Reference>
        <Reference>
          <Citation>Startup, H., Pugh, K., Dunn, G., Cordwell, J., Mander, H., Cernis, E., … Freeman, D. (2016). Worry processes in patients with persecutory delusions. British Journal of Clinical Psychology, 55, 387-400. https://doi.org/10.1111/bjc.12109</Citation>
        </Reference>
        <Reference>
          <Citation>Upthegrove, R., Marwaha, S., &amp; Birchwood, M. (2017). Depression and schizophrenia: Cause, consequence, or trans-diagnostic issue? Schizophrenia Bulletin, 43(2), 240-244. https://doi.org/10.1093/schbul/sbw097</Citation>
        </Reference>
        <Reference>
          <Citation>van Camp, L. S. C., Sabbe, B. G. C., &amp; Oldenburg, J. F. E. (2017). Cognitive insight: A systematic review. Clinical Psychology Review, 55, 12-24. https://doi.org/10.1016/j.cpr.2017.04.011</Citation>
        </Reference>
        <Reference>
          <Citation>Vorontsova, N., Garety, P., &amp; Freeman, D. (2013). Cognitive factors maintaining persecutory delusions in psychosis: The contribution of depression. Journal of Abnormal Psychology, 122(4), 1121-1131. https://doi.org/10.1037/a0034952</Citation>
        </Reference>
        <Reference>
          <Citation>Williams, J., Bucci, S., Berry, K., &amp; Varese, F. (2018). Psychological mediators of the association between childhood adversities and psychosis: A systematic review. Clinical Psychology Review, 65, 175-196. https://doi.org/10.1016/j.cpr.2018.05.009</Citation>
        </Reference>
        <Reference>
          <Citation>Zilverstand, A., Parvaz, M. A., &amp; Goldstein, R. Z. (2017). Neuroimaging cognitive reappraisal in clinical populations to define neural targets for enhancing emotion regulation. A systematic review. NeuroImage, 151, 105-116. https://doi.org/10.1016/j.neuroimage.2016.06.009</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909834</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-1878</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>BioEssays : news and reviews in molecular, cellular and developmental biology</Title>
          <ISOAbbreviation>Bioessays</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A New Way to Discover IRESs in Pathology or Stress Conditions? Harnessing Latest High-Throughput Technologies.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1900180</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/bies.201900180</ELocationID>
        <Abstract>
          <AbstractText>The cellular internal ribosomal entry site (IRES) is one of the most important elements to mediate cap-independent translational initiation, especially under conditions of stress and pathology. However, a high-throughput method to discover IRESs in these conditions is still lacking. Here, a possible way IRES long-read sequencing based on the latest high-throughput technologies is proposed to solve this problem. Based on this design, diversity and integrity of the transcriptome from original samples can be kept. The micro-environment that stimulates or inhibits IRES activity can also be mimicked. By using long read-length sequencing technology, additional experiments that are essential for ruling out the cryptic promoters or splicing events in routine IRES identification processes can be circumvented. It is hoped that this proposed methodology may be adopted for IRES element discovery, hence uncovering the full extent of the role of IRESs in disease, development, and stress.</AbstractText>
          <CopyrightInformation>© 2020 WILEY Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lei-Yun</ForeName>
            <Initials>LY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Jia-Jia</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Cheng-Xian</ForeName>
            <Initials>CX</Initials>
            <AffiliationInfo>
              <Affiliation>Central of Clinic Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yin</LastName>
            <ForeName>Ji-Ye</ForeName>
            <Initials>JY</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1244-5045</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hunan Key Laboratory of Precise Diagnosis and Treatment of Gastrointestinal Tumor, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hunan Provincial Gynecological Cancer Diagnosis and Treatment Engineering Research Center, Changsha, 410078, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>81773823</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81573463</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81974511</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017ZX09304014</GrantID>
            <Agency>National Science and Technology Major Project of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2016YFC0905000</GrantID>
            <Agency>National Science and Technology Major Project of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>CX20190155</GrantID>
            <Agency>Hunan Provincial Innovation Foundation for Postgraduate</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Bioessays</MedlineTA>
        <NlmUniqueID>8510851</NlmUniqueID>
        <ISSNLinking>0265-9247</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">IRES trans activating factors</Keyword>
        <Keyword MajorTopicYN="N">cancer</Keyword>
        <Keyword MajorTopicYN="N">cap-independent translational initiation</Keyword>
        <Keyword MajorTopicYN="N">internal ribosomal entry site</Keyword>
        <Keyword MajorTopicYN="N">long-read sequencing</Keyword>
        <Keyword MajorTopicYN="N">third-generation sequencing</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909834</ArticleId>
        <ArticleId IdType="doi">10.1002/bies.201900180</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>M. B. Mathews, N. Sonenberg, J. W. B. Hershey, Translation Mechanisms and Control, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Y. Yin, J. T. Zhang, W. Zhang, H. H. Zhou, Z. Q. Liu, Cancer Lett. 2018, 412, 81.</Citation>
        </Reference>
        <Reference>
          <Citation>B. J. Guan, V. van Hoef, R. Jobava, O. Elroy-Stein, L. S. Valasek, M. Cargnello, X. H. Gao, D. Krokowski, W. C. Merrick, S. R. Kimball, A. A. Komar, A. E. Koromilas, A. Wynshaw-Boris, I. Topisirovic, O. Larsson, M. Hatzoglou, Mol. Cell 2017, 68, 885.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Y. Yin, J. Shen, Z. Z. Dong, Q. Huang, M. Z. Zhong, D. Y. Feng, H. H. Zhou, J. T. Zhang, Z. Q. Liu, Clin. Cancer Res. 2011, 17, 4600.</Citation>
        </Reference>
        <Reference>
          <Citation>A. G. Hinnebusch, I. P. Ivanov, N. Sonenberg, Science 2016, 352, 1413.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Y. Yin, Z. Dong, Z. Q. Liu, J. T. Zhang, Biosci. Rep. 2011, 31, 1.</Citation>
        </Reference>
        <Reference>
          <Citation>I. N. Shatsky, I. M. Terenin, V. V. Smirnova, D. E. Andreev, Trends Biochem. Sci. 2018, 43, 882.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Sonenberg, A. G. Hinnebusch, Cell 2009, 136, 731.</Citation>
        </Reference>
        <Reference>
          <Citation>I. A. Roundtree, M. E. Evans, T. Pan, C. He, Cell 2017, 169, 1187.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Leppek, R. Das, M. Barna, Nat. Rev. Mol. Cell Biol. 2018, 19, 158.</Citation>
        </Reference>
        <Reference>
          <Citation>R. J. Jackson, Cold Spring Harb. Perspect. Biol. 2013, 5, pii: a011569.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Liberman, V. Gandin, Y. V. Svitkin, M. David, G. Virgili, M. Jaramillo, M. Holcik, B. Nagar, A. Kimchi, N. Sonenberg, Nucleic Acids Res. 2015, 43, 3764.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Xue, S. Tian, K. Fujii, W. Kladwang, R. Das, M. Barna, Nature 2015, 517, 33.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Lozano, R. Francisco-Velilla, E. Martinez-Salas, Open Biol. 2018, 8, 180155.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Marques-Ramos, M. M. Candeias, J. Menezes, R. Lacerda, M. Willcocks, A. Teixeira, N. Locker, L. Romao, RNA 2017, 23, 1712.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Meristoudis, T. Trangas, A. Lambrianidou, V. Papadopoulos, E. Dimitriadis, N. Courtis, P. Ioannidis, Biol. Chem. 2015, 396, 1301.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Y. Yin, Z. Z. Dong, R. Y. Liu, J. Chen, Z. Q. Liu, J. T. Zhang, Carcinogenesis 2013, 34, 1224.</Citation>
        </Reference>
        <Reference>
          <Citation>T. A. Karginov, D. P. H. Pastor, B. L. Semler, C. M. Gomez, Trends Genet. 2017, 33, 129.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Weingarten-Gabbay, S. Elias-Kirma, R. Nir, A. A. Gritsenko, N. Stern-Ginossar, Z. Yakhini, A. Weinberger, E. Segal, Science 2016, 351, aad4939.</Citation>
        </Reference>
        <Reference>
          <Citation>K. R. Kampen, S. O. Sulima, B. Verbelen, T. Girardi, S. Vereecke, G. Rinaldi, J. Verbeeck, J. Op de Beeck, A. Uyttebroeck, J. P. P. Meijerink, A. V. Moorman, C. J. Harrison, P. Spincemaille, J. Cools, D. Cassiman, S. M. Fendt, P. Vermeersch, K. De Keersmaecker, Leukemia 2019, 33, 319.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Ji, B. R. Harris, Y. Liu, Y. Deng, S. A. Gradilone, M. P. Cleary, J. Liu, D. Q. Yang, Int. J. Mol. Sci. 2017, 18, e93.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Demircioglu, E. Cukuroglu, M. Kindermans, T. Nandi, C. Calabrese, N. A. Fonseca, A. Kahles, K. V. Lehmann, O. Stegle, A. Brazma, A. N. Brooks, G. Ratsch, P. Tan, J. Goke, Cell 2019, 178, 1465.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Kazadi, C. Loeuillet, S. Deutsch, A. Ciuffi, M. Munoz, J. S. Beckmann, D. Moradpour, S. E. Antonarakis, A. Telenti, Nucleic Acids Res. 2008, 36, 6918.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Khan, A. Sharathchandra, A. Ponnuswamy, R. Grover, S. Das, Oncogene 2013, 32, 4148.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Mokrejs, T. Masek, V. Vopalensky, P. Hlubucek, P. Delbos, M. Pospisek, Nucleic Acids Res. 2010, 38, D131.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Meng, P. H. King, L. B. Nabors, N. L. Jackson, C. Y. Chen, P. D. Emanuel, S. W. Blume, Nucleic Acids Res. 2005, 33, 2962.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Lu, X. Sun, Y. Chen, Q. Jin, Q. Liang, S. Liu, Y. Li, Y. Zhou, W. Li, Z. Huang, Cell Mol. Life Sci. 2015, 72, 821.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Dhar, S. Roy, S. Das, Nucleic Acids Res. 2007, 35, 5409.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Ismail, M. Ul Hussain, Biochimie 2017, 139, 38.</Citation>
        </Reference>
        <Reference>
          <Citation>T. M. Chen, M. C. Lai, Y. H. Li, Y. L. Chan, C. H. Wu, Y. M. Wang, C. W. Chien, S. Y. Huang, H. S. Sun, S. J. Tsai, EBioMedicine 2019, 41, 299.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Zhang, A. Huang, A. Zhang, C. Zhou, Biomed. Pharmacother. 2017, 91, 788.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Coleman, W. K. Miskimins, RNA Biol. 2009, 6, 84.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Cole, A. Byrne, A. E. Beaudin, E. C. Forsberg, C. Vollmers, Nucleic Acids Res. 2018, 46, e62.</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Quail, M. Smith, P. Coupland, T. D. Otto, S. R. Harris, T. R. Connor, A. Bertoni, H. P. Swerdlow, Y. Gu, BMC Genomics 2012, 13, 341.</Citation>
        </Reference>
        <Reference>
          <Citation>E. L. van Dijk, Y. Jaszczyszyn, D. Naquin, C. Thermes, Trends Genet. 2018, 34, 666.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Han, J. T. Zhang, Mol. Cell Biol. 2002, 22, 7372.</Citation>
        </Reference>
        <Reference>
          <Citation>H. A. Saffran, J. R. Smiley, RNA 2009, 15, 1980.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Cornelis, S. A. Tinton, B. Schepens, Y. Bruynooghe, R. Beyaert, Nucleic Acids Res. 2005, 33, 3095.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Allam, N. Ali, J. Biol. Chem. 2010, 285, 5713.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Picelli, O. R. Faridani, A. K. Bjorklund, G. Winberg, S. Sagasser, R. Sandberg, Nat. Protoc. 2014, 9, 171.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Rhoads, K. F. Au, Genomics Proteomics Bioinf. 2015, 13, 278.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Eid, A. Fehr, J. Gray, K. Luong, J. Lyle, G. Otto, P. Peluso, D. Rank, P. Baybayan, B. Bettman, A. Bibillo, K. Bjornson, B. Chaudhuri, F. Christians, R. Cicero, S. Clark, R. Dalal, A. Dewinter, J. Dixon, M. Foquet, A. Gaertner, P. Hardenbol, C. Heiner, K. Hester, D. Holden, G. Kearns, X. Kong, R. Kuse, Y. Lacroix, S. Lin, Science 2009, 323, 133.</Citation>
        </Reference>
        <Reference>
          <Citation>M. L. Kotewicz, C. M. Sampson, J. M. D'Alessio, G. F. Gerard, Nucleic Acids Res. 1988, 16, 265.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Fu, A. Wang, K. F. Au, Genome Biol. 2019, 20, 26.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Wee, S. B. Bhyan, Y. Liu, J. Lu, X. Li, M. Zhao, Briefings Funct. Genomics 2019, 18, 1.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Lacerda, J. Menezes, L. Romao, Cell Mol. Life Sci. 2017, 74, 1659.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Hudder, R. Werner, J. Biol. Chem. 2000, 275, 34586.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. C. Tasi, T. Y. Chin, Y. J. Chen, C. C. Huang, S. L. Lee, T. Y. Wu, Int. J. Mol. Sci. 2015, 16, 8789.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Y. Yin, X. Li, X. P. Li, L. Xiao, W. Zheng, J. Chen, C. X. Mao, C. Fang, J. J. Cui, C. X. Guo, W. Zhang, Y. Gao, C. F. Zhang, Z. H. Chen, H. Zhou, H. H. Zhou, Z. Q. Liu, Cancer Lett. 2016, 377, 65.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Sugimoto, A. M. Chakrabarti, N. M. Luscombe, J. Ule, Nat. Protoc. 2017, 12, 611.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909835</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-9861</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of comparative neurology</Title>
          <ISOAbbreviation>J. Comp. Neurol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification of spinal afferent nerve endings in the colonic mucosa and submucosa that communicate directly with the spinal cord: the gut-brain axis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cne.24854</ELocationID>
        <Abstract>
          <AbstractText>The major sensory nerve pathway between the colon and central nervous system (spinal cord and brain) that underlies the gut-brain axis, is via spinal afferent neurons, with cell bodies in dorsal root ganglia (DRG). Our aim was to identify the sensory nerve endings in the colon that arise from single colorectal-projecting DRG neurons. C57BL/6 mice were anesthetized and lumbosacral L6-S1 DRG injected with dextran biotin. Mice recovered for 7 days. The whole colon was then removed and stained to visualize single axons and nerve endings immunoreactive to calcitonin gene-related peptide (CGRP). Single axons arising from DRG were identified in the distal colon and their morphological features and CGRP immunoreactivity characterized. After entering the colon, single axons ramified rostrally or caudally along many rows of myenteric ganglia with little circumferential displacement, giving off varicose endings in multiple ganglia. Nerve endings arising from two classes of colorectal-projecting DRG neuron were identified. One class were peptidergic neurons that had nerve endings in circular muscle, myenteric ganglia and submucosa. Another class of non-peptidergic neurons innervated mucosal crypts, myenteric ganglia and submucosa. Different morphological types of nerve endings which innervate different anatomical layers of colon can arise from the same axon and sensory neuron in DRG. These findings suggest single peptidergic and non-peptidergic sensory neurons in DRG are potentially capable of detecting sensory stimuli from different anatomical layers of the colon, via different types of nerve endings. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Spencer</LastName>
            <ForeName>Nick J</ForeName>
            <Initials>NJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-2190-5303</Identifier>
            <AffiliationInfo>
              <Affiliation>Visceral Neurophysiology Laboratory, College of Medicine and Public Health, Centre for Neuroscience, Flinders University, Bedford Park, South Australia, AUSTRALIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kyloh</LastName>
            <ForeName>Melinda A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Visceral Neurophysiology Laboratory, College of Medicine and Public Health, Centre for Neuroscience, Flinders University, Bedford Park, South Australia, AUSTRALIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Travis</LastName>
            <ForeName>Lee</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Visceral Neurophysiology Laboratory, College of Medicine and Public Health, Centre for Neuroscience, Flinders University, Bedford Park, South Australia, AUSTRALIA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dodds</LastName>
            <ForeName>Kelsi N</ForeName>
            <Initials>KN</Initials>
            <AffiliationInfo>
              <Affiliation>Visceral Neurophysiology Laboratory, College of Medicine and Public Health, Centre for Neuroscience, Flinders University, Bedford Park, South Australia, AUSTRALIA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Comp Neurol</MedlineTA>
        <NlmUniqueID>0406041</NlmUniqueID>
        <ISSNLinking>0021-9967</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">DRG</Keyword>
        <Keyword MajorTopicYN="N">RRID: AB_2314156</Keyword>
        <Keyword MajorTopicYN="N">colon</Keyword>
        <Keyword MajorTopicYN="N">nociception</Keyword>
        <Keyword MajorTopicYN="N">pain visceral pain</Keyword>
        <Keyword MajorTopicYN="N">sensory neuron</Keyword>
        <Keyword MajorTopicYN="N">spinal afferent</Keyword>
        <Keyword MajorTopicYN="N">spinal cord</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909835</ArticleId>
        <ArticleId IdType="doi">10.1002/cne.24854</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909836</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2052</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Animal genetics</Title>
          <ISOAbbreviation>Anim. Genet.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genome-wide association study for growth and fatness traits in Chinese Sujiang pigs.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/age.12899</ELocationID>
        <Abstract>
          <AbstractText>Growth and fatness traits are complex and economically important traits in the pig industry. The molecular basis underlying porcine growth and fatness traits remains largely unknown. To uncover genetic loci and candidate genes for these traits, we explored the GeneSeek GGP Porcine 80K SNP chip to perform a GWAS for seven growth and fatness traits in 365 individuals from the Sujiang pig, a recently developed breed in China. We identified two, 17, one and 11 SNPs surpassing the suggestively significant threshold (P &lt; 1.86 × 10<sup>-5</sup> ) for body weight, chest circumference, chest width and backfat thickness respectively. Of these SNPs, 20 represent novel genetic loci, and five and four SNPs were respectively associated with chest circumference and backfat thickness at a genome-wide significant threshold (P &lt; 9.31 × 10<sup>-7</sup> ). Eight SNPs had a pleiotropic effect on both chest circumference and backfat thickness. The most remarkable locus resided in a region between 72.95 and 76.27 Mb on pig chromosome 4, harboring a number of previously reported quantitative trait loci related to backfat deposition. In addition to two reported genes (PLAG1 and TAS2R38), we identified four genes including GABRB3, ZNF106, XKR4 and MGAM as novel candidates for body weight and backfat thickness at the mapped loci. Our findings provide insights into the genetic architecture of porcine growth and fatness traits and potential markers for selective breeding of Chinese Sujiang pigs.</AbstractText>
          <CopyrightInformation>© 2020 Stichting International Foundation for Animal Genetics.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9099-5651</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ni</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Unit of Pig Breeding, Jiangsu Sujiang Pig Breeding Farm, 225400, Taixing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tao</LastName>
            <ForeName>Y</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Unit of Pig Breeding, Jiangsu Sujiang Pig Breeding Farm, 225400, Taixing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Z</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>X</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Z</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>X</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal Science and Technology, Jiangsu Agri-animal Husbandry Vocational College, 225300, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6664-3998</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Animal Science, South China Agricultural University, 510642, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>31702089</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>201602</GrantID>
            <Agency>Phoenix Talent Project of Jiangsu Agri-animal Husbandry Vocational College</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>NSF201701</GrantID>
            <Agency>Natural Science Foundation of Jiangsu Agri-animal Husbandry Vocational College</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>NSFPT201802</GrantID>
            <Agency>Natural Science Foundation of Jiangsu Agri-animal Husbandry Vocational College</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Anim Genet</MedlineTA>
        <NlmUniqueID>8605704</NlmUniqueID>
        <ISSNLinking>0268-9146</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chinese pig</Keyword>
        <Keyword MajorTopicYN="N">GWAS</Keyword>
        <Keyword MajorTopicYN="N">QTL</Keyword>
        <Keyword MajorTopicYN="N">candidate genes</Keyword>
        <Keyword MajorTopicYN="N">phenotypic traits</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909836</ArticleId>
        <ArticleId IdType="doi">10.1111/age.12899</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Ai H., Ren J., Zhang Z., Ma J., Guo Y., Yang B., Huang L. (2012) Detection of quantitative trait loci for growth- and fatness-related traits in a large-scale White Duroc × Erhualian intercross pig population. Animal Genetics 43, 383-91.</Citation>
        </Reference>
        <Reference>
          <Citation>Anne-Sophie V.L., Minh N., Martin B., Carine N., Catherine C., Laurence M., Archibald A.L., Haley C.S., Nadine B., Michael T. (2003) A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature 425, 832-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Bolormaa S., Neto L.P., Zhang Y., Bunch R., Harrison B., Goddard M., Barendse W. (2011) A genome-wide association study of meat and carcass traits in Australian cattle. Journal of Animal Science 89, 2297-309.</Citation>
        </Reference>
        <Reference>
          <Citation>Celona B., Von D.J., Vatsavayai S.C., Kashima R., Johnson J.R., Tang A.A., Hata A., Miller B.L., Huang E.J., Krogan N.J. (2017) Suppression ofC9orf72RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. eLife, 6, e19032.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang C.C., Chow C.C., Tellier L.C., Vattikuti S., Purcell S.M., Lee J.J. (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, 7.</Citation>
        </Reference>
        <Reference>
          <Citation>Ding R., Yang M., Quan J., Li S., Zhuang Z., Zhou S., Zheng E., Hong L., Li Z., Cai G. (2019) Single-locus and multi-locus genome-wide association studies for intramuscular fat in Duroc pigs. Frontiers in Genetics 10, 619.</Citation>
        </Reference>
        <Reference>
          <Citation>Ferguson C., Hardy S.L., Werner D.F., Hileman S.M., Delorey T.M., Homanics G.E. (2007) New insight into the role of the β3 subunit of the GABAA-R in development, behavior, body weight regulation, and anesthesia revealed by conditional gene knockout. BMC Neuroscience, 8, 85.</Citation>
        </Reference>
        <Reference>
          <Citation>Gong H., Xiao S., Li W., Huang T., Huang X., Yan G., Huang Y., Qiu H., Jiang K., Wang X. (2019) Unravelling the genetic loci for growth and carcass traits in Chinese Bamaxiang pigs based on a 1.4 million SNP array. Journal of Animal Breeding and Genetics 136, 3-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Greenawalt D.M., Dobrin R., Chudin E., Hatoum I.J., Suver C., Beaulaurier J., Zhang B., Castro V., Zhu J., Sieberts S.K. (2011) A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Research 21, 1008-16.</Citation>
        </Reference>
        <Reference>
          <Citation>Ji J., Zhou L., Guo Y., Huang L., Ma J. (2017) Genome-wide association study identifies 22 new loci for body dimension and body weight traits in a White Duroc × Erhualian F2 intercross population. Asian-Australasian Journal of Animal Sciences 30, 1066-73.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnson Z.B., Nugent R.A. (2003) Heritability of body length and measures of body density and their relationship to backfat thickness and loin muscle area in swine. Journal of Animal Science 81, 1943-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Meng Q., Wang K., Liu X., Zhou H., Xu L., Wang Z., Fang M. (2017) Identification of growth trait related genes in a Yorkshire purebred pig population by genome-wide association studies. Asian-Australasian Journal of Animal Sciences 30, 462-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Murani E., Muraniova M., Ponsuksili S., Schellander K., Wimmers K. (2006) Molecular characterization and evidencing of the porcine CRH gene as a functional-positional candidate for growth and body composition. Biochemical and Biophysical Research Communications 342, 394-405.</Citation>
        </Reference>
        <Reference>
          <Citation>Nichols B.L., Quezada-Calvillo R., Robayo-Torres C.C., Ao Z., Hamaker B.R., Butte N.F., Marini J., Jahoor F., Sterchi E.E. (2009) Mucosal maltase-glucoamylase plays a crucial role in starch digestion and prandial glucose homeostasis of mice. The Journal of Nutrition 139, 684-90.</Citation>
        </Reference>
        <Reference>
          <Citation>PortoNetoL., Bunch R., Harrison B., Barendse W. (2012) Variation in the XKR4 gene was significantly associated with subcutaneous rump fat thickness in indicine and composite cattle. Animal Genetics 43, 785-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., De Bakker P.I., Daly M.J. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. The American Journal of Human Genetics 81, 559-75.</Citation>
        </Reference>
        <Reference>
          <Citation>Qiao R., Gao J., Zhang Z. et al. (2015) Genome-wide association analyses reveal significant loci and strong candidate genes for growth and fatness traits in two pig populations. Genetics Selection Evolution 47, 17.</Citation>
        </Reference>
        <Reference>
          <Citation>Ribani A., Bertolini F., Schiavo G., Scotti E., Utzeri V.J., Dall'Olio S., Trevisi P., Bosi P., Fontanesi L. (2017) Next generation semiconductor based sequencing of bitter taste receptor genes in different pig populations and association analysis using a selective DNA pool-seq approach. Animal Genetics 48, 97-102.</Citation>
        </Reference>
        <Reference>
          <Citation>Sato S., Uemoto Y., Kikuchi T., Egawa S., Kohira K., Saito T., Sakuma H., Miyashita S., Arata S., Kojima T. (2016) SNP- and haplotype-based genome-wide association studies for growth, carcass, and meat quality traits in a Duroc multigenerational population. BMC Genetics 17, 60.</Citation>
        </Reference>
        <Reference>
          <Citation>Tabor H.K., Risch N.J., Myers R.M. (2002) Candidate-gene approaches for studying complex genetic traits: practical considerations. Nature Reviews Genetics 3, 391-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Dyck F., Declercq J., Braem C.V., Van de Ven W.J. (2007) PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review). International Journal of Oncology 30, 765-74.</Citation>
        </Reference>
        <Reference>
          <Citation>Voz M.L., Agten N.S., Van de Ven W.J., Kas K. (2000) PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Research 60, 106.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang Q., Cui J., Chazaro I., Cupples L.A., Demissie S. (2005) Power and type I error rate of false discovery rate approaches in genome-wide association studies. BMC Genetics 6(Suppl 1), S134.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang J., Lee S.H., Goddard M.E., Visscher P.M. (2011) GCTA: a tool for genome-wide complex trait analysis. The American Journal of Human Genetics 88, 76-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhou L., Ji J., Peng S., Zhang Z., Fang S., Li L., Zhu Y., Huang L., Chen C., Ma J. (2016) A GWA study reveals genetic loci for body conformation traits in Chinese Laiwu pigs and its implications for human BMI. Mammalian Genome 27, 610-21.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909837</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4679</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical psychology</Title>
          <ISOAbbreviation>J Clin Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Training for a new environment: Using military operational concepts in counseling veterans.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jclp.22919</ELocationID>
        <Abstract>
          <AbstractText>Since September 11, 2001, the United States has engaged in an extended period of military conflict, resulting in 4.1 million men and women serving in support of Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn. Whereas not all servicemembers experience mental health issues, many have experienced difficulties with readjusting to the civilian world, often requiring mental health services both inside and outside of the Department of Veterans Affairs. Issues related to stigma and military culture contribute to barriers not only for veterans seeking treatment but for clinicians providing services who may lack experience with military culture. This article provides a framework to use military concepts in clinical sessions to further therapeutic engagement with the military/veteran client.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Morse</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Providence Vet Center, Providence, Rhode Island.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Psychol</MedlineTA>
        <NlmUniqueID>0217132</NlmUniqueID>
        <ISSNLinking>0021-9762</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cultural competency</Keyword>
        <Keyword MajorTopicYN="N">engagement</Keyword>
        <Keyword MajorTopicYN="N">military culture</Keyword>
        <Keyword MajorTopicYN="N">readjustment</Keyword>
        <Keyword MajorTopicYN="N">veterans</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909837</ArticleId>
        <ArticleId IdType="doi">10.1002/jclp.22919</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Adler, A. B., Bliese, P. D., McGurk, D., Hoge, C. W., &amp; Castro, C. A. (2009). Battlemind debriefing and battlemind training as early interventions with soldiers returning from Iraq: Randomization by platoon. Journal of Consulting and Clinical Psychology, 77(5), 928-940. https://doi.org/10.1037/a0016877</Citation>
        </Reference>
        <Reference>
          <Citation>Bryan, C. J., &amp; Morrow, C. E. (2011). Circumventing mental health stigma by embracing the warrior culture: Lessons learned from the Defender's Edge Program. Professional Psychology: Research and Practice, 40(1), 16-23. https://doi.org/10.1037/a0022290</Citation>
        </Reference>
        <Reference>
          <Citation>Canfield, J., &amp; Weiss, E. (2015). Integrating military and veteran culture in social work education: Implications for curriculum inclusion. Journal of Social Work Education, 51(Suppl. 1), S128-S144. https://doi.org/10.1080/10437797.2015.1001295</Citation>
        </Reference>
        <Reference>
          <Citation>Castro, C. A., &amp; Adler, A. B. (2011). Reconceptualizing combat-related posttraumatic stress disorder as an occupational hazard. In A. B. Adler, P. D. Bliese &amp; C. A. Castro (Eds.), Deployment psychology: Evidence-based strategies to promote mental health in the military (pp. 217-242). Washington, DC: American Psychological Association. https://doi.org/10.1037/12300-009</Citation>
        </Reference>
        <Reference>
          <Citation>Coll, J.E., &amp; Weiss, E. (2011). The influence of military culture and veteran worldviews on mental health treatment. The International Journal of Health, Wellness, and Society, 1(2), 75-86. https://doi.org/10.18848/2156-8960/cgp/v01i02/41168</Citation>
        </Reference>
        <Reference>
          <Citation>Coll, J. E., Weiss, E. L., &amp; Yarvis, J. S. (2011). No one leaves unchanged: Insights for civilian mental health care professionals into the military experience and culture. Social Work in Health Care, 50(7), 487-500. https://doi.org/10.1080/00981389.2010.528727</Citation>
        </Reference>
        <Reference>
          <Citation>Committee on the Assessment of Ongoing Efforts in the Treatment of Posttraumatic Stress Disorder (2014). Treatment for posttraumatic stress disorder in military and veteran populations: Final assessment. Washington DC: National Academies Press. https://doi.org/10.17226/18724</Citation>
        </Reference>
        <Reference>
          <Citation>Hoge, C. W. (2011). Interventions for war-related posttraumatic stress disorder: Meeting veterans where they are. JAMA, 306(5), 549-551. https://doi.org/10.1001/jama.2011.1096</Citation>
        </Reference>
        <Reference>
          <Citation>Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., &amp; Koffman, R. L. (2004). Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New England Journal of Medicine, 351(1), 13-22. https://doi.org/10.1056/NEJMoa040603</Citation>
        </Reference>
        <Reference>
          <Citation>Koenen, K. C., Stellman, S. D., Sommer, J. F., &amp; Stellman, J. M. (2008). Persisting posttraumatic stress disorder symptoms and their relationship to functioning in Vietnam veterans: A 14-year follow-up. Journal of Traumatic Stress, 21(1), 49-57. https://doi.org/10.1002/jts.20304</Citation>
        </Reference>
        <Reference>
          <Citation>Koenig, C. J., Maguen, S., Monroy, J. D., Mayott, L., &amp; Seal, K. H. (2014). Facilitating culture-centered communication between health care providers and veterans transitioning from military deployment to civilian life. Patient Education and Counseling, 95(3), 414-420. https://doi.org/10.1016/j.pec.2014.03.016</Citation>
        </Reference>
        <Reference>
          <Citation>Litz, B. T., Berke, D. S., Kline, N. K., Grimm, K., Rusowicz-Orazem, L., Resick, P. A., … Peterson, A. L. (2019). Patterns and predictors of change in trauma-focused treatments for war-related posttraumatic stress disorder. Journal of Consulting and Clinical Psychology, 87(11), 1019-1029. https://doi.org/10.1037/ccp0000426</Citation>
        </Reference>
        <Reference>
          <Citation>Lorber, W., &amp; Garcia, H. A. (2010). Not supposed to feel this: Traditional masculinity in psychotherapy with male veterans returning from Afghanistan and Iraq. Psychotherapy, 47(3), 246-305. https://doi.org/10.1037/a0021161</Citation>
        </Reference>
        <Reference>
          <Citation>Meyer, E. G., Writer, B. W., &amp; Brim, W. (2016). The importance of military cultural competence. Current Psychiatry Reports, 18(3), 26. https://doi.org/10.1007/s11920-016-0662-9</Citation>
        </Reference>
        <Reference>
          <Citation>Moss, J. A., Moore, R. L., &amp; Selleck, C. S. (2015). Veteran competencies for undergraduate nursing education. Advances in Nursing Science, 38(4), 306-316. https://doi.org/10.1097/ANS.0000000000000092</Citation>
        </Reference>
        <Reference>
          <Citation>Mott, J. M., Stanley, M. A., Street, R. L., Grady, R. H., &amp; Teng, E. J. (2014). Increasing engagement in evidence-based PTSD treatment through shared decision-making: A pilot study. Military Medicine, 179(2), 143-149. https://doi.org/10.7205/milmed-d-13-00363</Citation>
        </Reference>
        <Reference>
          <Citation>Nash, W. P. (2007). Combat/operational stress adaptation and injuries. In C. R. Figley &amp; W. P. Nash (Eds.), Combat stress injury: Theory, research, and management (pp. 33-63). New York, NY: Routledge. National Association.</Citation>
        </Reference>
        <Reference>
          <Citation>National Academies of Sciences, Engineering, and Medicine (2018). Evaluation of the department of veteransaffairs mental health services, Washington DC: National Academies Press. https://doi.org/10.17226/24915</Citation>
        </Reference>
        <Reference>
          <Citation>Reger, M. A., Etherage, J. R., Reger, G. M., &amp; Gahm, G. A. (2008). Civilian psychologists in an army culture: The ethical challenge of cultural competence. Military Psychology, 20(1), 21-35. https://doi.org/10.1080/08995600701753144</Citation>
        </Reference>
        <Reference>
          <Citation>Resick, P. A., Monson, C. M., &amp; Chard, K. M. (2017). Cognitive processing therapy for PTSD: A comprehensive manual. New York, NY: Guildford Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Shay, J. (1994). Achilles in Vietnam: Combat trauma and the undoing of character, New York, NY: Scribner.</Citation>
        </Reference>
        <Reference>
          <Citation>Shepardson, R. L., &amp; Funderburk, J. S. (2016). Likelihood of attending treatment for anxiety among veteran primary care patients: Patient preferences for treatment attributes. Journal of Clinical Psychology in Medical Settings, 23, 225-239. https://doi.org/10.1007/s10880-016-9462-y</Citation>
        </Reference>
        <Reference>
          <Citation>Zinzow, H. M., Britt, T. W., McFadden, A. C., Burnette, C. M., &amp; Gillispie, S. (2012). Connecting active duty and returning veterans to mental health treatment: Interventions and treatment adaptations that may reduce barriers to care. Clinical Psychology Review, 32, 741-753. https://doi.org/10.1016/j.cpr.2012.09.002</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909838</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1754-4505</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry</Title>
          <ISOAbbreviation>Spec Care Dentist</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Caries impact on quality of life among visually impaired adolescents: A cross-sectional study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/scd.12447</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To assess and compare the impacts of dental caries on quality of life among visually impaired and sighted 10- to 19-year-old adolescents before and after treatment in Lagos State, Nigeria.</AbstractText>
          <AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">A cross-sectional study of institutionalized sighted and visually impaired 10- to 19-year-old adolescents was carried out using interviewer-administered Oral Health Related Quality of Life questionnaire based on Child Oral Impact on Daily Performance (Child-OIDP) questionnaire. Frequencies of impact and mean impact scores were determined and compared between the two groups using chi-square test. SPSS IBM version 20 was used for the analysis. The level of significance was placed at P &lt; 0.05. The mean impact scores on quality of life among sighted and visually impaired adolescents were 14.45 ± 17.00 and 12.61 ± 17.83, respectively before treatment (P = 0.55) as well as 0.54 ± 1.81 and 2.02 ± 6.86 respectively after treatment (P = 0.10).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The visually impaired adolescents suffered similar burden of impact of dental caries as their sighted peers. The greatest impact was on eating and cleaning the teeth. Impact was greatly reduced following treatment. There is need for oral health promotion and early detection of dental caries among institutionalized visually impaired and sighted adolescents in order to prevent complications of dental caries.</AbstractText>
          <CopyrightInformation>© 2020 Special Care Dentistry Association and Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ligali</LastName>
            <ForeName>Taofeek Olalekan</ForeName>
            <Initials>TO</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6679-9252</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Dentistry, Department of Preventive and Child Dental Health, University of Maiduguri, Maiduguri, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Orenuga</LastName>
            <ForeName>Omolola Olubunmi</ForeName>
            <Initials>OO</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Dental Health, Faculty of Dental Sciences, College of Medicine University of Lagos, Lagos, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oredugba</LastName>
            <ForeName>Folakemi Adenike</ForeName>
            <Initials>FA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Child Dental Health, Faculty of Dental Sciences, College of Medicine University of Lagos, Lagos, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Spec Care Dentist</MedlineTA>
        <NlmUniqueID>8103755</NlmUniqueID>
        <ISSNLinking>0275-1879</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>D</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dental caries</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
        <Keyword MajorTopicYN="N">sensory impairment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909838</ArticleId>
        <ArticleId IdType="doi">10.1111/scd.12447</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Visual impairment definition. Available from: https://en.wikipedia.org/wiki/Visual_impairment. (Last accessed on 2017 Oct 28)</Citation>
        </Reference>
        <Reference>
          <Citation>Dijk KV. Definition: visual impairment-Blind People's Association. Available from: http://www.bpaindia.org/pdf/VIB%20Chapter-I.pdf (Last Accessed on 2017 Oct 28)</Citation>
        </Reference>
        <Reference>
          <Citation>Haddad MAO, Lobato FJ, Sampaio MW, Kara-José N. Pediatric and adolescent population with visual impairment: study of 385 cases. Clinics (Sao Paulo). 2006;61:239-246. PubMed.</Citation>
        </Reference>
        <Reference>
          <Citation>Mann J, Joseph SW, Lavie G, Carlin Y, Garfunkel AA. Periodontal treatment needs and oral hygiene for institutionalized individuals with handicapping conditions. Spec Care Dentist. 1984;4:173-176.</Citation>
        </Reference>
        <Reference>
          <Citation>Mahoney EK, Kumar N, Porter SR. Effect of visual impairment upon oral health care: a review. Br Dent J. 2008;204:63-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Selwitz RH, Ismail AL, Pitts NB. Dental caries. Lancet. 2007;369:51-59. PubMed.</Citation>
        </Reference>
        <Reference>
          <Citation>Cawson RA, Odell EW. Cawson's Essentials of Oral Pathology and Oral Medicine 7th Edition. Edinburg London: Churchill Livingstone; 2002:36-52. Chapter 3, Dental caries.</Citation>
        </Reference>
        <Reference>
          <Citation>Tagelsir A, Khogli AE, Nurelhuda NM. Oral health of visually impaired school children in Khartoum State. Sudan BMC Oral Health. 2013;13:33.</Citation>
        </Reference>
        <Reference>
          <Citation>Chukwumah NM, Folayan MO, Oziegbe EO, Umweni AA. Impact of dental caries and its treatment on the quality of life of 12- to 15-year-old adolescents in Benin. NigeriaInt J Paediatr Dent. 2016;26:66-76. PubMed.</Citation>
        </Reference>
        <Reference>
          <Citation>Oredugba FA, Sote EO. Dental caries prevalence among handicapped children in Lagos. Niger Postgrad Med J. 1999;6:122-125. PubMed.</Citation>
        </Reference>
        <Reference>
          <Citation>Mohan R, Raju R, Gubbihal R, Kousalya PS. Comprehensive dental care for the visually impaired: a review. Int J Oral Health Med Res. 2016;3:97-101.</Citation>
        </Reference>
        <Reference>
          <Citation>Mann J, Joseph SW, Lavie G, Carlin Y, Garfunkel AA. Periodontal treatment needs and oral hygiene for institutionalized individuals with handicapping conditions. Spec Care Dentist. 1984;4:173-176. PubMed.</Citation>
        </Reference>
        <Reference>
          <Citation>Finger ST, Jedrychowski JR. Parents' perception of access to dental care for children with handicapping conditions. Spec Care Dentist. 1989;9:195-199.</Citation>
        </Reference>
        <Reference>
          <Citation>Varkevisser CM, Pathmanathan I, Brownlee A. Designing and conducting health systems research projects. Ottawa Canada: International Development Research Centre. 1991:213-216.</Citation>
        </Reference>
        <Reference>
          <Citation>Gherunpong S, Tsakos G, Sheiham A. The prevalence and severity of oral impacts on daily performances in Thai primary school children. Health Qual Life Outcomes. 2004;2:57.</Citation>
        </Reference>
        <Reference>
          <Citation>Nandini NS. New insights into improving oral health of visually impaired children. J Ind SocPedoPrev Dent. 2003;21:742-743.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh A, Dhawan P, Singh S. Assessment of oral health-related quality of life in 9-15 year old children with visual impairment in Uttarakhand. India Dent Res J (Isfahan). 2017;14(1):43-49.</Citation>
        </Reference>
        <Reference>
          <Citation>Nurelhuda NM, Ahmed MF, Trovik TA, Åstrøm AN. Evaluation of oral health-related quality of life among Sudanese school children using Child-OIDP inventory. Health Quality Life Outcomes. 2010;8:152.</Citation>
        </Reference>
        <Reference>
          <Citation>Agrawal N, Pushpanjali K, Gupta N D, Garg AK. Child-Oral impacts on daily performances: a socio dental approach to assess prevalence and severity of oral impacts on daily performances in South Indian school children of Bangalore city: a cross-sectional survey. J Indian Assoc Public Health Dent. 2014;12:88-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Mashoto KO. Dental caries, oral-health-related quality of life and atraumatic restorative treatment (ART): a study of adolescents in Kilwa district of Tanzania. PhD Thesis, University of Bergen. ISBN 978-82-308-1808-4 Bergen, Norway 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Kumar S, Kumar A, Badiyani B, Kumar A, Basak D, Ismail MB. Oral health impact, dental caries experience, and associated factors in 12-15-year-old school children in India. Int J Adolesc Med Health. 2017;29. http://www.who.int/oral_health/action/information/surveillance/en/. Available from. Last accessed 2017 December 12.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909839</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-3083</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Scandinavian journal of immunology</Title>
          <ISOAbbreviation>Scand. J. Immunol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Interferon α in Cancer Immunoediting: From Elimination to Escape.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e12863</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/sji.12863</ELocationID>
        <Abstract>
          <AbstractText>Interferon α (IFNα) is a cytokine that mediates diverse immune responses to tumors. It is the oldest immune-based oncologic drug and has been widely used to treat various malignancies in humans. Yet, the use of IFNα in cancer therapy has only resulted in limited success, and even led to worse clinical outcomes under certain instances. The emergence of the cancer immunoediting concept-which implicates the host immune system in promoting tumor growth-recapitulates the need to evaluate the immune functions of IFNα. This review proposes that IFNα has dual opposing roles in cancer development based on the mutational status of its signaling components, which determines the expression of anti- or pro-tumorigenic IFN-stimulated genes (ISGs). This duality may translate into new applications of IFNα in cancer immunotherapy.</AbstractText>
          <CopyrightInformation>© 2020 The Foundation for the Scandinavian Journal of Immunology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vidal</LastName>
            <ForeName>Paolo S</ForeName>
            <Initials>PS</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Student, Department of Medical Microbiology, University of the Philippines Manila.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Scand J Immunol</MedlineTA>
        <NlmUniqueID>0323767</NlmUniqueID>
        <ISSNLinking>0300-9475</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">STAT1</Keyword>
        <Keyword MajorTopicYN="N">interferon α</Keyword>
        <Keyword MajorTopicYN="N">pro-tumorigenic</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909839</ArticleId>
        <ArticleId IdType="doi">10.1111/sji.12863</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909840</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-987X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of computational chemistry</Title>
          <ISOAbbreviation>J Comput Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Calibration of the dianionic phosphate group: Validation on the recognition site of the homodimeric enzyme phosphoglucose isomerase.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcc.26134</ELocationID>
        <Abstract>
          <AbstractText>We calibrate and validate the parameters necessary to represent the dianionic phosphate group (DPG) in molecular mechanics. DPG is an essential fragment of signaling biological molecules and protein-binding ligands. It is a constitutive fragment of biosensors, which bind to the dimer interface of phosphoglucose isomerase (PGI), an intracellular enzyme involved in sugar metabolism, as well as an extracellular protein known as autocrine motility factor (AMF) closely related to metastasis formation. Our long-term objective is to design DPG-based biosensors with enhanced affinities for AMF/PGI cancer biomarker in blood. Molecular dynamics with polarizable potentials could be used toward this aim. This requires to first evaluate the accuracy of such potentials upon representing the interactions of DPG with its PGI ligands and tightly bound water molecules. Such evaluations are done by comparisons with high-level ab initio quantum chemistry (QC) calculations. We focus on the Sum of Interactions Between Fragments Ab initio computed (SIBFA) polarizable molecular mechanics procedure. We present first the results of the DPG calibration. This is followed by comparisons between ΔE(SIBFA) and ΔE(QC) regarding bi-molecular complexes of DPG with the main-chain and side-chain PGI residues, which bind to it in the recognition site. We then consider DPG complexes with an increasing number of PGI residues. The largest QC complexes encompass the entirety of the recognition site, with six structural water molecules totaling up to 211 atoms. A persistent and satisfactory agreement could be shown between ΔE(SIBFA) and ΔE(QC). These validations constitute an essential first step toward large-scale molecular dynamics simulations of DPG-based biosensors bound at the PGI dimer interface. © 2020 Wiley Periodicals, Inc.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Devillers</LastName>
            <ForeName>Marion</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Equipe de Chimie Bioorganique et Bioinorganique, Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), Univ Paris-Saclay, Univ Paris-Sud, UMR 8182 CNRS, rue du Doyen Georges Poitou, F-91405, Orsay, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Piquemal</LastName>
            <ForeName>Jean-Philip</ForeName>
            <Initials>JP</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Chimie Théorique, Sorbonne Université, UMR 7616 CNRS, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biomolecular Engineering, The University of Texas at Austin, Texas, 78712.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salmon</LastName>
            <ForeName>Laurent</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Equipe de Chimie Bioorganique et Bioinorganique, Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), Univ Paris-Saclay, Univ Paris-Sud, UMR 8182 CNRS, rue du Doyen Georges Poitou, F-91405, Orsay, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gresh</LastName>
            <ForeName>Nohad</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7174-2907</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Chimie Théorique, Sorbonne Université, UMR 7616 CNRS, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>1998053</GrantID>
            <Agency>Centre Régional Informatique et d'Applications Numériques de Haute Normandie (CRIANN, Rouen, France)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>x2009-075009</GrantID>
            <Agency>Grand Equipement National de Calcul Intensif (GENCI), Institut du Développement et des Ressources en Informatique Scientifique (IDRIS), Centre Informatique de l'Enseignement Supérieur (CINES, France)</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Comput Chem</MedlineTA>
        <NlmUniqueID>9878362</NlmUniqueID>
        <ISSNLinking>0192-8651</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ab initio quantum chemistry</Keyword>
        <Keyword MajorTopicYN="N">biosensor</Keyword>
        <Keyword MajorTopicYN="N">dianionic phosphate</Keyword>
        <Keyword MajorTopicYN="N">phosphoglucose isomerase dimer</Keyword>
        <Keyword MajorTopicYN="N">polarizable molecular mechanics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909840</ArticleId>
        <ArticleId IdType="doi">10.1002/jcc.26134</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>H. R. Bourne, D. A. Sanders, F. McCormick, Nature 1990, 348, 125. https://doi.org/10.1038/348125a0.</Citation>
        </Reference>
        <Reference>
          <Citation>R. L. Veech, M. Todd King, R. Pawlosky, Y. Kashiwaya, P. C. Bradshaw, W. Curtis, IUBMB Life 2019, 71, 565. https://doi.org/doi.org/10.1002/iub.1997.</Citation>
        </Reference>
        <Reference>
          <Citation>F. Jordan, N. S. Nemeria, Bioorg. Chem. 2014, 57, 251. https://doi.org/10.1016/j.bioorg.2014.08.002.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Liang, Q. Han, Y. Tan, H. Ding, J. Li, Front. Mol. Biosci. 2019, 6, 4. https://doi.org/10.3389/fmolb.2019.00004.</Citation>
        </Reference>
        <Reference>
          <Citation>S. J. Humphrey, D. E. James, M. Mann, Trends Endocrinol. Metab. 2015, 26, 676. https://doi.org/10.1016/j.tem.2015.09.013.</Citation>
        </Reference>
        <Reference>
          <Citation>S. T. Chung, S. K. Chacko, A. L. Sunehag, M. W. Haymond, Diabetes 2015, 64, 3996. https://doi.org/10.2337/db15-0640.</Citation>
        </Reference>
        <Reference>
          <Citation>H.-S. Han, G. Kang, J. S. Kim, B. H. Choi, S.-H. Koo, Exp. Mol. Med. 2016, 48, e218. https://doi.org/10.1038/emm.2015.122.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Stincone, A. Prigione, T. Cramer, M. M. C. Wamelink, K. Campbell, E. Cheung, V. Olin-Sandoval, N.-M. Grüning, A. Krüger, M. Tauqeer Alam, M. A. Keller, M. Breitenbach, K. M. Brindle, J. D. Rabinowitz, M. Ralser, Biol. Rev. Camb. Philos. Soc. 2015, 90, 927. https://doi.org/10.1111/brv.12140.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Akram, S. M. A. Shah, N. Munir, M. Daniyal, I. M. Tahir, Z. Mahmood, M. Irshad, M. Akhlaq, S. Sultana, R. Zainab, J. Cell. Physiol. 2019, 234, 14473. https://doi.org/10.1002/jcp.28228.</Citation>
        </Reference>
        <Reference>
          <Citation>A. E. I. Proudfoot, M. A. Payton, T. N. C. Wells, J. Protein Chem. 1994, 13, 619.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Cleasby, A. Wonacott, T. Skarzynski, R. E. Hubbard, G. J. Davies, A. E. I. Proudfoot, A. R. Bernard, M. A. Payton, T. N. C. Wells, Nat. Struct. Biol. 1996, 3, 470.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Ahmad, S. Plancqueel, V. Dubosclard, N. Lazar, W. Ghattas, I. Li de la Sierra-Gallay, H. van Tilbeurgh, L. Salmon, FEBS Lett 2018, 592, 1667. https://doi.org/10.1002/1873-3468.13059.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Watanabe, K. Takehana, M. Date, T. Shinozaki, A. Raz, Cancer Res. 1996, 56, 2960.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Baumann, A. Kappl, T. Lang, K. Brand, W. Siegfried, E. Paterok, Cancer Invest. 1990, 8, 351. https://doi.org/10.3109/07357909009012053.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Devillers, L. Ahmad, H. Korri-Youssoufi, L. Salmon, Biosens. Bioelectron. 2017, 96, 178. https://doi.org/10.1016/j.bios.2017.04.031.</Citation>
        </Reference>
        <Reference>
          <Citation>C. J. Jeffery, B. J. Bahnson, W. Chien, D. Ringe, G. A. Petsko, Biochemistry 2000, 39, 955. https://doi.org/10.1021/bi991604m.</Citation>
        </Reference>
        <Reference>
          <Citation>C.-C. Chou, Y. J. Sun, M. Meng, C.-D. Hsiao, J. Biol. Chem. 2000, 275, 23154. https://doi.org/10.1074/jbc.M002017200.</Citation>
        </Reference>
        <Reference>
          <Citation>C. J. Jeffery, R. Hardré, L. Salmon, Biochemistry 2001, 40, 1560. https://doi.org/10.1021/bi0018483.</Citation>
        </Reference>
        <Reference>
          <Citation>J. H. Lee, K. Z. Chang, V. Patel, C. J. Jeffery, Biochemistry 2001, 40, 7799. https://doi.org/10.1021/bi002916o.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Arsenieva, R. Hardré, L. Salmon, C. J. Jeffery, Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 5872. https://doi.org/10.1073/pnas.052131799.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Tanaka, A. Haga, H. Uemura, H. Akiyama, T. Funasaka, H. Nagase, A. Raz, K. T. Nakamura, J. Mol. Biol. 2002, 318, 985. https://doi.org/10.1016/S0022-2836.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Davies, H. Muirhead, J. Chirgwin, Acta Crystallogr. D Biol. Crystallogr. 2003, 59, 1111. https://doi.org/10.1107/S0907444903007352.</Citation>
        </Reference>
        <Reference>
          <Citation>C. R. Søndergaard, M. H. M. Olsson, M. Rostkowski, J. H. Jensen, J. Chem. Theory Comput. 2011, 7, 2284. https://doi.org/10.1021/ct200133y.</Citation>
        </Reference>
        <Reference>
          <Citation>M. H. M. Olsson, C. R. Søndergaard, M. Rostkowski, J. H. Jensen, J. Chem. Theory Comput. 2011, 7, 525. https://doi.org/10.1021/ct100578z.</Citation>
        </Reference>
        <Reference>
          <Citation>T. J. Dolinsky, J. E. Nielsen, J. A. McCammon, N. A. Baker, Nucleic Acids Res. 2004, 32, W665. https://doi.org/10.1093/nar/gkh381.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Martínez-Rosell, T. Giorgino, G. De Fabritiis, J. Chem. Inf. Model. 2017, 57, 1511. https://doi.org/10.1021/acs.jcim.7b00190.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Roux, N. Gresh, L. E. Perera, J.-P. Piquemal, L. Salmon, J. Comput. Chem. 2007, 28, 938. https://doi.org/10.1002/jcc.20586.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Roux, F. Bhatt, J. Foret, B. de Courcy, N. Gresh, J.-P. Piquemal, C. J. Jeffery, L. Salmon, Proteins 2011, 79, 203. https://doi.org/10.1002/prot.22873.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, B. de Courcy, J.-P. Piquemal, J. Foret, S. Courtiol-Legourd, L. Salmon, J. Phys. Chem. B 2011, 115, 8304. https://doi.org/10.1021/jp2024654.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, D. Perahia, B. de Courcy, J. Foret, C. Roux, L. El-Khoury, J.-P. Piquemal, L. Salmon, J. Comput. Chem. 2016, 37, 2770. https://doi.org/10.1002/jcc.24503.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, G. A. Cisneros, T. A. Darden, J.-P. Piquemal, J. Chem. Theory Comput. 2007, 3, 1960. https://doi.org/10.1021/ct700134r.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Lagardère, L.-H. Jolly, F. Lipparini, F. Aviat, B. Stamm, Z. F. Jing, M. Harger, H. Torabifard, G. A. Cisneros, M. J. Schnieders, N. Gresh, Y. Maday, P. Y. Ren, J. W. Ponder, J. P. Piquemal, Chem. Sci. 2018, 9, 956. https://doi.org/10.1039/C7SC04531J.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, G.-B. Shi, J. Comput. Chem. 2004, 25, 160. https://doi.org/10.1002/jcc.10312.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, N. Audiffren, J.-P. Piquemal, J. de Ruyck, M. Ledecq, J. Wouters, J. Phys. Chem. B 2010, 114, 4884. https://doi.org/10.1021/jp907629k.</Citation>
        </Reference>
        <Reference>
          <Citation>B. Jeziorski, R. Moszynski, K. Szalewicz, Chem. Rev. 1994, 94, 1887. https://doi.org/10.1021/cr00031a008.</Citation>
        </Reference>
        <Reference>
          <Citation>A. J. Misquitta, B. Jeziorski, K. Szalewicz, Phys. Rev. Lett. 2003, 91, 033201. https://doi.org/10.1103/PhysRevLett.91.033201.</Citation>
        </Reference>
        <Reference>
          <Citation>W. J. Stevens, W. H. Fink, Chem. Phys. Lett. 1987, 139, 15. https://doi.org/10.1016/0009-2614.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Tiraboschi, B.-P. Roques, N. Gresh, J. Comput. Chem. 1999, 20, 1379.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Tiraboschi, N. Gresh, C. Giessner-Prettre, L. G. Pedersen, D. W. Deerfield, J. Comput. Chem. 2000, 21, 1011.</Citation>
        </Reference>
        <Reference>
          <Citation>L. El Khoury, S. Naseem-Khan, K. Kwapien, Z. Hobaika, R. G. Maroun, J.-P. Piquemal, N. Gresh, J. Comput. Chem. 2017, 38, 1897.</Citation>
        </Reference>
        <Reference>
          <Citation>T. H. Dunning, J. Chem. Phys. 1989, 90, 1007.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Feller, J. Comput. Chem. 1996, 17, 1571.</Citation>
        </Reference>
        <Reference>
          <Citation>M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, et al., Gaussian 09, Revision A.1, Gaussian Inc., Wallingford, CT, 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>M. W. Schmidt, K. K. Baldridge, J. A. Boatz, S. T. Elbert, M. S. Gordon, J. H. Jensen, S. Koseki, N. Matsunaga, K. A. Nguyen, S. Su, T. L. Windus, M. Dupuis, J. A. Montgomery, J. Comput. Chem. 1993, 14, 1347. https://doi.org/10.1002/jcc.540141112.</Citation>
        </Reference>
        <Reference>
          <Citation>R. M. Parrish, L. A. Burns, D. G. A. Smith, A. C. Simmonett, A. E. DePrince, E. G. Hohenstein, U. Bozkaya, A. Y. Sokolov, R. Di Remigio, R. M. Richard, et al., J. Chem. Theory Comput. 2017, 13, 3185. https://doi.org/10.1021/acs.jctc.7b00174.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Langlet, J. Caillet, J. Bergès, P. Reinhardt, J. Chem. Phys. 2003, 118, 6157. https://doi.org/10.1063/1.1558473.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Patkowski, K. Szalewicz, B. Jeziorski, J. Chem. Phys. 2006, 125, 154107. https://doi.org/10.1063/1.2358353.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Goerigk, S. Grimme, Phys. Chem. Chem. Phys. 2011, 13, 6670. https://doi.org/10.1039/c0cp02984j.</Citation>
        </Reference>
        <Reference>
          <Citation>S. F. Boys, F. Bernardi, Mol. Phys. 1970, 19, 553. https://doi.org/10.1080/00268977000101561.</Citation>
        </Reference>
        <Reference>
          <Citation>A. J. Stone, J. Phys. Chem. A 2011, 115, 7017. https://doi.org/10.1021/jp112251z.</Citation>
        </Reference>
        <Reference>
          <Citation>D. R. Garmer, W. J. Stevens, J. Phys. Chem. A 1989, 93, 8263. https://doi.org/10.1021/j100362a023.</Citation>
        </Reference>
        <Reference>
          <Citation>The HSL. Mathematical Software Library; Science and Technology Facilities Council. http://www.hsl.rl.ac.uk/.</Citation>
        </Reference>
        <Reference>
          <Citation>J.-P. Piquemal, N. Gresh, C. Giessner-Prettre, J. Phys. Chem. A 2003, 107, 10353. https://doi.org/10.1021/jp035748t.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, J. Comput. Chem. 1995, 16, 856. https://doi.org/10.1002/jcc.540160705.</Citation>
        </Reference>
        <Reference>
          <Citation>G. A. Evangelakis, J. P. Rizos, I. E. Lagaris, I. N. Demetropoulos, Comput. Phys. Commun. 1987, 46, 401.</Citation>
        </Reference>
        <Reference>
          <Citation>A. M. Baptista, P. J. Martel, S. B. Petersen, Proteins 1997, 27, 523.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Lee, B. T. Miller, A. Damjanović, B. R. Brooks, J Chem Theory Comput 2014, 10, 2738. https://doi.org/10.1021/ct500175m.</Citation>
        </Reference>
        <Reference>
          <Citation>B. K. Radak, C. Chipot, D. Suh, S. Jo, W. Jiang, J. C. Phillips, K. Schulten, B. Roux, J Chem Theory Comput 2017, 13, 5933. https://doi.org/10.1021/acs.jctc.7b00875.</Citation>
        </Reference>
        <Reference>
          <Citation>F. L. Barroso da Silva, L. G. Dias, Biophys. Rev 2017, 9, 699. https://doi.org/10.1007/s12551-017-0311-5.</Citation>
        </Reference>
        <Reference>
          <Citation>F. L. Barroso da Silva, F. Sterpone, P. Derreumaux, J. Chem. Theory Comput. 2019, 15, 3875. https://doi.org/10.1021/acs.jctc.9b00202.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Devereux, N. Gresh, J.-P. Piquemal, M. Meuwly, J. Comput. Chem. 2014, 35, 1577. https://doi.org/10.1002/jcc.23661.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Corongiu, E. Clementi, J. Chem. Phys. 1978, 69, 4885. https://doi.org/10.1063/1.436518.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, D. R. Garmer, J. Comput. Chem. 1996, 17, 1481.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, S. A. Kafafi, J.-F. Truchon, D. R. Salahub, J. Comput. Chem. 2004, 25, 823. https://doi.org/10.1002/jcc.20012.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Stone, The Theory of Intermolecular Forces, 2nd ed., Oxford University Press, Oxford, New York, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Creuzet, J. Langlet, N. Gresh, J. Chim. Phys. 1991, 88, 2399. https://doi.org/10.1051/jcp/1991882399.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Kwapien, M. Damergi, S. Nader, L. El Khoury, Z. Hobaika, R. G. Maroun, J.-P. Piquemal, L. Gavara, D. Berthomieu, J.-F. Hernandez, N. Gresh, J. Phys. Chem. B 2017, 121, 6295. https://doi.org/10.1021/acs.jpcb.7b01053.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, J. E. Sponer, M. Devereux, K. Gkionis, B. de Courcy, J.-P. Piquemal, J. Sponer, J. Phys. Chem. B 2015, 119, 9477. https://doi.org/10.1021/acs.jpcb.5b01695.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Gresh, S. Naseem-Khan, L. Lagardère, J.-P. Piquemal, J. E. Sponer, J. Sponer, J. Phys. Chem. B 2017, 121, 3997. https://doi.org/10.1021/acs.jpcb.7b01836.</Citation>
        </Reference>
        <Reference>
          <Citation>B. de Courcy, J.-P. Piquemal, C. Garbay, N. Gresh, J. Am. Chem. Soc. 2010, 132, 3312. https://doi.org/10.1021/ja9059156.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909841</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-4036</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biometrical journal. Biometrische Zeitschrift</Title>
          <ISOAbbreviation>Biom J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Regressive models for risk prediction of repeated multinomial outcomes: An illustration using Health and Retirement Study data.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/bimj.201800101</ELocationID>
        <Abstract>
          <AbstractText>Life expectancy is increasing in many countries and this may lead to a higher frequency of adverse health outcomes. Therefore, there is a growing demand for predicting the risk of a sequence of events based on specified factors from repeated outcomes. We proposed regressive models and a framework to predict the joint probabilities of a sequence of events for multinomial outcomes from longitudinal studies. The Markov chain is used to link marginal and sequence of conditional probabilities to predict the joint probability. Marginal and sequence of conditional probabilities are estimated using marginal and regressive models. An application is shown using the Health and Retirement Study data. The bias of parameter estimates for all models from all bootstrap simulation is less than 1% in most of the cases. The estimated mean squared error is also very low. Results from the simulation study show negligible bias and the usefulness of the proposed model. The proposed model and framework would be useful to solve real-life problems from various fields and big data analysis.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chowdhury</LastName>
            <ForeName>Rafiqul I</ForeName>
            <Initials>RI</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9224-4640</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Statistical Research and Training (ISRT), University of Dhaka, Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Islam</LastName>
            <ForeName>Mohammed Ataharul</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Statistical Research and Training (ISRT), University of Dhaka, Dhaka, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>HEQEP subproject 3293 of the University Grants Commission of Bangladesh and the World Bank</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Biom J</MedlineTA>
        <NlmUniqueID>7708048</NlmUniqueID>
        <ISSNLinking>0323-3847</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">multinomial outcomes</Keyword>
        <Keyword MajorTopicYN="N">regressive model</Keyword>
        <Keyword MajorTopicYN="N">repeated measures</Keyword>
        <Keyword MajorTopicYN="N">risk prediction</Keyword>
        <Keyword MajorTopicYN="N">sequence of events</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>04</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909841</ArticleId>
        <ArticleId IdType="doi">10.1002/bimj.201800101</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Arjas, E., &amp; Eerola, M. (1993). On predictive causality in longitudinal studies. Journal of Statistical Planning and Inference, 34, 361-368.</Citation>
        </Reference>
        <Reference>
          <Citation>Azzalini, A. (1994). Logistic regression for autocorrelated data with application to repeated measures. Biometrika, 81, 767-775.</Citation>
        </Reference>
        <Reference>
          <Citation>Bonney, G. E. (1986). Regressive logistic models for familial disease and other binary trials. Biometrics, 42, 611-625.</Citation>
        </Reference>
        <Reference>
          <Citation>Bonney, G. E. (1987). Logistic regression for dependent binary observations. Biometrics, 43, 951-973.</Citation>
        </Reference>
        <Reference>
          <Citation>Brant, R. (1990). Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics, 46, 1171-1178.</Citation>
        </Reference>
        <Reference>
          <Citation>Breslow, N. E., &amp; Clayton, D. G., (1993). Approximate inference in generalized linear mixed models. Journal of the American Statistical Association, 88, 9-25.</Citation>
        </Reference>
        <Reference>
          <Citation>Chowdhury, R. I., &amp; Islam, M. A. (2019). Prediction of risks of sequence of events using multistage proportional hazards model: A marginal-conditional modelling approach. Statistical Methods &amp; Applications, Online First Articles. https://doi.org/10.1007/s10260-019-00460-2.</Citation>
        </Reference>
        <Reference>
          <Citation>D'Agostino, R. B., Lee, M. L., Belanger, A. J., Cupples, L. A., Anderson, K., &amp; Kannel, W. B. (1990). Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham heart study. Statistics in Medicine, 9, 1501-1515.</Citation>
        </Reference>
        <Reference>
          <Citation>Harezlak, J., GaoS. &amp; Hui, S. L. (2003). An illness-death stochastic model in the analysis of longitudinal dementia data. Statistics in Medicine, 22, 1465-75.</Citation>
        </Reference>
        <Reference>
          <Citation>Harrell, F. E. (2001). Regression modeling strategies. New York: Springer.</Citation>
        </Reference>
        <Reference>
          <Citation>Hosmer, D. W., &amp; Lemeshow, S. (2013). Applied logistic regression (3rd ed.). Hoboken, NJ: Wiley.</Citation>
        </Reference>
        <Reference>
          <Citation>HRS (2014). Public use dataset, Health and retirement study. Ann Arbor, MI: University of Michigan, 1992-2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., &amp; Chowdhury, R. I. (2006). A higher order Markov model for analyzing covariate dependence. Applied Mathematical Modelling, 30, 477-488.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., &amp; Chowdhury, R. I. (2010). Prediction of disease status: A regressive model approach for repeated measures. Statistical Methodology, 7, 520-540.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., Chowdhury, R. I., Bae, S., &amp; Singh, K. P. (2014). Assessing the association in repeated measures of depression. Advances and Applications in Statistics, 42, 83-93.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., Chowdhury, R. I., Chakraborty, N., &amp; Bari, W. (2004). A multistage model for maternal morbidity during antenatal, delivery and postpartum periods. Statistics in Medicine, 23, 137-158.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., Chowdhury, R. I., &amp; Huda, S. (2009). Markov models with covariate dependence for repeated measures. New York, NY: Nova Science.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., Chowdhury, R. I., &amp; Huda, S. (2013). A multistate transition model for analyzing longitudinal depression data. The Bulletin of the Malaysian Mathematical Sciences Society Series 2, 36, 637-655.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., Chowdhury, R. I., &amp; Singh, K. P. (2012). A Markov model for analyzing polytomous outcome data. Pakistan Journal of Statistics and Operation Research, 8, 593-603.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam, M. A., Khalaf, S. S., &amp; Chowdhury, R. I. (2009). Estimation and tests for a longitudinal regression model based on Markov chain. Statistical Methodology, 6, 478-489.</Citation>
        </Reference>
        <Reference>
          <Citation>James, G., Witten, D., Hastie, T., &amp; Tibshirani, R. (2013). An introduction to statistical learning with applications in R. New York: Springer.</Citation>
        </Reference>
        <Reference>
          <Citation>Klein, J. P., Keiding, N., &amp; Copelan, E. A. (1994). Plotting summary predictions in multistate survival models: Probabilities of relapse and death in remission for bone marrow transplantation patients. Statistics in Medicine, 13, 2315-2332.</Citation>
        </Reference>
        <Reference>
          <Citation>Lawless, J. F. (2003). Statistical models and methods for lifetime data. New York: Wiley.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, Y., &amp; Nelder, J. A. (2004). Conditional and marginal models: another view. Statistical Science, 19, 219-238.</Citation>
        </Reference>
        <Reference>
          <Citation>Lindsey, J. K., &amp; Lamber, P. (1998). On the appropriateness of marginal models for repeated measurements in clinical trials. Statistics in Medicine, 17, 447-469.</Citation>
        </Reference>
        <Reference>
          <Citation>Long, S. J. (1997). Regression models for categorical and limited dependent variables. London: SAGE Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>McCullagh, P., (1980). Regression models for ordinal data. Journal of the Royal Statistical Society. Series B, 42, 109-142.</Citation>
        </Reference>
        <Reference>
          <Citation>McCullagh, P., &amp; Nelder, J. A. (1989). Generalized linear models (2nd ed.). Boca Raton, FL: Chapman and Hall/CRC.</Citation>
        </Reference>
        <Reference>
          <Citation>Muenz, L. R., &amp; Rubinstein, L. V. (1985). Markov models for covariate dependence of binary sequence. Biometrics, 41, 91-101.</Citation>
        </Reference>
        <Reference>
          <Citation>Peterson, B., &amp; Harrell, F. E. (1990). Partial proportional odds models for ordinal response variables. Journal of the Royal Statistical Society, Series C, 39, 205-217.</Citation>
        </Reference>
        <Reference>
          <Citation>Pierce, D. A., Stewart, W. H., &amp; Kopecky, K. J. (1979). Distribution free regression analysis of grouped survival data. Biometrics, 35, 785-793.</Citation>
        </Reference>
        <Reference>
          <Citation>Prentice, R. L., &amp; Gloeckler, L. A. (1978). Regression analysis of grouped survival data with application to breast cancer data. Biometrics, 34, 57-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Putter, H., Fiocco, M., &amp; Geskus, R. B. (2007). Tutorial in biostatistics: Competing risks and multi-state models. Statistics in Medicine, 26, 2389-2430.</Citation>
        </Reference>
        <Reference>
          <Citation>Putter, H., van der Hage, J., de Bock, G. H., Elgalta, R., &amp; van de Velde, C. J. H. (2006). Estimation and prediction in a multi-state model for breast cancer. Biometrical Journal, 3, 366-380.</Citation>
        </Reference>
        <Reference>
          <Citation>Rothman, K. J. (2002). Epidemiology: An introduction. New York, NY: Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Tripepi, G., Heinze, G. K., Jager, J., Stel, V. S., Dekker, F. W., &amp; Zoccali, C. (2013). Risk prediction models. Nephrology Dialysis Transplant, 28, 1975-1980.</Citation>
        </Reference>
        <Reference>
          <Citation>Wen, Yalu., He, Z., Li, M., &amp; Lu, Q. (2016). Risk prediction modeling of sequencing data using a forward random field method. Scientific Reports, 6, 21120.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu, F. (2003). Use of a Markov transition model to analyse longitudinal low-back pain data. Statistical Methods in Medical Research, 12, 321-331.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909842</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-4995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Laryngoscope</Title>
          <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Analysis of Abdominal Dermal-Fat Grafting to Repair Parotidectomy Defects: An 18-Year Cohort Study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28466</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the outcomes of abdominal dermal-fat grafting following superficial and total parotidectomy.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective chart review of parotidectomy patients was performed. Patients were divided into four groups based on surgical extent and grafting status: superficial parotidectomy (SP), superficial parotidectomy with grafting (SPg), total parotidectomy (TP), and total parotidectomy with grafting (TPg). Complication rates and operative times were then compared between surgically matched groups (SP vs. SPg, TP vs. TPg). Complications included graft necrosis, gustatory sweating, first-bite syndrome, infection, hematoma, sialocele, and seroma. Data was analyzed via chi-square and two-sample t testing, logistic regression, and one-way analysis of variance.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The cohort consisted of 330 patients: 106 SP (32.12%), 61 SPg (18.48%), 82 TP (24.85%), and 81 TPg (24.55%). No donor site complications occurred. TPg resulted in seven graft necroses (8.64%), and 22 reported gustatory sweating (27.20% vs. 10 TP patients (12.2%), P = 0.016); SPg resulted in two necroses (3.28%). There were no other statistically significant differences in complication rates. Graft recipients receiving adjuvant radiation were more likely to develop necrosis (odds ratio [OR] 4.60, 95% confidence interval [CI], 1.16-18.27, P = .0194). Patients who developed gustatory sweating were 8.38 years younger (95% CI 2.66-14.10, P = 0.002, follow-up time &gt; 48 days). Grafting did not increase operative times (TP/TPg: mean = 275.91/263.65 minutes, standard error of the mean = 41.96/33.75, P = 0.822).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An abdominal dermal-fat graft is an excellent reconstructive choice for a parotidectomy defect and is not associated with increased complication rates or prolonged operative time.</AbstractText>
          <AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">4 Laryngoscope, 2020.</AbstractText>
          <CopyrightInformation>© 2020 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gruszczynski</LastName>
            <ForeName>Nelson R</ForeName>
            <Initials>NR</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3907-8529</Identifier>
            <AffiliationInfo>
              <Affiliation>Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Anderies Bse</LastName>
            <ForeName>Barrett J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dey</LastName>
            <ForeName>Jacob K</ForeName>
            <Initials>JK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Price</LastName>
            <ForeName>Daniel L</ForeName>
            <Initials>DL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moore</LastName>
            <ForeName>Eric J</ForeName>
            <Initials>EJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janus</LastName>
            <ForeName>Jeffrey R</ForeName>
            <Initials>JR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, U.S.A.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Laryngoscope</MedlineTA>
        <NlmUniqueID>8607378</NlmUniqueID>
        <ISSNLinking>0023-852X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dermal-fat</Keyword>
        <Keyword MajorTopicYN="N">Frey's</Keyword>
        <Keyword MajorTopicYN="N">graft</Keyword>
        <Keyword MajorTopicYN="N">gustatory sweating</Keyword>
        <Keyword MajorTopicYN="N">parotidectomy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909842</ArticleId>
        <ArticleId IdType="doi">10.1002/lary.28466</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>BIBLIOGRAPHY</Title>
        <Reference>
          <Citation>Nitzan D, Kronenberg J, Horowitz Z, et al. Quality of life following parotidectomy for malignant and benign disease. Plast Reconstr Surg 2004;114:1060-1067.</Citation>
        </Reference>
        <Reference>
          <Citation>Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol 2010;74:134-148.</Citation>
        </Reference>
        <Reference>
          <Citation>Meier JD, Wenig BL, Manders EC, Nenonene EK. Continuous intraoperative facial nerve monitoring in predicting postoperative injury during parotidectomy. Laryngoscope 2006;116:1569-1572.</Citation>
        </Reference>
        <Reference>
          <Citation>Eisele DW, Wang SJ, Orloff LA. Electrophysiologic facial nerve monitoring during parotidectomy. Head Neck 2010;32:399-405.</Citation>
        </Reference>
        <Reference>
          <Citation>de Bree R, van der Waal I, Leemans CR. Management of Frey syndrome. Head Neck 2007; 29:773-778.</Citation>
        </Reference>
        <Reference>
          <Citation>Grammatica A, Perotti P, Mancini F, et al. Great auricular nerve preservation in parotid gland surgery: long-term outcomes. Laryngoscope 2015;125:1107-1112.</Citation>
        </Reference>
        <Reference>
          <Citation>Baum SH, Mohr C. Autologous dermis-fat grafts in head and neck patients: Indications and evaluation in reconstructive surgery. J Craniomaxillofac Surg 2018;46:1834-1842.</Citation>
        </Reference>
        <Reference>
          <Citation>Marchese-Ragona R, De Filippis C, Marioni G, Staffieri A. Treatment of complications of parotid gland surgery. Acta Otorhinolaryngol Ital 2005;25:174-178.</Citation>
        </Reference>
        <Reference>
          <Citation>Johns ME, Nachals NE. Salivary gland tumors. In: Paperalla MM, Shumarick DA, Gluckman JL, Meyerhoff WL, eds. Otolaryngology. Vol. 3. Philadelphia, PA: WB Saunders; 1991: 2099-2128.</Citation>
        </Reference>
        <Reference>
          <Citation>Fiachini G, Cerchiai N, Trico D, et al. Frey syndrome, first bite syndrome, great auricular nerve morbidity and quality of life following parotidectomy. Eur Arch Otorhinol 2018;275:1893-1902.</Citation>
        </Reference>
        <Reference>
          <Citation>Loyo M, Gourin CP. Free abdominal fat transfer for partial and total parotidectomy defect reconstruction. Laryngoscope 2016;126: 2694-2698.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang S, Li L, Chen J, et al. Effects of free fat grafting on the prevention of Frey's syndrome and facial depression after parotidectomy: a prospective randomized trial. Laryngoscope 2015;126:815-819.</Citation>
        </Reference>
        <Reference>
          <Citation>Nosan DK, Ochi JW, Davidson TM. Preservation of facial contour during parotidectomy. Otolaryngol Head Neck Surg 1991;104:293-298.</Citation>
        </Reference>
        <Reference>
          <Citation>Harada T, Inoue T, Harashina T, Hatoko M, Ueda K. Dermis-fat graft after parotidectomy to prevent Frey's syndrome and the concave deformity. Ann Plast Surg 1993;31:450-452.</Citation>
        </Reference>
        <Reference>
          <Citation>Chandarana S, Fung K, Franklin JH, Kotylak T, Matic DB, Yoo J. Effect of autologous platelet adhesives on dermal fat graft resorption following reconstruction of a superficial parotidectomy defect: a double-blinded prospective trial. Head Neck 2009;31:521-530.</Citation>
        </Reference>
        <Reference>
          <Citation>Yoo YM, Lee JS, Park MC, Kim C, Seo SJ, Lee IJ. Dermofat graft after superficial parotidectomy via a modified face-lift incision to prevent Frey syndrome and depressed deformity. J Craniofac Surg 2011;22:1021-1023.</Citation>
        </Reference>
        <Reference>
          <Citation>Govindaraj S, Cohen M, Genden EM, Costantino PD, Urken ML. The use of acellular dermis in the prevention of Frey's syndrome. Laryngoscope 2001;111:1993-1998.</Citation>
        </Reference>
        <Reference>
          <Citation>Dulguerov P, Quinodoz D, Cosendai G, Piletta P, Marchal F, Lehmann W. Prevention of Frey syndrome during parotidectomy. Arch Otolaryngol Head Neck Surg 1999;125:833-839.</Citation>
        </Reference>
        <Reference>
          <Citation>Schmitzer S, Simionescu C, Alexandrescu C, Burcea M. The anophthalmic socket - reconstructive options. J Med Life 2014;7(Spec 4):23-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Curry JM, Fisher KW, Heffelfinger RN, Rosen MR, Kean WM, Pribitkin EA. Superficial musculoaponeurotic system elevation and fat graft reconstruction after superficial parotidectomy. Laryngoscope 2008;118:210-215.</Citation>
        </Reference>
        <Reference>
          <Citation>Casler JD, Conley J. Sternocleidomastoid muscle transfer and superficial musculoaponeurotic system plication in the prevention of Frey's syndrome. Laryngoscope 1991;101:95-100.</Citation>
        </Reference>
        <Reference>
          <Citation>Asal K, Koybasioglu A, Inal E, et al. Sternocleidomastoid muscle flap reconstruction during parotidectomy to prevent Frey's syndrome and facial contour deformity. Ear Nose Throat J 2005;84:173-176.</Citation>
        </Reference>
        <Reference>
          <Citation>Lin HJ, Hsiao JR, Chang JS, et al. Resected specimen size: a reliable predictor of severe Frey syndrome after parotidectomy. Head Neck 2019;41:2285-2290.</Citation>
        </Reference>
        <Reference>
          <Citation>Rivner MH, Swift TR, Malik K. Influence of age and height on nerve conduction. Muscle Nerve 2001;24:1134-1141.</Citation>
        </Reference>
        <Reference>
          <Citation>Vaughan DW. Effects of advancing age on peripheral nerve regeneration. J Comp Neurol 1992;323:219-237.</Citation>
        </Reference>
        <Reference>
          <Citation>Sanabria A, Kowalski LP, Bradley PJ, et al. Sternocleidomastoid muscle flap in preventing Frey's syndrome after parotidectomy: a systematic review. Head Neck 2012;34:589-598.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909843</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-313X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Plant journal : for cell and molecular biology</Title>
          <ISOAbbreviation>Plant J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Wide-ranging transcriptome remodeling mediated by alternative polyadenylation in response to abiotic stresses in sorghum.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/tpj.14671</ELocationID>
        <Abstract>
          <AbstractText>Alternative polyadenylation (APA) regulates diverse developmental and physiological processes, through its effects on gene expression, mRNA stability, translatability, and transport. Sorghum is a major cereal crop in the world and despite its importance, not much is known about the role of post-transcriptional regulation in mediating responses to abiotic stresses in sorghum. A genome-wide APA analysis unveiled widespread occurrence of APA in sorghum in response to drought, heat, and salt stress. Abiotic stress treatments incited changes in poly(A) site choice in a large number of genes. Interestingly, abiotic stresses led to the re-directing of transcriptional output into non-productive pathways defined by the class of poly(A) site utilized. This result reveals APA to be part of a larger global response of sorghum to abiotic stresses that involves the re-direction of transcriptional output into non-productive transcriptional and translational pathways. A large number of stress-inducible poly(A) sites could not be linked with known, annotated genes, suggestive of the existence of numerous unidentified genes whose expression is strongly regulated by abiotic stresses. Furthermore, we uncovered a novel stress-specific cis-element in intronic poly(A) sites used in drought- and heat-stressed plants that might play an important role in non-canonical poly(A) site choice in response to abiotic stresses.</AbstractText>
          <CopyrightInformation>© 2020 The Authors The Plant Journal © 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chakrabarti</LastName>
            <ForeName>Manohar</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Plant and Soil Sciences, University of Kentucky, Lexington, KY, 40546.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Lorenzo</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Plant and Soil Sciences, University of Kentucky, Lexington, KY, 40546.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdel-Ghany</LastName>
            <ForeName>Salah E</ForeName>
            <Initials>SE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, and Program in Cell and Molecular Biology, Colorado State University, Fort Collins, CO, 80523.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reddy</LastName>
            <ForeName>Anireddy S N</ForeName>
            <Initials>ASN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, and Program in Cell and Molecular Biology, Colorado State University, Fort Collins, CO, 80523.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hunt</LastName>
            <ForeName>Arthur G</ForeName>
            <Initials>AG</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Plant and Soil Sciences, University of Kentucky, Lexington, KY, 40546.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Plant J</MedlineTA>
        <NlmUniqueID>9207397</NlmUniqueID>
        <ISSNLinking>0960-7412</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">APA</Keyword>
        <Keyword MajorTopicYN="N">Sorghum</Keyword>
        <Keyword MajorTopicYN="N">abiotic stress</Keyword>
        <Keyword MajorTopicYN="N">alternative polyadenylation</Keyword>
        <Keyword MajorTopicYN="N">drought</Keyword>
        <Keyword MajorTopicYN="N">heat</Keyword>
        <Keyword MajorTopicYN="N">salinity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909843</ArticleId>
        <ArticleId IdType="doi">10.1111/tpj.14671</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909844</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1464-5491</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Diabetic medicine : a journal of the British Diabetic Association</Title>
          <ISOAbbreviation>Diabet. Med.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/dme.14227</ELocationID>
        <Abstract>
          <AbstractText>This narrative review of the literature provides a summary and discussion of 25 years of research into the complex links between depression and diabetes. Systematic reviews have shown that depression occurs more frequently in people with type 1 or type 2 diabetes compared with people without diabetes. Currently, it remains unclear whether depression is also more common in people with impaired glucose metabolism or undiagnosed type 2 diabetes compared with people without diabetes. More prospective epidemiological research into the course of depression and an exploration of mechanisms in individuals with diabetes are needed. Depression in diabetes is associated with less optimal self-care behaviours, suboptimal glycaemic control, impaired quality of life, incident micro- and macrovascular diseases, and elevated mortality rates. Randomized controlled trails concluded that depression in diabetes can be treated with antidepressant medication, cognitive-behavioural therapy (individual, group-based or web-based), mindfulness-based cognitive therapy and stepped care. Although big strides forward have been made in the past 25 years, scientific evidence about depression in diabetes remains incomplete. Future studies should investigate mechanisms that link both conditions and test new diabetes-specific web- or app-based interventions for depression in diabetes. It is important to determine whether treatment or prevention of depression prevents future diabetes complications and lowers mortality rates.</AbstractText>
          <CopyrightInformation>© 2020 Diabetes UK.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pouwer</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Southern, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>STENO Diabetes Center Odense, Odense, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Psychology, Deakin University, Geelong, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schram</LastName>
            <ForeName>M T</ForeName>
            <Initials>MT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Heart and Vascular Centre, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iversen</LastName>
            <ForeName>M M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Western Norway University of Applied Sciences, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nouwen</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Middlesex University, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holt</LastName>
            <ForeName>R I G</ForeName>
            <Initials>RIG</Initials>
            <AffiliationInfo>
              <Affiliation>Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University Hospital Southampton NHS Foundation Trust, Southampton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Diabet Med</MedlineTA>
        <NlmUniqueID>8500858</NlmUniqueID>
        <ISSNLinking>0742-3071</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909844</ArticleId>
        <ArticleId IdType="doi">10.1111/dme.14227</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909845</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1443-1661</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society</Title>
          <ISOAbbreviation>Dig Endosc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Successful further endoscopic mucosal resection with an over-the-scope clip with circumferential mucosal incision for a residual rectal neuroendocrine tumor.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/den.13624</ELocationID>
        <Abstract>
          <AbstractText>Endoscopic submucosal resection with band ligation (ESMR-L)<sup>1</sup> and endoscopic submucosal dissection (ESD)<sup>2</sup> are endoscopic resection methods for small (≤10mm) rectal neuroendocrine tumors (NETs). Upon comparison of complete resection rates between ESMR-L and ESD, the vertical safety margin was significantly larger in ESMR-L than in ESD when performed for rectal NETs<sup>3</sup> .</AbstractText>
          <CopyrightInformation>© 2020 Japan Gastroenterological Endoscopy Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tashima</LastName>
            <ForeName>Tomoaki</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4515-5543</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Saitama Medical University International Medical Center, Saitama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nonaka</LastName>
            <ForeName>Kouichi</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Saitama Medical University International Medical Center, Saitama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ryozawa</LastName>
            <ForeName>Shomei</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4128-9990</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Saitama Medical University International Medical Center, Saitama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Dig Endosc</MedlineTA>
        <NlmUniqueID>9101419</NlmUniqueID>
        <ISSNLinking>0915-5635</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">endoscopic mucosal resection</Keyword>
        <Keyword MajorTopicYN="N">over-the-scope clip (OTSC)</Keyword>
        <Keyword MajorTopicYN="N">rectal neuroendocrine tumor</Keyword>
        <Keyword MajorTopicYN="N">residual tumor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909845</ArticleId>
        <ArticleId IdType="doi">10.1111/den.13624</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909846</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-896X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Protein science : a publication of the Protein Society</Title>
          <ISOAbbreviation>Protein Sci.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Structure of the BRK domain of the SWI/SNF chromatin remodelling complex subunit BRG1 reveals a potential role in protein-protein interactions.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/pro.3820</ELocationID>
        <Abstract>
          <AbstractText>BRG1/SMARCA4 and its paralog BRM/SMARCA2 are the ATPase subunits of human SWI/SNF chromatin remodelling complexes. These multi-subunit assemblies can act as either tumour suppressors or drivers of cancer, and inhibiting both BRG1 and BRM, is emerging as an effective therapeutic strategy in diverse cancers. BRG1 and BRM contain a BRK domain. The function of this domain is unknown, but it is often found in proteins involved in transcription and developmental signalling in higher eukaryotes, in particular in proteins that remodel chromatin. We report the NMR structure of the BRG1 BRK domain. It shows similarity to the glycine-tyrosine-phenylalanine (GYF) domain, an established protein-protein interaction module. Computational peptide-binding-site analysis of the BRK domain identifies a binding site that coincides with a highly conserved groove on the surface of the protein. This sets the scene for experiments to elucidate the role of this domain, and evaluate the potential of targeting it for cancer therapy.</AbstractText>
          <CopyrightInformation>© 2020 The Protein Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Allen</LastName>
            <ForeName>Mark D</ForeName>
            <Initials>MD</Initials>
            <AffiliationInfo>
              <Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bycroft</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zinzalla</LastName>
            <ForeName>Giovanna</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1130-4865</Identifier>
            <AffiliationInfo>
              <Affiliation>Microbiology, Tumor and Cell Biology (MTC) Department, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Protein Sci</MedlineTA>
        <NlmUniqueID>9211750</NlmUniqueID>
        <ISSNLinking>0961-8368</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BAF complexes</Keyword>
        <Keyword MajorTopicYN="N">NMR</Keyword>
        <Keyword MajorTopicYN="N">SMARCA4 subunit</Keyword>
        <Keyword MajorTopicYN="N">cancer</Keyword>
        <Keyword MajorTopicYN="N">heart diseases</Keyword>
        <Keyword MajorTopicYN="N">neurodevelopmental disorders</Keyword>
        <Keyword MajorTopicYN="N">protein-protein interactions</Keyword>
        <Keyword MajorTopicYN="N">structural determination</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909846</ArticleId>
        <ArticleId IdType="doi">10.1002/pro.3820</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909847</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2834</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of nursing management</Title>
          <ISOAbbreviation>J Nurs Manag</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Relationship Between Nurses' Work-Related Variables, Colleague Solidarity, And Job Motivation.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jonm.12949</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The study was conducted to evaluate the effects of nurses' work-related variables and colleague solidarity on their job motivation.</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The motivation of nurses is an important measure in effective and efficient provision of healthcare services.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The sample of this descriptive study included 172 nurses working at a private hospital in Turkey. The Colleague Solidarity Scale for Nurses, Nurses' Job Motivation Scale, and Demographic and Work-Related Variables Questionnaire were used for data collection. Data were analyzed using descriptive statistics, Pearson's correlation, and backward multiple regression analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a positive correlation between the scores on the Colleague Solidarity Scale for Nurses and the Nurses' Job Motivation Scale (r: 0.56, p &lt; 0.001). Of the nine independent variables evaluated in the multiple regression analysis, five had a significant effect on the job motivation of nurses (R<sup>2</sup> : 0.39, p &lt; 0.001, Durbin-Watson: 2.12).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of the study show that the three sub-dimensions of the Colleague Solidarity Scale for Nurses, salary and career opportunities were important factors affecting job motivation.</AbstractText>
          <AbstractText Label="IMPLICATIONS FOR NURSING MANAGEMENT" NlmCategory="CONCLUSIONS">In order to increase nurses' job motivation, nurse managers should work to improve collegial solidarity, create career opportunities, and develop salary policies.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Göktepe</LastName>
            <ForeName>Nilgün</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3567-7399</Identifier>
            <AffiliationInfo>
              <Affiliation>Koç University School of Nursing, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yalçin</LastName>
            <ForeName>Begüm</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Koç University School of Nursing, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Türkmen</LastName>
            <ForeName>Emine</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3356-5871</Identifier>
            <AffiliationInfo>
              <Affiliation>Koç University School of Nursing, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dirican</LastName>
            <ForeName>Ümmühan</ForeName>
            <Initials>Ü</Initials>
            <AffiliationInfo>
              <Affiliation>Şişli Memorial Hospital, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aydin</LastName>
            <ForeName>Melek</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Şişli Memorial Hospital, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Nurs Manag</MedlineTA>
        <NlmUniqueID>9306050</NlmUniqueID>
        <ISSNLinking>0966-0429</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Colleague solidarity</Keyword>
        <Keyword MajorTopicYN="N">job motivation</Keyword>
        <Keyword MajorTopicYN="N">nurses</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909847</ArticleId>
        <ArticleId IdType="doi">10.1111/jonm.12949</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909848</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3765</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry (Weinheim an der Bergstrasse, Germany)</Title>
          <ISOAbbreviation>Chemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Co-hydrolysis and Seed-induced Synthesis of Basic Mesoporous ZSM-5 Zeolites with Enhanced Catalytic Performance.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/chem.201904807</ELocationID>
        <Abstract>
          <AbstractText>For zeolite catalysts, the regulation of active site and pore structure plays an important role in the enhancement of their catalytic performance. In this work, we proposed a one-pot and organic template-free co-regulation route to straightforwardly synthesize basic mesoporous ZSM-5 zeolites with adjustable alkaline-earth metal species. The synthesis pathway combines two decisive strategies: 1) the seed-induced interface assembly growth method and 2) the acidic co-hydrolysis/condensation of aluminosilicate species and alkaline earth metal (e.g., Mg, Ca, Sr or Ba) sources. It is interesting that the mesoporous structure was self-evolved through particle-attached seed-interfacial crystallization without the assistance of any template. Meanwhile, the incorporation of alkaline-earth metals species is homogenous and highly dispersed in the solid products during the whole crystallization process, and finally generate the superior basicity. Catalysis tests of the as-synthesized samples displayed novel performance in the typical base reaction of Knoevenagel condensation, even for the bulky substrates due to the enhanced diffusion rising from meso/microporous network. This finding opens new possibilities for facile, cost-effective, and environment-friendly synthesis of mesoporous high-silica zeolites with tunable acid/base properties, and deepens our understanding of the particle-attached crystallization.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ye</LastName>
            <ForeName>Zhaoqi</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University, Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University, Department of Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Hongbin</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University, Fudan University Library, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yahong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University, Department of Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Fudan University, Chemistry, 220 Handan Rd., Yangpu District, 200433, Shanghai, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chemistry</MedlineTA>
        <NlmUniqueID>9513783</NlmUniqueID>
        <ISSNLinking>0947-6539</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Basic zeolite</Keyword>
        <Keyword MajorTopicYN="N">Knoevenagel condensation</Keyword>
        <Keyword MajorTopicYN="N">Mesoporous zeolite</Keyword>
        <Keyword MajorTopicYN="N">Non-classical crystallization</Keyword>
        <Keyword MajorTopicYN="N">Seed-induced synthesis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909848</ArticleId>
        <ArticleId IdType="doi">10.1002/chem.201904807</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909849</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2486</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Global change biology</Title>
          <ISOAbbreviation>Glob Chang Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Soil carbon loss with warming: New evidence from carbon-degrading enzymes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/gcb.14986</ELocationID>
        <Abstract>
          <AbstractText>Climate warming affects soil carbon (C) dynamics, with possible serious consequences for soil C stocks and atmospheric CO<sub>2</sub> concentrations. However, the mechanisms underlying changes in soil C storage are not well understood, hampering long-term predictions of climate C-feedbacks. The activity of the extracellular enzymes ligninase and cellulase can be used to track changes in the predominant C sources of soil microbes and can thus provide mechanistic insights into soil C loss pathways. Here we show, using meta-analysis, that reductions in soil C stocks with warming are associated with increased ratios of ligninase to cellulase activity. Furthermore, whereas long-term (≥5 years) warming reduced the soil recalcitrant C pool by 14%, short-term warming had no significant effect. Together, these results suggest that warming stimulates microbial utilization of recalcitrant C pools, possibly exacerbating long-term climate-C feedbacks.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ji</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-7026-6312</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Agroecology, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Circular Bioeconomy, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>iCLIMATE Interdisciplinary Centre for Climate Change, Aarhus University, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elsgaard</LastName>
            <ForeName>Lars</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Agroecology, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>iCLIMATE Interdisciplinary Centre for Climate Change, Aarhus University, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Groenigen</LastName>
            <ForeName>Kees Jan</ForeName>
            <Initials>KJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9165-3925</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Geography, College of Life and Environmental Sciences, University of Exeter, Exeter, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Olesen</LastName>
            <ForeName>Jørgen Eivind</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Agroecology, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>iCLIMATE Interdisciplinary Centre for Climate Change, Aarhus University, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Zhi</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9510-9281</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Agroecology, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geography, College of Life and Environmental Sciences, University of Exeter, Exeter, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laerke</LastName>
            <ForeName>Poul Erik</ForeName>
            <Initials>PE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Agroecology, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>iCLIMATE Interdisciplinary Centre for Climate Change, Aarhus University, Roskilde, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yuefang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Jiangsu Academy of Agricultural Sciences, East China Scientific Observing and Experimental Station of Development and Utilization of Rural Renewable Energy, Ministry of Agriculture and Rural Affairs, Nanjing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Yiqi</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4556-0218</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for Ecosystem Science and Society and Department of Biological Sciences, Northern Arizona University, Arizona, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hungate</LastName>
            <ForeName>Bruce A</ForeName>
            <Initials>BA</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Ecosystem Science and Society and Department of Biological Sciences, Northern Arizona University, Arizona, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sinsabaugh</LastName>
            <ForeName>Robert L</ForeName>
            <Initials>RL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of New Mexico, Albuquerque, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jørgensen</LastName>
            <ForeName>Uffe</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Agroecology, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Circular Bioeconomy, Aarhus University, Tjele, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Chang Biol</MedlineTA>
        <NlmUniqueID>9888746</NlmUniqueID>
        <ISSNLinking>1354-1013</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">climate-carbon feedback</Keyword>
        <Keyword MajorTopicYN="N">experimental warming</Keyword>
        <Keyword MajorTopicYN="N">extracellular enzyme</Keyword>
        <Keyword MajorTopicYN="N">labile carbon pool</Keyword>
        <Keyword MajorTopicYN="N">recalcitrant carbon pool</Keyword>
        <Keyword MajorTopicYN="N">soil carbon storage</Keyword>
        <Keyword MajorTopicYN="N">soil microorganism</Keyword>
        <Keyword MajorTopicYN="N">warming duration</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909849</ArticleId>
        <ArticleId IdType="doi">10.1111/gcb.14986</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909850</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The International journal of health planning and management</Title>
          <ISOAbbreviation>Int J Health Plann Manage</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Do online applications for free assistive technology devices by individuals with disabilities introduce moral hazard? Evidence from Shanghai, China.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hpm.2972</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To examine whether moral hazard may exist under unsupervised home-based online applications, leading to more assistive technology devices (ATDs) and larger per capita expenditures on ATDs than under supervised community center-based online applications.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Using the data from the Assistive Devices Resource Centre in Shanghai, descriptive statistics were estimated for the sociodemographics of applicants. Multiple linear regression and logistic regression were used to test the effect of the introduction of home-based online applications.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2015-2016, there were marked increases of 22.3% in the total number of ATDs and 27.2% in the total expenditure on ATDs compared with 2013-2014. The per capita number and expenditure also demonstrated an increasing trend. More devices were applied for in 2015-2016 than in 2013-2014, yielding a higher expenditure per capita (P &lt; .001). Interestingly, with an invisible price, more devices were applied for at home than in community centers (P &lt; .001), but the expenditure per capita was smaller (P &lt; .001).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The introduction of online applications increased the number of ATDs per capita. The home-based applications induced the purchase of more ATDs but not higher expenditures on ATDs. Individuals with disabilities tend to request the maximum number of ATDs allowed by the application rules, which is an indicator of moral hazard. The prices of ATDs were not visible for individuals with disabilities, which may cause individuals to order costlier ATDs when applying at home. Stricter review may be needed to reign in the potential moral hazard among online applicants with disabilities.</AbstractText>
          <CopyrightInformation>© 2019 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xiaojing</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6702-3202</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>China Research Center on Disability Issues, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Mei</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>China Research Center on Disability Issues, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Shanghai Assistive Devices Resource Center for People with Disabilities, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chengyue</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>China Research Center on Disability Issues, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Rong</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Shanghai Assistive Devices Resource Center for People with Disabilities, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Heqi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>China Research Center on Disability Issues, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Weili</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Shanghai Assistive Devices Resource Center for People with Disabilities, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>School of Community and Environmental Health, Old Dominion University, Virginia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>China Research Center on Disability Issues, Fudan University, Shanghai, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>B16031</GrantID>
            <Agency>111 Project</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>17ZDA078</GrantID>
            <Agency>National Social Science Fund of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>7177403</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Health Plann Manage</MedlineTA>
        <NlmUniqueID>8605825</NlmUniqueID>
        <ISSNLinking>0749-6753</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>H</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">assistive technology devices</Keyword>
        <Keyword MajorTopicYN="N">disability policy</Keyword>
        <Keyword MajorTopicYN="N">moral hazard</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909850</ArticleId>
        <ArticleId IdType="doi">10.1002/hpm.2972</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>World Health Organization. Disability and health. http://www.who.int/mediacentre/factsheets/fs352/en/2018. Accessed March 29 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Lagu T, Hannon NS, Rothberg MB, et al. Access to subspecialty care for patients with mobility impairment a survey. Ann Intern Med. 2013;158(6):441-446.</Citation>
        </Reference>
        <Reference>
          <Citation>Maart S, Jelsma J. Disability and access to health care-a community based descriptive study. Disabil Rehabil. 2014;36:1489-1493.</Citation>
        </Reference>
        <Reference>
          <Citation>Lagu T, Griffin C, Lindenauer PK. Ensuring access to health care for patients with disabilities. JAMA Intern Med. 2015;175(2):157-158.</Citation>
        </Reference>
        <Reference>
          <Citation>Bamer AM, Connell FA, Dudgeon BJ, Johnson KL. Frequency of purchase and associated costs of assistive technology for Washington state medicaid program enrollees with spina bifida by age. Disabil Health J. 2010;3(3):155-161.</Citation>
        </Reference>
        <Reference>
          <Citation>Harniss M, Raja DS, Matter R. Assistive technology access and service delivery in resource-limited environments: introduction to a special issue of disability and rehabilitation: assistive technology. Disabil Rehabil Assist Technol. 2015;10(4):267-270.</Citation>
        </Reference>
        <Reference>
          <Citation>Lofqvist C, Nygren C, Szeman Z, Iwarsson S. Assistive devices among very old people in five European countries. Scand J Occup Ther. 2005;12(4):181-192.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO Global Disability Action Plan 2014-2021: better health for all people with disability. Geneva: World Health Organization; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Shanghai Municipal Statistics Bureau. ShangHai Statistical Yearbook 2017. Beijing: China Statistics Press; 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>China Disabled Persons' Fadaration. China Statistical Yearbook on the Work for the Persons with Disabilities 2015. Beijing: China Statistics Press; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>China Disabled Persons' Fadaration. China Statistical Yearbook on the Work for the Persons with Disability. Beijing: China Statistics Press; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>McCall BP, Horwitz IB. An assessment of the effects of increased regulatory enforcement and legislative reform on occupational hearing loss workers' compensation claims: Oregon 1984-1998. Am J Ind Med. 2004;45(5):417-427.</Citation>
        </Reference>
        <Reference>
          <Citation>Autor DH, Duggan MG. The growth in the social security disability rolls: a fiscal crisis unfolding. J Econ Perspect. 2006;20(3):71-96.</Citation>
        </Reference>
        <Reference>
          <Citation>Karistrom A, Palme M, Svensson I. The employment effect of stricter rules for eligibility for DI: evidence from a natural experiment in Sweden. J Publ Econ. 2008;92:2071-2082.</Citation>
        </Reference>
        <Reference>
          <Citation>Staubli S. The impact of stricter criteria for disability insurance on labor force participation. J Publ Econ. 2011;95(9-10):1223-1235.</Citation>
        </Reference>
        <Reference>
          <Citation>Khorasani E, Keyvanara M, Etemadi M, Asadi S, Mohammadi M, Barati M. Insurance companies' point of view toward moral hazard incentives. J Medic Ethics Hist Med. 2016;9:12.</Citation>
        </Reference>
        <Reference>
          <Citation>Homaie Rad EN, Nouruzi A, Raeissi P. Moral hazard of dental services in armed force social security insurance before and after soldiery in 2012. Hakim. 2014;17:260-267.</Citation>
        </Reference>
        <Reference>
          <Citation>Ebrahimnia M, Khezri J, Teymourzadeh E, Amiri MM. Impact of deductibles on insured moral hazard in the armed forces health services: a case study in Tehran. J Military Medic. 2014;16:93-98.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Orgnaization the World Bank. World report on disability. Geneva: World Health Organisation; 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Banks LM, Kuper H, Polack S. Poverty and disability in low- and middle-income countries: a systematic review. PLoS ONE. 2017;12:e0189996.</Citation>
        </Reference>
        <Reference>
          <Citation>Hubbard SL, Fitzgerald SG, Reker DM, Boninger ML, Cooper RA, Kazis LE. Demographic characteristics of veterans who received wheelchairs and scooters from veterans health administration. J Rehabil Res Dev. 2006;43(7):831-844.</Citation>
        </Reference>
        <Reference>
          <Citation>Perera I, Ekanayake L. Conventional versus asset approaches: comparative appraisal of socioeconomic indicators for oral health research among adolescents in a developing country. Asia Pac J Public Health. 2010;22(4):407-414.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909851</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1463-1318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland</Title>
          <ISOAbbreviation>Colorectal Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Is neo-adjuvant chemo-radiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/codi.14950</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">There is current debate as to the optimal management of lateral pelvic Lymph nodes (LPLN) in rectal cancer between western and eastern centres. This paper aims to report the rate of histologically proven positive LPLNs in a group of patients undergoing conventional western approach to primary and recurrent rectal cancer.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">A retrospective cohort review of all patients who had undergone LPLN dissection at Royal Prince Alfred Hospital in Sydney Australia. This included pelvic exenteration patients who had LPLNs excised either en-bloc for laterally invasive or recurrent tumors or as part of a selective node dissection for suspicious lymph nodes on preoperative imaging. Histopathological results of these patients were compared to node status at preoperative imaging.</AbstractText>
          <AbstractText Label="RESULT" NlmCategory="RESULTS">71 patients satisfied the inclusion criteria. 27% (9/33) patients with radiologically positive LPLN treated with preoperative radiotherapy compared with 75% (9/12) patients with radiologically positive LPLN not treated with preoperative radiotherapy had positive nodes on histopathology (P=0.004). None of the 12 patients with radiologically negative nodes treated with radiotherapy compared with 25% (3/12) patients with radiologically negative nodes not treated with radiotherapy had positive nodes. 53% of patients developed postoperative complications.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggests that in patients with radiologically positive LPLN, chemo-radiotherapy may not be enough to sterilize these extra-mesorectal LNs as a large proportion (27%) will have residual viable adenocarcinoma cells. In patients with radiologically negative LPLNs however, the addition of chemo-radiotherapy may serve to adequately sterilize these LNs without the need for prophylactic LPLN dissection.</AbstractText>
          <CopyrightInformation>Colorectal Disease © 2020 The Association of Coloproctology of Great Britain and Ireland.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ahmadi</LastName>
            <ForeName>Nima</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Outcomes Research Centre (SOuRCe), Sydney Local Health District &amp; Sydney School of Public Health, University of Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>Kilian G M</ForeName>
            <Initials>KGM</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Outcomes Research Centre (SOuRCe), Sydney Local Health District &amp; Sydney School of Public Health, University of Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Academic Surgery at RPA, Sydney Local Health District.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Outcomes Research Centre (SOuRCe), Sydney Local Health District &amp; Sydney School of Public Health, University of Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quinn</LastName>
            <ForeName>Martha</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Austin</LastName>
            <ForeName>Kirk K S</ForeName>
            <Initials>KKS</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Outcomes Research Centre (SOuRCe), Sydney Local Health District &amp; Sydney School of Public Health, University of Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Solomon</LastName>
            <ForeName>Michael J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Outcomes Research Centre (SOuRCe), Sydney Local Health District &amp; Sydney School of Public Health, University of Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Institute of Academic Surgery at RPA, Sydney Local Health District.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Colorectal Dis</MedlineTA>
        <NlmUniqueID>100883611</NlmUniqueID>
        <ISSNLinking>1462-8910</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Lateral Pelvic Lymph node</Keyword>
        <Keyword MajorTopicYN="N">rectal cancer</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909851</ArticleId>
        <ArticleId IdType="doi">10.1111/codi.14950</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909852</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-0009</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Milbank quarterly</Title>
          <ISOAbbreviation>Milbank Q</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Unraveling the Complexity in the Design and Implementation of Bundled Payments: A Scoping Review of Key Elements From a Payer's Perspective.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-0009.12438</ELocationID>
        <Abstract>
          <AbstractText>Policy Points Because bundled payments are relatively new and require a different type of collaboration among payers, providers, and other actors, their design and implementation process is complex. By sorting the 53 key elements that contribute to this complexity into specific pre- and postcontractual phases as well as the actors involved in the health system, this framework provides a comprehensive overview of this complexity from a payer's perspective. Strategically, the design and implementation of bundled payments should not be approached by payers as merely the introduction of a new contracting model, but as part of a broader transformation into a more sustainable, value-based health care system.</AbstractText>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Traditional fee-for-service (FFS) payment models in health care stimulate volume-driven care rather than value-driven care. To address this issue, increasing numbers of payers are adopting contracts based on bundled payments. Because their design and implementation are complex, understanding the elements that contribute to this complexity from a payer's perspective might facilitate their adoption. Consequently, the objective of our study was to identify and structure the key elements in the design and implementation of bundled payment contracts.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Two of us independently and systematically examined the literature to identify all the elements considered relevant to our objective. We then developed a framework in which these elements were arranged according to the specific phases of a care procurement process and actors' interactions at various levels of the health system.</AbstractText>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">The final study sample consisted of 147 articles in which we identified the 53 elements included in the framework. These elements were found in all phases of the pre- and postcontractual procurement process and involved actors at different levels of the health care system. Examples of elements that were cited frequently and are typical of bundled payment procurement, as opposed to FFS procurement, are (1) specification of care services, patients' characteristics, and corresponding costs, (2) small and heterogeneous patient populations, (3) allocation of payment and savings/losses among providers, (4) identification of patients in the bundle, (5) alignment of the existing care delivery model with the new payment model, and (6) limited effects on quality and costs in the first pilots and demonstrations.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared with traditional FFS payment models, bundled payment contracts tend to introduce an alternative set of (financial) incentives, touch on almost all aspects of governance within organizations, and demand a different type of collaboration among organizations. Accordingly, payers should not strategically approach their design and implementation as merely the adoption of a new contracting model, but rather as part of a broader transformation toward a more sustainable value-based health care system, based less on short-term transactional negotiations and more on long-term collaborative relationships between payers and providers.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. The Milbank Quarterly published by Wiley Periodicals, Inc. on behalf of The Milbank Memorial Fund.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Steenhuis</LastName>
            <ForeName>Sander</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Talma Institute, Vrije Universiteit Amsterdam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Struijs</LastName>
            <ForeName>Jeroen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Public Health and the Environment, Bilthoven.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koolman</LastName>
            <ForeName>Xander</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Talma Institute, Vrije Universiteit Amsterdam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ket</LastName>
            <ForeName>Johannes</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>VU University Medical Center, Amsterdam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>VAN DER Hijden</LastName>
            <ForeName>Eric</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Talma Institute, Vrije Universiteit Amsterdam.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Dutch insurance companies Zilveren Kruis, VGZ, CZ, and Menzis</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>pharmaceutical company GSK</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Milbank Q</MedlineTA>
        <NlmUniqueID>8607003</NlmUniqueID>
        <ISSNLinking>0887-378X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">alternative payment models</Keyword>
        <Keyword MajorTopicYN="N">bundled payments</Keyword>
        <Keyword MajorTopicYN="N">design and implementation process</Keyword>
        <Keyword MajorTopicYN="N">value-based purchasing</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909852</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-0009.12438</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Ginsburg PB, Grossman JM. When the price isn't right: How inadvertent payment incentives drive medical care. Health Aff (Millwood). 2005;24:W5-376-384.</Citation>
        </Reference>
        <Reference>
          <Citation>McGuire TG. Physician agency and payment for primary medical care. In: Glied S, Smith PC, eds. The Oxford Handbook of Health Economics. Oxford, NY: Oxford University Press; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>OECD. Better ways to pay for health care. Organisation for Economic Co-operation and Development; 2016. https://www.oecd.org/els/health-systems/Better-ways-to-pay-for-health-care-FOCUS.pdf. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsiachristas A. Payment and economic evaluation of integrated care. Rotterdam, Netherlands: Erasmus School of Health Policy &amp; Management, Erasmus University; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>(HCP-LAN) HCPLAN. Alternative payment model framework. McLean, VA: MITRE Corporation; 2017. https://hcp-lan.org/workproducts/apm-refresh-whitepaper-final.pdf. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Nussbaum S, McClellan M, Metlay G. Principles for a framework for alternative payment models. JAMA. 2018;319(7):653-654.</Citation>
        </Reference>
        <Reference>
          <Citation>Porter ME, Kaplan RS. How to pay for health care. Harvard Business Review. 2016;94(7-8):88-98, 100, 134.</Citation>
        </Reference>
        <Reference>
          <Citation>Miller HD. From volume to value: better ways to pay for health care. Health Aff (Millwood). 2009;28(5):1418-1428.</Citation>
        </Reference>
        <Reference>
          <Citation>Berenson RA, Upadhyay DK, Delbanco SF, Murray R. Payment methods: how they work. Urban Institute and Catalyst for Payment Reform; 2016. https://www.urban.org/research/publication/payment-methods-how-they-work. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Prometheus Analytics. Episodes of Care Definitions. Vol. 5.5. Altarum; 2018. http://www.prometheusanalytics.net/deeper-dive/definitions-readable. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Gronniger T, Fiedler M, Patel K, Adler L, Ginsburg PB. How should the Trump administration handle Medicare's new bundled payment programs? Health Affairs Blog; 2017. https://www.healthaffairs.org/do/10.1377/hblog20170410.059551/full/. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Dummit LA, Kahvecioglu D, Marrufo G, et al. Association between hospital participation in a Medicare bundled payment initiative and payments and quality outcomes for lower extremity joint replacement episodes. JAMA. 2016;316(12):1267-1278.</Citation>
        </Reference>
        <Reference>
          <Citation>Wojtak A, Purbhoo D. Perspectives on advancing bundled payment in Ontario's home care system and beyond. Healthcare Q. 2015;18(1):18-25.</Citation>
        </Reference>
        <Reference>
          <Citation>Joynt Maddox KE, Orav EJ, Zheng J, Epstein AM. Evaluation of Medicare's bundled payments initiative for medical conditions. N Engl J Med. 2018;379(3):260-269.</Citation>
        </Reference>
        <Reference>
          <Citation>Tavare A, Jayakumar P. The experience and impact of bundled payment in orthopaedic surgery: a systematic review. Value in Health. 2017;20(5):A42-A43.</Citation>
        </Reference>
        <Reference>
          <Citation>Joynt Maddox KE, Sen AP, Samson LW, Zuckerman RB, DeLew N, Epstein AM. Elements of program design in Medicare's value-based and alternative payment models: a narrative review. J Gen Intern Med. 2017;32(11):1249-1254.</Citation>
        </Reference>
        <Reference>
          <Citation>Struijs JN, van Gils P, de Vries EF, Baan CA, Rosenthal MB. Current state of bundled payments around the world. Issue Brief. New York, NY: Commonwealth Fund; 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Miller HD. Ten barriers to healthcare payment reform and how to overcome them. Center for Healthcare Quality &amp; Payment Reform; 2012. http://www.chqpr.org/downloads/OvercomingBarrierstoPaymentReform.pdf. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Conrad DA. The theory of value-based payment incentives and their application to health care. Health Serv Res. 2015;50(Suppl. 2):2057-2089.</Citation>
        </Reference>
        <Reference>
          <Citation>Pham HH, Ginsburg PB, Lake TK, Maxfield MM. Episode-based payments: charting a course for health care payment reform. NIHCR Policy Analysis, no. 1. Washington, DC: National Institute for Health Care Reform; 2010. https://www.nihcr.org/publications/episode-based-payments/. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Blumenthal D, Squires D. The Promise and Pitfalls of Bundled Payments. To the Point. New York, NY: Commonwealth Fund; 2016. https://www.commonwealthfund.org/blog/2016/promise-and-pitfalls-bundled-payments. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation>
        </Reference>
        <Reference>
          <Citation>Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Meth. 2005;8(1):19-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implementation Sci. 2010;5(69).</Citation>
        </Reference>
        <Reference>
          <Citation>Sanderson J, Lonsdale C, Mannion R, Matharu T. Towards a framework for enhancing procurement and supply chain management practice in the NHS: lessons for managers and clinicians from a synthesis of the theoretical and empirical literature. Southampton, UK: Health Services and Delivery Research; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>van Raaij EM. Purchasing value: purchasing and supply management's contribution to health service performance. Rotterdam, Netherlands: Erasmus School of Health Policy &amp; Management, Erasmus University; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>van Weele AJ, van Berkel-Schoonen J, Walhof G. Procurement from a Strategic Perspective. 7th ed. Alphen, Netherlands: Vakmedianet; 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Concannon TW, Meissner P, Grunbaum JA, et al. A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med. 2012;27(8):985-991.</Citation>
        </Reference>
        <Reference>
          <Citation>Reschovsky JD, Rich EC, Lake TK. Factors contributing to variations in physicians’ use of evidence at the point of care: a conceptual model. J Gen Intern Med. 2015;30(Suppl. 3):S555-S561.</Citation>
        </Reference>
        <Reference>
          <Citation>Porter ME, Kaplan RS. How should we pay for health care? Harvard Business Review. 2014:15-041.</Citation>
        </Reference>
        <Reference>
          <Citation>Bailit M, Burns MBAM, Houy MPPM. Bundled payments one year later: an update on the status of implementations and operational findings. Health Care Incentives Improvement Institute; 2015. http://www.bailit-health.com/publications/2013-0610-HCI3-issue%20brief.pdf. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Matchar DB, Nguyen HV, Tian Y. Bundled payment and care of acute stroke: what does it take to make it work? Stroke. 2015;46(5):1414-1421.</Citation>
        </Reference>
        <Reference>
          <Citation>Mechanic RE. Medicare's Bundled Payment Initiatives: Considerations for Providers. Washington, DC: American Hospital Association; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Conrad DA, Grembowski D, Hernandez SE, Lau B, Marcus-Smith M. Emerging lessons from regional and state innovation in value-based payment reform: balancing collaboration and disruptive innovation. Milbank Q. 2014;92(3):568-623.</Citation>
        </Reference>
        <Reference>
          <Citation>Ridgely MS, de Vries D, Bozic KJ, Hussey PS. Bundled payment fails to gain a foothold in California: the experience of the IHA bundled payment demonstration. Health Aff (Millwood). 2014;33(8):1345-1352.</Citation>
        </Reference>
        <Reference>
          <Citation>RAND Corporation. Analysis of Bundled Payment. Santa Monica, CA: RAND Corporation; 2009. https://www.rand.org/pubs/technical_reports/TR562z20/analysis-of-bundled-payment.html. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Averill RF, Goldfield NI, Hughes JS, Eisenhandler J, Vertrees JC. Developing a prospective payment system based on episodes of care. J Ambulatory Care Manage. 2009;32(3):241-251.</Citation>
        </Reference>
        <Reference>
          <Citation>Hussey PS, Ridgely MS, Rosenthal MB. The PROMETHEUS bundled payment experiment: slow start shows problems in implementing new payment models. Health Aff (Millwood). 2011;30(11):2116-2124.</Citation>
        </Reference>
        <Reference>
          <Citation>George M, Bencic S, Bleiberg S, Alawa N, Sanghavi D. Case study: delivery and payment reform in congestive heart failure at two large academic centers. Healthcare (Amsterdam). 2014;2(2):107-112.</Citation>
        </Reference>
        <Reference>
          <Citation>Hussey PS, Mulcahy AW, Schnyer C, Schneider EC. Closing the quality gap: revisiting the state of the science (vol. 1: bundled payment: effects on health care spending and quality). Evid Rep Technol Assess. 2012;(208.1):1-155.</Citation>
        </Reference>
        <Reference>
          <Citation>Bushnell BD. Bundled payments in orthopedic surgery. Orthopedics. 2015;38(2):128-135.</Citation>
        </Reference>
        <Reference>
          <Citation>Shih T, Chen LM, Nallamothu BK. Will bundled payments change health care? Examining the evidence thus far in cardiovascular care. Circulation. 2015;131(24):2151-2158.</Citation>
        </Reference>
        <Reference>
          <Citation>Porter ME, Lee TH. From volume to value in health care: the work begins. JAMA. 2016;316(10):1047-1048.</Citation>
        </Reference>
        <Reference>
          <Citation>Sutherland JM, Hellsten E, Yu K. Bundles: An opportunity to align incentives for continuing care in Canada? Health Policy. 2012;107(2-3):209-217.</Citation>
        </Reference>
        <Reference>
          <Citation>Conrad DA, Vaughn M, Grembowski D, Marcus-Smith M. Implementing value-based payment reform: a conceptual framework and case examples. Med Care Res Rev. 2016;73(4):437-457.</Citation>
        </Reference>
        <Reference>
          <Citation>Sanderson J, Lonsdale C, Mannion R. What's needed to develop strategic purchasing in healthcare? Policy lessons from a realist review. Int J Health Policy Manage. 2018:1-14.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO. The World Health Report 2000-Health Systems: Improving Performance. Geneva, Switzerland: World Health Organisation; 2000. https://www.who.int/whr/2000/en/. Accessed December 5, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Bohmer RMJ. The hard work of health care transformation. N Engl J Med. 2016;375(8):709-711.</Citation>
        </Reference>
        <Reference>
          <Citation>Moriates C, Arora V, Shah N. Implementing value-based initiatives: a new challenge for clinicians and healthcare systems. In McGraw-Hill Education, Understanding Value-Based Healthcare, chap. 16. 2015.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909853</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1742-1241</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of clinical practice</Title>
          <ISOAbbreviation>Int. J. Clin. Pract.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Familial Mediterranean fever is associated with increased risk for ischemic heart disease and mortality - perspective derived from a large database.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13473</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.13473</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS OF THE STUDY" NlmCategory="OBJECTIVE">familial Mediterranean fever (FMF) is a hereditary, auto-inflammatory disease, characterized by recurrent, self-limiting attacks of fever with inflammation of the serosal membranes, joints, and skin. Chronic inflammation was previously associated with increased risk for ischemic heart disease (IHD). However, the association between FMF and IHD remains unclear. The objective of this study is to determine whether this association exists.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">utilizing the database of the largest health-care provider in Israel, a cross-sectional study was performed. The incidence of IHD was compared between patients diagnosed with FMF and age and sex-matched controls. Chi-square and t-test were used for categorial and continuous variables, and cox logistics regression model was used for multivariate analysis. Survival analysis was made using Kaplan-Meier plots and log-rank test.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">the study included 7,670 patients diagnosed with FMF and an equal number of controls without FMF. In a univariate analysis FMF was found to be associated with higher prevalence of IHD (OR 1.33) and increased mortality (OR 1.29). In a multivariate analysis FMF was found to be independently associated with increased risk for IHD (OR 1.44).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">the study shows that FMF is associated with both increased risk for IHD and higher mortality rates. An early diagnosis and treatment of this disease can potentially improve patients' life expectancy and decrease cardiac comorbidities.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gendelman</LastName>
            <ForeName>Omer</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine 'B'.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shapira</LastName>
            <ForeName>Raz</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine 'B'.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tiosano</LastName>
            <ForeName>Shmuel</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine 'B'.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pras</LastName>
            <ForeName>Elon</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>The Danek Gertner Institute of Human Genetics.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Comaneshter</LastName>
            <ForeName>Doron</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chief Physician's Office, Clalit Health Services Tel Aviv, Faculty of Health Sciences.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cohen</LastName>
            <ForeName>Arnon</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Chief Physician's Office, Clalit Health Services Tel Aviv, Faculty of Health Sciences.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amital</LastName>
            <ForeName>Howard</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine 'B'.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Clin Pract</MedlineTA>
        <NlmUniqueID>9712381</NlmUniqueID>
        <ISSNLinking>1368-5031</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">FMF</Keyword>
        <Keyword MajorTopicYN="N">auto-inflammatory disease</Keyword>
        <Keyword MajorTopicYN="N">comorbidity</Keyword>
        <Keyword MajorTopicYN="N">coronary heart disease</Keyword>
        <Keyword MajorTopicYN="N">ischemic heart disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909853</ArticleId>
        <ArticleId IdType="doi">10.1111/ijcp.13473</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909854</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0347</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Head &amp; neck</Title>
          <ISOAbbreviation>Head Neck</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hed.26061</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To compare the clinical outcomes of oligometastatic versus widely metastatic NPC patients.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Retrospective review of 157 patients with metastatic NPC at a tertiary hospital was performed. Multivariate analysis was carried out to compare the overall and progression-free survival (OS and PFS) of these two cohorts of NPC patients. The number of organ involvement and discrete metastatic lesions associated with improved OS and PFS were ascertained.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with oligometastatic NPC (single organ, less than six discrete metastatic lesions) had a better median OS than patients with widespread metastasis (24.8 versus 12.8 months, P &lt; .001). Similarly, the median PFS of oligometastatic NPC was better than that of polymetastatic NPC (11.7 versus 7.3 months, P &lt; .001).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Single organ disease with less than six discrete lesions is a good indicator of limited metastatic load in NPC, and is associated with improved survival.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chee</LastName>
            <ForeName>Jeremy</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4702-7951</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, National University Health System, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Xuandao</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, National University Health System, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eu</LastName>
            <ForeName>Donovan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, National University Health System, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loh</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, National University Health System, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National University Cancer Institute, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ho</LastName>
            <ForeName>Francis</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>National University Cancer Institute, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wong</LastName>
            <ForeName>Lea C</ForeName>
            <Initials>LC</Initials>
            <AffiliationInfo>
              <Affiliation>National University Cancer Institute, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tham</LastName>
            <ForeName>Ivan</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>National University Cancer Institute, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Chee S</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>National University Cancer Institute, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goh</LastName>
            <ForeName>Boon C</ForeName>
            <Initials>BC</Initials>
            <AffiliationInfo>
              <Affiliation>National University Cancer Institute, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lim</LastName>
            <ForeName>Chwee M</ForeName>
            <Initials>CM</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-9528-4365</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology-Head and Neck Surgery, National University Health System, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>National Medical Research Council</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Head Neck</MedlineTA>
        <NlmUniqueID>8902541</NlmUniqueID>
        <ISSNLinking>1043-3074</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">distant metastasis</Keyword>
        <Keyword MajorTopicYN="N">nasopharyngeal carcinoma</Keyword>
        <Keyword MajorTopicYN="N">oligometastasis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909854</ArticleId>
        <ArticleId IdType="doi">10.1002/hed.26061</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33(29):3356-3364.</Citation>
        </Reference>
        <Reference>
          <Citation>Ho JH. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1978;4(3-4):182-198.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2013;82(2):366-373.</Citation>
        </Reference>
        <Reference>
          <Citation>Gordin A, Golz A, Daitzchman M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management. Int J Radiat Oncol Biol Phys. 2007;68(2):370-376.</Citation>
        </Reference>
        <Reference>
          <Citation>Law A, Peters LJ, Dutu G, et al. The utility of PET/CT in staging and assessment of treatment response of nasopharyngeal cancer. J Med Imaging Radiat Oncol. 2011;55(2):199-205.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee AWM, Ng WT, Chan LK, et al. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement. Oral Oncol. 2012;48(10):1007-1013.</Citation>
        </Reference>
        <Reference>
          <Citation>Mak HW, Lee SH, Chee J, et al. Clinical outcome among nasopharyngeal cancer patients in a multi-ethnic Society in Singapore. PLoS One. 2015;10(5):e0126108.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee V, Kwong D, Leung TW, Lam KO, Tong CC, Lee A. Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma-how far have we achieved? Crit Rev Oncol Hematol. 2017;114:13-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Ma BBY, Lim WT, Goh BC, et al. Antitumor activity of Nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic phase 2 consortium (NCI-9742). J Clin Oncol. 2018;36(14):1412-1418.</Citation>
        </Reference>
        <Reference>
          <Citation>Chee J, Loh KS, Tham I, et al. Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system. J Cancer Res Clin Oncol. 2017;143(12):2563-2570.</Citation>
        </Reference>
        <Reference>
          <Citation>Fandi A, Bachouchi M, Azli N, et al. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol. 2000;18(6):1324-1330.</Citation>
        </Reference>
        <Reference>
          <Citation>Jin Y, Cai XY, Cai YC, et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area. Eur J Cancer. 2012;48(6):882-888.</Citation>
        </Reference>
        <Reference>
          <Citation>Khanfir A, Frikha M, Ghorbel A, Drira MM, Daoud J. Prognostic factors in metastatic nasopharyngeal carcinoma. Cancer Radiother. 2007;11(8):461-464.</Citation>
        </Reference>
        <Reference>
          <Citation>Li JX, Huang SM, Wen BX, Lu TX. Prognostic factors on overall survival of newly diagnosed metastatic nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2014;15(7):3169-3173.</Citation>
        </Reference>
        <Reference>
          <Citation>Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8(6):378-382.</Citation>
        </Reference>
        <Reference>
          <Citation>Weichselbaum RR. The 46th David A. Karnofsky memorial award lecture: oligometastasis-from conception to treatment. J Clin Oncol. 2018;36:3240-3250.</Citation>
        </Reference>
        <Reference>
          <Citation>Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget. 2015;6(11):8491-8524.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang F, Wu G, Yang K. Oligometastasis and oligo-recurrence: more than a mirage. Radiat Oncol. 2014;9:230.</Citation>
        </Reference>
        <Reference>
          <Citation>Tian YH, Zou WH, Xiao WW, et al. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: a subset with better overall survival. Head Neck. 2016;38(8):1152-1157.</Citation>
        </Reference>
        <Reference>
          <Citation>Shuang H, Feng J, Caineng C, et al. The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients. Clin Transl Oncol. 2018;21:213-219.</Citation>
        </Reference>
        <Reference>
          <Citation>Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467(7319):1114-1117.</Citation>
        </Reference>
        <Reference>
          <Citation>Roulston JE. Markers of tumor burden: an overview. Methods Mol Med. 2001;39:109-120.</Citation>
        </Reference>
        <Reference>
          <Citation>Jin Y, Ye X, Shao L, et al. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy. Eur J Cancer. 2013;49(7):1619-1626.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen C, Fei Z, Huang C, Ding J, Chen L. Prognostic value of tumor burden in nasopharyngeal carcinoma. Cancer Manag Res. 2018;10:3169-3175.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun Y, Li WF, Chen NY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol. 2016;17(11):1509-1520.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Chen L, Hu GQ, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381:1124-1135.</Citation>
        </Reference>
        <Reference>
          <Citation>Conde Moreno AJ, Ferrer Albiach C, Muelas Soria R, Gonzalez Vidal V, Garcia Gomez R, Albert Antequera M. Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options. Radiat Oncol. 2014;9:258.</Citation>
        </Reference>
        <Reference>
          <Citation>Chan OS, Ngan RK. Individualized treatment in stage IVC nasopharyngeal carcinoma. Oral Oncol. 2014;50(9):791-797.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909855</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1525-139X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Seminars in dialysis</Title>
          <ISOAbbreviation>Semin Dial</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Barriers to providing optimal dialysis care for undocumented immigrants: Policy challenges and solutions.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/sdi.12846</ELocationID>
        <Abstract>
          <AbstractText>Access to hemodialysis for undocumented immigrants with end stage renal disease (ESRD) is widely variable across the United States and highly dependent upon state policy. Some states have enacted policies to provide coverage for standard dialysis to undocumented immigrants, while other states do not provide coverage. Patients living in some states which do not provide coverage rely on emergency federal coverage through the Emergency Medical Treatment and Active Labor Act. However, this act requires that patients present with an acute, life-threatening condition in order to receive dialysis, which is then referred to as "emergency-only hemodialysis" (EoHD). Because EoHD requires patients to present in life-threatening condition, patients who rely on EoHD suffer from debilitating physical symptoms and psychosocial distress. Undocumented immigrants who receive EoHD also have staggeringly higher mortality rates than those who receive standard hemodialysis. Moreover, in comparison with standard dialysis, EoHD results in greater health care utilization and higher health care costs. Therefore, EoHD represents a very low value care practice, providing substandard care at a greater cost. Policy change is urgently needed to provide undocumented immigrants with ESRD access to the standard of care; that is, three-times weekly standard hemodialysis or peritoneal dialysis.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Welles</LastName>
            <ForeName>Christine C</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Denver Health and Hospital Authority, Denver, CO, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cervantes</LastName>
            <ForeName>Lilia</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9912-5684</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Denver Health and Hospital Authority, Denver, CO, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Office of Research, Denver Health and Hospital Authority, Denver, CO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K23DK117018</GrantID>
            <Agency>National Institute for Diabetes and Digestive and Kidney Diseases</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Semin Dial</MedlineTA>
        <NlmUniqueID>8911629</NlmUniqueID>
        <ISSNLinking>0894-0959</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ESRD</Keyword>
        <Keyword MajorTopicYN="N">emergency-only hemodialysis</Keyword>
        <Keyword MajorTopicYN="N">health care policy</Keyword>
        <Keyword MajorTopicYN="N">hemodialysis</Keyword>
        <Keyword MajorTopicYN="N">undocumented immigrants</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909855</ArticleId>
        <ArticleId IdType="doi">10.1111/sdi.12846</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Radford J, Noe-Bustamante L. Facts on U.S. Immigrants, 2017. Statistical portrait of the foreign-born population in the United States. https://www.pewresearch.org/hispanic/2019/06/03/facts-on-u-s-immigrants/. Posted June 3, 2019. Accessed November 11, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodriguez RA. Dialysis for undocumented immigrants in the United States. Adv Chronic Kidney Dis. 2015;22(1):60-65.</Citation>
        </Reference>
        <Reference>
          <Citation>Saran R, Robinson B, Abbott KC, et al. Renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3S1):A7.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodriguez RA. Evidence-based therapy for undocumented immigrants with ESRD. Nat Rev Nephrol. 2019;8(10):019-0137.</Citation>
        </Reference>
        <Reference>
          <Citation>Raghavan R. Caring for undocumented immigrants with kidney disease. Am J Kidney Dis. 2018;71(4):488-494.</Citation>
        </Reference>
        <Reference>
          <Citation>Emergency Medical Treatment and Labor Act, USC 42 §1395dd. 1986. http://uscode.house.gov/view.xhtml?req=(title:42%20section:1395dd%20edition:prelim). Accessed March 29, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Rettig RA. Special treatment-the story of Medicare's ESRD entitlement. N Engl J Med. 2011;364(7):596-598.</Citation>
        </Reference>
        <Reference>
          <Citation>Fernandez A, Rodriguez RA. Undocumented immigrants and access to health care. JAMA Intern Med. 2017;177(4):536-537.</Citation>
        </Reference>
        <Reference>
          <Citation>Raghavan R. New opportunities for funding dialysis-dependent undocumented individuals. Clin J Am Soc Nephrol. 2017;12(2):370-375.</Citation>
        </Reference>
        <Reference>
          <Citation>Straube BM. Reform of the US healthcare system: care of undocumented individuals with ESRD. Am J Kidney Dis. 2009;53(6):921-924.</Citation>
        </Reference>
        <Reference>
          <Citation>Cervantes L, Mundo W, Powe NR. The status of provision of standard outpatient dialysis for US undocumented immigrants with ESKD. Clin J Am Soc Nephrol. 2019;14:1258-1260. CJN.03460319.</Citation>
        </Reference>
        <Reference>
          <Citation>Campbell GA, Sanoff S, Rosner MH. Care of the undocumented immigrant in the United States with ESRD. Am J Kidney Dis. 2010;55(1):181-191.</Citation>
        </Reference>
        <Reference>
          <Citation>Cervantes L, Tuot D, Raghavan R, et al. Association of emergency-only vs standard hemodialysis with mortality and health care use among undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2018;178(2):188-195.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuruvilla R, Raghavan R. Health care for undocumented immigrants in Texas: past, present, and future. Tex Med. 2014;110(7):e1.</Citation>
        </Reference>
        <Reference>
          <Citation>Colorado Revised Statutes § 24-76.5-102(1). 1986. https://www.colorado.gov/pacific/sites/default/files/ESRD%20Emergency%20Memo%2012-6-18.pdf. Dec 2018. Accessed April 2, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>https://www.esrdncc.org/en/fistula-first-catheter-last. Accessed April 2, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Daugirdas JT, Depner TA, Inrig J, et al. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884-930.</Citation>
        </Reference>
        <Reference>
          <Citation>Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48(Suppl 1):S2-S90. https://doi.org/10.1053/j.ajkd.2006.1003.1051.</Citation>
        </Reference>
        <Reference>
          <Citation>Sidawy AN, Spergel LM, Besarab A, et al. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg. 2008;48(5 Suppl):S2-S25.</Citation>
        </Reference>
        <Reference>
          <Citation>Arhuidese IJ, Orandi BJ, Nejim B, Malas M. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. J Vasc Surg. 2018;68(4):1166-1174.</Citation>
        </Reference>
        <Reference>
          <Citation>Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465-473.</Citation>
        </Reference>
        <Reference>
          <Citation>Poinen K, Quinn RR, Clarke A, et al. Complications from tunneled hemodialysis catheters: a Canadian Observational Cohort Study. Am J Kidney Dis. 2019;73(4):467-475.</Citation>
        </Reference>
        <Reference>
          <Citation>Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int. 2005;68(1):311-318.</Citation>
        </Reference>
        <Reference>
          <Citation>Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol. 2004;15(7):1936-1942.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang HH, Cortés-Penfield NW, Mandayam S, et al. Dialysis catheter-related bloodstream infections in patients receiving hemodialysis on an emergency-only basis: a retrospective cohort analysis. Clin Infect Dis. 2019;68(6):1011-1016.</Citation>
        </Reference>
        <Reference>
          <Citation>Hymes JL, Mooney A, Van Zandt C, Lynch L, Ziebol R, Killion D. Dialysis catheter-related bloodstream infections: a cluster-randomized trial of the clearguard HD antimicrobial barrier cap. Am J Kidney Dis. 2017;69(2):220-227.</Citation>
        </Reference>
        <Reference>
          <Citation>Rojas-Moreno CA, Spiegel D, Yalamanchili V, et al. Catheter-related bloodstream infections in patients on emergent hemodialysis. Infect Control Hosp Epidemiol. 2016;37(3):301-305.</Citation>
        </Reference>
        <Reference>
          <Citation>Cervantes L, Hull M, Keniston A, Chonchol M, Hasnain-Wynia R, Fischer S. Symptom burden among latino patients with end-stage renal disease and access to standard or emergency-only hemodialysis. J Palliat Med. 2018;21(9):1329-1333.</Citation>
        </Reference>
        <Reference>
          <Citation>Cervantes L, Fischer S, Berlinger N, et al. The illness experience of undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2017;177(4):529-535.</Citation>
        </Reference>
        <Reference>
          <Citation>Nguyen OK, Vazquez MA, Charles L, et al. Association of scheduled vs emergency-only dialysis with health outcomes and costs in undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2019;179(2):175-183.</Citation>
        </Reference>
        <Reference>
          <Citation>Sheikh-Hamad D, Paiuk E, Wright AJ, Kleinmann C, Khosla U, Shandera WX. Care for immigrants with end-stage renal disease in Houston: a comparison of two practices. Tex Med. 2007;103(4):pp. 54-58, 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Cervantes L, O’Hare A, Chonchol M, et al. Circumstances of death among undocumented immigrants who rely on emergency-only hemodialysis. Clin J Am Soc Nephrol. 2018;13(9):1405-1406.</Citation>
        </Reference>
        <Reference>
          <Citation>Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med. 1994;331(6):365-376.</Citation>
        </Reference>
        <Reference>
          <Citation>Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730.</Citation>
        </Reference>
        <Reference>
          <Citation>Schweitzer EJ, Wiland A, Evans D, et al. The shrinking renal replacement therapy "break-even" point. Transplantation. 1998;66(12):1702-1708.</Citation>
        </Reference>
        <Reference>
          <Citation>Ansell D, Pallok K, Guzman MD, Flores M, Oberholzer J. Illinois law opens door to kidney transplants for undocumented immigrants. Health Aff (Millwood). 2015;34(5):781-787.</Citation>
        </Reference>
        <Reference>
          <Citation>Shen JI, Hercz D, Barba LM, et al. Association of citizenship status with kidney transplantation in medicaid patients. Am J Kidney Dis. 2018;71(2):182-190.</Citation>
        </Reference>
        <Reference>
          <Citation>Linden EA, Cano J, Coritsidis GN. Kidney transplantation in undocumented immigrants with ESRD: a policy whose time has come? Am J Kidney Dis. 2012;60(3):354-359.</Citation>
        </Reference>
        <Reference>
          <Citation>Fortin M-C, Williams-Jones B. Should we perform kidney transplants on foreign nationals? J Med Ethics. 2014;40(12):821-826.</Citation>
        </Reference>
        <Reference>
          <Citation>Herring AA, Woolhandler S, Himmelstein DU. Insurance status of U.S. organ donors and transplant recipients: the uninsured give, but rarely receive. Int J Health Serv. 2008;38(4):641-652.</Citation>
        </Reference>
        <Reference>
          <Citation>Evans RW, Applegate WH, Briscoe DM, et al. Cost-related immunosuppressive medication nonadherence among kidney transplant recipients. Clin J Am Soc Nephrol. 2010;5(12):2323-2328.</Citation>
        </Reference>
        <Reference>
          <Citation>Grubbs V. Undocumented immigrants and kidney transplant: costs and controversy. Health Aff (Project Hope). 2014;33(2):332-335.</Citation>
        </Reference>
        <Reference>
          <Citation>Baru JS, Lucas BR, Martinez C, Brauner D. Organ donation among undocumented hispanic immigrants: an assessment of knowledge and attitudes. J Clin Ethics. 2013;24(4):364-372.</Citation>
        </Reference>
        <Reference>
          <Citation>Zallman L, Woolhandler S, Himmelstein D, Bor D, McCormick D. Immigrants contributed an estimated $115.2 billion more to the Medicare Trust Fund than they took out in 2002-09. Health Aff (Millwood). 2013;32(6):1153-1160.</Citation>
        </Reference>
        <Reference>
          <Citation>Goss S. Letter to the Honorable Richard J. Durbin. Washington (DC): Social Security Administration Office of the Chief Actuary; 2007:5.</Citation>
        </Reference>
        <Reference>
          <Citation>Cervantes L, Richardson S, Raghavan R, et al. Clinicians' perspectives on providing emergency-only hemodialysis to undocumented immigrants: a qualitative study. Ann Intern Med. 2018;169(2):78-86.</Citation>
        </Reference>
        <Reference>
          <Citation>https://www.cbsnews.com/live-news/democratic-debates-2019-06-27-watch-dnc-debate-coverage-live-updates-today/. Published June 27, 2019. Updated June 28, 2019.Accessed July 27, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>https://www.nytimes.com/2019/07/03/health/undocumented-immigrants-health-care.html. Accessed July 11, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Cervantes L, Grafals M, Rodriguez RA. The United States needs a national policy on dialysis for undocumented immigrants with ESRD. Am J Kidney Dis. 2018;71(2):157-159.</Citation>
        </Reference>
        <Reference>
          <Citation>Williams ME. The ESRD uninsured matter. Adv Chron Kidney Dis. 2007;14(1):67-74.</Citation>
        </Reference>
        <Reference>
          <Citation>Suarez JJ. Strategies for responding to undocumented immigrants with kidney disease. AMA J Ethics. 2019;21(1):E86-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Renal Physicians Association Position Paper. Kidney Care for Vulnerable Populations. https://cdn.ymaws.com/www.renalmd.org/resource/resmgr/position_papers/kidney_care_for_vulnerable_p.pdf. Posted October 18, 2019.Accessed November 12, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>https://www.colorado.gov/pacific/sites/default/files/ESRD%20Emergency%20Medicaid%20FAQ%20Updated%201-31-19.pdf. Accessed July 11, 2019.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909856</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-7560</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Diabetes/metabolism research and reviews</Title>
          <ISOAbbreviation>Diabetes Metab. Res. Rev.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Complicated curve association of BMI at diagnosis with C-peptide in children and adults with new-onset type 1 diabetes.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e3285</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/dmrr.3285</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To investigate the association of body mass index (BMI) or BMI z-score (BMIz) at diagnosis with β-cell function in new-onset type 1 diabetes (T1D) patients in children and adults.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective cohort study; 256 children (&lt;18 years) and 245 adults (≥ 18 years) with less than one-year duration were recruited and followed for 4 years with an interval of 12 months. Smooth curve fitting, a two-piecewise linear model, and Cox proportional hazards models were utilized to investigate the influence of BMI/BMIz on C-peptide levels.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Heavier patients (BMIz≥-1 in children and BMI in adults≥20.2 kg/m<sup>2</sup> ) had greater C-peptide with a complicated J curve in all age groups after adjustment for age of onset, sex, and disease duration. Moreover, after 4 years of follow-up, patients with higher BMI/BMIz had a lower risk of β-cell failure (HR=0.7; 95% CI=0.6-1.0; p=0.026). However, no association was found between baseline BMI/BMIz at diagnosis and C-peptide rate of decline during 1 year follow-up.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Association between BMI/BMIz and C-peptide in T1D followed a complicated J curve pattern, and heavier patients had greater C-peptide at diagnosis and a lower risk of β-cell failure at 4 years, suggesting that baseline BMI is a useful predictor for β-cell function in patients with T1D. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>Siyuan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Chao</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Ting</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Yuting</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0234-5486</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xia</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Zhiguang</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-0374-1838</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Diabetes Metab Res Rev</MedlineTA>
        <NlmUniqueID>100883450</NlmUniqueID>
        <ISSNLinking>1520-7552</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Body mass index</Keyword>
        <Keyword MajorTopicYN="N">C-peptide</Keyword>
        <Keyword MajorTopicYN="N">Diabetes mellitus, type 1</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909856</ArticleId>
        <ArticleId IdType="doi">10.1002/dmrr.3285</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909857</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-6860</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
          <ISOAbbreviation>FASEB J.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification of novel interacting regions involving calcineurin and nuclear factor of activated T cells.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201902229</ELocationID>
        <Abstract>
          <AbstractText>Nuclear factor of activated T cells (NFAT) leads to the transcription of diverse inducible genes involved in many biological processes; therefore, aberrant NFAT expression is responsible for the development and exacerbation of various disorders. Since five isoforms of NFAT (NFATc1-c4, NFAT5) exhibit distinct and overlapping functions, selective control of a part, but not all, of NFAT family members is desirable. By comparing the binding activity of each NFATc1-c4 with its regulatory enzyme, calcineurin (CN), using a quantitative immunoprecipitation assay, we found a new CN-binding region (CNBR) selectively functioning in NFATc1 and NFATc4. This region, termed CNBR3, is located between two preexisting CNBR1 and CNBR2, within the Ca<sup>2+</sup> regulatory domain. The nuclear translocation of NFATc1 but not NFATc2 in T cells was suppressed by ectopic expression of CNBR3 and, accordingly, NFATc1-dependent cytokine expression was downregulated. Through competition assays using NFATc1-derived partial peptides and mass spectrometry with photoaffinity technology, we identified 18 amino acids in NFATc1 (Arg<sup>258</sup> to Pro<sup>275</sup> ) and 13 amino acids in CN catalytic subunit (CNA) (Asn<sup>77</sup> to Gly<sup>89</sup> ) responsible for CNA/CNBR3 binding in which Cys<sup>263</sup> and Asp<sup>82</sup> , respectively, played crucial roles. The possible selective regulation of NFAT-mediated biological processes by targeting this new CN/NFAT-binding region is suggested.</AbstractText>
          <CopyrightInformation>© 2020 Federation of American Societies for Experimental Biology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kitamura</LastName>
            <ForeName>Noriko</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy and Immunology Project, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shindo</LastName>
            <ForeName>Mayumi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Basic Technology Research, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ohtsuka</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakamura</LastName>
            <ForeName>Akira</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Life Science, Faculty of Science, Gakushuin University, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tanokura</LastName>
            <ForeName>Masaru</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hiroi</LastName>
            <ForeName>Takachika</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy and Immunology Project, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaminuma</LastName>
            <ForeName>Osamu</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy and Immunology Project, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>24590107</GrantID>
            <Agency>MEXT | Japan Society for the Promotion of Science (JSPS)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>21590086</GrantID>
            <Agency>MEXT | Japan Society for the Promotion of Science (JSPS)</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>FASEB J</MedlineTA>
        <NlmUniqueID>8804484</NlmUniqueID>
        <ISSNLinking>0892-6638</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">calcineurin-binding region</Keyword>
        <Keyword MajorTopicYN="N">cytokine</Keyword>
        <Keyword MajorTopicYN="N">immunosuppressant</Keyword>
        <Keyword MajorTopicYN="N">nuclear translocation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909857</ArticleId>
        <ArticleId IdType="doi">10.1096/fj.201902229</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Serfling E, Berberich-Siebelt F, Chuvpilo S, et al. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta. 2000;1498:1-18.</Citation>
        </Reference>
        <Reference>
          <Citation>Im SH, Rao A. Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol Cells. 2004;18:1-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen L, Glover JN, Hogan PG, Rao A, Harrison SC. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature. 1998;392:42-48.</Citation>
        </Reference>
        <Reference>
          <Citation>Zayzafoon M. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem. 2006;97:56-70.</Citation>
        </Reference>
        <Reference>
          <Citation>Ranger AM, Grusby MJ, Hodge MR, et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 1998;392:186-190.</Citation>
        </Reference>
        <Reference>
          <Citation>Hernandez GL, Volpert OV, Iniguez MA, et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med. 2001;193:607-620.</Citation>
        </Reference>
        <Reference>
          <Citation>Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17:2205-2232.</Citation>
        </Reference>
        <Reference>
          <Citation>Bierer BE, Hollander G, Fruman D, Burakoff SJ. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opin Immunol. 1993;5:763-773.</Citation>
        </Reference>
        <Reference>
          <Citation>Woo M, Przepiorka D, Ippoliti C, et al. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. Bone Marrow Transplant. 1997;20:1095-1098.</Citation>
        </Reference>
        <Reference>
          <Citation>Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707-747.</Citation>
        </Reference>
        <Reference>
          <Citation>Okamura H, Aramburu J, Garcia-Rodriguez C, et al. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell. 2000;6:539-550.</Citation>
        </Reference>
        <Reference>
          <Citation>Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene. 2001;20:2476-2489.</Citation>
        </Reference>
        <Reference>
          <Citation>Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science. 1999;285:2129-2133.</Citation>
        </Reference>
        <Reference>
          <Citation>Choi JM, Sohn JH, Park TY, Park JW, Lee SK. Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness. Immunol Lett. 2012;143:170-176.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu H, Bot I, Sliedregt K, et al. Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor. Circ Res. 2012;110:200-210.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang L, Li R, Shi W, et al. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice. Br J Pharmacol. 2013;170:426-439.</Citation>
        </Reference>
        <Reference>
          <Citation>Rojanathammanee L, Floden AM, Manocha GD, Combs CK. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition. J Neuroinflammation. 2015;12:42.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaminuma O, Kitamura F, Kitamura N, et al. Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells. J Immunol. 2008;180:319-326.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaminuma O, Kitamura N, Nishito Y, et al. Downregulation of NFAT3 due to lack of T-box transcription factor TBX5 is crucial for cytokine expression in T cells. J Immunol. 2018;200:92-100.</Citation>
        </Reference>
        <Reference>
          <Citation>Koch S, Reppert S, Finotto S. NFATc1 deletion in T lymphocytes inhibits the allergic trait in a murine model of asthma. Clin Exp Allergy. 2015;45:1356-1366.</Citation>
        </Reference>
        <Reference>
          <Citation>Kwon HK, Kim GC, Hwang JS, et al. Transcription factor NFAT1 controls allergic contact hypersensitivity through regulation of activation induced cell death program. Sci Rep. 2016;6:19453.</Citation>
        </Reference>
        <Reference>
          <Citation>Tripathi MK, Deane NG, Zhu J, et al. Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer. Cancer Res. 2014;74:6947-6957.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen ZL, Zhao SH, Wang Z, et al. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer. Chin J Cancer. 2011;30:62-68.</Citation>
        </Reference>
        <Reference>
          <Citation>Baumgart S, Glesel E, Singh G, et al. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. Gastroenterology. 2012;142:388-398.e381-387.</Citation>
        </Reference>
        <Reference>
          <Citation>Abdul HM, Sama MA, Furman JL, et al. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci. 2009;29:12957-12969.</Citation>
        </Reference>
        <Reference>
          <Citation>Ranger AM, Hodge MR, Gravallese EM, et al. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity. 1998;8:125-134.</Citation>
        </Reference>
        <Reference>
          <Citation>Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, Glimcher LH. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity. 1996;4:397-405.</Citation>
        </Reference>
        <Reference>
          <Citation>Erb KJ, Twardzik T, Palmetshofer A, Wohlleben G, Tatsch U, Serfling E. Mice deficient in nuclear factor of activated T-cell transcription factor c2 mount increased Th2 responses after infection with Nippostrongylus brasiliensis and decreased Th1 responses after mycobacterial infection. Infect Immun. 2003;71:6641-6647.</Citation>
        </Reference>
        <Reference>
          <Citation>Quang CT, Leboucher S, Passaro D, et al. The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells. Cell Death Dis. 2015;6:e1658.</Citation>
        </Reference>
        <Reference>
          <Citation>Fougere M, Gaudineau B, Barbier J, et al. NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene. Oncogene. 2010;29:2292-2301.</Citation>
        </Reference>
        <Reference>
          <Citation>Lunn CA, Kathju S, Wallace BJ, Kushner SR, Pigiet V. Amplification and purification of plasmid-encoded thioredoxin from Escherichia coli K12. J Biol Chem. 1984;259:10469-10474.</Citation>
        </Reference>
        <Reference>
          <Citation>Li H, Rao A, Hogan PG. Structural delineation of the calcineurin-NFAT interaction and its parallels to PP1 targeting interactions. J Mol Biol. 2004;342:1659-1674.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu J, Arai K, Arai N. Inhibition of NFATx activation by an oligopeptide: disrupting the interaction of NFATx with calcineurin. J Immunol. 2001;167:2677-2687.</Citation>
        </Reference>
        <Reference>
          <Citation>Garcia-Cozar FJ, Okamura H, Aramburu JF, et al. Two-site interaction of nuclear factor of activated T cells with activated calcineurin. J Biol Chem. 1998;273:23877-23883.</Citation>
        </Reference>
        <Reference>
          <Citation>Park S, Uesugi M, Verdine GL. A second calcineurin binding site on the NFAT regulatory domain. Proc Natl Acad Sci USA. 2000;97:7130-7135.</Citation>
        </Reference>
        <Reference>
          <Citation>Martinez-Martinez S, Rodriguez A, Lopez-Maderuelo MD, Ortega-Perez I, Vazquez J, Redondo JM. Blockade of NFAT activation by the second calcineurin binding site. J Biol Chem. 2006;281:6227-6235.</Citation>
        </Reference>
        <Reference>
          <Citation>Li H, Zhang L, Rao A, Harrison SC, Hogan PG. Structure of calcineurin in complex with PVIVIT peptide: portrait of a low-affinity signalling interaction. J Mol Biol. 2007;369:1296-1306.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodriguez A, Roy J, Martinez-Martinez S, et al. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. Mol Cell. 2009;33:616-626.</Citation>
        </Reference>
        <Reference>
          <Citation>Gal M, Li S, Luna RE, Takeuchi K, Wagner G. The LxVP and PxIxIT NFAT motifs bind jointly to overlapping epitopes on calcineurin's catalytic domain distant to the regulatory domain. Structure. 2014;22:1016-1027.</Citation>
        </Reference>
        <Reference>
          <Citation>Pemberton LF, Paschal BM. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic. 2005;6:187-198.</Citation>
        </Reference>
        <Reference>
          <Citation>Vihma H, Luhakooder M, Pruunsild P, Timmusk T. Regulation of different human NFAT isoforms by neuronal activity. J Neurochem. 2016;137:394-408.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaminuma O, Kitamura N, Mori A, Tatsumi H, Nemoto S, Hiroi T. NFAT1 and NFAT2 differentially regulate IL-17A expression in human T cells. Int Arch Allergy Immunol. 2012;158(suppl. 1):30-34.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909858</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0029</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Microscopy research and technique</Title>
          <ISOAbbreviation>Microsc. Res. Tech.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Microscopic research on the properties of optothermal microactuators with different lever ratios.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jemt.23434</ELocationID>
        <Abstract>
          <AbstractText>This paper presents microscopic research on properties of asymmetric optothermal microactuator (OTMA) with different lever ratios. A theoretical model is established on the basis of thermal flux theorem to describe the increase in temperature induced by laser irradiation and thermal expansion of OTMAs' expansion arms. The increases in temperature of three asymmetric OTMAs with total lengths/lever ratios of 540 μm/7.2, 1,080 μm/7.2, 1,080 μm/14.4 were simulated under irradiation of 2.8 mW laser beam, which revealed that a similar increase in temperature will distribute on three expansion arms, with maximum the temperature increase of 82.73, 87.67, and 88.03°C, respectively. Due to these increases in temperature, the arms expand longitudinally and thus the OTMAs are capable of deflecting laterally with enlarged deflection amplitudes. To obtain optimized deflecting properties, three OTMAs with aforementioned lever ratios are further microfabricated and experimented using an optical microscopic observation and measuring system combined with a charge-coupled device. The experimental results show that these OTMAs can be directly actuated by laser beam and acquire maximum deflections of 6.8, 7.2, and 11.4 μm when only 2.8 mW laser power is employed. In addition, it is demonstrated that, although doubling the lever ratio of OTMA does not correspondingly generate twofold deflection, the deflection amplitude can significantly increase with the increase in the lever ratio. With their characteristic elegances, the OTMAs are expected to be practically applied in the micro-electromechanical system and the micro-opto-electromechanical system.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Ziyao</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1161-7079</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Modern Optical Instrumentation, College of Optical Science and Engineering, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yingda</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8068-4606</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Modern Optical Instrumentation, College of Optical Science and Engineering, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>You</LastName>
            <ForeName>Qingyang</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Modern Optical Instrumentation, College of Optical Science and Engineering, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Haijun</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Modern Optical Instrumentation, College of Optical Science and Engineering, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>61540019</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Microsc Res Tech</MedlineTA>
        <NlmUniqueID>9203012</NlmUniqueID>
        <ISSNLinking>1059-910X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">asymmetric optothermal microactuator</Keyword>
        <Keyword MajorTopicYN="N">dynamic modelling</Keyword>
        <Keyword MajorTopicYN="N">lever ratio</Keyword>
        <Keyword MajorTopicYN="N">microdeflection</Keyword>
        <Keyword MajorTopicYN="N">microscopic observation and measuring</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909858</ArticleId>
        <ArticleId IdType="doi">10.1002/jemt.23434</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Bell, D. J., Lu, T. J., Fleck, N. A., &amp; Spearing, S. M. (2005). MEMS actuators and sensors: Observations on their performance and selection for purpose. Journal of Micromechanics and Microengineering, 15(7), S153-S164. https://doi.org/10.1088/0960-1317/15/7/022</Citation>
        </Reference>
        <Reference>
          <Citation>Butler, J. T., Bright, V. M., &amp; Cowan, W. D. (1999). Average power control and positioning of polysilicon thermal actuators. Sensors and Actuators a-Physical, 72(1), 88-97. https://doi.org/10.1016/s0924-4247(98)00211-8</Citation>
        </Reference>
        <Reference>
          <Citation>Hwang, W.-S., &amp; Park, H. C. J. A. J. (2015). Finite element modeling of piezoelectric sensors and actuators. AIAA Journal., 31(5), 930-937. https://doi.org/10.2514/3.11707</Citation>
        </Reference>
        <Reference>
          <Citation>Jing, C., Ding, G., &amp; Yang, Z. J. M. T. (2008). Su-8-metal composite electro-thermal micro actuators. Hebei, China: Micronanoelectronic Technology, 45(12), 706-711.</Citation>
        </Reference>
        <Reference>
          <Citation>Kolesar, E. S., Jayachandran, J. A., Odom, W. E., Ruff, M. D., Cox, L. A., Htun, T., … Yetto, J. M. (2004). Precision bi-directional motion of a linear mechanical shuttle with an electrothermal microengine. Thin Solid Films, 469, 450-454. https://doi.org/10.1016/j.tsf.2004.06.171</Citation>
        </Reference>
        <Reference>
          <Citation>Kwan, A. M. H., Song, S., Lu, X., Lu, L., Teh, Y.-K., Teh, Y.-F., … Tabata, O. (2012). Improved designs for an electrothermal in-plane microactuator. Journal of Microelectromechanical Systems, 21(3), 586-595. https://doi.org/10.1109/jmems.2012.2185820</Citation>
        </Reference>
        <Reference>
          <Citation>Kyokane, J., Tsujimoto, K., Yanagisawa, Y., Ueda, T., &amp; Fukuma, M. (2004). Actuator using electrostriction effect of fullerenol-doped polyurethane elastomer (PUE) films. IEICE Transactions on Electronics, E87C(2), 136-141. https://doi.org/10.1109/MWC.2004.1269720</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, C., Zhang, D.-X., &amp; Zhang, H.-J. (2009). Theoretical modeling of microscopic photothermal expansion and experimental study of photothermal microactuators. Acta Physica Sinica, 58(4), 2619-2624. https://doi.org/10.1360/972009-782</Citation>
        </Reference>
        <Reference>
          <Citation>Luo, J. J., He, J. H., Flewitt, A., Moore, D. F., Spearing, S. M., Fleck, N. A., &amp; Milne, W. I. (2005). Development of all metal electrothermal actuator and its applications. Journal of Microlithography Microfabrication and Microsystems, 4(2), 023012. https://doi.org/10.1117/1.18982431</Citation>
        </Reference>
        <Reference>
          <Citation>Mark, J. E. (2009). Polymer data handbook (2nd ed.). Washington,DC: Journal of the American Chemical Society, 131(44), 16330-16330. https://doi.org/10.1021/ja907879q</Citation>
        </Reference>
        <Reference>
          <Citation>Nabawy, M. R. A., &amp; Crowther, W. J. (2016). Dynamic electromechanical coupling of piezoelectric bending actuators. Micromachines, 7(1), 12. https://doi.org/10.3390/mi7010012</Citation>
        </Reference>
        <Reference>
          <Citation>Pallapa, M., &amp; Yeow, J. T. W. (2015). A review of the hybrid techniques for the fabrication of hard magnetic microactuators based on bonded magnetic powders. Smart Materials and Structures, 24(2), 025007. https://doi.org/10.1088/0964-1726/24/2/025007</Citation>
        </Reference>
        <Reference>
          <Citation>Pan, C. S., &amp; Hsu, W. Y. (1997). An electro-thermally and laterally driven polysilicon microactuator. Journal of Micromechanics and Microengineering, 7(1), 7-13. https://doi.org/10.1088/0960-1317/7/1/003</Citation>
        </Reference>
        <Reference>
          <Citation>Park, Y.-W., &amp; Kim, D.-Y. (2004). Development of a magnetostrictive microactuator. Journal of Magnetism and Magnetic Materials, 272, E1765-E1766. https://doi.org/10.1016/j.jmmm.2003.12.991</Citation>
        </Reference>
        <Reference>
          <Citation>Pekas, N., Zhang, Q., &amp; Juncker, D. (2012). Electrostatic actuator with liquid metal-elastomer compliant electrodes used for on-chip microvalving. Journal of Micromechanics and Microengineering, 22(9), 097001. https://doi.org/10.1088/0960-1317/22/9/097001</Citation>
        </Reference>
        <Reference>
          <Citation>Riethmuller, W., &amp; Benecke, W. (1988). Thermally excited silicon microactuators. IEEE Transactions on Electron Devices, 35(6), 758-763. https://doi.org/10.1109/16.2528</Citation>
        </Reference>
        <Reference>
          <Citation>So, H., &amp; Pisano, A. P. (2015). Electrothermal modeling, fabrication and analysis of low-power consumption thermal actuator with buckling arm. Microsystem Technologies-Micro-and Nanosystems-Information Storage and Processing Systems, 21(1), 195-202. https://doi.org/10.1007/s00542-013-1953-2</Citation>
        </Reference>
        <Reference>
          <Citation>Toda, M., Ono, T., Liu, F., &amp; Voiculescu, I. (2010). Evaluation of bimaterial cantilever beam for heat sensing at atmospheric pressure. Review of Scientific Instruments, 81(5), 055104. https://doi.org/10.1063/1.3397320</Citation>
        </Reference>
        <Reference>
          <Citation>Yan, D., Khajepour, A., &amp; Mansour, R. (2003). Modeling of two-hot-arm horizontal thermal actuator. Journal of Micromechanics and Microengineering, 13(2), 312-322. https://doi.org/10.1088/0960-1317/13/2/321</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, Y.-S., Lin, Y.-H., Hu, Y.-C., &amp; Liu, C.-H. (2009). A large-displacement thermal actuator designed for MEMS pitch-tunable grating. Journal of Micromechanics and Microengineering, 19(1), 015001. https://doi.org/10.1088/0960-1317/19/1/015001</Citation>
        </Reference>
        <Reference>
          <Citation>You, Q. Y., Zhang, H. J., Wang, Y. D., &amp; Chen, J. J. (2017). Dynamic properties of symmetric optothermal microactuator. Journal of Micromechanics and Microengineering, 27(10), 105011. https://doi.org/10.1088/1361-6439/aa7e10</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, D. X., Zhang, H. J., Liu, C., &amp; Jiang, J. (2008). Microscopic observation and laser-controlled microoptothermal drive mechanism. Microscopy Research and Technique, 71(2), 119-124. https://doi.org/10.1002/jemt.20533</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909859</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2869</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of sleep research</Title>
          <ISOAbbreviation>J Sleep Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Poor sleep quality associates with self-reported psychiatric and cardiometabolic symptoms independently of sleep timing patterns in a large sample of rural and urban workers.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e12969</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jsr.12969</ELocationID>
        <Abstract>
          <AbstractText>Poor sleep associates with mental and cardiometabolic pathological outcomes. The participation of sleep timing features in the pathways by which this relationship occurs is not clear. This study aims to evaluate the interrelationship between sleep quality and self-reported psychiatric/cardiometabolic symptoms, considering mediation and moderation effects of sleep timing patterns, and urban versus rural work environment, respectively; and to verify the association between sleep quality and polymorphisms of AANAT, RORA and TIMELESS genes. An epidemiological survey was performed in a rural area in southern Brazil. Eight-hundred and twenty-nine subjects were evaluated for sleep quality using the Pittsburgh Sleep Quality Index, and sleep timing patterns using the Munich Chronotype Questionnaire. Work characteristics and psychiatric/cardiometabolic symptoms were assessed using a structured self-report questionnaire. Three polymorphisms of AANAT, RORA and TIMELESS (rs3760138, rs782931 and rs774045, respectively) were genotyped in blood samples. We found statistically significant associations of poor sleep quality with self-reported psychiatric symptoms (B = 0.382; 95% CI 0.289-0.476; adjusted p-value &lt;.001), and with self-reported cardiometabolic symptoms (B = 0.079; 95% CI 0.013-0.151; adjusted p-value = .048). The genetic analysis showed that RORA GA/AA genotype was associated to poor sleep quality (B = 0.146, 95% CI 0.054-0.239; adjusted p-value = .004). No moderated mediation effects were observed in the conditional analysis. TIMELESS polymorphism was not included in the analysis due to the low frequency of risk genotypes. These results yield new insights regarding the interrelationship between sleep characteristics and psychiatric/cardiometabolic self-reported symptoms, taking into account genes related to the biological clocks and melatonin pathways.</AbstractText>
          <CopyrightInformation>© 2020 European Sleep Research Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Carvalho</LastName>
            <ForeName>Felipe Gutiérrez</ForeName>
            <Initials>FG</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8325-4553</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratório de Cronobiologia e Sono, Hospital de Clínicas de Porto Alegre (HCPA)/Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cunha</LastName>
            <ForeName>Ana Maria Delgado</ForeName>
            <Initials>AMD</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de Cronobiologia e Sono, Hospital de Clínicas de Porto Alegre (HCPA)/Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tonon</LastName>
            <ForeName>André Comiran</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de Cronobiologia e Sono, Hospital de Clínicas de Porto Alegre (HCPA)/Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pereira</LastName>
            <ForeName>Fernanda Dos Santos</ForeName>
            <Initials>FDS</Initials>
            <AffiliationInfo>
              <Affiliation>Centro de Pesquisa Experimental, Unidade de Análises Moleculares e de Proteínas (UAMP), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matte</LastName>
            <ForeName>Ursula</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Gene Therapy Center, Experimental Research Center, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Callegari-Jacques</LastName>
            <ForeName>Sidia Maria</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Estatística, Instituto de Matemática e Estatística, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hidalgo</LastName>
            <ForeName>Maria Paz</ForeName>
            <Initials>MP</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de Cronobiologia e Sono, Hospital de Clínicas de Porto Alegre (HCPA)/Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>FIPE/HCPA - GPPG 15-0459</GrantID>
            <Agency>Fundo de Incentivo à Pesquisa e Eventos</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Fundação de Amparo à pesquisa do Estado do Rio Grande do Sul (FAPERGS)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>PROBRAL - CAPES/DAAD</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Programa Nacional de Pós-Doutorado (PNPD - CAPES)</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Sleep Res</MedlineTA>
        <NlmUniqueID>9214441</NlmUniqueID>
        <ISSNLinking>0962-1105</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">biological rhythms</Keyword>
        <Keyword MajorTopicYN="N">chronobiology</Keyword>
        <Keyword MajorTopicYN="N">circadian rhythm</Keyword>
        <Keyword MajorTopicYN="N">genetics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909859</ArticleId>
        <ArticleId IdType="doi">10.1111/jsr.12969</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Axelrod, J., &amp; Weissbach, H. (1960). Enzymatic O-methylation of N-acetylserotonin to melatonin. Science, 131(3409), 1312. https://doi.org/10.1126/science.131.3409.1312</Citation>
        </Reference>
        <Reference>
          <Citation>Barquera, S., Pedroza-Tobías, A., Medina, C., Hernández-Barrera, L., Bibbins-Domingo, K., Lozano, R., &amp; Moran, A. E. (2015). Global overview of the epidemiology of atherosclerotic cardiovascular disease. Archives of Medical Research, 46(5), 328-338. https://doi.org/10.1016/J.ARCMED.2015.06.006</Citation>
        </Reference>
        <Reference>
          <Citation>Beijamini, F., Knutson, K. L., Lorenzi-Filho, G., Egan, K. J., Taporoski, T. P., De Paula, L. K. G., … von Schantz, M. (2016). Timing and quality of sleep in a rural Brazilian family-based cohort, the Baependi Heart Study. Scientific Reports, 6, 39283. https://doi.org/10.1038/srep39283</Citation>
        </Reference>
        <Reference>
          <Citation>Bertolazi, A. N., Fagondes, S. C., Hoff, L. S., Dartora, E. G., da Silva Miozzo, I. C., de Barba, M. E. F., &amp; Menna Barreto, S. S. (2011). Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality Index. Sleep Medicine, 12(1), 70-75. https://doi.org/10.1016/j.sleep.2010.04.020</Citation>
        </Reference>
        <Reference>
          <Citation>Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., &amp; Kupfer, D. J. (1989). The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193-213. https://doi.org/10.1016/0165-1781(89)90047-4</Citation>
        </Reference>
        <Reference>
          <Citation>Carvalho, F. G., Hidalgo, M. P., &amp; Levandovski, R. (2014). Differences in circadian patterns between rural and urban populations: An epidemiological study in countryside. Chronobiology International, 31(3), 442-449. https://doi.org/10.3109/07420528.2013.846350</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, W., &amp; Baler, R. (2000). The rat arylalkylamine N-acetyltransferase E-box: Differential use in a master vs. a slave oscillator. Molecular Brain Research, 81(1-2), 43-50. https://doi.org/10.1016/s0169-328x(00)00160-1</Citation>
        </Reference>
        <Reference>
          <Citation>Coelho, L. A., Peres, R., Amaral, F. G., Reiter, R. J., &amp; Cipolla-Neto, J. (2015). Daily differential expression of melatonin-related genes and clock genes in rat cumulus-oocyte complex: Changes after pinealectomy. Journal of Pineal Research, 58(4), 490-499. https://doi.org/10.1111/jpi.12234</Citation>
        </Reference>
        <Reference>
          <Citation>Coon, S. L., Roseboom, P. H., Baler, R., Weller, J. L., Namboodiri, M. A. A., Koonin, E. V., &amp; Klein, D. C. (1995). Pineal serotonin N-acetyltransferase: Expression cloning and molecular analysis. Science, 270(5242), 1681-1683. https://doi.org/10.1126/science.270.5242.1681</Citation>
        </Reference>
        <Reference>
          <Citation>Crnko, S., Du Pré, B. C., Sluijter, J. P. G., &amp; Van Laake, L. W. (2019). Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nature Reviews Cardiology, 16(7), 437-447. https://doi.org/10.1038/s41569-019-0167-4</Citation>
        </Reference>
        <Reference>
          <Citation>Dardente, H., Dardente, H., &amp; Cermakian, N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiology International, 24(2), 195-213. https://doi.org/10.1080/07420520701283693</Citation>
        </Reference>
        <Reference>
          <Citation>Etain, B., Jamain, S., Milhiet, V., Lajnef, M., Boudebesse, C., Dumaine, A., … Bellivier, F. (2014). Association between circadian genes, bipolar disorders and chronotypes. Chronobiology International, 31(7), 807-814. https://doi.org/10.3109/07420528.2014.906445</Citation>
        </Reference>
        <Reference>
          <Citation>Etain, B., Milhiet, V., Bellivier, F., &amp; Leboyer, M. (2011). Genetics of circadian rhythms and mood spectrum disorders. European Neuropsychopharmacology, 21(SUPPL.4), S676-S682. https://doi.org/10.1016/j.euroneuro.2011.07.007</Citation>
        </Reference>
        <Reference>
          <Citation>Hallam, K. T., Olver, J. S., &amp; Norman, T. R. (2005). Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers. Neuropsychopharmacology, 30(7), 1400-1404. https://doi.org/10.1038/sj.npp.1300739</Citation>
        </Reference>
        <Reference>
          <Citation>Hayes, A. F. (2013). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. New York, NY: Guilford Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Hertenstein, E., Feige, B., Gmeiner, T., Kienzler, C., Spiegelhalder, K., Johann, A., … Baglioni, C. (2019). Insomnia as a predictor of mental disorders: A systematic review and meta-analysis. Sleep Medicine Reviews, 43, 96-105. https://doi.org/10.1016/j.smrv.2018.10.006</Citation>
        </Reference>
        <Reference>
          <Citation>Karatsoreos, I. N. (2014). Links between circadian rhythms and psychiatric disease. Frontiers in Behavioral Neuroscience, 8, 162. https://doi.org/10.3389/fnbeh.2014.00162</Citation>
        </Reference>
        <Reference>
          <Citation>Kline, C. E., Hall, M. H., Buysse, D. J., Earnest, C. P., &amp; Church, T. S. (2018). Poor sleep quality is associated with insulin resistance in postmenopausal women with and without metabolic syndrome. Metabolic Syndrome and Related Disorders, 16(4), 183-189. https://doi.org/10.1089/met.2018.0013</Citation>
        </Reference>
        <Reference>
          <Citation>Kripke, D. F., Kline, L. E., Nievergelt, C. M., Murray, S. S., Shadan, F. F., Dawson, A., … Hahn, E. K. (2015). Genetic variants associated with sleep disorders. Sleep Medicine, 16(2), 217-224. https://doi.org/10.1016/j.sleep.2014.11.003</Citation>
        </Reference>
        <Reference>
          <Citation>Kurmangaliyev, Y. Z., Sutormin, R. A., Naumenko, S. A., Bazykin, G. A., &amp; Gelfand, M. S. (2013). Functional implications of splicing polymorphisms in the human genome. Human Molecular Genetics, 22(17), 3449-3459. https://doi.org/10.1093/hmg/ddt200</Citation>
        </Reference>
        <Reference>
          <Citation>Lane, J. M., Liang, J., Vlasac, I., Anderson, S. G., Bechtold, D. A., Bowden, J., … Saxena, R. (2017). Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nature Genetics, 49(2), 274-281. https://doi.org/10.1038/ng.3749</Citation>
        </Reference>
        <Reference>
          <Citation>Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., … Exome Aggregation Consortium (2016). Analysis of protein-coding genetic variation in 60,706 humans. Nature, 536(7616), 285-291. https://doi.org/10.1038/nature19057</Citation>
        </Reference>
        <Reference>
          <Citation>Lo, C. M. H., &amp; Lee, P. H. (2012). Prevalence and impacts of poor sleep on quality of life and associated factors of good sleepers in a sample of older Chinese adults. Health and Quality of Life Outcomes, 10, 72. https://doi.org/10.1186/1477-7525-10-72</Citation>
        </Reference>
        <Reference>
          <Citation>Miller, S. A., Dykes, D. D., &amp; Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 15(3), 1215.</Citation>
        </Reference>
        <Reference>
          <Citation>Moszyńska, A., Gebert, M., Collawn, J. F., &amp; Bartoszewski, R. (2017). SNPs in microRNA target sites and their potential role in human disease. Open Biology, 7(4), 170019. https://doi.org/10.1098/rsob.170019</Citation>
        </Reference>
        <Reference>
          <Citation>Okubo, N., Matsuzaka, M., Takahashi, I., Sawada, K., Sato, S., Akimoto, N., … Nakaji, S. (2014). Relationship between self-reported sleep quality and metabolic syndrome in general population. BMC Public Health, 14(1), 562. https://doi.org/10.1186/1471-2458-14-562</Citation>
        </Reference>
        <Reference>
          <Citation>Pilz, L. K., Keller, L. K., Lenssen, D., &amp; Roenneberg, T. (2018). Time to rethink sleep quality: PSQI scores reflect sleep quality on workdays. Sleep, 41(5), zsy029. https://doi.org/10.1093/sleep/zsy029</Citation>
        </Reference>
        <Reference>
          <Citation>Pilz, L. K., Levandovski, R., Oliveira, M. A. B., Hidalgo, M. P., &amp; Roenneberg, T. (2018). Sleep and light exposure across different levels of urbanisation in Brazilian communities. Scientific Reports, 8(1), 11389. https://doi.org/10.1038/s41598-018-29494-4</Citation>
        </Reference>
        <Reference>
          <Citation>Portaluppi, F., Smolensky, M. H., &amp; Touitou, Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiology International, 27(9-10), 1911-1929. https://doi.org/10.3109/07420528.2010.516381</Citation>
        </Reference>
        <Reference>
          <Citation>Soria, V., Martínez-Amorós, È., Escaramís, G., Valero, J., Crespo, J. M., Gutiérrez-Zotes, A., … Urretavizcaya, M. (2010). Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility. Journal of Pineal Research, 49(1), 35-44. https://doi.org/10.1111/j.1600-079X.2010.00763.x</Citation>
        </Reference>
        <Reference>
          <Citation>Strohmaier, S., Devore, E. E., Zhang, Y., &amp; Schernhammer, E. S. (2018). A review of data of findings on night shift work and the development of DM and CVD events: A synthesis of the proposed molecular mechanisms. Current Diabetes Reports, 18(12), 132. https://doi.org/10.1007/s11892-018-1102-5</Citation>
        </Reference>
        <Reference>
          <Citation>Takahashi, J. S., Hong, H.-K.-K., Ko, C. H., &amp; McDearmon, E. L. (2008). The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nature Reviews Genetics, 9(10), 764-775. https://doi.org/10.1038/nrg2430</Citation>
        </Reference>
        <Reference>
          <Citation>Tan, X., van Egmond, L., Chapman, C. D., Cedernaes, J., &amp; Benedict, C. (2018). Aiding sleep in type 2 diabetes: Therapeutic considerations. The Lancet Diabetes &amp; Endocrinology, 6(1), 60-68. https://doi.org/10.1016/S2213-8587(17)30233-4</Citation>
        </Reference>
        <Reference>
          <Citation>Tonon, A. C., Carissimi, A., Schimitt, R. L., de Lima, L. S., Pereira, F. D. S., &amp; Hidalgo, M. P. (2019). How do stress, sleep quality, and chronotype associate with clinically significant depressive symptoms? A study of young male military recruits in compulsory service. Brazilian Journal of Psychiatry, https://doi.org/10.1590/1516-4446-2018-0286</Citation>
        </Reference>
        <Reference>
          <Citation>Tufik, S., Santos-Silva, R., Taddei, J. A., &amp; Bittencourt, L. R. A. (2010). Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Medicine, 11(5), 441-446. https://doi.org/10.1016/j.sleep.2009.10.005</Citation>
        </Reference>
        <Reference>
          <Citation>Utge, S. J., Soronen, P., Loukola, A., Kronholm, E., Ollila, H. M., Pirkola, S., … Paunio, T. (2010). Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance. PLoS ONE, 5(2), e9259. https://doi.org/10.1371/journal.pone.0009259</Citation>
        </Reference>
        <Reference>
          <Citation>Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., … Murray, C. J. L. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 386(9995), 743-800. https://doi.org/10.1016/S0140-6736(15)60692-4</Citation>
        </Reference>
        <Reference>
          <Citation>Vriend, J., &amp; Reiter, R. J. (2015). Melatonin feedback on clock genes: A theory involving the proteasome. Journal of Pineal Research, 58(1), 1-11. https://doi.org/10.1111/jpi.12189</Citation>
        </Reference>
        <Reference>
          <Citation>Xi, B., He, D., Zhang, M., Xue, J., &amp; Zhou, D. (2014). Short sleep duration predicts risk of metabolic syndrome: A systematic review and meta-analysis. Sleep Medicine Reviews, 18(4), 293-297. https://doi.org/10.1016/j.smrv.2013.06.001</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909860</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-636X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chirality</Title>
          <ISOAbbreviation>Chirality</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Single-walled carbon nanotube absolute-handedness chirality assignment confirmation using metalized porphyrin's supramolecular structures via STM imaging technique.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/chir.23163</ELocationID>
        <Abstract>
          <AbstractText>This work reports confirmation of the experimental assignment of the absolute-handedness chirality of single-walled carbon nanotubes (SWNTs). This was achieved by applying the scanning tunneling microscopy (STM) imaging technique to a supramolecular composite consisting of a metalized porphyrin derivative (nickel-5,15-bisdodecylporphyrin [Ni-BDP]) affixed to the surfaces of chiral-concentrated SWNTs (with right-handed helix P- and left-handed helix M-). On the basis of the handedness chirality, different chiral supramolecular structures of Ni-BDP were observed on the surfaces of the two SWNT enantiomers. The incorporation of a metal center into the porphyrin ring did not significantly affect the SWNT absolute-handedness chirality assignment, the large pi-system porphyrin ring being the crucial factor. These findings will effectively pave the way towards the clear selective synthesis, separation, chemistry, and applications of SWNT enantiomers.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abd El-Mageed</LastName>
            <ForeName>Ahmed I A</ForeName>
            <Initials>AIA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9715-3710</Identifier>
            <AffiliationInfo>
              <Affiliation>Chemistry Department, Graduate School of Science, Osaka University, Toyonaka, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogawa</LastName>
            <ForeName>Takuji</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6237-2286</Identifier>
            <AffiliationInfo>
              <Affiliation>Chemistry Department, Graduate School of Science, Osaka University, Toyonaka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>25110002</GrantID>
            <Agency>Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology of Japan</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>International Joint Research Promotion Program of Osaka University</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>25110002</GrantID>
            <Agency>Ministry of Education, Culture, Science, Sports, and Technology of Japan</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Chirality</MedlineTA>
        <NlmUniqueID>8914261</NlmUniqueID>
        <ISSNLinking>0899-0042</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">absolute-handedness chirality</Keyword>
        <Keyword MajorTopicYN="N">metalized porphyrin</Keyword>
        <Keyword MajorTopicYN="N">scanning tunneling microscopy</Keyword>
        <Keyword MajorTopicYN="N">single-walled carbon nanotubes (SWNT)</Keyword>
        <Keyword MajorTopicYN="N">supramolecular structure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909860</ArticleId>
        <ArticleId IdType="doi">10.1002/chir.23163</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>(a) Dresselhaus MS, Dresselhaus G, Jorio A. UNUSUAL PROPERTIES AND STRUCTURE OF CARBON NANOTUBES. Annu. Rev. Mater. Res. 2004;34(1):247-278.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Yan Y, Miao J, Yang Z, et al. Carbon nanotube catalysts: recent advances in synthesis, characterization and applications. Chem. Soc. Rev. 2015;44(10):3295-3346.</Citation>
        </Reference>
        <Reference>
          <Citation>(c) Singh P, Campidelli S, Giordani S, Bonifazi D, Bianco A, Prato M. Organic functionalisation and characterisation of single-walled carbon nanotubes. Chem. Soc. Rev. 2009;38(8):2214-2230.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Avouris P. Molecular electronics with carbon nanotubes. Acc. Chem. Res. 2002;35(12):1026-1034.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Tans SJ, Verschueren AR, Dekker C. Room-temperature transistor based on a single carbon nanotube. Nature. 1998;393(6680):49-52.</Citation>
        </Reference>
        <Reference>
          <Citation>(c) Kong J, Franklin NR, Zhou C, et al. Nanotube molecular wires as chemical sensors. Science. 2000;287(5453):622-625.</Citation>
        </Reference>
        <Reference>
          <Citation>(d) Li J, Lu Y, Ye Q, Cinke M, Han J, Meyyappan M. Carbon Nanotube Sensors for Gas and Organic Vapor Detection. Nano Lett. 2003;3(7):929-933.</Citation>
        </Reference>
        <Reference>
          <Citation>(e) Liu Z, Tabakman S, Welsher K, Dai H. Carbon Nanotubes in Biology and Medicine: in vitro and in vivo Detection, Imaging and Drug Delivery. Nano Res. 2009;2(2):85-120.</Citation>
        </Reference>
        <Reference>
          <Citation>(f) Akasaka T, Watari F, Sato Y, Tohji K. Apatite formation on carbon nanotubes. Mater. Sci. Eng. C. 2006;26(4):675-678.</Citation>
        </Reference>
        <Reference>
          <Citation>(g) Serp P, Corrias M, Kalck P. Carbon nanotubes and nanofibers in catalysis. Appl. Catal. A. 2003;253(2):337-358.</Citation>
        </Reference>
        <Reference>
          <Citation>(h) Planeix J, Coustel N, Coq B, et al. Application of Carbon Nanotubes as Supports in Heterogeneous Catalysis. J. Am. Chem. Soc. 1994;116(17):7935-7936.</Citation>
        </Reference>
        <Reference>
          <Citation>El-Mageed A. I. A, PhD thesis (chapter IV), pp. 118-143, Osaka University, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Samsonidze GG, Grüneis A, Saito R, et al. Interband optical transitions in left- and right-handed single-wall carbon nanotubes. Phys. Rev. B. 2004;69(20):1-11, 205402</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Sánchez-Castillo A, Román-Velázquez C, Noguez C. Optical circular dichroism of single-wall carbon nanotubes. Phys. Rev. B. 2006;73(4):1-7, 045401.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Kataura H, Kumazawa Y, Maniwa Y, et al. Optical properties of single-wall carbon nanotubes. Synth. Met. 1999;103:(1), 2555-2558, 3.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Liu F. W. G, Peng X, Rahman A. F. M. M, Bauri A. K and Komatsu N, Handbook of Carbon Nano Materials, ed. F. D’Souza and K. M. Kadish, World Scientific 2012, 3, 203-232.</Citation>
        </Reference>
        <Reference>
          <Citation>Moss G. Basic terminology of stereochemistry (IUPAC Recommendations 1996). Pure Appl. Chem. 1996;68(12):2193-2222.</Citation>
        </Reference>
        <Reference>
          <Citation>Peng X, Komatsu N, Bhattacharya S, et al. Optically active single-walled carbon nanotubes. Nat. Nanotechnol. 2007;2(6):361-365.</Citation>
        </Reference>
        <Reference>
          <Citation>Peng X, Wang F, Bauri AK, Rahman AM, Komatsu N. Optical Resolution of Single-Walled Carbon Nanotubes through Molecular Recognition with Chiral Diporphyrin Nanotweezers. Chem. Lett. 2010;39(10):1022-1027.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Toshimitsu F, Nakashima N. Semiconducting single-walled carbon nanotubes sorting with a removable solubilizer based on dynamic supramolecular coordination chemistry. Nat. Commun. 2014;5(1):1-9, 5041</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Liu H, Nishide D, Tanaka T, Kataura H. Large-scale single-chirality separation of single-wall carbon nanotubes by simple gel chromatography. Nat. Commun. 2011;2(1):1-8. 309</Citation>
        </Reference>
        <Reference>
          <Citation>(c) Wang F, Matsuda K, Rahman AM, Kimura T, Komatsu N. Improved selectivity in discriminating handedness and diameter of single-walled carbon nanotubes with N-substituted 3,6-carbazolylene-bridged chiral diporphyrin nanotweezers. Nanoscale. 2011;3(10):4117-4124.</Citation>
        </Reference>
        <Reference>
          <Citation>Duong B, Arechabaleta R, Tao N. In situ AFM/STM characterization of porphyrin electrode films for electrochemical detection of neurotransmitters. J. Electroanal. Chem. 1998;447(1-2):63-69.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Smith KM, Falk JE. Porphyrins and Metalloporphyrins. Elsevier Amsterdam: Elsevier; 1975.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) El-Mageed AIA, Ogawa T. Metal ion effect on the supramolecular structures of metalloporphyrins on single-walled carbon nanotube surface. Appl. Surf. Sci. 2018;462:904-912.</Citation>
        </Reference>
        <Reference>
          <Citation>(c) Ishii T, Aizawa N, Kanehama R, et al. Syntheses and electronic structures of macrocyclic metal complexes with fullerene. Inorganica Chim. Acta. 2001;317(1-2):81-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Ehli C, Rahman GA, Jux N, et al. Interactions in single wall carbon nanotubes/pyrene/porphyrin nanohybrids. J. Am. Chem. Soc. 2006;128(34):11222-11231.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Iritani K, Tahara K, Hirose K, De Feyter S, Tobe Y. Construction of cyclic arrays of Zn-porphyrin units and their guest binding at the solid-liquid interface. Chem. Comm. 2016;52(100):14419-14422.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Ikeda T, Asakawa M, Miyake K, Goto M, Shimizu T. Scanning tunneling microscopy observation of self-assembled monolayers of strapped porphyrins. Langmuir. 2008;24(22):12877-12882.</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng L, Ye D, Xiong L, et al. Preparation of cobalt-tetraphenylporphyrin/reduced graphene oxide nanocomposite and its application on hydrogen peroxide biosensor. Anal. Chim. Acta. 2013;768:69-75.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Ma X, Hartmann NF, Baldwin JK, Doorn SK, Htoon H. Room-temperature single-photon generation from solitary dopants of carbon nanotubes. Nat. Nanotechnol. 2015;10(8):671-675.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Shi Z, Hong X, Bechtel HA, et al. Observation of a Luttinger-liquid plasmon in metallic single-walled carbon nanotubes. Nat. Photonics. 2015;9(8):515-519.</Citation>
        </Reference>
        <Reference>
          <Citation>(c) Baughman RH, Zakhidov AA, de Heer WA. Carbon nanotubes--the route toward applications. Science. 2002;297(5582):787-792.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Tahara K, Lei S, Adisoejoso J, De Feyter S, Tobe Y. Supramolecular surface-confined architectures created by self-assembly of triangular phenylene-ethynylene macrocycles via van der Waals interaction. Chem. Comm. 2010;46(45):8507-8525.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Barth JV, Costantini G, Kern K. in Nanoscience and Technology: A Collection of Reviews From Nature Journals. United States: World Scientific; 2010:67-75.</Citation>
        </Reference>
        <Reference>
          <Citation>(c) Barth JV. Molecular Architectonic on Metal Surfaces. Annu. Rev. Phys. Chem. 2007;58(1):375-407.</Citation>
        </Reference>
        <Reference>
          <Citation>(d) Abd El-Mageed AI, Handayani M, Chen Z, Inose T, Ogawa T. Assignment of the Absolute-Handedness Chirality of Single-Walled Carbon Nanotubes Using Organic Molecule Supramolecular Structures. Chem. Eur. J. 2019;25(8):1941-1948.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Binnig G, Rohrer H, Gerber C, Weibel E. Surface Studies by Scanning Tunneling Microscopy. Phys. Rev. Lett. 1982;49(1):57-61.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Katsonis N, Lacaze E, Feringa BL. Molecular chirality at fluid/solid interfaces: expression of asymmetry in self-organised monolayers. J. Mater. Chem. 2008;18(18):2065-2073.</Citation>
        </Reference>
        <Reference>
          <Citation>(c) Elemans JA, De Cat I, Xu H, De Feyter S. Two-dimensional chirality at liquid-solid interfaces. Chem. Soc. Rev. 2009;38(3):722-736.</Citation>
        </Reference>
        <Reference>
          <Citation>(d) Takami T, Ye T, Pathem BK, et al. Manipulating double-decker molecules at the liquid-solid interface. J. Am. Chem. Soc. 2010;132(46):16460-16466.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Pham VD, Repain V, Chacon C, et al. Properties of Functionalized Carbon Nanotubes and Their Interaction with a Metallic Substrate Investigated by Scanning Tunneling Microscopy. J. Phys. Chem. C. 2017;121(43):24264-24271.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Bassiouk M, Basiuk VA, Basiuk EV, et al. Noncovalent functionalization of single-walled carbon nanotubes with porphyrins. Appl. Surf. Sci. 2013;275:168-177.</Citation>
        </Reference>
        <Reference>
          <Citation>He C, He Q, Deng C, et al. Turn on fluorescence sensing of vapor phase electron donating amines via tetraphenylporphyrin or metallophenylporphrin doped polyfluorene. Chem. Comm. 2010;46(40):7536-7538.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu G, Wang F, Chaunchaiyakul S, et al. Simultaneous discrimination of diameter, handedness, and metallicity of single-walled carbon nanotubes with chiral diporphyrin nanocalipers. J. Am. Chem. Soc. 2013;135(12):4805-4814.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Katsonis N, Vicario J, Kudernac T, Visser J, Pollard MM, Feringa BL. Self-organized monolayer of meso-tetradodecylporphyrin coordinated to Au(111). J. Am. Chem. Soc. 2006;128(48):15537-15541.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Plamont R, Kikkawa Y, Takahashi M, et al. Nanoscopic Imaging ofmeso-Tetraalkylporphyrins Prepared in High Yields Enabled by Montmorrilonite K10 and 3 Å Molecular Sieves. Chem. Eur. J. 2013;19(34):11293-11300.</Citation>
        </Reference>
        <Reference>
          <Citation>Visser J, Katsonis N, Vicario J, Feringa BL. Two-dimensional molecular patterning by surface-enhanced Zn-porphyrin coordination. Langmuir. 2009;25(10):5980-5985.</Citation>
        </Reference>
        <Reference>
          <Citation>R. A. Gaussian09, Inc., Wallingford CT 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Zhao Y, Schultz NE, Truhlar DG, Chem J. Design of Density Functionals by Combining the Method of Constraint Satisfaction with Parametrization for Thermochemistry, Thermochemical Kinetics, and Noncovalent Interactions. Theory Comput. 2006;2(2):364-382.</Citation>
        </Reference>
        <Reference>
          <Citation>(b) Rodríguez-Galván A, Amelines-Sarria O, Rivera M, Carreón-Castro M d P, Basiuk VA. Adsorption and self-assembly of anticancer antibiotic doxorubicin on single-walled carbon nanotubes. NANO. 2016;11(04):1-9;1650038.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909861</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1522-726X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions</Title>
          <ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A modified predilation, sizing, and postdilation scoring system for patients undergoing metallic drug-eluting stent implantations.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.28711</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study sought to assess whether the predilation, scaffold/stent sizing, and postdilation (PSP) score for bioresorbable scaffold (BRS) implantation was associated with outcomes following metallic drug-eluting stent (DES) implantation.</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The PSP score is associated with patients' prognoses after BRS implantation.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This study involved 2,348 patients who underwent biodegradable polymer DES implantations during the PANDA III trial. The optimal PSP technique was defined according to previous studies of BRS implantations. The main outcome was target lesion failure (TLF) that comprised cardiac death, target-vessel myocardial infarction, or ischemia-driven target lesion revascularization.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-five (1.1%) patients fulfilled all the PSP criteria. The BRS-derived PSP score was of limited prognostic value for 2-year TLF after metallic DES implantation; optimal sizing was a protective factor, but optimal predilation was a risk factor. We built a new PSP model for DESs by identifying the following risk factors: predilation performed with a residual stenosis ≥70% or a balloon-to-quantitative coronary angiography (QCA)-determined reference vessel diameter (RVD) ratio &gt;1:1, sizing performed with an RVD &lt;2.25 mm or a stent diameter &gt;0.25 mm wider than the QCA-RVD, a postprocedural stenosis diameter ≥30%, age, and the baseline SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score. The new PSP scoring system predicted 2-year TLF (area under the curve, 0.69; 95% confidence interval, 0.65-0.73); a cutoff value of 19.2 points identified high-risk patients.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The new PSP scoring system, based on redefined PSP criteria, age, and the SYNTAX score, could help optimize metallic DES implantations.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Xueyan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Changdong</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Jinqing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Lihua</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Huan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Data Statistics Department, CCRF (Beijing) Inc., Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hou</LastName>
            <ForeName>Shuang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Data Statistics Department, CCRF (Beijing) Inc., Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Data Statistics Department, CCRF (Beijing) Inc., Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xinbo</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Data Statistics Department, CCRF (Beijing) Inc., Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Runlin</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1165-7302</Identifier>
            <AffiliationInfo>
              <Affiliation>Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Catheter Cardiovasc Interv</MedlineTA>
        <NlmUniqueID>100884139</NlmUniqueID>
        <ISSNLinking>1522-1946</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">metallic drug-eluting stent</Keyword>
        <Keyword MajorTopicYN="N">postdilation</Keyword>
        <Keyword MajorTopicYN="N">predilation</Keyword>
        <Keyword MajorTopicYN="N">sizing</Keyword>
        <Keyword MajorTopicYN="N">target lesion failure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909861</ArticleId>
        <ArticleId IdType="doi">10.1002/ccd.28711</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Ali ZA, Serruys PW, Kimura T, et al. 2-year outcomes with the absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet. 2017;390:760-772.</Citation>
        </Reference>
        <Reference>
          <Citation>Wykrzykowska JJ, Kraak RP, Hofma SH, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med. 2017;376:2319-2328.</Citation>
        </Reference>
        <Reference>
          <Citation>Stone GW, Gao R, Kimura T, et al. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis. Lancet. 2016;387:1277-1289.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoppmann P, Rai H, Colleran R, et al. Very late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography. Cardiovasc Revasc Med. 2019. https://doi.org/10.1016/j.carrev.2019.05.023. [Epub ahead of print]</Citation>
        </Reference>
        <Reference>
          <Citation>Bangalore S, Bezerra HG, Rizik DG, et al. The state of the Absorb bioresorbable scaffold: consensus from an expert panel. JACC Cardiovasc Interv. 2017;10:2349-2359.</Citation>
        </Reference>
        <Reference>
          <Citation>Stone GW, Abizaid A, Onuma Y, et al. Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials. J Am Coll Cardiol. 2017;70:2863-2874.</Citation>
        </Reference>
        <Reference>
          <Citation>Ortega-Paz L, Capodanno D, Gori T, et al. Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score. EuroIntervention. 2017;12:2110-2117.</Citation>
        </Reference>
        <Reference>
          <Citation>Philip F, Stewart S, Southard JA. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: network meta-analysis of randomized primary percutaneous coronary intervention trials. Catheter Cardiovasc Interv. 2016;88:38-48.</Citation>
        </Reference>
        <Reference>
          <Citation>Hofma SH, Brouwer J, Velders MA, et al. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV stent vs. cypher stent in primary PCI for acute myocardial infarction) trial. J Am Coll Cardiol. 2012;60:381-387.</Citation>
        </Reference>
        <Reference>
          <Citation>Menichelli M, Parma A, Pucci E, et al. Randomized trial of sirolimus-eluting stent versus bare-metal sStent in acute myocardial infarction (SESAMI). J Am Coll Cardiol. 2007;49:1924-1930.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu B, Gao R, Yang Y, et al. PANDA III Investigators. Biodegradable polymer-based sirolimus-eluting stents with differing elution and absorption kinetics: the PANDA III trial. J Am Coll Cardiol. 2016;67:2249-2258.</Citation>
        </Reference>
        <Reference>
          <Citation>Cutlip DE, Windecker S, Mehran R, et al. Academic research consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351.</Citation>
        </Reference>
        <Reference>
          <Citation>Rogers C, Parikh S, Seifert P, Edelman ER. Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation. 1996;94:2909-2914.</Citation>
        </Reference>
        <Reference>
          <Citation>Barbato E, Marco J, Wijns W. Direct stenting. Eur Heart J. 2003;24:394-403.</Citation>
        </Reference>
        <Reference>
          <Citation>Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56:1897-1907.</Citation>
        </Reference>
        <Reference>
          <Citation>Lüscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051-1058.</Citation>
        </Reference>
        <Reference>
          <Citation>Brodie BR. Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents? J Interv Cardiol. 2006;19:43-50.</Citation>
        </Reference>
        <Reference>
          <Citation>Kan J, Ge Z, Zhang JJ, et al. Incidence and clinical outcomes of stent fractures on the basis of 6,555 patients and 16,482 drug-eluting stents from 4 centers. JACC Cardiovasc Interv. 2016;9:1115-1123.</Citation>
        </Reference>
        <Reference>
          <Citation>Ellis SG, Steffenino G, Kereiakes DJ, et al. Clinical, angiographic, and procedural correlates of acute, subacute, and late Absorb scaffold thrombosis. JACC Cardiovasc Interv. 2017;10:1809-1815.</Citation>
        </Reference>
        <Reference>
          <Citation>Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001;103:1967-1971.</Citation>
        </Reference>
        <Reference>
          <Citation>Heestermans AA, van Werkum JW, Zwart B, et al. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome. J Thromb Haemost. 2010;8:2385-2393.</Citation>
        </Reference>
        <Reference>
          <Citation>Russo RJ, Silva PD, Yeager M. Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model. Heart. 2007;93:1609-1615.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909862</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1742-1241</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of clinical practice</Title>
          <ISOAbbreviation>Int. J. Clin. Pract.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of an ambulatory physical activity program on balance and motor abilities of retirees: a prospective study.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13474</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.13474</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Given the public health problem generated by posture and gait disorders, a preventive approach is essential.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We investigated the impact of an ambulatory physical activity program (APAP) on the motor skills of retirees.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">Retirees ≥ 60 years were recruited in this prospective study. The APAP was supported by a French regional health insurance plan. Between inclusion (T0) and 12 weeks (T1), subjects participated in an APAP (1 hour/week) that included strengthening muscular exercises, balance work, joint flexibility exercises, one-leg-balance test (OLB), stimulation of the foot arch, and rise-from-the-floor (RFF). Timed-up-and-go test (TUG) duration, gait speed (GS), OLB duration and RFF success were compared between T1 and T0.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred subjects (86% women) were enrolled; mean age was 73.8 years (45.5% ≥ 75 years). TUG durations (s) were lower at T1 than at T0 (8.98 and 9.64; P &lt; .0001). The GS (m/s) and OLB durations (s) were higher at T1 than at T0 (1.26 vs 1.12 for GS, 16.16 vs 13.02 for OLB; P &lt; .0001). The rate of participants who successfully completed RFF was higher at T1 (94%) than at T0 (76%) (P &lt; .0001). After the APAP, TUG duration was reduced in 64.5% of cases, the GS improved in 73% of cases, OLB duration increased in 50% of cases, and RFF became possible in 18.5% of cases (all P &lt; .0001).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Physical activity programs are effective for improving motor performance, even in older adults. Retirees must be encouraged to do regular physical activity to prevent or slow the functional decline associated with aging, and to improve their overall quality of life.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Manckoundia</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, Dijon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>UMR Inserm/U1093 Cognition Action, Sensorimotor Plasticity, University of Burgundy and Franche Comté, Dijon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barthélémy</LastName>
            <ForeName>Elise</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Caisse d'Assurance Retraite Santé au Travail" of Burgundy Franche Comté (CARSAT BFC).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bonnot</LastName>
            <ForeName>Renaud</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Caisse d'Assurance Retraite Santé au Travail" of Burgundy Franche Comté (CARSAT BFC).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>d'Athis</LastName>
            <ForeName>Philippe</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, François Mitterrand Hospital, University Hospital, Dijon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Clin Pract</MedlineTA>
        <NlmUniqueID>9712381</NlmUniqueID>
        <ISSNLinking>1368-5031</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">1 | INTRODUCTION</Keyword>
        <Keyword MajorTopicYN="N">balance; elderly; gait; physical exercises</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909862</ArticleId>
        <ArticleId IdType="doi">10.1111/ijcp.13474</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909863</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1462-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cellular microbiology</Title>
          <ISOAbbreviation>Cell. Microbiol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Universal highly efficient conditional knockout system in Leishmania, with a focus on UTR preservation.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13159</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cmi.13159</ELocationID>
        <Abstract>
          <AbstractText>Trypanosomatids are divergent eukaryotes of high medical and economical relevance. Their biology exhibits original features which remain poorly understood; particularly Leishmania is known for its high degree of genomic plasticity which makes genomic manipulation challenging. CRISPR-Cas9 has been applied successfully to these parasites providing a robust tool to study non-essential gene functions. Here, we have developed a versatile inducible system combining Di-CRE recombinase and CRISPR-Cas9 advantages. Cas9 is used to integrate the LoxP sequences and the Cre-recombinase catalyzes the recombination between LoxP sites thereby excising the target gene. We used an L. mexicana cell line expressing Di-CRE, Cas9 and T7 polymerase and then transfected donor DNAs and single guide RNAs as PCR products. Since the location of LoxP sequences in the genomic DNA can interfere with the function and localization of certain proteins of interest, we proposed to target the least transcribed regions upstream and/or downstream the gene of interest. To do so, we developed 'universal' template plasmids for donor DNA cassettes with or without a tag, where LoxP sequences may be located either immediately upstream the ATG and downstream the stop codon of the gene of interest, or in the least transcribed areas of intergenic regions. Our methodology is fast, PCR based (molecular cloning-free), highly efficient, versatile, and able to overcome the problems posed by genomic plasticity in Leishmania. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yagoubat</LastName>
            <ForeName>Akila</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>MiVEGEC, Univ. Montpellier, CNRS, IRD, CHU, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crobu</LastName>
            <ForeName>Lucien</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>MiVEGEC, Univ. Montpellier, CNRS, IRD, CHU, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berry</LastName>
            <ForeName>Laurence</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>LPHI - Laboratory of Pathogen Host Interactions &amp; MEA - Microscopie Electronique Analytique, CNRS, Univ. Montpellier, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuk</LastName>
            <ForeName>Nada</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>MiVEGEC, Univ. Montpellier, CNRS, IRD, CHU, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lefebvre</LastName>
            <ForeName>Michèle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>MiVEGEC, Univ. Montpellier, CNRS, IRD, CHU, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarrazin</LastName>
            <ForeName>Amélie</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Montpellier RIO Imaging Facility, Montpellier BIOCAMPUS, Univ. Montpellier, Arnaud de Villeneuve Campus Imaging Facility - Institut de Génétique Humaine-CNRS, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bastien</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>MiVEGEC, Univ. Montpellier, CNRS, IRD, CHU, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sterkers</LastName>
            <ForeName>Yvon</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5623-5664</Identifier>
            <AffiliationInfo>
              <Affiliation>MiVEGEC, Univ. Montpellier, CNRS, IRD, CHU, Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Cell Microbiol</MedlineTA>
        <NlmUniqueID>100883691</NlmUniqueID>
        <ISSNLinking>1462-5814</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword>
        <Keyword MajorTopicYN="N">CreLox</Keyword>
        <Keyword MajorTopicYN="N">Genome edition</Keyword>
        <Keyword MajorTopicYN="N">inducible knockout</Keyword>
        <Keyword MajorTopicYN="N">parasite</Keyword>
        <Keyword MajorTopicYN="N">trypanosomatids</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909863</ArticleId>
        <ArticleId IdType="doi">10.1111/cmi.13159</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909864</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1934-9289</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>80</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Current protocols in nucleic acid chemistry</Title>
          <ISOAbbreviation>Curr Protoc Nucleic Acid Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Synthesis of 4-Cyanoindole Nucleosides, 4-Cyanoindole-2'-Deoxyribonucleoside-5'-Triphosphate (4CIN-TP), and Enzymatic Incorporation of 4CIN-TP into DNA.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e101</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cpnc.101</ELocationID>
        <Abstract>
          <AbstractText>4-Cyanoindole-2'-deoxyribonucleoside (4CIN) is a fluorescent isomorphic nucleoside analogue with superior spectroscopic properties in terms of Stokes shift and quantum yield in comparison to the widely utilized isomorphic nucleoside analogue, 2-aminopurine-2'-deoxyribonucleoside (2APN). Notably, when inserted into single- or double-stranded DNA, 4CIN experiences substantially less in-strand fluorescence quenching compared to 2APN. Given the utility of these properties for a spectrum of research applications involving oligonucleotides and oligonucleotide-protein interactions (e.g., enzymatic processes, DNA hybridization, DNA damage), we envision that additional reagents based on 4-cyanoindole nucleosides may be widely utilized. This protocol expands on the previously published synthesis of 4CIN to include synthetic routes to both 4-cyanoindole-ribonucleoside (4CINr) and 4-cyanoindole-2'-deoxyribonucleoside-5'-triphosphate (4CIN-TP), as well as a method for the enzymatic incorporation of 4CIN-TP into DNA by a polymerase. These methods are anticipated to further enable the utilization of 4CIN in diverse applications involving DNA and RNA oligonucleotides. © 2020 by John Wiley &amp; Sons, Inc. Basic Protocol 1: Synthesis of 4-cyanoindole-2'-deoxyribonucleoside (4CIN) and 4CIN phosphoramidite 4 Basic Protocol 2: Synthesis of 4-cyanoindole-ribonucleoside (4CINr) Basic Protocol 3: Synthesis of 4-cyanoindole-2'-deoxyribonucleoside-5'-triphosphate (4CIN-TP) Basic Protocol 4: Steady state incorporation kinetics of 2AP-TP and 4CIN-TP by a DNA polymerase.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Passow</LastName>
            <ForeName>Kellan T</ForeName>
            <Initials>KT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antczak</LastName>
            <ForeName>Nicole M</ForeName>
            <Initials>NM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sturla</LastName>
            <ForeName>Shana J</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harki</LastName>
            <ForeName>Daniel A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01-GM110129</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>310030_185020</GrantID>
            <Acronym>SNSF_</Acronym>
            <Agency>Swiss National Science Foundation</Agency>
            <Country>Switzerland</Country>
          </Grant>
          <Grant>
            <GrantID>P30-CA77598</GrantID>
            <Acronym>GF</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Curr Protoc Nucleic Acid Chem</MedlineTA>
        <NlmUniqueID>101287865</NlmUniqueID>
        <ISSNLinking>1934-9270</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">4-cyanoindole</Keyword>
        <Keyword MajorTopicYN="N">fluorescent nucleosides</Keyword>
        <Keyword MajorTopicYN="N">polymerase incorporation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909864</ArticleId>
        <ArticleId IdType="doi">10.1002/cpnc.101</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>Literature Cited</Title>
        <Reference>
          <Citation>Ahmed, I. A., Acharyya, A., Eng, C. M., Rodgers, J. M., DeGrado, W. F., Jo, H., &amp; Gai, F. (2019). 4-Cyanoindole-2ʹ-deoxyribonucleoside as a dual fluorescence and infrared probe of DNA structure and dynamics. Molecules, 24, 602. doi: 10.3390/molecules24030602 .</Citation>
        </Reference>
        <Reference>
          <Citation>Armarego, W. L. F., &amp; Chai, C. L. L. (2009). Purification of laboratory chemicals (6th ed.). Amsterdam: Elsevier.</Citation>
        </Reference>
        <Reference>
          <Citation>Bloom, L. B., Otto, M. R., Beechem, J. M., &amp; Goodman, M. F. (1993). Influence of 5ʹ-nearest neighbors on the insertion kinetics of the fluorescent nucleotide analog 2-aminopurine by Klenow fragment. Biochemistry, 32, 11247-11258. doi: 10.1021/bi00092a039.</Citation>
        </Reference>
        <Reference>
          <Citation>Burgess, K., &amp; Cook, D. (2000). Syntheses of nucleoside triphosphates. Chemical Reviews, 100, 2047-2060. doi: 10.1021/cr990045m.</Citation>
        </Reference>
        <Reference>
          <Citation>Datta, K., Wowor, A. J., Richard, A. J., &amp; LiCata, V. J. (2006). Temperature dependence and thermodynamics of Klenow polymerase binding to primed-template DNA. Biophysical Journal, 90, 1739-1751. doi: 10.1529/biophysj.105.071837.</Citation>
        </Reference>
        <Reference>
          <Citation>Gahlon, H. L., &amp; Sturla, S. J. (2019). Determining steady-state kinetics of DNA polymerase nucleotide incorporation. Methods in Molecular Biology, 1973, 299-311. doi: 10.1007/978-1-4939-9216-4_19.</Citation>
        </Reference>
        <Reference>
          <Citation>Girgis, N. S., Cottam, H. B., &amp; Robins, R. K. (1988). Synthesis of 2ʹ-deoxyribofuranosyl indole nucleosides related to the antibiotics Sf-2140 and neosidomycin. Journal of Heterocyclic Chemistry, 25, 361-366. doi: 10.1002/jhet.5570250202.</Citation>
        </Reference>
        <Reference>
          <Citation>Harki, D. A., Graci, J. D., Edathil, J. P., Castro, C., Cameron, C. E., &amp; Peterson, B. R. (2007). Synthesis of a universal 5-nitroindole ribonucleotide and incorporation into RNA by a viral RNA-dependent RNA polymerase. ChemBioChem, 8, 1359-1362. doi: 10.1002/cbic.200700160.</Citation>
        </Reference>
        <Reference>
          <Citation>Harki, D. A., Graci, J. D., Korneeva, V. S., Ghosh, S. K., Hong, Z., Cameron, C. E., &amp; Peterson, B. R. (2002). Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-ribofuranosyl-3-nitropyrrole. Biochemistry, 41, 9026-9033. doi: 10.1021/bi026120w.</Citation>
        </Reference>
        <Reference>
          <Citation>Joyce, C. M., Potapova, O., Delucia, A. M., Huang, X., Basu, V. P., &amp; Grindley, N. D. (2008). Fingers-closing and other rapid conformational changes in DNA polymerase I (Klenow fragment) and their role in nucleotide selectivity. Biochemistry, 47, 6103-6116. doi: 10.1021/bi7021848.</Citation>
        </Reference>
        <Reference>
          <Citation>Kane, P. D., &amp; Mann, J. (1984). The preparation and utility of ethyl 2-(5ʹ-O-tert-butyldimethylsilyl-2ʹ,3ʹ-O-isopropylidene-beta-D-ribofuranosyl)propenoate as a key intermediate for C-nucleoside synthesis. Journal of the Chemical Society, Perkin Transactions 1, 657-660. doi: 10.1039/p19840000657.</Citation>
        </Reference>
        <Reference>
          <Citation>Kilin, V., Gavvala, K., Barthes, N. P., Michel, B. Y., Shin, D., Boudier, C., … Mely, Y. (2017). Dynamics of methylated cytosine flipping by UHRF1. Journal of the American Chemical Society, 139, 2520-2528. doi: 10.1021/jacs.7b00154.</Citation>
        </Reference>
        <Reference>
          <Citation>Kobayashi, Y., Nakatsuji, Y., Li, S., Tsuzuki, S., &amp; Takemoto, Y. (2018). Direct N-glycofunctionalization of amides with glycosyl trichloroacetimidate by thiourea/halogen bond donor co-catalysis. Angewandte Chemie International Edition, 57, 3646-3650. doi: 10.1002/anie.201712726.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, I., &amp; Berdis, A. (2006). Fluorescent analysis of translesion DNA synthesis by using a novel, non-natural nucleotide analogue. ChemBiochem, 7, 1990-1997. doi: 10.1002/cbic.200600128.</Citation>
        </Reference>
        <Reference>
          <Citation>Ludwig, J. (1981). A new route to nucleoside 5ʹ-triphosphates. Acta Biochimica Et Biophysica; Academiae Scientiarum Hungaricae, 16, 131-133.</Citation>
        </Reference>
        <Reference>
          <Citation>Mcclure, W. R., &amp; Scheit, K. H. (1973). Enzyme Kinetic Parameters of Fluorescent Atp Analog, 2-aminopurine triphosphate. FEBS Letters, 32, 267-269. doi: 10.1016/0014-5793(73)80849-X.</Citation>
        </Reference>
        <Reference>
          <Citation>O'Flaherty, D. K., &amp; Guengerich, F. P. (2014). Steady-state kinetic analysis of DNA polymerase single-nucleotide incorporation products. Current Protocols in Nucleic Acid Chemistry, 59, 7.21.1-7.21.13. doi: 10.1002/0471142700.nc0721s59.</Citation>
        </Reference>
        <Reference>
          <Citation>Passow, K. T., &amp; Harki, D. A. (2018). 4-cyanoindole-2ʹ-deoxyribonucleoside (4CIN): A universal fluorescent nucleoside analogue. Organic Letters, 20, 4310-4313. doi: 10.1021/acs.orglett.8b01746.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosemeyer, H., &amp; Seela, F. (1988). Stereoselective synthesis of pyrrolo[2,3-D]pyrimidine alpha-D-ribonucleosides and beta-D-ribonucleosides from anomerically pure D-ribofuranosyl chlorides: Solid-liquid phase-transfer glycosylation and N-15-NMR spectra. Helvetica Chimica Acta, 71, 1573-1585. doi: 10.1002/hlca.19880710623.</Citation>
        </Reference>
        <Reference>
          <Citation>Roy, B., Depaix, A., Perigaud, C., &amp; Peyrottes, S. (2016). Recent trends in nucleotide synthesis. Chemical Reviews, 116, 7854-7897. doi: 10.1021/acs.chemrev.6b00174.</Citation>
        </Reference>
        <Reference>
          <Citation>Sinkeldam, R. W., Greco, N. J., &amp; Tor, Y. (2010). Fluorescent analogs of biomolecular building blocks: Design, properties, and applications. Chemical Reviews, 110, 2579-2619. doi: 10.1021/cr900301e.</Citation>
        </Reference>
        <Reference>
          <Citation>Sokolova, T. N., Shevchenko, V. E., &amp; Preobrazhenskaya, M. N. (1980). Interaction of indoles with glycosyl halides in the presence of silver-oxide. Carbohydrate Research, 83, 249-261. doi: 10.1016/S0008-6215(00)84538-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Sowers, L. C., Fazakerley, G. V., Eritja, R., Kaplan, B. E., &amp; Goodman, M. F. (1986). Base pairing and mutagenesis: Observation of a protonated base pair between 2-aminopurine and cytosine in an oligonucleotide by proton NMR. Proceedings of the National Academy of Sciences of the United States of America, 83, 5434-5438. doi: 10.1073/pnas.83.15.5434.</Citation>
        </Reference>
        <Reference>
          <Citation>Stewart, A. O., &amp; Williams, R. M. (1985). C-glycosidation of pyridyl thioglycosides. Journal of the American Chemical Society, 107, 4289-4296. doi: 10.1021/ja00300a036.</Citation>
        </Reference>
        <Reference>
          <Citation>Struntz, N. B., &amp; Harki, D. A. (2016). Catch and release DNA Decoys: Capture and photochemical dissociation of NF-kappa B transcription factors. ACS Chemical Biology, 11, 1631-1638. doi: 10.1021/acschembio.6b00130.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun, Q., Edathil, J. P., Wu, R., Smidansky, E. D., Cameron, C. E., &amp; Peterson, B. R. (2008). One-pot synthesis of nucleoside 5ʹ-triphosphates from nucleoside 5ʹ-H-phosphonates. Organic Letters, 10, 1703-1706. doi: 10.1021/ol8003029.</Citation>
        </Reference>
        <Reference>
          <Citation>Ugarkar, B. G., Castellino, A. J., DaRe, J. M., Kopcho, J. J., Wiesner, J. B., Schanzer, J. M., &amp; Erion, M. D. (2000). Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues. Journal of Medicinal Chemistry, 43, 2894-2905. doi: 10.1021/jm0000259.</Citation>
        </Reference>
        <Reference>
          <Citation>Ward, D. C., Reich, E., &amp; Stryer, L. (1969). Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives. Journal of Biological Chemistry, 244, 1228-1237.</Citation>
        </Reference>
        <Reference>
          <Citation>Watanabe, S. M., &amp; Goodman, M. F. (1981). On the molecular basis of transition mutations: Frequencies of forming 2-aminopurine.cytosine and adenine.cytosine base mispairs in vitro. Proceedings of the National Academy of Sciences of the United States of America, 78, 2864-2868. doi: 10.1073/pnas.78.5.2864.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilcox, C. S., &amp; Otoski, R. M. (1986). Stereoselective preparations of ribofuranosyl chlorides and ribofuranosyl acetates. Solvent effects and stereoselectivity in the reaction of ribofuranosyl acetates with trimethylallylsilane. Tetrahedron Letters, 27, 1011-1014. doi: 10.1016/S0040-4039(86)80035-1.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson, D. L., Beharry, A. A., Srivastava, A., O'Connor, T. R., &amp; Kool, E. T. (2018). Fluorescence probes for ALKBH2 allow the measurement of DNA alkylation repair and drug resistance responses. Angewandte Chemie International Edition, 57, 12896-12900. doi: 10.1002/anie.201807593.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu, W., Chan, K. M., &amp; Kool, E. T. (2017). Fluorescent nucleobases as tools for studying DNA and RNA. Nature Chemistry, 9, 1043-1055. doi: 10.1038/nchem.2859.</Citation>
        </Reference>
        <Reference>
          <Citation>Yoshikawa, M., Kato, T., &amp; Takenishi, T. (1967). A novel method for phosphorylation of nucleosides to 5ʹ-nucleotides. Tetrahedron Letters, 50, 5065-5068. doi: 10.1016/S0040-4039(01)89915-9.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909865</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1420-9101</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>33</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of evolutionary biology</Title>
          <ISOAbbreviation>J. Evol. Biol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Erratum.</ArticleTitle>
        <Pagination>
          <MedlinePgn>138</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jeb.13582</ELocationID>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>J Evol Biol</MedlineTA>
        <NlmUniqueID>8809954</NlmUniqueID>
        <ISSNLinking>1010-061X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>J Evol Biol. 2019 Dec;32(12):1362-1367</RefSource>
          <PMID Version="1">31464022</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909865</ArticleId>
        <ArticleId IdType="doi">10.1111/jeb.13582</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCE</Title>
        <Reference>
          <Citation>Lichtenstein, J. L. L., Fisher, D. N., McEwen, B. L., Nondorf, D. T., Calvache, E., Schmitz, C., … Pruitt, J. N. (2019). Collective aggressiveness limits colony persistence in high- but not low-elevation sites at Amazonian social spiders. Journal of Evolutionary Biology, 32, 1362-1367. https://doi.org/10.1111/jeb.13532</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909866</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1742-1241</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of clinical practice</Title>
          <ISOAbbreviation>Int. J. Clin. Pract.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e13475</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.13475</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">In patients with chronic kidney disease (CKD), hyperkalaemia (potassium level ≥5.0 mEq/L) is associated with poor clinical outcomes. This study provides novel insights by comparing management costs of CKD patients with normokalaemia versus those with persistent hyperkalaemia regularly followed in renal clinics in Italy.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">To this aim a Markov model over life-time horizon was developed. Time to ESRD and time to death in CKD patients were derived from an observational multi-centre database including 1665 patients with non-dialysis CKD stage 1-5 under nephrology care in Italy (15 years follow-up). Resource use for CKD and hyperkalaemia management was obtained from the observational database, KDIGO international guidelines and clinical expert opinion.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Results showed that patients with normokalaemia vs persistent hyperkalaemia brought an average per patient lifetime cost-saving of €16,059 besides delayed onset of ESRD by 2.29 years and increased survival by 1.79 years with increment in total survival and dialysis-free survival in normokalaemia that decreased from early to advanced disease. Cost saving related to normokalaemia increased at more advanced CKD; however, it was already evident at early stage (3,388.97€ at stage 1-3a). OWSA confirmed cost-saving associated with normokalaemia across all parameter variations.</AbstractText>
          <AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">This model is the first to simulate the impact of hyperkalaemia in non-dialysis CKD patients on economic and clinical outcomes using real-world data from nephrology clinics. In these patients, persistent hyperkalaemia results into higher lifetime costs, besides poorer clinical outcomes, that are evident since the early stages of CKD. Maintaining normokalaemia should therefore be of main concern in CKD treatment planning to improve long-term economic and clinical outcomes.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Provenzano</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology and Dialysis Division, University Magna Graecia in Catanzaro, Catanzaro, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Francesco</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Hetegy, Health Economics Strategy &amp; Analytics, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iannazzo</LastName>
            <ForeName>Sergio</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Hetegy, Health Economics Strategy &amp; Analytics, Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garofalo</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology, Department of Advanced Medical and Surgical Sciences, Nephrology Unit - University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andreucci</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology and Dialysis Division, University Magna Graecia in Catanzaro, Catanzaro, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Genualdo</LastName>
            <ForeName>Raffaele</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology and Dialysis Unit, Pellegrini Hospital, ASL NA1 Centro, Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borrelli</LastName>
            <ForeName>Silvio</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology, Department of Advanced Medical and Surgical Sciences, Nephrology Unit - University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minutolo</LastName>
            <ForeName>Roberto</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology, Department of Advanced Medical and Surgical Sciences, Nephrology Unit - University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Conte</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology, Department of Advanced Medical and Surgical Sciences, Nephrology Unit - University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Nicola</LastName>
            <ForeName>Luca</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Nephrology, Department of Advanced Medical and Surgical Sciences, Nephrology Unit - University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Clin Pract</MedlineTA>
        <NlmUniqueID>9712381</NlmUniqueID>
        <ISSNLinking>1368-5031</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hyperkalaemia</Keyword>
        <Keyword MajorTopicYN="N">chronic kidney disease</Keyword>
        <Keyword MajorTopicYN="N">cost-analysis</Keyword>
        <Keyword MajorTopicYN="N">economic evaluation</Keyword>
        <Keyword MajorTopicYN="N">nephrology clinic</Keyword>
        <Keyword MajorTopicYN="N">real-world data</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909866</ArticleId>
        <ArticleId IdType="doi">10.1111/ijcp.13475</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909867</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4965</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomedical materials research. Part A</Title>
          <ISOAbbreviation>J Biomed Mater Res A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Enhanced Hemocompatibility and Antibacterial Activity on Titania Nanotubes with Tanfloc/Heparin Polyelectrolyte Multilayers.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jbm.a.36876</ELocationID>
        <Abstract>
          <AbstractText>Biomaterial-associated thrombus formation and bacterial infection remain major challenges for blood-contacting devices. For decades, titanium-based implants have been largely used for different medical applications. However, titanium can neither suppress blood coagulation, nor prevent bacterial infections. To address these challenges, tanfloc/heparin polyelectrolyte multilayers on titania nanotubes array surfaces (NT) were developed. The surfaces were characterized by scanning electron microscopy (SEM), X-ray photoelectron spectroscopy (XPS), and water contact angle measurements. To evaluate the hemocompatibility of the surfaces, fibrinogen adsorption, Factor XII activation, and platelet adhesion and activation were analyzed. The antibacterial activity was investigated against Gram-negative P. aeruginosa and Gram-positive S. aureus. Bacterial adhesion and morphology, as well as biofilm formation, were analyzed using fluorescence microscopy and SEM. The anti-thrombogenic properties of the surfaces were demonstrated by significant decreases in fibrinogen adsorption, Factor XII activation, and platelet adhesion and activation. Modifying NT with tanfloc/heparin also reduces the adhesion and proliferation of P. aeruginosa and S. aureus bacteria after 24 h of incubation, with no biofilm formation. The modified NT surfaces with tanfloc/heparin polyelectrolyte multilayers are a promising biomaterial for use on implant surfaces because of their enhanced blood biocompatibility and antibacterial properties. This article is protected by copyright. All rights reserved.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sabino</LastName>
            <ForeName>Roberta M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>School of Advanced Materials Discovery, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kauk</LastName>
            <ForeName>Kirsten</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biomedical Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Madruga</LastName>
            <ForeName>Liszt Y C</ForeName>
            <Initials>LYC</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Chemistry, Federal University of Rio Grande do Norte, Brazil.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemical and Biological Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kipper</LastName>
            <ForeName>Matt J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>School of Advanced Materials Discovery, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Biomedical Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemical and Biological Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martins</LastName>
            <ForeName>Alessandro F</ForeName>
            <Initials>AF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemical and Biological Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Laboratory of Materials, Macromolecules and Composites, Federal University of Technology, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Popat</LastName>
            <ForeName>Ketul C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>School of Advanced Materials Discovery, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Biomedical Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Colorado State University, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Biomed Mater Res A</MedlineTA>
        <NlmUniqueID>101234237</NlmUniqueID>
        <ISSNLinking>1549-3296</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibacterial</Keyword>
        <Keyword MajorTopicYN="N">antithrombogenic</Keyword>
        <Keyword MajorTopicYN="N">polyelectrolyte multilayer</Keyword>
        <Keyword MajorTopicYN="N">tanfloc</Keyword>
        <Keyword MajorTopicYN="N">titania nanotubes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909867</ArticleId>
        <ArticleId IdType="doi">10.1002/jbm.a.36876</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909868</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2151-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis care &amp; research</Title>
          <ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Treatment to Target in Psoriatic Arthritis with Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.24134</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the probability of achieving Clinical Disease Activity for Psoriatic Arthritis (cDAPSA) treatment targets of remission (REM) or low disease activity (LDA) with apremilast based on disease activity categories and corresponding responses in arthritis and other domains of psoriatic arthritis (PsA) not included in cDAPSA.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Pooled PALACE 1-3 analyses were performed. Probability analyses assessing the likelihood of achieving cDAPSA treatment targets by Week 52 were performed using multiple imputation for discontinuations and missing values. Longitudinal analyses were performed in patients grouped by cDAPSA category at Week 52.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 494 patients in the probability analyses, 46.9% with moderate and 24.9% with high disease activity at baseline achieved treatment targets (REM or LDA) by Week 52. For patients with moderate disease activity at baseline, small improvements (cDAPSA reductions ≥30%) by Week 16 were associated with achieving targets; patients achieving REM or LDA by Week 16 had high probabilities of remaining at treatment targets at Week 52. Of 375 patients with cDAPSA components available at Week 52, achieving targets with apremilast was associated with continuous disease activity improvements and no or mild arthritis and other PsA manifestations.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The probability of achieving treatment targets (REM or LDA) at Week 52 was greater for patients with moderate versus high disease activity at baseline. At a mean level, partial improvements by Week 16 were associated with achieving treatment targets. Patients receiving apremilast who achieved cDAPSA targets by Week 52 also had no or mild arthritis and other PsA manifestations.</AbstractText>
          <CopyrightInformation>© 2020, American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mease</LastName>
            <ForeName>Philip J</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Swedish Medical Center/Providence St, Joseph Health and University of Washington School of Medicine, Seattle, Washington.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gladman</LastName>
            <ForeName>Dafna D</ForeName>
            <Initials>DD</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology and Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogdie</LastName>
            <ForeName>Alexis</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Coates</LastName>
            <ForeName>Laura C</ForeName>
            <Initials>LC</Initials>
            <AffiliationInfo>
              <Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Behrens</LastName>
            <ForeName>Frank</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology and Fraunhofer Project Group Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kavanaugh</LastName>
            <ForeName>Arthur</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University of California, San Diego, School of Medicine, La Jolla, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mcinnes</LastName>
            <ForeName>Iain</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Queiro</LastName>
            <ForeName>Rubén</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital Universitario Central de Asturias, Oviedo, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guerette</LastName>
            <ForeName>Benoit</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Celgene Corporation, Summit, New Jersey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brunori</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Celgene Corporation, Summit, New Jersey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teng</LastName>
            <ForeName>Lichen</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Celgene Corporation, Summit, New Jersey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smolen</LastName>
            <ForeName>Josef S</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA>
        <NlmUniqueID>101518086</NlmUniqueID>
        <ISSNLinking>2151-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909868</ArticleId>
        <ArticleId IdType="doi">10.1002/acr.24134</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909869</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3773</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Angewandte Chemie (International ed. in English)</Title>
          <ISOAbbreviation>Angew. Chem. Int. Ed. Engl.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Molecular Design for Non-Doped OLEDs Based on a Twisted Heptagonal Acceptor: Delicate Balance between Rigidity and Rotatability.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201915397</ELocationID>
        <Abstract>
          <AbstractText>The development of efficient non-doped organic light-emitting diodes (OLEDs) is highly desired but very challenging because of severe aggregation-caused quenching (ACQ) effect. Herein, we wish to present a brand-new heptagonal diimide acceptor (BPI), which can restrict excessive intramolecular rotation and inhibit close intermolecular π-π stacking due to well-balanced rigidity and rotatability of heptagonal structure. The BPI-based luminogen (DMAC-BPI) shows significant aggregation-induced delayed florescence (AIDF) with an extremely high photoluminescence quantum yield (PLQY) (95.8 %) of neat film, and the corresponding non-doped OLEDs exhibit outstanding electroluminescence performance with maximum external quantum efficiency (EQEmax) as high as 24.7 % and remarkably low efficiency roll-off as low as 1.0 % at 1000 cd m-2, which represents the state-of-the-art performance for non-doped OLEDs. In addition, the synthetic route to DMAC-BPI is greatly streamlined and simplified through oxidative Ar-H/Ar-H homo-coupling reaction. This work not only opens a new door for designing efficient AIDF materials using the heptagonal acceptor, but also showcases the charm of C-H activation in discovering organic functional materials.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Zhenmei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Sichuan University, College of Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bin</LastName>
            <ForeName>Zhengyang</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Sichuan University, College of Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>Rongchuan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Sichuan University, College of Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Feng</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Sichuan University, College of Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lan</LastName>
            <ForeName>Jingbo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Sichuan University, College of Chemistry, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>You</LastName>
            <ForeName>Jingsong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Sichuan University, College of Chemistry, 29 Wangjiang Road, 610064, Chengdu, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Angew Chem Int Ed Engl</MedlineTA>
        <NlmUniqueID>0370543</NlmUniqueID>
        <ISSNLinking>1433-7851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">C-H activation</Keyword>
        <Keyword MajorTopicYN="N">aggregation-induced delayed fluorescence</Keyword>
        <Keyword MajorTopicYN="N">heptagonal diimide acceptor</Keyword>
        <Keyword MajorTopicYN="N">non-doped organic light-emitting diodes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909869</ArticleId>
        <ArticleId IdType="doi">10.1002/anie.201915397</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909870</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-3773</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Angewandte Chemie (International ed. in English)</Title>
          <ISOAbbreviation>Angew. Chem. Int. Ed. Engl.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Decarboxylative Conjunctive Cross-coupling of Vinyl Boronic Esters using Metallaphotoredox Catalysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201916340</ELocationID>
        <Abstract>
          <AbstractText>The synthesis of complex alkyl boronic esters via a conjunctive cross-coupling of vinyl boronic esters with carboxylic acids and aryl iodides is described. The reaction proceeds under mild metallaphotoredox conditions and involves an unprecedented decarboxylative radical addition/cross-coupling cascade of vinyl boronic esters. Excellent functional group tolerance is displayed, and application of a range of carboxylic acids, namely secondary α-amino acids, and aryl iodides provides efficient access to highly functionalized alkyl boronic esters. The decarboxylative conjunctive cross-coupling was also applied to the synthesis of sedum alkaloids.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mega</LastName>
            <ForeName>Riccardo S</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>University of Bristol, Chemistry, UNITED KINGDOM.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duong</LastName>
            <ForeName>Vincent K</ForeName>
            <Initials>VK</Initials>
            <AffiliationInfo>
              <Affiliation>University of Bristol, Chemistry, UNITED KINGDOM.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Noble</LastName>
            <ForeName>Adam</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University of Bristol, Chemistry, UNITED KINGDOM.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aggarwal</LastName>
            <ForeName>Varinder Kumar</ForeName>
            <Initials>VK</Initials>
            <AffiliationInfo>
              <Affiliation>Bristol University, Department of Chemistry, Cantock's Close, BS8 1TS, Bristol, UNITED KINGDOM.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Angew Chem Int Ed Engl</MedlineTA>
        <NlmUniqueID>0370543</NlmUniqueID>
        <ISSNLinking>1433-7851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">alkyl boronic esters</Keyword>
        <Keyword MajorTopicYN="N">carboxylic acids</Keyword>
        <Keyword MajorTopicYN="N">conjunctive cross-coupling</Keyword>
        <Keyword MajorTopicYN="N">decarboxylative crosscoupling</Keyword>
        <Keyword MajorTopicYN="N">metallaphotoredox catalysis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909870</ArticleId>
        <ArticleId IdType="doi">10.1002/anie.201916340</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909871</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2151-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis care &amp; research</Title>
          <ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.24133</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Southern Norway consists of a homogenous population of nearly 300 000 inhabitants, and is ideal as an epidemiological setting. We aimed to explore for potential changes in incidence of giant cell arteritis (GCA) in Southern Norway from 2000-2013, with comparisons of previous reports from the same population cohort from 1987-1994 and 1992-1996, and to investigate the mortality rates of GCA over a period of 14 years.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">All patients diagnosed with GCA during January 1, 2000 - December 31, 2013 were identified through the electronic and biopsy databases at our clinic. The diagnosis and information about death was confirmed by reviewing the patients' hospital records. Inclusion criteria were: i) Fulfillment of the American College of Rheumatology 1990 criteria for GCA, or, ii) histologically proven GCA, or, iii) confirmed arteritis of the large or medium sized vessels by imaging.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">206 patients were included, 147 (72%) were females. The annual incidence rate of GCA per 100 000 inhabitants ≥ 50 years was 16.8 (95% CI 14.6, 19.2), 24.5 for females (19.2, 26.5), 10.2 for males (7.9, 13.2). 46 patients (22%) died (24 women, 22 men). The overall standardized mortality ratio was 1.05 (0.77, 1.38), 0.92 for females (CI 0.61, 1.35), 1.38 for males (0.88, 2.05). Overall survival was significantly higher in females compared to males (p &lt; 0.001).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">GCA incidence is not increasing. We did not find excess mortality, however, males seem to have poorer survival compared to females.</AbstractText>
          <CopyrightInformation>© 2020, American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Andersen</LastName>
            <ForeName>Jintana B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Clinical Medicine, Sorlandet Hospital, Sorlandet sykehus HF, Postboks 416 Lundsiden, 4604, Kristiansand, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Myklebust</LastName>
            <ForeName>Geirmund</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Clinical Medicine, Sorlandet Hospital, Sorlandet sykehus HF, Postboks 416 Lundsiden, 4604, Kristiansand, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haugeberg</LastName>
            <ForeName>Glenn</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9279-5191</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Clinical Medicine, Sorlandet Hospital, Sorlandet sykehus HF, Postboks 416 Lundsiden, 4604, Kristiansand, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pripp</LastName>
            <ForeName>Are H</ForeName>
            <Initials>AH</Initials>
            <AffiliationInfo>
              <Affiliation>Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Diamantopoulos</LastName>
            <ForeName>Andreas P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Martina Hansens Hospital, Baerum, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA>
        <NlmUniqueID>101518086</NlmUniqueID>
        <ISSNLinking>2151-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909871</ArticleId>
        <ArticleId IdType="doi">10.1002/acr.24133</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909872</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1601-183X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Genes, brain, and behavior</Title>
          <ISOAbbreviation>Genes Brain Behav.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Investigating cortical features of Sotos syndrome using mice heterozygous for Nsd1.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e12637</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/gbb.12637</ELocationID>
        <Abstract>
          <AbstractText>Sotos syndrome is a developmental disorder characterized by a suite of clinical features. In children, the three cardinal features of Sotos syndrome are a characteristic facial appearance, learning disability, and overgrowth (height and/or head circumference &gt; 2 standard deviations above average). These features are also evident in adults with this syndrome. Over 90% of Sotos syndrome patients are haploinsufficient for the gene encoding nuclear receptor-binding SET domain-containing protein 1 (NSD1). NSD1 is a histone methyltransferase that catalyzes the methylation of lysine residue 36 on histone H3. However, although the symptomology of Sotos syndrome is well established, many aspects of NSD1 biology remain unknown. Here, we assessed the expression of Nsd1 within the mouse brain, and revealed a predominantly neuronal pattern of expression for this histone-modifying factor. We also generated a mouse strain lacking one allele of Nsd1 and analyzed morphological and behavioral characteristics in these mice, revealing behavioral characteristics reminiscent of some of the deficits seen in Sotos syndrome patients.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Oishi</LastName>
            <ForeName>Sabrina</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zalucki</LastName>
            <ForeName>Oressia</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sanchez Vega</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harkins</LastName>
            <ForeName>Danyon</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harvey</LastName>
            <ForeName>Tracey J</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kasherman</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Davila</LastName>
            <ForeName>Raul Ayala</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hale</LastName>
            <ForeName>Lauren</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>White</LastName>
            <ForeName>Melissa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences and South Australia Genome Editing Facility, University of Adelaide, Adelaide, SA, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Piltz</LastName>
            <ForeName>Sandra</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences and South Australia Genome Editing Facility, University of Adelaide, Adelaide, SA, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences and South Australia Genome Editing Facility, University of Adelaide, Adelaide, SA, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burne</LastName>
            <ForeName>Thomas H J</ForeName>
            <Initials>THJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3502-9789</Identifier>
            <AffiliationInfo>
              <Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harris</LastName>
            <ForeName>Lachlan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Piper</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6759-2560</Identifier>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Genes Brain Behav</MedlineTA>
        <NlmUniqueID>101129617</NlmUniqueID>
        <ISSNLinking>1601-183X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Date of resubmission: 26th November 2019</Keyword>
        <Keyword MajorTopicYN="N">Nsd1</Keyword>
        <Keyword MajorTopicYN="N">Sotos syndrome</Keyword>
        <Keyword MajorTopicYN="N">behaviour</Keyword>
        <Keyword MajorTopicYN="N">cerebral cortex</Keyword>
        <Keyword MajorTopicYN="N">intellectual disability</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909872</ArticleId>
        <ArticleId IdType="doi">10.1111/gbb.12637</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909873</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-3927</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Macromolecular rapid communications</Title>
          <ISOAbbreviation>Macromol Rapid Commun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Year of Polymers - 100 Years of Macromolecular Chemistry.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1900620</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/marc.201900620</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Schubert</LastName>
            <ForeName>Ulrich S</ForeName>
            <Initials>US</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstr. 10, 07743, Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Philosophenweg 7, 07743, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zechel</LastName>
            <ForeName>Stefan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstr. 10, 07743, Jena, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Philosophenweg 7, 07743, Jena, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Macromol Rapid Commun</MedlineTA>
        <NlmUniqueID>9888239</NlmUniqueID>
        <ISSNLinking>1022-1336</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909873</ArticleId>
        <ArticleId IdType="doi">10.1002/marc.201900620</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>H. Staudinger, Berichte der deutschen chemischen Gesellschaft (A and B Series) 1920, 53, 1073.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Frisch, D. Kodura, F. R. Bloesser, L. Michalek, C. Barner-Kowollik, Macromol. Rapid Commun. 2020, 1900414.</Citation>
        </Reference>
        <Reference>
          <Citation>N. Lüdecke, S. M. Weidner, H. Schlaad, Macromol. Rapid Commun. 2020, 1900404.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Probst, I. Elser, R. Schowner, M. J. Benedikter, M. R. Buchmeiser, Macromol. Rapid Commun. 2020, 1900398.</Citation>
        </Reference>
        <Reference>
          <Citation>E. Esen, M. A. R. Meier, Macromol. Rapid Commun. 2020, 1900375.</Citation>
        </Reference>
        <Reference>
          <Citation>B. V. K. J. Schmidt, Macromol. Rapid Commun. 2020, 1900333.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909874</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-3806</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Autism research : official journal of the International Society for Autism Research</Title>
          <ISOAbbreviation>Autism Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Relationship Between Sensory Reactivity Differences and Anxiety Subtypes in Autistic Children.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/aur.2259</ELocationID>
        <Abstract>
          <AbstractText>Autistic children are at greater risk of developing anxiety than their nonautistic peers. Sensory reactivity differences have been implicated as one of the risk factors. Specifically, sensory hyperreactivity has previously been linked to anxiety, including separation anxiety and specific phobia; however, minimal research has explored the influence of sensory hyporeactivity and seeking. Therefore, the present study examined the correlational relationship between sensory reactivity differences and anxiety subtypes in 41 autistic children aged between 3 and 14 years, using parent- and self-reported measures. We found positive correlations between sensory hyperreactivity and total anxiety, separation anxiety and physical injury fears. However, when controlling for autism traits, we found sensory hyperreactivity to be related to physical injury fears and specific phobia, and sensory hyporeactivity to be related to lower total and social anxiety. We found no significant relationships between sensory seeking and anxiety. These results indicate that sensory hyperreactivity and hyporeactivity might be implicated in specific anxiety symptomology. Our results also indicate minimal agreement between parent- and self-reported anxieties, which highlights the limitations of informant reports for anxiety and the pressing need for objective anxiety assessments for autistic children to be developed. Our findings have important implications for limiting the development of anxiety in autistic children and suggest that sensory reactivity differences should be considered when developing targeted interventions for certain anxiety disorders. Autism Res 2019, 00: 1-11. © 2019 The Authors. Autism Research published by International Society for Autism Research published by Wiley Periodicals, Inc. LAY SUMMARY: The present study found that when considering autism traits, greater sensory hyperreactivity, such as being oversensitive to sounds, was related to elevated phobia-related symptoms and sensory hyporeactivity, such as being under-responsive to touch, was related to lower total and social anxieties. Sensory seeking, such as a fascination with lights, was not related to anxiety. Our results have important implications for targeted anxiety interventions for autistic children. However, due to minimal agreement between the parent- and child-reported scores, developing more objective measures of anxiety would be beneficial.</AbstractText>
          <CopyrightInformation>© 2019 The Authors. Autism Research published by International Society for Autism Research published by Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>MacLennan</LastName>
            <ForeName>Keren</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-3148-3450</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Reading, Reading, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roach</LastName>
            <ForeName>Lauren</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>University of Reading, Reading, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tavassoli</LastName>
            <ForeName>Teresa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>University of Reading, Reading, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>MQ and Autistica</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Autism Res</MedlineTA>
        <NlmUniqueID>101461858</NlmUniqueID>
        <ISSNLinking>1939-3806</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anxiety</Keyword>
        <Keyword MajorTopicYN="N">anxiety disorders</Keyword>
        <Keyword MajorTopicYN="N">autism</Keyword>
        <Keyword MajorTopicYN="N">child</Keyword>
        <Keyword MajorTopicYN="N">risk factors</Keyword>
        <Keyword MajorTopicYN="N">sensory reactivity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909874</ArticleId>
        <ArticleId IdType="doi">10.1002/aur.2259</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Auyeung, B., Baron-Cohen, S., Wheelwright, S., &amp; Allison, C. (2008). The Autism Spectrum Quotient: Children's version (AQ-child). Journal of Autism and Developmental Disorders, 38(7), 1230-1240. https://doi.org/10.1007/s10803-007-0504-z</Citation>
        </Reference>
        <Reference>
          <Citation>Baranek, G. T., David, F. J., Poe, M. D., Stone, W. L., &amp; Watson, L. R. (2006). Sensory Experiences Questionnaire: Discriminating sensory features in young children with autism, developmental delays, and typical development: SEQ. Journal of Child Psychology and Psychiatry, 47(6), 591-601. https://doi.org/10.1111/j.1469-7610.2005.01546.x</Citation>
        </Reference>
        <Reference>
          <Citation>Bellini, S. (2006). The development of social anxiety in adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities, 21(3), 138-145. https://doi.org/10.1177/10883576060210030201</Citation>
        </Reference>
        <Reference>
          <Citation>Ben-Sasson, A., Cermak, S. A., Orsmond, G. I., Tager-Flusberg, H., Kadlec, M. B., &amp; Carter, A. S. (2008). Sensory clusters of toddlers with autism spectrum disorders: Differences in affective symptoms. Journal of Child Psychology and Psychiatry, 49(8), 817-825. https://doi.org/10.1111/j.1469-7610.2008.01899.x</Citation>
        </Reference>
        <Reference>
          <Citation>Black, K. R., Stevenson, R. A., Segers, M., Ncube, B. L., Sun, S. Z., Philipp-Muller, A., … Ferber, S. (2017). Linking anxiety and insistence on sameness in autistic children: The role of sensory hypersensitivity. Journal of Autism and Developmental Disorders, 47(8), 2459-2470. https://doi.org/10.1007/s10803-017-3161-x</Citation>
        </Reference>
        <Reference>
          <Citation>Boyd, B. A., Baranek, G. T., Sideris, J., Poe, M. D., Watson, L. R., Patten, E., &amp; Miller, H. (2010). Sensory features and repetitive behaviors in children with autism and developmental delays. Autism Research, 3(2). https://doi.org/10.1002/aur.124</Citation>
        </Reference>
        <Reference>
          <Citation>Carpenter, K. L. H., Baranek, G. T., Copeland, W. E., Compton, S., Zucker, N., Dawson, G., &amp; Egger, H. L. (2018). Sensory over-responsivity: An early risk factor for anxiety and behavioral challenges in young children. Journal of Abnormal Child Psychology, 47, 1075-1088. https://doi.org/10.1007/s10802-018-0502-y</Citation>
        </Reference>
        <Reference>
          <Citation>Dar, R., Kahn, D. T., &amp; Carmeli, R. (2012). The relationship between sensory processing, childhood rituals and obsessive-compulsive symptoms. Journal of Behavior Therapy and Experimental Psychiatry, 43(1), 679-684. https://doi.org/10.1016/j.jbtep.2011.09.008</Citation>
        </Reference>
        <Reference>
          <Citation>de Bruin, E. I., Ferdinand, R. F., Meester, S., de Nijs, P. F. A., &amp; Verheij, F. (2007). High rates of psychiatric co-morbidity in PDD-NOS. Journal of Autism and Developmental Disorders, 37(5), 877-886. https://doi.org/10.1007/s10803-006-0215-x</Citation>
        </Reference>
        <Reference>
          <Citation>DSM-5 American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. Arlington, TX: American Psychiatric Publishing.</Citation>
        </Reference>
        <Reference>
          <Citation>Dunn, W. (1999). Sensory profile (Vol. 555). San Antonio, TX: Psychological Corporation.</Citation>
        </Reference>
        <Reference>
          <Citation>Edwards, S. L., Rapee, R. M., Kennedy, S. J., &amp; Spence, S. H. (2010). The assessment of anxiety symptoms in preschool-aged children: The Revised Preschool Anxiety Scale. Journal of Clinical Child &amp; Adolescent Psychology, 39(3), 400-409. https://doi.org/10.1080/15374411003691701</Citation>
        </Reference>
        <Reference>
          <Citation>Factor, R. S., Ryan, S. M., Farley, J. P., Ollendick, T. H., &amp; Scarpa, A. (2017). Does the presence of anxiety and ADHD symptoms add to social impairment in children with autism spectrum disorder? Journal of Autism and Developmental Disorders, 47(4), 1122-1134. https://doi.org/10.1007/s10803-016-3025-9</Citation>
        </Reference>
        <Reference>
          <Citation>Ferrão, Y. A., Shavitt, R. G., Prado, H., Fontenelle, L. F., Malavazzi, D. M., de Mathis, M. A., … do Rosário, M. C. (2012). Sensory phenomena associated with repetitive behaviors in obsessive-compulsive disorder: An exploratory study of 1001 patients. Psychiatry Research, 197(3), 253-258. https://doi.org/10.1016/j.psychres.2011.09.017</Citation>
        </Reference>
        <Reference>
          <Citation>Gjevik, E., Eldevik, S., Fjaeran-Granum, T., &amp; Sponheim, E. (2011). Kiddie-SADS reveals high rates of DSM-IV disorders in children and adolescents with autism spectrum disorders. Journal of Autism and Developmental Disorders, 41(6), 761-769. https://doi.org/10.1007/s10803-010-1095-7</Citation>
        </Reference>
        <Reference>
          <Citation>Glod, M., Creswell, C., Waite, P., Jamieson, R., McConachie, H., Don South, M., &amp; Rodgers, J. (2017). Comparisons of the factor structure and measurement invariance of the Spence Children's Anxiety Scale-Parent version in children with autism spectrum disorder and typically developing anxious children. Journal of Autism and Developmental Disorders, 47(12), 3834-3846. https://doi.org/10.1007/s10803-017-3118-0</Citation>
        </Reference>
        <Reference>
          <Citation>Green, S. A., &amp; Ben-Sasson, A. (2010). Anxiety disorders and sensory over-responsivity in children with autism spectrum disorders: Is there a causal relationship? Journal of Autism and Developmental Disorders, 40(12), 1495-1504. https://doi.org/10.1007/s10803-010-1007-x</Citation>
        </Reference>
        <Reference>
          <Citation>Green, S. A., Ben-Sasson, A., Soto, T. W., &amp; Carter, A. S. (2012). Anxiety and sensory over-responsivity in toddlers with autism spectrum disorders: bidirectional effects across time. Journal of Autism and Developmental Disorders, 42(6), 1112-1119. https://doi.org/10.1007/s10803-011-1361-3</Citation>
        </Reference>
        <Reference>
          <Citation>Hallett, V., Ronald, A., Colvert, E., Ames, C., Woodhouse, E., Lietz, S., … Happé, F. (2013). Exploring anxiety symptoms in a large-scale twin study of children with autism spectrum disorders, their co-twins and controls. Journal of Child Psychology and Psychiatry, 54(11), 1176-1185. https://doi.org/10.1111/jcpp.12068</Citation>
        </Reference>
        <Reference>
          <Citation>Hilton, C. L., Harper, J. D., Kueker, R. H., Lang, A. R., Abbacchi, A. M., Todorov, A., &amp; LaVesser, P. D. (2010). Sensory responsiveness as a predictor of social severity in children with high functioning autism spectrum disorders. Journal of Autism and Developmental Disorders, 40(8), 937-945. https://doi.org/10.1007/s10803-010-0944-8</Citation>
        </Reference>
        <Reference>
          <Citation>Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65-70.</Citation>
        </Reference>
        <Reference>
          <Citation>Joosten, A. V., &amp; Bundy, A. C. (2010). Sensory processing and stereotypical and repetitive behaviour in children with autism and intellectual disability: Sensory processing in autism. Australian Occupational Therapy Journal, 57(6), 366-372. https://doi.org/10.1111/j.1440-1630.2009.00835.x</Citation>
        </Reference>
        <Reference>
          <Citation>Kenny, L., Hattersley, C., Molins, B., Buckley, C., Povey, C., &amp; Pellicano, E. (2016). Which terms should be used to describe autism? Perspectives from the UK Autism Community. Autism, 20(4), 442-462. https://doi.org/10.1177/1362361315588200</Citation>
        </Reference>
        <Reference>
          <Citation>Kerns, C. M., &amp; Kendall, P. C. (2012). The presentation and classification of anxiety in autism spectrum disorder. Clinical Psychology: Science and Practice, 19(4), 323-347. https://doi.org/10.1111/cpsp.12009</Citation>
        </Reference>
        <Reference>
          <Citation>Kerns, C. M., Renno, P., Kendall, P. C., Wood, J. J., &amp; Storch, E. A. (2017). Anxiety disorders interview schedule-autism addendum: Reliability and validity in children with autism spectrum disorder. Journal of Clinical Child &amp; Adolescent Psychology, 46(1), 88-100. https://doi.org/10.1080/15374416.2016.1233501</Citation>
        </Reference>
        <Reference>
          <Citation>Kerns, C. M., Kendall, P. C., Berry, L., Souders, M. C., Franklin, M. E., Schultz, R. T., … Herrington, J. (2014). Traditional and atypical presentations of anxiety in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(11), 2851-2861. https://doi.org/10.1007/s10803-014-2141-7</Citation>
        </Reference>
        <Reference>
          <Citation>Lai, J., Parham, D., &amp; Johnson-Ecker, C. (1999). Sensory dormancy and sensory defensiveness: Two sides of the same coin. Sensory Integration Special Interest Section Quarterly, 22(4), 1-4.</Citation>
        </Reference>
        <Reference>
          <Citation>Lane, A. E., Dennis, S. J., &amp; Geraghty, M. E. (2011). Brief report: Further evidence of sensory subtypes in autism. Journal of Autism and Developmental Disorders, 41(6), 826-831. https://doi.org/10.1007/s10803-010-1103-y</Citation>
        </Reference>
        <Reference>
          <Citation>Lane, A. E., Molloy, C. A., &amp; Bishop, S. L. (2014). Classification of children with autism spectrum disorder by sensory subtype: A case for sensory-based phenotypes: sensory phenotypes in autism. Autism Research, 7(3), 322-333. https://doi.org/10.1002/aur.1368</Citation>
        </Reference>
        <Reference>
          <Citation>Lane, S. J. (2002). Sensory modulation. In A. C. Bundy, S. J. Lane, &amp; E. A. Murray (Eds.), Sensory integration: Theory and practice (2nd ed., pp. 101-122). Philadelphia, PA: F. A. Davis.</Citation>
        </Reference>
        <Reference>
          <Citation>Leekam, S. R., Nieto, C., Libby, S. J., Wing, L., &amp; Gould, J. (2007). Describing the sensory abnormalities of children and adults with autism. Journal of Autism and Developmental Disorders, 37(5), 894-910. https://doi.org/10.1007/s10803-006-0218-7</Citation>
        </Reference>
        <Reference>
          <Citation>Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., … Lainhart, J. E. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36(7), 849-861. https://doi.org/10.1007/s10803-006-0123-0</Citation>
        </Reference>
        <Reference>
          <Citation>Lidstone, J., Uljarević, M., Sullivan, J., Rodgers, J., McConachie, H., Freeston, M., … Leekam, S. (2014). Relations among restricted and repetitive behaviors, anxiety and sensory features in children with autism spectrum disorders. Research in Autism Spectrum Disorders, 8(2), 82-92. https://doi.org/10.1016/j.rasd.2013.10.001</Citation>
        </Reference>
        <Reference>
          <Citation>Liss, M., Mailloux, J., &amp; Erchull, M. J. (2008). The relationships between sensory processing sensitivity, alexithymia, autism, depression, and anxiety. Personality and Individual Differences, 45(3), 255-259. https://doi.org/10.1016/j.paid.2008.04.009</Citation>
        </Reference>
        <Reference>
          <Citation>Liss, M., Timmel, L., Baxley, K., &amp; Killingsworth, P. (2005). Sensory processing sensitivity and its relation to parental bonding, anxiety, and depression. Personality and Individual Differences, 39(8), 1429-1439. https://doi.org/10.1016/j.paid.2005.05.007</Citation>
        </Reference>
        <Reference>
          <Citation>Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., Bishop, S. L., (2015). Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Manual (Part I): Modules 1-4. Los Angeles, CA: Western Psychological Corporation.</Citation>
        </Reference>
        <Reference>
          <Citation>Mayes, S. D., Calhoun, S. L., Aggarwal, R., Baker, C., Mathapati, S., Molitoris, S., &amp; Mayes, R. D. (2013). Unusual fears in children with autism. Research in Autism Spectrum Disorders, 7(1), 151-158. https://doi.org/10.1016/j.rasd.2012.08.002</Citation>
        </Reference>
        <Reference>
          <Citation>Mazurek, M. O., Vasa, R. A., Kalb, L. G., Kanne, S. M., Rosenberg, D., Keefer, A., … Lowery, L. A. (2013). Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders. Journal of Abnormal Child Psychology, 41(1), 165-176. https://doi.org/10.1007/s10802-012-9668-x</Citation>
        </Reference>
        <Reference>
          <Citation>Miller, L. J., Anzalone, M. E., Lane, S. J., Cermak, S. A., &amp; Osten, E. T. (2007). Concept evolution in sensory integration: A proposed nosology for diagnosis. The American Journal of Occupational Therapy, 61(2), 135-140. https://doi.org/10.5014/ajot.61.2.135</Citation>
        </Reference>
        <Reference>
          <Citation>Mukaddes, N. M., &amp; Fateh, R. (2010). High rates of psychiatric co-morbidity in individuals with Asperger's disorder. The World Journal of Biological Psychiatry, 11(2-2), 486-492. https://doi.org/10.3109/15622970902789130</Citation>
        </Reference>
        <Reference>
          <Citation>Muskett, A., Radtke, S., White, S., &amp; Ollendick, T. (2019). Autism spectrum disorder and specific phobia: The role of sensory sensitivity: brief review. Review Journal of Autism and Developmental Disorders, 6, 289-293. https://doi.org/10.1007/s40489-019-00159-w</Citation>
        </Reference>
        <Reference>
          <Citation>Naglieri, J. A., &amp; Brunnert, K. (2009). Wechsler nonverbal scale of ability (WNV). In J. A. Naglieri &amp; S. Goldstein (Eds.), Practitioner's guide to assessing intelligence and achievement (pp. 315-338). Hoboken, NJ: John Wiley &amp; Sons, Inc.</Citation>
        </Reference>
        <Reference>
          <Citation>Nauta, M. H., Scholing, A., Rapee, R. M., Abbott, M., Spence, S. H., &amp; Waters, A. (2004). A parent-report measure of children's anxiety: Psychometric properties and comparison with child-report in a clinic and normal sample. Behaviour Research and Therapy, 42(7), 813-839. https://doi.org/10.1016/S0005-7967(03)00200-6</Citation>
        </Reference>
        <Reference>
          <Citation>Neal, J. A., Edelmann, R. J., &amp; Glachan, M. (2002). Behavioural inhibition and symptoms of anxiety and depression: Is there a specific relationship with social phobia? British Journal of Clinical Psychology, 41(4), 361-374. https://doi.org/10.1348/014466502760387489</Citation>
        </Reference>
        <Reference>
          <Citation>Neil, L., Green, D., &amp; Pellicano, E. (2017). The psychometric properties of a new measure of sensory behaviors in autistic children. Journal of Autism and Developmental Disorders, 47(4), 1261-1268. https://doi.org/10.1007/s10803-016-3018-8</Citation>
        </Reference>
        <Reference>
          <Citation>Pfeiffer, B., Kinnealey, M., Reed, C., &amp; Herzberg, G. (2005). Sensory modulation and affective disorders in children and adolescents with Asperger's disorder. The American Journal of Occupational Therapy, 59(3), 335-345.</Citation>
        </Reference>
        <Reference>
          <Citation>Postorino, V., Kerns, C. M., Vivanti, G., Bradshaw, J., Siracusano, M., &amp; Mazzone, L. (2017). Anxiety disorders and obsessive-compulsive disorder in individuals with autism spectrum disorder. Current Psychiatry Reports, 19(12), 92. https://doi.org/10.1007/s11920-017-0846-y</Citation>
        </Reference>
        <Reference>
          <Citation>Rodgers, J., Glod, M., Connolly, B., &amp; McConachie, H. (2012). The relationship between anxiety and repetitive behaviours in autism spectrum disorder. Journal of Autism and Developmental Disorders, 42(11), 2404-2409. https://doi.org/10.1007/s10803-012-1531-y</Citation>
        </Reference>
        <Reference>
          <Citation>Rodgers, J., Wigham, S., McConachie, H., Freeston, M., Honey, E., &amp; Parr, J. R. (2016). Development of the anxiety scale for children with autism spectrum disorder (ASC-ASD): Measuring anxiety in ASD. Autism Research, 9(11), 1205-1215. https://doi.org/10.1002/aur.1603</Citation>
        </Reference>
        <Reference>
          <Citation>Russell, E., &amp; Sofronoff, K. (2005). Anxiety and social worries in children with Asperger syndrome. Australian and New Zealand Journal of Psychiatry, 39(7), 633-638. https://doi.org/10.1111/j.1440-1614.2005.01637.x</Citation>
        </Reference>
        <Reference>
          <Citation>Schoen, S. A., Miller, L. J., &amp; Green, K. E. (2008). Pilot study of the sensory over-responsivity scales: Assessment and inventory. American Journal of Occupational Therapy, 62(4), 393-406. https://doi.org/10.5014/ajot.62.4.393</Citation>
        </Reference>
        <Reference>
          <Citation>Schoen, S. A., Miller, L. J., &amp; Sullivan, J. (2017). The development and psychometric properties of the Sensory Processing Scale Inventory: A report measure of sensory modulation. Journal of Intellectual &amp; Developmental Disability, 42(1), 12-21. https://doi.org/10.3109/13668250.2016.1195490</Citation>
        </Reference>
        <Reference>
          <Citation>Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., &amp; Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child &amp; Adolescent Psychiatry, 47(8), 921-929. https://doi.org/10.1097/CHI.0b013e318179964f</Citation>
        </Reference>
        <Reference>
          <Citation>Siper, P. M., Kolevzon, A., Wang, A. T., Buxbaum, J. D., &amp; Tavassoli, T. (2017). A clinician-administered observation and corresponding caregiver interview capturing DSM-5 sensory reactivity symptoms in children with ASD: Sensory assessment for neurodevelopmental disorders. Autism Research, 10(6), 1133-1140. https://doi.org/10.1002/aur.1750</Citation>
        </Reference>
        <Reference>
          <Citation>Sivik, T. (1993). Alexithymia and hypersensitivity to touch and palpation. Integrative Physiological and Behavioral Science, 28(2), 130-136. https://doi.org/10.1007/BF02691215</Citation>
        </Reference>
        <Reference>
          <Citation>South, M., &amp; Rodgers, J. (2017). Sensory, emotional and cognitive contributions to anxiety in autism spectrum disorders. Frontiers in Human Neuroscience, 11, 20. https://doi.org/10.3389/fnhum.2017.00020</Citation>
        </Reference>
        <Reference>
          <Citation>Spain, D., Sin, J., Linder, K. B., McMahon, J., &amp; Happé, F. (2018). Social anxiety in autism spectrum disorder: A systematic review. Research in Autism Spectrum Disorders, 52, 51-68. https://doi.org/10.1016/j.rasd.2018.04.007</Citation>
        </Reference>
        <Reference>
          <Citation>Spence, S. H. (1998). A measure of anxiety symptoms among children. Behaviour Research and Therapy, 36(5), 545-566. https://doi.org/10.1016/S0005-7967(98)00034-5</Citation>
        </Reference>
        <Reference>
          <Citation>Steiger, J. H. (1980). Tests for comparing elements of a correlation matrix. Psychological Bulletin, 87(2), 245.</Citation>
        </Reference>
        <Reference>
          <Citation>Tavassoli, T., Bellesheim, K., Siper, P. M., Wang, A. T., Halpern, D., Gorenstein, M., … Buxbaum, J. D. (2016). Measuring sensory reactivity in autism spectrum disorder: Application and simplification of a clinician-administered Sensory Observation Scale. Journal of Autism and Developmental Disorders, 46(1), 287-293. https://doi.org/10.1007/s10803-015-2578-3</Citation>
        </Reference>
        <Reference>
          <Citation>Uljarević, M., Lane, A., Kelly, A., &amp; Leekam, S. (2016). Sensory subtypes and anxiety in older children and adolescents with autism spectrum disorder: Sensory subtypes and anxiety in autism. Autism Research, 9(10), 1073-1078. https://doi.org/10.1002/aur.1602</Citation>
        </Reference>
        <Reference>
          <Citation>Valla, J. P., Kovess, V., Chan Chee, C., Berthiaume, C., Vantalon, V., Piquet, C., … Alles-Jardel, M. (2002). A French study of the Dominic Interactive. Social Psychiatry and Psychiatric Epidemiology, 37(9), 441-448. https://doi.org/10.1007/s00127-002-0575-2</Citation>
        </Reference>
        <Reference>
          <Citation>van Steensel, F. J. A., Bögels, S. M., &amp; Dirksen, C. D. (2012). Anxiety and quality of life: Clinically anxious children with and without autism spectrum disorders compared. Journal of Clinical Child &amp; Adolescent Psychology, 41(6), 731-738. https://doi.org/10.1080/15374416.2012.698725</Citation>
        </Reference>
        <Reference>
          <Citation>van Steensel, F. J. A., Bögels, S. M., &amp; Perrin, S. (2011). Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clinical Child and Family Psychology Review, 14(3), 302-317. https://doi.org/10.1007/s10567-011-0097-0</Citation>
        </Reference>
        <Reference>
          <Citation>Wechsler, D. (1999). Wechsler abbreviated scale of intelligence. San Antonio, TX: The Psychological Corporation.</Citation>
        </Reference>
        <Reference>
          <Citation>White, S. W., Oswald, D., Ollendick, T., &amp; Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review, 29(3), 216-229. https://doi.org/10.1016/j.cpr.2009.01.003</Citation>
        </Reference>
        <Reference>
          <Citation>Wigham, S., Rodgers, J., South, M., McConachie, H., &amp; Freeston, M. (2015). The interplay between sensory processing abnormalities, intolerance of uncertainty, anxiety and restricted and repetative behaviours in autism spectrum disorder. Journal or Autism and Developmental Disorders, 45(4), 943-952. https://doi.org/10.1007/s10803-014-2248-x</Citation>
        </Reference>
        <Reference>
          <Citation>Wood, J. J., &amp; Gadow, K. D. (2010). Exploring the nature and function of anxiety in youth with autism spectrum disorders. Clinical Psychology: Science and Practice, 17, 281-292. https://doi.org/10.1111/j.1468-2850.2010.01220.x</Citation>
        </Reference>
        <Reference>
          <Citation>Woodbury-Smith, M. R., Robinson, J., Wheelwright, S., &amp; Baron-Cohen, S. (2005). Screening adults for Asperger syndrome using the AQ: A preliminary study of its diagnostic validity in clinical practice. Journal of Autism and Developmental Disorders, 35(3), 331-335. https://doi.org/10.1007/s10803-005-3300-7</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909876</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1752-8062</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and translational science</Title>
          <ISOAbbreviation>Clin Transl Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Regulatory Affairs 101: Introduction to Expedited Regulatory Pathways.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cts.12745</ELocationID>
        <Abstract>
          <AbstractText>Developing a novel drug, including discovery, nonclinical toxicology studies, initial clinical trials, and thorough pivotal studies, may take many years. Once an applicant has generated this comprehensive body of data, the final step prior to regulatory approval is Health Authority review of the marketing authorization application. Review by regulatory authorities to evaluate whether the data support a positive benefit/risk profile takes many months, adding additional time before patients may access therapy. In this article, we discuss the various opportunities the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) offer to expedite the drug development and regulatory approval timelines for drugs intended to treat serious diseases and unmet medical needs.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cox</LastName>
            <ForeName>Erica M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Denali Therapeutics Inc.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edmund</LastName>
            <ForeName>Anita V</ForeName>
            <Initials>AV</Initials>
            <AffiliationInfo>
              <Affiliation>Impact Clinical, LLC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kratz</LastName>
            <ForeName>Erica</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Denali Therapeutics Inc.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lockwood</LastName>
            <ForeName>Sarah H</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Denali Therapeutics Inc.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shankar</LastName>
            <ForeName>Aishwarya</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Denali Therapeutics Inc.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Transl Sci</MedlineTA>
        <NlmUniqueID>101474067</NlmUniqueID>
        <ISSNLinking>1752-8054</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Drug Development</Keyword>
        <Keyword MajorTopicYN="N">FDA</Keyword>
        <Keyword MajorTopicYN="N">Regulatory Affairs</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909876</ArticleId>
        <ArticleId IdType="doi">10.1111/cts.12745</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909875</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0461</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biochemical and molecular toxicology</Title>
          <ISOAbbreviation>J. Biochem. Mol. Toxicol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nicotinamide N-methyltransferase expression in SH-SY5Y human neuroblastoma cells decreases oxidative stress.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e22439</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jbt.22439</ELocationID>
        <Abstract>
          <AbstractText>Nicotinamide N-methyltransferase (NNMT) plays a central role in cellular metabolism, regulating pathways including epigenetic regulation, cell signalling, and energy production. Our previous studies have shown that the expression of NNMT in the human neuroblastoma cell line SH-SY5Y increased complex I activity and subsequent ATP synthesis. This increase in ATP synthesis was lower than the increase in complex I activity, suggesting uncoupling of the mitochondrial respiratory chain. We, therefore, hypothesised that pathways that reduce oxidative stress are also increased in NNMT-expressing SH-Y5Y cells. The expression of uncoupling protein-2 messenger RNA and protein were significantly increased in NNMT-expressing cells (57% ± 5.2% and 20.1% ± 1.5%, respectively; P = .001 for both). Total GSH (22 ± 0.3 vs 35.6 ± 1.1 nmol/mg protein), free GSH (21.9 ± 0.2 vs 33.5 ± 1 nmol/mg protein), and GSSG (0.6 ± 0.02 vs 1 ± 0.05 nmol/mg protein; P = .001 for all) concentrations were significantly increased in NNMT-expressing cells, whereas the GSH:GSSG ratio was decreased (39.4 ± 1.8 vs 32.3 ± 2.5; P = .02). Finally, reactive oxygen species (ROS) content was decreased in NNMT-expressing cells (0.3 ± 0.08 vs 0.12 ± 0.03; P = .039), as was the concentration of 8-isoprostane F2α (200 ± 11.5 vs 45 ± 2.6 pg/mg protein; P = .0012). Taken together, these results suggest that NNMT expression reduced ROS generation and subsequent lipid peroxidation by uncoupling the mitochondrial membrane potential and increasing GSH buffering capacity, most likely to compensate for increased complex I activity and ATP production.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mistry</LastName>
            <ForeName>Rakhee J</ForeName>
            <Initials>RJ</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Pharmaceutical Science, King's College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klamt</LastName>
            <ForeName>Fábio</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-9152-4229</Identifier>
            <AffiliationInfo>
              <Affiliation>Departmento de Bioqúimica, Instituto de Ciêcas Básicas de Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramsden</LastName>
            <ForeName>David B</ForeName>
            <Initials>DB</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parsons</LastName>
            <ForeName>Richard B</ForeName>
            <Initials>RB</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-5618-3780</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Pharmaceutical Science, King's College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Biochem Mol Toxicol</MedlineTA>
        <NlmUniqueID>9717231</NlmUniqueID>
        <ISSNLinking>1095-6670</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cancer</Keyword>
        <Keyword MajorTopicYN="N">mitochondria</Keyword>
        <Keyword MajorTopicYN="N">neurodegenerative disease</Keyword>
        <Keyword MajorTopicYN="N">oxidative stress</Keyword>
        <Keyword MajorTopicYN="N">redox balance</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909875</ArticleId>
        <ArticleId IdType="doi">10.1002/jbt.22439</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>S. Aksoy, C. L. Szumlanski, R. M. Weinshilboum, J. Biol. Chem. 1994, 269, 14835.</Citation>
        </Reference>
        <Reference>
          <Citation>R. B. Parsons, M. L. Smith, A. C. Williams, R. H. Waring, D. B. Ramsden, J. Neuropathol. Exp. Neurol. 2002, 61, 111.</Citation>
        </Reference>
        <Reference>
          <Citation>M. L. Smith, D. Burnett, P. Bennett, R. H. Waring, H. M. Brown, A. C. Williams, D. B. Ramsden, Biochim. Biophys. Acta 1998, 1442, 238.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Bockwoldt, D. Houry, M. Niere, T. I. Gossmann, I. Reinartz, A. Schug, M. Ziegler, I. Heiland, Proc. Natl. Acad. Sci. U. S. A 2019, 116, 15957.</Citation>
        </Reference>
        <Reference>
          <Citation>R. B. Parsons, S. Aravindan, A. Kadampeswaran, E. A. Evans, K. K. Sandhu, E. R. Levy, M. G. Thomas, B. M. Austen, D. B. Ramsden, Biochem. J. 2011, 436, 145.</Citation>
        </Reference>
        <Reference>
          <Citation>M. C. Haigis, L. P. Guarente, Genes Dev. 2006, 20, 2913.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Y. Liu, R. J. Mistry, C. A. Aguirre, E. S. Fasouli, M. G. Thomas, F. Klamt, D. B. Ramsden, R. B. Parsons, Biochem. Biophys. Res. Commun. 2015, 467, 491.</Citation>
        </Reference>
        <Reference>
          <Citation>R. B. Parsons, S. W. Smith, R. H. Waring, A. C. Williams, D. B. Ramsden, Neurosci. Lett. 2003, 342, 13.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. H. Milani, D. B. Ramsden, R. B. Parsons, J. Biochem. Mol. Toxicol. 2013, 27, 451.</Citation>
        </Reference>
        <Reference>
          <Citation>M. G. Thomas, D. Sartini, M. Emanuelli, M. J. van Haren, N. I. Martin, D. M. Mountford, D. J. Barlow, F. Klamt, D. B. Ramsden, M. Reza, R. B. Parsons, Biochem. J. 2016, 473, 3253.</Citation>
        </Reference>
        <Reference>
          <Citation>M. G. Thomas, M. Saldanha, R. J. Mistry, D. T. Dexter, D. B. Ramsden, R. B. Parsons, Cell Death Dis. 2013, 4, e669.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Sternak, T. I. Khomich, A. Jakubowski, M. Szafarz, W. Szczepański, M. Białas, M. Stojak, J. Szymura-Oleksiak, S. Chłopicki, Pharmacol. Rep. 2010, 62, 483.</Citation>
        </Reference>
        <Reference>
          <Citation>H. C. Kim, M. Mofarrahi, T. Vassilakopoulos, F. Maltais, I. Sigala, R. Debigare, I. Bellenis, S. N. A. Hussain, Am. J. Respir. Crit. Care Med. 2010, 181, 797.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Chłopicki, J. Swies, A. Mogielnicki, W. Buczko, M. Bartus, M. Lomnicka, Br. J. Pharmacol. 2007, 15, 230.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Pumpo, G. Sarnelli, A. Spinella, G. Budillon, R. Cuomo, Am. J. Gastroenterol. 2001, 96, 1183.</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Eckert, F. Coscia, A. Chryplewicz, J. W. Chang, K. M. Hernandez, S. Pan, S. M. Tienda, D. A. Nahotko, G. Li, I. Blaženović, R. R. Lastra, M. Curtis, S. D. Yamada, R. Perets, S. M. McGregor, J. Andrade, O. Fiehn, R. E. Moellering, M. Mann, E. Lengyel, Nature 2019, 569, 723.</Citation>
        </Reference>
        <Reference>
          <Citation>S. W. Tang, T. C. Yang, W. C. Lin, W. H. Chang, C. C. Wang, M. K. Lai, Carcinogenesis 2011, 32, 138.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Sartini, G. Muzzonigro, G. Milanese, V. Pozzi, A. Vici, S. Morganti, V. Rossi, R. Mazzucchelli, R. Montironi, M. Emanuelli, Cell Biochem. Biophys. 2013, 65, 473.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Mascitti, A. Santarelli, D. Sartini, C. Rubini, G. Colella, E. Salvolini, G. Ganzetti, A. Offidani, M. Emanuelli, Melanoma. Res. 2019, 29, 151.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Yu, Y. T. Wang, P. Chen, Y. H. Li, Y. X. Chen, H. Zeng, A. M. Yu, M. Huang, H. C. Bi, Cell. Physiol. Biochem. 2015, 35, 710.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Sartini, R. Seta, V. Pozzi, S. Morganti, C. Rubini, A. Zizzi, M. Tomasetti, L. Santarelli, M. Emanuelli, Biol. Chem. 2015, 396, 225.</Citation>
        </Reference>
        <Reference>
          <Citation>O. A. Ulanovskaya, A. M. Zuhl, B. F. Cravatt, Nat. Chem. Biol. 2013, 9, 300.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Tomida, I. Mikami, S. Takeuchi, H. Nishimura, H. Akiyama, J. Cancer Res. Clin. Oncol. 2009, 135, 1223.</Citation>
        </Reference>
        <Reference>
          <Citation>A. H. Schapira, Adv. Neurol. 1993, 60, 15.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Chiarugi, C. Dölle, R. Felici, M. Ziegler, Nat. Rev. Cancer 2012, 12, 741.</Citation>
        </Reference>
        <Reference>
          <Citation>S. S. Korshunov, V. P. Skulachev, A. A. Starkov, FEBS Lett. 1997, 416, 15.</Citation>
        </Reference>
        <Reference>
          <Citation>R. G. Hansford, B. A. Hogue, V. Mildaziene, J. Bioenerg. Biomembr. 1997, 29, 89.</Citation>
        </Reference>
        <Reference>
          <Citation>T. V. Votyakova, I. J. Reynolds, J. Neurochem. 2001, 79, 266.</Citation>
        </Reference>
        <Reference>
          <Citation>P. W. Ho, J. W. Ho, H. F. Liu, D. H. So, Z. H. Tse, K. H. Chan, D. B. Ramsden, S. L. Ho, Transl. Neurodegener. 2012, 1, 3.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. B. Andrews, B. Horvath, C. J. Barnstable, J. Elsworth, L. Yang, M. F. Beal, R. H. Roth, R. T. Matthews, T. L. Horvath, J. Neurosci. 2005, 25, 184.</Citation>
        </Reference>
        <Reference>
          <Citation>R. D. Hwang, L. Wiemerslage, C. J. LaBreck, M. Khan, K. Kannan, X. Wang, X. Zhu, D. Lee, Y. W. C. Fridell, Neurobiol. Dis. 2014, 69, 180.</Citation>
        </Reference>
        <Reference>
          <Citation>I. Samudio, M. Fiegl, M. Andreeff, Cancer Res. 2009, 69, 2163.</Citation>
        </Reference>
        <Reference>
          <Citation>C. V. Rizos, E. N. Liberopoulos, C. C. Tellis, A. D. Tselepis, M. S. Elisaf, Arch. Med. Sci. 2013, 9, 172.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Xin, Z. Qiao, J. Li, J. Liu, S. Song, X. Zhao, P. Miao, T. Tang, L. Wang, W. Liu, X. Yang, K. Dai, G. Huang, Oncotarget 2016, 7, 44252.</Citation>
        </Reference>
        <Reference>
          <Citation>N. M. Anderson, D. Li, H. L. Peng, F. J. F. Laroche, M. R. Mansour, E. Gjini, M. Aioub, D. J. Helman, J. E. Roderick, T. Cheng, I. Harrold, Y. Samaha, L. Meng, A. Amsterdam, D. S. Neuberg, T. T. Denton, T. Sanda, M. A. Kelliher, A. Singh, A. T. Look, H. Feng, Leukemia 2016, 30, 1365.</Citation>
        </Reference>
        <Reference>
          <Citation>M. Bolzoni, M. Chiu, F. Accardi, R. Vescovini, I. Airoldi, P. Storti, K. Todoerti, L. Agnelli, G. Missale, R. Andreoli, M. G. Bianchi, M. Allegri, A. Barilli, F. Nicolini, A. Cavalli, F. Costa, V. Marchica, D. Toscani, C. Mancini, E. Martella, V. Dall'Asta, G. Donofrio, F. Aversa, O. Bussolati, N. Giuliani, Blood 2016, 128, 667.</Citation>
        </Reference>
        <Reference>
          <Citation>J. Márquez, F. J. Alonso, J. M. Matés, J. A. Segura, M. Martín-Rufián, J. A. Campos-Sandoval, Neurochem. Res. 2017, 42, 1735.</Citation>
        </Reference>
        <Reference>
          <Citation>S. Manoharan, G. J. Guillemin, R. S. Abiramasundari, M. M. Essa, M. Akbar, M. D. Akbar, Oxid. Med. Cell Longev. 2016, 2016, 8590578. https://doi.org/10.1155/2016/8590578</Citation>
        </Reference>
        <Reference>
          <Citation>G. Y. Liou, P. Storz, Free. Radic. Res. 2010, 44, 479.</Citation>
        </Reference>
        <Reference>
          <Citation>P. Storz, Front. Biosci. 2005, 10, 1881.</Citation>
        </Reference>
        <Reference>
          <Citation>D. M. Townsend, K. D. Tew, Oncogene 2003, 22, 7369.</Citation>
        </Reference>
        <Reference>
          <Citation>R. B. Hamanaka, N. S. Chandel, Science 2011, 334, 1219.</Citation>
        </Reference>
        <Reference>
          <Citation>D. Anastasiou, G. Poulogiannis, J. M. Asara, M. B. Boxer, J. Jiang, M. Shen, G. Bellinger, A. T. Sasaki, J. W. Locasale, D. S. Auld, C. J. Thomas, M. G. Vander Heiden, L. C. Cantley, Science 2011, 334, 1278.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909877</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2151-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis care &amp; research</Title>
          <ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Low Back Pain as a Risk Factor for Recurrent Falls in People with Knee Osteoarthritis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.24136</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Knee osteoarthritis (OA) has been suggested to increase the risk of falls. Low back pain (LBP) is a potential risk factor for falls in people with knee OA, but this has not been addressed adequately in previous studies. This study aimed to investigate the relationship between LBP and falls in people with knee OA in a 12-month period.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Participants with knee OA (Kellgren and Lawrence [K&amp;L) grade ≥ 1) completed questionnaires for LBP and falls that occurred in the preceding 12 months. Binary and ordinal logistic regression analyses were performed to assess the relationship between LBP or moderate-to-severe LBP (numeric rating scale ≥ 4 points) and any fall (≥ 1 fall) or recurrent falls (≥ 2 falls) after adjustment for age, sex, K&amp;L grade, knee pain severity, and quadriceps strength. Sensitivity analyses were performed excluding people with sciatica, non-chronic LBP, K&amp;L grade 1, and those receiving pain medications.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 189 participants (age: 61-90 years, 78.3% women) in this study. Of these participants, 41 (21.6%) reported falls in the preceding 12 months. People with any LBP (n = 101) and those with moderate-to-severe LBP (n = 45) had 2.7 and 3.7 times higher odds of recurrent falls, respectively. Sensitivity analyses revealed a strong correlation between moderate-to-severe LBP and recurrent falls.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Thorough investigation of LBP as a risk factor for recurrent falls in people with knee OA may provide a novel insight into the pathomechanics of recurrent falls in this population.</AbstractText>
          <CopyrightInformation>© 2020, American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Iijima</LastName>
            <ForeName>Hirotaka</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-5504-1502</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of System Design Engineering, Faculty of Science and Technology, Keio University, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Japan Society for the Promotion of Science, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shimoura</LastName>
            <ForeName>Kanako</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aoyama</LastName>
            <ForeName>Tomoki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takahashi</LastName>
            <ForeName>Masaki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of System Design Engineering, Faculty of Science and Technology, Keio University, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA>
        <NlmUniqueID>101518086</NlmUniqueID>
        <ISSNLinking>2151-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909877</ArticleId>
        <ArticleId IdType="doi">10.1002/acr.24136</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909878</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2151-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis care &amp; research</Title>
          <ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>High Burden of Premature Arteriosclerosis on Renal Biopsies in Incident Lupus Nephritis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.24138</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Cardiovascular disease (CVD) is accelerated in patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN). Despite the literature suggesting renal arteriosclerosis predicts CVD in other glomerulonephritis diseases, arteriosclerosis grading and reporting might be particularly overlooked in LN biopsies. We aimed to examine the burden of renal arteriosclerosis in LN and to assess whether arteriosclerosis is under-reported in LN biopsies.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We identified all LN patients undergoing kidney biopsy between 1994 - 2017 at an academic center. We interpreted LN biopsy reports to classify the Banff categories of absent, mild, moderate, or severe renal arteriosclerosis. The prevalence of renal arteriosclerosis was compared with the prevalence published for age-matched healthy peers, and predictors of arteriosclerosis were examined. We over-read biopsies for Banff renal arteriosclerosis grading and compared to pathology reports.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 189 incident LN patients, renal arteriosclerosis prevalence was two decades earlier in LN patients compared to their healthy peers, affecting 40% of 31-39 yo LN compared to 44% of 50-59 yo healthy peers. A multivariable analysis showed a 3-fold higher odds of renal arteriosclerosis in LN patients over age 30. LN chronicity on biopsies predicted a 4-fold higher odds of renal arteriosclerosis. The over-reads determined that 50% of standard LN biopsy reports missed reporting the presence or absence of renal arteriosclerosis.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Renal arteriosclerosis is accelerated by two decades in LN patients compared to their healthy peers and overlooked by pathologists in half of the routine biopsy reports. We propose incorporating Banff renal arteriosclerosis grading in all LN biopsies.</AbstractText>
          <CopyrightInformation>© 2020, American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Garg</LastName>
            <ForeName>Shivani</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Rheumatology, University of Wisconsin, Madison.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bartels</LastName>
            <ForeName>Christie M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Rheumatology, University of Wisconsin, Madison.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>Karen E</ForeName>
            <Initials>KE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Rheumatology, University of Wisconsin, Madison.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Weixiong</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, University of Wisconsin, Madison.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Yabing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Pathology, RenMin Hospital of Wuhan University, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Semanik</LastName>
            <ForeName>Michael G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Nephrology, University of Wisconsin, Madison.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Maureen</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Population Health Sciences and Family Medicine, University of Wisconsin, Madison.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Panzer</LastName>
            <ForeName>Sarah E</ForeName>
            <Initials>SE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Nephrology, University of Wisconsin, Madison.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA>
        <NlmUniqueID>101518086</NlmUniqueID>
        <ISSNLinking>2151-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909878</ArticleId>
        <ArticleId IdType="doi">10.1002/acr.24138</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909879</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0461</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biochemical and molecular toxicology</Title>
          <ISOAbbreviation>J. Biochem. Mol. Toxicol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>6-O-(3″, 4″-di-O-trans-cinnamoyl)-α-l-rhamnopyranosylcatalpol and verbascoside: Cytotoxicity, cell cycle kinetics, apoptosis, and ROS production evaluation in tumor cells.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e22443</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jbt.22443</ELocationID>
        <Abstract>
          <AbstractText>The aim of this study was to evaluate the impact that 6-O-(3″, 4″-di-O-trans-cinnamoyl)-α- l-rhamnopyranosylcatalpol (Dicinn) and verbascoside (Verb), two compounds simultaneously reported in Verbascum ovalifolium, have on tumor cell viability, apoptosis, cell cycle kinetics, and intracellular reactive oxygen species (ROS) level. At 100 µg/mL and 48 hours incubation time, Dicinn and Verb produced good cytotoxic effects in A549, HT-29, and MCF-7 cells. Dicinn induced cell-cycle arrest at the G<sub>0</sub> /G<sub>1</sub> phase and apoptosis, whereas Verb increased the population of subG<sub>1</sub> cells and cell apoptosis rates. Furthermore, the two compounds exhibited time-dependent ROS generating effects in tumor cells (1-24 hours). Importantly, no cytotoxic effects were induced in nontumor MCF-10A cells by the two compounds up to 100 µg/mL. Overall, the effects exhibited by Verb in tumor cells were more potent, which can be correlated with its structural features, such as the presence of phenolic hydroxyl groups.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vasincu</LastName>
            <ForeName>Alexandru</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacodynamics and Clinical Pharmacy, Grigore T. Popa University of Medicine and Pharmacy of Iasi, Iasi, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Neophytou</LastName>
            <ForeName>Christiana M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luca</LastName>
            <ForeName>Simon Vlad</ForeName>
            <Initials>SV</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8785-249X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacognosy, Grigore T. Popa University of Medicine and Pharmacy of Iasi, Iasi, Romania.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacognosy with Medicinal Plant Unit, Medical University of Lublin, Lublin, Poland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biothermodynamics, TUM School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skalicka-Woźniak</LastName>
            <ForeName>Krystyna</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacognosy with Medicinal Plant Unit, Medical University of Lublin, Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miron</LastName>
            <ForeName>Anca</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacognosy, Grigore T. Popa University of Medicine and Pharmacy of Iasi, Iasi, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Constantinou</LastName>
            <ForeName>Andreas I</ForeName>
            <Initials>AI</Initials>
            <AffiliationInfo>
              <Affiliation>Medical School, University of Nicosia, Nicosia, Cyprus.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Biochem Mol Toxicol</MedlineTA>
        <NlmUniqueID>9717231</NlmUniqueID>
        <ISSNLinking>1095-6670</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">acylated catalpol diglycosides</Keyword>
        <Keyword MajorTopicYN="N">apoptosis</Keyword>
        <Keyword MajorTopicYN="N">cell cycle arrest</Keyword>
        <Keyword MajorTopicYN="N">cell viability</Keyword>
        <Keyword MajorTopicYN="N">verbascoside</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909879</ArticleId>
        <ArticleId IdType="doi">10.1002/jbt.22443</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>W. P. Steward, K. Brown, Br. J. Cancer 2013, 109, 1.</Citation>
        </Reference>
        <Reference>
          <Citation>G. M. Cragg, J. M. Pezzuto, Med. Princ. Pract. 2016, 25, 41.</Citation>
        </Reference>
        <Reference>
          <Citation>R. G. Amaral, S. A. dos Santos, L. N. Andrade, P. Severino, A. A. Carvalho, Clin. Oncol. 2019, 4, 1562.</Citation>
        </Reference>
        <Reference>
          <Citation>R. M. Taskova, C. H. Gotfredsen, S. R. Jensen, Phytochemistry 2006, 67, 286.</Citation>
        </Reference>
        <Reference>
          <Citation>S. V. Luca, M. E. Czerwinska, A. Miron, A. C. Aprotosoaie, L. Marcourt, J. L. Wolfender, S. Granica, K. Skalicka-Wozniak, J. Pharm. Biomed. Anal. 2019, 166, 295.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Zhu, L. Zhang, S. Ling, F. Quian, Y. Li, J. W. Xu, Molecules 2015, 20, 19823.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Zhang, T. Zhu, F. Quian, J. Xu, G. Dorje, Z. Zhao, F. Guo, Y. Li, Fitoterapia 2014, 98, 84.</Citation>
        </Reference>
        <Reference>
          <Citation>A. T. Nguyen, J. Fontaine, H. Malonne, M. Claeys, M. Luhmer, P. Duez, Phytochemistry 2005, 66, 1186.</Citation>
        </Reference>
        <Reference>
          <Citation>S. V. Luca, A. Miron, S. Ignatova, K. Skalicka-Wozniak, Phytochem. Rev. 2019, 18, 377.</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Xue, B. Yang, Molecules 2016, 21, 991.</Citation>
        </Reference>
        <Reference>
          <Citation>H. Qiu, P. Fu, W. Fan, C. Zuo, P. Feng, P. Shi, L. Cao, F. Liu, L. Zhou, F. Chen, H. Zhong, Z. Gou, Y. Liang, M. Shi, Phytother. Res. 2014, 28, 132.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Campo, R. Pavasini, S. Biscaglia, A. Ferri, E. Andrenacci, M. Tebaldi, R. Ferrari, Pharmacol. Res. 2015, 97, 1.</Citation>
        </Reference>
        <Reference>
          <Citation>K. W. Lee, H. J. Kim, Y. S. Lee, H. J. Park, J. W. Choi, J. Ha, K. T. Lee, Carcinogenesis 2007, 28, 1928.</Citation>
        </Reference>
        <Reference>
          <Citation>K. H. Kim, C. Beemelmanns, J. Clardy, S. Cao, Bioorg. Med. Chem. Lett. 2015, 25, 2834.</Citation>
        </Reference>
        <Reference>
          <Citation>U. S. Harput, Y. Genc, I. Saracoglu, Food Chem. Toxicol. 2012, 50, 1554.</Citation>
        </Reference>
        <Reference>
          <Citation>T. Mosmann, J. Immunol. Methods 1983, 65, 55.</Citation>
        </Reference>
        <Reference>
          <Citation>W. Q. Jia, Z. T. Wang, M. M. Zou, J. H. Lin, Y. H. Li, L. Zhang, R. X. Xu, Cell. Physiol. Biochem. 2018, 47, 1871.</Citation>
        </Reference>
        <Reference>
          <Citation>C. M. Neophytou, C. Constantinou, P. Papageorgis, A. I. Constantinou, Biochem. Pharmacol. 2014, 89, 31.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Girard-Lalancette, A. Pichette, J. Legault, Food Chem. 2009, 115, 720.</Citation>
        </Reference>
        <Reference>
          <Citation>A. Vasincu, B. S. Paulsen, D. Diallo, I. Vasincu, A. C. Aprotosoaie, V. Bild, C. Charalambous, A. I. Constantinou, A. Miron, C. M. Gavrilescu, Molecules 2014, 19, 19114.</Citation>
        </Reference>
        <Reference>
          <Citation>L. Zhou, Y. Feng, Y. Jin, X. Liu, H. Sui, N. Chai, X. Chen, N. Liu, Q. Ji, Y. Wang, Q. Li, BMC Cancer 2014, 14, 747.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Xiang, Z. Jing, W. Haixia, Y. Ruitao, W. Huaixiu, L. Zenggen, M. Lijuan, W. Yiping, T. Yanduo, Phytother. Res. 2017, 31, 1509.</Citation>
        </Reference>
        <Reference>
          <Citation>G. Kaur, N. Verma, Biotechnol. Rep. 2015, 6, 64.</Citation>
        </Reference>
        <Reference>
          <Citation>Y. M. Attia, D. M. El-Kersh, H. A. Wagdy, M. M. Elmazar, Sci. Rep. 2018, 8, 16939.</Citation>
        </Reference>
        <Reference>
          <Citation>C. Cheimonidi, P. Samara, P. Polychronopoulos, E. N. Tsakiri, T. Nikou, V. Myrianthopoulos, T. Sakellaropoulos, V. Zoumpourlis, E. Mikros, I. Papassideri, A. Argyropoulou, M. Halabalaki, L. G. Alexopoulos, A. L. Skaltsounis, O. E. Tsitsilonis, N. N. Aligiannis, I. P. Trougakos, Redox Biol. 2018, 16, 169.</Citation>
        </Reference>
        <Reference>
          <Citation>E. Szliszka, Z. P. Czuba, M. Domino, B. Mazur, G. Zydowicz, W. Krol, Molecules 2009, 14, 738.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909880</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1861-471X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Chemistry, an Asian journal</Title>
          <ISOAbbreviation>Chem Asian J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rational design of a near-infrared fluorescence probe for Ca2+ based on phosphorus-substituted rhodamines utilizing photoinduced electron transfer.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/asia.201901689</ELocationID>
        <Abstract>
          <AbstractText>Fluorescence imaging in the near-infrared (NIR) region (650-900 nm) is useful for bioimaging because background autofluorescence is low and tissue penetration is high in this range. In addition, NIR fluorescence is useful as a complementary color window to green and red for multicolor imaging. Here, we compared the photoinduced electron transfer (PeT)-mediated fluorescence quenching of silicon- and phosphorus-substituted rhodamines (SiRs and PRs) in order to guide the development of improved far-red to NIR fluorescent dyes. The results of density functional theory calculations and photophysical evaluation of a series of newly synthesized PRs confirmed that the fluorescence of PRs was more susceptible than that of SiRs to quenching via PeT. Based on this, we designed and synthesized a NIR fluorescence probe for Ca2+, CaPR-1, and its membrane-permeable acetoxymethyl derivative, CaPR-1 AM, which is distributed to the cytosol, in marked contrast to our previously reported Ca2+ far-red to NIR fluorescence probe based on the SiR scaffold, CaSiR-1 AM, which is mainly localized in lysosomes as well as cytosol in living cells. CaPR-1 showed longer-wavelength absorption and emission (up to 712 nm) than CaSiR-1. The new probe was able to image Ca2+ at dendrites and spines in brain slices, and should be a useful tool in neuroscience research.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Takahashi</LastName>
            <ForeName>Shodai</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Pharmaceutical Sciences, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hanaoka</LastName>
            <ForeName>Kenjiro</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Pharmaceutical Sciences, 7-3-1, Hongo, Bunkyo-ku, 113-0033, Tokyo, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okubo</LastName>
            <ForeName>Yohei</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Medicine, 113-0033, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Echizen</LastName>
            <ForeName>Honami</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Pharmaceutical Sciences, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ikeno</LastName>
            <ForeName>Takayuki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokto, Graduate School of Pharmaceutical Sciences, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Komatsu</LastName>
            <ForeName>Toru</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Pharmaceutical Sciences, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ueno</LastName>
            <ForeName>Tasuku</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Pharmaceutical Sciences, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirose</LastName>
            <ForeName>Kenzo</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Medicine, Tokyo, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iino</LastName>
            <ForeName>Masamitsu</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Nihon University, Division of Cellular and Molecular Pharmacology, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nagano</LastName>
            <ForeName>Tetsuo</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Drug Discovery Initiative, 7-3-1, Hongo, Bunkyo-ku, 113-0033, Tokyo, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Urano</LastName>
            <ForeName>Yasuteru</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Tokyo, Graduate School of Pharmaceutical Sciences, 7-3-1, Hongo, Bunkyo-ku, 113-0033, Tokyo, JAPAN.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Chem Asian J</MedlineTA>
        <NlmUniqueID>101294643</NlmUniqueID>
        <ISSNLinking>1861-471X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Calcium</Keyword>
        <Keyword MajorTopicYN="N">Fluorescence spectroscopy</Keyword>
        <Keyword MajorTopicYN="N">Fluorescent probes</Keyword>
        <Keyword MajorTopicYN="N">Neuroscience</Keyword>
        <Keyword MajorTopicYN="N">fluorescence</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909880</ArticleId>
        <ArticleId IdType="doi">10.1002/asia.201901689</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909882</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-6551</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>IUBMB life</Title>
          <ISOAbbreviation>IUBMB Life</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Blockade of high mobility group box 1 involved in the protective of curcumin on myocardial injury in diabetes in vivo and in vitro.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/iub.2226</ELocationID>
        <Abstract>
          <AbstractText>The aim of this study was to investigate the protective effect of curcumin (Cu) on myocardial injury in diabetic cardiomyopathy in vivo and in vitro. Serum and myocardial glucose, inflammatory cytokines, and cardiac function indexes of type 2 diabetes db/db mice were measured. The mechanism of action was confirmed by immunohistochemistry, immunofluorescence, and western blot experiments. H9C2 cells stimulated by glucose (Glu) were used as cell models in vitro. Cu treatment improved glucose tolerance and lipid profile and reduced the production of inflammatory cytokines. In addition, Cu decreased the serum biochemical indexes. Cu inhibits high mobility group box 1 (HMGB1) signaling pathway in db/db mice. Cu treatment also significantly inhibited pa-induced inflammatory signaling pathway in H9C2 cells. HMGB1 inhibitor or HMGB1 knockdown counteracted the effects of Cu on diabetic cardiomyopathy. The present study showed the protective effects of Cu on myocardial injury via HMGB1 pathway in diabetic cardiomyopathy in vivo and in vitro.</AbstractText>
          <CopyrightInformation>© 2020 International Union of Biochemistry and Molecular Biology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Xueyun</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Jing'an Shibei Hospital of Shanghai, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Peier</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Jing'an Shibei Hospital of Shanghai, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Le</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Jing'an Shibei Hospital of Shanghai, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Jinyue</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Jing'an Shibei Hospital of Shanghai, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Haihua</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Jing'an Shibei Hospital of Shanghai, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Yuting</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Jing'an Shibei Hospital of Shanghai, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Huaming</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-6997-0791</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Jing'an Shibei Hospital of Shanghai, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2019MS10</GrantID>
            <Agency>Health Research</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>IUBMB Life</MedlineTA>
        <NlmUniqueID>100888706</NlmUniqueID>
        <ISSNLinking>1521-6543</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HMGB1</Keyword>
        <Keyword MajorTopicYN="N">curcumin</Keyword>
        <Keyword MajorTopicYN="N">diabetics</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">myocardial injury</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909882</ArticleId>
        <ArticleId IdType="doi">10.1002/iub.2226</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Makimattila S, Virkamaki A, Groop PH, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation. 1996;94:1276-1282.</Citation>
        </Reference>
        <Reference>
          <Citation>Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137-149.</Citation>
        </Reference>
        <Reference>
          <Citation>Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54:1615-1625.</Citation>
        </Reference>
        <Reference>
          <Citation>Issa M, Alqahtani F, Ziada KM, et al. Incidence and outcomes of non-ST elevation myocardial infarction in patients hospitalized with decompensated diabetes. Am J Cardiol. 2018;122:1297-1302.</Citation>
        </Reference>
        <Reference>
          <Citation>Chung S, Ho C, Lam K, Lam K, Chung S. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058-1070.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu R, Zhang F, Chai R, et al. Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization. J Cell Mol Med. 2019;23(11):7617-7631.</Citation>
        </Reference>
        <Reference>
          <Citation>Vijayakumar EC, Bhatt LK, Prabhavalkar KS. High mobility group Box-1 (HMGB1): A potential target in therapeutics. Curr Drug Targets. 2019;20:1474-1485.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu S, Wang D, Huang L, et al. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages. J Biol Chem. 2019;294:8384-8394.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang H, Ding L, Shen T, Peng D. HMGB1 involved in stress-induced depression and its neuroinflammatory priming role: A systematic review. General Psychiatry. 2019;32:e100084.</Citation>
        </Reference>
        <Reference>
          <Citation>Kornblit B, Munthe-Fog L, Madsen HO, Strom J, Vindelov L, Garred P. Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care. 2008;12:R83.</Citation>
        </Reference>
        <Reference>
          <Citation>Choi SE, Park YS, Koh HC. NF-κB/p53-activated inflammatory response involves in diquat-induced mitochondrial dysfunction and apoptosis. Environ Toxicol. 2018;33:1005-1018.</Citation>
        </Reference>
        <Reference>
          <Citation>Radko K. Rho kinase inhibition in diabetic kidney disease. Br J Clin Pharmacol. 2013;76:551-559.</Citation>
        </Reference>
        <Reference>
          <Citation>Guzman-Ruiz R, Ortega F, Rodriguez A, et al. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in beta-cells. Int J Obes (Lond). 2014;38:1545-1554.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhou Z, Li H, Tian S, et al. Critical roles of NLRP3 inflammasome in IL-1beta secretion induced by Corynebacterium pseudotuberculosis in vitro. Mol Immunol. 2019;116:11-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu MF, Shu CC, Wang JY. NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1beta response and host susceptibility. Sci Rep. 2019;9:12534.</Citation>
        </Reference>
        <Reference>
          <Citation>Hou C, Zhu X, Shi C, et al. Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-kappaB pathway. Biomed Pharmacother. 2019;119:109455.</Citation>
        </Reference>
        <Reference>
          <Citation>Voulgaropoulou SD, van Amelsvoort T, Prickaerts J, Vingerhoets C. The effect of curcumin on cognition in Alzheimer's disease and healthy aging: A systematic review of pre-clinical and clinical studies. Brain Res. 2019;1725:146476.</Citation>
        </Reference>
        <Reference>
          <Citation>Yuan J, Botchway BOA, Zhang Y, Tan X, Wang X, Liu X. Curcumin can improve spinal cord injury by inhibiting TGF-beta-SOX9 signaling pathway. Cell Mol Neurobiol. 2019;39:569-575.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh AK, Jiang Y, Gupta S, Younus M, Ramzan M. Anti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammation. J Med Food. 2013;16:899-911.</Citation>
        </Reference>
        <Reference>
          <Citation>Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, Sahebkar A, Asemi Z, Mirzaei H. Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacol Res. 2019;147:104353.</Citation>
        </Reference>
        <Reference>
          <Citation>Hernandez M, Wicz S, Corral RS. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E2 pathway induced during Trypanosoma cruzi infection. Phytomedicine. 2016;23:1392-1400.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang Y, Duan W, Lin Y, et al. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med. 2013;65:667-679.</Citation>
        </Reference>
        <Reference>
          <Citation>Sukardi R, Sastroasmoro S, Siregar NC, et al. The role of curcumin as an inhibitor of oxidative stress caused by ischaemia re-perfusion injury in tetralogy of Fallot patients undergoing corrective surgery. Cardiol Young. 2016;26:431-438.</Citation>
        </Reference>
        <Reference>
          <Citation>Kealey A. Coronary artery disease and myocardial infarction in pregnancy: A review of epidemiology, diagnosis, and medical and surgical management. Can J Cardiol. 2010;26:185-189.</Citation>
        </Reference>
        <Reference>
          <Citation>Ramprasad G, Samaha FF. Dyslipidemia in type 2 diabetes mellitus. Curr Diab Rep. 2007;7:228-234.</Citation>
        </Reference>
        <Reference>
          <Citation>Warraich HJ, Rana JS. Dyslipidemia in diabetes mellitus and cardiovascular disease. Cardiovasc Endocrinol Metabol. 2017;6:27-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu J, Li J, Zhang N, Zhang C. Stem cell-based therapies in ischemic heart diseases: A focus on aspects of microcirculation and inflammation. Basic Res Cardiol. 2011;106:317-324.</Citation>
        </Reference>
        <Reference>
          <Citation>Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJP. Cardiovascular metabolic syndrome-An interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab. 2010;9:218-232.</Citation>
        </Reference>
        <Reference>
          <Citation>Hui T, Min-Hao X, Yu L, Liang Z, Yu-Ping X, Jian-Guang C. The roles of aerobic exercise training and suppression IL-6 gene expression by RNA interference in the development of insulin resistance. Cytokine. 2013;61:394-405.</Citation>
        </Reference>
        <Reference>
          <Citation>He Q, Dong M, Pan Q, Wang X, Guo L. Correlation between changes in inflammatory cytokines and the combination with hypertension in patients with type 2 diabetes mellitus. Minerva Endocrinol. 2019;44:252-258.</Citation>
        </Reference>
        <Reference>
          <Citation>Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141:347-357.</Citation>
        </Reference>
        <Reference>
          <Citation>Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: A functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets. 2011;15:1023-1035.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu Y, Yang L, Lv J, et al. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis. Int J Clin Experimental Pathol. 2015;8:6807.</Citation>
        </Reference>
        <Reference>
          <Citation>Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477-489.</Citation>
        </Reference>
        <Reference>
          <Citation>Tatsch E, Carvalho JAMD, Hausen BS, et al. Oxidative DNA damage is associated with inflammatory response, insulin resistance and microvascular complications in type 2 diabetes. Mutat Res/Fundam Mol Mech Mutagen. 2015;782:17-22.</Citation>
        </Reference>
        <Reference>
          <Citation>Subramanian S, Pallati PK, Sharma P, Agrawal DK, Nandipati KC. Significant association of TREM-1 with HMGB1, TLRs and RAGE in the pathogenesis of insulin resistance in obese diabetic populations. Am J Transl Res. 2017;9:3224.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909881</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4876</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part C, Seminars in medical genetics</Title>
          <ISOAbbreviation>Am J Med Genet C Semin Med Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Other genomic disorders and congenital heart disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.c.31762</ELocationID>
        <Abstract>
          <AbstractText>Congenital heart disease (CHD) is the common birth defect worldwide. Despite its recognized burden on public health, the etiology in the vast majority of individuals remains unknown. Chromosomal abnormality plays an important role, frequently observed as large cytogenetically visible rearrangement or small submicroscopic structural variation in the genome. Several genomic disorders are now recognized that are increasingly responsible for CHD with variable penetrance. Single gene disorders, epigenetic alterations, and environmental etiologies are also significant contributors. Our understanding of the genetic basis of CHD has increased exponentially with the escalating use of next generation sequencing to identify ever so small submicroscopic genomic imbalances at the level of coding exons in CHD. This review focuses on genomic disorders other than 22q11.2 deletion, that are major players in the etiology of human cardiac malformations.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lalani</LastName>
            <ForeName>Seema R</ForeName>
            <Initials>SR</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-0707-657X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet C Semin Med Genet</MedlineTA>
        <NlmUniqueID>101235745</NlmUniqueID>
        <ISSNLinking>1552-4868</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">NAHR</Keyword>
        <Keyword MajorTopicYN="N">chromosomal microarray analysis</Keyword>
        <Keyword MajorTopicYN="N">congenital heart disease</Keyword>
        <Keyword MajorTopicYN="N">genomic disorders</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909881</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.c.31762</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Al Turki, S., Manickaraj, A. K., Mercer, C. L., Gerety, S. S., Hitz, M. P., Lindsay, S., … Hurles, M. E. (2014). Rare variants in NR2F2 cause congenital heart defects in humans. American Journal of Human Genetics, 94(4), 574-585. https://doi.org/10.1016/j.ajhg.2014.03.007</Citation>
        </Reference>
        <Reference>
          <Citation>Aranguren, X. L., Beerens, M., Vandevelde, W., Dewerchin, M., Carmeliet, P., &amp; Luttun, A. (2011). Transcription factor COUP-TFII is indispensable for venous and lymphatic development in zebrafish and Xenopus laevis. Biochemical and Biophysical Research Communications, 410(1), 121-126. https://doi.org/10.1016/j.bbrc.2011.05.117</Citation>
        </Reference>
        <Reference>
          <Citation>Ballif, B. C., Theisen, A., Rosenfeld, J. A., Traylor, R. N., Gastier-Foster, J., Thrush, D. L., … Shaffer, L. G. (2010). Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities. American Journal of Human Genetics, 86(3), 454-461. https://doi.org/10.1016/j.ajhg.2010.01.038</Citation>
        </Reference>
        <Reference>
          <Citation>Baptista, J., Mercer, C., Prigmore, E., Gribble, S. M., Carter, N. P., Maloney, V., … Crolla, J. A. (2008). Breakpoint mapping and array CGH in translocations: Comparison of a phenotypically normal and an abnormal cohort. American Journal of Human Genetics, 82(4), 927-936. https://doi.org/10.1016/j.ajhg.2008.02.012</Citation>
        </Reference>
        <Reference>
          <Citation>Barber, J. C., Bunyan, D., Curtis, M., Robinson, D., Morlot, S., Dermitzel, A., … Maloney, V. K. (2010). 8p23.1 duplication syndrome differentiated from copy number variation of the defensin cluster at prenatal diagnosis in four new families. Molecular Cytogenetics, 3, 3. https://doi.org/10.1186/1755-8166-3-3</Citation>
        </Reference>
        <Reference>
          <Citation>Barber, J. C., Rosenfeld, J. A., Foulds, N., Laird, S., Bateman, M. S., Thomas, N. S., … Lamb, A. N. (2013). 8p23.1 duplication syndrome; common, confirmed, and novel features in six further patients. American Journal of Medical Genetics. Part A, 161A(3), 487-500. https://doi.org/10.1002/ajmg.a.35767</Citation>
        </Reference>
        <Reference>
          <Citation>Battaglia, A., Hoyme, H. E., Dallapiccola, B., Zackai, E., Hudgins, L., McDonald-McGinn, D., … Carey, J. C. (2008). Further delineation of deletion 1p36 syndrome in 60 patients: A recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics, 121(2), 404-410. https://doi.org/10.1542/peds.2007-0929</Citation>
        </Reference>
        <Reference>
          <Citation>Bi, W., Park, S. S., Shaw, C. J., Withers, M. A., Patel, P. I., &amp; Lupski, J. R. (2003). Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2. American Journal of Human Genetics, 73(6), 1302-1315. https://doi.org/10.1086/379979</Citation>
        </Reference>
        <Reference>
          <Citation>Boettger, L. M., Handsaker, R. E., Zody, M. C., &amp; McCarroll, S. A. (2012). Structural haplotypes and recent evolution of the human 17q21.31 region. Nature Genetics, 44(8), 881-885. https://doi.org/10.1038/ng.2334</Citation>
        </Reference>
        <Reference>
          <Citation>Breckpot, J., Thienpont, B., Arens, Y., Tranchevent, L. C., Vermeesch, J. R., Moreau, Y., … Devriendt, K. (2011). Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects. Cytogenetic and Genome Research, 135(3-4), 251-259. https://doi.org/10.1159/000331272</Citation>
        </Reference>
        <Reference>
          <Citation>Burn, J., &amp; Goodship, J. (1996). Developmental genetics of the heart. Current Opinion in Genetics &amp; Development, 6(3), 322-325.</Citation>
        </Reference>
        <Reference>
          <Citation>Carey, A. S., Liang, L., Edwards, J., Brandt, T., Mei, H., Sharp, A. J., … Gelb, B. D. (2013). Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circulation. Cardiovascular Genetics, 6(5), 444-451. https://doi.org/10.1161/CIRCGENETICS.113.000189</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, C. P., Liu, Y. P., Lin, S. P., Chen, M., Tsai, F. J., Chen, Y. T., … Wang, W. (2010). Ventriculomegaly, intrauterine growth restriction, and congenital heart defects as salient prenatal sonographic findings of Miller-Dieker lissencephaly syndrome associated with monosomy 17p (17p13.2 → pter) in a fetus. Taiwanese Journal of Obstetrics &amp; Gynecology, 49(1), 81-86. https://doi.org/10.1016/S1028-4559(10)60015-0</Citation>
        </Reference>
        <Reference>
          <Citation>Cheng, A., Dinulos, M. B. P., Neufeld-Kaiser, W., Rosenfeld, J., Kyriss, M., Madan-Khetarpal, S., … Liu, Y. J. (2017). 6q25.1 (TAB2) microdeletion syndrome: Congenital heart defects and cardiomyopathy. American Journal of Medical Genetics. Part A, 173(7), 1848-1857. https://doi.org/10.1002/ajmg.a.38254</Citation>
        </Reference>
        <Reference>
          <Citation>Choi, J. H., Kang, M., Kim, G. H., Hong, M., Jin, H. Y., Lee, B. H., … Yoo, H. W. (2011). Clinical and functional characteristics of a novel heterozygous mutation of the IGF1R gene and IGF1R haploinsufficiency due to terminal 15q26.2-&gt;qter deletion in patients with intrauterine growth retardation and postnatal catch-up growth failure. The Journal of Clinical Endocrinology and Metabolism, 96(1), E130-E134. https://doi.org/10.1210/jc.2010-1789</Citation>
        </Reference>
        <Reference>
          <Citation>Christiansen, J., Dyck, J. D., Elyas, B. G., Lilley, M., Bamforth, J. S., Hicks, M., … Somerville, M. J. (2004). Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease. Circulation Research, 94(11), 1429-1435. https://doi.org/10.1161/01.RES.0000130528.72330.5c</Citation>
        </Reference>
        <Reference>
          <Citation>Collins, R. T., 2nd, Kaplan, P., Somes, G. W., &amp; Rome, J. J. (2010). Long-term outcomes of patients with cardiovascular abnormalities and Williams syndrome. The American Journal of Cardiology, 105(6), 874-878. https://doi.org/10.1016/j.amjcard.2009.10.069</Citation>
        </Reference>
        <Reference>
          <Citation>Davidsson, J., Collin, A., Bjorkhem, G., &amp; Soller, M. (2008). Array based characterization of a terminal deletion involving chromosome subband 15q26.2: An emerging syndrome associated with growth retardation, cardiac defects and developmental delay. BMC Medical Genetics, 9, 2. https://doi.org/10.1186/1471-2350-9-2</Citation>
        </Reference>
        <Reference>
          <Citation>Derwinska, K., Bartnik, M., Wisniowiecka-Kowalnik, B., Jagla, M., Rudzinski, A., Pietrzyk, J. J., … Stankiewicz, P. (2012). Assessment of the role of copy-number variants in 150 patients with congenital heart defects. Medycyna Wieku Rozwojowego, 16(3), 175-182.</Citation>
        </Reference>
        <Reference>
          <Citation>Devriendt, K., Holvoet, M., &amp; Fryns, J. P. (1998). Further delineation of the KBG syndrome. Genetic Counseling, 9(3), 191-194.</Citation>
        </Reference>
        <Reference>
          <Citation>Dolcetti, A., Silversides, C. K., Marshall, C. R., Lionel, A. C., Stavropoulos, D. J., Scherer, S. W., … Bassett, A. S. (2013). 1q21.1 microduplication expression in adults. Genetics in Medicine, 15(4), 282-289. https://doi.org/10.1038/gim.2012.129</Citation>
        </Reference>
        <Reference>
          <Citation>Edelman, E. A., Girirajan, S., Finucane, B., Patel, P. I., Lupski, J. R., Smith, A. C., … Elsea, S. H. (2007). Gender, genotype, and phenotype differences in Smith-Magenis syndrome: A meta-analysis of 105 cases. Clinical Genetics, 71(6), 540-550. https://doi.org/10.1111/j.1399-0004.2007.00815.x</Citation>
        </Reference>
        <Reference>
          <Citation>Ergul, Y., Nisli, K., Kayserili, H., Karaman, B., Basaran, S., Koca, B., … Dindar, A. (2012). Cardiovascular abnormalities in Williams syndrome: 20 years' experience in Istanbul. Acta Cardiologica, 67(6), 649-655.</Citation>
        </Reference>
        <Reference>
          <Citation>Eronen, M., Peippo, M., Hiippala, A., Raatikka, M., Arvio, M., Johansson, R., … Kahkonen, M. (2002). Cardiovascular manifestations in 75 patients with Williams syndrome. Journal of Medical Genetics, 39(8), 554-558.</Citation>
        </Reference>
        <Reference>
          <Citation>Fakhro, K. A., Choi, M., Ware, S. M., Belmont, J. W., Towbin, J. A., Lifton, R. P., … Brueckner, M. (2011). Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proceedings of the National Academy of Sciences of the United States of America, 108(7), 2915-2920. https://doi.org/10.1073/pnas.1019645108</Citation>
        </Reference>
        <Reference>
          <Citation>Ferencz, C., Boughman, J. A., Neill, C. A., Brenner, J. I., &amp; Perry, L. W. (1989). Congenital cardiovascular malformations: Questions on inheritance. Baltimore-Washington infant study group. Journal of the American College of Cardiology, 14(3), 756-763.</Citation>
        </Reference>
        <Reference>
          <Citation>Ferrero, G. B., Biamino, E., Sorasio, L., Banaudi, E., Peruzzi, L., Forzano, S., … Silengo, M. C. (2007). Presenting phenotype and clinical evaluation in a cohort of 22 Williams-Beuren syndrome patients. European Journal of Medical Genetics, 50(5), 327-337. https://doi.org/10.1016/j.ejmg.2007.05.005</Citation>
        </Reference>
        <Reference>
          <Citation>Fregeau, B., Kim, B. J., Hernandez-Garcia, A., Jordan, V. K., Cho, M. T., Schnur, R. E., … Sherr, E. H. (2016). De novo mutations of RERE cause a genetic syndrome with features that overlap those associated with proximal 1p36 deletions. American Journal of Human Genetics, 98(5), 963-970. https://doi.org/10.1016/j.ajhg.2016.03.002</Citation>
        </Reference>
        <Reference>
          <Citation>Gajecka, M., Mackay, K. L., &amp; Shaffer, L. G. (2007). Monosomy 1p36 deletion syndrome. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 145C(4), 346-356. https://doi.org/10.1002/ajmg.c.30154</Citation>
        </Reference>
        <Reference>
          <Citation>Gao, Z., Kim, G. H., Mackinnon, A. C., Flagg, A. E., Bassett, B., Earley, J. U., … Svensson, E. C. (2010). Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development, 137(9), 1543-1551. https://doi.org/10.1242/dev.047696</Citation>
        </Reference>
        <Reference>
          <Citation>Garg, V., Kathiriya, I. S., Barnes, R., Schluterman, M. K., King, I. N., Butler, C. A., … Srivastava, D. (2003). GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature, 424(6947), 443-447. https://doi.org/10.1038/nature01827</Citation>
        </Reference>
        <Reference>
          <Citation>Gaussin, V., Morley, G. E., Cox, L., Zwijsen, A., Vance, K. M., Emile, L., … Vatner, S. F. (2005). Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circulation Research, 97(3), 219-226. https://doi.org/10.1161/01.RES.0000177862.85474.63</Citation>
        </Reference>
        <Reference>
          <Citation>Greenberg, F., Lewis, R. A., Potocki, L., Glaze, D., Parke, J., Killian, J., … Lupski, J. R. (1996). Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). American Journal of Medical Genetics, 62(3), 247-254.</Citation>
        </Reference>
        <Reference>
          <Citation>Greenway, S. C., Pereira, A. C., Lin, J. C., DePalma, S. R., Israel, S. J., Mesquita, S. M., … Seidman, C. E. (2009). De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nature Genetics, 41(8), 931-935. https://doi.org/10.1038/ng.415</Citation>
        </Reference>
        <Reference>
          <Citation>Grossfeld, P. D., Mattina, T., Lai, Z., Favier, R., Jones, K. L., Cotter, F., … Jones, C. (2004). The 11q terminal deletion disorder: A prospective study of 110 cases. American Journal of Medical Genetics. Part A, 129A(1), 51-61. https://doi.org/10.1002/ajmg.a.30090</Citation>
        </Reference>
        <Reference>
          <Citation>Gu, H., Smith, F. C., Taffet, S. M., &amp; Delmar, M. (2003). High incidence of cardiac malformations in connexin40-deficient mice. Circulation Research, 93(3), 201-206. https://doi.org/10.1161/01.RES.0000084852.65396.70</Citation>
        </Reference>
        <Reference>
          <Citation>Hart, A., Melet, F., Grossfeld, P., Chien, K., Jones, C., Tunnacliffe, A., … Bernstein, A. (2000). Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity, 13(2), 167-177.</Citation>
        </Reference>
        <Reference>
          <Citation>Hartman, R. J., Rasmussen, S. A., Botto, L. D., Riehle-Colarusso, T., Martin, C. L., Cragan, J. D., … Correa, A. (2011). The contribution of chromosomal abnormalities to congenital heart defects: A population-based study. Pediatric Cardiology, 32(8), 1147-1157. https://doi.org/10.1007/s00246-011-0034-5</Citation>
        </Reference>
        <Reference>
          <Citation>Heilstedt, H. A., Ballif, B. C., Howard, L. A., Lewis, R. A., Stal, S., Kashork, C. D., … Shaffer, L. G. (2003). Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. American Journal of Human Genetics, 72(5), 1200-1212. https://doi.org/10.1086/375179</Citation>
        </Reference>
        <Reference>
          <Citation>Hitz, M. P., Lemieux-Perreault, L. P., Marshall, C., Feroz-Zada, Y., Davies, R., Yang, S. W., … Andelfinger, G. (2012). Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genetics, 8(9), e1002903. https://doi.org/10.1371/journal.pgen.1002903</Citation>
        </Reference>
        <Reference>
          <Citation>Hoffman, J. I. (1995). Incidence of congenital heart disease: II. Prenatal incidence. Pediatric Cardiology, 16(4), 155-165.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoffman, J. I., &amp; Kaplan, S. (2002). The incidence of congenital heart disease. Journal of the American College of Cardiology, 39(12), 1890-1900. doi:S0735109702018867 [pii]. https://doi.org/10.1016/s0735-1097(02)01886-7</Citation>
        </Reference>
        <Reference>
          <Citation>Hoffman, J. I., Kaplan, S., &amp; Liberthson, R. R. (2004). Prevalence of congenital heart disease. American Heart Journal, 147(3), 425-439. https://doi.org/10.1016/j.ahj.2003.05.003</Citation>
        </Reference>
        <Reference>
          <Citation>Iascone, M., Ciccone, R., Galletti, L., Marchetti, D., Seddio, F., Lincesso, A. R., … Zuffardi, O. (2012). Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clinical Genetics, 81(6), 542-554. https://doi.org/10.1111/j.1399-0004.2011.01674.x</Citation>
        </Reference>
        <Reference>
          <Citation>Jefferies, J. L., Pignatelli, R. H., Martinez, H. R., Robbins-Furman, P. J., Liu, P., Gu, W., … Potocki, L. (2012). Cardiovascular findings in duplication 17p11.2 syndrome. Genetics in Medicine, 14(1), 90-94. https://doi.org/10.1038/gim.0b013e3182329723</Citation>
        </Reference>
        <Reference>
          <Citation>Jordan, V. K., Fregeau, B., Ge, X., Giordano, J., Wapner, R. J., Balci, T. B., … Scott, D. A. (2018). Genotype-phenotype correlations in individuals with pathogenic RERE variants. Human Mutation, 39(5), 666-675. https://doi.org/10.1002/humu.23400</Citation>
        </Reference>
        <Reference>
          <Citation>Kadalayil, L., Rafiq, S., Rose-Zerilli, M. J., Pengelly, R. J., Parker, H., Oscier, D., … Collins, A. (2015). Exome sequence read depth methods for identifying copy number changes. Briefings in Bioinformatics, 16(3), 380-392. https://doi.org/10.1093/bib/bbu027</Citation>
        </Reference>
        <Reference>
          <Citation>Keating, M. T. (1995). Genetic approaches to cardiovascular disease. Supravalvular aortic stenosis, Williams syndrome, and long-QT syndrome. Circulation, 92(1), 142-147.</Citation>
        </Reference>
        <Reference>
          <Citation>Kerstjens-Frederikse, W. S., Bongers, E. M., Roofthooft, M. T., Leter, E. M., Douwes, J. M., Van Dijk, A., … Berger, R. M. (2013). TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension. Journal of Medical Genetics, 50(8), 500-506. https://doi.org/10.1136/jmedgenet-2012-101152</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, B. J., Zaveri, H. P., Shchelochkov, O. A., Yu, Z., Hernandez-Garcia, A., Seymour, M. L., … Scott, D. A. (2013). An allelic series of mice reveals a role for RERE in the development of multiple organs affected in chromosome 1p36 deletions. PLoS ONE, 8(2), e57460. https://doi.org/10.1371/journal.pone.0057460</Citation>
        </Reference>
        <Reference>
          <Citation>Klaassens, M., Galjaard, R. J., Scott, D. A., Bruggenwirth, H. T., van Opstal, D., Fox, M. V., … de Klein, A. (2007). Prenatal detection and outcome of congenital diaphragmatic hernia (CDH) associated with deletion of chromosome 15q26: Two patients and review of the literature. American Journal of Medical Genetics. Part A, 143A(18), 2204-2212. https://doi.org/10.1002/ajmg.a.31892</Citation>
        </Reference>
        <Reference>
          <Citation>Kleefstra, T., Brunner, H. G., Amiel, J., Oudakker, A. R., Nillesen, W. M., Magee, A., … van Bokhoven, H. (2006). Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. American Journal of Human Genetics, 79(2), 370-377. https://doi.org/10.1086/505693</Citation>
        </Reference>
        <Reference>
          <Citation>Kleefstra, T., van Zelst-Stams, W. A., Nillesen, W. M., Cormier-Daire, V., Houge, G., Foulds, N., … Brunner, H. G. (2009). Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. Journal of Medical Genetics, 46(9), 598-606. https://doi.org/10.1136/jmg.2008.062950</Citation>
        </Reference>
        <Reference>
          <Citation>Koolen, D. A., Kramer, J. M., Neveling, K., Nillesen, W. M., Moore-Barton, H. L., Elmslie, F. V., … de Vries, B. B. (2012). Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nature Genetics, 44(6), 639-641. https://doi.org/10.1038/ng.2262</Citation>
        </Reference>
        <Reference>
          <Citation>Koolen, D. A., Sharp, A. J., Hurst, J. A., Firth, H. V., Knight, S. J., Goldenberg, A., … de Vries, B. B. (2008). Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. Journal of Medical Genetics, 45(11), 710-720. https://doi.org/10.1136/jmg.2008.058701</Citation>
        </Reference>
        <Reference>
          <Citation>Koolen, D. A., Vissers, L. E., Pfundt, R., de Leeuw, N., Knight, S. J., Regan, R., … de Vries, B. B. (2006). A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nature Genetics, 38(9), 999-1001. https://doi.org/10.1038/ng1853</Citation>
        </Reference>
        <Reference>
          <Citation>Kowase, K., Nakamura, T., Okumura, W., Okamoto, E., Yamaguchi, E., Sato, H., … Nagai, R. (1997). Novel deletion on the short arm of chromosome 17 in a patient with multiple cardiac anomalies. Japanese Circulation Journal, 61(10), 882-885.</Citation>
        </Reference>
        <Reference>
          <Citation>Lalani, S. R., Shaw, C., Wang, X., Patel, A., Patterson, L. W., Kolodziejska, K., … Belmont, J. W. (2013). Rare DNA copy number variants in cardiovascular malformations with extracardiac abnormalities. European Journal of Human Genetics, 21(2), 173-181. https://doi.org/10.1038/ejhg.2012.155</Citation>
        </Reference>
        <Reference>
          <Citation>Lalani, S. R., Ware, S. M., Wang, X., Zapata, G., Tian, Q., Franco, L. M., … Belmont, J. W. (2013). MCTP2 is a dosage-sensitive gene required for cardiac outflow tract development. Human Molecular Genetics, 22(21), 4339-4348. https://doi.org/10.1093/hmg/ddt283</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, P., Carvalho, C. M., Hastings, P. J., &amp; Lupski, J. R. (2012). Mechanisms for recurrent and complex human genomic rearrangements. Current Opinion in Genetics &amp; Development, 22(3), 211-220. https://doi.org/10.1016/j.gde.2012.02.012</Citation>
        </Reference>
        <Reference>
          <Citation>Mattina, T., Perrotta, C. S., &amp; Grossfeld, P. (2009). Jacobsen syndrome. Orphanet Journal of Rare Diseases, 4, 9. https://doi.org/10.1186/1750-1172-4-9</Citation>
        </Reference>
        <Reference>
          <Citation>Mefford, H. C., Sharp, A. J., Baker, C., Itsara, A., Jiang, Z., Buysse, K., … Eichler, E. E. (2008). Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. The New England Journal of Medicine, 359(16), 1685-1699. https://doi.org/10.1056/NEJMoa0805384</Citation>
        </Reference>
        <Reference>
          <Citation>Merla, G., Brunetti-Pierri, N., Piccolo, P., Micale, L., &amp; Loviglio, M. N. (2012). Supravalvular aortic stenosis: Elastin arteriopathy. Circulation. Cardiovascular Genetics, 5(6), 692-696. https://doi.org/10.1161/CIRCGENETICS.112.962860</Citation>
        </Reference>
        <Reference>
          <Citation>Metcalfe, K., Rucka, A. K., Smoot, L., Hofstadler, G., Tuzler, G., McKeown, P., … Tassabehji, M. (2000). Elastin: Mutational spectrum in supravalvular aortic stenosis. European Journal of Human Genetics, 8(12), 955-963. https://doi.org/10.1038/sj.ejhg.5200564</Citation>
        </Reference>
        <Reference>
          <Citation>Micale, L., Turturo, M. G., Fusco, C., Augello, B., Jurado, L. A., Izzi, C., … Merla, G. (2010). Identification and characterization of seven novel mutations of elastin gene in a cohort of patients affected by supravalvular aortic stenosis. European Journal of Human Genetics, 18(3), 317-323. https://doi.org/10.1038/ejhg.2009.181</Citation>
        </Reference>
        <Reference>
          <Citation>Mitchell, S. C., Korones, S. B., &amp; Berendes, H. W. (1971). Congenital heart disease in 56,109 births. Incidence and natural history. Circulation, 43(3), 323-332. https://doi.org/10.1161/01.cir.43.3.323</Citation>
        </Reference>
        <Reference>
          <Citation>Morris CA. Williams Syndrome. 1999. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. https://www.ncbi.nlm.nih.gov/books/NBK1249/</Citation>
        </Reference>
        <Reference>
          <Citation>Myers, S. M., &amp; Challman, T. D. (2004). Congenital heart defects associated with Smith-Magenis syndrome: Two cases of total anomalous pulmonary venous return. American Journal of Medical Genetics. Part A, 131(1), 99-100. https://doi.org/10.1002/ajmg.a.30290</Citation>
        </Reference>
        <Reference>
          <Citation>Nemer, G., Fadlalah, F., Usta, J., Nemer, M., Dbaibo, G., Obeid, M., … Bitar, F. (2006). A novel mutation in the GATA4 gene in patients with tetralogy of Fallot. Human Mutation, 27(3), 293-294. https://doi.org/10.1002/humu.9410</Citation>
        </Reference>
        <Reference>
          <Citation>Nicolini, F., Beghi, C., &amp; Gherli, T. (2009). Aortic valve regurgitation in a patient affected by KBG syndrome. The Journal of Heart Valve Disease, 18(1), 122-124.</Citation>
        </Reference>
        <Reference>
          <Citation>Nimmakayalu, M., Major, H., Sheffield, V., Solomon, D. H., Smith, R. J., Patil, S. R., … Shchelochkov, O. A. (2011). Microdeletion of 17q22q23.2 encompassing TBX2 and TBX4 in a patient with congenital microcephaly, thyroid duct cyst, sensorineural hearing loss, and pulmonary hypertension. American Journal of Medical Genetics. Part A, 155A(2), 418-423. https://doi.org/10.1002/ajmg.a.33827</Citation>
        </Reference>
        <Reference>
          <Citation>Novara, F., Rinaldi, B., Sisodiya, S. M., Coppola, A., Giglio, S., Stanzial, F., … Zuffardi, O. (2017). Haploinsufficiency for ANKRD11-flanking genes makes the difference between KBG and 16q24.3 microdeletion syndromes: 12 new cases. European Journal of Human Genetics, 25(6), 694-701. https://doi.org/10.1038/ejhg.2017.49</Citation>
        </Reference>
        <Reference>
          <Citation>Parrott, A., James, J., Goldenberg, P., Hinton, R. B., Miller, E., Shikany, A., … Ware, S. M. (2015). Aortopathy in the 7q11.23 microduplication syndrome. American Journal of Medical Genetics. Part A, 167A(2), 363-370. https://doi.org/10.1002/ajmg.a.36859</Citation>
        </Reference>
        <Reference>
          <Citation>Penny, L. A., Dell'Aquila, M., Jones, M. C., Bergoffen, J., Cunniff, C., Fryns, J. P., … Mattina, T. (1995). Clinical and molecular characterization of patients with distal 11q deletions. American Journal of Human Genetics, 56(3), 676-683.</Citation>
        </Reference>
        <Reference>
          <Citation>Pereira, F. A., Qiu, Y., Zhou, G., Tsai, M. J., &amp; Tsai, S. Y. (1999). The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes &amp; Development, 13(8), 1037-1049.</Citation>
        </Reference>
        <Reference>
          <Citation>Priest, J. R., Girirajan, S., Vu, T. H., Olson, A., Eichler, E. E., &amp; Portman, M. A. (2012). Rare copy number variants in isolated sporadic and syndromic atrioventricular septal defects. American Journal of Medical Genetics. Part A, 158A(6), 1279-1284. https://doi.org/10.1002/ajmg.a.35315</Citation>
        </Reference>
        <Reference>
          <Citation>Rosenfeld, J. A., Crolla, J. A., Tomkins, S., Bader, P., Morrow, B., Gorski, J., … Shaffer, L. G. (2010). Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. American Journal of Medical Genetics. Part A, 152A(8), 1951-1959. https://doi.org/10.1002/ajmg.a.33516</Citation>
        </Reference>
        <Reference>
          <Citation>Sacharow, S., Li, D., Fan, Y. S., &amp; Tekin, M. (2012). Familial 16q24.3 microdeletion involving ANKRD11 causes a KBG-like syndrome. American Journal of Medical Genetics. Part A, 158A(3), 547-552. https://doi.org/10.1002/ajmg.a.34436</Citation>
        </Reference>
        <Reference>
          <Citation>Samarakoon, P. S., Sorte, H. S., Kristiansen, B. E., Skodje, T., Sheng, Y., Tjonnfjord, G. E., … Lyle, R. (2014). Identification of copy number variants from exome sequence data. BMC Genomics, 15, 661. https://doi.org/10.1186/1471-2164-15-661</Citation>
        </Reference>
        <Reference>
          <Citation>Sanchez-Valle, A., Pierpont, M. E., &amp; Potocki, L. (2011). The severe end of the spectrum: Hypoplastic left heart in Potocki-Lupski syndrome. American Journal of Medical Genetics. Part A, 155A(2), 363-366. https://doi.org/10.1002/ajmg.a.33844</Citation>
        </Reference>
        <Reference>
          <Citation>Scott, D. A., Klaassens, M., Holder, A. M., Lally, K. P., Fernandes, C. J., Galjaard, R. J., … Lee, B. (2007). Genome-wide oligonucleotide-based array comparative genome hybridization analysis of non-isolated congenital diaphragmatic hernia. Human Molecular Genetics, 16(4), 424-430. https://doi.org/10.1093/hmg/ddl475</Citation>
        </Reference>
        <Reference>
          <Citation>Silversides, C. K., Lionel, A. C., Costain, G., Merico, D., Migita, O., Liu, B., … Bassett, A. S. (2012). Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS Genetics, 8(8), e1002843. https://doi.org/10.1371/journal.pgen.1002843</Citation>
        </Reference>
        <Reference>
          <Citation>Sirmaci, A., Spiliopoulos, M., Brancati, F., Powell, E., Duman, D., Abrams, A., … Tekin, M. (2011). Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. American Journal of Human Genetics, 89(2), 289-294. https://doi.org/10.1016/j.ajhg.2011.06.007</Citation>
        </Reference>
        <Reference>
          <Citation>Slavotinek, A. M., Moshrefi, A., Davis, R., Leeth, E., Schaeffer, G. B., Burchard, G. E., … Pennacchio, L. A. (2006). Array comparative genomic hybridization in patients with congenital diaphragmatic hernia: Mapping of four CDH-critical regions and sequencing of candidate genes at 15q26.1-15q26.2. European Journal of Human Genetics, 14(9), 999-1008. https://doi.org/10.1038/sj.ejhg.5201652</Citation>
        </Reference>
        <Reference>
          <Citation>Smith, A. C., McGavran, L., Robinson, J., Waldstein, G., Macfarlane, J., Zonona, J., … Magenis, E. (1986). Interstitial deletion of (17)(p11.2p11.2) in nine patients. American Journal of Medical Genetics, 24(3), 393-414. https://doi.org/10.1002/ajmg.1320240303</Citation>
        </Reference>
        <Reference>
          <Citation>Song, L., Fassler, R., Mishina, Y., Jiao, K., &amp; Baldwin, H. S. (2007). Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. Developmental Biology, 301(1), 276-286. https://doi.org/10.1016/j.ydbio.2006.08.004</Citation>
        </Reference>
        <Reference>
          <Citation>Stefansson, H., Helgason, A., Thorleifsson, G., Steinthorsdottir, V., Masson, G., Barnard, J., … Stefansson, K. (2005). A common inversion under selection in Europeans. Nature Genetics, 37(2), 129-137. https://doi.org/10.1038/ng1508</Citation>
        </Reference>
        <Reference>
          <Citation>Steinberg, K. M., Antonacci, F., Sudmant, P. H., Kidd, J. M., Campbell, C. D., Vives, L., … Eichler, E. E. (2012). Structural diversity and African origin of the 17q21.31 inversion polymorphism. Nature Genetics, 44(8), 872-880. https://doi.org/10.1038/ng.2335</Citation>
        </Reference>
        <Reference>
          <Citation>Stromme, P., Bjornstad, P. G., &amp; Ramstad, K. (2002). Prevalence estimation of Williams syndrome. Journal of Child Neurology, 17(4), 269-271.</Citation>
        </Reference>
        <Reference>
          <Citation>Sweeney, E., Peart, I., Tofeig, M., &amp; Kerr, B. (1999). Smith-Magenis syndrome and tetralogy of Fallot. Journal of Medical Genetics, 36(6), 501-502.</Citation>
        </Reference>
        <Reference>
          <Citation>Tan, T. Y., Aftimos, S., Worgan, L., Susman, R., Wilson, M., Ghedia, S., … Peters, G. (2009). Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome. Journal of Medical Genetics, 46(7), 480-489. https://doi.org/10.1136/jmg.2008.065391</Citation>
        </Reference>
        <Reference>
          <Citation>Tassabehji, M., Metcalfe, K., Donnai, D., Hurst, J., Reardon, W., Burch, M., … Read, A. P. (1997). Elastin: Genomic structure and point mutations in patients with supravalvular aortic stenosis. Human Molecular Genetics, 6(7), 1029-1036.</Citation>
        </Reference>
        <Reference>
          <Citation>Thienpont, B., Mertens, L., de Ravel, T., Eyskens, B., Boshoff, D., Maas, N., … Devriendt, K. (2007). Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. European Heart Journal, 28(22), 2778-2784. https://doi.org/10.1093/eurheartj/ehl560</Citation>
        </Reference>
        <Reference>
          <Citation>Thienpont, B., Zhang, L., Postma, A. V., Breckpot, J., Tranchevent, L. C., Van Loo, P., … Larsen, L. A. (2010). Haploinsufficiency of TAB2 causes congenital heart defects in humans. American Journal of Human Genetics, 86(6), 839-849. https://doi.org/10.1016/j.ajhg.2010.04.011</Citation>
        </Reference>
        <Reference>
          <Citation>Thomas, D. G., Jacques, S. M., Flore, L. A., Feldman, B., Evans, M. I., &amp; Qureshi, F. (2000). Prenatal diagnosis of smith-magenis syndrome (del 17p11.2). Fetal Diagnosis and Therapy, 15(6), 335-337.</Citation>
        </Reference>
        <Reference>
          <Citation>Torfs, C. P., &amp; Christianson, R. E. (1998). Anomalies in down syndrome individuals in a large population-based registry. American Journal of Medical Genetics, 77(5), 431-438. https://doi.org/10.1002/(SICI)1096-8628(19980605)77:5&lt;431::AID-AJMG15&gt;3.0.CO;2-J</Citation>
        </Reference>
        <Reference>
          <Citation>Tumer, Z., Harboe, T. L., Blennow, E., Kalscheuer, V. M., Tommerup, N., &amp; Brondum-Nielsen, K. (2004). Molecular cytogenetic characterization of ring chromosome 15 in three unrelated patients. American Journal of Medical Genetics. Part A, 130A(4), 340-344. https://doi.org/10.1002/ajmg.a.30035</Citation>
        </Reference>
        <Reference>
          <Citation>van Bon, B. W., Balciuniene, J., Fruhman, G., Nagamani, S. C., Broome, D. L., Cameron, E., … de Vries, B. B. (2011). The phenotype of recurrent 10q22q23 deletions and duplications. European Journal of Human Genetics, 19(4), 400-408. https://doi.org/10.1038/ejhg.2010.211</Citation>
        </Reference>
        <Reference>
          <Citation>Van der Aa, N., Rooms, L., Vandeweyer, G., van den Ende, J., Reyniers, E., Fichera, M., … Kooy, R. F. (2009). Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. European Journal of Medical Genetics, 52(2-3), 94-100. https://doi.org/10.1016/j.ejmg.2009.02.006</Citation>
        </Reference>
        <Reference>
          <Citation>Warburton, D., Ronemus, M., Kline, J., Jobanputra, V., Williams, I., Anyane-Yeboa, K., … Levy, D. (2014). The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Human Genetics, 133(1), 11-27. https://doi.org/10.1007/s00439-013-1353-9</Citation>
        </Reference>
        <Reference>
          <Citation>Wat, M. J., Shchelochkov, O. A., Holder, A. M., Breman, A. M., Dagli, A., Bacino, C., … Kang, S. H. (2009). Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. American Journal of Medical Genetics. Part A, 149A(8), 1661-1677. https://doi.org/10.1002/ajmg.a.32896</Citation>
        </Reference>
        <Reference>
          <Citation>Weiss, K., Applegate, C., Wang, T., &amp; Batista, D. A. (2015). Familial TAB2 microdeletion and congenital heart defects including unusual valve dysplasia and tetralogy of fallot. American Journal of Medical Genetics. Part A, 167A(11), 2702-2706. https://doi.org/10.1002/ajmg.a.37210</Citation>
        </Reference>
        <Reference>
          <Citation>Willemsen, M. H., Fernandez, B. A., Bacino, C. A., Gerkes, E., de Brouwer, A. P., Pfundt, R., … Kleefstra, T. (2010). Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome. European Journal of Human Genetics, 18(4), 429-435. https://doi.org/10.1038/ejhg.2009.192</Citation>
        </Reference>
        <Reference>
          <Citation>Willemsen, M. H., Vulto-van Silfhout, A. T., Nillesen, W. M., Wissink-Lindhout, W. M., van Bokhoven, H., Philip, N., … Kleefstra, T. (2012). Update on Kleefstra Syndrome. Molecular Syndromology, 2(3-5), 202 -212.</Citation>
        </Reference>
        <Reference>
          <Citation>Wong, J. T., Chan, D. K., Wong, K. Y., Tan, M., Rudduck, C., &amp; Tien, S. L. (2003). Smith-Magenis syndrome and cyanotic congenital heart disease: A case report. Clinical Dysmorphology, 12(1), 73-74. https://doi.org/10.1097/01.mcd.0000046500.61757.80</Citation>
        </Reference>
        <Reference>
          <Citation>Ye, M., Coldren, C., Liang, X., Mattina, T., Goldmuntz, E., Benson, D. W., … Grossfeld, P. (2010). Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Human Molecular Genetics, 19(4), 648-656. https://doi.org/10.1093/hmg/ddp532</Citation>
        </Reference>
        <Reference>
          <Citation>Yusupov, R., Roberts, A. E., Lacro, R. V., Sandstrom, M., &amp; Ligon, A. H. (2011). Potocki-Lupski syndrome: An inherited dup(17)(p11.2p11.2) with hypoplastic left heart. American Journal of Medical Genetics. Part A, 155A(2), 367-371. https://doi.org/10.1002/ajmg.a.33845</Citation>
        </Reference>
        <Reference>
          <Citation>Zaidi, S., Choi, M., Wakimoto, H., Ma, L., Jiang, J., Overton, J. D., … Lifton, R. P. (2013). De novo mutations in histone-modifying genes in congenital heart disease. Nature, 498(7453), 220-223. https://doi.org/10.1038/nature12141</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, Y., Li, Y., Wang, Y., Shan, B., &amp; Duan, Y. (2013). 8p23.1 duplication detected by array-CGH with complete atrioventricular septal defect and unilateral hand preaxial hexadactyly. American Journal of Medical Genetics. Part A, 161A(3), 561-565. https://doi.org/10.1002/ajmg.a.35596</Citation>
        </Reference>
        <Reference>
          <Citation>Zollino, M., Orteschi, D., Murdolo, M., Lattante, S., Battaglia, D., Stefanini, C., … Marangi, G. (2012). Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nature Genetics, 44(6), 636-638. https://doi.org/10.1038/ng.2257</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909883</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1864-564X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>ChemSusChem</Title>
          <ISOAbbreviation>ChemSusChem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Novel Aqueous Biphasic System Using Poly(Ionic Liquid)s with Controllable Structure for Highly Efficient Extractions.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cssc.201902214</ELocationID>
        <Abstract>
          <AbstractText>Ionic liquids (ILs) based aqueous biphasic systems (ABSs) provide a sustainable and efficient alternative to conventional liquid-liquid extraction techniques, and can be used for the extraction, recovery, and purification of diverse solutes. Yet constructing a high-performance ABS showing excellent phase splitting ability and extraction performance remains challenging. In this work, we proposed a family of novel ABSs based on poly(ionic liquids) (PILs) with the customized structure and controllable molecular weight for bioactive compound extraction. Several tailor-made PILs consisting of hydrophobic backbone, hydrophilic imidazolium pendant groups and strong hydrogen bond basic counter-anions were prepared by reversible addition fragmentation chain transfer (RAFT) polymerization that perfectly balance their hydrophobicity-hydrophilicity and functionality, affording outstanding phase splitting ability, which was better than both IL monomer and normal free radical polymer.  More importantly, PIL-based ABSs exhibited unprecedented high partition coefficient for six bioactive compounds, tryptophan, phenylalanine, etc. , as well as high extraction yield. The performance of PIL-based ABSs could be tuned by changing the PIL features, i.e. molecular weight and anionic character. This work not only reveals tailor-made PIL-based ABSs are promising platform for bioactive compound extraction, but also provides significant clues for the design of new ABSs for various applications.</AbstractText>
          <CopyrightInformation>© 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xing</LastName>
            <ForeName>Huabin</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Zhejiang University, College of Chemical and Biological Engineering, 38 Zheda Road, 310027, Hangzhou, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ke</LastName>
            <ForeName>Yuqi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Zhejiang University, College of Chemical and Biological Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jingzhu</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Zhejiang University, College of Chemical and Biological Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Yuanbang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Zhejiang University, College of Chemical and Biological Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Qiwei</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Zhejiang University, College of Chemical and Biological Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Qilong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Zhejiang University, College of Chemical and Biological Engineering, CHINA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>ChemSusChem</MedlineTA>
        <NlmUniqueID>101319536</NlmUniqueID>
        <ISSNLinking>1864-5631</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ionic liquids</Keyword>
        <Keyword MajorTopicYN="N">Poly(ionic liquid)s</Keyword>
        <Keyword MajorTopicYN="N">aqueous biphasic system</Keyword>
        <Keyword MajorTopicYN="N">separation</Keyword>
        <Keyword MajorTopicYN="N">sustainable chemistry</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909883</ArticleId>
        <ArticleId IdType="doi">10.1002/cssc.201902214</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909884</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1522-726X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions</Title>
          <ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.28722</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The FUTURE-I study aimed to assess preliminary safety and effectiveness with the long-term clinical and imaging follow-up for the Firesorb (MicroPort, Shanghai, China), a thinner-strut sirolimus-eluting bioresorbable scaffold (BRS).</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">First-generation BRS has been associated with unexpected device-related adverse outcomes at long-term follow-up.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective, open-label, first-in-man study, patients with single de novo lesions in native coronary arteries were randomized 2:1 into two cohorts after successful Firesorb implantation: cohort 1 (n = 30) underwent multimodality imaging assessment at 6 and 24 months; and cohort 2 (n = 15) at 12 and 36 months. All patients underwent clinical follow-up at 1, 6, and 12 months and annually up to 5 years.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Between January and March 2016, 45 patients were enrolled. At 3-year follow-up, one patient had experienced target lesion failure and none scaffold thrombosis. In-scaffold minimal lumen diameter decreased significantly from 6-month to 2-year (2.53 ± 0.24 mm vs. 2.27 ± 0.37 mm, p = .0003), and only numerically from 1-year to 3-year follow-up (2.48 ± 0.28 mm vs. 2.22 ± 0.13 mm, p = .08). By optical coherence tomography, neointimal strut coverage at 3-year follow-up was 99.8%, and very low rate of late scaffold discontinuity was observed, only in one patient on two cross sections with three malapposed struts.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">At 3-year follow-up of the FUTURE-I study, implantation of the thinner-strut Firesorb BRS appeared preliminary feasible and effective in the treatment of patients with noncomplex coronary lesions.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Zhongwei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Changdong</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Hongbing</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Mengyue</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Jingang</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mu</LastName>
            <ForeName>Chaowei</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiu</LastName>
            <ForeName>Hong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Yida</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yanyan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiao</LastName>
            <ForeName>Shubin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suryapranata</LastName>
            <ForeName>Harry</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Runlin</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1165-7302</Identifier>
            <AffiliationInfo>
              <Affiliation>Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Clinical Research Center for Cardiovascular Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>FUTURE-I Investigators</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Catheter Cardiovasc Interv</MedlineTA>
        <NlmUniqueID>100884139</NlmUniqueID>
        <ISSNLinking>1522-1946</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">bioresorbable scaffold</Keyword>
        <Keyword MajorTopicYN="N">intravascular ultrasound</Keyword>
        <Keyword MajorTopicYN="N">optical coherence tomography</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909884</ArticleId>
        <ArticleId IdType="doi">10.1002/ccd.28722</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Bangalore S, Bezerra HG, Rizik DG, et al. The state of the absorb bioresorbable scaffold: consensus from an expert panel. JACC Cardiovasc Interv. 2017;10(23):2349-2359.</Citation>
        </Reference>
        <Reference>
          <Citation>Ali ZA, Serruys PW, Kimura T, et al. 2-year outcomes with the absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet. 2017;390(10096):760-772.</Citation>
        </Reference>
        <Reference>
          <Citation>Tenekecioglu E, Torii R, Katagiri Y, Asano T, Modolo R, Miyazaki Y, Chichareon P, Poon EKW, Gijsen F, Thondapu V and others. Early strut protrusion and late neointima thickness in absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years. EuroIntervention. 2019;15(4):e370-e379.</Citation>
        </Reference>
        <Reference>
          <Citation>Stone GW, Abizaid A, Onuma Y, et al. Effect of technique on outcomes following Bioresorbable vascular scaffold implantation: analysis from the ABSORB trials. J Am Coll Cardiol. 2017;70(23):2863-2874.</Citation>
        </Reference>
        <Reference>
          <Citation>Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, van Es GA, Zuckerman B and others. Standardized end point definitions for coronary intervention trials: the academic research Consortium-2 consensus document. Circulation. 2018;137(24):2635-2650.</Citation>
        </Reference>
        <Reference>
          <Citation>Mintz GS, Garcia-Garcia HM, Nicholls SJ, et al. Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention. 2011;6(9):1123-1130.</Citation>
        </Reference>
        <Reference>
          <Citation>Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59(12):1058-1072.</Citation>
        </Reference>
        <Reference>
          <Citation>Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hebert K and others. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373(9667):897-910.</Citation>
        </Reference>
        <Reference>
          <Citation>Garcia-Garcia HM, Serruys PW, Campos CM, et al. Assessing bioresorbable coronary devices: methods and parameters. JACC Cardiovasc Imaging. 2014;7(11):1130-1148.</Citation>
        </Reference>
        <Reference>
          <Citation>Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM and others. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37(5):1478-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Abizaid A, Costa RA, Schofer J, Ormiston J, Maeng M, Witzenbichler B, Botelho RV, Costa JR, Jr., Chamie D, Abizaid AS and others. Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve Novolimus-eluting bioresorbable coronary scaffold system for the treatment of single de novo coronary lesions. JACC Cardiovasc Interv. 2016;9(6):565-74.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, Adriaenssens T, Loh JP, Lattuca B, Wykrzykowska JJ and others. Mechanisms of very late bioresorbable scaffold thrombosis: the INVEST registry. J Am Coll Cardiol. 2017;70(19):2330-2344.</Citation>
        </Reference>
        <Reference>
          <Citation>Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, Garcia-Garcia HM, Regar E, Kamberi M, Powers JC, Rapoza R and others. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation. 2010;122(22):2288-300.</Citation>
        </Reference>
        <Reference>
          <Citation>Serruys PW, Chevalier B, Dudek D, Cequier A, Carrie D, Iniguez A, Dominici M, van der Schaaf RJ, Haude M, Wasungu L and others. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet. 2015;385(9962):43-54.</Citation>
        </Reference>
        <Reference>
          <Citation>Han Y, Xu B, Fu G, et al. A randomized trial comparing the NeoVas Sirolimus-eluting bioresorbable scaffold and metallic everolimus-eluting stents. JACC Cardiovasc Interv. 2018;11(3):260-272.</Citation>
        </Reference>
        <Reference>
          <Citation>Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Igarashi K and others. Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial. EuroIntervention. 2016;12(9):1090-1101.</Citation>
        </Reference>
        <Reference>
          <Citation>Seth A, Onuma Y, Chandra P, Bahl VK, Manjunath CN, Mahajan AU, Kumar V, Goel PK, Wander GS, Kaul U and others. Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial. EuroIntervention. 2019;15(7):607-614.</Citation>
        </Reference>
        <Reference>
          <Citation>Kocka V, Maly M, Tousek P, et al. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'. Eur Heart J. 2014;35(12):787-794.</Citation>
        </Reference>
        <Reference>
          <Citation>Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Smits PC, Chevalier B and others. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2014;7(12):1400-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Raber L, Brugaletta S, Yamaji K, O'Sullivan CJ, Otsuki S, Koppara T, Taniwaki M, Onuma Y, Freixa X, Eberli FR and others. Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings. J Am Coll Cardiol. 2015;66(17):1901-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Puricel S, Cuculi F, Weissner M, Schmermund A, Jamshidi P, Nyffenegger T, Binder H, Eggebrecht H, Munzel T, Cook S and others. Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors. J Am Coll Cardiol. 2016;67(8):921-31.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909885</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1755-148X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pigment cell &amp; melanoma research</Title>
          <ISOAbbreviation>Pigment Cell Melanoma Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Extracellular vesicles released by melanocytes after UVA irradiation promote intercellular signaling via miR21.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/pcmr.12860</ELocationID>
        <Abstract>
          <AbstractText>Skin pigmentation is controlled by complex crosstalk between melanocytes and keratinocytes and is primarily induced by exposure to ultraviolet (UV) irradiation. Several aspects of UVA-induced signaling remain to be explored. In skin cells, UVA induces plasma membrane damage, which is repaired by lysosomal exocytosis followed by instant shedding of extracellular vesicles (EVs) from the plasma membrane. The released EVs are taken up by neighboring cells. To elucidate the intercellular crosstalk induced by UVA irradiation, EVs were purified from UVA-exposed melanocytes and added to keratinocytes. Transcriptome analysis of the keratinocytes revealed activation of TGF-β and IL-6/STAT3-signaling pathways and subsequent up-regulation of microRNA (miR)21. EVs induced phosphorylation of ERK and JNK, reduced protein levels of PDCD4 and PTEN and augment anti-apoptotic signaling. Consequently, keratinocyte proliferation and migration were stimulated and UV-induced apoptosis was significantly reduced. Interestingly, melanoma cells and melanoma spheroids also generate increased amounts of EVs with capacity to stimulate proliferation and migration upon UVA. In conclusion, we present a novel intercellular crosstalk mediated by UVA-induced lysosome-derived EVs leading to activation of proliferation and anti-apoptotic signaling via miR21.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wäster</LastName>
            <ForeName>Petra</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Pathology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eriksson</LastName>
            <ForeName>Ida</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Pathology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vainikka</LastName>
            <ForeName>Linda</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4371-1238</Identifier>
            <AffiliationInfo>
              <Affiliation>Experimental Pathology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Öllinger</LastName>
            <ForeName>Karin</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-4075-159X</Identifier>
            <AffiliationInfo>
              <Affiliation>Experimental Pathology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Pigment Cell Melanoma Res</MedlineTA>
        <NlmUniqueID>101318927</NlmUniqueID>
        <ISSNLinking>1755-1471</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">UV</Keyword>
        <Keyword MajorTopicYN="N">extracellular vesicles</Keyword>
        <Keyword MajorTopicYN="N">keratinocytes</Keyword>
        <Keyword MajorTopicYN="N">melanocytes</Keyword>
        <Keyword MajorTopicYN="N">miR21</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909885</ArticleId>
        <ArticleId IdType="doi">10.1111/pcmr.12860</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909887</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0496</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric pulmonology</Title>
          <ISOAbbreviation>Pediatr. Pulmonol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pharmacokinetics of isoniazid in children with tuberculosis-A comparative study at two doses.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.24624</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To compare the pharmacokinetics of isoniazid (INH) at doses 5 and 10 mg/kg/day.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">INH concentrations were estimated by high-performance liquid chromatography in 24 Indian children aged 1 to 15 years on antituberculosis therapy. Blood samples were collected at 0, 2, 4, 6, 8 hours after administration of INH. Patients were randomly given INH at 5 or 10 mg/kg/day and maximum concentrations (C<sub>max</sub> ) and area under the curve (AUC<sub>(0-8)</sub> ) were determined in each group. The 2-hour concentration of INH was used as C<sub>max</sub> for this study.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean (standard deviation) C<sub>max</sub> was reached in 2 hours and was 2.68 ± 1.19 µg/mL in 5 mg/kg/day group and 8.86 ± 3.94 µg/mL in 10 mg/kg/day group (P &lt; .05). The normal therapeutic range at 2-hour concentrations for INH in adults achieving good clinical response is between 3 and 5 µg/mL. Among 5 mg/kg/day, only 4 (33%) patients had INH concentrations within the 2-hour concentrations therapeutic range whereas in 10 mg/kg/day group, 11 (91%) patients achieved C<sub>max</sub> higher than the 2-hour concentrations therapeutic range and 1 (9%) patient had C<sub>max</sub> within the 2-hour concentrations therapeutic range. The mean AUC<sub>(0-8)</sub> in 5 mg/kg/day group was 10.04 ± 6.12 and 35.93 ± 25.37 µg·h/mL in 10 mg/kg/day group (P = .0001).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Children on daily INH 10 mg/kg/day have higher AUC and C<sub>max</sub> than the required therapeutic range whereas over 65% of children with daily 5 mg/kg/day INH therapy failed to achieve the optimal therapeutic range.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shah</LastName>
            <ForeName>Ira</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric TB Clinic, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kumar Das</LastName>
            <ForeName>Sajal</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric TB Clinic, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shetty</LastName>
            <ForeName>Naman S</ForeName>
            <Initials>NS</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-3600-126X</Identifier>
            <AffiliationInfo>
              <Affiliation>Pediatric TB Clinic, Department of Pediatric Infectious Diseases, B J Wadia Hospital for Children, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kannan</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Pharmacology, National Institute for Research in Tuberculosis, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramachandran</LastName>
            <ForeName>Geetha</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Pharmacology, National Institute for Research in Tuberculosis, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kumar</LastName>
            <ForeName>Ak Hemanth</ForeName>
            <Initials>AH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Pharmacology, National Institute for Research in Tuberculosis, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Pulmonol</MedlineTA>
        <NlmUniqueID>8510590</NlmUniqueID>
        <ISSNLinking>1099-0496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">INH</Keyword>
        <Keyword MajorTopicYN="N">Indian children</Keyword>
        <Keyword MajorTopicYN="N">pharmacokinetics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909887</ArticleId>
        <ArticleId IdType="doi">10.1002/ppul.24624</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Schaaf HS, Parkin DP, Seifart HI, et al. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child. 2005;90:614-618.</Citation>
        </Reference>
        <Reference>
          <Citation>Pickering LK, ed. Tuberculosis. Red Book. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:642-660.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Morb Mortal Wkly Rep. 2000;49:1-51.</Citation>
        </Reference>
        <Reference>
          <Citation>McIlleron H, Willemse M, Cilliers K, et al. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis. 2009;48:1547-1553.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (WHO). Report of the meeting on TB medicines for children. Geneva, Switzerland. 2008.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (WHO). Guidance for National Tuberculosis Programmes for the Management of Tuberculosis in Children. Geneva, Switzerland: World Health Organization; 2006. http://whqlibdoc.who.int/hq/2006/WHO.HTM.TB.2006.371.eng.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs. 2002;62:2169-2183.</Citation>
        </Reference>
        <Reference>
          <Citation>Shah I, Jadhao N, Mali N, Deshpande S, Gogtay N, Thatte U. Pharmacokinetics of isoniazid in Indian children with tuberculosis on daily treatment. Int J Tuberc Lung Dis. 2019;23(1):52-57.</Citation>
        </Reference>
        <Reference>
          <Citation>Roy V, Tekur U, Chopra K. Pharmacokinetics of isoniazid in pulmonary tuberculosis-a comparative study at two dose levels. Indian Pediatr. 1996;33:287-292.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva, Switzerland: World Health Organization; 2014. http://apps.who.int/medicinedocs/documents/s21535en/s21535en.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Kumar A, Gupta D, Nagaraja SB, Singh V, Sethi GR, Prasad J. Updated national guidelines for pediatric tuberculosis in India, 2012. Indian Pediatr. 2013;50:301-306.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (WHO) Growth charts. http://www.who.int/childgrowth/standards/weight_for_age/en. Accessed June 1, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Khadilkar V, Yadav S, Agrawal KK, et al. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian Children. Indian Pediatr. 2015;52(1):47-55.</Citation>
        </Reference>
        <Reference>
          <Citation>Randomisation And Online Databases For Clinical Trials. https://www.sealedenvelope.com/. Accessed May 1, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Hemanth A, Sudha V, Ramachandran G. Simple and rapid liquid chromatography method for simultaneous determination of isoniazid and pyrazinamide in plasma. SAARC J Tuber Lung Dis HIV/AIDS. 2012;9(1):13-18.</Citation>
        </Reference>
        <Reference>
          <Citation>Kiser JJ, Zhu R, D'Argenio DZ, et al. Isoniazid pharmacokinetics, pharmacodynamics and dosing in South African infants. Ther Drug Monit. 2012;34:446-451.</Citation>
        </Reference>
        <Reference>
          <Citation>Pea F, Milaneschi R, Baraldo M, Talmassons G, Furlanut M. Isoniazid and its hydrazine metabolite in patients with tuberculosis. Clin Drug Investig. 1999;17:145-154.</Citation>
        </Reference>
        <Reference>
          <Citation>Mitchison DA. Role of individual drugs in chemotherapy of tuberculosis. Int J Tuberc Lung Dis. 2000;4:796-806.</Citation>
        </Reference>
        <Reference>
          <Citation>Ramachandran G, Kumar AH, Srinivasan R, et al. Effect of rifampicin &amp; isoniazid on the steady state pharmacokinetics of moxifloxacin. Indian J Med Res. 2012;136:979.</Citation>
        </Reference>
        <Reference>
          <Citation>Mukherjee A, Velpandian T, Singla M, Kanhiya K, Kabra SK, Lodha R. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children. BMC Infect Dis. 2015;15(1):126.</Citation>
        </Reference>
        <Reference>
          <Citation>Ramachandran G, Hemanth Kumar AK, Bhavani PK, et al. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children. Int J Tuberc Lung Dis. 2013;17:800-806.</Citation>
        </Reference>
        <Reference>
          <Citation>Seth V, Beotra A, Seth SD, et al. Serum concentrations of rifampicin and isoniazid in tuberculosis. Indian Pediatr. 1993;30:1091-1098.</Citation>
        </Reference>
        <Reference>
          <Citation>Thee S, Seddon JA, Donald PR, et al. Pharmacokinetic of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. Antimicrob Agents Chemother. 2011;55:5560-5567.</Citation>
        </Reference>
        <Reference>
          <Citation>Graham SM, Bell DJ, Nyirongo S, Hartkoorn R, Ward SA, Molyneux EM. Low levels pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status and human immunodeficiency virus infection. Antimicrob Agents Chemother. 2006;50:407-413.</Citation>
        </Reference>
        <Reference>
          <Citation>Henegar C, Behets F, Vanden Driessche K, Tabala M, Van Rie A. Impact of HIV on clinical presentation and outcomes of tuberculosis treatment at primary care level. Int J Tuberc Lung Dis. 2013;17:1411-1413.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909886</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1939-3806</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Autism research : official journal of the International Society for Autism Research</Title>
          <ISOAbbreviation>Autism Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Magnetic Resonance Spectroscopy Study of Superior Visual Search Abilities in Children with Autism Spectrum Disorder.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/aur.2258</ELocationID>
        <Abstract>
          <AbstractText>Although diagnosed on the basis of deficits in social communication and interaction, autism spectrum disorder (ASD) is also characterized by superior performance on a variety of visuospatial tasks, including visual search. In neurotypical individuals, region-specific concentrations of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) are associated with individual differences in attention and perception. While it has been hypothesized that ASD may be associated with an excitatory-inhibitory imbalance, it remains unclear how this may contribute to accelerated visual search performance in individuals with ASD. To investigate this, 21 children with ASD and 20 typically developing children participated in a visual search task and a magnetic resonance spectroscopy study to detect neurochemical concentrations, including GABA. Region-specific neurochemicals were examined in the right frontal eye fields, right temporal-parietal junction (rTPJ), and bilateral visual cortex (VIS). GABA concentrations did not differ between groups; however, in children with ASD, greater GABA concentration in the VIS was related to more efficient search. Additionally, lower VIS GABA levels were also associated with increased social impairment. Finally, we found reduced N-acetyl aspartate, total creatine, glutamate and glutamine (Glx), GABA/Glx in the rTPJ, suggestive of neuronal dysfunction in a critical network hub. Our results show that GABA concentrations in the VIS are related to efficient search in ASD, thus providing further evidence of enhanced discrimination in ASD. Autism Res 2019, 00: 1-13. © 2019 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: Children with autism spectrum disorder (ASD) often perform better than their non-ASD peers on visual search tasks; however, it is unclear how they achieve this superior performance. Using magnetic resonance spectroscopy to measure neurochemicals in the brain, we found that the level of one, gamma-aminobutyric acid, in the visual cortex was directly related to search abilities in children with ASD. These results suggest that faster search may relate to enhanced perceptual functioning in children with ASD.</AbstractText>
          <CopyrightInformation>© 2019 International Society for Autism Research, Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Edmondson</LastName>
            <ForeName>David A</ForeName>
            <Initials>DA</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7380-2843</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, Purdue University, West Lafayette, Indiana.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Imaging Research Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Pingyu</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, Purdue University, West Lafayette, Indiana.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McNally Keehn</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dydak</LastName>
            <ForeName>Ulrike</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, Purdue University, West Lafayette, Indiana.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Keehn</LastName>
            <ForeName>Brandon</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0001-8796-2250</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Speech, Language, and Hearing Sciences, Purdue University, West Lafayette, Indiana.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychological Sciences, Purdue University, West Lafayette, Indiana.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>F31 ES028081</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21-MH114095</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>209257</GrantID>
            <Agency>Purdue Institute for Integrative Neuroscience</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Autism Res</MedlineTA>
        <NlmUniqueID>101461858</NlmUniqueID>
        <ISSNLinking>1939-3806</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">autism spectrum disorder</Keyword>
        <Keyword MajorTopicYN="N">frontal eye field</Keyword>
        <Keyword MajorTopicYN="N">gamma-aminobutyric acid</Keyword>
        <Keyword MajorTopicYN="N">magnetic resonance spectroscopy</Keyword>
        <Keyword MajorTopicYN="N">temporal-parietal junction</Keyword>
        <Keyword MajorTopicYN="N">visual cortex</Keyword>
        <Keyword MajorTopicYN="N">visual search</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909886</ArticleId>
        <ArticleId IdType="doi">10.1002/aur.2258</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Andreychenko, A., Boer, V. O., Arteaga De Castro, C. S., Luijten, P. R., &amp; Klomp, D. W. J. (2012). Efficient spectral editing at 7 T: GABA detection with MEGA-sLASER. Magnetic Resonance in Medicine, 68(4), 1018-1025. https://doi.org/10.1002/mrm.24131</Citation>
        </Reference>
        <Reference>
          <Citation>APA. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.</Citation>
        </Reference>
        <Reference>
          <Citation>Bejjani, A., O'Neill, J., Kim, J. A., Frew, A. J., Yee, V. W., Ly, R., … Levitt, J. G. (2012). Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. PLoS One, 7(7), e38786. https://doi.org/10.1371/journal.pone.0038786</Citation>
        </Reference>
        <Reference>
          <Citation>Blaser, E., Eglington, L., Carter, A. S., &amp; Kaldy, Z. (2014). Pupillometry reveals a mechanism for the autism spectrum disorder (ASD) advantage in visual tasks. Scientific Reports, 4, 1-5. https://doi.org/10.1038/srep04301</Citation>
        </Reference>
        <Reference>
          <Citation>Brix, M. K., Ersland, L., Hugdahl, K., Grüner, R., Posserud, M.-B., Hammar, Å., … Beyer, M. K. (2015). Brain MR spectroscopy in autism spectrum disorder-The GABA excitatory/inhibitory imbalance theory revisited. Frontiers in Human Neuroscience, 9(June), 1-12. https://doi.org/10.3389/fnhum.2015.00365</Citation>
        </Reference>
        <Reference>
          <Citation>Carter, R. M., &amp; Huettel, S. A. (2013). A nexus model of the temporal-parietal junction. Trends in Cognitive Sciences, 17(7), 328-336. https://doi.org/10.1016/j.tics.2013.05.007</Citation>
        </Reference>
        <Reference>
          <Citation>Carvalho Pereira, A., Violante, I. R., Mouga, S., Oliveira, G., &amp; Castelo-Branco, M. (2018). Medial frontal lobe neurochemistry in autism spectrum disorder is marked by reduced N-acetylaspartate and unchanged gamma-aminobutyric acid and glutamate + glutamine levels. Journal of Autism and Developmental Disorders, 48(5), 1467-1482. https://doi.org/10.1007/s10803-017-3406-8</Citation>
        </Reference>
        <Reference>
          <Citation>Castelli, F. (2002). Autism, asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain, 125(8), 1839-1849. https://doi.org/10.1093/brain/awf189</Citation>
        </Reference>
        <Reference>
          <Citation>Constantino, J. N., &amp; Gruber, C. (2012). The Social Responsiveness Scale, second edition (SRS-2). Torrance, CA: Western Psychological Services.</Citation>
        </Reference>
        <Reference>
          <Citation>Corbetta, M., Patel, G., &amp; Shulman, G. L. (2008). The reorienting system of the human brain: From environment to theory of mind. Neuron, 58(3), 306-324. https://doi.org/10.1016/j.neuron.2008.04.017</Citation>
        </Reference>
        <Reference>
          <Citation>Corrigan, N. M., Shaw, D. W. W., Estes, A. M., Richards, T. L., Munson, J., Friedman, S. D., … Dager, S. R. (2013). Atypical developmental patterns of brain chemistry in children with autism spectrum disorder. JAMA Psychiatry, 70(9), 964-974. https://doi.org/10.1001/jamapsychiatry.2013.1388</Citation>
        </Reference>
        <Reference>
          <Citation>de Graaf, R. A. (2018). In Vivo NMR spectroscopy-Dynamic aspects. In Vivo NMR Spectroscopy, 129-210. https://doi.org/10.1002/9781119382461.ch3</Citation>
        </Reference>
        <Reference>
          <Citation>DeVito, T. J., Drost, D. J., Neufeld, R. W. J., Rajakumar, N., Pavlosky, W., Williamson, P., &amp; Nicolson, R. (2007). Evidence for cortical dysfunction in autism: A proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 61(4), 465-473. https://doi.org/10.1016/j.biopsych.2006.07.022</Citation>
        </Reference>
        <Reference>
          <Citation>Dickinson, A., Bruyns-Haylett, M., Smith, R., Jones, M., &amp; Milne, E. (2016). Superior orientation discrimination and increased peak gamma frequency in autism spectrum conditions. Journal of Abnormal Psychology, 125(3), 412-422. https://doi.org/10.1037/abn0000148</Citation>
        </Reference>
        <Reference>
          <Citation>Edden, R. A. E., Muthukumaraswamy, S. D., Freeman, T. C. A., &amp; Singh, K. D. (2009). Orientation discrimination performance is predicted by GABA concentration and gamma oscillation frequency in human primary visual cortex. Journal of Neuroscience, 29(50), 15721-15726. https://doi.org/10.1523/JNEUROSCI.4426-09.2009</Citation>
        </Reference>
        <Reference>
          <Citation>Elsabbagh, M., Fernandes, J., Jane Webb, S., Dawson, G., Charman, T., &amp; Johnson, M. H. (2013). Disengagement of visual attention in infancy is associated with emerging autism in toddlerhood. Biological Psychiatry, 74(3), 189-194. https://doi.org/10.1016/j.biopsych.2012.11.030</Citation>
        </Reference>
        <Reference>
          <Citation>Evans, C. J., McGonigle, D. J., &amp; Edden, R. A. E. (2010). Diurnal stability of γ-aminobutyric acid concentration in visual and sensorimotor cortex. Journal of Magnetic Resonance Imaging, 31(1), 204-209. https://doi.org/10.1002/jmri.21996</Citation>
        </Reference>
        <Reference>
          <Citation>Fachada, N., Rodrigues, J., Lopes, V., Martins, R., &amp; AC, R. (2016). micompr: An R package for multivariate independent comparison of observations. The R Journal, 8(2), 405-420.</Citation>
        </Reference>
        <Reference>
          <Citation>Friedman, S. D., Shaw, D. W., Artru, A. A., Richards, T. L., Gardner, J., Dawson, G., … Dager, S. R. (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology, 60(1), 100-107. https://doi.org/10.1212/WNL.60.1.100</Citation>
        </Reference>
        <Reference>
          <Citation>Friedman, S. D., Shaw, D. W. W., Artru, A. A., Dawson, G., Petropoulos, H., &amp; Dager, S. R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63(7), 786-794. https://doi.org/10.1001/archpsyc.63.7.786</Citation>
        </Reference>
        <Reference>
          <Citation>Gaetz, W., Bloy, L., Wang, D. J., Port, R. G., Blaskey, L., Levy, S. E., &amp; Roberts, T. P. L. L. (2014). GABA estimation in the brains of children on the autism spectrum: Measurement precision and regional cortical variation. NeuroImage, 86, 1-9. https://doi.org/10.1016/j.neuroimage.2013.05.068</Citation>
        </Reference>
        <Reference>
          <Citation>Gliga, T., Bedford, R., Charman, T., Johnson, M. H., Baron-Cohen, S., Bolton, P., … Tucker, L. (2015). Enhanced visual search in infancy predicts emerging autism symptoms. Current Biology, 25(13), 1727-1730. https://doi.org/10.1016/j.cub.2015.05.011</Citation>
        </Reference>
        <Reference>
          <Citation>Gomot, M., Bernard, F. A., Davis, M. H., Belmonte, M. K., Ashwin, C., Bullmore, E. T., &amp; Baron-Cohen, S. (2006). Change detection in children with autism: An auditory event-related fMRI study. NeuroImage, 29(2), 475-484. https://doi.org/10.1016/j.neuroimage.2005.07.027</Citation>
        </Reference>
        <Reference>
          <Citation>Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., &amp; Matsuda, T. (2011). Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 Tesla instrument. Journal of Autism and Developmental Disorders, 41(4), 447-454. https://doi.org/10.1007/s10803-010-1065-0</Citation>
        </Reference>
        <Reference>
          <Citation>Hardan, A. Y., Minshew, N. J., Melhem, N. M., Srihari, S., Jo, B., Bansal, R., … Stanley, J. A. (2008). An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Research: Neuroimaging, 163(2), 97-105. https://doi.org/10.1016/j.pscychresns.2007.12.002</Citation>
        </Reference>
        <Reference>
          <Citation>Harris, A. D., Puts, N. A. J., Barker, P. B., &amp; Edden, R. A. E. (2015). Spectral-editing measurements of GABA in the human brain with and without macromolecule suppression. Magnetic Resonance in Medicine, 74(6), 1523-1529. https://doi.org/10.1002/mrm.25549</Citation>
        </Reference>
        <Reference>
          <Citation>Harris, A. D., Puts, N. A. J., &amp; Edden, R. A. E. (2015). Tissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations. Journal of Magnetic Resonance Imaging, 42(5), 1431-1440. https://doi.org/10.1002/jmri.24903</Citation>
        </Reference>
        <Reference>
          <Citation>Hessels, R. S., Hooge, I. T. C., Snijders, T. M., &amp; Kemner, C. (2014). Is there a limit to the superiority of individuals with ASD in visual search? Journal of Autism and Developmental Disorders, 44(2), 443-451. https://doi.org/10.1007/s10803-013-1886-8</Citation>
        </Reference>
        <Reference>
          <Citation>Horder, J., Petrinovic, M. M., Mendez, M. A., Bruns, A., Takumi, T., Spooren, W., … Murphy, D. G. (2018). Glutamate and GABA in autism spectrum disorder-A translational magnetic resonance spectroscopy study in man and rodent models. Translational Psychiatry, 8(1), 1-11. https://doi.org/10.1038/s41398-018-0155-1</Citation>
        </Reference>
        <Reference>
          <Citation>Hussman, J. P. (2001). Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. Journal of Autism and Developmental Disorders, 31(2), 247-248. https://doi.org/10.1016/0002-9610(92)90118-B</Citation>
        </Reference>
        <Reference>
          <Citation>Jakobs, O., Langner, R., Caspers, S., Roski, C., Cieslik, E. C., Zilles, K., … Eickhoff, S. B. (2012). Across-study and within-subject functional connectivity of a right temporo-parietal junction subregion involved in stimulus-context integration. NeuroImage, 60(4), 2389-2398. https://doi.org/10.1016/j.neuroimage.2012.02.037</Citation>
        </Reference>
        <Reference>
          <Citation>Joseph, R. M., Keehn, B., Connolly, C., Wolfe, J. M., &amp; Horowitz, T. S. (2009). Why is visual search superior in autism spectrum disorder? Developmental Science, 12(6), 1083-1096. https://doi.org/10.1111/j.1467-7687.2009.00855.x</Citation>
        </Reference>
        <Reference>
          <Citation>Kaiser, L. G., Young, K., &amp; Matson, G. B. (2007). Elimination of spatial interference in PRESS-localized editing spectroscopy. Magnetic Resonance in Medicine, 58(4), 813-818. https://doi.org/10.1002/mrm.21407</Citation>
        </Reference>
        <Reference>
          <Citation>Kaldy, Z., Giserman, I., Carter, A. S., &amp; Blaser, E. (2016). The mechanisms underlying the ASD advantage in visual search. Journal of Autism and Developmental Disorders, 46(5), 1513-1527. https://doi.org/10.1007/s10803-013-1957-x</Citation>
        </Reference>
        <Reference>
          <Citation>Keehn, B., Brenner, L., Palmer, E., Lincoln, A. K., &amp; Müller, R.-A. (2008). Functional brain organization for visual search in ASD. Journal of the International Neuropsychological Society, 14(6), 990-1003. https://doi.org/10.1017/S1355617708081356</Citation>
        </Reference>
        <Reference>
          <Citation>Keehn, B., &amp; Joseph, R. M. (2016). Exploring what's missing: What do target absent trials reveal about autism search superiority? Journal of Autism and Developmental Disorders, 46(5), 1686-1698. https://doi.org/10.1007/s10803-016-2700-1</Citation>
        </Reference>
        <Reference>
          <Citation>Keehn, B., Nair, A., Lincoln, A. J., Townsend, J., &amp; Müller, R. A. (2016). Under-reactive but easily distracted: An fMRI investigation of attentional capture in autism spectrum disorder. Developmental Cognitive Neuroscience, 17, 46-56. https://doi.org/10.1016/j.dcn.2015.12.002</Citation>
        </Reference>
        <Reference>
          <Citation>Keehn, B., Shih, P., Brenner, L. A., Townsend, J., &amp; Müller, R.-A. (2013). Functional connectivity for an "Island of sparing" in autism spectrum disorder: An fMRI study of visual search. Human Brain Mapping, 34(10), 2524-2537. https://doi.org/10.1002/hbm.22084</Citation>
        </Reference>
        <Reference>
          <Citation>Kemner, C., Van Ewijk, L., Van Engeland, H., &amp; Hooge, I. (2008). Brief report: Eye movements during visual search tasks indicate enhanced stimulus discriminability in subjects with PDD. Journal of Autism and Developmental Disorders, 38(3), 553-558. https://doi.org/10.1007/s10803-007-0406-0</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, S. (2015). ppcor: An R package for a fast calculation to semi-partial correlation coefficients. Communications for Statistical Applications and Methods, 22(6), 665-674.</Citation>
        </Reference>
        <Reference>
          <Citation>Kleinhans, N. M., Schweinsburg, B. C., Cohen, D. N., Müller, R.-A., &amp; Courchesne, E. (2007). N-acetyl aspartate in autism spectrum disorders: Regional effects and relationship to fMRI activation. Brain Research, 1162, 85-97. https://doi.org/10.1016/j.brainres.2007.04.081</Citation>
        </Reference>
        <Reference>
          <Citation>Klomp, D. W. J., Bitz, A. K., Heerschap, A., &amp; Scheenen, T. W. J. (2009). Proton spectroscopic imaging of the human prostate at 7 T. NMR in Biomedicine, 22(5), 495-501. https://doi.org/10.1002/nbm.1360</Citation>
        </Reference>
        <Reference>
          <Citation>Kubas, B., Kułak, W., Sobaniec, W., Tarasow, E., Łebkowska, U., &amp; Walecki, J. (2012). Metabolite alterations in autistic children: A 1H MR spectroscopy study. Advances in Medical Sciences, 57(1), 152-156. https://doi.org/10.2478/v10039-012-0014-x</Citation>
        </Reference>
        <Reference>
          <Citation>Lenth, R. (2019). emmeans: Estimated marginal means, aka least-square means. R package version 1.4.1. https://CRAN.R-project.org/package=emmeans</Citation>
        </Reference>
        <Reference>
          <Citation>Levitt, J. G., O'Neill, J., Blanton, R. E., Smalley, S., Fadale, D., McCracken, J. T., … Alger, J. R. (2003). Proton magnetic resonance spectroscopic imaging of the brain in childhood autism. Biological Psychiatry, 54(12), 1355-1366. https://doi.org/10.1016/S0006-3223(03)00688-7</Citation>
        </Reference>
        <Reference>
          <Citation>Ligneul, C., Palombo, M., Hernández-Garzón, E., Carrillo-de Sauvage, M.-A., Flament, J., Hantraye, P., … Valette, J. (2019). Diffusion-weighted magnetic resonance spectroscopy enables cell-specific monitoring of astrocyte reactivity in vivo. NeuroImage, 191, 457-469. https://doi.org/10.1016/j.neuroimage.2019.02.046</Citation>
        </Reference>
        <Reference>
          <Citation>Lombardo, M. V., Chakrabarti, B., Bullmore, E. T., Wheelwright, S. J., Sadek, S. A., Suckling, J., &amp; Baron-Cohen, S. (2010). Shared neural circuits for mentalizing about the self and others. Journal of Cognitive Neuroscience, 22(7), 1623-1635. https://doi.org/10.1162/jocn.2009.21287</Citation>
        </Reference>
        <Reference>
          <Citation>Lord, C., Luyster, R., Gotham, K., &amp; Guthrie, W. (2012). Autism diagnostic observation schedule, second edition (ADOS-2) manual (Part II): Toddler moddule. Torrance, CA: Western Psychological Services.</Citation>
        </Reference>
        <Reference>
          <Citation>Marjańska, M., Lehéricy, S., Valabrègue, R., Popa, T., Worbe, Y., Russo, M., … Meunier, S. (2013). Brain dynamic neurochemical changes in dystonic patients: A magnetic resonance spectroscopy study. Movement Disorders, 28(2), 201-209. https://doi.org/10.1002/mds.25279</Citation>
        </Reference>
        <Reference>
          <Citation>Mescher, M., Merkle, H., Kirsch, J., Garwood, M., &amp; Gruetter, R. (1998). Simultaneous in vivo spectral editing and water suppression. NMR in Biomedicine, 11(6), 266-272. https://doi.org/10.1002/(SICI)1099-1492(199810)11:6&lt;266::AID-NBM530&gt;3.0.CO;2-J</Citation>
        </Reference>
        <Reference>
          <Citation>Milne, E., Dunn, S. A., Freeth, M., &amp; Rosas-Martinez, L. (2013). Visual search performance is predicted by the degree to which selective attention to features modulates the ERP between 350 and 600ms. Neuropsychologia, 51(6), 1109-1118. https://doi.org/10.1016/j.neuropsychologia.2013.03.002</Citation>
        </Reference>
        <Reference>
          <Citation>Mottron, L., Dawson, M., Soulières, I., Hubert, B., &amp; Burack, J. (2006). Enhanced perceptual functioning in autism: An update, and eight principles of autistic perception. Journal of Autism and Developmental Disorders, 36(1), 27-43. https://doi.org/10.1007/s10803-005-0040-7</Citation>
        </Reference>
        <Reference>
          <Citation>Muthukumaraswamy, S. D., Edden, R. A. E., Jones, D. K., Swettenham, J. B., &amp; Singh, K. D. (2009). Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proceedings of the National Academy of Sciences, 106(20), 8356-8361. https://doi.org/10.1073/pnas.0900728106</Citation>
        </Reference>
        <Reference>
          <Citation>O'Riordan, M., &amp; Plaisted, K. (2001). Enhanced discrimination in autism. The Quarterly Journal of Experimental Psychology Section A, 54(4), 961-979. https://doi.org/10.1080/713756000</Citation>
        </Reference>
        <Reference>
          <Citation>Port, R. G., Gaetz, W., Bloy, L., Wang, D. J., Blaskey, L., Kuschner, E. S., … Roberts, T. P. L. (2017). Exploring the relationship between cortical GABA concentrations, auditory gamma-band responses and development in ASD: Evidence for an altered maturational trajectory in ASD. Autism Research, 10(4), 593-607. https://doi.org/10.1002/aur.1686</Citation>
        </Reference>
        <Reference>
          <Citation>Provencher, S. W. (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine, 30(6), 672-679. https://doi.org/10.1002/mrm.1910300604</Citation>
        </Reference>
        <Reference>
          <Citation>Puts, N. A. J., Wodka, E. L., Harris, A. D., Crocetti, D., Tommerdahl, M., Mostofsky, S. H., &amp; Edden, R. A. E. (2017). Reduced GABA and altered somatosensory function in children with autism spectrum disorder. Autism Research, 10(4), 608-619. https://doi.org/10.1002/aur.1691</Citation>
        </Reference>
        <Reference>
          <Citation>R Core Team. (2019). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.</Citation>
        </Reference>
        <Reference>
          <Citation>Remington, A. M., Swettenham, J., Campbell, R., &amp; Coleman, M. (2009). Selective attention and perceptual load in autism spectrum disorder. Psychological Science, 20(11), 1388-1393. https://doi.org/10.1111/j.1467-9280.2009.02454.x</Citation>
        </Reference>
        <Reference>
          <Citation>Remington, A. M., Swettenham, J. G., &amp; Lavie, N. (2012). Lightening the load: Perceptual load impairs visual detection in typical adults but not in autism. Journal of Abnormal Psychology, 121(2), 544-551. https://doi.org/10.1037/a0027670</Citation>
        </Reference>
        <Reference>
          <Citation>Robertson, C. E., Ratai, E. M., &amp; Kanwisher, N. (2016). Reduced GABAergic action in the autistic brain. Current Biology, 26(1), 80-85. https://doi.org/10.1016/j.cub.2015.11.019</Citation>
        </Reference>
        <Reference>
          <Citation>Rojas, D. C., Singel, D., Steinmetz, S., Hepburn, S., &amp; Brown, M. S. (2014). Decreased left perisylvian GABA concentration in children with autism and unaffected siblings. NeuroImage, 86, 28-34. https://doi.org/10.1016/j.neuroimage.2013.01.045</Citation>
        </Reference>
        <Reference>
          <Citation>Ronen, I., Ercan, E., &amp; Webb, A. (2013). Axonal and glial microstructural information obtained with diffusion-weighted magnetic resonance spectroscopy at 7T. Frontiers in Integrative Neuroscience, 7, 1-10. https://doi.org/10.3389/fnint.2013.00013</Citation>
        </Reference>
        <Reference>
          <Citation>Rubenstein, J. L. R., &amp; Merzenich, M. M. (2003). Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior, 2(5), 255-267. https://doi.org/10.1034/j.1601-183X.2003.00037.x</Citation>
        </Reference>
        <Reference>
          <Citation>Rutter, M., Bailey, A., &amp; Lord, C. (2003). The social communication questionnaire: Manual. Western Psychological Services. Torrance, CA: Western Psychological Services</Citation>
        </Reference>
        <Reference>
          <Citation>Sandberg, K., Blicher, J. U., Dong, M. Y., Rees, G., Near, J., &amp; Kanai, R. (2014). Occipital GABA correlates with cognitive failures in daily life. NeuroImage, 87, 55-60. https://doi.org/10.1016/j.neuroimage.2013.10.059</Citation>
        </Reference>
        <Reference>
          <Citation>Sapey-Triomphe, L. A., Lamberton, F., Sonié, S., Mattout, J., &amp; Schmitz, C. (2019). Tactile hypersensitivity and GABA concentration in the sensorimotor cortex of adults with autism. Autism Research, 12(4), 562-575. https://doi.org/10.1002/aur.2073</Citation>
        </Reference>
        <Reference>
          <Citation>Shih, P., Keehn, B., Oram, J. K., Leyden, K. M., Keown, C. L., &amp; Müller, R.-A. (2011). Functional differentiation of posterior superior temporal sulcus in autism: A functional connectivity magnetic resonance imaging study. Biological Psychiatry, 70(3), 270-277. https://doi.org/10.1016/j.biopsych.2011.03.040</Citation>
        </Reference>
        <Reference>
          <Citation>Shulman, G. L., Astafiev, S. V., McAvoy, M. P., D'Avossa, G., &amp; Corbetta, M. (2007). Right TPJ deactivation during visual search: Functional significance and support for a filter hypothesis. Cerebral Cortex, 17(11), 2625-2633. https://doi.org/10.1093/cercor/bhl170</Citation>
        </Reference>
        <Reference>
          <Citation>Shulman, G. L., McAvoy, M. P., Cowan, M. C., Astafiev, S. V., Tansy, A. P., D'Avossa, G., &amp; Corbetta, M. (2003). Quantitative analysis of attention and detection signals during visual search. Journal of Neurophysiology, 90(5), 3384-3397. https://doi.org/10.1152/jn.00343.2003</Citation>
        </Reference>
        <Reference>
          <Citation>Song, C., Sandberg, K., Andersen, L. M., Blicher, J. U., &amp; Rees, G. (2017). Human occipital and parietal GABA selectively influence visual perception of orientation and size. The Journal of Neuroscience, 37(37), 8929-8937. https://doi.org/10.1523/jneurosci.3945-16.2017</Citation>
        </Reference>
        <Reference>
          <Citation>Sowell, E. R. (2004). Longitudinal mapping of cortical thickness and brain growth in normal children. Journal of Neuroscience, 24(38), 8223-8231. https://doi.org/10.1523/JNEUROSCI.1798-04.2004</Citation>
        </Reference>
        <Reference>
          <Citation>Sumner, P., Edden, R. A. E., Bompas, A., Evans, C. J., &amp; Singh, K. D. (2010). More GABA, less distraction: A neurochemical predictor of motor decision speed. Nature Neuroscience, 13(7), 825-827. https://doi.org/10.1038/nn.2559</Citation>
        </Reference>
        <Reference>
          <Citation>Wickham, H. (2016). ggplot2: Elegant graphics for data analysis. New York, NY: Springer-Verlag.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson, M., Andronesi, O., Barker, P. B., Bartha, R., Bizzi, A., Bolan, P. J., … Howe, F. A. (2019). Methodological consensus on clinical proton MRS of the brain: Review and recommendations. Magnetic Resonance in Medicine, 82(2), 527-550. https://doi.org/10.1002/mrm.27742</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909888</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2151-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis care &amp; research</Title>
          <ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Utilizing clinical characteristics and patient-reported outcome measures to categorize lupus subtypes.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.24135</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The Type 1 and Type 2 SLE categorization system was recently proposed in order to validate the patients' perspective of disease and to capture a more comprehensive spectrum of symptoms. The objective of this study was to characterize the clinical manifestations of SLE subtypes and to determine the correlation between the patient- and physician-reported measures used in the model.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This was a cross-sectional study of SLE patients in a university clinic. Patients completed the Systemic Lupus Activity Questionnaire (SLAQ) and 2011 ACR Fibromyalgia (FM) criteria. Active SLE was defined as SLEDAI ≥6, clinical SLEDAI ≥4, or active lupus nephritis. We identified 4 groups: Type 1 SLE (active SLE without FM), Type 2 SLE (inactive SLE with FM), Mixed SLE (active SLE with FM), Minimal SLE (inactive SLE without FM).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In this cohort of 212 patients (92% female, mean age 45 years), 30% had Type 1 SLE, 8% had Type 2 SLE, 13% had Mixed SLE and 49% had minimal SLE. Regardless of SLE disease activity, patients with FM (21%), reported higher SLAQ scores, patient global assessment scores, and self-reported lupus flare which resulted in discordance between patient- and physician- reported measures.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Fatigue, widespread pain, sleep dysfunction, and mood disorders are common symptoms in SLE. Identifying these symptoms as Type 2 SLE may be a method to improve patient communication and understanding. The level of Type 2 SLE impacts patients' perception of disease and self-reported symptoms. The SLAQ may need to be re-interpreted based on the fibromyalgia severity scale.</AbstractText>
          <CopyrightInformation>© 2020, American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rogers</LastName>
            <ForeName>Jennifer L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Division of Rheumatology and Immunology, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eudy</LastName>
            <ForeName>Amanda M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Division of Rheumatology and Immunology, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pisetsky</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Durham VA Hospital and Duke University Medical Center, Division of Rheumatology and Immunology, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Criscione-Schreiber</LastName>
            <ForeName>Lisa G</ForeName>
            <Initials>LG</Initials>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Division of Rheumatology and Immunology, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Kai</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-8406-2932</Identifier>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Division of Rheumatology and Immunology, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doss</LastName>
            <ForeName>Jayanth</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Division of Rheumatology and Immunology, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clowse</LastName>
            <ForeName>Megan E B</ForeName>
            <Initials>MEB</Initials>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Division of Rheumatology and Immunology, Durham, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA>
        <NlmUniqueID>101518086</NlmUniqueID>
        <ISSNLinking>2151-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909888</ArticleId>
        <ArticleId IdType="doi">10.1002/acr.24135</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909889</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-9914</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of applied clinical medical physics</Title>
          <ISOAbbreviation>J Appl Clin Med Phys</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Analyses of integrated EPID images for on-treatment quality assurance to account for interfractional variations in volumetric modulated arc therapy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acm2.12805</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate the effects of interfractional variation, such as anatomical changes and setup errors, on dose delivery during treatment for prostate cancer (PC) and head and neck cancer (HNC) by courses of volumetric modulated arc therapy (VMAT) aided by on-treatment electronic portal imaging device (EPID) images.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Seven patients with PC and 20 patients with HNC who had received VMAT participated in this study. After obtaining photon fluence at the position of the EPID for each treatment arc from on-treatment integrated EPID images, we calculated the differences between the fluence for the first fraction and each subsequent fraction for each arc. The passing rates were investigated based on a tolerance level of 3% of the maximum fluence during the treatment courses and the correlations between the passing rates and anatomical changes.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In PC, the median and lowest passing rates were 99.8% and 95.2%, respectively. No correlations between passing rates and interfractional variation were found. In HNC, the median passing rate of all fractions was 93.0%, and the lowest passing rate was 79.6% during the 35th fraction. Spearman's correlation coefficients between the passing rates and changes in weight or neck volume were - 0.77 and - 0.74, respectively.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Analyses of the on-treatment EPID images facilitates estimates of the interfractional anatomical variation in HNC patients during VMAT and thus improves assessments of the need for re-planning or adaptive strategies and the timing thereof.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Matsushita</LastName>
            <ForeName>Norimasa</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakamura</LastName>
            <ForeName>Mitsuhiro</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sasaki</LastName>
            <ForeName>Makoto</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yano</LastName>
            <ForeName>Shinsuke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yoshimura</LastName>
            <ForeName>Michio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mizowaki</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Appl Clin Med Phys</MedlineTA>
        <NlmUniqueID>101089176</NlmUniqueID>
        <ISSNLinking>1526-9914</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">electronic portal imaging device</Keyword>
        <Keyword MajorTopicYN="N">head and neck cancer</Keyword>
        <Keyword MajorTopicYN="N">interfraction variation</Keyword>
        <Keyword MajorTopicYN="N">prostate cancer</Keyword>
        <Keyword MajorTopicYN="N">volumetric modulated arc therapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909889</ArticleId>
        <ArticleId IdType="doi">10.1002/acm2.12805</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Kupelian PA, Langen KM, Zeidan OA, et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:876-882.</Citation>
        </Reference>
        <Reference>
          <Citation>Shibayama Y, Arimura H, Hirose T, et al. Investigation of interfractional shape variations based on statistical point distribution model for prostate cancer radiation therapy. Med Phys. 2017;44:1837-1845.</Citation>
        </Reference>
        <Reference>
          <Citation>Haekal M, Arimura H, Hirose T, et al. Computational analysis of interfractional anisotropic shape variations of the rectum in prostate cancer radiation therapy. Phys Med. 2018;46:168-179.</Citation>
        </Reference>
        <Reference>
          <Citation>Barker JL, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004;59:960-970.</Citation>
        </Reference>
        <Reference>
          <Citation>Ajani AA, Qureshi MM, Kovalchuk N, Orlina L, Sakai O, Truong MT. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography. Med Dosim. 2013;38:238-242.</Citation>
        </Reference>
        <Reference>
          <Citation>Brouwer CL, Steenbakkers RJ, Langendijk JA, Sijtsema NM. Identifying patient who may benefit from adaptive radiotherapy: Does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help? Radiother Oncol. 2015;115:285-294.</Citation>
        </Reference>
        <Reference>
          <Citation>Marzi S, Pinnaro P, D’Alessio D, et al. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: Effect on the probability of xerostomia incidence. Clin Oncol. 2012;24:54-62.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwartz D, Garden A, Shah S, et al. Adaptive radiotherapy for head and neck cancer-Dosimetric results from a prospective clinical trial. Radiother Oncol. 2013;106:80-84.</Citation>
        </Reference>
        <Reference>
          <Citation>Mencarelli A, Van Kranen S, Hamming-Vrieze O, et al. Deformable image registration for adaptive radiation therapy of head and neck cancer: Accuracy and precision in the presence of tumor changes. Int J Radiat Oncol Biol Phys. 2014;90:680-687.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Kranen S, Hamming-Vrieze O, Wolf A, Damen E, Van Herk M, Sonke J. Head and neck margin reduction with adaptive radiation therapy: robustness of treatment plans against anatomy changes. Int J Radiat Oncol Biol Phys. 2016;96:653-660.</Citation>
        </Reference>
        <Reference>
          <Citation>Sheng Y, Li T, Lee R, et al. Exploring the margin recipe for online adaptive radiation therapy for intermediate risk prostate cancer: An intra-fractional seminal vesicles motion analysis. Int J Radiat Oncol Biol Phys. 2017;98:473-480.</Citation>
        </Reference>
        <Reference>
          <Citation>Fuangrod T, Woodruff HC, Van Uytven E, et al. A system for EPID-based real-time treatment delivery verification during dynamic IMRT treatment. Med Phys. 2013;40:091907.</Citation>
        </Reference>
        <Reference>
          <Citation>Consorti R, Fidanzio A, Brainovich V, et al. EPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: Initial clinical experience. Phys Med. 2017;42:157-161.</Citation>
        </Reference>
        <Reference>
          <Citation>Bedford JL, Hanson IM, Hansen VN, et al. Comparison of forward- and back-projection in vivo EPID dosimetry for VMAT treatment of the prostate. Phys Med Biol. 2018;63:025008.</Citation>
        </Reference>
        <Reference>
          <Citation>Camilleri J, Mazurier J, Franck D, Dudouet P, Latorzeff I, Franceries X. Clinical results of an EPID-based in-vivo dosimetry method for pelvic cancers treated by intensity-modulated radiation therapy. Phys Med. 2014;30:690-695.</Citation>
        </Reference>
        <Reference>
          <Citation>Celi S, Costa E, Wessels C, et al. EPID based in vivo dosimetry system: clinical experience and results. J Appl Clin Med Phys. 2016;17:262-276.</Citation>
        </Reference>
        <Reference>
          <Citation>Nailon WH, Welsh K, McDonald K, et al. EPID-based in vivo dosimetry using Dosimetry Check™: overview and clinical experience in a 5-yr study including breast, lung, prostate, and head and neck cancer patients. J Appl Clin Med Phys. 2019;20:6-16.</Citation>
        </Reference>
        <Reference>
          <Citation>Piermattei A, Greco F, Grusio M, et al. A validation study of a dedicated software for an automated in vivo dosimetry control in radiotherapy. Med Biol Eng Comput. 2018;56:1939-1947.</Citation>
        </Reference>
        <Reference>
          <Citation>Kang S, Li J, Ma J, et al. Evaluation of interfraction setup variations for postmastectomy radiation therapy using EPID-based in vivo dosimetry. J Appl Clin Med Phys. 2019;20:43-52.</Citation>
        </Reference>
        <Reference>
          <Citation>Cilla S, Meluccio D, Fidanzio A, et al. Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors. Phys Med. 2016;32:52-58.</Citation>
        </Reference>
        <Reference>
          <Citation>Tachibana H, Takagi K, Moriya S. Impact of shoulder deformation on volumetric modulated arc therapy doses for head and neck cancer. Phys Med. 2018;53:118-128.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhuang AH, Olch AJ. Sensitivity study of an automated system for daily patient QA using EPID exit dose images. J Appl Clin Med Phys. 2018;19:114-124.</Citation>
        </Reference>
        <Reference>
          <Citation>Castelli J, Simon A, Louvel G, et al. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia. Radiat Oncol. 2015;10:6.</Citation>
        </Reference>
        <Reference>
          <Citation>Capelle L, Mackenzie M, Field C, Parliament M, Ghosh S, Scrimger R. Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results. Clin Oncol. 2012;24:208-215.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Lin C, Wu J, et al. A longitudinal evaluation of early anatomical changes of parotid gland in intensity modulated radiotherapy of nasopharyngeal carcinoma patients with parapharyngeal space involvement. J Med Radiat Sci. 2017;64:188-194.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909890</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2151-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis care &amp; research</Title>
          <ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Driving Ability and Safety in Rheumatoid Arthritis: A Systematic Review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.24137</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify whether rheumatoid arthritis (RA) is associated with driving ability and/or the use of assistive devices or modifications to improve driving ability.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic literature review following PRISMA guidelines of RA and driving ability/adaptations by searching multiple databases from inception to April 2018. Eligible studies were original articles in the English language with quantitative data regarding the study objective and had at least 5 RA patients. Similar outcomes were extracted across studies and grouped into categories for review.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Our search yielded 1935 potential reports, of which 22 fulfilled eligibility criteria, totaling 6285 RA patients. The prevalence of driving issues with RA was highly variable among the studies. Some of the shared themes addressed in these publications included RA in association with rates of motor vehicle crashes, self-reported driving difficulty, inability to drive, use of driving adaptations, use of assistance by other people for transport, and difficulty with general transportation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Recognizing variability among individual reports, driving difficulties and the use of driving adaptations are relatively common in those with RA. Given the central importance of automobile driving for the quality of life of RA patients, further investigations of driving ability and potential driving adaptations that can help to overcome barriers to safe driving are needed.</AbstractText>
          <CopyrightInformation>© 2020, American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Daniel J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mikuls</LastName>
            <ForeName>Ted R</ForeName>
            <Initials>TR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmidt</LastName>
            <ForeName>Cynthia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>McGoogan Library of Medicine, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>England</LastName>
            <ForeName>Bryant R</ForeName>
            <Initials>BR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bergman</LastName>
            <ForeName>Debra A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rizzo</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Merickel</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Michaud</LastName>
            <ForeName>Kaleb</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-5350-3934</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA>
        <NlmUniqueID>101518086</NlmUniqueID>
        <ISSNLinking>2151-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">activities of daily living</Keyword>
        <Keyword MajorTopicYN="N">driving</Keyword>
        <Keyword MajorTopicYN="N">mobility</Keyword>
        <Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword>
        <Keyword MajorTopicYN="N">safety</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909890</ArticleId>
        <ArticleId IdType="doi">10.1002/acr.24137</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909891</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1932-8494</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Anatomical record (Hoboken, N.J. : 2007)</Title>
          <ISOAbbreviation>Anat Rec (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Screening of potential biomarkers for Yin-deficiency-heat syndrome based on UHPLC-MS method and the mechanism of Zhibai Dihuang granule therapeutic effect.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ar.24352</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Yin-deficiency-heat (YDH) syndrome is a subhealth state of the individual, mainly manifested as oral ulcers, dry mouth, constipation, and other symptoms. Zhibai Dihuang granule (ZDG), as a classic traditional Chinese medicine, is effective in treating YDH syndrome. We screened the potential biomarkers for diagnosing YDH syndrome, and explored the mechanisms of the therapeutic effect of ZDG.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Plasma samples from the Pinghe (PH, healthy control) group, the Shanghuo (SH, YDH syndrome) group, and the ZDG treated group (therapeutic group) were analyzed by using metabolomics profiling. The data were analyzed by multivariate statistical and bioinformatics analyses.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We screened four differential metabolites such as, decanoylcarnitine, dodecanoylcarnitine, phosphatidylcholine (PC), and Aspartate (Asp) Arginine (Arg) Proline (Pro) in the SH group and the PH group. The results showed that the combination of above four metabolites could serve as a potential biomarker for the early diagnosis of YDH syndrome. The metabolites decanoylcarnitine and glucose were found to be differentially expressed in the YDH syndrome group and tended to be normalized after ZDG treatment.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The increased levels of four differential metabolites (decanoylcarnitine, dodecanoylcarnitine, PC, and Asp Arg Pro) revealed that individuals with YDH syndrome may have increased energy metabolism in the body, which could lead to disorders of fatty acids β-oxidation and immune function. The levels of two differential metabolites including decanoylcarnitine and glucose returned to normal after ZDG treatment, indicating that ZDG could treat YDH syndrome by regulating glucose metabolism and fatty acids β-oxidation. Our study provides a new method for the diagnosis of YDH syndrome, and may provide theoretical basis for novel therapeutic strategies of YDH syndrome.</AbstractText>
          <CopyrightInformation>© 2020 American Association for Anatomy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yi</LastName>
            <ForeName>Wen-Jing</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhi-Bin</ForeName>
            <Initials>ZB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Ting-Ting</ForeName>
            <Initials>TT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bi</LastName>
            <ForeName>De-Qing</ForeName>
            <Initials>DQ</Initials>
            <AffiliationInfo>
              <Affiliation>Xiaoshan Hospital of Traditional Chinese Medicine, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Chang-Ming</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Su</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yu-Ting</ForeName>
            <Initials>YT</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gan</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tu</LastName>
            <ForeName>Hui-Hui</ForeName>
            <Initials>HH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Huai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ji-Cheng</ForeName>
            <Initials>JC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-9631-8931</Identifier>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2017A030311014</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017A030310484</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>201804010369</GrantID>
            <Agency>Guangzhou Science and Technology Project</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2014CB543002</GrantID>
            <Agency>National Basic Research Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81573709</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81772266</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anat Rec (Hoboken)</MedlineTA>
        <NlmUniqueID>101292775</NlmUniqueID>
        <ISSNLinking>1932-8486</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Traditional Chinese medicine</Keyword>
        <Keyword MajorTopicYN="N">Yin-deficiency-heat syndrome</Keyword>
        <Keyword MajorTopicYN="N">Zhibai Dihuang granule</Keyword>
        <Keyword MajorTopicYN="N">biomarkers</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909891</ArticleId>
        <ArticleId IdType="doi">10.1002/ar.24352</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Brass, E. P. (2004). Carnitine and sports medicine: use or abuse? Annals New York Academy of Sciences, 1033, 67-78.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, R., Han, S., Liu, X., Wang, K., Zhou, Y., Yang, C., &amp; Zhang, X. (2018). Perturbations in amino acids and metabolic pathways in osteoarthritis patients determined by targeted metabolomics analysis. Journal of Chromatography B, 1085, 54-62.</Citation>
        </Reference>
        <Reference>
          <Citation>Department of Medical Administration, State Administration of Traditional Chinese Medicine. (2017). Diagnostic and efficacy standards for TCM syndrome. Beijing: China Press of Traditional Chinese Medicine.</Citation>
        </Reference>
        <Reference>
          <Citation>Guangyan, W., &amp; TengMingzi, Z. (2018). Clinical efficacy Tianwang Buxin Dan treatment on atrial fibrillaton combined with coronary heart disease (Yin Deficiency and Fire Prosperity). Chinese Journal of Experimental Traditional Medicine Formulae, 24(17), 247-253.</Citation>
        </Reference>
        <Reference>
          <Citation>He, M., Xi, B., &amp; Chengping, W. (2013). Clinical features of the fire-heat symptom. China Journal of Traditional Chinese Medicine and Pharmacy, 28(3), 791-792.</Citation>
        </Reference>
        <Reference>
          <Citation>Hsu, Y. H., Chen, T. H., Wu, M. Y., Lin, Y. F., Chen, W. L., Cheng, T. H., &amp; Chen, C. H. (2014). Protective effects of ZhibaiDihuang Granule on renal tubular cells affected with gentamicin-induced apoptosis. Journal of Ethnopharmacology, 151, 635-642.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang, T., Zhong, L. L. D., Lin, C.-Y., Zhao, L., Ning, Z.-W., Dong-Dong, H., … Bian, Z.-X. (2018). Approaches in studying the pharmacology of Chinese Medicine formulas: bottom-up, top-down-And meeting in the middle. Chinese Medicine, 13, 15.</Citation>
        </Reference>
        <Reference>
          <Citation>Ide, T., &amp; Tanaka, A. (2000). α-Lipoic acid ameliorated oxidative stress induced by perillaoil, but the combination of these dietary factors was ineffective to cause marked deceases in serum lipid levels in rats. Nutrition Research, 48, 49-64.</Citation>
        </Reference>
        <Reference>
          <Citation>Jie, B., Qin-jing, G., Si-min, L., Yong-fu, Z., Ning-ning, C., Wei-jun, Z., … Yong-sheng, F. (2015). Case-control study of inducing factors in ‘Shanghuo’. China Journal of Traditional Chinese Medicine and Pharmacy, 30(4), 1013-1016.</Citation>
        </Reference>
        <Reference>
          <Citation>Jing-bo, Y., Hui, S., &amp; Yue, H. (2014). Study on the metabonomics contributing to animal model of TCM syndrome. China Journal of Traditional Chinese Medicine and Pharmacy, 29(7), 2259-2262.</Citation>
        </Reference>
        <Reference>
          <Citation>Kamleh, M. A., Blackburn, G. J., Watson, D. G., Xu, N., Ståhle, M., &amp; Wheelock, C. E. (2015). LC-MS Metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment. Journal of Proteome Research, 14(1), 557-566.</Citation>
        </Reference>
        <Reference>
          <Citation>Kersten, S. (2014). Integrated physiology and systems biology of PPARα. Molecular Metabolism, 3, 354-371.</Citation>
        </Reference>
        <Reference>
          <Citation>Kraemer, W. D., Volek, J. S., Spiering, B. A., &amp; Vingren, J. L. (2005). L-carnitine supplementation: A new paradigm for its role in exercise. Monatshefte Chemie, 136(8), 1383-1390.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, J. M., Lee, Y. K., Mamrosh, J. L., Busby, S. A., Griffin, P. R., Pathak, M. C., … Moore, D. D. (2011). A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabeticeffects. Nature, 474, 506-510.</Citation>
        </Reference>
        <Reference>
          <Citation>Lehmann, R., Zhao, X., Weigert, C., Simon, P., Fehrenbach, E., Fritsche, J., … Niess, A. M. (2010). Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation. PLoS One, 5(7), e11519.</Citation>
        </Reference>
        <Reference>
          <Citation>Lei, S. S., Lv, G. Y., &amp; Jin, Z. W. (2015). Effect of extracts from Dendrobiiifficinalisflos on hyperthyroidism Yin deficiency mice. Article in Chinese, 40(9), 1793-1797.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, J. W., &amp; Deng, T. T. (1995). Dictionary of traditional Chinese Medicine (p. 942). Beijing: People's Medical Publishing.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, X., He, Q. H., Granuleg, Y. J., Bai, Y., Kuang, N. Z., &amp; Liu, C. S. (2014). Effect of ZhibaiDihuang granule on uPA of Uu-infection infertility patients. Chininese Journal Integrted Traditonal and Western Medicine, 3(12), 149-152.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, Y. Y., Granuleg, X. X., Zhao, L., Zhang, H., Lv, L., Zhou, G. C., … Zhang, G. Q. (2013). High-performance liquid chromatography-electrospray ionization time-of-flight mass spectrometry analysis of radix sapos-hnikoviae for metabolomics research. Journal of Chromatographic Science, 51(2), 99-106.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, C., Mao, L., Ping, Z., Jiang, T., Wang, C., Chen, Z., … Li, J. (2016). Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome. Evidence-Based Complementary and Alternative Medicine, 5176731.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, C. M., Chen, J., Yang, S., Mao, L. G., Jiang, T. T., Tu, H. H., … Li, J. C. (2018). The Chinese herbal formula ZhibaiDihuang Granule treat Yin-deficiency-heat syndrome rats by regulating the immune responses. Journal of Ethnopharmacology, 225, 271-278.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, C. M., Chen, J., Yang, S., Jiang, T.-T., Chen, Z.-L., Tu, H.-H., … Li, J.-C. (2018). iTRAQ-based proteomic analysis to identify the molecular mechanism of ZhibaiDihuang Granule in the Yin-deficiency-heat syndrome rats. Chinese Medicine, 13(1), 2.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, S., Brown, J. D., Stanya, K. J., Homan, E., Leidl, M., Inouye, K., … Lee, C. H. (2013). A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. Nature, 502, 550-554.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, Y., Liu, P., &amp; Dai, R. (2012). Analysis of plasma proteome from cases of the different traditional Chinese medicine syndromes in patients with chronic hepatitis B. Journal of Pharmaceutical and Biomedical Analysis, 59(5), 173-178.</Citation>
        </Reference>
        <Reference>
          <Citation>Mai, M., Tönjes, A., Kovacs, P., Stumvoll, M., Fiedler, G. M., &amp; Leichtle, A. B. (2013). Serum Levels of Acylcarnitines Are Altered in Prediabetic Conditions. PLoS One, 8(12), e82459.</Citation>
        </Reference>
        <Reference>
          <Citation>Malaguarnera, M., Gargante, M. P., Cristaldi, E., Colonna, V., Messano, M., Koverech, A., … Motta, M. (2008). Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Archives of Gerontology and Geriatrics, 46(2), 181-190.</Citation>
        </Reference>
        <Reference>
          <Citation>Murase, T., Nagasawa, A., Suzuki, J., Wakisaka, T., Hase, T., &amp; Tokimitsu, I. (2002). Dietary alpha-linolenic acid-rich diacylglycerols reduce body weight gain accompanying the stimulation of intestinal beta-oxidation and related gene expressions in C57BL/KsJ-db/db mice. The Journal of Nutrition, 132(10), 3018-3022.</Citation>
        </Reference>
        <Reference>
          <Citation>Neri, S., Pistone, G., Saraceno, B., Pennisi, G., Luca, S., &amp; Malaguarnera, M. (2003). L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C. Neuropsychobiology, 47(2), 94-97.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicholson, J. K., Connelly, J., Lindon, J. C., &amp; Holmes, E. (2002). Metabonomics:a platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery, 1(2), 153-161.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicholson, J. K., &amp; Lindon, J. C. (2008). Systems biology: Metabonomics. Nature, 455(7216), 1054-1056.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicholson, J. K., Lindon, J. C., &amp; Holmes, E. (1999). Metabonomics: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29(11), 1181-1189.</Citation>
        </Reference>
        <Reference>
          <Citation>Nizioł, J., Bonifay, V., Ossoliński, K., Ossoliński, T., Ossolińska, A., Sunner, J., … Ruman, T. (2018). Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA. Analytical and Bioanalytical Chemistry, 410(16), 3859-3869.</Citation>
        </Reference>
        <Reference>
          <Citation>Noland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ikayeva, O., … Muoio, D. M. (2009). Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J BiolChem, 284(34), 22840-22852.</Citation>
        </Reference>
        <Reference>
          <Citation>Perng, W., Villamor, E., Mora-Plazas, M., Marin, C., &amp; Baylin, A. (2015). Alpha-linolenic acid (ALA) is inversely related to development of adiposity in school-age children. European Journal of Clinical Nutrition, 69(2), 167-172.</Citation>
        </Reference>
        <Reference>
          <Citation>Qi, S., Wei, G., &amp; You-lin, L. (2015). Study of qi-deficiency syndrome identification modes of coronary heart disease patients based on metabonomics. China Journal of Traditional Chinese Medicine and Pharmacy, 30(2), 372-375.</Citation>
        </Reference>
        <Reference>
          <Citation>Ridgway, N. D. (2013). The role of phosphatidylcholine and choline metabolites to cell proliferation and survival. Journal Critical Reviews in Biochemistry and Molecular Biology, 48(1), 20-38.</Citation>
        </Reference>
        <Reference>
          <Citation>Tailor, J., King, R. D., &amp; Ahmann, T. (2002). Application of metabolomics toplant genotype discrimination using statistics and machine learning. Bioinformatics, 18(Suppl. 2), 241-248.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, Q., &amp; Zhu, Y. B. (2009). Epidemiological investigation of constitutional types of Chinese medicine in general population: Base on 21,948 epidemiological investigation data of nine provinces in China. Journal of Traditional Chinese Medicine and Pharmacy, 24(1), 7-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Wong, K. L., Wong, R. N., Zhang, L., Liu, W. K., Ng, T. B., Shaw, P. C., … Sze, S. C. (2014). Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential. Chinese Medicine, 9, 19.</Citation>
        </Reference>
        <Reference>
          <Citation>Xiang, Z., Granuleg, X. Q., Cai, X. J., &amp; Zeng, S. (2011). Metabolomcs study on quality control and discrimination of three Curcuma species based on gas chromatograph-mass spectrometry. Phytochemical Analysis, 22, 411-418.</Citation>
        </Reference>
        <Reference>
          <Citation>Xie, H.-h., Xu, J.-y., Xie, T., Meng, X., Lin, L.-l., He, L.-l., … Wang, S.-c. (2016). Effects of Pinelliaternata (Thunb.) Berit.on the metabolomic profiles of placenta and amniotic fluid in pregnant rats. Journal of Ethnopharmacology, 183, 38-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu, Z., Zhang, Y., Jia, D., &amp; Zou, W. (2008). The protective effects of hepatic-derived phospholipids on alcohol induced hepatic injury. Acta Nutrimenta Sinica, 30, 313-315.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, A., Sun, H., Wang, Z., Sun, W., Wang, P., &amp; Wang, X. (2010). Metabolomics: Towards understanding Traditional Chinese medicine. Planta Medica, 76(17), 2026-2035.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, H., Zhou, J., Zhang, L., Ma, J., Sun, Y., &amp; Zhao, Y. (2015). Characteristics of blood glucose excursions in type 2 diabetes mellitus patients with three different Traditional Chinese Medicine syndromes. Journal of Traditional Chinese Medicine, 35(5), 537-545.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao, L., Gao, H., Zhao, Y., &amp; Lin, D. (2012). Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Granule in treatment of streptozotocin-induced diabetic nephropathy, 142, 647-656.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909892</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0496</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric pulmonology</Title>
          <ISOAbbreviation>Pediatr. Pulmonol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Primary malignant lung tumors in children: A report from the Australian Childhood Cancer Registry, 1983-2015.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.24636</ELocationID>
        <Abstract>
          <AbstractText>Lung cancers in children under the age of 15 are very uncommon, with a scarcity of literature describing patient characteristics and survival. This study assessed first primary malignant cancers occurring in the trachea, bronchus, or lung (International Classification of Diseases for Oncology, 3rd edition [ICD-O-3] codes C33-C34) for the period 1983-2015, using data from the population-based Australian Childhood Cancer Registry. Variables of interest included morphology, sex, age group, and metastatic status at diagnosis. Mode of treatment was also assessed where possible. The Kaplan-Meier method was used to calculate 5-year observed survival. Of the 53 in-scope patients, almost half (n = 23, 43%) were diagnosed with pleuropulmonary blastoma and a further 8 (15%) had a carcinoid tumor. Few of the patients with details available on stage at diagnosis (n = 7 of 43, 16%) presented with metastatic disease. Surgical excision was the most common treatment (30 of 37 children, 81%), with two-thirds (n = 28 of 43, 65%) receiving chemotherapy. Five-year observed survival was estimated to be 74% (95% CI = 61%-85%). Our results represent one of the largest and most complete population-based cohorts of children with primary malignant lung cancers available to date. Detection of childhood lung cancer can be difficult due to the rarity of this disease and symptoms that are typically nonspecific.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Youlden</LastName>
            <ForeName>Danny R</ForeName>
            <Initials>DR</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-2721-9083</Identifier>
            <AffiliationInfo>
              <Affiliation>Cancer Council Queensland, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Foresto</LastName>
            <ForeName>Steven A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Oncology Service, Children's Health Queensland Hospital and Health Service, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Clinical Medicine, University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aitken</LastName>
            <ForeName>Joanne F</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Council Queensland, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Resilient Regions, University of Southern Queensland, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Public Health, University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Pulmonol</MedlineTA>
        <NlmUniqueID>8510590</NlmUniqueID>
        <ISSNLinking>1099-0496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Australia</Keyword>
        <Keyword MajorTopicYN="N">carcinoid tumors</Keyword>
        <Keyword MajorTopicYN="N">childhood</Keyword>
        <Keyword MajorTopicYN="N">lung cancer</Keyword>
        <Keyword MajorTopicYN="N">pleuropulmonary blastoma</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909892</ArticleId>
        <ArticleId IdType="doi">10.1002/ppul.24636</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Dishop MK, Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. Arch Pathol Lab Med. 2008;132:1079-1103.</Citation>
        </Reference>
        <Reference>
          <Citation>Baade PD, Youlden DR, Valery PC, et al. Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer. 2010;102:620-626.</Citation>
        </Reference>
        <Reference>
          <Citation>Neville HL, Hogan AR, Zhuge Y, et al. Incidence and outcomes of malignant pediatric lung neoplasms. J Surg Res. 2009;156:224-230.</Citation>
        </Reference>
        <Reference>
          <Citation>Rojas Y, Shi YX, Zhang W, et al. Primary malignant pulmonary tumors in children: a review of the national cancer data base. J Pediatr Surg. 2015;50:1004-1008.</Citation>
        </Reference>
        <Reference>
          <Citation>Messinger YH, Stewart DR, Priest JR, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015;121:276-285.</Citation>
        </Reference>
        <Reference>
          <Citation>Cross SF, Arbuckle S, Priest JR, Marshall G, Charles A, Dalla Pozza L. Familial pleuropulmonary blastoma in Australia. Pediatr Blood Cancer. 2010;55:1417-1419.</Citation>
        </Reference>
        <Reference>
          <Citation>Priest JR, Watterson J, Strong L, et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr. 1996;128:220-224.</Citation>
        </Reference>
        <Reference>
          <Citation>Moraes TJ, Langer JC, Forte V, Shayan K, Sweezey N. Pediatric pulmonary carcinoid: a case report and review of the literature. Pediatr Pulmonol. 2003;35:318-322.</Citation>
        </Reference>
        <Reference>
          <Citation>Pizzo P, Poplack D, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott, Williams &amp; Wilkins; 2006:1780.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909893</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0496</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric pulmonology</Title>
          <ISOAbbreviation>Pediatr. Pulmonol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Meteorological factors affecting respiratory syncytial virus infection: A time-series analysis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.24629</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Respiratory syncytial virus (RSV) infection is a major cause of hospitalization in children. Meteorological factors are known to influence seasonal RSV epidemics, but the relationship between meteorological factors and RSV infection in children is not well understood. We aimed to explore the relationship between meteorological factors and RSV infections among hospitalized children, using different statistical models.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective review concerning children with RSV infections admitted to a tertiary pediatric hospital in Wenzhou, China, between January 2008 and December 2017. The relationship between meteorological factors (average daily temperatures, average daily relative humidity, rainfall, rainfall days, and wind speed) and the incidence of RSV in hospitalized children was analyzed using three time-series models, namely an autoregressive integrated moving average (ARIMA) model, a generalized additive model (GAM), and a least absolute shrinkage and selection operator (LASSO)-based model.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 15 858 (17.6%) children tested positive for RSV infection. The ARIMA model revealed a marked seasonal pattern in the RSV detection rate, which peaked in winter and spring. The model was a good predictor of RSV incidence (R<sup>2</sup> : 83.5%). The GAM revealed that a lower temperature and higher wind speed preceded increases in RSV detection. The LASSO-based model revealed that temperature and relative humidity were negatively correlated with RSV detection.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Seasonality of RSV infection in hospitalized children correlated strongly with temperature. The LASSO-based model can be used to predict annual RSV epidemics using weather forecast data.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Hailin</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Children's Respiratory Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wen</LastName>
            <ForeName>Shunhang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Children's Respiratory Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Jingwei</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Research, Eye Hospital, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xiaofang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Children's Respiratory Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Fangfang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Children's Respiratory Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-1200-3068</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Pulmonol</MedlineTA>
        <NlmUniqueID>8510590</NlmUniqueID>
        <ISSNLinking>1099-0496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">meteorological factors</Keyword>
        <Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword>
        <Keyword MajorTopicYN="N">seasonal variation</Keyword>
        <Keyword MajorTopicYN="N">time-series analysis</Keyword>
        <Keyword MajorTopicYN="N">weather</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909893</ArticleId>
        <ArticleId IdType="doi">10.1002/ppul.24629</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390:946-958.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu JX, Liu CY, Xiao Y, et al. Respiratory syncytial virus seasonality, Beijing, China, 2007-2015. Emerg Infect Dis. 2019;25:1127-1135.</Citation>
        </Reference>
        <Reference>
          <Citation>Feng L, Li Z, Zhao S, et al. Viral etiologies of hospitalized acute lower respiratory infection patients in China, 2009-2013. PLoS One. 2014;9:e99419.</Citation>
        </Reference>
        <Reference>
          <Citation>Wen SH, Lv FF, Chen XF, et al. Application of a nucleic acid-based multiplex kit to identify viral and atypical bacterial aetiology of lower respiratory tract infection in hospitalized children. J Med Microbiol. 2019;68:1211-1218.</Citation>
        </Reference>
        <Reference>
          <Citation>Mirsaeidi M, Motahari H, Khamesi MT, Sharifi A, Campos M, Schraufnagel DE. Climate change and respiratory infections. Ann Am Thorac Soc. 2016;13:1223-1230.</Citation>
        </Reference>
        <Reference>
          <Citation>Omer SB, Sutanto A, Sarwo H, et al. Climatic, temporal, and geographic characteristics of respiratory syncytial virus disease in a tropical island population. Epidemiol Infect. 2008;136:1319-1327.</Citation>
        </Reference>
        <Reference>
          <Citation>du Prel JB, Puppe W, Grondahl B, et al. Are meteorological parameters associated with acute respiratory tract infections? Clin Infect Dis. 2009;49:861-868.</Citation>
        </Reference>
        <Reference>
          <Citation>Hammami D, Lee TS, Ouarda TBMJ, Lee J. Predictor selection for downscaling GCM data with LASSO. J Geophys Res. 2012;117:D17116-D17116.</Citation>
        </Reference>
        <Reference>
          <Citation>Gao L, Schulz K, Bernhardt M. Statistical downscaling of ERA-interim forecast precipitation data in complex terrain using LASSO algorithm. Adv Meteorol. 2014;2014:472741.</Citation>
        </Reference>
        <Reference>
          <Citation>Kottek M, Grieser J, Beck C, Rudolf B, Rubel F. World map of the Köppen-Geiger climate classification updated. Meteorol Z. 2006;15:259-263.</Citation>
        </Reference>
        <Reference>
          <Citation>Gurgel RQ, Bezerra PG, Duarte MC, et al. Relative frequency, possible risk factors, viral codetection rates, and seasonality of respiratory syncytial virus among children with lower respiratory tract infection in northeastern Brazil. Medicine. 2016;95:e3090.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Martinez CE, Sossa-Briceno MP, Acuna-Cordero R. Relationship between meteorological conditions and respiratory syncytial virus in a tropical country. Epidemiol Infect. 2015;143:2679-2686.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang XL, Shao XJ, Wang J, Guo WL. Temporal characteristics of respiratory syncytial virus infection in children and its correlation with climatic factors at a public pediatric hospital in Suzhou. J Clin Virol. 2013;58:666-670.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen ZR, Zhu Y, Wang YQ, et al. Association of meteorological factors with childhood viral acute respiratory infections in subtropical China: an analysis over 11 years. Arch Virol. 2014;159:631-639.</Citation>
        </Reference>
        <Reference>
          <Citation>Tang JW, Loh TP. Correlations between climate factors and incidence-a contributor to RSV seasonality. Rev Med Virol. 2014;24:15-34.</Citation>
        </Reference>
        <Reference>
          <Citation>Darniot M, Pitoiset C, Milliere L, et al. Different meteorological parameters influence metapneumovirus and respiratory syncytial virus activity. J Clin Virol. 2018;104:77-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu Y, Kan HD, Xu JM, et al. Temporal relationship between hospital admissions for pneumonia and weather conditions in Shanghai, China: a time-series analysis. BMJ Open. 2014;4:e004961.</Citation>
        </Reference>
        <Reference>
          <Citation>Yusuf S, Piedimonte G, Auais A, et al. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect. 2007;135:1077-1090.</Citation>
        </Reference>
        <Reference>
          <Citation>Nascimento-Carvalho CM, Cardoso MRA, Barral A, et al. Seasonal patterns of viral and bacterial infections among children hospitalized with community-acquired pneumonia in a tropical region. Scand J Infect Dis. 2010;42:839-844.</Citation>
        </Reference>
        <Reference>
          <Citation>Tian DD, Jiang R, Chen XJ, Ye Q. Meteorological factors on the incidence of MP and RSV pneumonia in children. PLoS One. 2017;12:e173409.</Citation>
        </Reference>
        <Reference>
          <Citation>Meerhoff TJ, Paget JW, Kimpen JL, Schellevis F. Variation of respiratory syncytial virus and the relation with meteorological factors in different winter seasons. Pediatr Infect Dis J. 2009;28:860-866.</Citation>
        </Reference>
        <Reference>
          <Citation>Paynter S, Ware RS, Weinstein P, Williams G, Sly PD. Childhood pneumonia: a neglected, climate-sensitive disease? Lancet. 2010;376:1804-1805.</Citation>
        </Reference>
        <Reference>
          <Citation>Morley C, Grimwood K, Maloney S, Ware RS. Meteorological factors and respiratory syncytial virus seasonality in subtropical Australia. Epidemiol Infect. 2018;146:757-762.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu YL, Liu J, Chen FL, et al. Impact of meteorological factors on lower respiratory tract infections in children. J Int Med Res. 2016;44:30-41.</Citation>
        </Reference>
        <Reference>
          <Citation>Paynter S, Weinstein P, Ware RS, et al. Sunshine, rainfall, humidity and child pneumonia in the tropics: time-series analyses. Epidemiol Infect. 2013;141:1328-1336.</Citation>
        </Reference>
        <Reference>
          <Citation>Gamba-Sanchez N, Rodriguez-Martinez CE, Sossa-Briceno MP. Epidemic activity of respiratory syncytial virus is related to temperature and rainfall in equatorial tropical countries. Epidemiol Infect. 2016;144:2057-2063.</Citation>
        </Reference>
        <Reference>
          <Citation>Arnott A, Vong S, Mardy S, et al. A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype. J Clin Microbiol. 2011;49:3504-3513.</Citation>
        </Reference>
        <Reference>
          <Citation>Alonso WJ, Laranjeira BJ, Pereira SAR, et al. Comparative dynamics, morbidity and mortality burden of pediatric viral respiratory infections in an equatorial city. Pediatr Infect Dis J. 2012;31:E9-E14.</Citation>
        </Reference>
        <Reference>
          <Citation>Paynter S, Ware RS, Sly PD, Williams G, Weinstein P. Seasonal immune modulation in humans: observed patterns and potential environmental drivers. J Infection. 2015;70:1-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Brady MT, Byington CL, Davies HD, et al. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134:415-420.</Citation>
        </Reference>
        <Reference>
          <Citation>Reis AD, Fink MCD, Machado CM, et al. Comparison of direct immunofluorescence, conventional cell culture and polymerase chain reaction techniques for detecting respiratory syncytial virus in nasopharyngeal aspirates from infants. Rev Inst Med Trop Sp. 2008;50:37-40.</Citation>
        </Reference>
        <Reference>
          <Citation>Hossain MZ, Bambrick H, Wraith D, et al. Sociodemographic, climatic variability and lower respiratory tract infections: a systematic literature review. Int J Biometeorol. 2019;63:209-219.</Citation>
        </Reference>
        <Reference>
          <Citation>Ye Q, Fu JF, Mao JH, Shang SQ. Haze is a risk factor contributing to the rapid spread of respiratory syncytial virus in children. Environ Sci Pollut R. 2016;23:20178-20185.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909894</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-6155</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal for specialists in pediatric nursing : JSPN</Title>
          <ISOAbbreviation>J Spec Pediatr Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The effect of thermoregulation quality improvement initiatives on the admission temperature of premature/very low birth-weight infants in neonatal intensive care units: A systematic review.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e12286</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jspn.12286</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this review was to ascertain the impact of thermoregulation quality improvement initiatives (QIs) on the admission temperatures of premature/very-low-birth-weight infants in neonatal intensive care units (NICUs).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of databases Cumulative Index to Nursing and Allied Health Literature, Medline, Embase, and the Cochrane library was carried out. Specific inclusion and exclusion criteria were adhered to, with no publication date limitations added. The chosen studies were examined for quality, data were extracted and analysed, before a narrative synthesis was performed. The last search occurred on January 7, 2019, with PRISMA flow diagrams completed for identified studies.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies of varying methodology design were included in this review. Variations of thermoregulation interventions were included in the 10 studies. Nevertheless, all of them demonstrated that admission temperature rates can be significantly improved by implementing a thermoregulation QI. The multidisciplinary team and ongoing education were seen as much needed components to the overall sustainability, and continuing success of the QI's.</AbstractText>
          <AbstractText Label="PRACTICAL IMPLICATIONS" NlmCategory="CONCLUSIONS">This systematic review determines that thermoregulation QIs can positively impact the admission temperatures of premature/very-low-birth-weight infants in the NICU. Prevention of hypothermia is aimed at reducing the risks of developing major neonatal morbidities. The pooling of the results from the 10 studies helps in the sharing of outcome measures and thus, improving quantitative synthesis. More frequent monitoring of the axillary temperature would help in preventing hypothermia and hyperthermia occurring. Ongoing education and staff training are essential for managing thermoregulation successfully. Examining the compliance rates to such quality initiatives, and the variations in interventions would benefit from further research to ensure better standardisation of clinical practice.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Donnellan</LastName>
            <ForeName>Denise</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-5776-6942</Identifier>
            <AffiliationInfo>
              <Affiliation>Neonatal Intensive Care Unit, University Hospital Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moore</LastName>
            <ForeName>Zena</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing and Midwifery, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patton</LastName>
            <ForeName>Declan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing and Midwifery, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Connor</LastName>
            <ForeName>Tom</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing and Midwifery, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nugent</LastName>
            <ForeName>Linda</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing and Midwifery, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Health and Safety Executive</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Spec Pediatr Nurs</MedlineTA>
        <NlmUniqueID>101142025</NlmUniqueID>
        <ISSNLinking>1539-0136</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>N</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">premature infant</Keyword>
        <Keyword MajorTopicYN="N">quality improvement</Keyword>
        <Keyword MajorTopicYN="N">quality initiative</Keyword>
        <Keyword MajorTopicYN="N">temperature</Keyword>
        <Keyword MajorTopicYN="N">thermoregulation</Keyword>
        <Keyword MajorTopicYN="N">very low birth-weight infant</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909894</ArticleId>
        <ArticleId IdType="doi">10.1111/jspn.12286</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Aylott, M. (2006). The neonatal energy triangle part 1: Metabolic adaption. Paediatric Nursing, 18(6), 38-42. https://doi.org/10.7748/paed.18.6.38.s30</Citation>
        </Reference>
        <Reference>
          <Citation>Bhavsar, S. R., Kabra, N. S., Avasthi, B. S., Sharma, R. S., Dash, S. W., &amp; Tali, S. H. (2015). Efficacy and safety of polyethelene wrap in preventing hypothermia in preterm and low birth weight neonates during transport: A randomised controlled trial. Perinatology, 16(1), 23-30.</Citation>
        </Reference>
        <Reference>
          <Citation>Billimoira, Z., Chawla, S., Bajaj, M., &amp; Natarajan, G. (2013). Improving admission temperature in extremely low birth weight infants: A hospital-based multi-intervention quality improvement project. Journal of Perinatal Medicine, 41(4), 455-460. https://doi.org/10.1515/jpm-2012-0259</Citation>
        </Reference>
        <Reference>
          <Citation>Bisinger, R. L., &amp; Annibale, D. J. (2010). Thermoregulation in very low-birth-weight infants during the golden hour. Advances in Neonatal Care, 10(5), 230-238. https://doi.org/10.1097/anc.0b013e318f0ae63</Citation>
        </Reference>
        <Reference>
          <Citation>Caglar, S., Gozen, D., &amp; Ince, Z. (2014). Heat loss prevention (help) after birth in preterm infants using vinyl isolation bag or polyethylene wrap. Journal of Obstetric, Gynecologic &amp; Neonatal Nursing, 43(2), 216-223. https://doi.org/10.1111/1552-6909.12291</Citation>
        </Reference>
        <Reference>
          <Citation>Castrodale, V., &amp; Rinehart, S. (2014). The golden hour: Improving the stabilization of the very-low-birth-weight infant. Advances in Neonatal Care, 14(1), 9-14. https://doi.org/10.1097/anc.0b013e31828d0289</Citation>
        </Reference>
        <Reference>
          <Citation>Chawla, S., Amaram, A., Gopal, S. P., &amp; Natarajan, G. (2011). Safety and efficacy of Trans-warmer mattress for preterm neonates: Results of a randomised controlled trial. Journal of Perinatology, 31(12), 780-784. https://doi.org/10.1038/jp.2011.33</Citation>
        </Reference>
        <Reference>
          <Citation>Cheung, Y. Y., Jung, B., Sohn, J. H., &amp; Ogrinc, G. (2012). Statistical control charts: Simplifying the analysis of data for quality improvement. Radiographics, 32, 2113-2126. https://doi.org/10.1148/rg.327125713</Citation>
        </Reference>
        <Reference>
          <Citation>Chitty, H., &amp; Wyllie, J. (2013). Importance of maintaining the newly born temperature in the normal range from delivery to admission. Seminars in Fetal &amp; Neonatal Medicine, 18, 362-368. https://doi.org/10.1016/j.siny.2013.08.002</Citation>
        </Reference>
        <Reference>
          <Citation>Choi, H. S., Lee, S. M., Eun, H., Park, M., Park, K. I., &amp; Namgung, R. (2018). The impact of a quality improvement effort in reducing admission hypothermia in preterm infants following delivery. Korean Journal of Pediatrics, 61(8), 239-244. https://doi.org/10.3345/kjp.2018.61.8.239</Citation>
        </Reference>
        <Reference>
          <Citation>Corado, T., Phelan, A. G., &amp; Zukowsky, K. (2012). Hypothermia and occlusive skin wrap in the low birth weight premature infant: An evidentiary review. Newborn &amp; Nursing Infant Reviews, 12, 78-85. https://doi.org/10.1053/j.nainr.2012.03.001</Citation>
        </Reference>
        <Reference>
          <Citation>Doglioni, N., Cavallin, F., Mardegan, V., Palatron, S., Fillippone, M., Vecchiato, L., … Trevisanuto, D. (2014). Total body polyethylene wraps for preventing hypothermia in preterm infants: A randomized trial. Journal of Pediatrics, 165(2), 261-266. https://doi.org/10.1016/jpeds.2014.04.010</Citation>
        </Reference>
        <Reference>
          <Citation>Duryea, E. L., Nelson, D. B., Wyckoff, M. H., Grant, E. N., Tao, W., Sadana, N., … Levano, K. J. (2016). The impact of ambient operating room temperature on neonatal and maternal hypothermia and associated morbidities: A randomised controlled trial. American Journal of Obstetrics &amp; Gynecology, 505, 1-7. https://doi.org/10.1016/j.ajog.2016.01.190</Citation>
        </Reference>
        <Reference>
          <Citation>Farhadi, R., Naderi, M., Rahmani, Z., Gafari, V., &amp; Khalilian, A. (2012). Effect of ‘Zipkif’ plastic bag on prevention of hypothermia in preterm infants: A randomised control trial. Journal of Mazandaran University of Medical Sciences, 22(93), 19-26.</Citation>
        </Reference>
        <Reference>
          <Citation>Fawcett, K. (2014). Preventing admission hypothermia in very low birth weight neonates. Neonatal Network, 33(3), 143-149. https://doi.org/10.1891/0730-0832.33.3.143</Citation>
        </Reference>
        <Reference>
          <Citation>Frazer, M., Ciarlo, A., Herr, J., &amp; Brierre, C. E. (2018). Quality improvement initiative to prevent admission hypothermia in very-low-birth weight newborns. Journal of Obstetric, Gynecologic &amp; Neonatal Nursing, 47(4), 520-528. https://doi.org/10.1016/j-jogn.2018.03003</Citation>
        </Reference>
        <Reference>
          <Citation>Fry, T. J., Marfurt, S., &amp; Wengler, S. (2018). Systematic review of quality improvement initiatives related to cue-based feeding in preterm infants. Nursing for Women's Health, 22(5), 403-410. https://doi.org/10.1016/j.nwh.2018.07.006</Citation>
        </Reference>
        <Reference>
          <Citation>Glynn, L. (2006). A critical appraisal tool for library and information research. Library Hi Tech, 24(3), 387-399. https://doi.org/10.1108/07378830610692154</Citation>
        </Reference>
        <Reference>
          <Citation>Godfrey, K., Nativio, D. G., Bender, C. V., &amp; Schlenk, E. A. (2013). Occlusive bags to prevent hypothermia in premature infants: A quality improvement initiative. Journal of the National Association of Neonatal Nurses, 13(5), 311-316. https://doi.org/10.1097/anc.0b013e31828d040a</Citation>
        </Reference>
        <Reference>
          <Citation>Harer, M. W., Vergales, B., Cady, T., Early, A., Chisholm, C., &amp; Swanson, J. R. (2017). Implementation of a multidisciplinary guideline improves preterm infant admission temperatures. Journal of Perinatology, 37(11), 1242-1247. https://doi.org/10.1038/jp.2017.112</Citation>
        </Reference>
        <Reference>
          <Citation>Higgins, J. P. T., &amp; Green, S. (2011). Cochrane handbook for systematic reviews of interventions. London, England: Wiley.</Citation>
        </Reference>
        <Reference>
          <Citation>Kent, A. L., &amp; Williams, J. (2008). Increasing ambient operating theatre temperature and wrapping in polyethylene improves admission temperature in premature infants. Journal of Pediatrics and Child Health, 4, 325-331. https://doi.org/10.1111/j.1440-1754.2007.01264</Citation>
        </Reference>
        <Reference>
          <Citation>Knobel, R. B. (2014). Thermal stability of the premature infant in the neonatal intensive care. Newborn &amp; Infant Nursing Reviews, 14, 72-76. https://doi.org/10.1053/j.nainr.2014.03.002</Citation>
        </Reference>
        <Reference>
          <Citation>Knobel, R. B., Wimmer, J. E., &amp; Holbert, D. (2005). Heat loss prevention for preterm infants in the delivery room. Journal of Perinatology, 25(5), 304-308. https://doi.org/10.1038/sj.jp.7211289</Citation>
        </Reference>
        <Reference>
          <Citation>Knobel-Dail, R. (2014). Role of effective thermoregulation in premature neonates. Research and Reports in Neonatology, 4, 147-156. https://doi.org/10.2147/rrn.s52377</Citation>
        </Reference>
        <Reference>
          <Citation>Laptook, A. R., &amp; Watkinson, M. (2008). Temperature management in the delivery room. Seminars in Fetal &amp; Neonatal Medicine, 13, 383-391. https://doi.org/10.1016/j.siny.2008.04.003</Citation>
        </Reference>
        <Reference>
          <Citation>Lee, H. C., Ho, Q. T., &amp; Rhine, W. D. (2008). A quality improvement project to improve admission temperatures in very low birth weight infants. Journal of Perinatology, 28(11), 754-758. https://doi.org/10.1038/jp.2008.92</Citation>
        </Reference>
        <Reference>
          <Citation>Leslie, A., Wardle, S.P., Budge, H., Marlow, N., &amp; Brocklehurst, P. (2007). Randomised controlled trial of gel warming mattresses to prevent hypothermia during resuscitation at birth of premature infants. Neonatal Society, London. https://www.neonatalsociety.ac.uk/abstracts/lesliea_2007</Citation>
        </Reference>
        <Reference>
          <Citation>Lyu, Y., Shah, P. S., Ye, X. Y., Warre, R., Piedbouef, B., &amp; Deshpandey, A. (2015). Association between admission temperature and mortality and major morbitity in preterm infants born at fewer than 33 weeks gestation. Journal of American Medical Association Pediatrica, 169, 1-8. https://doi.org/10.1001/jamapediatrics.2015.0277</Citation>
        </Reference>
        <Reference>
          <Citation>Manani, M., Jegatheesan, P., DeSandre, G., Song, D., Showalter, L., &amp; Govindaswami, B. (2013). Elimination of admission hypothermia in preterm very low-birth-weight infants by standardization of delivery room management. The Permanente Journal, 17(3), 8-13. https://doi.org/10.7812/tpp/12-130</Citation>
        </Reference>
        <Reference>
          <Citation>McCall, E., Alderdice, F., Halliday, H., Johnston, L., &amp; Vohra, S. (2014). Challenges of minimizing heat loss at birth: A narrative overview of evidence-based thermal care interventions. Newborn and Infant Nursing Reviews, 14(2), 56-63. https://doi.org/10.1053/j.nainr.2014.03.008</Citation>
        </Reference>
        <Reference>
          <Citation>McCall, E. M., Alderdice, F., Halliday, H. L., Vohra, S., &amp; Johnston, L. (2018). Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews, 2018(2), CD004210. https://doi.org/10.1002/14651858.CD004210.pub5</Citation>
        </Reference>
        <Reference>
          <Citation>McCarthy, L. K., Molloy, E. J., Twomey, A. R., Murphy, J. F., &amp; O'Donnell, C. P. (2013). A randomised trial of exothermic mattresses for preterm newborns in polyethene bags. Pediatrics, 132(1), 135-141. https://doi.org/10.1542/peds.2013-0279</Citation>
        </Reference>
        <Reference>
          <Citation>Miller, S. S., Lee, H. C., &amp; Gould, J. B. (2011). Hypothermia in very low birth weight infants: Distribution, risk factors and outcomes. Journal of Perinatology, 31, 49-56. https://doi.org/10.1038/jp.2010.177</Citation>
        </Reference>
        <Reference>
          <Citation>Nnap (2017) UK National Neonatal Audit Programme. National Neonatal Audit Programme. 2017 Annual Report on 2016 Data. London: Royal College of Paediatrics and Child Health.</Citation>
        </Reference>
        <Reference>
          <Citation>Oatley, H. K., Blencowe, H., &amp; Lawn, J. E. (2016). The effects of coverings, including plastic bags and wraps, on mortality and morbidity in preterm and full-term neonates. Journal of Perinatology, 36, S83-S89. https://www.nature.com/articles/jp201635</Citation>
        </Reference>
        <Reference>
          <Citation>O'Brien, E. A., Colaizy, T. T., Brumbaugh, J. E., Cress, G. A., &amp; Johnson, K. J. (2018). Body temperatures of very low birth weight infants on admission to a neonatal intensive care unit. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 32(16), 2763-2766. https://doi.org/10.1080/14767058.2018.1446076</Citation>
        </Reference>
        <Reference>
          <Citation>Pinheiro, J. M., Furdon, S. A., Boynton, S., Dugan, R., Reu-Donlon, C., &amp; Jensen, S. (2014). Decreasing hypothermia during delivery room stabilization of preterm neonates. Pediatrics, 133(1), 218-226. https://doi.org/10.1542/peds.2013-1293</Citation>
        </Reference>
        <Reference>
          <Citation>Russo, A., McCready, M., Torres, L., Venturini, S., Theuriere, C., Spaight, M., &amp; Periman, J. (2014). Reducing hypothermia in preterm infants following delivery. Pediatrics, 133(4), 1055-1062. https://doi.org/10.1542/peds.2013-2544</Citation>
        </Reference>
        <Reference>
          <Citation>Singh, A., Duckett, J., Newton, T., &amp; Watkinson, M. (2010). Improving neonatal unit admission temperatures in preterm babies: Exothermic mattresses, polythene bags, or a traditional approach? Journal of Perinatology, 30, 45-49. https://doi.org/10.1038/jp.2009.94</Citation>
        </Reference>
        <Reference>
          <Citation>De Siqueira Caldas, J. P., De Castro Millen, F., De Camargo, J. F., Cavalcanti Castro, P. A., De Fonseca Camilo, Al, &amp; Martinis Marba, S. T. (2018). Effectiveness of a measure program to prevent admission hypothermia in very low-birth weight preterm infants. Journal of Pediatrics, 94(4), 368-373. https://doi.org/10.1016/j.jped.2017.06.016</Citation>
        </Reference>
        <Reference>
          <Citation>Ting, J. Y., Synnes, A. R., Lee, S. K., &amp; Shah, P. S. (2018). Association of admission temperature and death or adverse &amp;hyphen-qj11;neurodevelopmental outcomes in extremely low-gestational age neonates. Journal of Perinatology, 38, 844-849. https://doi.org/10.1038/s41372-018-0099-6</Citation>
        </Reference>
        <Reference>
          <Citation>Trembath, A., Iams, J. D., &amp; Walsh, M. (2013). Quality initiatives related to moderately preterm, late preterm, and early term births. Clinical Perinatology, 40, 777-789. https://doi.org/10.1016/j.clp.2013.07.011</Citation>
        </Reference>
        <Reference>
          <Citation>Von (2017). Vermont oxford network, Vermont oxford network database of very low birth weight infants born in 2016. Burlington, VT: Vermont Oxford Network.</Citation>
        </Reference>
        <Reference>
          <Citation>Weiner, G.M., &amp; Zaichkin, J. (2016). Textbook of Neonatal Resusitation (NRP). 7th ed. USA, American Academy of Pediatrics.</Citation>
        </Reference>
        <Reference>
          <Citation>Wells, S., Tamir, O., Gray, J., Naidoo, D., Bekhit, M., &amp; Goldmann, D. (2018). Are quality improvement collaboratives effective? A systematic review. BMJ Quality &amp; Safety, 27, 226-240. https://doi.org/10.1136/bmjqs-2017-006926</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson, E., Maier, R. F., Norman, M., Misselwitz, B., Howell, E. A., Zeitlin, J., &amp; Bonamy, A.-K. (2016). Admission Hypothermia in very preterm infants and Neonatal Mortality and Morbidity. Journal of Pediatrics, 175, 61-67. https://doi.org/10.1016/j.jpeds.2016.04.016</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson, E., Zeitlin, J., Piedvache, A., Misselwitz, B., Christensson, K., Maier, R., … Bonamy, A.-K. (2018). Cohort study from 11 European countries highlighted differences in the use and efficacy of hypothermia prevention strategies after very preterm birth. Acta Paediatrica, 107(6), 958-966. https://doi.org/10.1111/apa.14230</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organisation (1997). Thermal Control of the Newborn: A practical guide. World Health Organisation Geneva. http://www.WHO/RHT/MSM/97.2. [Accessed 07 January 2019].</Citation>
        </Reference>
        <Reference>
          <Citation>Wyllie, J., Bruinenberg, J., Roehr, C. C., Rudiger, M., Trevisanuto, D., &amp; Urlesberger, B. (2015). European Resuscitation Council Guidelines for Resuscitation 2015 Section 7. Resuscitation and support of transition of babies at birth. Resuscitation, 95, 249-263. https://doi.org/10.1016/j.resusitation.2015.07.029</Citation>
        </Reference>
        <Reference>
          <Citation>Yip, W. Y., Quek, B. H., &amp; Wan Fong, M. (2017). A quality improvement project to reduce hypothermia in preterm infants on admission to the neonatal intensive care unit. International Journal for Quality in Health Care, 29(7), 922-928. https://doi.org/10.1093/intqhc/mzx131</Citation>
        </Reference>
        <Reference>
          <Citation>Zaka, N., Alexander, E. C., Maikam, L., Norman, I. C. F., Akhbari, M., Moxon, S., … Pearson, L. (2018). Quality improvement initiatives for hospitalised small and sick newborns on low and middle-income countries: A systematic review. Implementation Science, 13, 20. https://doi.org/10.1186/s13012-018-0712-2</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909895</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1932-8494</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Anatomical record (Hoboken, N.J. : 2007)</Title>
          <ISOAbbreviation>Anat Rec (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Serum proteins TGFBI, PCSK9, and CCL14 are potential biomarkers for different traditional Chinese medicine syndromes of multidrug-resistant tuberculosis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ar.24353</ELocationID>
        <Abstract>
          <AbstractText>Patients with multidrug-resistant tuberculosis (MDR-TB) tend to have a long course of anti-TB treatment and severe side effects. Traditional Chinese Medicine (TCM) has a synergistic effect in attenuation of MDR-TB. However, the lack of objective biological standards to classify and diagnose MDR-TB TCM syndromes could result in less effective TCM treatment. Therefore, in this study, we identified differentially expressed proteins (DEPs) in serum of individuals with MDR-TB TCM syndromes by applying isobaric tags for relative and absolute quantification coupled with two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) method and bioinformatics analysis. The functional analysis of DEPs was also performed. Additionally, DEPs among three different TCM syndromes of MDR-TB were validated by enzyme-linked immunosorbent assay (ELISA). Finally, a receiver operating characteristic (ROC) curve was performed to estimate the diagnostic ability of DEPs. A total of 71 DEPs were identified in the three different MDR-TB TCM syndrome groups such as the pulmonary Yin deficiency (PYD) syndrome group, the Hyperactivity of Fire due to Yin deficiency (HFYD) syndrome group, and the deficiency of Qi and Yin (DQY) syndrome group. The results showed that the expression level of transforming growth factor-beta-induced protein ig-h3 (TGFBI) was lower in the PYD syndrome group (p = .002), the proprotein convertase subtilisin/kexin type 9 (PCSK9) was overexpressed in the HFYD syndrome group (p &lt; .0001), and the C-C motif chemokine ligand 14 (CCL14) expression level was reduced in the DQY syndrome group (p = .004). Our study demonstrated that serum TGFBI, PCSK9, and CCL14 may serve as potential novel biomarkers for PYD syndrome, HFYD syndrome and DQY syndrome of MDR-TB, respectively. The study provides a biological basis for MDR-TB TCM syndromes classification and can be of great significance for the treatment of different TCM syndromes.</AbstractText>
          <CopyrightInformation>© 2020 American Association for Anatomy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yu-Ting</ForeName>
            <Initials>YT</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yi</LastName>
            <ForeName>Wen-Jing</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Ting-Ting</ForeName>
            <Initials>TT</Initials>
            <AffiliationInfo>
              <Affiliation>South China University of Technology School of Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tu</LastName>
            <ForeName>Hui-Hui</ForeName>
            <Initials>HH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Li-Liang</ForeName>
            <Initials>LL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pneumology, Shaoxing Municipal Hospital, Shaoxing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Li-Ying</ForeName>
            <Initials>LY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, Zhejiang Hospital, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Chang-Ming</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Yu-Shuai</ForeName>
            <Initials>YS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gan</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>South China University of Technology School of Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhi-Bin</ForeName>
            <Initials>ZB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Huai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ji-Cheng</ForeName>
            <Initials>JC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4198-2480</Identifier>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>201804010369</GrantID>
            <Agency>Guangzhou Science and Technology Project</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2014CB543002</GrantID>
            <Agency>National Basic Research Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81573709</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81772266</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017A030311014</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017A030310484</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anat Rec (Hoboken)</MedlineTA>
        <NlmUniqueID>101292775</NlmUniqueID>
        <ISSNLinking>1932-8486</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">TCM syndromes</Keyword>
        <Keyword MajorTopicYN="N">multidrug-resistant tuberculosis</Keyword>
        <Keyword MajorTopicYN="N">proteomics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909895</ArticleId>
        <ArticleId IdType="doi">10.1002/ar.24353</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Adhvaryu, M., &amp; Vakharia, B. (2011). Drug-resistant tuberculosis: Emerging treatment options. Clinical Pharmacology, 3, 51-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Awodu, O. A., Ajayi, I. O., &amp; Famodu, A. A. (2007). Haemorheological variables in Nigeria pulmonary tuberculosis patients undergoing therapy. Clinical Hemorheology and Microcirculation, 36, 267-275.</Citation>
        </Reference>
        <Reference>
          <Citation>Bae, J. S., Lee, S. H., Kim, J. E., Choi, J. Y., Park, R. W., Yong Park, J., … Kim, I. S. (2002). Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin. Biochemical and Biophysical Research Communications, 294, 940-948.</Citation>
        </Reference>
        <Reference>
          <Citation>Bailo, R., Bhatt, A., &amp; Ainsa, J. A. (2015). Lipid transport in mycobacterium tuberculosis and its implications in virulence and drug development. Biochemical Pharmacology, 96, 159-167.</Citation>
        </Reference>
        <Reference>
          <Citation>Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Konrad, R. J., Troutt, J. S., Schaper, N. C., &amp; Stehouwer, C. D. A. (2014). Circulating PCSK9 is a strong determinant of plasma triacylglycerols and total cholesterol in homozygous carriers of apolipoprotein epsilon 2. Clinical Science, 126, 679-684.</Citation>
        </Reference>
        <Reference>
          <Citation>Chan, D. C., Wong, A. T. Y., Pang, J., Barrett, P. H. R., &amp; Watts, G. F. (2015). Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: A stable isotope study in the postprandial state. Clinical Science, 128, 379-385.</Citation>
        </Reference>
        <Reference>
          <Citation>Cheung, F. (2011). TCM made in China. Nature, 480, S82-S83.</Citation>
        </Reference>
        <Reference>
          <Citation>Choe, L. H., Aggarwal, K., Franck, Z., &amp; Lee, K. H. (2005). A comparison of the consistency of proteome quantitation using two-dimensional electrophoresis and shotgun isobaric tagging in Escherichia coli cells. Electrophoresis, 26, 2437-2449.</Citation>
        </Reference>
        <Reference>
          <Citation>Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., … Barrell, B. G. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 393, 537-544.</Citation>
        </Reference>
        <Reference>
          <Citation>Daffe, M., &amp; Draper, P. (1998). The envelope layers of mycobacteria with reference to their pathogenicity. Advances in Microbial Physiology, 39, 131-203.</Citation>
        </Reference>
        <Reference>
          <Citation>Demers, A., Samami, S., Lauzier, B., Des Rosiers, C., Ngo Sock, E. T., Ong, H., &amp; Mayer, G. (2015). PCSK9 induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 2517-2525.</Citation>
        </Reference>
        <Reference>
          <Citation>Forrellad, M. A., McNeil, M., Santangelo Mde, L., Blanco, F. C., Garcia, E., Klepp, L. I., … Bigi, F. (2014). Role of the Mce1 transporter in the lipid homeostasis of Mycobacterium tuberculosis. Tuberculosis (Edinburgh, Scotland), 94, 170-177.</Citation>
        </Reference>
        <Reference>
          <Citation>Forssmann, U., Hartung, I., Balder, R., Fuchs, B., Escher, S. E., Spodsberg, N., … Elsner, J. (2004). N-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation. Journal of Immunology, 173, 3456-3466.</Citation>
        </Reference>
        <Reference>
          <Citation>Graham, J. R., Williams, C. M., &amp; Yang, Z. (2014). MicroRNA-27b targets gremlin 1 to modulate fibrotic responses in pulmonary cells. Journal of Cellular Biochemistry, 115, 1539-1548.</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta, S., Erdmann, G., Schulz-Maronde, S., Escher, S. E., Richter, R., Forssmann, W. G., … Forssmann, U. (2008). N-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2. Allergy, 63, 1317-1323.</Citation>
        </Reference>
        <Reference>
          <Citation>Gupta, S., Fuchs, B., Schulz-Maronde, S., Heitland, A., Escher, S. E., Mack, M., … Forssmann, U. (2008). Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation. Journal of Leukocyte Biology, 83, 765-773.</Citation>
        </Reference>
        <Reference>
          <Citation>Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F. P., Li, M., … Nakamura, Y. (2004). SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nature Cell Biology, 6, 731-740.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, T. T., Wang, C., Wei, L. L., Yu, X. M., Shi, L. Y., Xu, D. D., … Li, J. C. (2015). Serum protein gamma-glutamyl hydrolase, Ig gamma-3 chain C region, and haptoglobin are associated with the syndromes of pulmonary tuberculosis in traditional Chinese medicine. BMC Complementary and Alternative Medicine, 15, 243.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, J. E., Jeong, H. W., Nam, J. O., Lee, B. H., Choi, J. Y., Park, R. W., … Kim, I. S. (2002). Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. The Journal of Biological Chemistry, 277, 46159-46165.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, M. J., Wainwright, H. C., Locketz, M., Bekker, L. G., Walther, G. B., Dittrich, C., … Russell, D. G. (2010). Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Molecular Medicine, 2, 258-274.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, C. M., Chen, J., Yang, S., Jiang, T. T., Chen, Z. L., Tu, H. H., … Li, J. C. (2018). iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang granule in the yin-deficiency-heat syndrome rats. Chinese Medicine, 13, 2.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, Y., &amp; He, F. (2010). Chinese medicine in the treatment of tuberculosis of the status and prospect [in Chinese]. Guiding Journal of Traditional Chinese Medicine and Pharmacology, 16, 100-102.</Citation>
        </Reference>
        <Reference>
          <Citation>Lu, J., Ye, S., Qin, R., Deng, Y., &amp; Li, C. P. (2013). Effect of Chinese herbal medicine extracts on cell-mediated immunity in a rat model of tuberculosis induced by multiple drug-resistant bacilli. Molecular Medicine Reports, 8, 227-232.</Citation>
        </Reference>
        <Reference>
          <Citation>Meressa, D., Hurtado, R. M., Andrews, J. R., Diro, E., Abato, K., Daniel, T., … Goldfeld, A. E. (2015). Achieving high treatment success for multidrug-resistant TB in Africa: Initiation and scale-up of MDR TB care in Ethiopia-An observational cohort study. Thorax, 70, 1181-1188.</Citation>
        </Reference>
        <Reference>
          <Citation>Naruse, K., Ueno, M., Satoh, T., Nomiyama, H., Tei, H., Takeda, M., … Miura, R. (1996). A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics, 34, 236-240.</Citation>
        </Reference>
        <Reference>
          <Citation>Ouellet, H., Johnston, J. B., &amp; de Montellano, P. R. O. (2011). Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis. Trends in Microbiology, 19, 530-539.</Citation>
        </Reference>
        <Reference>
          <Citation>Papastavros, T., Dolovich, L. R., Holbrook, A., Whitehead, L., &amp; Loeb, M. (2002). Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis. CMAJ, 167, 131-136.</Citation>
        </Reference>
        <Reference>
          <Citation>Park, S. W., Moon, Y. A., &amp; Horton, J. D. (2004). Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. The Journal of Biological Chemistry, 279, 50630-50638.</Citation>
        </Reference>
        <Reference>
          <Citation>Pham, A. Q., Doan, A., &amp; Andersen, M. (2014). Pyrazinamide-induced hyperuricemia. P T, 39, 695-715.</Citation>
        </Reference>
        <Reference>
          <Citation>Poirier, S., Mayer, G., Benjannet, S., Bergeron, E., Marcinkiewicz, J., Nassoury, N., … Seidah, N. G. (2008). The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2. The Journal of Biological Chemistry, 283, 2363-2372.</Citation>
        </Reference>
        <Reference>
          <Citation>Prihoda, N. D., Arjanova, O. V., Yurchenko, L. V., Sokolenko, N. I., Vihrova, L. A., Pylypchuk, V. S., &amp; Kutsyna, G. A. (2007). Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOT. Journal of Medicinal Plants Research, 1, 117-122.</Citation>
        </Reference>
        <Reference>
          <Citation>Reyes, N., Bettin, A., Reyes, I., &amp; Geliebter, J. (2015). Microarray analysis of the in vitro granulomatous response to Mycobacterium tuberculosis H37Ra. Colombia Medica, 46, 26-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Ross, P. L., Huang, Y. L. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., … Pappin, D. J. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Molecular &amp; Cellular Proteomics, 3, 1154-1169.</Citation>
        </Reference>
        <Reference>
          <Citation>Rucker, N., Billig, S., Bucker, R., Jahn, D., Wittmann, C., &amp; Bange, F. C. (2015). Acetate dissimilation and assimilation in Mycobacterium tuberculosis depend on carbon availability. Journal of Bacteriology, 197, 3182-3190.</Citation>
        </Reference>
        <Reference>
          <Citation>Shehzad, A., Rehman, G., Ul-Islam, M., Khattak, W. A., &amp; Lee, Y. S. (2013). Challenges in the development of drugs for the treatment of tuberculosis. The Brazilian Journal of Infectious Diseases, 17, 74-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Shiming, C. (2017). Current status and recommendations of prevention and treatment of multidrug-resistant tuberculosis in China. Cheng Shiming. China flood control association. China Tropical Medicine, 17, 213-215.</Citation>
        </Reference>
        <Reference>
          <Citation>Su, J., Liang, G., Bao, L., Yang, X., Li, X., &amp; Duan, Z. (2012). Analysis of culture and drug-resistance of Mycobacterium tuberculosis in Kunming. Chinese Journal of Anti-Tuberculosis, 34, 32-35.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun, X. M., Eden, E. R., Tosi, I., Neuwirth, C. K., Wile, D., Naoumova, R. P., &amp; Soutar, A. K. (2005). Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia. Human Molecular Genetics, 14, 1161-1169.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun, Y., Harley, D., Vally, H., &amp; Sleigh, A. (2015). Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China. BMC Public Health, 15, 1027.</Citation>
        </Reference>
        <Reference>
          <Citation>Takeda, K., Kaisho, T., &amp; Akira, S. (2003). Toll-like receptors. Annual Review of Immunology, 21, 335-376.</Citation>
        </Reference>
        <Reference>
          <Citation>Tang, J. L., Liu, B. Y., &amp; Ma, K. W. (2008). Traditional Chinese medicine. Lancet, 372, 1938-1940.</Citation>
        </Reference>
        <Reference>
          <Citation>Thapa, N., Kang, K. B., &amp; Kim, I. S. (2005). Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone, 36, 232-242.</Citation>
        </Reference>
        <Reference>
          <Citation>Thulasingam, S., Massilamany, C., Gangaplara, A., Dai, H., Yarbaeva, S., Subramaniam, S., … Reddy, J. (2011). miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells. Molecular and Cellular Biochemistry, 352, 181-188.</Citation>
        </Reference>
        <Reference>
          <Citation>Triantafilou, K., &amp; Triantafilou, M. (2012). Visualising PAMP-PRR interactions using nanoscale imaging. Neisseria Meningitidis: Advanced Methods and Protocols, 799, 253-266.</Citation>
        </Reference>
        <Reference>
          <Citation>Turken, O., Kunter, E., Sezer, M., Solmazgul, E., Cerrahoglu, K., Bozkanat, E., … Ilvan, A. (2002). Hemostatic changes in active pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease, 6, 927-932.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, L. J., Yang, C. L. H., Or, T. C. T., Chen, G., Zhou, J., Li, J. C. B., &amp; Lau, A. S. Y. (2011). Differential effects of radix Paeoniae Rubra (Chishao) on cytokine and chemokine expression inducible by mycobacteria. Chinese Medicine, 6, 14.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, L. X., Wu, Y. Y., &amp; Wang, Y. (2011). Effect of Qibudan on expression of TLR2 in tuberculosis infection. Chinese Pharmacological Bulletin, 27, 1284-1287.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, S. S., Zhou, J., Fang, D., &amp; Zhou, J. M. (2011). Research on TCM law of tuberculosis and related to objects indicators [in Chinese]. Clinical Journal of Chinese Medicine, 03, 13-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, S. S., Zhou, J., Zhang, Y. F., Wang, L., Feng, X., &amp; Wang, Y. (2014). Study on the rule of TCM syndromes in pulmonary tuberculosis[in Chinese]. World Journal of Integrated Traditional and Western Medicine, 9, 498-500.</Citation>
        </Reference>
        <Reference>
          <Citation>Wen, G. Y., Partridge, M. A., Li, B. Y., Hong, M., Liao, W. P., Cheng, S. K., … Hei, T. K. (2011). TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells. Cancer Letters, 308, 23-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Wen, L., Liu, Y. F., Jiang, C., Zeng, S. Q., Su, Y., Wu, W. J., … Feng, Q. S. (2018). Comparative proteomic profiling and biomarker identification of traditional Chinese medicine-based HIV/AIDS syndromes. Scientific Reports, 8, 4187.</Citation>
        </Reference>
        <Reference>
          <Citation>Wipperman, M. F., Sampson, N. S., &amp; Thomas, S. T. (2014). Pathogen roid rage: Cholesterol utilization by Mycobacterium tuberculosis. Critical Reviews in Biochemistry and Molecular Biology, 49, 269-293.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization, Global Tuberculosis Programme. (2019). Global tuberculosis control: WHO report (Vol. 15). Geneva: WHO.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu, D., Li, Y., Li, X., Wei, L. L., Pan, Z., Jiang, T. T., … Li, J. C. (2015). Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics, 15, 58-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu, D. D., Deng, D. F., Li, X., Wei, L. L., Li, Y. Y., Yang, X. Y., … Li, J. C. (2014). Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics, 14, 322-331.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu, H. D., You, C. G., Zhang, R. L., Gao, P., &amp; Wang, Z. R. (2007). Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis by macrophages. The Journal of International Medical Research, 35, 84-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu, X. B., Steere, R. R., Fedorchuk, C. A., Pang, J. J., Lee, J. Y., Lim, J. H., … Li, J. D. (2011). Activation of epidermal growth factor receptor is required for NTHi-induced NF-kappa B-dependent inflammation. PLoS One, 6, e28216.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, L. B., Rudser, K. D., Higgins, L., Rosen, H. R., Zaman, A., Corless, C. L., … Gourley, G. R. (2011). Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics. Digestive Diseases and Sciences, 56, 3305-3,315.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, L. S., Xu, X. E., Liu, X. P., Jin, H., Chen, Z. Q., Liu, X. H., … Shi, Q. (2012). iTRAQ-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1p. Journal of Proteomics, 77, 480-491.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, X., Yuan, Y., Pang, Y., Wang, B., Bai, Y., Wang, Y., … Zhao, Y. (2015). The burden of MDR/XDR tuberculosis in coastal plains population of China. PLoS One, 10, e0117361.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, Y., Sun, H., Mo, X., Liu, Y., Jia, H., Li, X., … Li, Q. (2012). Prediction of novel genes associated with negative regulators of toll-like receptors-induced inflammation based on endotoxin tolerance. Inflammation, 35, 1889-1899.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, Y., Sun, H. X., Li, X. Y., Ding, Q., Wei, P. J., &amp; Zhou, J. G. (2015). Transforming growth factor Beta-induced is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in human peripheral blood mononuclear cells. Iran J Allergy Asthm, 14, 321-330.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao, Y., Feng, Q., Tang, K., Zhang, C., Sun, H., Luo, T., … Sun, Q. (2012). The population structure of drug-resistant Mycobacterium tuberculosis clinical isolates from Sichuan in China. Infection, Genetics and Evolution, 12, 718-724.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhenhui, L., Huiyong, Z., Peihua, G., Xiaoyan, G., Zhongshun, Z., Heping, X., … Mengbai, F. (2014). Clinical study on TCM syndrome identification and chemotherapy for 388 cases of multidrug-resistant pulmonary tuberculosis. J TCM, 55, 1469-1,474.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu, J., Chen, X., Liao, Z., He, C., &amp; Hu, X. (2015). TGFBI protein high expression predicts poor prognosis in colorectal cancer patients. International Journal of Clinical and Experimental Pathology, 8, 702-710.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909897</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0496</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric pulmonology</Title>
          <ISOAbbreviation>Pediatr. Pulmonol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Validation of a computerized scoring system for foreign body aspiration: An observational study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.24632</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The diagnosis of foreign body aspiration (FBA) is challenging. In a previous study, we developed a computerized scoring system (CSS) to support decision-making. In the present study, we aimed to validate it on a further cohort.</AbstractText>
          <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">In this observational study, 100 children referred to the emergency department of a tertiary pediatric hospital for suspected FBA and treated according to standard protocol, were assigned a probability score using the CSS, between 0 and 1 (0, very low probability; 1, very high). The diagnosis of FBA was based on bronchoscopy, and if discharged without bronchoscopy, determined via telephone questionnaire, 4 to 6 months after discharge, supplemented by clinical re-evaluation and bronchoscopy, if respiratory symptoms persisted.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-five out of 100 children (35%) underwent bronchoscopy with 12 of 35 (34%) positive for FBA. Sixty-five patients were discharged without bronchoscopy and completed a telephone questionnaire. Seven patients required clinical re-evaluation for persistent respiratory symptoms, in two out of them, additional bronchoscopies were performed and were negative. The CSS median probability score was 0.94 in patients with FBA, as compared to 0.73 in patients without FBA (P = .007). The CSS area under the receiver operating curve was 0.74. At a probability score threshold of 0.6, the sensitivity and specificity were 100% and 41%, respectively.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The present validation study suggests a high sensitivity of the CSS for the identification of FBA in children. We suggest that it might aid decision-making with regard to the need for bronchoscopy in children presenting to the emergency room.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stafler</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8880-8212</Identifier>
            <AffiliationInfo>
              <Affiliation>Pulmonary Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nachalon</LastName>
            <ForeName>Yuval</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Ear, Nose, and Throat Clinic, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stern</LastName>
            <ForeName>Yoram</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ear, Nose, and Throat Clinic, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leshno</LastName>
            <ForeName>Moshe</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mei Zahav</LastName>
            <ForeName>Meir</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-6683-0264</Identifier>
            <AffiliationInfo>
              <Affiliation>Pulmonary Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prais</LastName>
            <ForeName>Dario</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Pulmonary Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kadmon</LastName>
            <ForeName>Gili</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Pediatric Intensive Care Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Pulmonol</MedlineTA>
        <NlmUniqueID>8510590</NlmUniqueID>
        <ISSNLinking>1099-0496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">algorithm</Keyword>
        <Keyword MajorTopicYN="N">bronchoscopy</Keyword>
        <Keyword MajorTopicYN="N">computer</Keyword>
        <Keyword MajorTopicYN="N">diagnosis</Keyword>
        <Keyword MajorTopicYN="N">risk assessment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909897</ArticleId>
        <ArticleId IdType="doi">10.1002/ppul.24632</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Kim IA, Shapiro N, Bhattacharyya N. The national cost burden of bronchial foreign body aspiration in children. Laryngoscope. 2015;125:1221-1224.</Citation>
        </Reference>
        <Reference>
          <Citation>Paksu S, Paksu MS, Kilic M, Guner SN, Baysal K. Foreign body aspiration in childhood. Pediatr Emerg Care. 2012;28(3):259-264.</Citation>
        </Reference>
        <Reference>
          <Citation>Reilly J, Thompson J, MacArthur C, et al. Pediatric aerodigestive foreign body injuries are complications related to timeliness of diagnosis. Laryngoscope. 1997;107:17-20.</Citation>
        </Reference>
        <Reference>
          <Citation>Karakoc A, Karadag B, Akbenlioglu C, et al. Foreign body aspiration: What is the outcome? Peditr Pulm. 2002;34:30-36.</Citation>
        </Reference>
        <Reference>
          <Citation>Carlens J, Fuge J, Price T, et al. Complications and risk factors in pediatric bronchoscopy in a tertiary pediatric respiratory center. Pediatr Pulm. 2018;53:619-627.</Citation>
        </Reference>
        <Reference>
          <Citation>Schmidt H, Manegold BC. Foreign body aspiration in children. Surg Endosc. 2000;14:644-648.</Citation>
        </Reference>
        <Reference>
          <Citation>Sheehan CC, Lopez J, Elmaraghy CA. Low rate of positive bronchoscopy for suspected foreign body aspiration in infants. Int J Pediatr Otorhinolaryngol. 2018;104:72-75.</Citation>
        </Reference>
        <Reference>
          <Citation>Ayed AK, Jafar AM, Owayed A. Foreign body aspiration in children: diagnosis and treatment. Pediatr Surg Int. 2003;19:485-488.</Citation>
        </Reference>
        <Reference>
          <Citation>Ciftci AO, Bingol-Kologlu M, Senocak ME, Tanyel FC, Buyukpamukcu N. Bronchoscopy for foreign body aspiration in children. J Pediatr Surg. 2003;38:1170-1176.</Citation>
        </Reference>
        <Reference>
          <Citation>Cavel O, Bergeron M, Garel L, Arcand P, Froehlich P. Questioning the legitimacy of rigid bronchoscopy as a tool for establishing the diagnosis of a bronchial foreign body. Int J Pediatr Otorhinolaryngol. 2012;76:194-201.</Citation>
        </Reference>
        <Reference>
          <Citation>Janahi IA, Khan S, Chandra P, et al. A new clinical algorythm for management of suspected foreign body aspiration in children. BMC Pulm Med. 2017;17(1):61.</Citation>
        </Reference>
        <Reference>
          <Citation>Cohen S, Avital A, Godfrey S, Gross M, Kerem E, Springer C. Suspected foreign body inhalation in children: What are the indications for bronchoscopy? J Pediatr. 2009;155:276-280.</Citation>
        </Reference>
        <Reference>
          <Citation>Zaupa P, Saxena AK, Barounig A, Hollwarth ME. Management strategies in foreign body aspiration. Indian J Pediatr. 2009;76(2):157-161.</Citation>
        </Reference>
        <Reference>
          <Citation>Haller L, Barazzone-Argiroffo C, Vidal I, Anooshiravani-Dumont M, Mornand A. Safely decreasing rigid bronchoscopies for foreign body aspiration in children: an algorithm for the emergency department. Eur J Surg. 2018;28(3):273-278.</Citation>
        </Reference>
        <Reference>
          <Citation>Kadmon G, Stern Y, Bron-Harlev E, Nahum E, Battat E, Schonfeld T. Computerized scoring system for the diagnosis of foreign body aspiration in children. Ann Otol Rhinol Laryngol. 2008;117(11):839-843.</Citation>
        </Reference>
        <Reference>
          <Citation>Pitiot V, Grall M, Ploin D, Truy E, Ayari Khalfallah S. The use of CT-scan in foreign body aspiration in children: A 6 years' experience. Int J Pediatr Otorhinolaryngol. 2017;102:169-173.</Citation>
        </Reference>
        <Reference>
          <Citation>Ahmed OG, Guillerman RP, Giannoni CM. Protocol incorporating airway CT decreases negative bronchoscopy rates for suspected foreign bodies in pediatric patients. Int J Pediatr Otorhinolaryngol. 2018;109:133-137.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909896</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1758-2652</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the International AIDS Society</Title>
          <ISOAbbreviation>J Int AIDS Soc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Electronic and other new media technology interventions for HIV care and prevention: a systematic review.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e25439</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jia2.25439</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Electronic and other new media technologies (eHealth) can facilitate large-scale dissemination of information and effective delivery of interventions for HIV care and prevention. There is a need to both monitor a rapidly changing pipeline of technology-based care and prevention methods and to assess whether the interventions are appropriately diversified. We systematically review and critically appraise the research pipeline of eHealth interventions for HIV care and prevention, including published studies and other funded projects.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Two peer-reviewed literature databases were searched for studies describing the development, trial testing or implementation of new technology interventions, published from September 2014 to September 2018. The National Institutes of Health database of grants was searched for interventions still in development. Interventions were included if eHealth was utilized and an outcome directly related to HIV treatment or prevention was targeted. We summarized each intervention including the stage of development, eHealth mode of delivery, target population and stage of the HIV care and prevention continua targeted.</AbstractText>
          <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">Of 2178 articles in the published literature, 113 were included with 84 unique interventions described. The interventions utilize a variety of eHealth technologies and target various points on the prevention and care continua, with greater emphasis on education, behaviour change and testing than linkage to medical care. There were a variety of interventions for HIV care support but none for PrEP care. Most interventions were developed for populations in high income countries. An additional 62 interventions with funding were found in the development pipeline, with greater emphasis on managing HIV and PrEP care.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our systematic review found a robust collection of eHealth interventions in the published literature as well as unpublished interventions still in development. In the published literature, there is an imbalance of interventions favouring education and behaviour change over linkage to care, retention in care, and adherence, especially for PrEP. The next generation of interventions already in the pipeline might address these neglected areas of care and prevention, but the development process is slow. Researchers need new methods for more efficient and expedited intervention development so that current and future needs are addressed.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Journal of the International AIDS Society published by John Wiley &amp; Sons Ltd on behalf of the International AIDS Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maloney</LastName>
            <ForeName>Kevin M</ForeName>
            <Initials>KM</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-6205-9839</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bratcher</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilkerson</LastName>
            <ForeName>Ryan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sullivan</LastName>
            <ForeName>Patrick S</ForeName>
            <Initials>PS</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-7728-0587</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30AI050409</GrantID>
            <Agency>Center for AIDS Research, Emory University</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>J Int AIDS Soc</MedlineTA>
        <NlmUniqueID>101478566</NlmUniqueID>
        <ISSNLinking>1758-2652</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CitationSubset>X</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">eHealth</Keyword>
        <Keyword MajorTopicYN="N">mobile applications</Keyword>
        <Keyword MajorTopicYN="N">primary prevention</Keyword>
        <Keyword MajorTopicYN="N">secondary prevention</Keyword>
        <Keyword MajorTopicYN="N">smartphones</Keyword>
        <Keyword MajorTopicYN="N">social media</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>04</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909896</ArticleId>
        <ArticleId IdType="doi">10.1002/jia2.25439</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793-800.</Citation>
        </Reference>
        <Reference>
          <Citation>Medland NA, McMahon JH, Chow EP, Elliott JH, Hoy JF, Fairley CK. The HIV care cascade: a systematic review of data sources, methodology and comparability. J Int AIDS Soc. 2015;18:20634.</Citation>
        </Reference>
        <Reference>
          <Citation>Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017;31(5):731-4.</Citation>
        </Reference>
        <Reference>
          <Citation>Muessig KE, Nekkanti M, Bauermeister J, Bull S. Hightow-Weidman LB. A systematic review of recent smartphone, Internet and Web 2.0 interventions to address the HIV continuum of care. Curr HIV/AIDS Rep. 2015;12(1):173-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Carnicer-Pont D, Barbera-Gracia MJ, Fernandez-Davila P, de Olalla PG, Munoz R, Jacques-Avino C, et al. Use of new technologies to notify possible contagion of sexually-transmitted infections among men. Gac Sanit. 2015;29(3):190-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Chan PA, Towey C, Poceta J, Rose J, Bertrand T, Kantor R, et al. Online hookup sites for meeting sexual partners among men who have sex with men in Rhode Island, 2013: a call for public health action. Public Health Rep. 2016;131(2):264-71.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010-2015. HIV Surveillance Supplemental Report. 2018. Available from: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-23-1.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 dependent areas, 2016. HIV Surveillance Supplemental Report; 2018. Available from: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-23-4.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men-20 US cities, 2014. Clin Infect Dis. 2016;63(5):672-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Fiellin LE, Hieftje KD, Pendergrass TM, Kyriakides TC, Duncan LR, Dziura JD, et al. Video game intervention for sexual risk reduction in minority adolescents: randomized controlled trial. J Med Internet Res. 2017;19:e314.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauermeister JA, Pingel ES, Jadwin-Cakmak L, Harper GW, Horvath K, Weiss G, et al. Acceptability and preliminary efficacy of a tailored online HIV/STI testing intervention for young men who have sex with men: the Get Connected! program. AIDS Behav. 2015;19(10):1860-74.</Citation>
        </Reference>
        <Reference>
          <Citation>Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra25.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411-22.</Citation>
        </Reference>
        <Reference>
          <Citation>Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, Nakabiito C, et al.Preexposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections; March 3-6, 2013; Atlanta, GA; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Sharpe JD, Kamara MT. A systematic evaluation of mobile apps to improve the uptake of and adherence to HIV pre-exposure prophylaxis. Sex Health. 2018;15(6):587.</Citation>
        </Reference>
        <Reference>
          <Citation>Amankwaa I, Boateng D, Quansah DY, Akuoko CP, Evans C. Effectiveness of short message services and voice call interventions for antiretroviral therapy adherence and other outcomes: a systematic review and meta-analysis. PLoS ONE. 2018;13:e0204091.</Citation>
        </Reference>
        <Reference>
          <Citation>Scott RE, Mars M. Principles and framework for eHealth strategy development. J Med Internet Res. 2013;15:e155.</Citation>
        </Reference>
        <Reference>
          <Citation>Drozd F, Skeie LG, Kraft P, Kvale D. A web-based intervention trial for depressive symptoms and subjective well-being in patients with chronic HIV infection. Aids Care. 2014;26(9):1080-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Browne FA, Wechsberg WM, Kizakevich PN, Zule WA, Bonner CP, Madison AN, et al. mHealth versus face-to-face: study protocol for a randomized trial to test a gender-focused intervention for young African American women at risk for HIV in North Carolina. BMC Public Health. 2018;18(1):982.</Citation>
        </Reference>
        <Reference>
          <Citation>Cordova D, Alers-Rojas F, Lua FM, Bauermeister J, Nurenberg R, Ovadje L, et al. The usability and acceptability of an adolescent mHealth HIV/STI and drug abuse preventive intervention in primary care. Behav Med. 2018;44:36-47.</Citation>
        </Reference>
        <Reference>
          <Citation>Cordova D, Bauermeister JA, Fessler K, Delva J, Nelson A, Nurenberg R, et al. A community-engaged approach to developing an mHealth HIV/STI and drug abuse preventive intervention for primary care: a qualitative study. JMIR Mhealth Uhealth. 2015;3:e106.</Citation>
        </Reference>
        <Reference>
          <Citation>Besoain F, Perez-Navarro A, Cayla JA, Avino CJ, de Olalla PG. Prevention of sexually transmitted infections using mobile devices and ubiquitous computing. Int J Health Geogr. 2015;14:18.</Citation>
        </Reference>
        <Reference>
          <Citation>Scott CK, Dennis ML, Gustafson DH. Using smartphones to decrease substance use via self-monitoring and recovery support: study protocol for a randomized control trial. Trials. 2017;18(1):374.</Citation>
        </Reference>
        <Reference>
          <Citation>Goldenberg T, McDougal SJ, Sullivan PS, Stekler JD, Stephenson R. Preferences for a mobile HIV prevention app for men who have sex with men. JMIR Mhealth Uhealth. 2014;2:e47.</Citation>
        </Reference>
        <Reference>
          <Citation>Goldenberg T, McDougal SJ, Sullivan PS, Stekler JD, Stephenson R. Building a mobile HIV prevention app for men who have sex with men: an iterative and community-driven process. JMIR Public Health Surveill. 2015;1:e18.</Citation>
        </Reference>
        <Reference>
          <Citation>Sullivan PS, Driggers R, Stekler JD, Siegler A, Goldenberg T, McDougal SJ, et al. Usability and acceptability of a mobile comprehensive HIV prevention app for men who have sex with men: a pilot study. JMIR Mhealth Uhealth. 2017;5:e26.</Citation>
        </Reference>
        <Reference>
          <Citation>Winskell K, Sabben G, Akelo V, Ondeng'e K, Obong'o C, Stephenson R, et al. A smartphone game-based intervention (Tumaini) to prevent HIV among young africans: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2018;6:e10482.</Citation>
        </Reference>
        <Reference>
          <Citation>Wray T, Chan PA, Simpanen E, Operario D. eTEST: developing a smart home HIV testing kit that enables active, real-time follow-up and referral after testing. JMIR Mhealth Uhealth. 2017;5:e62.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauermeister JA, Golinkoff JM, Horvath KJ, Hightow-Weidman LB, Sullivan PS, Stephenson R. A Multilevel tailored web app-based intervention for linking young men who have sex with men to quality care (get connected): protocol for a randomized controlled trial. JMIR Res Protoc. 2018;7:e10444.</Citation>
        </Reference>
        <Reference>
          <Citation>Horvath KJ, Bauermeister JA. eHealth literacy and intervention tailoring impacts the acceptability of a HIV/STI testing intervention and sexual decision making among young gay and bisexual men. AIDS Educ Prev. 2017;29(1):14-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Yan J, Zhang A, Zhou L, Huang Z, Zhang P, Yang G. Development and effectiveness of a mobile phone application conducting health behavioral intervention among men who have sex with men, a randomized controlled trial: study protocol. BMC Public Health. 2017;17(1):355.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang C, Linas B, Kirk G, Bollinger R, Chang L, Chander G, et al. Feasibility and acceptability of smartphone-based ecological momentary assessment of alcohol use among African American men who have sex with men in Baltimore. JMIR Mhealth Uhealth. 2015;3(2):e67.</Citation>
        </Reference>
        <Reference>
          <Citation>Dillingham R, Ingersoll K, Flickinger TE, Waldman AL, Grabowski M, Laurence C, et al. PositiveLinks: a mobile health intervention for retention in HIV care and clinical outcomes with 12-month follow-up. AIDS Patient Care STDS. 2018;32(6):241-50.</Citation>
        </Reference>
        <Reference>
          <Citation>Flickinger TE, DeBolt C, Waldman AL, Reynolds G, Cohn WF, Beach MC, et al. Social support in a virtual community: analysis of a clinic-affiliated online support group for persons living with HIV/AIDS. AIDS Behav. 2017;21(11):3087-99.</Citation>
        </Reference>
        <Reference>
          <Citation>Flickinger TE, DeBolt C, Wispelwey E, Laurence C, Plews-Ogan E, Waldman AL, et al. Content analysis and user characteristics of a smartphone-based online support group for people living with HIV. Telemed J E Health. 2016;22(9):746-54.</Citation>
        </Reference>
        <Reference>
          <Citation>Flickinger TE, DeBolt C, Xie A, Kosmacki A, Grabowski M, Waldman AL, et al. Addressing stigma through a virtual community for people living with HIV: a mixed methods study of the positivelinks mobile Health intervention. AIDS Behav. 2018;22(10):3395-406.</Citation>
        </Reference>
        <Reference>
          <Citation>Dworkin M, Chakraborty A, Lee S, Monahan C, Hightow-Weidman L, Garofalo R, et al. A realistic talking human embodied agent mobile phone intervention to promote HIV medication adherence and retention in care in young HIV-positive african american men who have sex with men: qualitative study. JMIR Mhealth Uhealth. 2018;6:e10211.</Citation>
        </Reference>
        <Reference>
          <Citation>Himelhoch S, Kreyenbuhl J, Palmer-Bacon J, Chu M, Brown C, Potts W. Pilot feasibility study of Heart2HAART: a smartphone application to assist with adherence among substance users living with HIV. AIDS Care. 2017;29(7):898-904.</Citation>
        </Reference>
        <Reference>
          <Citation>Jacobs RJ, Caballero J, Ownby RL, Kane MN. Development of a culturally appropriate computer-delivered tailored Internet-based health literacy intervention for Spanish-dominant Hispanics living with HIV. BMC Med Inform Decis Mak. 2014;14:103.</Citation>
        </Reference>
        <Reference>
          <Citation>Martin CA, Upvall MJ. A mobile phone HIV medication adherence intervention: acceptability and feasibility study. J Assoc Nurses AIDS Care. 2016;27(6):804-16.</Citation>
        </Reference>
        <Reference>
          <Citation>Perera AI, Thomas MG, Moore JO, Faasse K, Petrie KJ. Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: a randomized clinical trial. AIDS Patient Care STDS. 2014;28(11):579-86.</Citation>
        </Reference>
        <Reference>
          <Citation>Swendeman D, Ramanathan N, Baetscher L, Medich M, Scheffler A, Comulada WS, et al. Smartphone self-monitoring to support self-management among people living with HIV: perceived benefits and theory of change from a mixed-methods randomized pilot study. J Acquir Immune Defic Syndr. 2015;69 Suppl 1:S80-91.</Citation>
        </Reference>
        <Reference>
          <Citation>Venter W, Coleman J, Chan VL, Shubber Z, Phatsoane M, Gorgens M, et al. Improving linkage to HIV care through mobile phone apps: randomized controlled trial. JMIR Mhealth Uhealth. 2018;6:e155.</Citation>
        </Reference>
        <Reference>
          <Citation>Westergaard RP, Genz A, Panico K, Surkan PJ, Keruly J, Hutton HE, et al. Acceptability of a mobile health intervention to enhance HIV care coordination for patients with substance use disorders. Addict Sci Clin Pract. 2017;12(1):11.</Citation>
        </Reference>
        <Reference>
          <Citation>Levy ME, Watson CC, Wilton L, Criss V, Kuo I, Glick SN, et al. Acceptability of a mobile smartphone application intervention to improve access to HIV prevention and care services for black men who have sex with men in the district of Columbia. Digit Cult Educ. 2015;7(2):169-91.</Citation>
        </Reference>
        <Reference>
          <Citation>Ochalek TA, Heil SH, Higgins ST, Badger GJ, Sigmon SC. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study. Drug Alcohol Depend. 2018;190:224-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Reback CJ, Runger D, Fletcher JB, Swendeman D. Ecological momentary assessments for self-monitoring and counseling to optimize methamphetamine treatment and sexual risk reduction outcomes among gay and bisexual men. J Subst Abuse Treat. 2018;92:17-26.</Citation>
        </Reference>
        <Reference>
          <Citation>Steinberg A, Griffin-Tomas M, Abu-Odeh D, Whitten A. Evaluation of a mobile phone app for providing adolescents with sexual and reproductive health information, New York City, 2013-2016. Public Health Rep. 2018;133(3):234-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Ahmed-Little Y, Bothra V, Cordwell D, Freeman Powell D, Ellis D, Klapper P, et al. Attitudes towards HIV testing via home-sampling kits ordered online (RUClear pilots 2011-12). J Public Health. 2016;38(3):585-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauermeister JA, Tingler RC, Demers M, Harper GW. Development of a tailored HIV prevention intervention for single young men who have sex with men who meet partners online: protocol for the myDEx project. JMIR Res Protoc. 2017;6:e141.</Citation>
        </Reference>
        <Reference>
          <Citation>Billings DW, Leaf SL, Spencer J, Crenshaw T, Brockington S, Dalal RS. A randomized trial to evaluate the efficacy of a web-based HIV behavioral intervention for high-risk African American women. AIDS Behav. 2015;19(7):1263-74.</Citation>
        </Reference>
        <Reference>
          <Citation>Brady SS, Sieving RE, Terveen LG, Rosser BRS, Kodet AJ, An Rothberg VD. Interactive website to reduce sexual risk risk behavior: process evaluation of TeensTalkHealth. JMIR Res Protoc. 2015;4:e106</Citation>
        </Reference>
        <Reference>
          <Citation>Danielson CK, McCauley JL, Gros KS, Jones AM, Barr SC, Borkman AL, et al. Development and usability testing of an evidence-based HIV prevention website for female African-American adolescents. Health Inform J. 2016;22(2):194-208.</Citation>
        </Reference>
        <Reference>
          <Citation>Fernandez MI, Hosek SG, Hotton AL, Gaylord SE, Hernandez N, Alfonso SV, et al. A Randomized controlled trial of POWER: an internet-based HIV prevention intervention for black bisexual Men. AIDS Behav. 2016;20(9):1951-60.</Citation>
        </Reference>
        <Reference>
          <Citation>Greene GJ, Madkins K, Andrews K, Dispenza J, Mustanski B. Implementation and evaluation of the keep it up! online HIV prevention intervention in a community-based setting. AIDS Educ Prev. 2016;28(3):231-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Motley DN, Hammond S, Mustanski B. Strategies chosen by YMSM during goal setting to reduce risk for HIV and other sexually transmitted infections: results from the keep it up! 2.0 prevention trial. AIDS Educ Prev. 2017;29(1):1-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Mustanski B, Madkins K, Greene GJ, Parsons JT, Johnson BA, Sullivan P, et al. Internet-based HIV prevention with at-home sexually transmitted infection testing for young men having sex with men: study protocol of a randomized controlled trial of keep it up! 2.0. JMIR Res Protoc. 2017;6:e1.</Citation>
        </Reference>
        <Reference>
          <Citation>Mustanski B, Parsons JT, Sullivan PS, Madkins K, Rosenberg E, Swann G. Biomedical and behavioral outcomes of keep it up!: an eHealth HIV prevention program RCT. Am J Prev Med. 2018;55(2):151-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Manavi K, Hodson J. Observational study of factors associated with return of home sampling kits for sexually transmitted infections requested online in the UK. BMJ Open. 2017;7(10):e017978.</Citation>
        </Reference>
        <Reference>
          <Citation>Jones R, Lacroix LJ, Nolte K. "Is Your Man Stepping Out?" An online pilot study to evaluate acceptability of a guide-enhanced HIV prevention soap opera video series and feasibility of recruitment by Facebook advertising. J Assoc Nurses AIDS Care. 2015;26(4):368-86.</Citation>
        </Reference>
        <Reference>
          <Citation>Kasatpibal N, Viseskul N, Srikantha W, Fongkaew W, Surapagdee N, Grimes RM. Effects of Internet-based instruction on HIV-prevention knowledge and practices among men who have sex with men. Nurs Health Sci. 2014;16(4):514-20.</Citation>
        </Reference>
        <Reference>
          <Citation>Klein CH, Kuhn T, Altamirano M, Lomonaco C. C-SAFE: a computer-delivered sexual health promotion program for Latinas. Health Prom Pract. 2017;18(4):516-25.</Citation>
        </Reference>
        <Reference>
          <Citation>Maksut JL, Eaton LA, Siembida EJ, Driffin DD, Baldwin R. A test of concept study of at-home, self-administered HIV testing with web-based peer counseling via video chat for men who have sex with men. JMIR Public Health Surveill. 2016;2:e170.</Citation>
        </Reference>
        <Reference>
          <Citation>Mustanski B, Greene GJ, Ryan D, Feasibility Whitton SW. Acceptability, and initial efficacy of an online sexual health promotion program for LGBT youth: the queer sex Ed intervention. J Sex Res. 2015;52(2):220-30.</Citation>
        </Reference>
        <Reference>
          <Citation>Platteau T, Fransen K, Apers L, Kenyon C, Albers L, Vermoesen T, et al. Swab2know: an HIV-testing strategy using oral fluid samples and online communication of test results for men who have sex with men in Belgium. J Med Internet Res. 2015;17:e213.</Citation>
        </Reference>
        <Reference>
          <Citation>Loos J, Manirankunda L, Platteau T, Albers L, Fransen K, Vermoesen T, et al. Acceptability of a community-based outreach HIV-testing intervention using oral fluid collection devices and web-based HIV test result collection among sub-Saharan African migrants: a mixed-method study. JMIR Public Health Surveill. 2016;2:e33.</Citation>
        </Reference>
        <Reference>
          <Citation>Widman L, Golin CE, Noar SM, Massey J, Prinstein MJ. Projectheartforgirls. Com: development of a web-based HIV/STD prevention program for adolescent girls emphasizing sexual communication skills. AIDS Educ Prev. 2016;28(5):365-77.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson E, Free C, Morris TP, Kenward MG, Syred J, Baraitser P. Can Internet-based sexual health services increase diagnoses of sexually transmitted infections (STI)? Protocol for a randomized evaluation of an internet-based STI testing and results service. JMIR Res Protoc. 2016;5:e9.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson E, Free C, Morris TP, Syred J, Ahamed I, Menon-Johansson AS, et al. Internet-accessed sexually transmitted infection (e-STI) testing and results service: a randomised, single-blind, controlled trial. PLoS Med. 2017;14:e1002479.</Citation>
        </Reference>
        <Reference>
          <Citation>Ybarra ML, Korchmaros JD, Prescott TL, Birungi R. A randomized controlled trial to increase HIV preventive information, motivation, and behavioral skills in Ugandan adolescents. Ann Behav Med. 2015;49(3):473-85.</Citation>
        </Reference>
        <Reference>
          <Citation>Cote J, Godin G, Ramirez-Garcia P, Rouleau G, Bourbonnais A, Gueheneuc YG, et al. Virtual intervention to support self-management of antiretroviral therapy among people living with HIV. J Med Internet Res. 2015;17:e6.</Citation>
        </Reference>
        <Reference>
          <Citation>Cruess DG, Burnham KE, Finitsis DJ, Goshe BM, Strainge L, Kalichman M, et al. A randomized clinical trial of a brief internet-based group intervention to reduce sexual transmission risk behavior among HIV-positive gay and bisexual men. Ann Behav Med. 2018;52(2):116-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Green SM, Lockhart E, Marhefka SL. Advantages and disadvantages for receiving Internet-based HIV/AIDS interventions at home or at community-based organizations. AIDS Care. 2015;27(10):1304-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Hirshfield S, Downing MJ Jr, Parsons JT, Grov C, Gordon RJ, Houang ST, et al. Developing a video-based ehealth intervention for HIV-positive gay, bisexual, and other men who have sex with men: study protocol for a randomized controlled trial. JMIR Res Protoc. 2016;5:e125.</Citation>
        </Reference>
        <Reference>
          <Citation>Horvath KJ, Amico KR, Erickson D, Ecklund AM, Martinka A, DeWitt J, et al. Thrive with me: protocol for a randomized controlled trial to test a peer support intervention to improve antiretroviral therapy adherence among men who have sex with men. JMIR Res Protoc. 2018;7:e10182.</Citation>
        </Reference>
        <Reference>
          <Citation>Mi G, Wu Z, Wang X, Shi CX, Yu F, Li T, et al. Effects of a quasi-randomized web-based intervention on risk behaviors and treatment seeking among HIV-positive men who have sex with men in Chengdu, China. Curr HIV Res. 2015;13(6):490-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Milam J, Morris S, Jain S, Sun XY, Dube MP, Daar ES, et al. Randomized controlled trial of an internet application to reduce HIV transmission behavior among HIV infected men who have sex with men. AIDS Behav. 2016;20(6):1173-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Millard T, McDonald K, Elliott J, Slavin S, Rowell S, Girdler S. Informing the development of an online self-management program for men living with HIV: a needs assessment. BMC Public Health. 2014;14(1):1209.</Citation>
        </Reference>
        <Reference>
          <Citation>Millard T, McDonald K, Girdler S, Slavin S, Elliot J. Online self-management for gay men living with HIV: a pilot study. Sex Health. 2015;12(4):308-14.</Citation>
        </Reference>
        <Reference>
          <Citation>Miranda J, Cote J. The use of intervention mapping to develop a tailored web-based intervention, condom-HIM. JMIR Public Health Surveill. 2017;3:e20.</Citation>
        </Reference>
        <Reference>
          <Citation>Peterson J, Cota M, Gray H, Bazerman L, Kuo I, Kurth A, et al. Technology use in linking criminal justice reentrants to HIV care in the community: a qualitative formative research study. J Health Commun. 2015;20(3):245-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Anand T, Nitpolprasert C, Ananworanich J, Pakam C, Nonenoy S, Jantarapakde J, et al. Innovative strategies using communications technologies to engage gay men and other men who have sex with men into early HIV testing and treatment in Thailand. J Virus Eradic. 2015;1(2):111-5.</Citation>
        </Reference>
        <Reference>
          <Citation>Anand T, Nitpolprasert C, Trachunthong D, Kerr SJ, Janyam S, Linjongrat D, et al. A novel online-to-offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up. J Int AIDS Soc. 2017;20(1):1-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Haas SM, Perazzo JD, Ruffino AH, Ancona RM, Lyons M. The Know∗Now project: facilitated serosorting in HIV-status sexual partner communication. AIDS Educ Prev. 2017;29(5):432-42.</Citation>
        </Reference>
        <Reference>
          <Citation>Klein CH, Kuhn T, Huxley D, Kennel J, Withers E, Lomonaco CG. Preliminary findings of a technology-delivered sexual health promotion program for black men who have sex with men: quasi-experimental outcome study. JMIR Public Health Surveill. 2017;3:e78.</Citation>
        </Reference>
        <Reference>
          <Citation>Lau JT, Lee AL, Tse WS, Mo PK, Fong F, Wang Z, et al. A Randomized control trial for evaluating efficacies of two online cognitive interventions with and without fear-appeal imagery approaches in preventing unprotected anal sex among Chinese men who have sex with men. AIDS Behav. 2016;20(9):1851-62.</Citation>
        </Reference>
        <Reference>
          <Citation>Marsch LA, Guarino H, Grabinski MJ, Syckes C, Dillingham ET, Xie H, et al. Comparative effectiveness of web-based vs. educator-delivered HIV prevention for adolescent substance users: a randomized, controlled trial. J Subst Abuse Treat. 2015;59:30-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Mitchell JW, Lee JY, Godoy F, Asmar L, Perez G. HIV-discordant and concordant HIV-positive male couples' recommendations for how an eHealth HIV prevention toolkit for concordant HIV-negative male couples could be improved to meet their specific needs. AIDS Care. 2018;30 Suppl 2:54-60.</Citation>
        </Reference>
        <Reference>
          <Citation>Stephenson R, Freeland R, Sullivan SP, Riley E, Johnson BA, Mitchell J, et al. Home-based HIV testing and counseling for male couples (project nexus): a protocol for a randomized controlled trial. JMIR Res Protoc. 2017;6:e101.</Citation>
        </Reference>
        <Reference>
          <Citation>van den Berg JJ, Silverman T, Fernandez MI, Henny KD, Gaul ZJ, Sutton MY, et al. Using eHealth to reach black and hispanic men who have sex with men regarding treatment as prevention and preexposure prophylaxis: protocol for a small randomized controlled trial. JMIR Res Protoc. 2018;7:e11047.</Citation>
        </Reference>
        <Reference>
          <Citation>De Boni RB, Lentini N, Santelli AC, Barbosa A Jr, Cruz M, Bingham T, et al. Self-testing, communication and information technology to promote HIV diagnosis among young gay and other men who have sex with men (MSM) in Brazil. J Int AIDS Soc. 2018;21:e25116.</Citation>
        </Reference>
        <Reference>
          <Citation>Dolwick Grieb SM, Flores-Miller A, Gulledge N, Clifford R, Page K. 'Vive': designing an intervention to improve timely HIV diagnosis among Latino immigrant men. Prog Community Health Partnersh. 2016;10(3):365-72.</Citation>
        </Reference>
        <Reference>
          <Citation>Dolwick Grieb SM, Flores-Miller A, Page KR. ¡Solo Se Vive Una Vez! (You Only Live Once): a pilot evaluation of individually tailored video modules aiming to increase HIV testing among foreign-born latino men. J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S104-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Stephenson R, Metheny N, Sharma A, Sullivan S, Riley E. Providing Home-based HIV testing and counseling for transgender youth (project moxie): protocol for a pilot randomized controlled trial. JMIR Res Protoc. 2017;6:e237.</Citation>
        </Reference>
        <Reference>
          <Citation>Cho H, Porras T, Baik D, Beauchemin M, Schnall R. Understanding the predisposing, enabling, and reinforcing factors influencing the use of a mobile-based HIV management app: a real-world usability evaluation. Int J Med Inform. 2018;117:88-95.</Citation>
        </Reference>
        <Reference>
          <Citation>Cho H, Yen PY, Dowding D, Merrill J, Schnall R. A multi-level usability evaluation of mobile health applications: a case study. J Biomed Inform. 2018;86:79-89.</Citation>
        </Reference>
        <Reference>
          <Citation>Schnall R, Cho H, Mangone A, Pichon A, Jia H. Mobile health technology for improving symptom management in low income persons living with HIV. AIDS Behav. 2018;22(10):3373-83.</Citation>
        </Reference>
        <Reference>
          <Citation>Chiu CJ, Menacho L, Fisher C, Young SD. Ethics issues in social media-based HIV prevention in low- and middle-income countries. Camb Q Healthc Ethics. 2015;24(3):303-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Garett R, Menacho L, Young SD. Ethical issues in using social media to deliver an HIV prevention intervention: results from the HOPE Peru study. Prev Sci. 2017;18(2):225-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Young SD. Social media technologies for HIV prevention study retention among minority men who have sex with men (MSM). AIDS Behav. 2014;18(9):1625-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Young SD, Cumberland WG, Lee SJ, Jaganath D, Szekeres G, Coates T. Social networking technologies as an emerging tool for HIV prevention: a cluster randomized trial. Ann Intern Med. 2013;159(5):318-24.</Citation>
        </Reference>
        <Reference>
          <Citation>Young SD, Cumberland WG, Nianogo R, Menacho LA, Galea JT, Coates T. The HOPE social media intervention for global HIV prevention in Peru: a cluster randomised controlled trial. Lancet HIV. 2015;2(1):e27-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Young SD, Holloway I, Jaganath D, Rice E, Westmoreland D, Coates T. Project HOPE: online social network changes in an HIV prevention randomized controlled trial for African American and Latino men who have sex with men. Am J Public Health. 2014;104(9):1707-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Alarcon Gutierrez M, Fernandez Quevedo M, Martin Valle S, Jacques-Avino C, Diez David E, Cayla JA, et al. Acceptability and effectiveness of using mobile applications to promote HIV and other STI testing among men who have sex with men in Barcelona, Spain. Sex Transm Infect. 2018;94(6):443-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauermeister J, Sullivan PS, Gravens L, Wolfe J, Countryman K, Smith-Bankhead N, et al. Reducing HIV vulnerability through a multilevel life skills intervention for adolescent men (The iREACH Project): protocol for a randomized controlled trial. JMIR Res Protoc. 2018;7:e10174.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang E, Marlin RW, Young SD, Medline A, Klausner JD. Using grindr, a smartphone social-networking application, to increase HIV self-testing among black and Latino men who have sex with men in Los Angeles, 2014. AIDS Educ Prev. 2016;28(4):341-50.</Citation>
        </Reference>
        <Reference>
          <Citation>Jenkins Hall W, Sun CJ, Tanner AE, Mann L, Stowers J, Rhodes SD. HIV-prevention opportunities with gps-based social and sexual networking applications for men who have sex with men. AIDS Educ Prev. 2017;29(1):38-48.</Citation>
        </Reference>
        <Reference>
          <Citation>Lampkin D, Crawley A, Lopez TP, Mejia CM, Yuen W, Levy V. Reaching suburban men who have sex with men for STD and HIV services through online social networking outreach: a public health approach. J Acquir Immune Defic Syndr. 2016;72(1):73-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Lelutiu-Weinberger C, Pachankis JE, Gamarel KE, Surace A, Golub SA, Parsons JT. Feasibility, acceptability, and preliminary efficacy of a live-chat social media intervention to reduce HIV risk among young men who have sex with men. AIDS Behav. 2015;19(7):1214-27.</Citation>
        </Reference>
        <Reference>
          <Citation>Patel VV, Ginsburg Z, Golub SA, Horvath KJ, Rios N, Mayer KH, et al. Empowering with PrEP (E-PrEP), a peer-led social media-based intervention to facilitate hiv preexposure prophylaxis adoption among young black and latinx gay and bisexual men: protocol for a cluster randomized controlled trial. JMIR Res Protoc. 2018;7:e11375.</Citation>
        </Reference>
        <Reference>
          <Citation>Rhodes SD, Mccoy TP, Tanner AE, Stowers J, Bachmann LH, Nguyen AL, et al. Using social media to increase HIV testing among gay and bisexual men, other men who have sex with men, and transgender persons: outcomes from a randomized community trial. Clin Infect Dis. 2016;62(11):1450-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun CJ, Stowers J, Miller C, Bachmann LH, Rhodes SD. Acceptability and feasibility of using established geosocial and sexual networking mobile applications to promote HIV and STD testing among men who have sex with men. AIDS Behav. 2015;19(3):543-52.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun WH, Wong CKH, Wong WCW. A peer-led, social media-delivered, safer sex intervention for Chinese college students: randomized controlled trial. J Med Int Res. 2017;19:e284.</Citation>
        </Reference>
        <Reference>
          <Citation>Tucker JD, Wei CY, Li HC, Liu CC, Tang SY, Tang WM, et al. Crowdsourcing to promote HIV testing among MSM in China: study protocol for a stepped wedge randomized controlled trial. Trials. 2017;18:447.</Citation>
        </Reference>
        <Reference>
          <Citation>Tang W, Wei C, Cao B, Wu D, Li KT, Lu H, et al. Crowdsourcing to expand HIV testing among men who have sex with men in China: a closed cohort stepped wedge cluster randomized controlled trial. PLoS Med. 2018;15:e1002645.</Citation>
        </Reference>
        <Reference>
          <Citation>Washington TA, Applewhite S, Glenn W. Using Facebook as a platform to direct young black men who have sex with men to a video-based hiv testing intervention: a feasibility study. Urban Soc Work. 2017;1(1):36-52.</Citation>
        </Reference>
        <Reference>
          <Citation>Tanner AE, Mann L, Song E, Alonzo J, Schafer K, Arellano E, et al. Wecare: a social media-based intervention designed to increase HIV care linkage, retention, and health outcomes for racially and ethnically diverse young MSM. AIDS Educ Prev. 2016;28(3):216-30.</Citation>
        </Reference>
        <Reference>
          <Citation>Baltierra NB, Muessig KE, Pike EC, LeGrand S, Bull SS, Hightow-Weidman LB. More than just tracking time: complex measures of user engagement with an internet-based health promotion intervention. J Biomed Inform. 2016;59:299-307.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauermeister JA, Muessig KE, LeGrand S, Flores DD, Choi SK, Dong W, et al. HIV and sexuality stigma reduction through engagement in online forums: results from the healthmpowerment intervention. AIDS Behav. 2019;23(3):742-52.</Citation>
        </Reference>
        <Reference>
          <Citation>Hightow-Weidman L, LeGrand S, Simmons R, Egger JR, Choi SK, Muessig K, et al. HealthMpowerment: effects of a mobile phone-optimized, Internet-based intervention on condomless anal intercourse among young black men who have sex with men and transgender women. 9th IAS Conference on HIV Science (IAS 2017); July 23-26, 2017; Paris, France; 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Hightow-Weidman LB, Muessig KE, Pike EC, LeGrand S, Baltierra N, Rucker AJ, et al. HealthMpowerment.org: building community through a mobile-optimized, online health promotion intervention. Health Educ Behav. 2015;42(4):493-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Hightow-Weidman L, Muessig K, Knudtson K, Srivatsa M, Lawrence E, LeGrand S, et al. A gamified smartphone app to support engagement in care and medication adherence for HIV-positive young men who have sex with men (AllyQuest): development and pilot study. JMIR Public Health Surveill. 2018;4:e34.</Citation>
        </Reference>
        <Reference>
          <Citation>LeGrand S, Muessig KE, McNulty T, Soni K, Knudtson K, Lemann A, et al. Epic allies: development of a gaming app to improve antiretroviral therapy adherence among young HIV-positive men who have sex with men. JMIR Serious Games. 2016;4:e6.</Citation>
        </Reference>
        <Reference>
          <Citation>LeGrand S, Muessig KE, Platt A, Soni K, Egger JR, Nwoko N, et al. Epic allies, a gamified mobile phone app to improve engagement in care, antiretroviral uptake, and adherence among young men who have sex with men and young transgender women who have sex with men: protocol for a randomized controlled trial. JMIR Res Protoc. 2018;7:e94.</Citation>
        </Reference>
        <Reference>
          <Citation>Whiteley L, Brown L, Lally M, Heck N, van den Berg JJ. A mobile gaming intervention to increase adherence to antiretroviral treatment for youth living with HIV: development guided by the information, motivation, and behavioral skills model. JMIR Mhealth Uhealth. 2018;6:e96.</Citation>
        </Reference>
        <Reference>
          <Citation>Shegog R, Craig Rushing S, Gorman G, Jessen C, Torres J, Lane TL, et al. NATIVE-it's your game: adapting a technology-based sexual health curriculum for american indian and alaska native youth. J Primary Prevent. 2017;38(1-2):27-48.</Citation>
        </Reference>
        <Reference>
          <Citation>Schonnesson LN, Bowen AM, Williams ML. Project SMART: preliminary results from a test of the efficacy of a Swedish internet-based HIV risk-reduction intervention for men who have sex with men. Arch Sex Behav. 2016;45(6):1501-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Montanaro E, Fiellin LE, Fakhouri T, Kyriakides TC, Duncan LR. Using videogame apps to assess gains in adolescents' substance use knowledge: new opportunities for evaluating intervention exposure and content mastery. J Med Internet Res. 2015;17:e245.</Citation>
        </Reference>
        <Reference>
          <Citation>Fiellin LE, Kyriakides TC, Hieftje KD, Pendergrass TM, Duncan LR, Dziura JD, et al. The design and implementation of a randomized controlled trial of a risk reduction and human immunodeficiency virus prevention videogame intervention in minority adolescents: PlayForward: Elm City Stories. Clin Trials. 2016;13(4):400-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Lukhele BW, Musumari P, El-Saaidi C, Techasrivichien T, Suguimoto SP, Ono Kihara M, et al. Efficacy of mobile serious games in increasing HIV risk perception in swaziland: a randomized control trial (sgprev trial) research protocol. JMIR Res Protoc. 2016;5:e224.</Citation>
        </Reference>
        <Reference>
          <Citation>Enah C, Piper K, Moneyham L. Qualitative evaluation of the relevance and acceptability of a web-based HIV prevention game for rural adolescents. J Pediatr Nurs. 2015;30(2):321-8.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909898</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1932-8494</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Anatomical record (Hoboken, N.J. : 2007)</Title>
          <ISOAbbreviation>Anat Rec (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Study on potential biomarkers of energy metabolism-related to early-stage Yin-deficiency-heat syndrome based on metabolomics and transcriptomics.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ar.24355</ELocationID>
        <Abstract>
          <AbstractText>Yin-deficiency-heat (YDH) syndrome is a common sub-health state of the human body in traditional Chinese medicine (TCM). However, due to the lack of objective quantitative diagnostic indicators, patients with early-stage YDH syndrome cannot be treated in time and can develop a pathological (disease) state. Therefore, it is necessary to apply modern diagnostic techniques in order to identify the biological markers for the diagnosis of early-stage YDH syndrome. In the present study, we performed Solexa sequencing and non-targeted metabolomics analysis using high-performance liquid chromatography coupled with mass spectrometry to screen differentially expressed mRNAs and differential metabolites in individuals with early-stage YDH syndrome and healthy controls. Bioinformatics methods were used to perform enrichment analysis of differentially expressed mRNAs and differential metabolites for biological functions and signaling pathways. Furthermore, we found that differentially expressed mRNAs and differential metabolites were related to energy metabolism. Real-time PCR was used to validate the mRNA expression in the serum of subjects with early-stage YDH syndrome. We found that the mitochondrially encoded NADH dehydrogenase 2 (MT-ND2) mRNA was differentially expressed in the serum of individuals with early-stage YDH syndrome. Receiver operating characteristic (ROC) curve and logistic regression analysis were used to evaluate the efficacy of the diagnostic model based on eight differential metabolites. We combined the three metabolites such as Glycine, Sphingomyelin, and Isocitrate to establish the diagnostic model with a sensitivity of 0.853 and a specificity of 0.800. The combination of the above three metabolites may serve as a potential biomarker for the diagnosis of early-stage YDH syndrome. Our study reveals potential biomarker for the diagnosis of early-stage YDH syndrome and also provides a new method for the quantification and objectification of TCM syndromes.</AbstractText>
          <CopyrightInformation>© 2020 American Association for Anatomy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gan</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>South China University of Technology School of Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Ting-Ting</ForeName>
            <Initials>TT</Initials>
            <AffiliationInfo>
              <Affiliation>South China University of Technology School of Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yi</LastName>
            <ForeName>Wen-Jing</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Ren</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Health Management Center, The People's Liberation Army No.117 Hospital, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Fang-Yan</ForeName>
            <Initials>FY</Initials>
            <AffiliationInfo>
              <Affiliation>Xiaoshan Hospital of Traditional Chinese Medicine, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Chang-Ming</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhi-Bin</ForeName>
            <Initials>ZB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Yu-Shuai</ForeName>
            <Initials>YS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yu-Ting</ForeName>
            <Initials>YT</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tu</LastName>
            <ForeName>Hui-Hui</ForeName>
            <Initials>HH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Huai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ji-Cheng</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Medical Research Center, Yubei People's Hospital, Shaoguan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>201804010369</GrantID>
            <Agency>Guangzhou Science and Technology Project</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2014CB543002</GrantID>
            <Agency>National Basic Research Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81573709</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81772266</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017A030310484</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017A030311014</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anat Rec (Hoboken)</MedlineTA>
        <NlmUniqueID>101292775</NlmUniqueID>
        <ISSNLinking>1932-8486</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Solexa sequencing</Keyword>
        <Keyword MajorTopicYN="N">Yin-deficiency</Keyword>
        <Keyword MajorTopicYN="N">biomarkers</Keyword>
        <Keyword MajorTopicYN="N">high-performance liquid chromatography-mass spectrometry</Keyword>
        <Keyword MajorTopicYN="N">mRNAs</Keyword>
        <Keyword MajorTopicYN="N">metabolites</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909898</ArticleId>
        <ArticleId IdType="doi">10.1002/ar.24355</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Chen, Z. Y., Liu, J. H., Liang, K., Liang, W. X., Ma, S. H., Zeng, G. J., … He, J. G. (2012). The diagnostic value of a multivariate logistic regression analysis model with transvaginal power Doppler ultrasonography for the prediction of ectopic pregnancy. Journal of International Medical Research, 40, 184-193.</Citation>
        </Reference>
        <Reference>
          <Citation>da Silva, R. P., Clow, K., Brosnan, J. T., &amp; Brosnan, M. E. (2014). Synthesis of guanidinoacetate and creatine from amino acids by rat pancreas. British Journal of Nutrition, 111, 571-577.</Citation>
        </Reference>
        <Reference>
          <Citation>Dickinson, H., Ellery, S., Ireland, Z., LaRosa, D., Snow, R., &amp; Walker, D. W. (2014). Creatine supplementation during pregnancy: Summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy. BMC Pregnancy and Childbirth, 14, 150.</Citation>
        </Reference>
        <Reference>
          <Citation>Felig, P., Owen, O. E., Wahren, J., &amp; Cahill, G. F., Jr. (1969). Amino acid metabolism during prolonged starvation. Journal of Clinical Investigation, 48, 584-594.</Citation>
        </Reference>
        <Reference>
          <Citation>Garbati, P., Adriano, E., Salis, A., Ravera, S., Damonte, G., Millo, E., &amp; Balestrino, M. (2014). Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency. Neurochemical Research, 39, 37-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Han, G. X., Xia, L., Li, S. S., Jin, Q. H., Song, Y., Shen, H., … Zhu, H. Y. (2017). The association between the C5263T mutation in the mitochondrial ND2 gene and Coronary heart disease among young Chinese Han people. Biomedical and Environmental Sciences, 30, 280-287.</Citation>
        </Reference>
        <Reference>
          <Citation>Hannun, Y. A., &amp; Obeid, L. M. (1995). Ceramide: An intracellular signal for apoptosis. Trends in Biochemical Sciences, 20, 73-77.</Citation>
        </Reference>
        <Reference>
          <Citation>He, Y. M., Gao, Q. Y., Qing, Y., Zhang, Y., Wu, Y. Q., &amp; Li, H. S. (1986). Exploration the rule of time and place according to local conditions from the results of physique investigation. Journal of Traditional Chinese Medicine, 5, 48-51 [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Hou, F. G., Ling, C. Q., Zhao, G., &amp; He, X. M. (2005). Study on quantization standard of deficiency of the liver in constitution in primary liver cancer [In Chinese]. Journal of Anhui College, 24, 8-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, H., Liu, J., Wang, T., Gao, J. R., Sun, Y., Huang, C. B., … Qin, X. J. (2016). Urinary metabolite profiling provides potential differentiation to explore the mechanisms of adjuvant-induced arthritis in rats. Biomedical Chromatography, 30, 1397-1405.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, J. X., &amp; Zhang, P. (2012). Current status of quantitative diagnosis of Yin-deficiency constitution [In Chinese]. Chinese Journal of Cancer, 21, 305-310.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, W. Y. 2005. Clinical observation on the treatment of girls with sexual precocious puberty by nourishing yin to lessen fire. The Fourth Session of the Five-time Chinese Medicine Pediatrics Conference of Guangdong Province. [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Li, Y. S., &amp; Yang, X. (2009). Yin-deficiency Theory and Metabolomics Comparative Study (pp. 82-86). Beijing: Beijing University of Chinese Medicine [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, R., Hu, L. L., Sun, A., Cao, Y. J., Tang, T., Zhang, X. P., &amp; Zhang, Q. H. (2014). mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes. Archives of Medical Research, 45, 318-324.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, R. X., Hong, J., Xu, X. Q., Feng, Q., Zhang, D. Y., Gu, Y. Y., … Wang, W. Q. (2017). Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nature Medicine, 23, 859-868.</Citation>
        </Reference>
        <Reference>
          <Citation>Matus-Ortega, M. G., Cárdenas-Monroy, C. A., Flores-Herrera, O., Mendoza-Hernández, G., Miranda, M., González-Pedrajo, B., … Pardo, J. P. (2015). New complexes containing the internal alternative NADH dehydrogenase (Ndi1) in mitochondria of Saccharomyces cerevisiae. Yeast, 32, 629-641.</Citation>
        </Reference>
        <Reference>
          <Citation>Miao, H. M., Ou, J. J., Peng, Y., Zhang, X., Chen, Y. J., Hao, L. J., … Liang, H. J. (2016). Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM. Nature Communications, 7, 11716.</Citation>
        </Reference>
        <Reference>
          <Citation>Gavery, M. R., &amp; Roberts, S. B. (2012). Characterizing short read sequencing for gene discovery and RNA-Seq analysis in Crassostrea gigas. Comparative Biochemistry and Physiology. Part D, Genomics &amp; Proteomics, 7, 94-99.</Citation>
        </Reference>
        <Reference>
          <Citation>Newman, N. J. (2011). Treatment of Leber hereditary optic neuropathy. Brain, 134, 2447-2455.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicholson, J. K., &amp; Lindon, J. C. (2008). Systems biology: Metabonomics. Nature, 455, 1054-1056.</Citation>
        </Reference>
        <Reference>
          <Citation>Nunes-Nesi, A., Araújo, W. L., Obata, T., &amp; Fernie, A. R. (2013). Regulation of the mitochondrial tricarboxylic acid cycle. Current Opinion in Plant Biology, 16, 335-343.</Citation>
        </Reference>
        <Reference>
          <Citation>Ren, W. K., Wang, P., Yan, J. M., Liu, G., Zeng, B. H., Hussain, T., … Yin, Y. L. (2017). Melatonin alleviates weanling stress in mice: Involvement of intestinal microbiota. Journal of Pineal Research, 64, e12448.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, C., Liu, C. M., Wei, L. L., Shi, L. Y., Pan, Z. F., Mao, L. G., … Li, J. C. (2016). A Group of Novel Serum Diagnostic Biomarkers for multidrug-resistant tuberculosis by iTRAQ-2D LC-MS/MS and Solexa sequencing. International Journal of Biological Sciences, 12, 246-256.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, C., Yang, S., Liu, C. M., Jiang, T. T., Chen, Z. L., Tu, H. H., … Li, J. C. (2018). Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis. Tuberculosis, 108, 26-34.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, F. F. (2009). Study on quantitative diagnosis and principle of herbs of viral myocarditis on the basis of document date. Nanjing: Nanjing University of Chinese Medicine [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, L. S., Liu, Y. M., Du, L. T., Li, J., Jiang, X. M., Zheng, G. X., … Wang, C. X. (2015). Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Molecular Medicine Reports, 12, 615-622.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, N. N., &amp; Wu, C. Y. (2008). Study on the correlation between Yin-deficiency and Disease and constitution. Journal of Nanjing University of Traditional Chinese Medicine, 24, 4-5 [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, Q. (2005). Constitutional doctrine of TCM. Beijing: People's Medical Publishing House [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, Q., Ren, X. J., Yao, S. L., &amp; Wu, H. D. (2010). Clinical observation on the endocrinal and immune functions in subjects with Yin-deficiency constitution. Chinese Journal of Integrative Medicine, 16, 28-32.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, Q., &amp; Zhu, Y. B. (2009). Epidemiological survey of TCM constitution in general population in China--Based on the data of 21948 epidemiological surveys in 9 provinces and cities. China Journal of Traditional Chinese Medicine, 1, 7-12 [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Xue, W. Y., Cheng, L., Zeng, L., You, F., Liu, X. G., &amp; Zhang, L. (2019). Clinical observation of Parochetus communis Buch compound in the treatment of decreased ovarian reserve in kidney Yin-deficiency. Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine, 9, 156-157 [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Yamabe, S., Tsuchida, N., Yamazaki, S., &amp; Sakaki, S. (2015). Frontier orbitals and transition states in the oxidation and degradation of l-ascorbic acid: A DFT study. Organic &amp; Biomolecular Chemistry, 13, 4002-4015.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu, J. B., Sun, H., Han, Y., Sun, W. J., Wang, P., &amp; Wang, X. J. (2014). Study on the metabonomics contributing to animal model of TCM constitution. China Journal of Traditional Chinese Medicine &amp; Pharmacy, 29, 2259-2262.</Citation>
        </Reference>
        <Reference>
          <Citation>Yuan, J. J., Ma, S. Q., He, H., Song, Y. W., Zhou, G. X., Huang, L. L., &amp; Li, B. (2017). Preliminary clinical observation of creatine phosphate sodium treatment for Leber hereditary optic neuropathy. Ophthalmology CHN, 26, 126-130 [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Yuan, Z. J. (2011). A comparative study on metabolomics of Yang Deficiency constitution, Yin-deficiency constitution and Spleen-Stomach Deficiency constitution and Stomach-Yin-deficiency constitution. Beijing: Beijing University of Chinese Medicine [In Chinese].</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, A. H., Sun, H., Wang, Z. G., Sun, W. J., Wang, P., &amp; Wang, X. J. (2010). Metabolomics: Towards understanding traditional Chinese medicine. Planta Medica, 76, 2026-2035.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, X., Guo, J., Fan, S. F., Li, Y. Y., Wei, L. L., Yang, X. Y., … Li, J. C. (2013). Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis. PLoS One, 8, e81076.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909899</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1932-8494</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Anatomical record (Hoboken, N.J. : 2007)</Title>
          <ISOAbbreviation>Anat Rec (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Review on the systems biology research of Yin-deficiency-heat syndrome in traditional Chinese medicine.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ar.24354</ELocationID>
        <Abstract>
          <AbstractText>Traditional Chinese medicine (TCM) is a systematic medical method that has existed for more than 3,000 years. Unlike Western medicine, the disease diagnosis in TCM is carried out by inspection, auscultation, olfaction, interrogation, and palpation. The patient is then treated according to the disease and corresponding TCM syndrome. However, the development of Chinese medicine is stagnated, partially because it can be influenced by subjective factors, such as the experience and knowledge of TCM practitioners, and there is a lack of relevant biological research on TCM syndromes. Yin-deficiency-heat (YDH) syndrome in TCM is characterized by a series of pathological changes caused by the insufficiency of Yin-fluid, inability to moisturize, and the failure to suppress Yang. In recent years, systems biology research on TCM syndromes has gradually become the focus of TCM research, including syndrome differentiation and functional research using systems biology methodologies such as proteomics, transcriptomics, and metabolomics. This journal aims to publish a series of issues on the systems biology research of TCM syndromes that can provide biological indicators for the syndrome differentiation of YDH syndrome and can provide perspectives on the biological research of YDH syndrome.</AbstractText>
          <CopyrightInformation>© 2020 American Association for Anatomy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Ting-Ting</ForeName>
            <Initials>TT</Initials>
            <AffiliationInfo>
              <Affiliation>South China University of Technology School of Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University Medical School, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ji-Cheng</ForeName>
            <Initials>JC</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4198-2480</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy and Embryology, Zhejiang University Medical School, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>201804010369</GrantID>
            <Agency>Guangzhou Science and Technology Project</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2014CB543002</GrantID>
            <Agency>National Basic Research Program of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81573709</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>81772266</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017A030310484</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>2017A030311014</GrantID>
            <Agency>Natural Science Foundation of Guangdong Province</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anat Rec (Hoboken)</MedlineTA>
        <NlmUniqueID>101292775</NlmUniqueID>
        <ISSNLinking>1932-8486</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">TCM syndrome</Keyword>
        <Keyword MajorTopicYN="N">Yin-deficiency-heat syndrome</Keyword>
        <Keyword MajorTopicYN="N">systems biology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909899</ArticleId>
        <ArticleId IdType="doi">10.1002/ar.24354</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Chen, Q. L., Lu, Y. Y., Zhang, G. B., Song, Y. N., Zhou, Q. M., Zhang, H., … Su, S. B. (2013). Characteristic analysis from excessive to deficient syndromes in hepatocarcinoma underlying miRNA Array data. Evidence-Based Complementary and Alternative Medicine, 2013, 324636.</Citation>
        </Reference>
        <Reference>
          <Citation>Guan, X. G., Guo, Y. Z., &amp; Du, J. (2011). Exploring the scientific nature of traditional Chinese medicine from the theory of Yin and Yang, the theory of the five elements and the theory of vitality. Acta Chinese Medicine and Pharmacology, 39, 3-5.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, H., Nie, L., Li, Y., &amp; Xie, J. (2012). Application of ultra-performance liquid chromatography coupled with mass spectrometry to metabonomic study on spontaneously hypertensive rats and intervention effects of Ping Gan prescription. Journal of Separation Science, 35, 483-489.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, N., Liu, H. F., Li, S. D., Zhou, W. X., Zhang, Y. X., Zhang, Q., &amp; Yan, X. Z. (2015). An integrated metabonomic and proteomic study on kidney-Yin deficiency syndrome patients with diabetes mellitus in China. Acta Pharmacologica Sinica, 36, 689-698.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, T. T., Wang, C., Wei, L. L., Yu, X. M., Shi, L. Y., Xu, D. D., … Li, J. C. (2015). Serum protein gamma-glutamyl hydrolase, Ig gamma-3 chain C region, and haptoglobin are associated with the syndromes of pulmonary tuberculosis in traditional Chinese medicine. BMC Complementary and Alternative Medicine, 15, 243.</Citation>
        </Reference>
        <Reference>
          <Citation>Kanawong R, Obafemi-Ajayi T, Ma T, Xu D, Li S, Duan Y.2012. Automated tongue feature extraction for ZHENG classification in traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012:912852, 1, 14.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, Y., Nie, L., Jiang, H., Lin, J., Zhou, H., Xie, J., … Zhang, Y. (2013). Metabonomics study of essential hypertension and its Chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy. Evidence-Based Complementary and Alternative Medicine, 2013, 625906.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, C., Mao, L., Ping, Z., Jiang, T., Wang, C., Chen, Z., … Li, J. (2016). Serum protein KNG1, APOC3, and PON1 as potential biomarkers for Yin-deficiency-heat syndrome. Evidence-Based Complementary and Alternative Medicine, 2016, 5176731.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, C. M., Chen, J., Yang, S., Jiang, T. T., Chen, Z. L., Tu, H. H., … Li, J. C. (2018). iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats. Chinese Medicine, 8(13), 2.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, J., Li, Y., Wei, L., Yang, X., Xie, Z., Jiang, T., … Li, J. C. (2014). Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the traditional Chinese medicine syndromes of tuberculosis. Journal of Ethnopharmacology, 155, 1322-1331.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, S., Chen, Y., Xie, S., Xu, Q., Chen, J., Wang, C., … Zhang, N. (2016). Gene expression profiles of HIV/AIDS patients with Qi-Yin deficiency and dampness-heat retention. Journal of Alternative and Complementary Medicine, 22, 865-879.</Citation>
        </Reference>
        <Reference>
          <Citation>Ma, X. J., Yin, H. J., &amp; Chen, K. J. (2009). Differential gene expression profiles in coronary heart disease patients of blood stasis syndrome in traditional Chinese medicine and clinical role of target gene. Chinese Journal of Integrative Medicine, 15, 101-106.</Citation>
        </Reference>
        <Reference>
          <Citation>Nguyen, T. D., Olliaro, P., Dondorp, A. M., Baird, J. K., Lam, H. M., Farrar, J., … Boni, M. F. (2015). Optimum population-level use of artemisinin combination therapies: A modelling study. The Lancet Global Health, 3, e758-e766.</Citation>
        </Reference>
        <Reference>
          <Citation>O'Brien, K. A., Abbas, E., Zhang, J., Guo, Z. X., Luo, R., Bensoussan, A., &amp; Komesaroff, P. A. (2009). An investigation into the reliability of Chinese medicine diagnosis according to Eight Guiding Principles and Zang-Fu Theory in Australians with hypercholesterolemia. Journal of Alternative and Complementary Medicine, 15, 259-266.</Citation>
        </Reference>
        <Reference>
          <Citation>Payton, J. E., Grieselhuber, N. R., Chang, L. W., Murakami, M., Geiss, G. K., Link, D. C., … Ley, T. J. (2009). High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. The Journal of Clinical Investigation, 119, 1714-1726.</Citation>
        </Reference>
        <Reference>
          <Citation>Song, Y. N., Zhang, H., Guan, Y., Peng, J. H., Lu, Y. Y., Hu, Y. Y., &amp; Su, S. B. (2012). Classification of traditional Chinese medicine syndromes in patients with chronic hepatitis B by SELDI-based ProteinChip analysis. Evidence-Based Complementary and Alternative Medicine, 2012, 626320.</Citation>
        </Reference>
        <Reference>
          <Citation>Tang, J. L., Liu, B. Y., &amp; Ma, K. W. (2008). Traditional Chinese medicine. Lancet, 372(9654), 1938-1940.</Citation>
        </Reference>
        <Reference>
          <Citation>Tao, F., Lü, P., Xu, C., Zheng, M., Liu, W., Shen, M., &amp; Ruan, S. (2017). Metabolomics analysis for defining serum biochemical markers in colorectal cancer patients with Qi deficiency syndrome or Yin deficiency syndrome. Evidence-Based Complementary and Alternative Medicine, 2017, 7382752.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, J., &amp; Yu, G. (2014). Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches. Chinese Journal of Integrative Medicine, 20, 163-169.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, P., &amp; Chen, Z. (2013). Traditional Chinese medicine ZHENG and OMICS convergence: A systems approach to post-genomics medicine in a global world. Omics: A Journal of Integrative Biology, 17, 451-459.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, X., Zhang, A., Sun, H., &amp; Wang, P. (2012). Systems biology technologies enable personalized traditional Chinese medicine: A systematic review. The American Journal of Chinese Medicine, 40, 1109-1122.</Citation>
        </Reference>
        <Reference>
          <Citation>Wen, Y., Wang, Y., Feng, T. T., &amp; Wei, S. B. (2018). Differential proteomics analysis of endometriosis in blood stasis syndrome. Chinese Journal of Integrative Medicine, 24, 925-929.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilkins, M. R. (1995). Government backs proteome proposal. Nature, 378, 653.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilkins, M. R., Sanchez, J. C., Gooley, A. A., Appel, R. D., Humphery-Smith, I., Hochstrasser, D. F., &amp; Williams, K. L. (1996). Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnology &amp; Genetic Engineering Reviews, 13, 19-50.</Citation>
        </Reference>
        <Reference>
          <Citation>Wishart, D. S. (2007). Current progress in computational metabolomics. Briefings in Bioinformatics, 8, 279-293.</Citation>
        </Reference>
        <Reference>
          <Citation>Witt, C., Brinkhaus, B., Jena, S., Linde, K., Streng, A., Wagenpfeil, S., … Willich, S. N. (2005). Acupuncture in patients with osteoarthritis of the knee: A randomised trial. Lancet, 366, 136-143.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu, T., Yang, M., Liu, T., Yang, L., &amp; Ji, G. (2015). A metabolomics approach to stratify patients diagnosed with diabetes mellitus into excess or deficiency syndromes. Evidence-Based Complementary and Alternative Medicine, 2015, 350703.</Citation>
        </Reference>
        <Reference>
          <Citation>Xu, W., Zhang, L., Huang, Y., Yang, Q., Xiao, H., &amp; Zhang, D. (2012). Discrimination of type 2 diabetes mellitus corresponding to different traditional Chinese medicine syndromes based on plasma fatty acid profiles and chemometric methods. Journal of Ethnopharmacology, 143, 463-468.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, M., &amp; Lao, L. (2019). Emerging applications of metabolomics in traditional Chinese medicine treating hypertension: Biomarkers, pathways and more. Frontiers in Pharmacology, 10, 158.</Citation>
        </Reference>
        <Reference>
          <Citation>Yao, W., Yang, H., &amp; Ding, G. (2013). Mechanisms of Qi-blood circulation and Qi deficiency syndrome in view of blood and interstitial fluid circulation. Journal of Traditional Chinese Medicine, 33, 538-544.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu, Y., Yang, S., Mao, L. G., Liu, C. M., Chen, J., Hu, Y. T., … Jiang, T. T. (2018). Identification of potential metabolic biomarkers in Yin deficiency syndrome using LC-MS. Anatical Record (Hoboken), (2018). https://doi.org/10.1002/ar.24025 [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, A., Sun, H., Wang, P., Han, Y., &amp; Wang, X. (2012). Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach. Complementary Therapies in Medicine, 20, 93-99.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, H., Guan, Y., Lu, Y. Y., Hu, Y. Y., Huang, S., &amp; Su, S. B. (2013). Circulating miR-583 and miR-663 refer to ZHENG differentiation in chronic hepatitis B. Evidence-Based Complementary and Alternative Medicine, 2013, 751341.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909900</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0496</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric pulmonology</Title>
          <ISOAbbreviation>Pediatr. Pulmonol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Risk factors for fixed airflow obstruction in children and adolescents with asthma: 4-Year follow-up.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.24625</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Asthma is a disease with reversible bronchoconstriction; however, some patients develop fixed airflow obstruction (FAO). Previous studies have reported the incidence and risk factors of FAO in adults; however, the corresponding factors in children remain poorly understood.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the incidence and risk factors of FAO in children and adolescents with asthma.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">Observational and prospective cohort study with a 4-year follow-up of clinically stable patients with asthma (from 6-8 years old). Anthropometric data, history of asthma, number of hospitalizations, frequent exacerbations, asthma severity, asthma control, inhaled corticosteroid dose, atopy, and lung function were analyzed as potential risk factors for FAO. FAO was defined by a ratio of the forced expiratory volume in the first second to the forced vital capacity below the lower limit of normal, even after inhaled and oral corticosteroid treatment.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Four hundred and twenty-eight patients were recruited, and 358 were analyzed. The FAO incidence in children and adolescents with asthma was 9.5% (n = 34), starting at 10 years of age. Age, body mass index, hospitalizations for asthma, bronchodilator response, frequent exacerbations, length of exacerbations, and asthma severity were associated with FAO. Frequent exacerbations (odds ratio [OR] = 4.0; 95% confidence interval [CI] = 1.3-11.7) and asthma severity categorized as steps 4 to 5 (OR = 3.5; 95% CI = 1.6-7.6) remained risk factors.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Frequent exacerbations and asthma severity are the risk factors for FAO in children and adolescents with asthma.</AbstractText>
          <CopyrightInformation>© 2020 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sousa</LastName>
            <ForeName>Andrey W</ForeName>
            <Initials>AW</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-4896-6464</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barros Cabral</LastName>
            <ForeName>Anna L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonology, Darcy Vargas Children's Hospital, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arruda Martins</LastName>
            <ForeName>Milton</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-9690-9371</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carvalho</LastName>
            <ForeName>Celso R F</ForeName>
            <Initials>CRF</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0003-3046-3412</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physical Therapy, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2016/05968-1</GrantID>
            <Agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)-Finance Code 001</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>312.279/2018</GrantID>
            <Agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Pulmonol</MedlineTA>
        <NlmUniqueID>8510590</NlmUniqueID>
        <ISSNLinking>1099-0496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">asthma phenotype</Keyword>
        <Keyword MajorTopicYN="N">disease</Keyword>
        <Keyword MajorTopicYN="N">exacerbation</Keyword>
        <Keyword MajorTopicYN="N">hospitalization</Keyword>
        <Keyword MajorTopicYN="N">lung function</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909900</ArticleId>
        <ArticleId IdType="doi">10.1002/ppul.24625</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Global Initiative for Asthma. GINA report: global strategy for asthma management and prevention. GINA 2018. [Internet]. 2018 [cited 2019 Jun 25]. https://ginasthma.org/wp-content/uploads/2019/01/2018-GINA.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716-725. https://doi.org/10.1038/nm.2678</Citation>
        </Reference>
        <Reference>
          <Citation>Tashkin DP, Chipps BE, Trudo F, Zangrilli JG. Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses. J Asthma. 2014;51:603-609. https://doi.org/10.3109/02770903.2014.895012</Citation>
        </Reference>
        <Reference>
          <Citation>Eschenbacher WL. Defining airflow obstruction. Chronic Obstr Pulm Dis. 2016;3:515-518. https://doi.org/10.15326/jcopdf.3.2.2015.0166</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang L, He L, Gong J, Liu C. Risk factors associated with irreversible airway obstruction in asthma: a systematic review and meta-analysis. BioMed Res Int. 2016;2016:1-10. https://doi.org/10.1155/2016/9868704</Citation>
        </Reference>
        <Reference>
          <Citation>Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63:1046-1051. https://doi.org/10.1136/thx.2008.098483</Citation>
        </Reference>
        <Reference>
          <Citation>Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-187. https://doi.org/10.1164/ajrccm.159.1.9712108</Citation>
        </Reference>
        <Reference>
          <Citation>Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;9:1414-1422. https://doi.org/10.1056/NEJMoa022363</Citation>
        </Reference>
        <Reference>
          <Citation>Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315-323. https://doi.org/10.1164/rccm.200906-0896OC</Citation>
        </Reference>
        <Reference>
          <Citation>Fitzpatrick AM, Teague WG, Meyers DA, et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institute of Health/National heart, lung and blood institute severe asthma research program. J Allergy Clin Immunol. 2011;127:382-389. https://doi.org/10.1016/j.jaci.2010.11.015</Citation>
        </Reference>
        <Reference>
          <Citation>McGeachie MJ, Yates KP, Zhou X, et al. Patterns of growth and decline in lung function in persistent childhood asthma. N Engl J Med. 2016;374:1842-1852. https://doi.org/10.1056/NEJMoa1513737</Citation>
        </Reference>
        <Reference>
          <Citation>Cabral ALB, Sousa AW, Carvalho CRF, Martins MA. Phenotypes of asthma in low-income children and adolescents: cluster analysis. J Bras Pneumol. 2016;43:44-50. https://doi.org/10.1590/S1806-37562016000000039</Citation>
        </Reference>
        <Reference>
          <Citation>Queiroz MVNP, Queiroz JVC, Lasmar LMLBF. Severe pediatric asthma refractory to treatment: the ongoing challenge of exacerbation. Clin Res Pulmonol. 2017;5:1043. https://www.repositorio.ufop.br/handle/123456789/9926</Citation>
        </Reference>
        <Reference>
          <Citation>Bui DS, Burgess JA, Lowe AJ, et al. Childhood lung function predicts adult chronic obstructive pulmonary disease and asthma-chronic obstructive pulmonary disease overlap syndrome. Am J Respir Crit Care Med. 2017;196:39-46. https://doi.org/10.1164/rccm.201606-1272OC</Citation>
        </Reference>
        <Reference>
          <Citation>Schultz ES, Hallberg J, Andersson N, et al. Early life determinants of lung function change from childhood to adolescence. Respir Med. 2018;139:48-54. https://doi.org/10.1016/j.rmed.2018.04.009</Citation>
        </Reference>
        <Reference>
          <Citation>Global Initiative for asthma. GINA report: global strategy for asthma management and prevention. GINA 2012. [Internet]. 2012 [cited 2019 May 11]. https://ginasthma.org/wp-content/uploads/2019/01/2012-GINA.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324-1343. https://doi.org/10.1183/09031936.00080312</Citation>
        </Reference>
        <Reference>
          <Citation>Bray GA. Classification and evaluation of the obesities. Med Clin North Am. 1989;73:161-184. https://doi.org/10.1016/s0025-7125(16)30697-6</Citation>
        </Reference>
        <Reference>
          <Citation>Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7:284-294. https://doi.org/10.1111/j.2047-6310.2012.00064.x</Citation>
        </Reference>
        <Reference>
          <Citation>Pellegrino R. Interpretative strategies for lung function test. Series “ATS/ERS task force: Standardisation of lung function testing”. Eur Respir J. 2005;26:948-968.</Citation>
        </Reference>
        <Reference>
          <Citation>Pereira CAC. Espirometria. J Pneumol. 2002;28:1-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Global Lung Initiative. (2012). European Respiratory Society. http://www.ers-education.org/guidelines/global-lung-function-initiative.aspx</Citation>
        </Reference>
        <Reference>
          <Citation>Global Initiative for Asthma. GINA report: global strategy for asthma management and prevention. GINA 2014. [Internet]. 2014 [cited 2019 April 14]. https://ginasthma.org/wp-content/uploads/2019/01/2014-GINA.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the childhood asthma control test. J Allergy Clin Immunol. 2007;119:817-825. https://doi.org/10.1016/j.jaci.2006.12.662</Citation>
        </Reference>
        <Reference>
          <Citation>Roxo JP, Ponte EV, Ramos DC, Pimentel L, D'Oliveira Junior A, Cruz AA. Portuguese-language version of the childhood asthma control test. J Bras Pneumol. 2010;36:159-166. https://doi.org/10.1590/S1806-37132010000200002</Citation>
        </Reference>
        <Reference>
          <Citation>Ferry OR, Duffy DL, Ferreira MAR. Early life environmental predictors of asthma age-of-onset. Immun Inflamm Dis. 2014;2:141-151. https://doi.org/10.1002/iid3.27</Citation>
        </Reference>
        <Reference>
          <Citation>Wenzel SE. Severe asthma and its phenotype. J Asthma. 2008;45:32-36. https://doi.org/10.1080/02770900802570114</Citation>
        </Reference>
        <Reference>
          <Citation>Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38:709-750. https://doi.org/10.1111/j.1365-2222.2008.02958.x</Citation>
        </Reference>
        <Reference>
          <Citation>Cerveri I, Corsico AG, Accordini S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC&lt;70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax. 2008;63:1040-1045. https://doi.org/10.1136/thx.2008.095554</Citation>
        </Reference>
        <Reference>
          <Citation>Krishnan S, Dozor AJ, Bacharier L, et al. Clinical characterization of children with resistant airflow obstruction, a multicenter study. J Asthma. 2018;56:611-617. https://doi.org/10.1080/02770903.2018.1477956</Citation>
        </Reference>
        <Reference>
          <Citation>Konstantellou E, Papaioannou AI, Loukides S, et al. Persistent airflow obstruction in patients with asthma: characteristics of a distinct clinical phenotype. Respir Med. 2015;109:1404-1409. https://doi.org/10.1016/j.rmed.2015.09.009</Citation>
        </Reference>
        <Reference>
          <Citation>Contoli M, Baraldo S, Marku B, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol. 2010;125:830-837. https://doi.org/10.1016/j.jaci.2010.01.003</Citation>
        </Reference>
        <Reference>
          <Citation>Kirkby J, Bountziouka V, Lum S, Wade A, Stocks J. Natural variability of lung function in young healthy school children. Eur Respir J. 2016;48:411-419. https://doi.org/10.1183/13993003.01795-2015</Citation>
        </Reference>
        <Reference>
          <Citation>Newby C, Agbetile J, Hargadon B, et al. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134:287-294. https://doi.org/10.1016/j.jaci.2014.04.005</Citation>
        </Reference>
        <Reference>
          <Citation>Prakash YS, Halayko AJ, Gosens R, Panettieri RA Jr, Camoretti-Mercado B, Penn RB. An Official American Thoracic Society Research Statement: Current challenges facing research and therapeutic advances in airway remodeling. Am J Respir Crit Care Med. 2017;195:e4-e19. https://doi.org/10.1164/rccm.201611-2248ST</Citation>
        </Reference>
        <Reference>
          <Citation>Green M, Mead J, Turner JM. Variability of maximum expiratory flow-volume curves. J Appl Physiol. 1974;37:67-74. https://doi.org/10.1152/jappl.1974.37.1.67</Citation>
        </Reference>
        <Reference>
          <Citation>Barisione G, Crimi E, Bartolini S, et al. How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1. Eur Respir J. 2009;33:1396-1402. https://doi.org/10.1183/09031936.00183708</Citation>
        </Reference>
        <Reference>
          <Citation>Yii ACA, Tan GL, Tan KL, Lapperre TS, Koh MS. Fixed airways obstruction among patients with severe asthma: findings from the Singapore general hospital-severe asthma phenotypes study. BMC Pulm Med. 2014;14:191. https://doi.org/10.1186/1471-2466-14-191</Citation>
        </Reference>
        <Reference>
          <Citation>Sakagami T, Hasegawa T, Koya T, et al. Cluster analysis identifies characteristic phenotypes of asthma with accelerated lung function decline. J Asthma. 2014;51:113-118. https://doi.org/10.3109/02770903.2013.852201</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909901</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2324-9269</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular genetics &amp; genomic medicine</Title>
          <ISOAbbreviation>Mol Genet Genomic Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1077</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/mgg3.1077</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long non-coding RNA (lncRNA) has been regarded as crucial regulator for cancer progression. Roles of KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1) in cancers including osteosarcoma and colon cancer have been previously reported. However, its role in ovarian cancer (OC) remains unclear.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Expression level of KCNQ1OT1 on OC cells and normal cell was analyzed with quantitative real-time PCR. Gain and loss-of-function experiments were performed to analyze the biological roles of KCNQ1OT1 in OC. Moreover, whether KCNQ1OT1 functions its role via mediating MICRORNA-142-5p (MIR-142-5p)/calpain 10 (CAPN10) axis was analyzed. In addition, effects of KCNQ1OT1, MIR-142-5p, and CAPN10 on overall survival of OC patients were analyzed at Kaplan-Meier plotter website.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We showed KCNQ1OT1 was elevated expression in OC cells and indicated poorer overall survival of OC patients. Besides, we found KCNQ1OT1 could promote OC cell proliferation and migration in vitro. Moreover, MIR-142-5p was found reduced expression, while CAPN10 was found elevated expression in OC cells compared with normal cell. Kaplan-Meier curve analysis showed low MIR-142-5p or high CAPN10 expression were indicators for poorer overall survival of OC patients. At length, we showed KCNQ1OT1 could regulate OC development via MIR-142-5p/CAPN10 axis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Taken together, KCNQ1OT1 upregulates CAPN10 expression via sponging MIR-142-5p, thus promoting the proliferation and migration of OC.</AbstractText>
          <CopyrightInformation>© 2019 The Authors. Molecular Genetics &amp; Genomic Medicine published by Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Hongli</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Fujian, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ruixin</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Fujian, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Fenhong</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Fujian, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lai</LastName>
            <ForeName>Haiqing</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Fujian, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yanlong</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-1822-0485</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Fujian, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2012D050</GrantID>
            <Agency>Fujian Natural Science Fund Project</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Mol Genet Genomic Med</MedlineTA>
        <NlmUniqueID>101603758</NlmUniqueID>
        <ISSNLinking>2324-9269</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">
CAPN10
</Keyword>
        <Keyword MajorTopicYN="N">
KCNQ1OT1
</Keyword>
        <Keyword MajorTopicYN="N">
MIR-142-5p
</Keyword>
        <Keyword MajorTopicYN="N">ovarian cancer</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909901</ArticleId>
        <ArticleId IdType="doi">10.1002/mgg3.1077</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Bartonicek, N., Maag, J. L., &amp; Dinger, M. E. (2016). Long noncoding RNAs in cancer: Mechanisms of action and technological advancements. Molecular Cancer, 15(1), 43. https://doi.org/10.1186/s12943-016-0530-6</Citation>
        </Reference>
        <Reference>
          <Citation>Chan, D., Tsoi, M. Y., Liu, C. D., Chan, S. H., Law, S. Y., Chan, K. W., … Tang, J. C. (2013). Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma. World Journal of Gastroenterology, 19(18), 2772-2780.</Citation>
        </Reference>
        <Reference>
          <Citation>Jia, Y., Duan, Y., Liu, T., Wang, X., Lv, W., Wang, M., … Liu, L. (2019). LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging MIR-142-5p to regulate CDK5. Cell Death &amp; Disease, 10(8), 573. https://doi.org/10.1038/s41419-019-1811-y</Citation>
        </Reference>
        <Reference>
          <Citation>Li, N., &amp; Zhan, X. (2019). Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer. EPMA Journal, 10(3), 273-290. https://doi.org/10.1007/s13167-019-00175-0</Citation>
        </Reference>
        <Reference>
          <Citation>Li, Y., Li, C., Li, D., Yang, L., Jin, J., &amp; Zhang, B. (2019). lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway. OncoTargets and Therapy, 12, 2649-2660.</Citation>
        </Reference>
        <Reference>
          <Citation>Long, J., Xiong, J., Bai, Y. I., Mao, J., Lin, J., Xu, W., … Zhao, H. (2019). Construction and investigation of a lncRNA-associated ceRNA regulatory network in cholangiocarcinoma. Frontiers in Oncology, 9, 649. https://doi.org/10.3389/fonc.2019.00649</Citation>
        </Reference>
        <Reference>
          <Citation>Long, X., Song, K., Hu, H., Tian, Q. I., Wang, W., Dong, Q., … Di, W. (2019). Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. Journal of Experimental &amp; Clinical Cancer Research, 38(1), 345. https://doi.org/10.1186/s13046-019-1329-2</Citation>
        </Reference>
        <Reference>
          <Citation>Mitsuya, K., Meguro, M., Lee, M. P., Katoh, M., Schulz, T. C., Kugoh, H., … Oshimura, M. (1999). LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Human Molecular Genetics, 8(7), 1209-1217. https://doi.org/10.1093/hmg/8.7.1209</Citation>
        </Reference>
        <Reference>
          <Citation>Nagy, A., Lánczky, A., Menyhárt, O., &amp; Győrffy, B. (2018). Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Scientific Reports, 8, 9227.</Citation>
        </Reference>
        <Reference>
          <Citation>Qi, X. U., Yu, X.-J., Wang, X.-M., Song, T.-N., Zhang, J., Guo, X.-Z., … Shao, M. (2019). Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression. Molecular Therapy - Nucleic Acids, 17, 804-818. https://doi.org/10.1016/j.omtn.2019.06.010</Citation>
        </Reference>
        <Reference>
          <Citation>Salmena, L., Poliseno, L., Tay, Y., Kats, L., &amp; Pandolfi, P. P. (2011). A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell, 146, 353-358. https://doi.org/10.1016/j.cell.2011.07.014</Citation>
        </Reference>
        <Reference>
          <Citation>Siegel, R. L., Miller, K. D., &amp; Jemal, A. (2017). Cancer statistics, 2017. CA: A Cancer Journal for Clinicians, 67(1), 7-30. https://doi.org/10.3322/caac.21387</Citation>
        </Reference>
        <Reference>
          <Citation>Siegel, R. L., Miller, K. D., &amp; Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68(1), 7-30. https://doi.org/10.3322/caac.21442</Citation>
        </Reference>
        <Reference>
          <Citation>Sorensen, R. D., Schnack, T. H., Karlsen, M. A., &amp; Hogdall, C. K. (2015). Serous ovarian, fallopian tube and primary peritoneal cancers: A common disease or separate entities - a systematic review. Gynecologic Oncology, 136(3), 571-581. https://doi.org/10.1016/j.ygyno.2015.01.534</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, J. Y., Lu, A. Q., &amp; Chen, L. J. (2019). LncRNAs in ovarian cancer. Clinica Chimica Acta, 490, 17-27. https://doi.org/10.1016/j.cca.2018.12.013</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, Z., Liu, Z., Fang, X., &amp; Yang, H. (2017). MIR-142-5p suppresses tumorigenesis by targeting PIK3CA in non-small cell lung cancer. Cellular Physiology and Biochemistry, 43(6), 2505-2515. https://doi.org/10.1159/000484459</Citation>
        </Reference>
        <Reference>
          <Citation>Xian, D., &amp; Zhao, Y. (2019). LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway. Journal of Cellular and Molecular Medicine, 23(6), 3808-3823.</Citation>
        </Reference>
        <Reference>
          <Citation>Yan, H., Li, H., Silva, M. A., Guan, Y., Yang, L. I., Zhu, L., … Ren, C. (2019). LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. Journal of Experimental &amp; Clinical Cancer Research, 38(1), 356. https://doi.org/10.1186/s13046-019-1356-z</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, K., Yan, J., Yi, B., Rui, Y., &amp; Hu, H. (2019). High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma. Future Oncology, 15(10), 1085-1095.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao, X., Tang, D. Y., Zuo, X., Zhang, T. D., &amp; Wang, C. (2019). Identification of lncRNA-miRNA-mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant. Journal of Cellular Physiology, 234(11), 19886-19894. https://doi.org/10.1002/jcp.28587</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909903</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>EMERGENCIAS 2020 - and beyond.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-2</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Miró</LastName>
            <ForeName>Òscar</ForeName>
            <Initials>Ò</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>EMERGENCIAS 2020… y más allá.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909903</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909902</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0496</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric pulmonology</Title>
          <ISOAbbreviation>Pediatr. Pulmonol.</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Six-year experience with treatment of early donor-specific anti-HLA antibodies in pediatric lung transplantation using a human immunoglobulin-based protocol.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.24639</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Experience with the treatment of early donor-specific anti-HLA antibodies (eDSA) after lung transplantation in children is very limited. At our institution, we have treated patients with eDSA since 2013 with successive infusions of intravenous human immunoglobulins (IVIG), combined in some cases with a single dose of Rituximab and plasmapheresis (therapeutic plasma exchange [tPE]) or immunoabsorption. The aim of this study was to present the 6-year results of IVIG-based therapy in pediatric lung recipients.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Records of pediatric (&lt;18 years old) patients transplanted at our institution between 01/2013 and 03/2019 were reviewed. Outcomes were compared between patients with eDSA treated with IVIG (IVIG group) and without eDSA (control group). Median (interquartile range [IQR]) follow-up amounted to 28 (12-52) months.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period, 66 lung-transplanted pediatric patients were included, of which 27 (41%) formed the IVIG group and 38 (57%) the control group. Among the IVIG patients, 14 (52%) patients showed concomitant graft dysfunction (possible clinical antibody-mediated rejection). The median time to eDSA detection was 24 (14-63) days after transplantation. eDSA were cleared in 25 (96%) of the 26 patients which completed treatment. At 3 years, graft survival (%) was 73 vs 85 (P = .65); freedom (%) from chronic lung allograft rejection (CLAD) was 89 vs 78 (P = .82); and from infection 47 vs 31 (P = .15), in IVIG vs control patients, respectively.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">After lung transplantation, an IVIG-based treatment for eDSA yielded high eDSA clearance. IVIG and control patients showed similar CLAD-free and graft survival.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Pediatric Pulmonology published by Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ius</LastName>
            <ForeName>Fabio</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0002-8084-3360</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Müller</LastName>
            <ForeName>Carsten</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic for Paediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sommer</LastName>
            <ForeName>Wiebke</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>German Center for Lung Research (DZL/BREATH), Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verboom</LastName>
            <ForeName>Murielle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Transfusion Medicine, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hallensleben</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Transfusion Medicine, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salman</LastName>
            <ForeName>Jawad</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siemeni</LastName>
            <ForeName>Thierry</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kühn</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Avsar</LastName>
            <ForeName>Murat</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bobylev</LastName>
            <ForeName>Dmitry</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poyanmehr</LastName>
            <ForeName>Reza</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Erdfelder</LastName>
            <ForeName>Caroline</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Böthig</LastName>
            <ForeName>Dietmar</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carlens</LastName>
            <ForeName>Julia</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">http://orcid.org/0000-0001-8578-864X</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinic for Paediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bayir</LastName>
            <ForeName>Lale</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic for Paediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>Gesine</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic for Paediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blasczyk</LastName>
            <ForeName>Rainer</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Transfusion Medicine, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Falk</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>German Center for Lung Research (DZL/BREATH), Hannover, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tecklenburg</LastName>
            <ForeName>Andreas</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Patient Care, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haverich</LastName>
            <ForeName>Axel</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>German Center for Lung Research (DZL/BREATH), Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tudorache</LastName>
            <ForeName>Igor</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schwerk</LastName>
            <ForeName>Nicolaus</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic for Paediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>German Center for Lung Research (DZL/BREATH), Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Warnecke</LastName>
            <ForeName>Gregor</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>German Center for Lung Research (DZL/BREATH), Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Pulmonol</MedlineTA>
        <NlmUniqueID>8510590</NlmUniqueID>
        <ISSNLinking>1099-0496</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">early anti-HLA donor-specific antibodies</Keyword>
        <Keyword MajorTopicYN="N">human intravenous immunoglobulins</Keyword>
        <Keyword MajorTopicYN="N">pediatric lung transplantation</Keyword>
        <Keyword MajorTopicYN="N">treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909902</ArticleId>
        <ArticleId IdType="doi">10.1002/ppul.24639</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Smith JD, Ibrahim MW, Newell H, et al. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation. J Heart Lung Transplant. 2014;33:1074-1082.</Citation>
        </Reference>
        <Reference>
          <Citation>Ius F, Sommer W, Tudorache I, et al. Early-donor-specific antibodies in lung transplantation: risk factors and impact on survival. J Heart Lung Transplant. 2014;33:1255-1263.</Citation>
        </Reference>
        <Reference>
          <Citation>Safavi S, Robinson DR, Soresi S, Carby M, Smith JD. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant. 2014;33:1273-1281.</Citation>
        </Reference>
        <Reference>
          <Citation>R. Morrell M, Pilewski JM, Gries CJ, et al. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. J Heart Lung Transplant. 2014;33:1288-1294.</Citation>
        </Reference>
        <Reference>
          <Citation>Roux A, Bendib Le Lan I, Holifanjaniaina S, et al. Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics. Am J Transplant. 2016;16:1216-1228.</Citation>
        </Reference>
        <Reference>
          <Citation>Le Pavec J, Suberbielle C, Lamrani L, et al. De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with worse outcomes. J Heart Lung Transplant. 2016;35:1067-1077.</Citation>
        </Reference>
        <Reference>
          <Citation>Tikkanen JM, Singer LG, Kim SJ, et al. De novo DQ donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2016;194:596-606.</Citation>
        </Reference>
        <Reference>
          <Citation>Levine DJ, Glanville AR, Aboyoun C, et al. Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2016;35:397-406.</Citation>
        </Reference>
        <Reference>
          <Citation>Verleden SE, Vanaudenaerde BM, Emonds MP, et al. Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation. Eur Respir J. 2017;50(5):1701248. https://doi.org/10.1183/13993003.01248-2017</Citation>
        </Reference>
        <Reference>
          <Citation>Hachem RR, Kamoun M, Budev MM, et al. Human Leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study. Am J Transplant. 2018;37:1119-1130.</Citation>
        </Reference>
        <Reference>
          <Citation>Tambur AR, Campbell P, Claas FH, et al. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. Am J Transplant. 2018;18(7):1604-1614.</Citation>
        </Reference>
        <Reference>
          <Citation>Hachem RR, Yusen RD, Meyers BF, et al. Anti-HLA antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant. 2010;29:973-980.</Citation>
        </Reference>
        <Reference>
          <Citation>Witt CA, Gaut JP, Yusen RD, et al. Acute antibody-mediated rejection after lung transplantation: a retrospective, single center, case series. J Heart Lung Transplant. 2013;32:1034-1040.</Citation>
        </Reference>
        <Reference>
          <Citation>Jackups R Jr., Canter C, Sweet SC, Mohanakumar T, Morris GP. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection. J Clin Apher. 2013;28:301-308.</Citation>
        </Reference>
        <Reference>
          <Citation>Ius F, Sommer W, Tudorache I, et al. Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation. J Heart Lung Transplant. 2015;34:50-58.</Citation>
        </Reference>
        <Reference>
          <Citation>Ius F, Sommer W, Kieneke D, et al. IgM-enriched human intravenous immunoglobulin-based treatment of patients with early donor specific anti-HLA antibodies after lung transplantation. Transplantation. 2016;100:2682-2692.</Citation>
        </Reference>
        <Reference>
          <Citation>Islam AK, Sinha N, DeVos JM, et al. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation. Clin Transplant. 2017;31(8):e13028.</Citation>
        </Reference>
        <Reference>
          <Citation>Vacha M, Chery G, Hulbert A, et al. Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? Clin Transplant. 2017;31(3):e12886.</Citation>
        </Reference>
        <Reference>
          <Citation>Ius F, Verboom M, Sommer W, et al. Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation. Am J Transplant. 2018;18:2295-2304.</Citation>
        </Reference>
        <Reference>
          <Citation>Hayes D Jr, Kopp BT, Sheikh SI, et al. Pretransplant panel reactive antibodies and lung transplant outcomes in children. Thorac Cardiovasc Surg. 2017;65:36-42.</Citation>
        </Reference>
        <Reference>
          <Citation>Verleden SE, Todd JL, Sato M, et al. Impact of CLAD phenotype on survival after lung re-transplantation: a multicenter study. Am J Transplant. 2015;15:2223-2230.</Citation>
        </Reference>
        <Reference>
          <Citation>Walpen AJ, Laumonier T, Aebi C, Mohacsi PJ, Rieben R. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum. Xenotransplantation. 2004;11:141-148.</Citation>
        </Reference>
        <Reference>
          <Citation>Goldfarb SB, Hayes D Jr, Levvey BJ, et al. International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Twenty-First Pediatric Lung and Heart-Lung Transplantation Report - 2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant. 2018;37:1196-1206.</Citation>
        </Reference>
        <Reference>
          <Citation>Dipchand AI, Webber S, Mason K, et al. Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: a report from the CTOC-04 study. Am J Transplant. 2018;18:2163-2174.</Citation>
        </Reference>
        <Reference>
          <Citation>Irving CA, Carter V, Gennery AR, et al. Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation. J Heart Lung Transplant. 2015;34:1310-1317.</Citation>
        </Reference>
        <Reference>
          <Citation>Engen RM, Park GE, Schumacher CS, et al. Donor-specific antibody surveillance and graft outcomes in pediatric kidney transplant recipients. Transplantation. 2018;102:2072-2079.</Citation>
        </Reference>
        <Reference>
          <Citation>Brugière O, Roux A, Le Pavec J, et al. Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome. Eur Respir J. 2018;52(2):1701898.</Citation>
        </Reference>
        <Reference>
          <Citation>Jordan SC, Toyoda M, Kahwaji J, Vo AA. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Am J Transplant. 2011;11:196-202.</Citation>
        </Reference>
        <Reference>
          <Citation>Tedla FM, Roche-Recinos A, Brar A. Intravenous immunoglobulin in kidney transplantation. Curr Opin Organ Transplant. 2015;20:630-637.</Citation>
        </Reference>
        <Reference>
          <Citation>Koenig A, Mariat C, Mousson C, Wood KJ, Rifle G, Thaunat O. B cells and antibodies in transplantation. Transplantation. 2016;100:1460-1464.</Citation>
        </Reference>
        <Reference>
          <Citation>Lobo PI. Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease. Front Immunol. 2016;7:198. https://doi.org/10.3389/fimmu.2016.00198</Citation>
        </Reference>
        <Reference>
          <Citation>Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30:636-645.</Citation>
        </Reference>
        <Reference>
          <Citation>Haynes SE, Saini S, Schowengerdt KO. Post-transplant lymphoproliferative disease and other malignancies after pediatric cardiac transplantation: an evolving landscape. Curr Opin Organ Transplant. 2015;20:562-569.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Besien K, Bachier-Rodriguez L, Satlin M, et al. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leuk Lymphoma. 2019:1-4. https://doi.org/10.1080/10428194.2018</Citation>
        </Reference>
        <Reference>
          <Citation>Delapierre B, Reman O, Dina J, et al. Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation. Curr Res Transl Med. 2019;67:145-148.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909904</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Acute coronary syndrome - always a difficult diagnosis in emergencies: the rule of 9.</ArticleTitle>
        <Pagination>
          <MedlinePgn>3-4</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Domínguez-Rodríguez</LastName>
            <ForeName>Alberto</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital Universitario de Canarias, Servicio de Cardiología, Tenerife, España. Facultad de Ciencias de la Salud, Universidad Europea de Canarias, Tenerife, España. CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hernández-Vaquero</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Área del Corazón, Hospital Universitario Central de Asturias, Oviedo, España. Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Síndrome coronario agudo: un diagnóstico siempre difícil en urgencias –la regla del 9–.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909904</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909905</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chest pain: Should we be scared or take a heart felt approach?</ArticleTitle>
        <Pagination>
          <MedlinePgn>5-6</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Anna Marie</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, EE.UU.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hollander</LastName>
            <ForeName>Judd E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, EE.UU.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Dolor torácico: ¿temerlo o abordarlo con sensatez?</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909905</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909906</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Acute adverse effects of synthetic drugs: beginning to understand the magnitude of the problem in Spain.</ArticleTitle>
        <Pagination>
          <MedlinePgn>7-8</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Galicia</LastName>
            <ForeName>Miguel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clinic, Barcelona, España. Grupo de Trabajo de Toxicología de la Societat Catalana de Medicina d'Urgències i Emergencies (SoCMUETox).</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Efectos adversos agudos en usuarios de drogas sintéticas: una aproximación a la magnitud del problema en España.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909906</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909907</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nontraumatic chest pain and suspicion of acute coronary syndrome: associated clinical and electrocardiographic findings on initial evaluation.</ArticleTitle>
        <Pagination>
          <MedlinePgn>9-18</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To analyze clinical data and electrocardiographic (ECG) findings obtained during the initial evaluation of patients with nontraumatic chest pain (NTCP). To explore associations between these findings and the initial and final diagnoses of acute coronary syndrome (ACS). To assess which variables initially over- or underestimate risk ACS.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Consecutive patients with NTCP attended in a chest pain unit during the 10-year period of 2008-2017 were included if the suspected and discharge diagnoses of interest (ACS or non-ACS) had been recorded. Thirtythree independent variables (demographic, 2; cardiovascular, 5; chest pain, 22; ECG, 4). We included all variables in models to calculate crude and adjusted odds ratios (ORs) between each independent variable and the initial and final diagnoses. The adjusted ORs were compared to determine whether the initial and final diagnoses of ACS differed significantly in relation to the variables.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 34 552 patient visits were attended. The ORs for the 33 variables were significantly associated with initial and final NTCP classification as ACS or non-ACS, and in many cases the association was confirmed by the adjusted ORs. The adjusted ORs for 19 variables were significantly different in their relation to the initial and final diagnoses of ACS: 10 overpredicted the probability of the diagnosis and 9 underpredicted it.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The variables traditionally used to warn of ACS in emergency patients with NTCP identify individuals likely to be initially and finally diagnosed with ACS. However, some of these variables overestimate or underestimate the risk of a final ACS diagnosis. Emergency medicine physicians should be aware of variables associated with underestimation of risk.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Miró</LastName>
            <ForeName>Òscar</ForeName>
            <Initials>Ò</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España. The GREAT (Global Reaseach on Acute Conditions Team) network, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martínez-Nadal</LastName>
            <ForeName>Gemma</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España. The GREAT (Global Reaseach on Acute Conditions Team) network, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiménez</LastName>
            <ForeName>Sònia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gómez-Angelats</LastName>
            <ForeName>Elisenda</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alonso</LastName>
            <ForeName>Josep R</ForeName>
            <Initials>JR</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antolín</LastName>
            <ForeName>Albert</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salgado</LastName>
            <ForeName>Emilio</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perelló</LastName>
            <ForeName>Rafel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gualandro</LastName>
            <ForeName>Danielle M</ForeName>
            <Initials>DM</Initials>
            <AffiliationInfo>
              <Affiliation>The GREAT (Global Reaseach on Acute Conditions Team) network, Roma, Italia. Cardiovascular Research Institute Basel (CRIB) and Cardiology Department, University Hospital Basel, Basilea, Suiza.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Strebel</LastName>
            <ForeName>Ivo</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Research Institute Basel (CRIB) and Cardiology Department, University Hospital Basel, Basilea, Suiza.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>López-Ayala</LastName>
            <ForeName>Pedro</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Research Institute Basel (CRIB) and Cardiology Department, University Hospital Basel, Basilea, Suiza.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosselló</LastName>
            <ForeName>Xavier</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Centro Nacional de Investigación Cardiovascular, Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bragulat</LastName>
            <ForeName>Ernest</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sánchez</LastName>
            <ForeName>Miquel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Müller</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>The GREAT (Global Reaseach on Acute Conditions Team) network, Roma, Italia. Cardiovascular Research Institute Basel (CRIB) and Cardiology Department, University Hospital Basel, Basilea, Suiza.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>López-Barbeito</LastName>
            <ForeName>Beatriz</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic, Universitat de Barcelona, Barcelona, España. The GREAT (Global Reaseach on Acute Conditions Team) network, Roma, Italia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Asociación entre los datos clínicos y electrocardiográficos iniciales en pacientes con dolor torácico no traumático y la sospecha inicial y el diagnóstico final de síndrome coronario agudo.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">Evaluar la utilidad del cuestionario COPD Asessment Test (CAT) para valorar la recuperación de la exacerbación de la enfermedad pulmonar obstructiva crónica (EA-EPOC). Evaluar si la puntuación CAT aumenta la capacidad predictiva de mala evolución de una escala de gravedad para EA-EPOC.</AbstractText>
        <AbstractText Label="METODO" NlmCategory="UNASSIGNED">Se incluyeron las consultas consecutivas por DTNT en una unidad de dolor torácico durante 10 años (2008-2017) en las que se disponía de los diagnósticos inicial de sospecha (SCA/no SCA) y final de alta de urgencias (SCA/no SCA). Se incluyeron 33 variables independientes (2 demográficas, 5 comorbilidad cardiovascular, 22 dolor torácico, 4 datos ECG). Se calcularon las odds ratio (OR) para la clasificación (inicial y final) como SCA para cada variable independiente, crudas y ajustadas en modelos globales que incluían todas ellas. En estos modelos ajustados se comparó si las OR para la clasificación inicial y final como SCA eran significativamente diferentes.</AbstractText>
        <AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Se incluyeron 34.552 visitas. Las 33 variables analizadas mostraron asociación significativa para la clasificación inicial y final del DTNT como SCA, y en muchos casos esta asociación se mantuvo en el modelo ajustado. Diecinueve variables mostraron OR significativamente diferentes para la sospecha inicial de SCA que para el diagnóstico final de SCA: 10 sobrestimaban la asociación final y 9 la subestimaban.</AbstractText>
        <AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">Los datos clínicos iniciales clásicamente utilizados para sospechar SCA pacientes con DTNT en urgencias identifican todos ellos individualmente a pacientes con riesgo incrementado de ser clasificado inicial y finalmente como SCA; sin embargo, algunos de ellos sobreestiman y otros subestiman inicialmente el riesgo final. Los urgenciólogos debieran sensibilizarse más con estos datos subestimados.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acute coronary syndrome</Keyword>
        <Keyword MajorTopicYN="N">Chest pain</Keyword>
        <Keyword MajorTopicYN="N">Chest pain unit</Keyword>
        <Keyword MajorTopicYN="N">Diagnosis</Keyword>
        <Keyword MajorTopicYN="N">Diagnóstico</Keyword>
        <Keyword MajorTopicYN="N">Dolor torácico</Keyword>
        <Keyword MajorTopicYN="N">Emergency department</Keyword>
        <Keyword MajorTopicYN="N">Síndrome coronario agudo</Keyword>
        <Keyword MajorTopicYN="N">Unidad de dolor torácico</Keyword>
        <Keyword MajorTopicYN="N">Urgencias</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909907</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909908</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Predicting a diagnosis of acute coronary syndrome during telephone evaluation by an emergency dispatcher: the SCARE predictive scale.</ArticleTitle>
        <Pagination>
          <MedlinePgn>19-25</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Correctly identifying patients with acute coronary syndrome (ACS) on first contact is essential, yet emergency dispatchers currently lack a risk scale that can help predict an ACS diagnosis. Our main aim was to develop and validate such a risk scale.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Prospective, observational single-center study in 2016 (January 1 to December 31). We included patients who called our emergency dispatch center to report nontraumatic chest pain. Included patients were randomly assigned to a development or a validation sample. The predictive SCARE scale was built with logistic regression analysis. Discrimination and calibration were analyzed by calculating the area under the receiver operating characteristic curve; calibration was assessed with the Hosmer-Lemeshow test.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The development sample included 902 patients. The regression model identified 7 variables associated with a final diagnosis of ACS: male sex, age, smoking, typical pain characteristics, first episode of chest pain, diaphoresis, and physician intuition (the teledispatcher's suspicion). When we applied the scale in the validation sample of 465 patients the area under the curve was 0.81 (95% CI, 0.76-0.87). The Hosmer-Lemeshow statistic was 5.18 (P=.74).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The SCARE scale had good discrimination and calibration properties. The scale should be further validated in an external sample from a multicenter study before it is implemented by emergency dispatch centers.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guerineau</LastName>
            <ForeName>Audrey</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, CHR Orléans, Orléans, Francia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rozelle</LastName>
            <ForeName>Clément</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, CHR Orléans, Orléans, Francia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sevestre</LastName>
            <ForeName>Elodie</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, CHR Orléans, Orléans, Francia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Narcisse</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, CHR Orléans, Orléans, Francia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laribi</LastName>
            <ForeName>Saïd</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Tours University, School of Medicine, and Tours University Hospital, Emergency Medicine Department, Tours, Francia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Giovannetti</LastName>
            <ForeName>Olivier</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, CHR Orléans, Orléans, Francia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Escala predictiva para el diagnóstico de síndrome coronario agudo en la atención telefónica en un centro coordinador de emergencias: escala SCARE.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">La correcta identificación en el primer contacto médico de los pacientes con un síndrome coronario agudo (SCA) es esencial. No existe ninguna escala predictiva para el diagnóstico de SCA en los centros de coordinación de emergencias (CCE) que facilite la toma de decisiones al equipo médico. El objetivo primario es construir y validar una escala de estas características.</AbstractText>
        <AbstractText Label="METODO" NlmCategory="UNASSIGNED">Estudio prospectivo, observacional, unicéntrico, realizado durante 1 año (2016). Se incluyeron los pacientes que consultaron telefónicamente por dolor torácico no traumático en un CCE. Los pacientes incluidos se repartieron en las muestra de derivación y validación de forma aleatoria. La escala predictiva –escala SCARE– se construyó mediante regresión logística, la discriminación y calibración del modelo se realizó con el cálculo del área bajo la curva (ABC) de la característica operativa del receptor y el test de Hosmer-Lemeshow.</AbstractText>
        <AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">La muestra de derivación incluyó 902 pacientes y 7 de las variables recogidas se relacionaron con un diagnóstico final de SCA: sexo masculino, edad, tabaquismo, dolor torácico de características típicas, primer episodio de dolor torácico, diaforesis y la intuición del médico que realizó la entrevista telefónica. La utilización de la escala desarrollada en los 465 pacientes de la muestra de validación obtuvo un ABC de 0,81 (intervalo de confianza al 95% 0,76-0,87) y el test de Hosmer-Lemeshow fue de 5,18 (p = 0,74).</AbstractText>
        <AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">La escala SCARE mostró una correcta discriminación y calibración. Es necesaria una validación externa multicéntrica antes de implementar su uso en los CCE.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acute coronary syndrome prediction scale</Keyword>
        <Keyword MajorTopicYN="N">Assessment</Keyword>
        <Keyword MajorTopicYN="N">Chest pain</Keyword>
        <Keyword MajorTopicYN="N">Dolor torácico</Keyword>
        <Keyword MajorTopicYN="N">Escala predictiva de síndrome coronario agudo</Keyword>
        <Keyword MajorTopicYN="N">Evaluación</Keyword>
        <Keyword MajorTopicYN="N">Intuición médica</Keyword>
        <Keyword MajorTopicYN="N">Intuition, medical</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909908</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909909</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Amphetamine and methamphetamine poisonings attended in hospital emergency departments: clinical features and the usefulness of laboratory confirmation.</ArticleTitle>
        <Pagination>
          <MedlinePgn>26-32</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine whether clinical and toxicologic findings differed between cases of amphetamine (AMP) and methamphetamine (mAMP) poisoning attended in 2 Balearic Island hospital emergency departments.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Retrospective observational study of AMP and mAMP cases with laboratory confirmation between 2013 and 2018. We compared clinical and toxicologic variables as well as clinical management between groups.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">1) A total of 120 cases were found: 86 (71.7%) with AMP poisoning and 34 (28.3%) with mAMP poisoning. 2) Drug poisoning was confirmed by gas chromatography associated with mass spectrometry (GC-MS) in 787 urine samples found to be positive during screening. One hundred fifty-four (19.6%) were confirmed by GC-MS. Thirtyfour of them did not meet the inclusion criteria. 3) Significant differences between AMP and mAMP cases were found for age (32.3 vs 28.4 y, respectively); sex (72.1% vs 94.1% men); and Spanish nationality (64.0% vs 29.4%). Reasons for admission and clinical features also differed: the reasons were aberrant behavior (15.1% in the AMP group vs 0% in the mAMP group) and palpitations (1.2% vs 20.6%); agitation was observed in 27.9% and 8.8%, respectively. Clinical management was similar in the 2 groups. Multiple drug poisoning was detected in 76.6% patients and was more common in patients in the AMP group (82.6% vs 61.8%). The additional drugs in these cases were mainly cocaine (63.0%), cannabis (48.9%), 3,4-methylenedioxy-N-methamphetamine (MDMA) (38.0%), and alcohol (35.9%). Cannabis was detected in a significantly higher proportion in the AMP group (45.3%) than in the mAMP group (17.6%). False positives were found in 78.7% of the samples. The culprit drug was most often MDMA (71.2%).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AMP poisonings were associated with age over 30 years, Spanish nationality, aberrant behavior, agitation, multiple drug findings, and the use of cannabis. Poisonings caused by mAMP abuse were associated with age under 30 years, non-Spanish nationality, palpitations, and single-drug use.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Roset Ferrer</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Psiquiatría, Hospital Universitari Son Espases, Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gomila Muñiz</LastName>
            <ForeName>Isabel</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Análisis Clínicos, Hospital Universitari Son Llàtzer, Palma de Mallorca, España. Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elorza Guerrero</LastName>
            <ForeName>Miguel Ángel</ForeName>
            <Initials>MÁ</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España. Servicio de Análisis Clínicos, Unidad de Toxicología Clínica, Hospital Universitari Son Espases, Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Puiguriguer Ferrando</LastName>
            <ForeName>Jordi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España. Servicio de Urgencias, Unidad de Toxicología Clínica, Hospital Universitari Son Espases, Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leciñena Estean</LastName>
            <ForeName>María Ángeles</ForeName>
            <Initials>MÁ</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Urgencias, Hospital Can Misses, Ibiza, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tuero León</LastName>
            <ForeName>Gaspar</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Medicina Intensiva, Hospital Can Misses, Ibiza, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sahuquillo Frías</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Análisis Clínicos, Hospital Can Misses, Ibiza, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ripoll Vera</LastName>
            <ForeName>Tomás</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España. Servicio de Cardiología, Hospital Universitari Son Llàtzer, Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Socias Crespi</LastName>
            <ForeName>Lorenzo</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España. Servicio de Medicina Intensiva, Hospital Universitario Son Llàtzer, Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sanchís Cortés</LastName>
            <ForeName>Pilar</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España. Departamento de Química, Universidad de las Islas Baleares, Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barceló Martín</LastName>
            <ForeName>Bernardino</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España. Servicio de Análisis Clínicos, Unidad de Toxicología Clínica, Hospital Universitari Son Espases, Palma de Mallorca, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Intoxicaciones por anfetamina y metanfetamina atendidas en los servicios de urgencias: características clínicas y utilidad de la confirmación analítica.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">Investigar si existen diferencias clínicas y toxicológicas en pacientes intoxicados por anfetamina (ANF) y metanfetamina (MANF) atendidos en servicios de urgencias.</AbstractText>
        <AbstractText Label="METODO" NlmCategory="UNASSIGNED">Estudio observacional retrospectivo de intoxicaciones por ANF y MANF con confirmación analítica en Baleares (2013-2018). Se compararon variables clínicas, toxicológicas y de manejo clínico entre grupos.</AbstractText>
        <AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">1) Se incluyeron 120 pacientes, 86 (71,7%) grupo ANF y 34 (28,3%) grupo MANF. 2) La confirmación de derivados anfetamínicos se realizó por cromatografía de gases-espectrometría de masas en 787 muestras de orina previamente positivas mediante un método de cribado cualitativo. Se confirmaron 154 (19,6%) muestras. De ellas, 34 fueron excluidas. 3) Se encontraron diferencias significativas entre ANF y MANF en: edad (32,3 vs 28,4 años); sexo (72,1 vs 94,1% hombres); nacionalidad española (64,0 vs 29,4%); en motivos de admisión: alteración de conducta (15,1 vs 0%) y palpitaciones (1,2 vs 20,6%); y en características clínicas: agitación (27,9 vs 8,8%). No hubo diferencias de manejo clínico. El 76,6% de casos fueron polintoxicaciones, más comunes en ANF (82,6 vs 61,8%). En estos casos se detectó principalmente cocaína (63,0%), cannabis (48,9%), MDMA (38,0%) y alcohol (35,9%). La mayor asociación del cannabis con el grupo de ANF fue estadísticamente significativa (45,3 vs 17,6%). La causa de los falsos positivos se identificó en el 78,7% de muestras, siendo el MDMA (71,2%) la principal.</AbstractText>
        <AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">Se observaron diferencias entre ANF y MANF en cuanto a variables demográficas y motivo de asistencia; no obstante en esta serie hubo un alto porcentaje de polintoxicaciones.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N"> Anfetamina</Keyword>
        <Keyword MajorTopicYN="N">Amphetamine</Keyword>
        <Keyword MajorTopicYN="N">Confirmación analítica</Keyword>
        <Keyword MajorTopicYN="N">Emergency department</Keyword>
        <Keyword MajorTopicYN="N">Intoxicaciones</Keyword>
        <Keyword MajorTopicYN="N">Laboratory confirmation</Keyword>
        <Keyword MajorTopicYN="N">Metanfetamina</Keyword>
        <Keyword MajorTopicYN="N">Methamphetamine</Keyword>
        <Keyword MajorTopicYN="N">Poisoning</Keyword>
        <Keyword MajorTopicYN="N">Servicio de urgencias</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909909</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909910</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Factors associated with a rapid call for assistance for patients with ischemic stroke.</ArticleTitle>
        <Pagination>
          <MedlinePgn>33-39</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To identify factors related to a rapid response to the onset of symptoms and a call for help for patients with ischemic stroke.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Observational cross-sectional study of all patients with ischemic stroke admitted consecutively to Hospital Universitario de Burgos in Spain during 1 year. We collected sociodemographic, clinical, behavioral, cognitive, and contextual data for all patients and applied uni- and multivariate analysis to explore possible associations with the patient's response time.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 425 patients were included. The mean patient response time was 140.00 minutes. Patient delay accounted for 72.6% of the total prehospital response time. Factors associated with a rapid call for help were the presence of an accompanying person (OR, 9.57; 95% CI, 3.89-23.52), daytime onset of symptoms (OR, 8.77; 3.40- 22.63), patient knowledge of how to act in case of stroke symptoms (OR, 3.84; 2.77-7.09), first medical contact through the public health system's emergency medical service (OR, 3.03; 1.62-5.68), patient perception of symptoms as severe or very severe (OR, 2.38; 1.17-4.83), and stroke onset in an urban area (OR, 2.17; 1.16-4.06).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The patient's response time between onset of symptoms is related to behavioral, cognitive and contextual factors that should be taken into account when planning future patient education campaigns.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Soto-Cámara</LastName>
            <ForeName>Raúl</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Emergencias Sanitarias de Castilla y LeónSACYL, Burgos, España. Departamento de Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad de Burgos, Burgos, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>González-Santos</LastName>
            <ForeName>Josefa</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad de Burgos, Burgos, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>González-Berna</LastName>
            <ForeName>Jerónimo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad de Burgos, Burgos, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trejo-Gabriel-Galán</LastName>
            <ForeName>José M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Neurología, Hospital Universitario de Burgos, Burgos, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Factores asociados a una rápida petición de ayuda en los pacientes con ictus isquémico.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">Identificar los factores asociados con una respuesta inicial inmediata a los síntomas en los pacientes que han padecido un ictus isquémico.</AbstractText>
        <AbstractText Label="METODO" NlmCategory="UNASSIGNED">Estudio observacional transversal en el que se incluyeron a todos los pacientes con ictus isquémico ingresados de forma consecutiva en el Hospital Universitario de Burgos (España) durante 1 año. Se recogieron parámetros sociodemográficos, clínicos, conductuales, cognitivos y contextuales, y se estudió su posible relación con el tiempo de reacción del paciente (TR) mediante análisis univariante y multivariante.</AbstractText>
        <AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Se incluyeron 425 pacientes (mediana del TR de 140 minutos). El TR supuso un 72,6% del tiempo prehospitalario total (TPH), con una respuesta inmediata si el paciente se encontraba acompañado (OR 9,57; IC95% 3,89-23,52), si los síntomas se iniciaban durante el día (OR 8,77; 3,40-22,63), si el paciente sabía cómo actuar ante un posible ictus (OR 3,84; 2,77-7,09), si el primer contacto médico era con el servicio de emergencias médicas (SEM) (OR 3,03; 1,62-5,68), si el paciente percibía la situación como grave o muy grave (OR 2,38; 1,17-4,83) o si el ictus ocurría en el ámbito urbano (OR 2,17; 1,16-4,06).</AbstractText>
        <AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">El intervalo de tiempo entre el inicio de los síntomas y la respuesta inicial del paciente se relaciona con factores conductuales, cognitivos y contextuales, los cuales deberían ser considerados en la planificación de futuras campañas educacionales.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N"> Ictus</Keyword>
        <Keyword MajorTopicYN="N">Behavior</Keyword>
        <Keyword MajorTopicYN="N">Comportamiento</Keyword>
        <Keyword MajorTopicYN="N">Decision-making</Keyword>
        <Keyword MajorTopicYN="N">Decisión</Keyword>
        <Keyword MajorTopicYN="N">Factores de tiempo</Keyword>
        <Keyword MajorTopicYN="N">Response time</Keyword>
        <Keyword MajorTopicYN="N">Stroke</Keyword>
        <Keyword MajorTopicYN="N">Tiempo de respuesta</Keyword>
        <Keyword MajorTopicYN="N">Time factors</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909910</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909911</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinical characteristics and course in emergency department patients with chronic obstructive pulmonary disease and symptomatic acute venous thromboembolic disease: secondary analysis of the ESPHERIA registry.</ArticleTitle>
        <Pagination>
          <MedlinePgn>40-44</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the impact of chronic obstructive pulmonary disease (COPD) on prognosis in patients diagnosed with venous thromboembolic disease (VTED) in Spanish emergency departments.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Secondary analysis of data from the ESPHERIA (Spanish acronym for Risk Profile of Patients VTED Attended in Spanish Emergency Departments) registry.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 801 patients, 71 (9%) with COPD, were included. Pulmonary thromboembolism was recorded in 77.%% of the patients with COPD (vs in 47.1% of patients without COPD; P&lt;.001). Patients with COPD had evidence of right ventricular dysfunction on computed tomography angiography more often than other VTED patients (18.2% vs 13.1%; P&lt;.001) and more often required ventilatory support (7% vs 0.5%; P&lt;.001). VTED patients with COPD also had a higher rate of readmission or mortality at 180 days (hazard ratio, 1.52; 95% CI, 1.00-2.29; P = .048)] than patients without COPD.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">COPD affects the prognosis of patients diagnosed with VTED in Spanish emergency departments as evidenced by hospital readmission and mortality.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Carriel Mancilla</LastName>
            <ForeName>Jorge</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Urgencias, Hospital General de Villalba, Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiménez Hernández</LastName>
            <ForeName>Sonia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Área de Urgencias, Hospital Clínic de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martín-Sánchez</LastName>
            <ForeName>Francisco Javier</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Urgencias, IdISSC, Hospital Clínico San Carlos, Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiménez</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Neumología, Hospital Ramón y Cajal, Madrid, España. Departamento de Medicina, Universidad de Alcalá (IRYCIS), Alcalá de Henares, Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fuentes Ferrer</LastName>
            <ForeName>Manuel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Medicina Preventiva, IdISSC, Hospital Clínico San Carlos, Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruiz-Artacho</LastName>
            <ForeName>Pedro</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Medicina Interna, Clínica Universidad de Navarra, Madrid, España. Interdisciplinar Teragnosis and Radiosomics (INTRA) Research Group, Universidad de Navarra, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>Grupo de Enfermedad Tromboembólica Venosa de la Sociedad Española de Medicina
      de Urgencias y Emergencias (ETV-SEMES)</CollectiveName>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Características y evolución de los pacientes con enfermedad pulmonar obstructiva crónica y enfermedad tromboembólica venosa aguda sintomática en urgencias: subanálisis del registro ESPHERIA.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">Determinar el impacto pronóstico de la enfermedad pulmonar obstructiva crónica (EPOC) en los pacientes diagnosticados de enfermedad tromboembólica venosa (ETV) en servicios de urgencias (SU) españoles.</AbstractText>
        <AbstractText Label="METODO" NlmCategory="UNASSIGNED">Análisis secundario del registro ESPHERIA que incluyó pacientes consecutivos con ETV sintomática en 53 SU.</AbstractText>
        <AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Se incluyeron 801 pacientes de los que 71 (9%) tenían EPOC, siendo la tromboembolia pulmonar la forma de presentación más frecuente de ETV en este subgrupo de pacientes (77,5% vs 47,1%, p &lt; 0,001). Los pacientes con EPOC tuvieron con más frecuencia disfunción de ventrículo derecho en la angiotomografía pulmonar (18,2% vs 13,1%; p &lt; 0,001) y necesidad de soporte ventilatorio (7% vs 0,5%; p &lt; 0,001). Los pacientes con ETV y EPOC tuvieron mayor incidencia de reingreso o mortalidad en el seguimiento a 180 días [HR 1,52 (IC 95% 1,00-2,29; p = 0,048)], comparados con los pacientes con ETV sin EPOC.</AbstractText>
        <AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">La EPOC tiene impacto pronóstico en los pacientes diagnosticados de ETV en SU españoles, en términos de mortalidad y reingreso hospitalario.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chronic obstructive pulmonary disease</Keyword>
        <Keyword MajorTopicYN="N">Emergency department</Keyword>
        <Keyword MajorTopicYN="N">Enfermedad pulmonar obstructiva crónica. . . . . </Keyword>
        <Keyword MajorTopicYN="N">Enfermedad tromboembólica venosa</Keyword>
        <Keyword MajorTopicYN="N">Urgencias</Keyword>
        <Keyword MajorTopicYN="N">Venous thromboembolism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909911</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909912</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Standard basic life support training of the European Resuscitation Council versus blended training: a randomized trial of a new teaching method.</ArticleTitle>
        <Pagination>
          <MedlinePgn>45-48</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the immediate and 9-month results of blended versus standard training in basic life support and the use of an automatic external defibrillator (BLS/AED).</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Randomized trial comparing the results of standard BLS/AED training to blended training. The control group received 4 hours of standard instruction from a trainer and the experimental blended-training group received 2 hours of virtual training and 2 hours of in-person instruction.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-nine students participated, 45 in the control group and 44 in the experimental group. The controls achieved better mean (SD) knowledge scores immediately after training (8.6 [0.9] vs 8.0 [1.14] in the experimental group, P=.013). The blended training group scored better on certain skill markers (hands-off time in seconds and compressions followed by complete chest recoil). Participant knowledge had decreased at 9 months without significant between-group differences. Overall, retention fell from a score of 8.31 (1.1) to 6.04 (1.6) (P=.001) in 9 months and the loss was similar in the 2 groups. No differences in practical skills between the groups were observed at the end of the course or 9 months later.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The blended training method led to better results on some skill items.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Castillo García</LastName>
            <ForeName>Jordi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona. Facultad de Medicina y Ciencias de la Salud, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, España. Consell Català de Resuscitació . Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cerdà Vila</LastName>
            <ForeName>Manel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Consell Català de Resuscitació . Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Balanzó Fernández</LastName>
            <ForeName>Xavier</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Consell Català de Resuscitació . Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quintana Riera</LastName>
            <ForeName>Salvador</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Consell Català de Resuscitació . Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferrés-Amat</LastName>
            <ForeName>Elvira</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio Oral y Maxilofacial del Servició de Odontología Pediátrica. Hospital de Nens de Barcelona. Universitat Internacional de Catalunya, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodríguez Higueras</LastName>
            <ForeName>Encarnación</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Consell Català de Resuscitació . Barcelona, España. Enfermería en la Facultad de Medicina y Ciencias de la Salud, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Estudio experimental aleatorizado de innovación docente que compara metodología mixta frente a presencial para la formación en soporte vital básico estándar del European Resuscitation Council.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">Evaluar los resultados de la formación mixta frente a la presencial en un curso de soporte vital básico/desfibrilador externo automático (SVB/DEA), así como su retención a los 9 meses.</AbstractText>
        <AbstractText Label="METODO" NlmCategory="UNASSIGNED">Estudio experimental aleatorizado que compara los resultados de la formación en SVB/DEA entre un grupo control (GC) que recibió formación presencial de 4 horas frente a un grupo experimental (GE) que recibió formación en metodología mixta: 2 horas virtuales y 2 horas presenciales.</AbstractText>
        <AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Participaron 89 alumnos (45 del GC y 44 del GE). Después de la formación, el GC obtuvo mejores puntuaciones en conocimientos [8,6 (DE 0,9) frente a 8,0 (DE 1,14), p = 0,013]. El GE obtuvo mejores puntuaciones en las habilidades del tiempo en segundos de “hands off” y en el porcentaje de la rexpansión completa del tórax. Los conocimientos decaen a los 9 meses, pero sin diferencias entre los dos grupos. La retención global baja de 8,31 (DE 1,1) a 6,04 (DE 1,6) (p = 0,001), en 9 meses, pero de forma similar en ambos grupos. En las habilidades prácticas no hubo diferencias entre los dos grupos ni al finalizar el curso ni a los 9 meses.</AbstractText>
        <AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">Con la metodología virtual se obtienen mejores resultados en algunos parámetros de las habilidades.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Blended training</Keyword>
        <Keyword MajorTopicYN="N">Cardiac arrest</Keyword>
        <Keyword MajorTopicYN="N">Cardiopulmonary resuscitation</Keyword>
        <Keyword MajorTopicYN="N">Educación</Keyword>
        <Keyword MajorTopicYN="N">Education</Keyword>
        <Keyword MajorTopicYN="N">Formación mixta</Keyword>
        <Keyword MajorTopicYN="N">Parada cardiaca</Keyword>
        <Keyword MajorTopicYN="N">Reanimación cardiopulmonar</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909912</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909913</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intraosseous access in adults in cardiac arrest: a systematic review and meta-analysis.</ArticleTitle>
        <Pagination>
          <MedlinePgn>49-56</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the efficacy of intraosseous access versus venous access in out-of-hospital cardiac arrest in terms of return of spontaneous circulation (ROSC) and survival to hospital discharge with or without favorable neurologic status.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Systematic review and meta-analysis of articles indexed in MEDLINE (PubMed), Embase, the Web of Science, and the Cochrane Library. Other terms adapted to the language of each index were also used. We included observational studies and clinical trials published from January 1, 1950, to May 31, 2019, if the study population included adult patients in cardiac arrest outside the hospital and in whom an intraosseous or intravenous catheter was inserted. Risk of bias was evaluated with the Cochrane and GRADE (Grading of Recommendations Assessment, Development and Evaluation) tools.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 434 papers to include in the qualitative review and 5 studies for meta-analysis. Intraosseous access was related to a lower rate of ROSC (odds ratio [OR], 0.69; 95% CI, 0.57-0.83; P=.02; I2=65%) and worse survival to discharge (OR, 0.65; 95% CI, 0.51-0.83); P&lt;.01, I2=30%).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intraosseous access in out-of-hospital cardiac arrest is related to poorer outcomes in terms of ROSC and survival at hospital discharge.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Morales-Cané</LastName>
            <ForeName>Ignacio</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Maimónides de Investigación Biomédica de Córdoba, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valverde-León</LastName>
            <ForeName>María Del Rocío</ForeName>
            <Initials>MDR</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Maimónides de Investigación Biomédica de Córdoba, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodríguez-Borrego</LastName>
            <ForeName>María Aurora</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Maimónides de Investigación Biomédica de Córdoba, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>López-Soto</LastName>
            <ForeName>Pablo Jesús</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Maimónides de Investigación Biomédica de Córdoba, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Vía intraósea en adultos en situación de parada cardiaca: revisión sistemática y metanálisis.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">Evaluar la efectividad, en relación al retorno a circulación espontánea, la supervivencia al alta y la supervivencia al alta con buen estado neurológico, del acceso intraóseo frente al acceso venoso en la resucitación en parada cardiaca extrahospitalaria.</AbstractText>
        <AbstractText Label="METODO" NlmCategory="UNASSIGNED">Se realiza una revisión sistemática y metanálisis en las bases de datos Medline (PubMed), Embase, Web of Science y Cochrane Library. Se incluyeron estudios observacionales y ensayos clínicos registrados en las bases de datos mencionadas desde el 1 de enero de 1950 hasta el 31 de mayo de 2019, en los que la población incluida fueran pacientes adultos en situación de parada cardiaca extrahospitalaria y que tuvieran canalizado un acceso intraóseo o intravenoso. La evaluación del riesgo de sesgo se realizó mediante la herramienta de evaluación de sesgo de Cochrane y la herramienta GRADE.</AbstractText>
        <AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Se identificaron 434 referencias de las que 5 se incluyen en la síntesis cualitativa y cuantitativa. El acceso intraóseo se relaciona con una peor tasa de retorno a circulación espontánea [OR 0,69 (IC 95%: 0,57-0,83), p = 0,02, I 2 = 65%] y una peor supervivencia al alta hospitalaria [OR 0,65 (IC 95%: 0,51-0,83); p &lt; 0,01, I2 = 30%] en comparación con el acceso venoso.</AbstractText>
        <AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">El acceso intraóseo en pacientes en situación de parada cardiaca extrahospitalaria se relaciona con peores resultados en términos de retorno a circulación espontánea y supervivencia al alta hospitalaria.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N"> Circulación espontánea</Keyword>
        <Keyword MajorTopicYN="N">Alta hospitalaria</Keyword>
        <Keyword MajorTopicYN="N">Hospital discharge</Keyword>
        <Keyword MajorTopicYN="N">Intraosseous catheter</Keyword>
        <Keyword MajorTopicYN="N">Spontaneous circulation</Keyword>
        <Keyword MajorTopicYN="N">Vía intraósea</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909913</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909914</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.</ArticleTitle>
        <Pagination>
          <MedlinePgn>57-58</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Alabed</LastName>
            <ForeName>Samer</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Academic Unit of Radiology, University of Sheffield, Sheffield, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sabouni</LastName>
            <ForeName>Ammar</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>KasrAlAiny School of Medicine, Cairo University, El Cairo, Egipto.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Providencia</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, Londres, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Atallah</LastName>
            <ForeName>Edmond</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Nottingham University Hospitals NHS Trust, Nottingham, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qintar</LastName>
            <ForeName>Mohammed</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Medicine, Saint Luke's Mid America Heart Institute; University of Missouri-Kansas City, Kansas City, MO, Estados Unidos.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chico</LastName>
            <ForeName>Timothy Ja</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Adenosina frente a antagonistas de los canales del calcio intravenosos en la taquicardia supraventricular.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909914</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909915</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.</ArticleTitle>
        <Pagination>
          <MedlinePgn>59-60</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berbenetz</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Queen's University, Kingston, Canadá.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yongjun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Schulich School of Medicine &amp; Dentistry, Western University, London, Canadá.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>James</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiology, Royal Free Hospital, Londres, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Godfrey</LastName>
            <ForeName>Charlotte</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>St Helier Hospital, Londres, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmad</LastName>
            <ForeName>Mahmood</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiology Department, Royal Free Hospital, Royal Free London NHS Foundation Trust, Londres, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vital</LastName>
            <ForeName>Flávia Mr</ForeName>
            <Initials>FM</Initials>
            <AffiliationInfo>
              <Affiliation>Cochrane Brazil Minas Gerais, Muriaé, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lambiase</LastName>
            <ForeName>Pier</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Cardiology in the Young, The Heart Hospital, University College London Hospitals, Londres, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Banerjee</LastName>
            <ForeName>Amitava</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Health Informatics Research, University College London, Londres, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bakhai</LastName>
            <ForeName>Ameet</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Barnet General Hospital Cardiology Department, Royal Free London NHS Foundation Trust, Barnet, Reino Unido.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chong</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Western University, London, Canadá.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Ventilación no invasiva con presión positiva (CPAP o doble nivel) para el edema agudo de pulmón cardiogénico.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909915</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909917</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sentenced.</ArticleTitle>
        <Pagination>
          <MedlinePgn>63-64</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pampín-Huerta</LastName>
            <ForeName>Francisco Ramón</ForeName>
            <Initials>FR</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad de Reanimación y Cuidados Intensivos, Hospital HM Modelo, A Coruña, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Sentencias.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909917</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909916</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Animals and emergency care: a role for the Spanish Society of Emergency Medicine (SEMES).</ArticleTitle>
        <Pagination>
          <MedlinePgn>61-62</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>de Castellví Guimerá</LastName>
            <ForeName>Juan Luis</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Oficial de Seguridad y Prevención del Parlamento Europeo, Bruselas. Técnico en Emergencias Sanitarias. Miembro del GRAAN ANIMAL de SEMES.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lozano Sandoval</LastName>
            <ForeName>Chelo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Responsable de Comunicación de SEMES.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Sociedad Española de Medicina de Urgencias y Emergencias (SEMES), atención de emergencias y animales.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909916</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909918</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Last wishes.</ArticleTitle>
        <Pagination>
          <MedlinePgn>65-67</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pastor</LastName>
            <ForeName>Antonio Juan</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Catalán de la Salud, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Últimas voluntades.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909918</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909919</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>On the role of tranexamic acid in emergency department patients with trauma.</ArticleTitle>
        <Pagination>
          <MedlinePgn>68</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Viejo-Moreno</LastName>
            <ForeName>Rubén</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad Medicalizada de EmergenciasGuadalajara. Gerencia de Urgencias, Emergencias y Transporte Sanitario. SESCAM, Guadalajara, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Puncel</LastName>
            <ForeName>Carmen Benito</ForeName>
            <Initials>CB</Initials>
            <AffiliationInfo>
              <Affiliation>Médico Intensiva, Hospital Universitario de Guadalajara, Guadalajara, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carriedo Scher</LastName>
            <ForeName>Cristina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Dirección médica. GUETS-SESCAM, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Acerca del papel del ácido tranexámico en pacientes con traumatismo en urgencias y emergencias.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909919</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909920</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Another perspective on the management of multiple intentional-injury victims in the future: the Victory I Consensus.</ArticleTitle>
        <Pagination>
          <MedlinePgn>69-70</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rodríguez Aguado</LastName>
            <ForeName>Orestes Octavio</ForeName>
            <Initials>OO</Initials>
            <AffiliationInfo>
              <Affiliation>Empresa Pública de Emergencias Sanitarias, Cádiz, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Domínguez Manzano</LastName>
            <ForeName>Noelia</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad de Gestión Clínica de Urgencias, Hospital Universitario Puerta Del Mar, Cádiz, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marín Paz</LastName>
            <ForeName>Antonio Jesús</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Facultad de Enfermería y Fisioterapia, Universidad de Cádiz, Cádiz, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sainz Otero</LastName>
            <ForeName>Ana María</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Facultad de Enfermería y Fisioterapia, Universidad de Cádiz, Cádiz, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Consenso Victoria I: otra perspectiva cara al futuro de los incidentes con múltiples víctimas intencionados.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909920</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909921</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Author's reply.</ArticleTitle>
        <Pagination>
          <MedlinePgn>70-71</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Martín-Ibáñez</LastName>
            <ForeName>Luis</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Trabajo Enfermería Militar SEMES. Subgrupo Cadena de Supervivencia en Atentados Terroristas. Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Respuesta de los autores.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909921</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909922</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>On the usefulness of brain natriuretic peptide as a prognostic biomarker in patients with influenza syndrome.</ArticleTitle>
        <Pagination>
          <MedlinePgn>71-72</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tazón-Varela</LastName>
            <ForeName>Manuel Antonio</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Urgencias, Hospital de Laredo, Laredo, Cantabria, España. Grupo Salud Comunitaria del Instituto de Investigación Sanitaria Valdecilla (IDIVAL).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alonso-Valle</LastName>
            <ForeName>Héctor</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Urgencias, Hospital universitario Marqués de Valdecilla, Santander, Cantabria, España. Grupo Salud Comunitaria del Instituto de Investigación Sanitaria Valdecilla (IDIVAL).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muñoz-Cacho</LastName>
            <ForeName>Pedro</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad Docente de la Gerencia de Atención Primaria, Servicio Cántabro de Salud, Cantabria, España. Grupo Salud Comunitaria del Instituto de Investigación Sanitaria Valdecilla (IDIVAL).</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Reflexiones sobre la utilidad de NT-proBNP como biomarcador pronóstico en pacientes con síndrome gripal.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909922</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909923</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Brugada syndrome, Brugada phenocopy, or simply arrythmia induced by cocaine intoxication?</ArticleTitle>
        <Pagination>
          <MedlinePgn>72-74</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cepas-Guillén</LastName>
            <ForeName>Pedro L</ForeName>
            <Initials>PL</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pujol-López</LastName>
            <ForeName>Margarida</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>San Antonio</LastName>
            <ForeName>Rodolfo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, España. Centro de Investigación Biomédica en Red de Enfermedades Cardiovaculares (CIBERCV), Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arbelo</LastName>
            <ForeName>Elena</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, España. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, España. Centro de Investigación Biomédica en Red de Enfermedades Cardiovaculares (CIBERCV), Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salgado</LastName>
            <ForeName>Emilio</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Servicio de Urgencias y Toxicología Clínica, Hospital Clínic, Barcelona, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brugada</LastName>
            <ForeName>Josep</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, España. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, España. Centro de Investigación Biomédica en Red de Enfermedades Cardiovaculares (CIBERCV), Madrid, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>¿Síndrome de Brugada, fenocopia de Brugada o solo intoxicación arritmogénica?</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909923</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
      <PMID Version="1">31909924</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2386-5857</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title>
          <ISOAbbreviation>Emergencias</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intercostal pseudohernia following blunt chest trauma.</ArticleTitle>
        <Pagination>
          <MedlinePgn>74</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Navas Cuéllar</LastName>
            <ForeName>José Aurelio</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad de Gestión Clínica de Cirugía General y del Aparato Digestivo, Hospital Universitario Virgen del Valme, Sevilla, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiménez Vega</LastName>
            <ForeName>Francisco Javier</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad de Gestión Clínica de Cirugía General y del Aparato Digestivo, Hospital Universitario Virgen del Valme, Sevilla, España.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ortega Carrasco</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad de Gestión Clínica de Cirugía General y del Aparato Digestivo, Hospital Universitario Virgen del Valme, Sevilla, España.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>spa</Language>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Pseudohernia intercostal tras un traumatismo torácico cerrado.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Emergencias</MedlineTA>
        <NlmUniqueID>9805751</NlmUniqueID>
        <ISSNLinking>1137-6821</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909924</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909925</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1559-3908</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Emergency medicine practice</Title>
          <ISOAbbreviation>Emerg Med Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Points &amp; Pearls: Emergency department management of non-ST-segment elevation myocardial infarction</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1-e2</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nusbaum</LastName>
            <ForeName>Jeffrey</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>EMS Fellow, University of Pittsburgh Medical Center, Pittsburgh, PA</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Nachi</ForeName>
            <Initials>N</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Emerg Med Pract</MedlineTA>
        <NlmUniqueID>100889097</NlmUniqueID>
        <ISSNLinking>1524-1971</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Emerg Med Pract. 2020 Jan;22(1):1-24</RefSource>
          <PMID Version="1">31855327</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909925</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">31909926</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1549-9669</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jan</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric emergency medicine practice</Title>
          <ISOAbbreviation>Pediatr Emerg Med Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Points &amp; Pearls: Emergency department management of rash and fever in the pediatric patient</ArticleTitle>
        <Pagination>
          <MedlinePgn>e1-e2</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pade</LastName>
            <ForeName>Kathryn H.</ForeName>
            <Initials>KH</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Emergency Medicine Ultrasound Fellow, Department of Emergency Medicine, Stanford University School of Medicine, Lucile Packard Children’s Hospital, Palo Alto, CA</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Emerg Med Pract</MedlineTA>
        <NlmUniqueID>101260506</NlmUniqueID>
        <ISSNLinking>1549-9650</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Pediatr Emerg Med Pract. 2020 Jan;17(1):1-24</RefSource>
          <PMID Version="1">31855328</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31909926</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
